{
    "cot": [
        {
            "input": "3: HR, 114.0; 3: RR, 16.0; 3: SpO2, 100.0; 3: SBP, 126.0; 3: DBP, 63.0; 3: MAP, 84.0; 3: Temp, 98.2; 9: Pain, 0.0; 36: HR, 108.0; 36: RR, 18.0; 36: SpO2, 99.0; 36: SBP, 123.0; 36: DBP, 73.0; 36: MAP, 89.667; 38: SpO2, 99.0; 38: Perf, 0.32; 38: SBP, 123.0; 38: DBP, 73.0; 38: MAP, 89.667; 39: SpO2, 98.246; 39: Perf, 0.303; 40: SpO2, 98.941; 40: Perf, 0.264; 41: SpO2, 97.966; 41: Perf, 0.291; 42: SpO2, 99.070; 42: Perf, 0.266; 43: SpO2, 97.966; 43: Perf, 0.331; 44: SpO2, 98.254; 44: Perf, 0.302; 45: SpO2, 99.919; 45: Perf, 0.264; 46: SpO2, 100.0; 46: Perf, 0.251; 47: SpO2, 100.0; 47: Perf, 0.266; 48: SpO2, 100.0; 48: Perf, 0.286; 49: SpO2, 100.0; 49: Perf, 0.282; 50: SpO2, 100.0; 50: Perf, 0.297; 51: SpO2, 100.0; 51: Perf, 0.348; 52: SpO2, 99.655; 52: Perf, 0.328; 52: SBP, 110.0; 52: DBP, 73.0; 52: MAP, 85.333; 53: SpO2, 98.732; 53: Perf, 0.274; 54: SpO2, 100.0; 54: Perf, 0.534; 54: Pain, 0.0; 55: SpO2, 99.914; 55: Perf, 0.471; 56: SpO2, 99.136; 56: Perf, 0.417; 57: SpO2, 99.776; 57: Perf, 0.461; 58: SpO2, 99.559; 58: Perf, 0.428; 59: SpO2, 98.157; 59: Perf, 0.373; 60: SpO2, 99.897; 60: Perf, 0.304; 61: SpO2, 99.661; 61: Perf, 0.328; 62: SpO2, 99.0; 62: Perf, 0.323; 63: SpO2, 98.949; 63: Perf, 0.330; 64: SpO2, 99.655; 64: Perf, 0.363; 65: SpO2, 98.789; 65: Perf, 0.436; 66: WAM DIFTYP, AUTO; 66: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 66: HEMATOCRIT (HCT), 32.6 %; 66: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.11 K/uL; 66: PLATELET COUNT (PLT), 347 K/uL; 66: EOSINOPHIL % (AUTO DIFF), 0.0 %; 66: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 66: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 66: WHITE BLOOD CELLS (WBC), 12.3 K/uL; 66: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.95 K/uL; 66: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 66: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.5 g/dL; 66: MONOCYTE % (AUTO DIFF), 9.6 %; 66: LYMPHOCYTE % (AUTO DIFF), 7.7 %; 66: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 27.0 pg; 66: HEMOGLOBIN (HGB), 10.6 g/dL; 66: RED BLOOD CELLS (RBC), 3.92 MIL/uL; 66: NRBC PERCENT (HEMATOLOGY), 0.0 %; 66: BASOPHIL % (AUTO DIFF), 0.2 %; 66: RED CELL DISTRIBUTION WIDTH (RDW), 16.1 %; 66: MEAN CORPUSCULAR VOLUME (MCV), 83.2 fL; 66: MONOCYTE ABSOLUTE (AUTO DIFF), 1.18 K/uL; 66: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 66: NEUTROPHIL % (AUTO DIFF), 82.1 %; 66: HR, 104.0; 66: RR, 16.0; 66: SpO2, 99.525; 66: Perf, 0.388; 66: SBP, 103.0; 66: DBP, 63.0; 66: MAP, 76.333; 67: SpO2, 99.138; 67: Perf, 0.552; 67: SBP, 103.0; 67: DBP, 63.0; 67: MAP, 76.333; 68: SpO2, 98.729; 68: Perf, 0.543; 69: SpO2, 98.586; 69: Perf, 0.541; 70: SpO2, 98.102; 70: Perf, 0.534; 71: SpO2, 98.0; 71: Perf, 0.458; 72: SpO2, 98.0; 72: Perf, 0.475; 73: SpO2, 98.475; 73: Perf, 0.447; 74: SpO2, 98.845; 74: Perf, 0.445; 75: SpO2, 98.712; 75: Perf, 0.485; 76: SpO2, 99.271; 76: Perf, 0.767; 77: SpO2, 98.276; 77: Perf, 0.812; 78: SpO2, 98.0; 78: Perf, 0.635; 79: SpO2, 98.655; 79: Perf, 0.639; 80: SpO2, 98.153; 80: Perf, 0.571; 81: SpO2, 98.458; 81: Perf, 0.606; 82: SpO2, 98.552; 82: Perf, 0.689; 82: SBP, 100.0; 82: DBP, 60.0; 82: MAP, 73.333; 83: SpO2, 98.068; 83: Perf, 0.686; 84: SpO2, 98.879; 84: Perf, 0.740; 85: SpO2, 98.525; 85: Perf, 0.788; 86: SpO2, 99.068; 86: Perf, 0.682; 87: SpO2, 98.552; 87: Perf, 1.312; 88: SpO2, 98.0; 88: Perf, 1.848; 89: SpO2, 97.845; 89: Perf, 1.742; 90: SpO2, 97.831; 90: Perf, 1.476; 91: SpO2, 98.0; 91: Perf, 1.267; 92: SARS-COV-2 RNA, Not Detected; 92: SpO2, 98.0; 92: Perf, 1.059; 93: SpO2, 98.0; 93: Perf, 1.031; 94: SpO2, 98.0; 94: Perf, 1.012; 95: SpO2, 98.169; 95: Perf, 0.956; 96: HR, 101.0; 96: RR, 18.0; 96: SpO2, 98.914; 96: Perf, 1.175; 96: SBP, 104.0; 96: DBP, 61.0; 96: MAP, 75.333; 97: SpO2, 98.576; 97: Perf, 1.789; 97: SBP, 104.0; 97: DBP, 61.0; 97: MAP, 75.333; 98: SpO2, 98.0; 98: Perf, 1.576; 99: SpO2, 98.0; 99: Perf, 1.743; 100: SpO2, 98.712; 100: Perf, 1.520; 101: SpO2, 98.103; 101: Perf, 1.484; 102: SpO2, 97.373; 102: Perf, 1.195; 103: SpO2, 98.153; 103: Perf, 0.925; 104: SpO2, 99.586; 104: Perf, 1.084; 105: SpO2, 99.424; 105: Perf, 1.391; 106: SpO2, 98.879; 106: Perf, 1.341; 107: SpO2, 100.0; 107: Perf, 1.634; 108: CORRECTED CALCIUM, 9.3 mg/dL; 108: ALKALINE PHOSPHATASE, 222 U/L; 108: BLOOD UREA NITROGEN (BUN), 15 mg/dL; 108: ALT (SGPT), 138 U/L; 108: BILIRUBIN TOTAL, 1.9 mg/dL; 108: POTASSIUM, 3.8 mmol/L; 108: GLUCOSE, 134 mg/dL; 108: CALCIUM, 9.3 mg/dL; 108: EGFR REFIT WITHOUT RACE (2021), 79 mL/min/1.73 m2; 108: SODIUM, 131 mmol/L; 108: CHLORIDE, 94 mmol/L; 108: PROTEIN TOTAL, 7.7 g/dL; 108: AST (SGOT), 61 U/L; 108: CO2, 23 mmol/L; 108: CREATININE, 0.98 mg/dL; 108: ANION GAP, 14 mmol/L; 108: ALBUMIN, 4.0 g/dL; 108: GLOBULIN, 3.7 g/dL; 0: Age, 76; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.8; 0: Triage HR, 114.0; 0: Triage RR, 16.0; 0: Triage SBP, 126.0; 0: Triage DBP, 63.0; 0: Triage acuity, 3-Urgent; 0: CC, DEHYDRATION",
            "answer": true,
            "llm_answer": "No",
            "llm_explanation": "The time series reveals normal SpO2 levels consistently around 98-100% and steady blood pressure readings without severe hypotension or significant fluctuations, suggesting stable physiological conditions. Despite elevated HR and elevated immature granulocytes, these alone don't indicate imminent sepsis, though the high neutrophil percentage and white blood cell count might suggest an infection. However, without clear evidence of worsening vital signs or organ dysfunction emerging in the data provided, the patient is not at high risk of developing sepsis within 12 hours.",
            "claims": [
                "The time series reveals normal SpO2 levels consistently around 98-100%.",
                "The blood pressure readings are steady without severe hypotension or significant fluctuations.",
                "Stable physiological conditions are suggested by normal SpO2 levels and steady blood pressure.",
                "The heart rate (HR) is elevated.",
                "Elevated immature granulocytes are present.",
                "Elevated HR and elevated immature granulocytes do not indicate imminent sepsis.",
                "The high neutrophil percentage may suggest an infection.",
                "The white blood cell count might suggest an infection.",
                "There is no clear evidence of worsening vital signs in the data provided.",
                "There is no indication of organ dysfunction emerging in the data provided.",
                "The patient is not at high risk of developing sepsis within 12 hours."
            ],
            "relevant_claims": [
                "The heart rate (HR) is elevated.",
                "Elevated immature granulocytes are present.",
                "The high neutrophil percentage may suggest an infection.",
                "The white blood cell count might suggest an infection.",
                "There is no indication of organ dysfunction emerging in the data provided."
            ],
            "alignment_scores": [
                0.8,
                0.6,
                0.7,
                0.8,
                0.8
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SOFA Score Increase (\u22652 points)"
            ],
            "alignment_reasonings": [
                "An elevated heart rate is one of the criteria listed under SIRS, which are used to identify systemic inflammation consistent with early sepsis. Although the specific heart rate value isn't provided, an elevated HR is directly relevant to this category. However, the claim alone doesn't confirm full SIRS positivity without additional criteria.",
                "Elevated immature granulocytes suggest the presence of inflammation or infection, which is conceptually related to the systemic inflammation identified by SIRS criteria. While not explicitly listed as a SIRS criterion, immature granulocytes indicate an active response to infection, providing indirect but meaningful alignment with SIRS Positivity.",
                "A high neutrophil percentage is an indication of an inflammatory response potentially due to infection, which aligns with the concept of systemic inflammation involved in early sepsis as described by the SIRS criteria. While neutrophil percentage isn't explicitly a SIRS criterion, it is closely related to elevated white blood cells, which are part of the criteria. The alignment is relevant but indirect, warranting a moderately strong rating.",
                "The claim mentions a white blood cell count that suggests an infection. Although it does not specify whether the count is elevated or reduced, the context infers it is likely abnormal, linking it to systemic inflammation, which is a component of the SIRS criteria. However, the vagueness of \"might suggest an infection\" reduces the certainty, so the alignment is high but not perfect.",
                "The claim emphasizes the absence of organ dysfunction, which is directly relevant to the SOFA Score Increase category as it is designed to detect new organ dysfunction. The alignment is strong because the statement directly discusses organ function status, which is closely related to SOFA scores, although it is phrased negatively (absence of dysfunction)."
            ],
            "final_alignment_score": 0.7399999999999999
        },
        {
            "input": "6: HR, 72.0; 6: RR, 18.0; 6: SpO2, 95.0; 6: SBP, 140.0; 6: DBP, 96.0; 6: MAP, 110.667; 6: Pain, 8.0; 6: Temp, 98.1; 19: HR, 79.0; 19: SpO2, 92.0; 19: SBP, 140.0; 19: DBP, 96.0; 19: MAP, 110.667; 20: SpO2, 97.333; 20: SBP, 140.0; 20: DBP, 96.0; 20: MAP, 110.667; 21: SpO2, 94.026; 22: SpO2, 94.379; 22: Perf, 1.397; 23: SpO2, 95.661; 23: Perf, 1.858; 24: SpO2, 93.052; 24: Perf, 2.022; 25: SpO2, 92.220; 25: Perf, 2.138; 26: SpO2, 93.475; 26: Perf, 2.172; 27: POC PH (V) ISTAT, 7.41; 27: POC TCO2 (V) ISTAT, 26 mmol/L; 27: POC LACTATE ISTAT, 1.58 mmol/L; 27: POC PCO2 (V) ISTAT, 38.8 mmHg; 27: POC PO2 (V) ISTAT, 30 mmHg; 27: POC HCO3 (V) ISTAT, 24.6 mmol/L; 27: POC O2 SATURATION ISTAT VENOUS, 58 %; 27: POC BASE EXCESS ISTAT, 0 mmol/L; 27: SpO2, 93.879; 27: Perf, 2.195; 28: SpO2, 94.643; 28: Perf, 2.079; 29: SpO2, 93.352; 30: SpO2, 92.661; 31: SpO2, 94.458; 31: Perf, 2.148; 32: SpO2, 94.879; 32: Perf, 2.341; 33: WAM DIFTYP, AUTO; 33: WHITE BLOOD CELLS (WBC), 12.6 K/uL; 33: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 33: NEUTROPHIL % (AUTO DIFF), 83.4 %; 33: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.6 pg; 33: RED BLOOD CELLS (RBC), 4.41 MIL/uL; 33: MONOCYTE ABSOLUTE (AUTO DIFF), 0.70 K/uL; 33: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 33: NRBC PERCENT (HEMATOLOGY), 0.0 %; 33: LYMPHOCYTE % (AUTO DIFF), 10.5 %; 33: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 33: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 33: BASOPHIL % (AUTO DIFF), 0.2 %; 33: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 33: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.32 K/uL; 33: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.6 g/dL; 33: EOSINOPHIL % (AUTO DIFF), 0.0 %; 33: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.53 K/uL; 33: RED CELL DISTRIBUTION WIDTH (RDW), 13.0 %; 33: HEMATOCRIT (HCT), 40.2 %; 33: MONOCYTE % (AUTO DIFF), 5.5 %; 33: HEMOGLOBIN (HGB), 13.5 g/dL; 33: MEAN CORPUSCULAR VOLUME (MCV), 91.2 fL; 33: PLATELET COUNT (PLT), 202 K/uL; 33: SpO2, 93.881; 33: Perf, 2.597; 34: SpO2, 93.569; 34: Perf, 2.418; 35: SpO2, 93.051; 35: Perf, 2.030; 35: SBP, 82.0; 35: DBP, 71.0; 35: MAP, 74.667; 36: SpO2, 93.932; 36: Perf, 1.853; 37: SpO2, 93.707; 37: Perf, 1.826; 38: SpO2, 93.559; 38: Perf, 1.822; 39: SpO2, 93.328; 39: Perf, 1.862; 40: SpO2, 94.797; 40: Perf, 2.180; 41: SpO2, 92.729; 41: Perf, 2.138; 42: SpO2, 93.586; 42: Perf, 2.102; 43: SpO2, 93.847; 43: Perf, 2.15; 44: SpO2, 92.397; 44: Perf, 2.078; 45: SpO2, 91.271; 45: Perf, 2.132; 46: SpO2, 90.793; 46: Perf, 2.216; 47: SpO2, 91.237; 47: Perf, 2.514; 48: SpO2, 91.983; 48: Perf, 2.57; 49: HR, 70.0; 49: SpO2, 92.914; 49: Perf, 2.288; 50: SpO2, 91.746; 50: Perf, 2.022; 51: SpO2, 92.879; 51: Perf, 2.147; 52: SpO2, 93.203; 52: Perf, 2.179; 53: SpO2, 92.203; 53: Perf, 2.168; 54: SpO2, 93.672; 54: Perf, 2.118; 55: SpO2, 93.373; 55: Perf, 2.159; 56: SpO2, 92.810; 56: Perf, 2.301; 57: SpO2, 92.780; 57: Perf, 2.435; 58: SpO2, 93.441; 58: Perf, 2.373; 59: SpO2, 92.414; 59: Perf, 2.294; 60: SpO2, 93.237; 60: Perf, 2.240; 61: SpO2, 93.138; 61: Perf, 1.998; 62: SpO2, 93.017; 62: Perf, 2.243; 63: SpO2, 94.136; 63: Perf, 2.593; 64: HR, 67.0; 64: SpO2, 94.828; 64: Perf, 2.848; 64: SBP, 122.0; 64: DBP, 80.0; 64: MAP, 94.0; 65: SpO2, 93.034; 65: Perf, 2.602; 65: SBP, 122.0; 65: DBP, 80.0; 65: MAP, 94.0; 66: SpO2, 91.948; 66: Perf, 2.722; 67: SpO2, 93.973; 67: Perf, 2.708; 68: ANION GAP, 14 mmol/L; 68: ALT (SGPT), 19 U/L; 68: CO2, 22 mmol/L; 68: ALBUMIN, 4.3 g/dL; 68: ALKALINE PHOSPHATASE, 63 U/L; 68: GLOBULIN, 3.1 g/dL; 68: BLOOD UREA NITROGEN (BUN), 17 mg/dL; 68: BILIRUBIN TOTAL, 0.9 mg/dL; 68: AST (SGOT), 23 U/L; 68: CALCIUM, 9.8 mg/dL; 68: CREATININE, 1.24 mg/dL; 68: POTASSIUM, 4.0 mmol/L; 68: EGFR REFIT WITHOUT RACE (2021), 56 mL/min/1.73 m2; 68: PROTEIN TOTAL, 7.4 g/dL; 68: CORRECTED CALCIUM, 9.6 mg/dL; 68: CHLORIDE, 96 mmol/L; 68: SODIUM, 132 mmol/L; 68: GLUCOSE, 124 mg/dL; 68: LIPASE, 41 U/L; 87: IOPAMIDOL, 76 % IV SOLN (RADIOLOGY) 500 ML; 94: HR:, 68.0; 94: RR, 17.0; 94: SpO2, 93.448; 94: SBP, 134.0; 94: DBP, 69.0; 94: MAP, 90.667; 94: Pain, 0.0; 95: SpO2, 93.576; 95: SBP, 134.0; 95: DBP, 69.0; 95: MAP, 90.667; 96: SpO2, 93.862; 96: Perf, 2.867; 97: SpO2, 92.644; 97: Perf, 3.977; 98: SpO2, 92.534; 98: Perf, 4.487; 99: SpO2, 92.305; 99: Perf, 4.551; 100: SpO2, 91.542; 100: Perf, 4.468; 101: SpO2, 91.603; 101: Perf, 3.958; 102: SpO2, 90.678; 102: Perf, 4.415; 103: SpO2, 90.259; 103: Perf, 4.996; 104: SpO2, 90.729; 104: Perf, 5.183; 105: SpO2, 90.847; 105: Perf, 5.788; 106: SpO2, 92.966; 106: Perf, 3.739; 107: SpO2, 92.966; 107: Perf, 2.844; 108: SpO2, 94.069; 108: Perf, 2.802; 109: SpO2, 94.610; 109: Perf, 2.876; 110: SpO2, 95.345; 110: Perf, 2.937; 111: SpO2, 95.203; 111: Perf, 2.839; 112: SpO2, 94.814; 112: Perf, 2.809; 113: SpO2, 95.586; 113: Perf, 2.783; 114: SpO2, 95.254; 114: Perf, 2.725; 115: SpO2, 93.931; 115: Perf, 2.339; 116: SpO2, 90.983; 116: Perf, 2.184; 116: LR IV BOLUS -, 500 ML; 117: SpO, 2: 91.220; 117: Perf, 2.278; 118: SpO2, 91.534; 118: Perf, 2.451; 119: SpO2, 91.763; 119: Perf, 2.482; 0: Age, 88; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 72.0; 0: Triage RR, 18.0; 0: Triage SBP, 140.0; 0: Triage DBP, 96.0; 0: Triage acuity, 3-Urgent; 0: CC, ABDOMINAL PAIN",
            "answer": false,
            "llm_answer": "Yes",
            "llm_explanation": "The patient demonstrates concerning signs of deteriorating oxygen saturation (SpO2) levels that are consistently below 94% and show a progressive decline, with several readings below 92%. The hypotensive episode at Time 35.0 (SBP of 82, DBP of 71) also indicates potential sepsis-related shock, particularly when combined with consistently high perfusion index (Perf) values that can suggest increased peripheral perfusion typically seen with vasodilation in sepsis. Additionally, the patient's age (88 years old) and current symptoms of high abdominal pain contribute significantly to a high risk of sepsis.",
            "claims": [
                "The patient demonstrates concerning signs of deteriorating oxygen saturation (SpO2) levels.",
                "The SpO2 levels are consistently below 94%.",
                "The SpO2 levels show a progressive decline.",
                "Several SpO2 readings are below 92%.",
                "The patient experienced a hypotensive episode at Time 35.0.",
                "The patient's systolic blood pressure (SBP) is 82.",
                "The patient's diastolic blood pressure (DBP) is 71.",
                "The hypotensive episode indicates potential sepsis-related shock.",
                "High perfusion index (Perf) values suggest increased peripheral perfusion.",
                "Increased peripheral perfusion is typically seen with vasodilation in sepsis.",
                "The patient's age is 88 years old.",
                "The patient's current symptoms include high abdominal pain.",
                "The patient's age and symptoms contribute significantly to a high risk of sepsis."
            ],
            "relevant_claims": [
                "The patient demonstrates concerning signs of deteriorating oxygen saturation (SpO2) levels.",
                "The SpO2 levels show a progressive decline.",
                "Several SpO2 readings are below 92%.",
                "Increased peripheral perfusion is typically seen with vasodilation in sepsis.",
                "The patient's age is 88 years old.",
                "The patient's age and symptoms contribute significantly to a high risk of sepsis."
            ],
            "alignment_scores": [
                0.7,
                0.7,
                0.7,
                0.4,
                1.0,
                0.7
            ],
            "alignment_category": [
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "Elevated Shock Index (\u22651.0)",
                "Elderly Susceptibility (Age \u226565 years)",
                "Elderly Susceptibility (Age \u226565 years)"
            ],
            "alignment_reasonings": [
                "The claim about deteriorating oxygen saturation aligns with the SOFA score component related to impaired respiratory function (e.g., PaO\u2082/FiO\u2082). While SpO2 levels are not directly measured by the SOFA criteria, they are indicative of potential issues with blood oxygenation, which are relevant to respiratory components of SOFA. Thus, there is a moderate alignment with the SOFA category based on the connection to potential organ dysfunction.",
                "A progressive decline in SpO2 levels can be indicative of impaired oxygenation, which is conceptually related to the respiratory component of the SOFA score (e.g., PaO\u2082/FiO\u2082 < 300). While SpO2 is not a direct measure in the SOFA criteria, the decline suggests a potential worsening of respiratory function that could contribute to an increase in SOFA score. Thus, the alignment is indirect but significant.",
                "SpO2 readings below 92% suggest impaired oxygenation, which is conceptually related to assessments like PaO\u2082/FiO\u2082 used in the SOFA score to indicate respiratory dysfunction. Although SpO2 isn\u2019t directly used in the SOFA score, it nevertheless signifies potential organ dysfunction, aligning the claim moderately well with the category.",
                "The claim about increased peripheral perfusion due to vasodilation in sepsis loosely aligns with the concept of hemodynamic instability, which the Elevated Shock Index category measures. Vasodilation can lead to altered blood pressure and heart rate, components reflected in the shock index. However, the claim does not directly mention heart rate or systolic blood pressure, so the alignment is indirect and not very strong.",
                "The claim directly specifies that the patient is 88 years old, which aligns perfectly with the Elderly Susceptibility category since being aged 65 years or older is identified as a strong risk factor for rapid sepsis progression and higher mortality.",
                "The claim references the patient's age as a significant contributor to a high risk of sepsis, which aligns with the 'Elderly Susceptibility' category if the age is indeed 65 years or older. While the specific age is not provided, the general reference to age suggests some alignment with this category. The mention of unspecified symptoms adds some ambiguity, hence why the alignment is not rated higher. If more information were provided about the symptoms and age, this could affect the chosen category and rating."
            ],
            "final_alignment_score": 0.6999999999999998
        },
        {
            "input": "7: HR, 122.0; 7: RR, 19.0; 7: SpO2, 96.0; 7: SBP, 141.0; 7: DBP, 99.0; 7: MAP, 113.0; 7: Temp, 101.7; 10: Pain, 5.0; 25: SpO2, 97.0; 28: SpO2, 95.0; 29: SpO2, 95.847; 29: Perf, 2.744; 30: SpO2, 96.0; 30: Perf, 2.426; 31: SpO2, 96.276; 31: Perf, 1.912; 32: SpO2, 95.508; 32: Perf, 2.054; 33: SpO2, 95.448; 33: Perf, 2.287; 34: SpO2, 95.0; 34: Perf, 2.120; 35: SpO2, 95.0; 35: Perf, 2.073; 36: SpO2, 94.931; 36: Perf, 2.025; 37: SpO2, 94.831; 37: Perf, 2.353; 38: SpO2, 94.948; 38: Perf, 2.507; 39: SpO2, 94.746; 39: Perf, 2.149; 40: SpO2, 94.793; 40: Perf, 2.478; 41: SpO2, 93.763; 41: Perf, 2.571; 41: SBP, 161.0; 41: DBP, 79.0; 41: MAP, 106.333; 42: SpO2, 94.458; 42: Perf, 2.453; 43: SpO2, 93.948; 43: Perf, 2.944; 44: SpO2, 93.915; 44: Perf, 3.298; 45: SpO2, 94.586; 45: Perf, 2.991; 46: SpO2, 93.441; 46: Perf, 2.730; 47: SpO2, 93.568; 47: Perf, 1.832; 48: SpO2, 94.576; 49: SpO2, 94.492; 49: Perf, 1.823; 50: SpO2, 94.259; 50: Perf, 1.940; 50: Pain, 0.0; 51: SpO2, 94.203; 51: Perf, 1.974; 52: SpO2, 93.780; 52: Perf, 1.835; 53: SpO2, 92.672; 53: Perf, 1.057; 54: SpO2, 92.034; 54: Perf, 1.235; 55: SpO2, 92.276; 55: Perf, 1.395; 56: SpO2, 93.237; 56: Perf, 1.808; 57: SpO2, 94.525; 57: Perf, 2.943; 58: SpO2, 94.190; 58: Perf, 4.109; 59: SpO2, 94.237; 59: Perf, 3.728; 60: SpO2, 94.103; 60: Perf, 3.958; 61: SpO2, 94.339; 61: Perf, 3.283; 62: SpO2, 95.085; 62: Perf, 2.947; 63: POC PH (V) ISTAT, 7.45; 63: POC O2 SATURATION ISTAT VENOUS, 73 %; 63: POC PCO2 (V) ISTAT, 36.4 mmHg; 63: POC TCO2 (V) ISTAT, 26 mmol/L; 63: POC PO2 (V) ISTAT, 37 mmHg; 63: POC HCO3 (V) ISTAT, 25.3 mmol/L; 63: POC BASE EXCESS ISTAT, 1 mmol/L; 63: POC LACTATE ISTAT, 2.11 mmol/L; 63: SpO2, 94.828; 63: Perf, 2.951; 64: SpO2, 94.729; 64: Perf, 2.876; 65: SpO2, 94.224; 65: Perf, 2.912; 66: SpO2, 94.068; 66: Perf, 2.771; 67: SpO2, 94.0; 67: Perf, 2.611; 68: SpO2, 93.793; 68: Perf, 2.431; 69: SpO2, 93.627; 69: Perf, 2.341; 70: SpO2, 93.828; 70: Perf, 2.342; 70: Pain, 10.0; 71: SpO2, 93.729; 71: Perf, 2.431; 72: SpO2, 93.879; 72: Perf, 2.424; 73: SpO2, 93.831; 73: Perf, 2.465; 74: SpO2, 94.508; 74: Perf, 2.437; 75: SpO2, 94.483; 75: Perf, 2.640; 76: SpO2, 94.407; 76: Perf, 2.442; 77: SpO2, 93.879; 77: Perf, 2.260; 78: SpO2, 93.424; 78: Perf, 2.185; 79: SpO2, 93.085; 79: Perf, 2.197; 80: SpO2, 93.517; 80: Perf, 2.056; 81: SpO2, 93.322; 81: Perf, 2.152; 82: SpO2, 93.931; 82: Perf, 2.176; 82: ACETAMINOPHEN, 500 MG PO TABS; 83: SpO, 2: 93.831; 83: Perf, 2.772; 84: SpO2, 94.034; 84: Perf, 2.811; 85: SpO2, 93.310; 85: Perf, 1.924; 85: LR IV BOLUS -, 1000 ML; 86: SpO, 2: 92.949; 86: Perf, 1.520; 87: SpO2, 93.190; 87: Perf, 1.522; 88: SpO2, 93.492; 88: Perf, 1.592; 89: SpO2, 94.102; 89: Perf, 2.008; 90: HR, 112.263; 90: RR, 24.941; 90: SpO2, 94.241; 90: Perf, 2.526; 90: 1min HRV, 2.278; 90: 5min HRV, 2.278; 91: HR, 112.797; 91: RR, 25.695; 91: SpO2, 94.0; 91: Perf, 2.527; 91: 1min HRV, 2.096; 92: HR, 112.810; 92: RR, 25.328; 92: SpO2, 94.828; 92: Perf, 2.403; 92: 1min HRV, 1.882; 93: HR, 112.898; 93: RR, 25.864; 93: SpO2, 95.0; 93: Perf, 2.415; 93: 1min HRV, 1.685; 94: HR, 112.305; 94: RR, 24.356; 94: SpO2, 94.831; 94: Perf, 2.243; 94: 1min HRV, 3.770; 95: HR, 112.052; 95: RR, 24.569; 95: SpO2, 95.0; 95: Perf, 2.181; 95: 1min HRV, 1.974; 95: 5min HRV, 2.747; 96: HR, 112.237; 96: RR, 25.051; 96: SpO2, 94.847; 96: Perf, 2.044; 96: 1min HRV, 1.699; 97: HR, 112.172; 97: RR, 23.862; 97: SpO2, 95.672; 97: Perf, 2.615; 97: 1min HRV, 1.409; 100: 5min HRV, 1.576; 105: ALT (SGPT), 91 U/L; 105: SODIUM, 135 mmol/L; 105: ANION GAP, 13 mmol/L; 105: ALKALINE PHOSPHATASE, 48 U/L; 105: ALBUMIN, 3.4 g/dL; 105: AST (SGOT), 64 U/L; 105: PROTEIN TOTAL, 7.1 g/dL; 105: CREATININE, 1.13 mg/dL; 105: CHLORIDE, 99 mmol/L; 105: POTASSIUM, 4.3 mmol/L; 105: CO2, 23 mmol/L; 105: BLOOD UREA NITROGEN (BUN), 22 mg/dL; 105: EGFR REFIT WITHOUT RACE (2021), 58 mL/min/1.73 m2; 105: GLOBULIN, 3.7 g/dL; 105: CALCIUM, 9.0 mg/dL; 105: GLUCOSE, 203 mg/dL; 105: CORRECTED CALCIUM, 9.5 mg/dL; 105: BILIRUBIN TOTAL, 0.7 mg/dL; 115: C-REACTIVE PROTEIN (CRP), 7.0 mg/dL; 115: Pain, 10.0; 119: WHITE BLOOD CELLS (WBC), 5.0 K/uL; 119: HEMOGLOBIN (HGB), 12.6 g/dL; 119: MEAN CORPUSCULAR VOLUME (MCV), 91.8 fL; 119: RED CELL DISTRIBUTION WIDTH (RDW), 13.2 %; 119: HEMATOCRIT (HCT), 37.0 %; 119: PLATELET COUNT (PLT), 115 K/uL; 119: RED BLOOD CELLS (RBC), 4.03 MIL/uL; 119: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.1 g/dL; 119: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.3 pg; 119: BASOPHILS ABSOLUTE (MANUAL DIFF), 0.05 K/uL; 119: EOSINOPHILS ABSOLUTE (MANUAL DIFF), 0.52 K/uL; 119: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 0.18 K/uL; 119: METAMYELOCYTES % (MANUAL DIFF), 0.9 %; 119: BASOPHILS % (MANUAL DIFF), 0.9 %; 119: MONOCYTES ABSOLUTE (MANUAL DIFF), 0.26 K/uL; 119: LYMPHOCYTES % (MANUAL DIFF), 3.5 %; 119: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 48.7 %; 119: EOSINOPHILS % (MANUAL DIFF), 10.4 %; 119: MONOCYTES % (MANUAL DIFF), 5.2 %; 119: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 3.98 K/uL; 119: METAMYELOCYTES ABSOLUTE (MANUAL DIFF), 0.05 K/uL; 119: NEUTROPHILS BANDS % (MANUAL DIFF), 30.4 %; 0: Age, 55; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 38.7; 0: Triage HR, 122.0; 0: Triage RR, 19.0; 0: Triage SBP, 141.0; 0: Triage DBP, 99.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER,COUGH",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient is at high risk of developing sepsis as indicated by the elevated heart rate (HR) consistently over 110 beats per minute and respiratory rate (RR) above normal, coupled with fever (high temperature initially at 38.7\u00b0C/101.7\u00b0F), and a high level of lactate (2.11 mmol/L) indicating possible infection or metabolic distress. The elevated C-reactive protein (CRP) and a high band count suggest an inflammatory response, which could be indicative of sepsis. Additionally, the patient has received a lactated ringer IV bolus, a common intervention suggesting the medical team is managing potential sepsis or a serious condition.",
            "claims": [
                "The patient is at high risk of developing sepsis.",
                "The patient has an elevated heart rate (HR) consistently over 110 beats per minute.",
                "A heart rate consistently over 110 beats per minute is considered elevated.",
                "The patient has a respiratory rate (RR) above normal.",
                "The patient has a fever with a high temperature initially at 38.7\u00b0C (101.7\u00b0F).",
                "A high temperature of 38.7\u00b0C (101.7\u00b0F) indicates a fever.",
                "The patient has a high level of lactate at 2.11 mmol/L.",
                "A high level of lactate can indicate possible infection or metabolic distress.",
                "The patient has elevated C-reactive protein (CRP).",
                "An elevated C-reactive protein (CRP) level suggests an inflammatory response.",
                "The patient has a high band count.",
                "A high band count can be indicative of sepsis.",
                "The patient has received a lactated Ringer IV bolus.",
                "Receiving a lactated Ringer IV bolus is a common intervention for managing potential sepsis or a serious condition."
            ],
            "relevant_claims": [
                "The patient has an elevated heart rate (HR) consistently over 110 beats per minute.",
                "A heart rate consistently over 110 beats per minute is considered elevated.",
                "The patient has a respiratory rate (RR) above normal.",
                "The patient has a fever with a high temperature initially at 38.7\u00b0C (101.7\u00b0F).",
                "A high temperature of 38.7\u00b0C (101.7\u00b0F) indicates a fever.",
                "The patient has a high level of lactate at 2.11 mmol/L.",
                "A high level of lactate can indicate possible infection or metabolic distress.",
                "The patient has elevated C-reactive protein (CRP).",
                "An elevated C-reactive protein (CRP) level suggests an inflammatory response.",
                "A high band count can be indicative of sepsis.",
                "The patient has received a lactated Ringer IV bolus.",
                "Receiving a lactated Ringer IV bolus is a common intervention for managing potential sepsis or a serious condition."
            ],
            "alignment_scores": [
                0.8,
                0.9,
                0.8,
                0.9,
                0.8,
                1.0,
                0.8,
                0.4,
                0.3,
                0.7,
                0.3,
                0.4
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Elevated Serum Lactate (\u22652 mmol/L)"
            ],
            "alignment_reasonings": [
                "The claim references an elevated heart rate consistently over 110 beats per minute, which surpasses the SIRS criterion of a heart rate greater than 90 bpm. Thus, it directly relates to one of the SIRS criteria utilized in identifying systemic inflammation and potential early sepsis. Given that the elevated heart rate is specifically mentioned in the SIRS criteria, the alignment is strong but not complete because it mentions only one SIRS criterion, and a SIRS diagnosis requires at least two criteria.",
                "The claim describes a heart rate consistently over 110 beats per minute, which directly exceeds the SIRS criterion of a heart rate >90 bpm. This strongly aligns with the SIRS category used to identify systemic inflammation in early sepsis. The alignment is high because it meets one of the SIRS criteria, although SIRS requires two criteria for positivity, hence the rating is not a full 1.0.",
                "An elevated respiratory rate is one of the SIRS criteria (respiratory rate\u202f>\u202f20\u202f/min), which identifies systemic inflammation associated with early sepsis. Although the claim does not specify the exact value, the information suggests enough of a link to sepsis by meeting this criterion, thereby showing strong alignment with the SIRS category.",
                "The claim explicitly mentions a fever with a high temperature initially at 38.7\u00b0C, which meets one of the SIRS criteria (temperature\u202f>\u202f38\u202f\u00b0C). This indicates systemic inflammation consistent with early sepsis. The alignment is very strong, as it provides clear evidence satisfying part of the SIRS criteria. However, full alignment would require meeting at least two SIRS criteria.",
                "The claim mentions a high temperature of 38.7\u00b0C, which exceeds the 38\u00b0C threshold specified in the SIRS criteria. A fever is a critical component in identifying systemic inflammation consistent with early sepsis. Although the full SIRS criterion involves the presence of an additional criterion, the mentioned fever is a direct and significant component of the SIRS criteria, hence a high alignment rating.",
                "The claim explicitly mentions a lactate level of 2.11 mmol/L, which is directly referenced in the Elevated Serum Lactate category. This category highlights a serum lactate level of \u22652 mmol/L as an indicator of tissue hypoperfusion and a high risk of sepsis mortality, perfectly aligning with the claim.",
                "The claim pertains to elevated lactate, which is directly linked to the \"Elevated Serum Lactate\" category. Although it mentions lactate in the context of possible infection or metabolic distress, it does not specifically reference the threshold value (\u22652 mmol/L) that signifies tissue hypoperfusion in sepsis. Thus, while the connection to potential sepsis risk is clear, the absence of specific numerical evidence results in a slightly lower alignment rating.",
                "Elevated C-reactive protein (CRP) is an indicator of systemic inflammation, which aligns with the concept of SIRS criteria used to identify systemic inflammatory responses. However, CRP itself is not explicitly listed as one of the SIRS criteria, such as elevated temperature, heart rate, respiratory rate, or abnormal white blood cell counts. Therefore, while CRP suggests inflammation related to sepsis, the alignment is indirect, resulting in a moderate alignment rating.",
                "An elevated C-reactive protein (CRP) level indicates an inflammatory response but is not one of the explicit criteria listed under SIRS (temperature, heart rate, respiratory rate, or white blood cell count). While CRP elevation suggests inflammation, its connection to SIRS is indirect and not as strong as other factors. Therefore, while it hints at potential systemic inflammation, it doesn't directly contribute to a SIRS diagnosis.",
                "An increased band count, which refers to immature white blood cells, often suggests an inflammatory or infectious process that ties to systemic inflammation. While bandemia isn't explicitly part of the listed SIRS criteria, it complements an elevated white blood cell count, which is part of SIRS. The alignment is thus indirect but relevant, warranting a moderately strong rating.",
                "Administration of a lactated Ringer IV bolus often corresponds to efforts to manage dehydration or hypotension, which are situations where IV fluids are necessary. While the claim doesn't explicitly mention hypotension criteria, receiving a fluid bolus suggests attempts to correct possible haemodynamic instability, loosely aligning with sepsis-associated hypotension due to potential shock management. The alignment is indirect and speculative, with a low rating due to lack of specific information on blood pressure.",
                "The claim mentions receiving a lactated Ringer IV bolus, which is not a direct measure of serum lactate levels but is related to the management of conditions associated with elevated lactate or sepsis, such as fluid resuscitation for potential sepsis. The alignment rating is low because the claim is more about a treatment associated with managing such conditions rather than the elevated lactate itself, which is the clear risk factor listed in this category."
            ],
            "final_alignment_score": 0.6749999999999999
        },
        {
            "input": "7: HR, 144.0; 7: RR, 18.0; 7: SpO2, 98.0; 7: SBP, 152.0; 7: DBP, 98.0; 7: MAP, 116.0; 7: Temp, 97.7; 19: RR, 36.0; 83: HR, 133.739; 83: RR, 22.636; 83: 1min HRV, 10.734; 83: SBP, 156.0; 83: DBP, 109.0; 83: MAP, 124.667; 83: LR IV BOLUS -, 1000 ML; 84: HR:, 132.264; 84: RR, 25.761; 84: SpO2, 96.519; 84: 1min HRV, 12.989; 85: HR, 129.170; 85: SpO2, 96.674; 85: 1min HRV, 12.830; 85: 5min HRV, 13.946; 86: HR, 131.635; 86: SpO2, 96.712; 86: 1min HRV, 16.313; 87: HR, 129.811; 87: RR, 20.0; 87: SpO2, 96.075; 87: 1min HRV, 9.957; 88: HR, 128.827; 88: RR, 21.231; 88: SpO2, 96.596; 88: 1min HRV, 12.831; 89: HR, 126.340; 89: RR, 20.057; 89: SpO2, 97.302; 89: 1min HRV, 10.653; 90: HR, 128.415; 90: RR, 17.208; 90: SpO2, 96.358; 90: 1min HRV, 11.254; 90: 5min HRV, 13.239; 91: HR, 125.577; 91: RR, 20.981; 91: SpO2, 97.0; 91: 1min HRV, 12.190; 91: SBP, 167.0; 91: DBP, 108.0; 91: MAP, 127.667; 92: HR, 124.604; 92: RR, 16.547; 92: SpO2, 97.321; 92: 1min HRV, 12.536; 93: HR, 125.811; 93: RR, 20.660; 93: SpO2, 96.755; 93: 1min HRV, 7.732; 94: HR, 122.830; 94: RR, 22.811; 94: SpO2, 97.038; 94: 1min HRV, 16.489; 95: HR, 120.717; 95: RR, 22.849; 95: SpO2, 96.755; 95: 1min HRV, 16.859; 95: 5min HRV, 15.336; 95: SBP, 167.0; 95: DBP, 108.0; 95: MAP, 127.667; 96: HR, 121.692; 96: RR, 25.192; 96: SpO2, 96.712; 96: Perf, 0.877; 96: 1min HRV, 7.205; 97: HR, 121.679; 97: RR, 22.830; 97: SpO2, 96.264; 97: Perf, 0.895; 97: 1min HRV, 13.014; 98: HR, 120.462; 98: RR, 20.635; 98: SpO2, 96.019; 98: Perf, 0.886; 98: 1min HRV, 10.239; 99: HR, 120.056; 99: RR, 26.093; 99: SpO2, 96.037; 99: Perf, 0.836; 99: 1min HRV, 10.386; 100: HR, 119.925; 100: RR, 23.943; 100: SpO2, 95.0; 100: Perf, 0.802; 100: 1min HRV, 19.736; 100: 5min HRV, 13.378; 101: HR, 123.292; 101: RR, 19.422; 101: SpO2, 96.020; 101: Perf, 0.8; 101: 1min HRV, 26.040; 102: SARS-COV-2 RNA, Not Detected; 102: HR, 129.909; 102: RR, 25.833; 102: SpO2, 97.098; 102: Perf, 0.8; 102: 1min HRV, 15.681; 103: HR, 128.442; 103: RR, 28.347; 103: SpO2, 97.75; 103: Perf, 0.757; 103: 1min HRV, 12.615; 104: HR, 125.321; 104: RR, 28.0; 104: SpO2, 98.660; 104: Perf, 0.692; 104: 1min HRV, 7.775; 105: HR, 125.537; 105: RR, 49.0; 105: SpO2, 97.444; 105: Perf, 0.71; 105: 1min HRV, 12.504; 105: 5min HRV, 17.522; 106: HR, 124.577; 106: SpO2, 98.481; 106: Perf, 0.752; 106: 1min HRV, 10.585; 106: SBP, 172.0; 106: DBP, 120.0; 106: MAP, 137.333; 107: HR, 123.264; 107: SpO2, 98.566; 107: Perf, 0.76; 107: 1min HRV, 9.122; 108: WAM DIFTYP, AUTO; 108: HEMOGLOBIN (HGB), 13.5 g/dL; 108: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.12 K/uL; 108: BASOPHIL ABSOLUTE (AUTO DIFF), 0.12 K/uL; 108: LYMPHOCYTE % (AUTO DIFF), 9.3 %; 108: NEUTROPHIL ABSOLUTE (AUTO DIFF), 11.26 K/uL; 108: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 34.2 pg; 108: MONOCYTE ABSOLUTE (AUTO DIFF), 1.10 K/uL; 108: NEUTROPHIL % (AUTO DIFF), 80.8 %; 108: EOSINOPHIL % (AUTO DIFF), 0.2 %; 108: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 108: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.9 %; 108: BASOPHIL % (AUTO DIFF), 0.9 %; 108: HEMATOCRIT (HCT), 40.8 %; 108: WHITE BLOOD CELLS (WBC), 13.9 K/uL; 108: MONOCYTE % (AUTO DIFF), 7.9 %; 108: RED BLOOD CELLS (RBC), 3.95 MIL/uL; 108: PLATELET COUNT (PLT), 215 K/uL; 108: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.29 K/uL; 108: MEAN CORPUSCULAR VOLUME (MCV), 103.3 fL; 108: RED CELL DISTRIBUTION WIDTH (RDW), 12.8 %; 108: NRBC PERCENT (HEMATOLOGY), 0.0 %; 108: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.1 g/dL; 108: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 108: HR, 123.192; 108: SpO2, 95.923; 108: Perf, 0.761; 108: 1min HRV, 11.873; 109: HR, 124.208; 109: SpO2, 96.340; 109: Perf, 0.791; 109: 1min HRV, 4.982; 110: HR, 125.692; 110: SpO2, 96.231; 110: Perf, 0.8; 110: 1min HRV, 5.283; 110: 5min HRV, 9.970; 111: HR, 126.623; 111: SpO2, 95.642; 111: Perf, 0.8; 111: 1min HRV, 5.043; 112: HR, 126.434; 112: SpO2, 97.113; 112: Perf, 0.8; 112: 1min HRV, 11.187; 113: HR, 127.231; 113: SpO2, 97.365; 113: Perf, 0.800; 113: 1min HRV, 10.667; 114: HR, 126.415; 114: SpO2, 97.868; 114: Perf, 0.876; 114: 1min HRV, 6.807; 115: HR, 126.096; 115: SpO2, 96.65; 115: Perf, 0.883; 115: 1min HRV, 6.921; 115: 5min HRV, 8.705; 116: HR, 121.943; 116: SpO2, 95.358; 116: Perf, 0.908; 116: 1min HRV, 6.774; 117: HR, 121.593; 117: SpO2, 94.630; 117: Perf, 0.94; 117: 1min HRV, 6.756; 118: HR, 122.365; 118: SpO2, 96.283; 118: Perf, 0.94; 118: 1min HRV, 3.852; 119: HR, 123.075; 119: SpO2, 97.302; 119: Perf, 0.950; 119: 1min HRV, 5.567; 0: Age, 52; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.5; 0: Triage HR, 144.0; 0: Triage RR, 18.0; 0: Triage SBP, 152.0; 0: Triage DBP, 98.0; 0: Triage acuity, 2-Emergent; 0: CC, EAR PAIN",
            "answer": true,
            "llm_answer": "No",
            "llm_explanation": "The patient presents with changes in heart rate and respiratory rate, but there is no significant drop in blood pressure or SpO2 levels that would indicate organ dysfunction typical of sepsis. The HR and RR are elevated, which can suggest stress or pain, but these alone do not confirm sepsis without more signs like fever or altered mental status. Moreover, lab markers such as white blood cells, though elevated, are not conclusive without accompanying clinical signs. Without clear evidence of infection and organ failure, the risk of sepsis appears low within the next 12 hours.",
            "claims": [
                "The patient presents with changes in heart rate and respiratory rate.",
                "There is no significant drop in blood pressure.",
                "There is no significant drop in SpO2 levels.",
                "A significant drop in blood pressure would indicate organ dysfunction typical of sepsis.",
                "The heart rate (HR) is elevated.",
                "The respiratory rate (RR) is elevated.",
                "Elevated HR and RR can suggest stress or pain.",
                "Elevated HR and RR alone do not confirm sepsis.",
                "More signs like fever or altered mental status are necessary to confirm sepsis.",
                "Lab markers such as white blood cells can be elevated.",
                "Elevated white blood cells are not conclusive without accompanying clinical signs.",
                "Without clear evidence of infection, the risk of sepsis appears low.",
                "Without evidence of organ failure, the risk of sepsis appears low.",
                "The risk of sepsis appears low within the next 12 hours."
            ],
            "relevant_claims": [
                "The patient presents with changes in heart rate and respiratory rate.",
                "There is no significant drop in blood pressure.",
                "The heart rate (HR) is elevated.",
                "The respiratory rate (RR) is elevated.",
                "Elevated HR and RR can suggest stress or pain."
            ],
            "alignment_scores": [
                0.8,
                0.3,
                0.8,
                0.7,
                0.3
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "SIRS Positivity (\u22652 Criteria)",
                "High qSOFA Score (\u22652)",
                "SIRS Positivity (\u22652 Criteria)"
            ],
            "alignment_reasonings": [
                "The claim mentions changes in heart rate and respiratory rate, both of which are criteria under SIRS (heart rate >90 bpm, respiratory rate >20/min). This suggests systemic inflammation consistent with early sepsis. While the claim does not specify whether the criteria thresholds are met, it aligns well with the SIRS category. Thus, the alignment rating is high but not maximum, as specific values are not provided.",
                "The claim relates to blood pressure stability, which is associated with the category of sepsis-associated hypotension. However, the claim indicates that there's no significant drop in blood pressure, contrasting with the hypotension definition in the category. Thus, there is a low but relevant alignment as it confirms the absence of a key risk factor.",
                "An elevated heart rate is one of the criteria listed under SIRS, which are used to identify systemic inflammation consistent with early sepsis. Although the specific heart rate value isn't provided, an elevated HR is directly relevant to this category. However, the claim alone doesn't confirm full SIRS positivity without additional criteria.",
                "An elevated respiratory rate aligns with one of the criteria in the qSOFA score, specifically indicating a respiratory rate of \u226522/min. This is a direct factor in assessing sepsis risk through qSOFA. While the claim indicates elevated RR, it does not specify the exact value, slightly reducing the certainty and strength of alignment. However, it still fits well within the High qSOFA Score category, reflecting significant risk if the threshold is met.",
                "Elevated heart rate (HR) and respiratory rate (RR) are components of the SIRS criteria, which indicate systemic inflammation potentially due to infection. However, the claim suggests stress or pain instead of systemic inflammatory response, which weakens the alignment with sepsis prediction. The relationship is indirect, thus a lower alignment rating is appropriate."
            ],
            "final_alignment_score": 0.58
        },
        {
            "input": "4: HR, 110.0; 4: RR, 20.0; 4: SpO2, 95.0; 4: SBP, 121.0; 4: DBP, 75.0; 4: MAP, 90.333; 4: LPM O2, 2.0; 4: Pain, 9.0; 4: Temp, 101.0; 8: HR, 110.423; 8: SpO2, 97.286; 8: 1min HRV, 6.363; 9: HR, 109.491; 9: SpO2, 95.462; 9: 1min HRV, 7.100; 9: 5min HRV, 7.163; 10: HR, 109.019; 10: SpO2, 93.042; 10: 1min HRV, 5.598; 11: HR, 108.231; 11: SpO2, 100.0; 11: 1min HRV, 6.479; 12: HR, 108.057; 12: SpO2, 97.25; 12: 1min HRV, 6.938; 13: HR, 107.808; 13: SpO2, 92.0; 13: 1min HRV, 6.788; 14: HR, 108.057; 14: 1min HRV, 6.794; 14: 5min HRV, 6.848; 15: HR, 107.642; 15: 1min HRV, 8.627; 16: HR, 106.577; 16: SpO2, 100.0; 16: 1min HRV, 5.616; 17: HR, 106.736; 17: SpO2, 100.0; 17: 1min HRV, 8.881; 18: HR, 106.404; 18: SpO2, 100.0; 18: 1min HRV, 6.987; 19: HR, 106.660; 19: SpO2, 95.0; 19: 1min HRV, 5.812; 19: 5min HRV, 7.624; 20: HR, 104.981; 20: SpO2, 93.7; 20: 1min HRV, 5.233; 21: HR, 105.113; 21: SpO2, 86.75; 21: 1min HRV, 4.250; 22: HR, 104.981; 22: 1min HRV, 6.263; 23: HR, 104.904; 23: 1min HRV, 5.129; 24: HR, 105.264; 24: 1min HRV, 6.084; 24: 5min HRV, 5.666; 25: HR, 106.077; 25: 1min HRV, 3.849; 26: HR, 106.283; 26: 1min HRV, 4.909; 27: HR, 105.660; 27: SpO2, 99.5; 27: 1min HRV, 5.928; 27: LR IV BOLUS -, 1000 ML; 28: HR:, 106.038; 28: SpO2, 100.0; 28: 1min HRV, 6.198; 28: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 29: HR:, 105.585; 29: SpO2, 100.0; 29: 1min HRV, 6.069; 29: 5min HRV, 5.721; 30: HR, 104.827; 30: 1min HRV, 6.000; 30: ACETAMINOPHEN, 1 000 MG/100 ML (10 MG/ML) IV SOLN; 31: HR:, 104.113; 31: 1min HRV, 5.008; 32: HR, 103.811; 32: 1min HRV, 4.507; 33: HR, 103.962; 33: 1min HRV, 5.163; 34: HR, 103.302; 34: SpO2, 97.0; 34: 1min HRV, 4.079; 34: 5min HRV, 5.647; 35: HR, 103.019; 35: SpO2, 99.0; 35: 1min HRV, 4.333; 36: HR, 104.208; 36: SpO2, 98.2; 36: 1min HRV, 4.511; 37: HR, 103.283; 37: SpO2, 97.0; 37: 1min HRV, 4.111; 38: HR, 103.192; 38: SpO2, 96.591; 38: 1min HRV, 8.164; 39: HR, 102.094; 39: SpO2, 100.0; 39: 1min HRV, 4.334; 39: 5min HRV, 6.205; 40: HR, 102.769; 40: SpO2, 100.0; 40: 1min HRV, 4.169; 41: HR, 103.019; 41: SpO2, 97.667; 41: 1min HRV, 4.208; 42: HR, 103.0; 42: SpO2, 100.0; 42: 1min HRV, 3.939; 43: HR, 102.269; 43: SpO2, 100.0; 43: 1min HRV, 4.882; 44: HR, 102.811; 44: SpO2, 100.0; 44: 1min HRV, 4.287; 44: 5min HRV, 4.601; 45: HR, 102.308; 45: SpO2, 99.922; 45: Perf, 0.195; 45: 1min HRV, 4.202; 49: 5min HRV, 4.202; 53: POC PH (V) ISTAT, 7.38; 53: POC LACTATE ISTAT, 0.60 mmol/L; 53: POC HCO3 (V) ISTAT, 27.6 mmol/L; 53: POC PO2 (V) ISTAT, 31 mmHg; 53: POC PCO2 (V) ISTAT, 46.3 mmHg; 53: POC BASE EXCESS ISTAT, 3 mmol/L; 53: POC O2 SATURATION ISTAT VENOUS, 59 %; 53: POC TCO2 (V) ISTAT, 29 mmol/L; 64: RSV, Not Detected; 64: SARS-COV-2 RNA, Not Detected; 64: INFLUENZA A, Not Detected; 64: INFLUENZA B, Not Detected; 65: WAM DIFTYP, AUTO; 65: LYMPHOCYTE % (AUTO DIFF), 4.8 %; 65: PLATELET COUNT (PLT), 100 K/uL; 65: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 65: RED BLOOD CELLS (RBC), 2.91 MIL/uL; 65: RED CELL DISTRIBUTION WIDTH (RDW), 14.2 %; 65: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.3 g/dL; 65: BASOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 65: BASOPHIL % (AUTO DIFF), 0.1 %; 65: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.39 K/uL; 65: HEMATOCRIT (HCT), 27.9 %; 65: NEUTROPHIL ABSOLUTE (AUTO DIFF), 7.41 K/uL; 65: MONOCYTE % (AUTO DIFF), 3.8 %; 65: MONOCYTE ABSOLUTE (AUTO DIFF), 0.31 K/uL; 65: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 32.0 pg; 65: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 65: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 65: HEMOGLOBIN (HGB), 9.3 g/dL; 65: MEAN CORPUSCULAR VOLUME (MCV), 95.9 fL; 65: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 65: EOSINOPHIL % (AUTO DIFF), 0.0 %; 65: NEUTROPHIL % (AUTO DIFF), 90.9 %; 65: NRBC PERCENT (HEMATOLOGY), 0.0 %; 65: WHITE BLOOD CELLS (WBC), 8.2 K/uL; 78: INR, 1.1; 78: PROTHROMBIN TIME, 14.0 seconds; 79: PART. THROMBOPLASTIN TIME, 35.6 seconds; 99: CALCIUM, 8.6 mg/dL; 99: AST (SGOT), 47 U/L; 99: BLOOD UREA NITROGEN (BUN), 25 mg/dL; 99: PROTEIN TOTAL, 6.5 g/dL; 99: BILIRUBIN TOTAL, 0.3 mg/dL; 99: POTASSIUM, 3.5 mmol/L; 99: CORRECTED CALCIUM, 8.9 mg/dL; 99: GLOBULIN, 2.9 g/dL; 99: ANION GAP, 11 mmol/L; 99: ALKALINE PHOSPHATASE, 134 U/L; 99: GLUCOSE, 156 mg/dL; 99: EGFR REFIT WITHOUT RACE (2021), 101 mL/min/1.73 m2; 99: CREATININE, 0.56 mg/dL; 99: SODIUM, 133 mmol/L; 99: CHLORIDE, 97 mmol/L; 99: CO2, 25 mmol/L; 99: LIPASE, 19 U/L; 99: ALT (SGPT), 45 U/L; 99: ALBUMIN, 3.6 g/dL; 103: HR, 95.0; 103: SpO2, 100.0; 103: SBP, 97.0; 103: DBP, 66.0; 103: MAP, 76.333; 103: LPM O2, 2.0; 103: Pain, 8.0; 103: Temp, 99.3; 104: KETAMINE, IVPB (ED/CDU PAIN INDICATION); 119: HR:, 91.0; 119: SpO2, 100.0; 119: SBP, 96.0; 119: DBP, 65.0; 119: MAP, 75.333; 119: LPM O2, 2.0; 119: Pain, 3.0; 0: Age, 65; 0: Gender, F; 0: Race, White; 0: Means of arrival, EMS; 0: Triage Temp, 38.3; 0: Triage HR, 110.0; 0: Triage RR, 20.0; 0: Triage SBP, 121.0; 0: Triage DBP, 75.0; 0: Triage acuity, 2-Emergent; 0: CC, VOMITING",
            "answer": true,
            "llm_answer": "No",
            "llm_explanation": "The patient's vital signs and lab results are generally stable. The heart rate is elevated but mostly stable, and while there are fluctuations in HRV and SpO2, severe sepsis indicators like low blood pressure, increased lactate levels, or significant respiratory distress are not present. The patient received fluids and medication, possibly suggesting dehydration or pain management rather than sepsis. Overall, there are no strong indicators of a high risk of developing sepsis within the next 12 hours.",
            "claims": [
                "The patient's vital signs and lab results are generally stable.",
                "The heart rate is elevated but mostly stable.",
                "There are fluctuations in HRV and SpO2.",
                "Severe sepsis indicators are not present.",
                "Severe sepsis indicators include low blood pressure.",
                "Severe sepsis indicators include increased lactate levels.",
                "Severe sepsis indicators include significant respiratory distress.",
                "The patient received fluids and medication.",
                "The fluids and medication may suggest dehydration.",
                "The fluids and medication may suggest pain management.",
                "The fluids and medication do not strongly indicate sepsis.",
                "Overall, there are no strong indicators of a high risk of developing sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "Severe sepsis indicators are not present."
            ],
            "alignment_scores": [
                0.3
            ],
            "alignment_category": [
                "SOFA Score Increase (\u22652 points)"
            ],
            "alignment_reasonings": [
                "The claim suggests the absence of severe sepsis indicators, which indirectly points to no significant increase in organ dysfunction. SOFA Score is a tool for assessing organ dysfunction in sepsis. The lack of severe sepsis indicators can imply there isn't an increase in SOFA score, but this is inferred rather than directly related to evidence from the claim, resulting in a lower alignment."
            ],
            "final_alignment_score": 0.3
        },
        {
            "input": "2: HR, 130.0; 2: RR, 18.0; 2: SpO2, 99.0; 2: SBP, 150.0; 2: DBP, 80.0; 2: MAP, 103.333; 2: Temp, 100.8; 49: POC PH (V) ISTAT, 7.43; 49: POC TCO2 (V) ISTAT, 28 mmol/L; 49: POC PO2 (V) ISTAT, 32 mmHg; 49: POC BASE EXCESS ISTAT, 2 mmol/L; 49: POC LACTATE ISTAT, 1.79 mmol/L; 49: POC O2 SATURATION ISTAT VENOUS, 63 %; 49: POC HCO3 (V) ISTAT, 26.6 mmol/L; 49: POC PCO2 (V) ISTAT, 40.5 mmHg; 57: SpO2, 98.706; 58: HR, 115.429; 58: RR, 34.846; 58: SpO2, 98.917; 58: Perf, 0.15; 58: 1min HRV, 7.583; 59: HR, 114.293; 59: RR, 21.190; 59: SpO2, 98.792; 59: Perf, 0.15; 59: 1min HRV, 10.194; 60: HR, 111.712; 60: RR, 19.220; 60: SpO2, 98.419; 60: 1min HRV, 7.770; 60: 5min HRV, 10.260; 60: Temp, 99.8; 61: HR, 113.948; 61: RR, 20.172; 61: SpO2, 97.979; 61: 1min HRV, 12.083; 62: HR, 111.25; 62: RR, 19.85; 62: SpO2, 99.909; 62: Perf, 0.12; 62: 1min HRV, 8.237; 63: HR, 112.828; 63: RR, 19.5; 63: SpO2, 100.0; 63: Perf, 0.08; 63: 1min HRV, 9.478; 64: HR, 115.017; 64: RR, 21.339; 64: SpO2, 99.333; 64: Perf, 0.087; 64: 1min HRV, 9.341; 65: HR, 113.879; 65: RR, 18.155; 65: SpO2, 98.75; 65: Perf, 0.1; 65: 1min HRV, 9.050; 65: 5min HRV, 11.233; 66: HR, 112.610; 66: RR, 19.169; 66: SpO2, 93.7; 66: 1min HRV, 7.226; 67: HR, 109.241; 67: RR, 20.914; 67: SpO2, 97.846; 67: 1min HRV, 16.590; 68: HR, 109.780; 68: RR, 25.322; 68: SpO2, 100.0; 68: 1min HRV, 6.405; 69: HR, 115.678; 69: RR, 21.390; 69: SpO2, 97.6; 69: 1min HRV, 13.991; 70: HR, 119.172; 70: RR, 24.172; 70: 1min HRV, 12.028; 70: 5min HRV, 20.794; 71: HR, 114.431; 71: RR, 19.983; 71: SpO2, 99.190; 71: 1min HRV, 6.842; 72: WAM DIFTYP, AUTO; 72: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.5 g/dL; 72: EOSINOPHIL % (AUTO DIFF), 0.4 %; 72: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 21.7 pg; 72: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 72: HEMOGLOBIN (HGB), 11.2 g/dL; 72: BASOPHIL % (AUTO DIFF), 0.4 %; 72: MEAN CORPUSCULAR VOLUME (MCV), 69.1 fL; 72: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.16 K/uL; 72: RED CELL DISTRIBUTION WIDTH (RDW), 14.6 %; 72: PLATELET COUNT (PLT), 284 K/uL; 72: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 72: HEMATOCRIT (HCT), 35.6 %; 72: NRBC PERCENT (HEMATOLOGY), 0.0 %; 72: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 72: NEUTROPHIL % (AUTO DIFF), 81.5 %; 72: RED BLOOD CELLS (RBC), 5.15 MIL/uL; 72: MONOCYTE ABSOLUTE (AUTO DIFF), 0.76 K/uL; 72: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 72: MONOCYTE % (AUTO DIFF), 6.9 %; 72: WHITE BLOOD CELLS (WBC), 11.1 K/uL; 72: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 72: NEUTROPHIL ABSOLUTE (AUTO DIFF), 9.02 K/uL; 72: LYMPHOCYTE % (AUTO DIFF), 10.5 %; 72: HR, 114.797; 72: RR, 16.220; 72: SpO2, 99.0; 72: 1min HRV, 12.736; 73: HR, 116.593; 73: RR, 22.322; 73: SpO2, 99.667; 73: 1min HRV, 10.852; 74: INR, 1.1; 74: PROTHROMBIN TIME, 13.7 seconds; 74: HR, 114.271; 74: RR, 15.136; 74: SpO2, 99.158; 74: 1min HRV, 13.033; 75: PART. THROMBOPLASTIN TIME, 26.9 seconds; 75: HR, 115.983; 75: RR, 18.569; 75: SpO2, 99.172; 75: Perf, 0.335; 75: 1min HRV, 9.179; 75: 5min HRV, 11.055; 76: HR, 117.833; 76: RR, 20.333; 76: SpO2, 98.857; 76: Perf, 0.339; 76: 1min HRV, 20.298; 77: HR, 119.635; 77: RR, 18.315; 77: SpO2, 97.810; 77: 1min HRV, 11.138; 78: HR, 118.458; 78: RR, 15.915; 78: SpO2, 98.906; 78: 1min HRV, 7.851; 78: SBP, 136.0; 78: DBP, 86.0; 78: MAP, 102.667; 79: HR, 118.390; 79: RR, 21.864; 79: SpO2, 97.0; 79: 1min HRV, 10.976; 80: HR, 116.345; 80: RR, 19.190; 80: SpO2, 92.25; 80: 1min HRV, 6.229; 80: 5min HRV, 12.280; 81: HR, 117.068; 81: RR, 16.475; 81: SpO2, 100.0; 81: 1min HRV, 9.360; 82: HR, 114.948; 82: RR, 13.672; 82: SpO2, 99.0; 82: 1min HRV, 8.781; 83: HR, 113.831; 83: RR, 17.407; 83: SpO2, 98.0; 83: 1min HRV, 9.350; 84: SPECIFIC GRAVITY, URINE (UA): 1.014; 84: PROTEIN, URINE (UA): Negative; 84: GLUCOSE, URINE (UA): Negative; 84: PH, URINE (UA): 7.0; 84: NITRITE, URINE (UA): Negative; 84: LEUKOCYTE ESTERASE, URINE (UA): Negative; 84: KETONE, URINE (UA): Negative; 84: BLOOD, URINE (UA): Negative; 84: HR, 114.525; 84: RR, 19.186; 84: SpO2, 99.111; 84: 1min HRV, 12.467; 85: HR, 112.828; 85: RR, 16.103; 85: SpO2, 98.0; 85: 1min HRV, 8.069; 85: 5min HRV, 11.248; 85: SBP, 141.0; 85: DBP, 83.0; 85: MAP, 102.333; 85: Temp, 102.6; 86: HR, 119.357; 86: RR, 19.462; 86: SpO2, 87.762; 86: 1min HRV, 11.205; 87: HR, 114.0; 87: 1min HRV, 2.966; 90: POTASSIUM, 3.7 mmol/L; 90: EGFR REFIT WITHOUT RACE (2021), 89 mL/min/1.73 m2; 90: PROTEIN TOTAL, 7.5 g/dL; 90: ALKALINE PHOSPHATASE, 167 U/L; 90: BILIRUBIN TOTAL, 0.7 mg/dL; 90: CO2, 23 mmol/L; 90: SODIUM, 138 mmol/L; 90: CREATININE, 0.82 mg/dL; 90: ALBUMIN, 4.7 g/dL; 90: CORRECTED CALCIUM, 9.0 mg/dL; 90: ALT (SGPT), 25 U/L; 90: AST (SGOT), 14 U/L; 90: CHLORIDE, 101 mmol/L; 90: GLOBULIN, 2.8 g/dL; 90: BLOOD UREA NITROGEN (BUN), 14 mg/dL; 90: ANION GAP, 14 mmol/L; 90: GLUCOSE, 111 mg/dL; 90: CALCIUM, 9.6 mg/dL; 90: 5min HRV, 15.033; 92: RSV, Not Detected; 92: INFLUENZA B, Not Detected; 92: INFLUENZA A, Not Detected; 92: SARS-COV-2 RNA, Not Detected; 95: LR IV BOLUS -, 1000 ML; 96: KETOROLAC, 30 MG/ML (1 ML) INJ SOLN; 100: HR, 103.0; 100: RR, 25.0; 100: SpO2, 97.0; 100: SBP, 126.0; 100: DBP, 80.0; 100: MAP, 95.333; 0: Age, 44; 0: Gender, F; 0: Race, Black or African American; 0: Means of arrival, Self; 0: Triage Temp, 38.2; 0: Triage HR, 130.0; 0: Triage RR, 18.0; 0: Triage SBP, 150.0; 0: Triage DBP, 80.0; 0: Triage acuity, 2-Emergent; 0: CC, HIP PAIN",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The patient's recorded vital signs and lab results do not strongly indicate sepsis within 12 hours. Although the elevated heart rate and temperature are concerning, other markers, such as lactate level (1.79 mmol/L) and white blood cell count (11.1 K/uL), are within acceptable ranges. Additionally, there is no indication of organ dysfunction or overwhelming infection in the provided data, suggesting the patient is not at immediate high risk of sepsis.",
            "claims": [
                "The patient's recorded vital signs and lab results do not strongly indicate sepsis within 12 hours.",
                "The elevated heart rate is concerning.",
                "The elevated temperature is concerning.",
                "The lactate level is 1.79 mmol/L.",
                "A lactate level of 1.79 mmol/L is within acceptable ranges.",
                "The white blood cell count is 11.1 K/uL.",
                "A white blood cell count of 11.1 K/uL is within acceptable ranges.",
                "There is no indication of organ dysfunction in the provided data.",
                "There is no indication of overwhelming infection in the provided data.",
                "The absence of organ dysfunction and overwhelming infection suggests the patient is not at immediate high risk of sepsis."
            ],
            "relevant_claims": [
                "The patient's recorded vital signs and lab results do not strongly indicate sepsis within 12 hours.",
                "The elevated heart rate is concerning.",
                "The elevated temperature is concerning.",
                "The lactate level is 1.79 mmol/L.",
                "The white blood cell count is 11.1 K/uL.",
                "There is no indication of overwhelming infection in the provided data."
            ],
            "alignment_scores": [
                0.1,
                0.5,
                0.6,
                0.2,
                0.3,
                0.4
            ],
            "alignment_category": [
                "No specific category aligns well",
                "Elevated Shock Index (\u22651.0)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "SIRS Positivity (\u22652 Criteria)",
                "Early Antibiotic/Culture Orders (within 2 hours)"
            ],
            "alignment_reasonings": [
                "The claim generally states an absence of strong indicators of sepsis risk within the next 12 hours and does not align with any specific expert category, all of which define positive indicators for sepsis risk. While the claim mentions vitals and labs, it does so in a context of lacking evidence for sepsis, marginally relating to overall risk assessment but not to any of the specific criteria that strongly predict sepsis.",
                "While an elevated heart rate alone doesn't directly indicate a specific sepsis criterion, it is a component of the shock index, which considers heart rate in relation to systolic blood pressure. The claim expresses concern about the heart rate, implying possible hemodynamic instability, which aligns somewhat with the concept of elevated shock index, albeit indirectly without information on blood pressure. Therefore, the alignment with the category is moderate at 0.5.",
                "The mention of an \"elevated temperature\" directly relates to one of the SIRS criteria, specifically temperature exceeding 38\u00b0C. However, without additional data on whether the threshold is met or if other SIRS criteria are present, the alignment is not complete. Nonetheless, the concern for elevated temperature suggests a conceptual link to systemic inflammation, justifying a moderate alignment rating.",
                "The claim of a lactate level of 1.79 mmol/L does not meet the threshold for the Elevated Serum Lactate category, which specifies a level of \u22652 mmol/L as a significant marker indicating tissue hypoperfusion and elevated sepsis risk. However, the mention of lactate is conceptually relevant to this category, hence a minimal alignment.",
                "An elevated white blood cell count is part of the SIRS criteria used to identify systemic inflammation. However, in this case, the WBC count of 11.1 K/uL does not meet the SIRS specific threshold of >12,000/\u00b5L. Thus, the alignment is weak, indicating a marginal relevance.",
                "The absence of indicators for an overwhelming infection suggests that there might not be immediate clinical suspicion supporting the need for early antibiotic administration or culture orders, which are actions taken when such suspicion is present. However, the claim still touches on the concept of assessing potential infection, aligning it loosely with the category\u2019s theme, hence a moderate alignment rating."
            ],
            "final_alignment_score": 0.35000000000000003
        },
        {
            "input": "4: HR, 95.0; 4: RR, 14.0; 4: SpO2, 100.0; 4: SBP, 142.0; 4: DBP, 87.0; 4: MAP, 105.333; 4: Pain, 5.0; 4: Temp, 99.8; 38: POC PH (V) ISTAT, 7.40; 38: POC BASE EXCESS ISTAT, 5 mmol/L; 38: POC TCO2 (V) ISTAT, 32 mmol/L; 38: POC O2 SATURATION ISTAT VENOUS, 33 %; 38: POC HCO3 (V) ISTAT, 30.1 mmol/L; 38: POC PO2 (V) ISTAT, 21 mmHg; 38: POC LACTATE ISTAT, 0.78 mmol/L; 38: POC PCO2 (V) ISTAT, 48.5 mmHg; 42: SpO2, 95.429; 42: SBP, 132.0; 42: DBP, 79.0; 42: MAP, 96.667; 43: SpO2, 97.695; 43: Perf, 1.460; 44: SpO2, 97.655; 44: Perf, 1.709; 45: SpO2, 97.847; 45: Perf, 1.616; 46: SpO2, 97.431; 46: Perf, 1.456; 47: SpO2, 97.831; 47: Perf, 1.534; 48: SpO2, 97.729; 48: Perf, 1.598; 49: SpO2, 97.690; 49: Perf, 1.836; 50: SpO2, 96.966; 50: Perf, 1.689; 51: SpO2, 96.862; 51: Perf, 1.797; 52: SpO2, 98.153; 52: Perf, 1.553; 53: SpO2, 97.085; 53: Perf, 1.476; 54: SpO2, 96.828; 54: Perf, 1.469; 55: SpO2, 97.695; 55: Perf, 1.439; 56: SpO2, 97.276; 56: Perf, 1.384; 57: SpO2, 97.237; 57: Perf, 1.219; 58: SpO2, 96.508; 58: Perf, 1.283; 59: SpO2, 96.655; 59: Perf, 1.297; 59: Pain, 5.0; 60: SpO2, 98.153; 60: Perf, 1.605; 61: SpO2, 97.793; 61: Perf, 1.55; 62: SpO2, 98.559; 62: Perf, 1.715; 63: SpO2, 97.119; 63: Perf, 1.324; 64: SpO2, 97.5; 64: Perf, 1.432; 65: SpO2, 96.983; 65: Perf, 1.462; 66: SpO2, 96.931; 66: Perf, 1.344; 67: SpO2, 95.898; 67: Perf, 1.367; 68: SpO2, 97.932; 68: Perf, 2.006; 69: SpO2, 97.828; 69: Perf, 2.007; 70: SpO2, 97.322; 70: Perf, 1.516; 70: ACETAMINOPHEN, 325 MG PO TABS; 71: SpO, 2: 98.293; 71: Perf, 2.057; 71: LR IV BOLUS -, 1000 ML; 72: SpO, 2: 96.864; 72: Perf, 1.716; 73: SpO2, 97.525; 73: Perf, 1.641; 74: SpO2, 96.810; 74: Perf, 1.119; 75: SpO2, 96.576; 75: Perf, 1.097; 76: SpO2, 96.828; 76: Perf, 0.97; 77: SpO2, 96.729; 77: Perf, 0.978; 78: SpO2, 97.103; 78: Perf, 1.133; 79: SpO2, 97.746; 79: Perf, 0.817; 80: SpO2, 97.780; 80: Perf, 0.655; 81: SpO2, 98.121; 81: Perf, 0.556; 82: SpO2, 97.407; 82: Perf, 0.713; 83: SpO2, 97.845; 83: Perf, 0.911; 84: SpO2, 97.322; 84: Perf, 1.002; 85: SpO2, 96.763; 85: Perf, 0.847; 86: SpO2, 97.310; 86: Perf, 0.828; 87: SpO2, 97.542; 87: Perf, 0.783; 88: SpO2, 97.121; 88: Perf, 0.765; 89: HR, 87.0; 89: RR, 16.0; 89: SpO2, 97.763; 89: Perf, 1.317; 89: SBP, 137.0; 89: DBP, 80.0; 89: MAP, 99.0; 90: SpO2, 98.458; 90: Perf, 1.344; 90: SBP, 137.0; 90: DBP, 80.0; 90: MAP, 99.0; 91: SpO2, 97.586; 91: Perf, 1.229; 92: SpO2, 98.424; 92: Perf, 1.203; 93: WAM DIFTYP, AUTO; 93: BASOPHIL % (AUTO DIFF), 0.0 %; 93: MEAN CORPUSCULAR VOLUME (MCV), 90.7 fL; 93: MONOCYTE ABSOLUTE (AUTO DIFF), 0.40 K/uL; 93: MONOCYTE % (AUTO DIFF), 9.4 %; 93: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 93: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.2 %; 93: NEUTROPHIL % (AUTO DIFF), 62.1 %; 93: NEUTROPHIL ABSOLUTE (AUTO DIFF), 2.65 K/uL; 93: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 93: NRBC PERCENT (HEMATOLOGY), 0.0 %; 93: EOSINOPHIL % (AUTO DIFF), 0.2 %; 93: PLATELET COUNT (PLT), 140 K/uL; 93: BASOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 93: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 93: RED BLOOD CELLS (RBC), 4.85 MIL/uL; 93: WHITE BLOOD CELLS (WBC), 4.3 K/uL; 93: HEMATOCRIT (HCT), 44.0 %; 93: LYMPHOCYTE % (AUTO DIFF), 28.1 %; 93: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.3 pg; 93: RED CELL DISTRIBUTION WIDTH (RDW), 12.1 %; 93: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.3 g/dL; 93: HEMOGLOBIN (HGB), 14.2 g/dL; 93: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.20 K/uL; 93: SpO2, 97.776; 93: Perf, 1.051; 94: SpO2, 98.390; 94: Perf, 1.286; 95: SpO2, 97.458; 95: Perf, 1.696; 96: SpO2, 97.552; 96: Perf, 1.981; 97: SpO2, 98.136; 97: Perf, 2.354; 98: SpO2, 97.741; 98: Perf, 3.455; 99: SpO2, 97.525; 99: Perf, 3.604; 100: CORRECTED CALCIUM, 8.1 mg/dL; 100: AST (SGOT), 55 U/L; 100: EGFR FOR AFRICAN AMERICAN, 135 mL/min/1.73 m2; 100: CREATININE, 0.83 mg/dL; 100: BILIRUBIN TOTAL, 0.4 mg/dL; 100: CALCIUM, 8.5 mg/dL; 100: CO2, 26 mmol/L; 100: PROTEIN TOTAL, 7.4 g/dL; 100: SODIUM, 136 mmol/L; 100: EGFR REFIT WITHOUT RACE (2021), 116 mL/min/1.73 m2; 100: CHLORIDE, 99 mmol/L; 100: GLUCOSE, 97 mg/dL; 100: ALT (SGPT), 47 U/L; 100: POTASSIUM, 3.7 mmol/L; 100: ANION GAP, 11 mmol/L; 100: ALKALINE PHOSPHATASE, 67 U/L; 100: BLOOD UREA NITROGEN (BUN), 8 mg/dL; 100: GLOBULIN, 2.9 g/dL; 100: ALBUMIN, 4.5 g/dL; 100: SpO2, 98.0; 100: Perf, 2.318; 101: SpO2, 97.431; 101: Perf, 3.629; 102: SpO2, 97.441; 102: Perf, 3.987; 103: SpO2, 97.655; 103: Perf, 4.155; 104: SpO2, 97.644; 104: Perf, 5.328; 105: SpO2, 97.627; 105: Perf, 5.882; 106: SpO2, 98.069; 106: Perf, 4.651; 107: SpO2, 98.034; 107: Perf, 3.996; 108: SpO2, 97.224; 108: Perf, 4.485; 109: SpO2, 96.847; 109: Perf, 6.229; 110: SpO2, 97.241; 110: Perf, 5.401; 111: SpO2, 97.424; 111: Perf, 5.043; 112: SpO2, 97.695; 112: Perf, 4.544; 113: SpO2, 97.897; 113: Perf, 4.034; 114: SpO2, 97.898; 114: Perf, 3.892; 115: SpO2, 97.914; 115: Perf, 3.896; 116: SpO2, 97.983; 116: Perf, 3.929; 117: SpO2, 97.593; 117: Perf, 3.813; 118: SpO2, 97.845; 118: Perf, 3.414; 119: SpO2, 98.424; 119: Perf, 2.615; 0: Age, 30; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 37.7; 0: Triage HR, 95.0; 0: Triage RR, 14.0; 0: Triage SBP, 142.0; 0: Triage DBP, 87.0; 0: Triage acuity, 3-Urgent; 0: CC, GENERALIZED BODY ACHES,FEVER,HEADACHE",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The patient's vital signs, such as HR, SBP, DBP, RR, and SpO2, are within normal ranges across the dataset, and there aren't major fluctuations indicating acute deterioration. The lactate level is relatively low (0.78 mmol/L), which is a positive sign as higher lactate levels can indicate sepsis risk. Additionally, laboratory results, including white blood cell count, hemoglobin, and electrolyte levels, are within normal limits. There is no significant indication from the provided data that the patient is at high risk of developing sepsis within the next 12 hours.",
            "claims": [
                "The patient's vital signs are within normal ranges across the dataset.",
                "There are no major fluctuations in the patient's vital signs indicating acute deterioration.",
                "The lactate level is relatively low at 0.78 mmol/L.",
                "A low lactate level is a positive sign as higher lactate levels can indicate sepsis risk.",
                "Laboratory results, including white blood cell count, hemoglobin, and electrolyte levels, are within normal limits.",
                "There is no significant indication from the provided data that the patient is at high risk of developing sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "A low lactate level is a positive sign as higher lactate levels can indicate sepsis risk."
            ],
            "alignment_scores": [
                0.8
            ],
            "alignment_category": [
                "Elevated Serum Lactate (\u22652 mmol/L)"
            ],
            "alignment_reasonings": [
                "The claim references lactate levels, specifically highlighting that elevated lactate is associated with increased sepsis risk. Although the claim mentions low lactate as a positive sign, its relevancy to this category is high due to the direct mention of lactate's role in sepsis prediction, albeit from an opposite perspective. Therefore, the alignment is strong but slightly indirect, as it references the lack of the risk factor."
            ],
            "final_alignment_score": 0.8
        },
        {
            "input": "5: HR, 113.0; 5: RR, 18.0; 5: SpO2, 100.0; 5: SBP, 119.0; 5: DBP, 63.0; 5: MAP, 81.667; 5: Temp, 97.9; 48: HR, 107.171; 48: RR, 21.667; 48: 1min HRV, 7.060; 48: SBP, 132.0; 48: DBP, 86.0; 48: MAP, 101.333; 49: HR, 103.707; 49: RR, 15.017; 49: 1min HRV, 7.922; 50: HR, 101.559; 50: RR, 13.593; 50: 1min HRV, 13.327; 50: 5min HRV, 15.889; 51: HR, 104.948; 51: RR, 18.052; 51: 1min HRV, 12.539; 52: HR, 108.780; 52: RR, 13.593; 52: 1min HRV, 9.291; 53: HR, 107.305; 53: RR, 16.288; 53: 1min HRV, 21.887; 54: HR, 107.741; 54: RR, 17.103; 54: 1min HRV, 9.699; 55: HR, 104.525; 55: RR, 13.729; 55: 1min HRV, 16.064; 55: 5min HRV, 16.311; 56: HR, 103.672; 56: RR, 16.586; 56: 1min HRV, 11.985; 57: HR, 98.949; 57: RR, 16.254; 57: 1min HRV, 18.393; 58: HR, 102.288; 58: RR, 15.847; 58: 1min HRV, 24.567; 59: HR, 101.603; 59: RR, 16.172; 59: 1min HRV, 14.703; 60: HR, 99.780; 60: RR, 19.017; 60: 1min HRV, 11.709; 60: 5min HRV, 18.947; 61: HR, 99.810; 61: RR, 20.776; 61: 1min HRV, 5.400; 62: HR, 100.475; 62: RR, 17.441; 62: 1min HRV, 4.773; 63: HR, 101.138; 63: RR, 17.345; 63: 1min HRV, 24.163; 64: HR, 100.864; 64: RR, 19.864; 64: 1min HRV, 14.177; 65: HR, 99.373; 65: RR, 19.254; 65: 1min HRV, 5.808; 65: 5min HRV, 13.977; 66: HR, 99.138; 66: RR, 18.052; 66: 1min HRV, 6.775; 67: HR, 101.780; 67: RR, 18.068; 67: 1min HRV, 6.950; 68: HR, 103.224; 68: RR, 16.897; 68: 1min HRV, 11.861; 69: HR, 102.525; 69: RR, 18.661; 69: 1min HRV, 25.985; 70: HR, 100.695; 70: RR, 18.576; 70: 1min HRV, 6.207; 70: 5min HRV, 16.112; 71: HR, 101.224; 71: RR, 18.5; 71: 1min HRV, 5.814; 72: HR, 101.203; 72: RR, 18.339; 72: 1min HRV, 30.666; 73: HR, 100.517; 73: RR, 18.086; 73: 1min HRV, 4.284; 74: HR, 101.390; 74: RR, 18.661; 74: 1min HRV, 4.836; 75: HR, 100.153; 75: RR, 18.356; 75: SpO2, 100.0; 75: 1min HRV, 5.396; 75: 5min HRV, 14.719; 75: SBP, 125.0; 75: DBP, 78.0; 75: MAP, 93.667; 76: HR, 100.586; 76: RR, 19.707; 76: 1min HRV, 6.736; 76: SBP, 125.0; 76: DBP, 78.0; 76: MAP, 93.667; 77: HR, 101.0; 77: RR, 19.915; 77: 1min HRV, 25.271; 78: HR, 102.207; 78: RR, 18.776; 78: 1min HRV, 7.651; 79: HR, 104.186; 79: RR, 19.339; 79: 1min HRV, 23.564; 80: HR, 99.559; 80: RR, 18.339; 80: 1min HRV, 5.302; 80: 5min HRV, 18.504; 81: HR, 99.276; 81: RR, 16.224; 81: 1min HRV, 10.391; 81: LR IV BOLUS -, 1000 ML; 82: HR:, 100.0; 82: RR, 14.407; 82: 1min HRV, 21.803; 83: POC PH (V) ISTAT, 7.41; 83: POC PCO2 (V) ISTAT, 35.4 mmHg; 83: POC TCO2 (V) ISTAT, 24 mmol/L; 83: POC HCO3 (V) ISTAT, 22.5 mmol/L; 83: POC BASE EXCESS ISTAT, -2 mmol/L; 83: POC PO2 (V) ISTAT, 37 mmHg; 83: POC O2 SATURATION ISTAT VENOUS, 72 %; 83: POC LACTATE ISTAT, 2.36 mmol/L; 83: HR, 99.948; 83: RR, 15.759; 83: 1min HRV, 10.178; 84: HR, 103.169; 84: RR, 16.407; 84: 1min HRV, 7.486; 85: HR, 100.627; 85: RR, 17.203; 85: 1min HRV, 18.625; 85: 5min HRV, 16.917; 86: HR, 100.121; 86: RR, 17.862; 86: 1min HRV, 14.181; 87: HR, 104.373; 87: RR, 16.220; 87: 1min HRV, 31.188; 88: HR, 106.397; 88: RR, 17.448; 88: 1min HRV, 25.171; 89: HR, 105.441; 89: RR, 20.017; 89: 1min HRV, 20.929; 90: HR, 103.661; 90: RR, 19.424; 90: 1min HRV, 12.967; 90: 5min HRV, 24.426; 91: HR, 102.724; 91: RR, 20.190; 91: 1min HRV, 10.363; 92: HR, 103.864; 92: RR, 19.576; 92: 1min HRV, 16.807; 93: HR, 103.259; 93: RR, 16.793; 93: 1min HRV, 26.245; 94: HR, 105.390; 94: RR, 19.475; 94: 1min HRV, 25.257; 95: SARS-COV-2 RNA, Not Detected; 95: HR, 101.914; 95: RR, 19.966; 95: 1min HRV, 6.939; 95: 5min HRV, 19.694; 96: HR, 101.814; 96: RR, 19.458; 96: 1min HRV, 6.218; 97: HR, 103.153; 97: RR, 19.356; 97: 1min HRV, 15.343; 98: HR, 103.741; 98: RR, 19.431; 98: 1min HRV, 11.374; 99: HR, 105.475; 99: RR, 18.034; 99: 1min HRV, 18.055; 100: HR, 101.655; 100: RR, 20.897; 100: 1min HRV, 14.612; 100: 5min HRV, 16.578; 101: ALKALINE PHOSPHATASE, 156 U/L; 101: GLOBULIN, 1.7 g/dL; 101: POTASSIUM, 4.1 mmol/L; 101: CHLORIDE, 102 mmol/L; 101: LIPASE, 70 U/L; 101: AST (SGOT), 36 U/L; 101: EGFR REFIT WITHOUT RACE (2021), 65 mL/min/1.73 m2; 101: ANION GAP, 13 mmol/L; 101: PROTEIN TOTAL, 5.7 g/dL; 101: CO2, 21 mmol/L; 101: ALBUMIN, 4.0 g/dL; 101: CALCIUM, 9.7 mg/dL; 101: BLOOD UREA NITROGEN (BUN), 15 mg/dL; 101: ALT (SGPT), 14 U/L; 101: BILIRUBIN TOTAL, 0.3 mg/dL; 101: SODIUM, 136 mmol/L; 101: CORRECTED CALCIUM, 9.7 mg/dL; 101: CREATININE, 1.23 mg/dL; 101: GLUCOSE, 169 mg/dL; 101: HR, 104.136; 101: RR, 22.610; 101: 1min HRV, 22.822; 102: HR, 109.593; 102: RR, 18.373; 102: 1min HRV, 24.401; 103: HR, 106.448; 103: RR, 19.793; 103: 1min HRV, 68.019; 104: HR, 106.407; 104: RR, 17.610; 104: 1min HRV, 13.481; 105: HIGH SENSITIVITY TROPONIN, 7 ng/L; 105: HR, 104.328; 105: RR, 20.259; 105: SpO2, 100.0; 105: 1min HRV, 10.131; 105: 5min HRV, 35.905; 106: HR, 107.525; 106: RR, 18.576; 106: 1min HRV, 13.288; 107: HR, 106.458; 107: RR, 18.542; 107: 1min HRV, 9.333; 108: HR, 103.862; 108: RR, 24.103; 108: 1min HRV, 5.588; 109: HR, 103.831; 109: RR, 22.441; 109: 1min HRV, 5.072; 110: HR, 105.603; 110: RR, 21.655; 110: 1min HRV, 14.536; 110: 5min HRV, 12.758; 111: HR, 108.847; 111: RR, 19.763; 111: 1min HRV, 18.562; 112: HR, 106.695; 112: RR, 21.356; 112: 1min HRV, 23.629; 113: HR, 107.224; 113: RR, 18.172; 113: 1min HRV, 12.075; 114: HR, 106.678; 114: RR, 20.932; 114: 1min HRV, 20.000; 115: HR, 106.810; 115: RR, 18.948; 115: 1min HRV, 24.795; 115: 5min HRV, 21.082; 116: HR, 108.983; 116: RR, 22.593; 116: 1min HRV, 24.284; 117: HR, 115.508; 117: RR, 21.136; 117: 1min HRV, 18.287; 118: HR, 109.741; 118: RR, 20.052; 118: 1min HRV, 14.957; 119: HR, 105.932; 119: RR, 21.271; 119: 1min HRV, 22.043; 0: Age, 65; 0: Gender, M; 0: Race, Native Hawaiian or Other Pacific Islander; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 113.0; 0: Triage RR, 18.0; 0: Triage SBP, 119.0; 0: Triage DBP, 63.0; 0: Triage acuity, 3-Urgent; 0: CC, PALPITATIONS,ABDOMINAL PAIN",
            "answer": true,
            "llm_answer": "No",
            "llm_explanation": "The patient's vital signs such as heart rate and respiratory rate remain elevated but stable over the two-hour period, which could be a concern but not necessarily indicative of high sepsis risk alone. The lactate level of 2.36 mmol/L is slightly elevated, yet not critical. Other laboratory values such as albumin, creatinine, and electrolytes present no alarming abnormalities. Therefore, while there are signs requiring monitoring, they do not present a significant immediate risk of sepsis within the next 12 hours.",
            "claims": [
                "The patient's vital signs, such as heart rate and respiratory rate, remain elevated but stable over the two-hour period.",
                "Elevated but stable vital signs could be a concern.",
                "Elevated vital signs are not necessarily indicative of high sepsis risk alone.",
                "The lactate level is 2.36 mmol/L.",
                "A lactate level of 2.36 mmol/L is slightly elevated.",
                "A lactate level of 2.36 mmol/L is not critical.",
                "Other laboratory values, such as albumin, creatinine, and electrolytes, present no alarming abnormalities.",
                "Signs requiring monitoring are present.",
                "The signs present do not indicate a significant immediate risk of sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "Elevated but stable vital signs could be a concern.",
                "The lactate level is 2.36 mmol/L.",
                "A lactate level of 2.36 mmol/L is slightly elevated.",
                "The signs present do not indicate a significant immediate risk of sepsis within the next 12 hours."
            ],
            "alignment_scores": [
                0.3,
                1.0,
                0.9,
                0.0
            ],
            "alignment_category": [
                "AElevated NEWS Score (\u22655 points)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "No specific expert category directly applies"
            ],
            "alignment_reasonings": [
                "The claim references \"elevated but stable vital signs,\" suggesting potential concern for clinical deterioration. However, without specific details on how these vital signs match NEWS score criteria, the alignment is weak. The claim hints at possible deterioration but lacks specificity to strongly connect with the NEWS score category.",
                "The claim directly references a lactate level of 2.36 mmol/L, which is above the threshold of 2 mmol/L specified in the \"Elevated Serum Lactate\" category. This laboratory value explicitly indicates tissue hypoperfusion associated with increased sepsis mortality risk, demonstrating perfect alignment with the category.",
                "The claim refers to an elevated lactate level of 2.36 mmol/L, which exceeds the threshold of 2 mmol/L identified for this category. Elevated lactate indicates tissue hypoperfusion, a key indicator of sepsis risk. Although the level is only slightly above the threshold, it strongly aligns with the category's criteria for elevated sepsis mortality risk. Therefore, the alignment is very high, but slightly less than perfect due to the \"slightly elevated\" phrasing.",
                "The claim suggests a lack of significant immediate risk of sepsis but does not align directly with any expert categories that predict or assess high sepsis risk. It indicates an absence of warning signs or criteria that might concern a clinician familiar with these expert categories, but no specific category corresponds to the absence of sepsis risk factors."
            ],
            "final_alignment_score": 0.55
        },
        {
            "input": "6: HR, 91.0; 6: RR, 20.0; 6: SpO2, 100.0; 6: SBP, 140.0; 6: DBP, 119.0; 6: MAP, 126.0; 6: Temp, 97.7; 89: HR, 86.122; 89: RR, 14.545; 89: SpO2, 99.611; 89: Perf, 1.259; 89: 1min HRV, 64.115; 90: HR, 83.644; 90: RR, 13.949; 90: SpO2, 99.034; 90: Perf, 1.051; 90: 1min HRV, 101.623; 90: 5min HRV, 86.748; 91: HR, 85.712; 91: RR, 16.102; 91: SpO2, 99.475; 91: Perf, 0.914; 91: 1min HRV, 87.323; 91: SBP, 136.0; 91: DBP, 51.0; 91: MAP, 79.333; 92: HR, 86.0; 92: RR, 14.638; 92: SpO2, 99.155; 92: Perf, 0.880; 92: 1min HRV, 90.021; 93: HR, 83.678; 93: RR, 14.0; 93: SpO2, 99.0; 93: Perf, 0.866; 93: 1min HRV, 74.305; 94: HR, 83.5; 94: RR, 14.431; 94: SpO2, 99.0; 94: Perf, 0.86; 94: 1min HRV, 58.107; 95: HR, 84.559; 95: RR, 15.898; 95: SpO2, 99.0; 95: Perf, 0.831; 95: 1min HRV, 54.349; 95: 5min HRV, 74.663; 96: HR, 83.569; 96: RR, 14.552; 96: SpO2, 99.0; 96: Perf, 0.846; 96: 1min HRV, 75.772; 96: SBP, 135.0; 96: DBP, 64.0; 96: MAP, 87.667; 97: HR, 82.254; 97: RR, 15.220; 97: SpO2, 99.0; 97: Perf, 0.851; 97: 1min HRV, 69.625; 98: HR, 84.271; 98: RR, 15.678; 98: SpO2, 98.831; 98: Perf, 0.818; 98: 1min HRV, 71.319; 99: HR, 83.069; 99: RR, 21.138; 99: SpO2, 99.121; 99: Perf, 0.781; 99: 1min HRV, 69.271; 100: HR, 83.983; 100: RR, 16.475; 100: SpO2, 98.831; 100: Perf, 0.745; 100: 1min HRV, 64.848; 100: 5min HRV, 70.448; 101: HR, 84.966; 101: RR, 15.661; 101: SpO2, 98.898; 101: Perf, 0.710; 101: 1min HRV, 70.236; 102: HR, 81.534; 102: RR, 15.879; 102: SpO2, 98.759; 102: Perf, 0.722; 102: 1min HRV, 64.743; 103: HR, 82.0; 103: RR, 14.424; 103: SpO2, 98.712; 103: Perf, 0.696; 103: 1min HRV, 60.270; 104: HR, 81.293; 104: RR, 13.224; 104: SpO2, 98.759; 104: Perf, 0.694; 104: 1min HRV, 75.829; 105: HR, 83.356; 105: RR, 14.746; 105: SpO2, 99.136; 105: Perf, 0.688; 105: 1min HRV, 64.337; 105: 5min HRV, 68.181; 106: HR, 82.763; 106: RR, 14.780; 106: SpO2, 98.644; 106: Perf, 0.685; 106: 1min HRV, 68.190; 107: HR, 81.603; 107: RR, 14.655; 107: SpO2, 99.0; 107: Perf, 0.680; 107: 1min HRV, 59.350; 108: HR, 81.220; 108: RR, 21.627; 108: SpO2, 98.932; 108: Perf, 0.709; 108: 1min HRV, 76.786; 109: HR, 80.966; 109: RR, 19.362; 109: SpO2, 99.0; 109: Perf, 0.725; 109: 1min HRV, 76.180; 110: HR, 80.661; 110: RR, 16.288; 110: SpO2, 99.0; 110: Perf, 0.707; 110: 1min HRV, 66.222; 110: 5min HRV, 70.035; 111: HR, 81.220; 111: RR, 23.169; 111: SpO2, 99.0; 111: Perf, 0.679; 111: 1min HRV, 77.056; 111: SBP, 136.0; 111: DBP, 64.0; 111: MAP, 88.0; 112: HR, 81.983; 112: RR, 18.586; 112: SpO2, 99.0; 112: Perf, 0.652; 112: 1min HRV, 60.951; 113: WAM DIFTYP, AUTO; 113: RED CELL DISTRIBUTION WIDTH (RDW), 15.2 %; 113: LYMPHOCYTE % (AUTO DIFF), 14.9 %; 113: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.1 g/dL; 113: HEMATOCRIT (HCT), 35.1 %; 113: HEMOGLOBIN (HGB), 10.9 g/dL; 113: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.08 K/uL; 113: MONOCYTE ABSOLUTE (AUTO DIFF), 0.87 K/uL; 113: NRBC PERCENT (HEMATOLOGY), 0.0 %; 113: RED BLOOD CELLS (RBC), 3.62 MIL/uL; 113: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.1 pg; 113: NEUTROPHIL % (AUTO DIFF), 75.4 %; 113: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 113: BASOPHIL % (AUTO DIFF), 0.5 %; 113: PLATELET COUNT (PLT), 252 K/uL; 113: NEUTROPHIL ABSOLUTE (AUTO DIFF), 9.80 K/uL; 113: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.94 K/uL; 113: EOSINOPHIL % (AUTO DIFF), 1.9 %; 113: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.25 K/uL; 113: WHITE BLOOD CELLS (WBC), 13.0 K/uL; 113: MONOCYTE % (AUTO DIFF), 6.7 %; 113: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.6 %; 113: MEAN CORPUSCULAR VOLUME (MCV), 97.0 fL; 113: BASOPHIL ABSOLUTE (AUTO DIFF), 0.07 K/uL; 113: HR, 82.797; 113: RR, 14.271; 113: SpO2, 99.0; 113: Perf, 0.625; 113: 1min HRV, 70.045; 114: HR, 82.190; 114: RR, 19.414; 114: SpO2, 98.828; 114: Perf, 0.61; 114: 1min HRV, 61.600; 115: HR, 82.508; 115: RR, 13.017; 115: SpO2, 99.508; 115: Perf, 0.654; 115: 1min HRV, 63.268; 115: 5min HRV, 66.921; 116: HR, 82.155; 116: RR, 12.103; 116: SpO2, 99.397; 116: Perf, 0.662; 116: 1min HRV, 73.993; 117: HR, 81.576; 117: RR, 13.119; 117: SpO2, 99.0; 117: Perf, 0.662; 117: 1min HRV, 64.195; 118: HR, 81.763; 118: RR, 11.136; 118: SpO2, 99.0; 118: Perf, 0.653; 118: 1min HRV, 60.004; 119: HR, 79.017; 119: RR, 10.286; 119: SpO2, 99.0; 119: Perf, 0.659; 119: 1min HRV, 83.610; 0: Age, 90; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.5; 0: Triage HR, 91.0; 0: Triage RR, 20.0; 0: Triage SBP, 140.0; 0: Triage DBP, 119.0; 0: Triage acuity, 3-Urgent; 0: CC, GENERAL WEAKNESS,APPETITE DECREASED,EAR PAIN",
            "answer": true,
            "llm_answer": "No",
            "llm_explanation": "The patient's vital signs, including heart rate, respiratory rate, and blood pressure, remain relatively stable and do not show significant deviations indicative of sepsis. The oxygen saturation levels are consistently near or at 99%, which is healthy. Although the patient is older and presents with general weakness, there are no noticeable signs of infection or systemic inflammation (such as fever or abnormal white blood cell count) that commonly suggest an imminent risk of sepsis. Hence, the risk of developing sepsis within the next 12 hours seems low based on this data.",
            "claims": [
                "The patient's vital signs, including heart rate, respiratory rate, and blood pressure, remain relatively stable.",
                "The patient's vital signs do not show significant deviations indicative of sepsis.",
                "The oxygen saturation levels are consistently near or at 99%.",
                "An oxygen saturation level of 99% is considered healthy.",
                "The patient is older.",
                "The patient presents with general weakness.",
                "There are no noticeable signs of infection present.",
                "There are no noticeable signs of systemic inflammation.",
                "Common signs of systemic inflammation include fever or an abnormal white blood cell count.",
                "There is no fever in the patient.",
                "There is no abnormal white blood cell count in the patient.",
                "The data suggests that the risk of developing sepsis within the next 12 hours seems low.",
                "The assessment of the risk of sepsis is based on the patient's current data."
            ],
            "relevant_claims": [
                "The patient's vital signs do not show significant deviations indicative of sepsis.",
                "There are no noticeable signs of systemic inflammation.",
                "There is no abnormal white blood cell count in the patient."
            ],
            "alignment_scores": [
                0.3,
                0.2,
                0.3
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)"
            ],
            "alignment_reasonings": [
                "The claim mentions that the patient's vital signs do not show significant deviations indicative of sepsis. This suggests that the criteria often used for early identification of sepsis, such as SIRS criteria, are not met. SIRS criteria include specific vital sign deviations (e.g., temperature, heart rate), and no significant deviations imply a low alignment with SIRS positivity. The alignment is low but somewhat relevant due to the context of exclusion of SIRS-like symptoms.",
                "The claim mentions an absence of systemic inflammation, which relates to the SIRS criteria used to identify sepsis. While this suggests a low likelihood of meeting SIRS positivity, the context remains relevant. The alignment is weak since the claim states the non-presence of a key factor for the category.",
                "The absence of an abnormal white blood cell count suggests that one of the SIRS criteria is not met, indicating lower suspicion of systemic inflammation consistent with early sepsis. The claim is related to the SIRS criteria, but since it's about the lack of an abnormal WBC count, the alignment is weak."
            ],
            "final_alignment_score": 0.26666666666666666
        },
        {
            "input": "3: HR, 74.0; 3: RR, 18.0; 3: SpO2, 94.0; 3: SBP, 113.0; 3: DBP, 71.0; 3: MAP, 85.0; 3: Pain, 4.0; 3: Temp, 99.7; 7: Pain, 3.0; 31: SpO2, 94.462; 31: SBP, 137.0; 31: DBP, 75.0; 31: MAP, 95.667; 32: SpO2, 93.0; 33: SpO2, 94.725; 33: Perf, 14.482; 34: SpO2, 94.914; 34: Perf, 18.411; 35: SpO2, 94.883; 35: Perf, 19.336; 36: SpO2, 94.982; 36: Perf, 16.918; 37: SpO2, 95.695; 37: Perf, 17.487; 38: SpO2, 95.690; 38: Perf, 17.235; 39: SpO2, 94.966; 39: Perf, 16.932; 40: SpO2, 94.559; 40: Perf, 16.699; 41: HR, 70.0; 41: RR, 18.0; 41: SpO2, 95.879; 41: Perf, 14.595; 41: SBP, 136.0; 41: DBP, 69.0; 41: MAP, 91.333; 41: Pain, 3.0; 42: SpO2, 95.7; 42: Perf, 17.597; 42: SBP, 136.0; 42: DBP, 69.0; 42: MAP, 91.333; 43: SpO2, 95.983; 43: Perf, 16.952; 44: SpO2, 96.0; 44: Perf, 18.613; 45: SpO2, 96.0; 45: Perf, 18.248; 46: SpO2, 94.881; 46: Perf, 17.846; 47: SpO2, 95.862; 47: Perf, 13.458; 48: SpO2, 96.254; 48: Perf, 14.139; 49: SpO2, 95.690; 49: Perf, 15.089; 50: SpO2, 96.153; 50: Perf, 14.664; 51: SpO2, 96.0; 51: Perf, 16.012; 52: SpO2, 96.034; 52: Perf, 16.036; 53: SpO2, 95.763; 53: Perf, 15.591; 56: SARS-COV-2 RNA, Not Detected; 56: INFLUENZA A, Not Detected; 56: RSV, Not Detected; 56: INFLUENZA B, Not Detected; 61: WAM DIFTYP, AUTO; 61: HEMATOCRIT (HCT), 41.4 %; 61: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 61: MONOCYTE ABSOLUTE (AUTO DIFF), 1.72 K/uL; 61: MEAN CORPUSCULAR VOLUME (MCV), 90.0 fL; 61: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.3 g/dL; 61: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 61: PLATELET COUNT (PLT), 222 K/uL; 61: BASOPHIL % (AUTO DIFF), 0.1 %; 61: NEUTROPHIL % (AUTO DIFF), 87.1 %; 61: NEUTROPHIL ABSOLUTE (AUTO DIFF), 17.23 K/uL; 61: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.7 %; 61: LYMPHOCYTE % (AUTO DIFF), 3.4 %; 61: RED BLOOD CELLS (RBC), 4.60 MIL/uL; 61: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.67 K/uL; 61: NRBC PERCENT (HEMATOLOGY), 0.0 %; 61: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.0 pg; 61: WHITE BLOOD CELLS (WBC), 19.8 K/uL; 61: HEMOGLOBIN (HGB), 13.8 g/dL; 61: MONOCYTE % (AUTO DIFF), 8.7 %; 61: EOSINOPHIL % (AUTO DIFF), 0.0 %; 61: RED CELL DISTRIBUTION WIDTH (RDW), 13.5 %; 61: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.13 K/uL; 61: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 71: SpO2, 95.972; 71: Perf, 19.384; 72: SpO2, 95.638; 72: Perf, 19.893; 73: SpO2, 95.593; 73: Perf, 18.497; 74: SpO2, 95.542; 74: Perf, 19.283; 75: SpO2, 95.259; 75: Perf, 19.124; 76: SpO2, 94.492; 76: Perf, 17.902; 77: POC PH (V) ISTAT, 7.44; 77: POC HCO3 (V) ISTAT, 28.5 mmol/L; 77: POC BASE EXCESS ISTAT, 4 mmol/L; 77: POC PO2 (V) ISTAT, 43 mmHg; 77: POC LACTATE ISTAT, 0.69 mmol/L; 77: POC TCO2 (V) ISTAT, 30 mmol/L; 77: POC PCO2 (V) ISTAT, 41.8 mmHg; 77: POC O2 SATURATION ISTAT VENOUS, 80 %; 77: SpO2, 94.0; 77: Perf, 15.710; 78: SpO2, 95.119; 78: Perf, 15.465; 79: SpO2, 95.136; 79: Perf, 15.434; 80: SpO2, 94.069; 80: Perf, 15.169; 81: SpO2, 94.831; 81: Perf, 14.358; 82: SpO2, 94.069; 82: Perf, 14.436; 83: SpO2, 94.0; 83: Perf, 16.667; 84: SpO2, 94.0; 84: Perf, 16.033; 85: HIGH SENSITIVITY TROPONIN, 14 ng/L; 85: SpO2, 94.0; 85: Perf, 14.911; 86: SpO2, 94.949; 86: Perf, 14.176; 87: SpO2, 95.052; 87: Perf, 15.782; 88: ALT (SGPT), 70 U/L; 88: BILIRUBIN TOTAL, 0.9 mg/dL; 88: CORRECTED CALCIUM, 9.1 mg/dL; 88: POTASSIUM, 3.2 mmol/L; 88: SODIUM, 139 mmol/L; 88: CREATININE, 1.40 mg/dL; 88: ALBUMIN, 4.1 g/dL; 88: GLOBULIN, 2.6 g/dL; 88: EGFR REFIT WITHOUT RACE (2021), 53 mL/min/1.73 m2; 88: ANION GAP, 13 mmol/L; 88: CO2, 27 mmol/L; 88: AST (SGOT), 72 U/L; 88: GLUCOSE, 156 mg/dL; 88: BLOOD UREA NITROGEN (BUN), 19 mg/dL; 88: PROTEIN TOTAL, 6.7 g/dL; 88: ALKALINE PHOSPHATASE, 133 U/L; 88: CALCIUM, 9.2 mg/dL; 88: CHLORIDE, 99 mmol/L; 88: SpO2, 95.407; 88: Perf, 13.756; 89: SpO2, 94.305; 89: Perf, 15.369; 90: SpO2, 94.103; 90: Perf, 15.427; 91: SpO2, 93.983; 91: Perf, 12.664; 92: SpO2, 93.190; 92: Perf, 15.533; 93: SpO2, 93.237; 93: Perf, 16.274; 94: SpO2, 93.407; 94: Perf, 12.725; 95: SpO2, 92.569; 95: Perf, 10.715; 96: SpO2, 94.034; 96: Perf, 13.330; 97: SpO2, 92.845; 97: Perf, 14.170; 98: SpO2, 93.254; 98: Perf, 12.813; 99: SpO2, 91.695; 99: Perf, 8.233; 100: SpO2, 92.690; 100: Perf, 13.570; 101: SpO2, 92.729; 101: Perf, 12.566; 102: SpO2, 92.448; 102: Perf, 15.272; 103: GLUCOSE, URINE (UA): Negative; 103: PH, URINE (UA): 5.0; 103: SPECIFIC GRAVITY, URINE (UA): 1.026; 103: NITRITE, URINE (UA): Negative; 103: KETONE, URINE (UA): Negative; 103: SpO2, 93.576; 103: Perf, 12.770; 104: SpO2, 91.466; 104: Perf, 12.215; 105: SpO2, 94.458; 105: Perf, 14.273; 106: SpO2, 93.458; 106: Perf, 11.702; 107: SpO2, 92.690; 107: Perf, 12.907; 108: SpO2, 92.475; 108: Perf, 12.899; 109: SpO2, 91.345; 109: Perf, 8.859; 110: SpO2, 92.492; 110: Perf, 13.471; 111: SpO2, 90.932; 111: Perf, 9.334; 112: SpO2, 95.172; 112: Perf, 14.262; 113: SpO2, 94.102; 113: Perf, 13.637; 114: SpO2, 93.0; 114: Perf, 13.566; 115: SpO2, 93.0; 115: Perf, 14.340; 116: SpO2, 93.0; 116: Perf, 13.576; 117: SpO2, 93.569; 117: Perf, 12.735; 118: SpO2, 94.407; 118: Perf, 8.632; 119: SpO2, 93.310; 119: Perf, 11.099; 0: Age, 73; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.6; 0: Triage HR, 74.0; 0: Triage RR, 18.0; 0: Triage SBP, 113.0; 0: Triage DBP, 71.0; 0: Triage acuity, 3-Urgent; 0: CC, FEVER",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The vital signs (e.g., heart rate, respiratory rate, blood pressure, and temperature) remain relatively stable and within normal ranges throughout the time series, with no significant deterioration. Additionally, key lab results such as white blood cell count, although elevated, do not show a clear progression towards a septic profile, and lactate levels are low, indicating no acute metabolic disturbances associated with sepsis. Oxygen saturation levels, while slightly fluctuating, remain generally above critical thresholds. Overall, there is no strong evidence in the data pointing to high-risk sepsis development within the next 12 hours.",
            "claims": [
                "The vital signs remain relatively stable throughout the time series.",
                "The vital signs are within normal ranges.",
                "There is no significant deterioration in vital signs.",
                "Key lab results include an elevated white blood cell count.",
                "The elevated white blood cell count does not show a clear progression towards a septic profile.",
                "Lactate levels are low.",
                "Low lactate levels indicate no acute metabolic disturbances associated with sepsis.",
                "Oxygen saturation levels slightly fluctuate.",
                "Oxygen saturation levels remain generally above critical thresholds.",
                "Overall, there is no strong evidence pointing to high-risk sepsis development within the next 12 hours."
            ],
            "relevant_claims": [
                "Low lactate levels indicate no acute metabolic disturbances associated with sepsis."
            ],
            "alignment_scores": [
                0.3
            ],
            "alignment_category": [
                "Elevated Serum Lactate (\u22652 mmol/L)"
            ],
            "alignment_reasonings": [
                "The claim refers to lactate levels, which are directly related to the category concerning elevated serum lactate. However, the claim mentions low lactate levels, while the category concerns elevated levels (\u22652 mmol/L) as an indicator of sepsis risk. Thus, while related, the claim and the category are not aligned in a way that indicates a high sepsis risk. The alignment is weak as it addresses the opposite scenario of what the category describes."
            ],
            "final_alignment_score": 0.3
        },
        {
            "input": "5: HR, 79.0; 5: RR, 18.0; 5: SpO2, 94.0; 5: SBP, 118.0; 5: DBP, 46.0; 5: MAP, 70.0; 5: Temp, 99.1; 69: WAM DIFTYP, AUTO; 69: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 69: WHITE BLOOD CELLS (WBC), 15.8 K/uL; 69: NEUTROPHIL ABSOLUTE (AUTO DIFF), 14.65 K/uL; 69: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.8 pg; 69: BASOPHIL % (AUTO DIFF), 0.3 %; 69: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.42 K/uL; 69: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 69: HEMOGLOBIN (HGB), 9.4 g/dL; 69: MONOCYTE ABSOLUTE (AUTO DIFF), 0.62 K/uL; 69: LYMPHOCYTE % (AUTO DIFF), 2.7 %; 69: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 69: NEUTROPHIL % (AUTO DIFF), 92.7 %; 69: EOSINOPHIL % (AUTO DIFF), 0.0 %; 69: MONOCYTE % (AUTO DIFF), 3.9 %; 69: MEAN CORPUSCULAR VOLUME (MCV), 94.9 fL; 69: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 69: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.06 K/uL; 69: HEMATOCRIT (HCT), 29.9 %; 69: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.4 g/dL; 69: RED CELL DISTRIBUTION WIDTH (RDW), 24.4 %; 69: NRBC PERCENT (HEMATOLOGY), 0.0 %; 69: PLATELET COUNT (PLT), 220 K/uL; 69: RED BLOOD CELLS (RBC), 3.15 MIL/uL; 80: HR, 79.0; 80: 1min HRV, 0.632; 80: SBP, 115.0; 80: DBP, 56.0; 80: MAP, 75.667; 81: HR, 77.627; 81: RR, 26.727; 81: SpO2, 95.828; 81: 1min HRV, 11.200; 82: HR, 74.552; 82: RR, 21.397; 82: SpO2, 90.466; 82: Perf, 1.034; 82: 1min HRV, 7.666; 83: HR, 72.559; 83: RR, 23.136; 83: SpO2, 92.373; 83: Perf, 1.478; 83: 1min HRV, 4.965; 84: HR, 71.259; 84: RR, 26.483; 84: SpO2, 92.741; 84: Perf, 1.973; 84: 1min HRV, 1.575; 84: 5min HRV, 26.452; 85: HR, 71.0; 85: RR, 24.576; 85: SpO2, 94.254; 85: Perf, 1.915; 85: 1min HRV, 4.954; 86: HR, 71.0; 86: RR, 21.237; 86: SpO2, 93.898; 86: Perf, 2.031; 86: 1min HRV, 0.982; 87: HR, 70.310; 87: RR, 21.121; 87: SpO2, 93.517; 87: Perf, 2.059; 87: 1min HRV, 4.349; 88: HR, 70.0; 88: RR, 20.712; 88: SpO2, 92.661; 88: Perf, 2.121; 88: 1min HRV, 0.977; 89: HR, 70.0; 89: RR, 20.259; 89: SpO2, 92.155; 89: Perf, 2.087; 89: 1min HRV, 7.373; 89: 5min HRV, 7.905; 90: HR, 69.949; 90: RR, 19.492; 90: SpO2, 92.610; 90: Perf, 2.144; 90: 1min HRV, 1.040; 91: HR, 70.0; 91: RR, 18.746; 91: SpO2, 92.271; 91: Perf, 2.171; 91: 1min HRV, 0.737; 92: HR, 70.0; 92: RR, 17.569; 92: SpO2, 92.379; 92: Perf, 2.239; 92: 1min HRV, 8.331; 93: HR, 70.0; 93: RR, 17.780; 93: SpO2, 91.576; 93: Perf, 2.413; 93: 1min HRV, 0.865; 94: HR, 70.0; 94: RR, 17.310; 94: SpO2, 91.724; 94: Perf, 2.581; 94: 1min HRV, 0.730; 94: 5min HRV, 3.782; 94: SBP, 102.0; 94: DBP, 57.0; 94: MAP, 72.0; 95: HR, 70.0; 95: RR, 17.797; 95: SpO2, 92.442; 95: Perf, 2.55; 95: 1min HRV, 1.324; 95: SBP, 102.0; 95: DBP, 57.0; 95: MAP, 72.0; 96: HR, 70.0; 96: RR, 23.610; 96: SpO2, 92.695; 96: Perf, 2.430; 96: 1min HRV, 1.110; 97: HR, 72.276; 97: RR, 25.0; 97: SpO2, 95.0; 97: Perf, 1.765; 97: 1min HRV, 101.809; 98: HR, 71.169; 98: RR, 26.373; 98: SpO2, 96.678; 98: Perf, 1.388; 98: 1min HRV, 20.553; 99: HR, 71.0; 99: RR, 24.466; 99: SpO2, 96.810; 99: Perf, 1.301; 99: 1min HRV, 5.030; 99: 5min HRV, 47.921; 99: NORMOSOL-R IV BOLUS -, 1000 ML; 100: HR:, 70.983; 100: RR, 26.254; 100: SpO2, 96.797; 100: Perf, 1.325; 100: 1min HRV, 31.615; 101: HR, 70.052; 101: RR, 22.190; 101: SpO2, 96.690; 101: Perf, 1.399; 101: 1min HRV, 0.887; 102: HR, 70.0; 102: RR, 24.831; 102: SpO2, 97.153; 102: Perf, 1.319; 102: 1min HRV, 0.702; 103: HR, 70.0; 103: RR, 24.237; 103: SpO2, 96.390; 103: Perf, 1.486; 103: 1min HRV, 0.833; 104: HR, 70.0; 104: RR, 21.776; 104: SpO2, 96.966; 104: Perf, 1.278; 104: 1min HRV, 0.877; 104: 5min HRV, 14.315; 105: HR, 70.0; 105: RR, 20.390; 105: SpO2, 96.508; 105: Perf, 1.329; 105: 1min HRV, 0.787; 106: HR, 70.0; 106: RR, 23.086; 106: SpO2, 96.103; 106: Perf, 1.450; 106: 1min HRV, 0.884; 107: HR, 70.0; 107: RR, 23.0; 107: SpO2, 96.305; 107: Perf, 1.023; 107: 1min HRV, 0.746; 108: HR, 70.0; 108: RR, 18.983; 108: SpO2, 96.288; 108: Perf, 1.068; 108: 1min HRV, 0.762; 109: HR, 70.0; 109: RR, 22.017; 109: SpO2, 96.517; 109: Perf, 0.975; 109: 1min HRV, 0.715; 109: 5min HRV, 0.781; 110: HR, 70.0; 110: RR, 17.712; 110: SpO2, 96.390; 110: Perf, 0.929; 110: 1min HRV, 0.772; 111: HR, 70.0; 111: RR, 21.914; 111: SpO2, 96.879; 111: Perf, 0.999; 111: 1min HRV, 0.665; 112: HR, 70.0; 112: RR, 21.915; 112: SpO2, 96.322; 112: Perf, 0.921; 112: 1min HRV, 0.640; 113: HR, 70.0; 113: RR, 22.638; 113: SpO2, 98.224; 113: Perf, 0.748; 113: 1min HRV, 0.715; 114: HR, 70.0; 114: RR, 19.017; 114: SpO2, 97.085; 114: Perf, 0.698; 114: 1min HRV, 0.565; 114: 5min HRV, 0.677; 115: HR, 70.0; 115: RR, 19.237; 115: SpO2, 97.475; 115: Perf, 0.734; 115: 1min HRV, 0.925; 116: HR, 70.0; 116: RR, 20.345; 116: SpO2, 98.155; 116: Perf, 0.717; 116: 1min HRV, 6.745; 117: HR, 70.0; 117: RR, 19.746; 117: SpO2, 95.98; 117: Perf, 0.707; 117: 1min HRV, 1.062; 118: HR, 70.0; 118: RR, 24.983; 118: SpO2, 96.436; 118: Perf, 0.771; 118: 1min HRV, 3.949; 119: HR, 70.0; 119: RR, 23.0; 119: SpO2, 97.328; 119: Perf, 0.813; 119: 1min HRV, 0.969; 119: 5min HRV, 3.700; 0: Age, 87; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.3; 0: Triage HR, 79.0; 0: Triage RR, 18.0; 0: Triage SBP, 118.0; 0: Triage DBP, 46.0; 0: Triage acuity, 3-Urgent; 0: CC, EMESIS",
            "answer": true,
            "llm_answer": "No",
            "llm_explanation": "The patient's data does not show clear indicators of high sepsis risk. The heart rate is relatively stable and within normal limits, and the respiratory rate, though variable, does not consistently indicate significant respiratory distress. The SpO2 levels are generally maintained above 90%, and no severe hypotension is evident despite low initial diastolic blood pressure. The white blood cell count is elevated, but without other significant abnormalities or rapidly worsening symptoms, the immediate risk for sepsis within 12 hours appears low.",
            "claims": [
                "The patient's data does not show clear indicators of high sepsis risk.",
                "The heart rate is relatively stable.",
                "The heart rate is within normal limits.",
                "The respiratory rate is variable.",
                "The respiratory rate does not consistently indicate significant respiratory distress.",
                "The SpO2 levels are generally maintained above 90%.",
                "No severe hypotension is evident.",
                "The initial diastolic blood pressure is low.",
                "The white blood cell count is elevated.",
                "There are no other significant abnormalities present.",
                "There are no rapidly worsening symptoms.",
                "The immediate risk for sepsis within 12 hours appears low."
            ],
            "relevant_claims": [
                "The patient's data does not show clear indicators of high sepsis risk.",
                "The respiratory rate does not consistently indicate significant respiratory distress.",
                "No severe hypotension is evident.",
                "The initial diastolic blood pressure is low.",
                "The white blood cell count is elevated.",
                "There are no rapidly worsening symptoms.",
                "The immediate risk for sepsis within 12 hours appears low."
            ],
            "alignment_scores": [
                0.0,
                0.3,
                0.3,
                0.3,
                1.0,
                0.3,
                0.0
            ],
            "alignment_category": [
                "None",
                "Elevated NEWS Score (\u22655 points)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated NEWS Score (\u22655 points)",
                "Not explicitly aligned with any category"
            ],
            "alignment_reasonings": [
                "The claim states there are no clear indicators of high sepsis risk, suggesting no alignment with the expert categories. None of the specific risk factors or criteria used for sepsis prediction are mentioned or implied in the claim. Therefore, it does not align with any category meaningfully.",
                "The claim mentions that the respiratory rate does not consistently indicate significant respiratory distress. While it lacks direct identification of a high respiratory rate, it hints at respiratory assessment, which is a part of the NEWS score that evaluates deranged vitals. Since the claim does not show clearly elevated respiratory parameters, the alignment is weak.",
                "The claim directly references the absence of severe hypotension, which is related to the category concerning sepsis-associated hypotension. The alignment is weak because the claim states a negative (absence of hypotension) rather than an affirmative risk factor for sepsis, thus providing less predictive value for sepsis risk.",
                "The claim refers to a low diastolic blood pressure, which could indicate hypotension. However, the expert category specifically focuses on systolic blood pressure (SBP) and mean arterial pressure (MAP) for marking hypotension, not diastolic blood pressure. While low diastolic pressure might contribute to evaluating overall blood pressure condition, it doesn't directly fit the specified criteria for sepsis-associated hypotension. Thus, the alignment is weak.",
                "The claim directly references an elevated white blood cell count, which is explicitly listed as one of the criteria under the SIRS positivity category for identifying systemic inflammation. This aligns perfectly with the category, indicating early sepsis risk.",
                "The claim suggests that there are no rapidly worsening symptoms, which implies a stable clinical condition without alarming changes. This corresponds most closely with the concept behind the NEWS score, which tracks deranged vitals and deteriorating conditions. However, the absence of worsening symptoms does not directly indicate a NEWS score; hence, the alignment is weak but related to the context of monitoring for deterioration.",
                "The claim suggests the patient has a low risk for sepsis within 12 hours but does not provide specific information that matches any of the expert categories listed. Each category is used to identify factors or scores that increase sepsis risk, whereas the claim indicates a low risk without specifying why. Therefore, it does not align with any specific expert category provided."
            ],
            "final_alignment_score": 0.3142857142857142
        },
        {
            "input": "2: HR, 110.0; 2: RR, 20.0; 2: SpO2, 99.0; 2: SBP, 170.0; 2: DBP, 125.0; 2: MAP, 140.0; 2: Temp, 98.3; 7: Pain, 8.0; 23: POC, HCG, ISTAT QUALITATIVE: Negative; 23: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 35: SpO2, 96.875; 35: SBP, 166.0; 35: DBP, 133.0; 35: MAP, 144.0; 36: SpO2, 96.729; 36: Perf, 2.419; 36: SBP, 181.0; 36: DBP, 117.0; 36: MAP, 138.333; 37: SpO2, 96.793; 37: Perf, 3.050; 38: SpO2, 98.407; 38: Perf, 3.127; 39: SpO2, 97.810; 39: Perf, 3.470; 40: SpO2, 96.864; 40: Perf, 2.914; 41: SpO2, 97.305; 41: Perf, 2.716; 42: SpO2, 98.690; 42: Perf, 4.093; 43: SpO2, 99.0; 43: Perf, 4.271; 44: SpO2, 98.879; 44: Perf, 4.363; 45: SpO2, 98.898; 45: Perf, 3.121; 46: SpO2, 98.034; 46: Perf, 3.241; 47: SpO2, 98.345; 47: Perf, 5.429; 48: SpO2, 98.339; 48: Perf, 4.260; 49: SpO2, 98.121; 49: Perf, 5.469; 50: SpO2, 98.085; 50: Perf, 4.044; 51: SpO2, 98.441; 51: Perf, 3.807; 52: SpO2, 98.121; 52: Perf, 4.583; 53: SpO2, 99.086; 53: Perf, 2.823; 54: SpO2, 98.898; 54: Perf, 2.241; 55: SpO2, 98.831; 55: Perf, 2.983; 56: SpO2, 98.695; 56: Perf, 3.286; 57: SpO2, 98.0; 57: Perf, 4.375; 58: SpO2, 98.220; 58: Perf, 4.053; 59: SpO2, 97.793; 59: Perf, 4.217; 60: SpO2, 98.0; 60: Perf, 2.665; 61: SpO2, 98.712; 61: Perf, 2.182; 62: SpO2, 98.466; 62: Perf, 3.111; 63: SpO2, 98.475; 63: Perf, 2.669; 64: SpO2, 98.741; 64: Perf, 2.308; 65: SpO2, 99.0; 65: Perf, 2.785; 66: SpO2, 98.186; 66: Perf, 3.892; 67: ALT (SGPT), 79 U/L; 67: CHLORIDE, 103 mmol/L; 67: BILIRUBIN TOTAL, 0.4 mg/dL; 67: EGFR FOR AFRICAN AMERICAN, 148 mL/min/1.73 m2; 67: ALBUMIN, 4.2 g/dL; 67: CO2, 23 mmol/L; 67: EGFR REFIT WITHOUT RACE (2021), 128 mL/min/1.73 m2; 67: BLOOD UREA NITROGEN (BUN), 9 mg/dL; 67: CREATININE, 0.65 mg/dL; 67: SODIUM, 138 mmol/L; 67: PROTEIN TOTAL, 8.0 g/dL; 67: GLUCOSE, 130 mg/dL; 67: GLOBULIN, 3.8 g/dL; 67: CALCIUM, 9.5 mg/dL; 67: ANION GAP, 12 mmol/L; 67: CORRECTED CALCIUM, 9.3 mg/dL; 67: POTASSIUM, 4.3 mmol/L; 67: ALKALINE PHOSPHATASE, 109 U/L; 67: AST (SGOT), 48 U/L; 67: SpO2, 98.552; 67: Perf, 2.511; 68: SpO2, 98.458; 68: Perf, 2.268; 69: SpO2, 98.138; 69: Perf, 3.142; 70: WAM DIFTYP, AUTO; 70: LYMPHOCYTE % (AUTO DIFF), 31.8 %; 70: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.6 g/dL; 70: RED BLOOD CELLS (RBC), 5.35 MIL/uL; 70: NEUTROPHIL % (AUTO DIFF), 57.8 %; 70: RED CELL DISTRIBUTION WIDTH (RDW), 11.8 %; 70: MONOCYTE % (AUTO DIFF), 7.3 %; 70: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 70: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.0 pg; 70: PLATELET COUNT (PLT), 258 K/uL; 70: WHITE BLOOD CELLS (WBC), 12.5 K/uL; 70: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.29 K/uL; 70: NRBC PERCENT (HEMATOLOGY), 0.0 %; 70: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 70: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 70: BASOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 70: MONOCYTE ABSOLUTE (AUTO DIFF), 0.91 K/uL; 70: EOSINOPHIL % (AUTO DIFF), 2.3 %; 70: NEUTROPHIL ABSOLUTE (AUTO DIFF), 7.21 K/uL; 70: MEAN CORPUSCULAR VOLUME (MCV), 86.2 fL; 70: HEMATOCRIT (HCT), 46.1 %; 70: BASOPHIL % (AUTO DIFF), 0.4 %; 70: HEMOGLOBIN (HGB), 15.5 g/dL; 70: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 3.97 K/uL; 70: SpO2, 98.983; 70: Perf, 4.796; 71: SpO2, 98.638; 71: Perf, 4.103; 72: SpO2, 97.898; 72: Perf, 5.212; 73: SpO2, 97.949; 73: Perf, 6.655; 74: SpO2, 97.810; 74: Perf, 6.88; 75: SpO2, 97.712; 75: Perf, 7.503; 76: SpO2, 98.017; 76: Perf, 5.833; 77: SpO2, 98.068; 77: Perf, 5.273; 78: SpO2, 98.153; 78: Perf, 3.641; 79: SpO2, 97.534; 79: Perf, 4.4; 80: SpO2, 97.203; 80: Perf, 4.165; 81: SpO2, 97.569; 81: Perf, 4.237; 82: SpO2, 98.390; 82: Perf, 2.841; 83: SpO2, 98.407; 83: Perf, 1.946; 84: SpO2, 97.845; 84: Perf, 3.521; 85: SpO2, 98.017; 85: Perf, 3.399; 86: SpO2, 97.828; 86: Perf, 5.287; 87: SpO2, 97.542; 87: Perf, 5.983; 88: SpO2, 97.492; 88: Perf, 6.082; 89: SpO2, 97.534; 89: Perf, 6.151; 90: SpO2, 98.0; 90: Perf, 6.157; 91: SpO2, 98.103; 91: Perf, 4.832; 92: SpO2, 97.847; 92: Perf, 5.332; 92: ACETAMINOPHEN, 325 MG PO TABS; 92: IBUPROFEN, 400 MG PO TABS; 93: SpO2, 97.712; 93: Perf, 5.169; 93: LR IV BOLUS -, 1000 ML; 94: SpO, 2: 99.414; 94: Perf, 1.990; 94: Pain, 10.0; 94: HYDROMORPHONE, 1 MG/ML INJ SYRG; 95: SpO, 2: 99.0; 95: Perf, 3.394; 96: SpO2, 98.983; 96: Perf, 2.202; 97: SpO2, 98.305; 97: Perf, 3.937; 98: SARS-COV-2 RNA, Not Detected; 98: SpO2, 97.949; 98: Perf, 5.096; 99: SpO2, 97.810; 99: Perf, 4.267; 100: SpO2, 97.847; 100: Perf, 3.105; 101: SpO2, 97.776; 101: Perf, 2.793; 102: SpO2, 97.797; 102: Perf, 3.051; 103: SpO2, 98.328; 103: Perf, 2.511; 104: SpO2, 97.932; 104: Perf, 2.896; 105: SpO2, 97.5; 105: Perf, 2.787; 106: SpO2, 97.017; 106: Perf, 3.046; 107: SpO2, 96.797; 107: Perf, 3.829; 108: SpO2, 96.328; 108: Perf, 4.211; 109: SpO2, 96.508; 109: Perf, 4.35; 110: SpO2, 96.441; 110: Perf, 4.361; 111: SpO2, 96.914; 111: Perf, 4.117; 112: SpO2, 96.949; 112: Perf, 4.180; 113: SpO2, 97.672; 113: Perf, 3.597; 114: SpO2, 97.136; 114: Perf, 3.844; 115: SpO2, 97.793; 115: Perf, 3.008; 116: SpO2, 98.729; 116: Perf, 1.443; 117: SpO2, 99.448; 117: Perf, 1.378; 118: SpO2, 99.356; 118: Perf, 1.376; 119: SpO2, 98.627; 119: Perf, 1.548; 0: Age, 19; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.8; 0: Triage HR, 110.0; 0: Triage RR, 20.0; 0: Triage SBP, 170.0; 0: Triage DBP, 125.0; 0: Triage acuity, 3-Urgent; 0: CC, BLOOD IN URINE,ABDOMINAL PAIN",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "Despite initial hypertension and elevated heart rate, the patient's vital signs stabilize over time. The consistently normal oxygen saturation and perfusion index, along with laboratory results within normal ranges, do not indicate an acute or worsening condition. Additionally, the patient responds to pain medication and fluids, suggesting improvement rather than deterioration, making a high risk of developing sepsis unlikely.",
            "claims": [
                "The patient initially has hypertension and an elevated heart rate.",
                "The patient's vital signs stabilize over time.",
                "The oxygen saturation is consistently normal.",
                "The perfusion index is consistently normal.",
                "Laboratory results are within normal ranges.",
                "The vital signs do not indicate an acute or worsening condition.",
                "The patient responds to pain medication.",
                "The patient responds to fluids.",
                "The patient's response to treatment suggests improvement rather than deterioration.",
                "A high risk of developing sepsis is unlikely."
            ],
            "relevant_claims": [
                "The patient initially has hypertension and an elevated heart rate."
            ],
            "alignment_scores": [
                0.6
            ],
            "alignment_category": [
                "Elevated Shock Index (\u22651.0)"
            ],
            "alignment_reasonings": [
                "The claim mentions both hypertension and an elevated heart rate. While hypertension itself isn't directly mentioned in the elevated shock index criteria, the combination of high blood pressure and elevated heart rate points towards potential haemodynamic concerns. The elevated heart rate is part of the shock index calculation (heart rate \u00f7 systolic BP), indicating the category is somewhat applicable. However, without specifying the systolic BP or shock index calculation, the alignment isn't fully direct or specific."
            ],
            "final_alignment_score": 0.6
        },
        {
            "input": "6: Pain, 0.0; 16: HR, 110.0; 16: RR, 13.0; 16: SpO2, 97.0; 16: SBP, 126.0; 16: DBP, 108.0; 16: MAP, 114.0; 16: Temp, 97.7; 35: HR, 106.5; 35: RR, 24.346; 35: 1min HRV, 16.264; 36: HR, 108.483; 36: RR, 22.741; 36: SpO2, 86.5; 36: 1min HRV, 9.079; 37: HR, 106.458; 37: RR, 21.780; 37: 1min HRV, 19.289; 37: 5min HRV, 15.922; 38: HR, 104.793; 38: RR, 19.517; 38: SpO2, 97.4; 38: 1min HRV, 28.309; 39: HR, 106.237; 39: RR, 19.627; 39: SpO2, 98.0; 39: 1min HRV, 15.942; 40: HR, 101.254; 40: RR, 21.559; 40: SpO2, 99.714; 40: 1min HRV, 13.774; 41: HR, 102.086; 41: RR, 19.293; 41: SpO2, 99.459; 41: 1min HRV, 13.604; 42: HR, 102.898; 42: RR, 22.898; 42: SpO2, 99.0; 42: 1min HRV, 19.309; 42: 5min HRV, 20.796; 43: HR, 104.172; 43: RR, 20.310; 43: SpO2, 98.5; 43: Perf, 0.09; 43: 1min HRV, 13.262; 44: HR, 102.559; 44: RR, 23.898; 44: SpO2, 100.0; 44: Perf, 0.09; 44: 1min HRV, 12.124; 45: HR, 105.845; 45: RR, 22.483; 45: SpO2, 86.25; 45: Perf, 0.09; 45: 1min HRV, 8.539; 46: HR, 107.763; 46: RR, 23.237; 46: 1min HRV, 70.170; 47: HR, 101.407; 47: RR, 21.119; 47: SpO2, 96.409; 47: 1min HRV, 15.426; 47: 5min HRV, 36.245; 48: HR, 100.207; 48: RR, 20.517; 48: SpO2, 100.0; 48: 1min HRV, 27.094; 49: HR, 98.237; 49: RR, 20.119; 49: SpO2, 99.0; 49: 1min HRV, 12.805; 50: HR, 97.948; 50: RR, 24.276; 50: SpO2, 98.773; 50: Perf, 0.08; 50: 1min HRV, 16.305; 51: HR, 99.068; 51: RR, 25.390; 51: SpO2, 98.275; 51: Perf, 0.085; 51: 1min HRV, 35.372; 52: HR, 104.593; 52: RR, 19.102; 52: SpO2, 96.632; 52: Perf, 0.09; 52: 1min HRV, 10.054; 52: 5min HRV, 26.196; 53: HR, 103.931; 53: RR, 22.5; 53: SpO2, 99.390; 53: 1min HRV, 12.152; 54: HR, 103.203; 54: RR, 19.814; 54: SpO2, 100.0; 54: 1min HRV, 11.907; 55: HR, 104.259; 55: RR, 20.207; 55: SpO2, 99.933; 55: 1min HRV, 7.388; 56: HR, 105.661; 56: RR, 19.475; 56: SpO2, 99.939; 56: 1min HRV, 13.360; 57: HR, 104.724; 57: RR, 22.966; 57: SpO2, 100.0; 57: 1min HRV, 12.334; 57: 5min HRV, 12.666; 57: SBP, 99.0; 57: DBP, 65.0; 57: MAP, 76.333; 58: HR, 102.525; 58: RR, 20.220; 58: SpO2, 100.0; 58: 1min HRV, 20.083; 59: HR, 98.328; 59: RR, 16.862; 59: SpO2, 99.545; 59: Perf, 0.100; 59: 1min HRV, 34.211; 60: HR, 100.034; 60: RR, 19.203; 60: SpO2, 100.0; 60: Perf, 0.1; 60: 1min HRV, 10.732; 61: POC PH (V) ISTAT, 7.55; 61: POC HCO3 (V) ISTAT, 26.0 mmol/L; 61: POC LACTATE ISTAT, 1.13 mmol/L; 61: POC O2 SATURATION ISTAT VENOUS, 73 %; 61: POC PO2 (V) ISTAT, 33 mmHg; 61: POC PCO2 (V) ISTAT, 30.0 mmHg; 61: POC TCO2 (V) ISTAT, 27 mmol/L; 61: POC BASE EXCESS ISTAT, 4 mmol/L; 61: HR, 97.661; 61: RR, 19.508; 61: SpO2, 90.267; 61: 1min HRV, 10.219; 62: HR, 95.644; 62: RR, 20.322; 62: SpO2, 98.0; 62: 1min HRV, 17.941; 62: 5min HRV, 25.552; 63: HR, 94.483; 63: RR, 22.017; 63: SpO2, 95.0; 63: 1min HRV, 19.813; 63: SBP, 109.0; 63: DBP, 65.0; 63: MAP, 79.667; 64: HR, 95.288; 64: RR, 21.695; 64: 1min HRV, 9.077; 65: HR, 94.259; 65: RR, 21.897; 65: SpO2, 100.0; 65: 1min HRV, 35.389; 66: HR, 94.712; 66: RR, 22.814; 66: 1min HRV, 12.444; 67: HR, 95.576; 67: RR, 19.407; 67: SpO2, 99.0; 67: 1min HRV, 13.691; 67: 5min HRV, 20.499; 68: HR, 102.983; 68: RR, 21.190; 68: SpO2, 93.333; 68: 1min HRV, 29.881; 69: HR, 105.983; 69: RR, 19.759; 69: 1min HRV, 19.558; 70: HR, 105.898; 70: RR, 21.119; 70: 1min HRV, 20.311; 71: HR, 103.864; 71: RR, 19.390; 71: 1min HRV, 28.157; 72: HR, 94.831; 72: RR, 18.729; 72: SpO2, 98.946; 72: 1min HRV, 32.574; 72: 5min HRV, 38.943; 73: HR, 91.241; 73: RR, 23.483; 73: SpO2, 96.877; 73: 1min HRV, 26.875; 74: HR, 92.763; 74: RR, 23.254; 74: SpO2, 98.773; 74: 1min HRV, 27.392; 74: NORMOSOL-R IV BOLUS -, 1000 ML; 75: HR:, 87.534; 75: RR, 21.103; 75: SpO2, 95.188; 75: 1min HRV, 30.984; 76: HR, 87.237; 76: RR, 19.102; 76: SpO2, 99.25; 76: 1min HRV, 33.549; 77: HR, 88.534; 77: RR, 21.690; 77: SpO2, 99.077; 77: 1min HRV, 31.958; 77: 5min HRV, 34.560; 78: HR, 87.881; 78: RR, 22.814; 78: SpO2, 99.179; 78: 1min HRV, 14.725; 78: SBP, 103.0; 78: DBP, 61.0; 78: MAP, 75.0; 79: HR, 85.525; 79: RR, 17.0; 79: SpO2, 99.125; 79: Perf, 0.16; 79: 1min HRV, 24.524; 80: HR, 87.586; 80: RR, 21.828; 80: SpO2, 98.233; 80: Perf, 0.16; 80: 1min HRV, 23.789; 81: HR, 88.966; 81: RR, 17.322; 81: SpO2, 95.346; 81: 1min HRV, 20.920; 82: 5min HRV, 23.024; 94: EGFR FOR AFRICAN AMERICAN, 115 mL/min/1.73 m2; 94: PROTEIN TOTAL, 6.3 g/dL; 94: SODIUM, 131 mmol/L; 94: MAGNESIUM, 2.0 mg/dL; 94: AST (SGOT), 20 U/L; 94: CORRECTED CALCIUM, 9.2 mg/dL; 94: CREATININE, 0.46 mg/dL; 94: POTASSIUM, 3.8 mmol/L; 94: ANION GAP, 10 mmol/L; 94: BILIRUBIN TOTAL, 1.0 mg/dL; 94: ALBUMIN, 3.2 g/dL; 94: GLUCOSE, 124 mg/dL; 94: BLOOD UREA NITROGEN (BUN), 12 mg/dL; 94: ALKALINE PHOSPHATASE, 71 U/L; 94: ALT (SGPT), 14 U/L; 94: CO2, 25 mmol/L; 94: EGFR REFIT WITHOUT RACE (2021), 100 mL/min/1.73 m2; 94: CHLORIDE, 96 mmol/L; 94: GLOBULIN, 3.1 g/dL; 94: CALCIUM, 8.6 mg/dL; 104: SARS-COV-2 RNA, Not Detected; 113: TROPONIN I, <.017 ng/mL; 0: Age, 74; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.5; 0: Triage HR, 110.0; 0: Triage RR, 13.0; 0: Triage SBP, 126.0; 0: Triage DBP, 108.0; 0: Triage acuity, 2-Emergent; 0: CC, GENERAL WEAKNESS,COUGH",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The patient does not exhibit significant signs of sepsis risk within the next 12 hours. Vital signs such as heart rate, respiratory rate, blood pressure, and oxygen saturation remain relatively stable without significant deviations indicative of sepsis. Although there are occasional fluctuations, none reach levels typically associated with sepsis (e.g., severe hypotension, extreme tachycardia, or significant oxygen desaturation). The absence of markedly elevated lactate levels and normal laboratory values further support the low likelihood of sepsis progression.",
            "claims": [
                "The patient does not exhibit significant signs of sepsis risk within the next 12 hours.",
                "Vital signs such as heart rate, respiratory rate, blood pressure, and oxygen saturation remain relatively stable.",
                "There are no significant deviations in vital signs indicative of sepsis.",
                "Occasional fluctuations in vital signs do occur, but none reach levels typically associated with sepsis.",
                "Severe hypotension is not present.",
                "Extreme tachycardia is not present.",
                "Significant oxygen desaturation is not present.",
                "There is an absence of markedly elevated lactate levels.",
                "Normal laboratory values further support the low likelihood of sepsis progression."
            ],
            "relevant_claims": [
                "Occasional fluctuations in vital signs do occur, but none reach levels typically associated with sepsis.",
                "Significant oxygen desaturation is not present.",
                "There is an absence of markedly elevated lactate levels."
            ],
            "alignment_scores": [
                0.3,
                0.3,
                0.3
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "SOFA Score Increase (\u22652 points)",
                "Elevated Serum Lactate (\u22652 mmol/L)"
            ],
            "alignment_reasonings": [
                "The claim mentions fluctuations in vital signs, which is relevant to the NEWS Score category that assesses deranged vital signs predicting clinical deterioration. However, since it states that none of the vitals reach levels associated with sepsis, there is limited alignment with a high NEWS score (\u22655), indicating only a minor connection.",
                "Oxygen desaturation is related to impaired oxygenation, which is part of the SOFA scoring. However, the claim states that significant oxygen desaturation is not present, indicating that there is no current issue with oxygenation that would directly lead to a SOFA score change. Therefore, the alignment is minimal but relevant as it pertains to the assessment of oxygen-related risks.",
                "The claim directly references lactate levels, a key aspect of this category. However, the claim indicates an absence of markedly elevated lactate levels, suggesting no elevated risk from this specific criterion. Thus, while the reference to lactate is direct, the alignment with elevated sepsis risk according to this category is low."
            ],
            "final_alignment_score": 0.3
        },
        {
            "input": "5: HR, 95.0; 5: RR, 18.0; 5: SpO2, 99.0; 5: SBP, 131.0; 5: DBP, 71.0; 5: MAP, 91.0; 5: Pain, 10.0; 5: Temp, 100.0; 7: Pain, 10.0; 15: SpO2, 97.914; 15: Perf, 3.922; 15: SBP, 135.0; 15: DBP, 78.0; 15: MAP, 97.0; 16: SpO2, 97.621; 16: Perf, 4.766; 16: SBP, 128.0; 16: DBP, 76.0; 16: MAP, 93.333; 17: SpO2, 98.0; 17: Perf, 4.448; 18: SpO2, 97.431; 18: Perf, 4.878; 19: SpO2, 97.0; 19: Perf, 4.727; 20: SpO2, 97.508; 20: Perf, 4.079; 21: SpO2, 97.328; 21: Perf, 4.229; 22: SpO2, 97.831; 22: Perf, 3.967; 23: SpO2, 98.293; 23: Perf, 2.087; 24: SpO2, 97.729; 24: Perf, 3.178; 25: SpO2, 97.458; 25: Perf, 3.914; 26: SpO2, 97.759; 26: Perf, 3.689; 27: SpO2, 97.814; 27: Perf, 3.198; 28: SpO2, 97.345; 28: Perf, 3.3; 29: SpO2, 97.068; 29: Perf, 3.367; 30: SpO2, 97.0; 30: Perf, 3.384; 31: SpO2, 97.241; 31: Perf, 3.321; 32: SpO2, 97.932; 32: Perf, 3.390; 33: SpO2, 97.414; 33: Perf, 3.948; 34: SpO2, 97.119; 34: Perf, 4.267; 35: SpO2, 97.322; 35: Perf, 3.937; 36: SpO2, 97.569; 36: Perf, 3.674; 37: SpO2, 97.288; 37: Perf, 3.535; 38: SpO2, 97.845; 38: Perf, 3.626; 39: SpO2, 97.545; 39: Perf, 3.52; 40: SpO2, 97.805; 41: SpO2, 97.390; 41: Perf, 2.040; 42: SpO2, 97.542; 42: Perf, 3.324; 43: SpO2, 97.241; 43: Perf, 2.687; 44: SpO2, 97.051; 44: Perf, 2.293; 45: SpO2, 97.017; 45: Perf, 2.477; 46: SpO2, 97.0; 46: Perf, 2.558; 47: SpO2, 97.237; 47: Perf, 2.516; 48: SpO2, 97.0; 48: Perf, 2.645; 49: SpO2, 97.542; 49: Perf, 2.349; 50: SpO2, 97.328; 50: Perf, 2.295; 51: SpO2, 97.492; 51: Perf, 2.235; 52: SpO2, 97.814; 52: Perf, 2.463; 53: SpO2, 97.517; 53: Perf, 3.578; 54: SpO2, 97.153; 54: Perf, 3.237; 55: SpO2, 97.121; 55: Perf, 3.452; 56: SpO2, 97.017; 56: Perf, 4.274; 57: SpO2, 98.085; 57: Perf, 3.315; 58: SpO2, 97.379; 58: Perf, 3.838; 59: SpO2, 96.966; 59: Perf, 4.163; 60: SpO2, 96.759; 60: Perf, 3.612; 61: SpO2, 96.949; 61: Perf, 2.512; 62: SpO2, 97.0; 62: Perf, 2.677; 63: SpO2, 96.915; 63: Perf, 2.779; 64: SpO2, 97.305; 64: Perf, 2.938; 65: SpO2, 97.172; 65: Perf, 3.611; 66: SpO2, 98.932; 66: Perf, 2.547; 67: SpO2, 98.407; 67: Perf, 2.685; 68: SpO2, 97.914; 68: Perf, 2.764; 69: SpO2, 97.915; 69: Perf, 3.33; 70: SpO2, 97.862; 70: Perf, 2.763; 71: SpO2, 97.966; 71: Perf, 2.603; 72: SpO2, 97.759; 72: Perf, 3.783; 73: SpO2, 97.424; 73: Perf, 4.199; 74: SpO2, 96.746; 74: Perf, 3.387; 75: SpO2, 96.707; 75: Perf, 3.408; 76: SpO2, 96.780; 76: Perf, 3.828; 77: SpO2, 97.138; 77: Perf, 4.055; 78: SpO2, 97.271; 78: Perf, 4.364; 79: SpO2, 97.797; 79: Perf, 4.315; 80: SpO2, 98.0; 80: Perf, 4.72; 81: SpO2, 98.068; 81: Perf, 3.370; 82: SpO2, 97.914; 82: Perf, 4.015; 83: SpO2, 97.492; 83: Perf, 3.757; 84: SpO2, 97.763; 84: Perf, 3.819; 85: SpO2, 97.897; 85: Perf, 3.276; 86: SpO2, 97.864; 86: Perf, 3.438; 87: SpO2, 97.638; 87: Perf, 4.142; 88: SpO2, 97.339; 88: Perf, 3.754; 89: POC, HCG, ISTAT QUALITATIVE: Negative; 89: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 89: SpO2, 97.356; 89: Perf, 3.648; 90: SpO2, 97.759; 90: Perf, 2.604; 91: SpO2, 97.831; 91: Perf, 3.684; 91: LR IV BOLUS -, 1000 ML; 92: SpO, 2: 97.345; 92: Perf, 3.88; 93: SpO2, 97.288; 93: Perf, 3.398; 94: SpO2, 97.492; 94: Perf, 2.554; 95: SpO2, 97.259; 95: Perf, 3.043; 96: SpO2, 97.797; 96: Perf, 2.942; 97: SpO2, 97.793; 97: Perf, 2.923; 98: SpO2, 98.153; 98: Perf, 4.124; 99: SpO2, 98.190; 99: Perf, 4.331; 100: SpO2, 98.542; 100: Perf, 3.513; 101: SpO2, 98.203; 101: Perf, 3.262; 102: SpO2, 98.345; 102: Perf, 3.276; 103: SpO2, 98.305; 103: Perf, 3.638; 104: SpO2, 98.224; 104: Perf, 3.374; 105: SpO2, 98.0; 105: Perf, 3.113; 106: SpO2, 98.0; 106: Perf, 3.541; 107: SpO2, 98.0; 107: Perf, 3.784; 108: SpO2, 98.322; 108: Perf, 3.647; 109: SpO2, 98.293; 109: Perf, 2.863; 110: SpO2, 98.136; 110: Perf, 3.490; 111: WAM DIFTYP, AUTO; 111: PLATELET COUNT (PLT), 335 K/uL; 111: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.04 K/uL; 111: RED BLOOD CELLS (RBC), 4.56 MIL/uL; 111: HEMOGLOBIN (HGB), 12.0 g/dL; 111: EOSINOPHIL % (AUTO DIFF), 0.0 %; 111: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.62 K/uL; 111: MONOCYTE ABSOLUTE (AUTO DIFF), 1.12 K/uL; 111: LYMPHOCYTE % (AUTO DIFF), 11.4 %; 111: NEUTROPHIL % (AUTO DIFF), 79.7 %; 111: BASOPHIL % (AUTO DIFF), 0.2 %; 111: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 111: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 111: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 111: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.52 K/uL; 111: RED CELL DISTRIBUTION WIDTH (RDW), 15.5 %; 111: WHITE BLOOD CELLS (WBC), 13.3 K/uL; 111: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 26.3 pg; 111: MONOCYTE % (AUTO DIFF), 8.4 %; 111: HEMATOCRIT (HCT), 37.5 %; 111: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 111: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.0 g/dL; 111: MEAN CORPUSCULAR VOLUME (MCV), 82.2 fL; 111: NRBC PERCENT (HEMATOLOGY), 0.0 %; 111: SpO2, 98.034; 111: Perf, 3.432; 112: SpO2, 97.983; 112: Perf, 3.777; 113: SpO2, 98.0; 113: Perf, 4.029; 114: SpO2, 98.0; 114: Perf, 3.815; 115: SpO2, 98.034; 115: Perf, 3.668; 116: SpO2, 98.0; 116: Perf, 3.089; 117: SpO2, 98.121; 117: Perf, 3.028; 118: SpO2, 97.678; 118: Perf, 3.533; 119: SpO2, 97.086; 119: Perf, 3.043; 0: Age, 34; 0: Gender, F; 0: Race, Native Hawaiian or Other Pacific Islander; 0: Means of arrival, Self; 0: Triage Temp, 37.8; 0: Triage HR, 95.0; 0: Triage RR, 18.0; 0: Triage SBP, 131.0; 0: Triage DBP, 71.0; 0: Triage acuity, 5-Non-Urgent; 0: CC, PAIN TOOTH",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "Based on the provided EHR data, the patient does not appear to be at high risk of developing sepsis within the next 12 hours. The patient's vital signs, including heart rate, respiratory rate, blood pressure, and oxygen saturation, remain relatively stable and within normal ranges. Although there is a high pain score and mild fever initially, important blood parameters like white blood cell count and perfusion index do not indicate significant derangements typical of sepsis. Thus, no immediate high risk of sepsis is apparent.",
            "claims": [
                "The patient does not appear to be at high risk of developing sepsis within the next 12 hours.",
                "The patient's vital signs remain relatively stable.",
                "The patient's vital signs are within normal ranges.",
                "The patient has a high pain score initially.",
                "The patient has a mild fever initially.",
                "Important blood parameters like white blood cell count do not indicate significant derangements typical of sepsis.",
                "The perfusion index does not indicate significant derangements typical of sepsis.",
                "No immediate high risk of sepsis is apparent."
            ],
            "relevant_claims": [
                "The patient has a mild fever initially.",
                "Important blood parameters like white blood cell count do not indicate significant derangements typical of sepsis.",
                "The perfusion index does not indicate significant derangements typical of sepsis.",
                "No immediate high risk of sepsis is apparent."
            ],
            "alignment_scores": [
                0.3,
                0.8,
                0.3,
                0.3
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "A mild fever may indicate potential systemic inflammation, relevant to SIRS criteria, but the claim does not specify if the fever reaches the threshold of >38\u00b0C. The alignment is weak because \"mild\" suggests the fever may not meet the criteria for SIRS, thus diminishing its specificity as a sepsis predictor.",
                "The claim specifically mentions that the white blood cell count, a parameter explicitly listed under the SIRS criteria, does not show significant derangement. This directly relates to the absence of a SIRS criterion signal for systemic inflammation in early sepsis. The alignment is strong because WBC count is a specific component of the SIRS criteria, though the context is inverse (absence of derangement), reflecting a lower sepsis risk.",
                "The perfusion index is not directly mentioned in any of the given categories, but it is related to tissue perfusion and circulatory stability. The \"Elevated Serum Lactate\" category is associated with tissue hypoperfusion in sepsis. Although perfusion index and serum lactate are different measures, they both relate to the circulation's efficacy. The claim indicates no significant derangements in the perfusion index, suggesting no current concerns for tissue hypoperfusion, so there is a weak indirect alignment given the focus on perfusion metrics in the category.",
                "The claim suggests that there is no immediate high risk of sepsis, which may imply that predictive scores like NEWS are not currently elevated (NEWS below 5 points). While no specific category perfectly matches a statement of low risk, the absence of a high NEWS score aligns to some extent with no immediate sepsis risk. The severity and news-based assessment are implicitly considered though not explicitly mentioned; hence, the alignment rating is relatively low."
            ],
            "final_alignment_score": 0.42500000000000004
        },
        {
            "input": "7: HR, 117.0; 7: RR, 21.0; 7: SpO2, 99.0; 7: SBP, 143.0; 7: DBP, 92.0; 7: MAP, 109.0; 7: Pain, 1.0; 7: Temp, 98.4; 25: POC, HCG, ISTAT QUALITATIVE: Positive; 25: POC, BHCG, ISTAT QUANTITATIVE: >2000.0 IU/L; 35: WAM DIFTYP, AUTO; 35: MEAN CORPUSCULAR VOLUME (MCV), 82.4 fL; 35: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 35: RED CELL DISTRIBUTION WIDTH (RDW), 11.9 %; 35: MONOCYTE ABSOLUTE (AUTO DIFF), 0.73 K/uL; 35: PLATELET COUNT (PLT), 229 K/uL; 35: RED BLOOD CELLS (RBC), 5.22 MIL/uL; 35: MONOCYTE % (AUTO DIFF), 9.4 %; 35: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.7 pg; 35: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 35: EOSINOPHIL % (AUTO DIFF), 0.4 %; 35: HEMATOCRIT (HCT), 43.0 %; 35: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 35: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 35: LYMPHOCYTE % (AUTO DIFF), 25.2 %; 35: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 35: HEMOGLOBIN (HGB), 15.0 g/dL; 35: WHITE BLOOD CELLS (WBC), 7.8 K/uL; 35: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.96 K/uL; 35: BASOPHIL % (AUTO DIFF), 0.3 %; 35: NRBC PERCENT (HEMATOLOGY), 0.0 %; 35: NEUTROPHIL ABSOLUTE (AUTO DIFF), 5.02 K/uL; 35: NEUTROPHIL % (AUTO DIFF), 64.3 %; 35: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.9 g/dL; 36: SpO2, 99.333; 37: SpO2, 99.458; 37: Perf, 1.035; 38: SpO2, 99.153; 38: Perf, 0.986; 39: SpO2, 99.0; 39: Perf, 1.041; 40: SpO2, 99.085; 40: Perf, 0.993; 41: SpO2, 99.517; 41: Perf, 0.938; 42: SpO2, 99.051; 42: Perf, 0.87; 43: SpO2, 99.0; 43: Perf, 1.305; 44: SpO2, 98.879; 44: Perf, 2.141; 45: SpO2, 98.746; 45: Perf, 1.711; 46: SpO2, 98.586; 46: Perf, 1.433; 47: SpO2, 98.932; 47: Perf, 1.495; 48: SpO2, 99.0; 48: Perf, 1.245; 49: SpO2, 99.0; 49: Perf, 1.705; 50: SpO2, 99.0; 50: Perf, 1.848; 51: SpO2, 99.310; 51: Perf, 1.121; 52: SpO2, 99.458; 52: Perf, 0.928; 53: SpO2, 99.864; 53: Perf, 0.844; 53: LR IV BOLUS -, 1000 ML; 54: SpO, 2: 99.5; 54: Perf, 0.705; 55: SpO2, 99.593; 55: Perf, 0.620; 56: SpO2, 100.0; 56: Perf, 0.649; 57: SpO2, 99.237; 57: Perf, 0.774; 58: SpO2, 99.203; 58: Perf, 0.742; 59: SpO2, 100.0; 59: Perf, 0.723; 60: SpO2, 99.458; 60: Perf, 0.647; 61: SpO2, 100.0; 61: Perf, 0.638; 62: GLUCOSE, URINE (UA): Negative; 62: SPECIFIC GRAVITY, URINE (UA): 1.028; 62: BLOOD, URINE (UA): Negative; 62: NITRITE, URINE (UA): Negative; 62: PH, URINE (UA): 6.0; 62: SpO2, 99.288; 62: Perf, 0.617; 63: SpO2, 99.931; 63: Perf, 0.602; 64: SpO2, 99.759; 64: Perf, 0.59; 65: INR, 1.3; 65: PART. THROMBOPLASTIN TIME, 29.9 seconds; 65: PROTHROMBIN TIME, 16.4 seconds; 65: SpO2, 99.229; 65: Perf, 0.584; 66: POTASSIUM, 3.2 mmol/L; 66: ALKALINE PHOSPHATASE, 165 U/L; 66: AST (SGOT), 103 U/L; 66: ALT (SGPT), 222 U/L; 66: CREATININE, 0.47 mg/dL; 66: GLOBULIN, 3.6 g/dL; 66: SODIUM, 135 mmol/L; 66: EGFR REFIT WITHOUT RACE (2021), 123 mL/min/1.73 m2; 66: CALCIUM, 9.8 mg/dL; 66: GLUCOSE, 104 mg/dL; 66: CORRECTED CALCIUM, 9.5 mg/dL; 66: ANION GAP, 15 mmol/L; 66: BILIRUBIN TOTAL, 1.0 mg/dL; 66: PROTEIN TOTAL, 8.0 g/dL; 66: LIPASE, 66 U/L; 66: CO2, 23 mmol/L; 66: ALBUMIN, 4.4 g/dL; 66: BLOOD UREA NITROGEN (BUN), 8 mg/dL; 66: EGFR FOR AFRICAN AMERICAN, 142 mL/min/1.73 m2; 66: CHLORIDE, 97 mmol/L; 66: SpO2, 100.0; 66: Perf, 0.583; 67: SpO2, 100.0; 67: Perf, 0.564; 68: SpO2, 100.0; 68: Perf, 0.563; 69: SpO2, 100.0; 69: Perf, 0.597; 70: SpO2, 99.881; 70: Perf, 0.587; 71: SpO2, 99.897; 71: Perf, 0.568; 72: SpO2, 100.0; 72: Perf, 0.541; 73: SpO2, 99.931; 73: Perf, 0.524; 74: SpO2, 100.0; 74: Perf, 0.507; 75: SpO2, 100.0; 75: Perf, 0.523; 76: SARS-COV-2 RNA, Not Detected; 76: SpO2, 100.0; 76: Perf, 0.531; 77: SpO2, 100.0; 77: Perf, 0.511; 78: SpO2, 100.0; 78: Perf, 0.512; 79: SpO2, 100.0; 79: Perf, 0.500; 80: SpO2, 100.0; 80: Perf, 0.504; 81: SpO2, 99.793; 81: Perf, 0.511; 82: SpO2, 99.271; 82: Perf, 0.52; 83: SpO2, 99.931; 83: Perf, 0.522; 84: SpO2, 100.0; 84: Perf, 0.553; 85: ANTIBODY SCREEN 3, NEG; 85: ABO/RH (AUTOMATION), O Positive; 85: BLOOD TYPE VERIFICATION-AUTOMATION, O Positive; 85: SpO2, 100.0; 85: Perf, 0.55; 86: SpO2, 99.914; 86: Perf, 0.55; 87: SpO2, 99.220; 87: Perf, 0.55; 88: SpO2, 100.0; 88: Perf, 0.524; 89: SpO2, 100.0; 89: Perf, 0.529; 90: SpO2, 100.0; 90: Perf, 0.527; 91: SpO2, 100.0; 91: Perf, 0.525; 92: SpO2, 100.0; 92: Perf, 0.54; 93: SpO2, 99.8; 93: Perf, 0.534; 94: SpO2, 100.0; 94: Perf, 0.528; 95: SpO2, 99.845; 95: Perf, 0.547; 96: SpO2, 100.0; 96: Perf, 0.53; 97: SpO2, 99.949; 97: Perf, 0.53; 98: SpO2, 99.842; 98: Perf, 0.53; 99: SpO2, 99.881; 99: Perf, 0.53; 100: SpO2, 99.931; 100: Perf, 0.53; 101: SpO2, 99.982; 101: Perf, 0.538; 102: SpO2, 100.0; 102: Perf, 0.539; 103: SpO2, 100.0; 103: Perf, 0.56; 104: SpO2, 100.0; 104: Perf, 0.575; 105: SpO2, 99.911; 105: Perf, 0.562; 106: SpO2, 98.538; 106: Perf, 0.56; 107: SpO2, 99.288; 107: Perf, 0.552; 108: SpO2, 99.707; 108: Perf, 0.559; 109: SpO2, 99.864; 109: Perf, 0.571; 110: SpO2, 99.931; 110: Perf, 0.58; 111: SpO2, 100.0; 111: Perf, 0.584; 112: SpO2, 100.0; 112: Perf, 0.586; 112: DOXYLAMINE-PYRIDOXINE (VIT B, 6) 10-10 MG PO TBEC; 112: ZZZ, IMS TEMPLATE; 113: SpO2, 100.0; 113: Perf, 0.649; 114: SpO2, 100.0; 114: Perf, 0.693; 115: SpO2, 100.0; 115: Perf, 0.658; 116: SpO2, 100.0; 116: Perf, 0.625; 0: Age, 41; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.9; 0: Triage HR, 117.0; 0: Triage RR, 21.0; 0: Triage SBP, 143.0; 0: Triage DBP, 92.0; 0: Triage acuity, 3-Urgent; 0: CC, ABDOMINAL PAIN",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The patient's vital signs, including heart rate, respiratory rate, blood pressure, and SpO2, are stable and within normal ranges aside from initially elevated heart rate and respiratory rate, which can occur with pain or stress. The bloodwork does not indicate any significant signs of infection or organ dysfunction typically associated with sepsis, such as leukocytosis or elevated lactate levels. Additionally, there is no mention of signs that would indicate systemic infection or inflammatory response within this timeframe, indicating a low risk for sepsis within the next 12 hours.",
            "claims": [
                "The patient's vital signs are stable and within normal ranges.",
                "The heart rate is initially elevated.",
                "The respiratory rate is initially elevated.",
                "Elevated heart rate and respiratory rate can occur with pain or stress.",
                "The bloodwork does not indicate any significant signs of infection.",
                "The bloodwork does not indicate any significant signs of organ dysfunction.",
                "Leukocytosis is typically associated with sepsis.",
                "Elevated lactate levels are typically associated with sepsis.",
                "There is no mention of signs indicating systemic infection within this timeframe.",
                "There is no mention of signs indicating inflammatory response within this timeframe.",
                "The lack of significant findings indicates a low risk for sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The heart rate is initially elevated.",
                "Elevated heart rate and respiratory rate can occur with pain or stress.",
                "There is no mention of signs indicating systemic infection within this timeframe.",
                "There is no mention of signs indicating inflammatory response within this timeframe."
            ],
            "alignment_scores": [
                0.7,
                0.5,
                0.3,
                0.7
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "SIRS Positivity (\u22652 Criteria)"
            ],
            "alignment_reasonings": [
                "An elevated heart rate is one of the criteria for SIRS, which helps identify systemic inflammation indicative of early sepsis. While the claim notes only the heart rate and not the presence of at least two criteria required for SIRS positivity, it directly matches part of the description, leading to a strong but not complete alignment.",
                "Elevated heart rate and respiratory rate are both criteria used for diagnosing SIRS, which relates to systemic inflammation and can be indicative of early sepsis. However, the claim notes that these can occur due to pain or stress as well, not exclusively sepsis-related causes. Thus, while there is some alignment with the SIRS criteria, the explanation given does not directly implicate a sepsis-related cause, leading to a moderate alignment rating.",
                "The claim suggests an absence of signs indicating systemic infection, which indirectly aligns with a lack of urgency typically prompting early antibiotic administration or blood culture collection. This reflects a lower suspicion of acute infection in line with early sepsis risk recognition. However, since there is no direct mention of early interventions, the alignment is weak.",
                "The claim refers to the lack of signs indicating an inflammatory response, which suggests an assessment in terms of the SIRS criteria, as these criteria (e.g., abnormal temperature, heart rate, or WBC count) are used to detect systemic inflammation. While the absence of these signs means the patient might not meet SIRS criteria, the claim's relevance to the process of evaluating these signs justifies a relatively high alignment rating."
            ],
            "final_alignment_score": 0.55
        },
        {
            "input": "23: HR, 110.0; 23: RR, 18.0; 23: SpO2, 99.0; 23: SBP, 108.0; 23: DBP, 51.0; 23: MAP, 70.0; 23: Pain, 0.0; 23: Temp, 100.6; 51: HR, 102.542; 51: RR, 18.780; 51: 1min HRV, 30.357; 52: HR, 101.707; 52: RR, 20.155; 52: 1min HRV, 3.753; 53: HR, 104.932; 53: RR, 20.983; 53: SpO2, 98.0; 53: 1min HRV, 30.198; 53: 5min HRV, 25.872; 54: HR, 109.966; 54: RR, 22.707; 54: 1min HRV, 9.378; 55: HR, 108.271; 55: RR, 19.339; 55: SpO2, 98.278; 55: 1min HRV, 22.000; 56: HR, 107.345; 56: RR, 19.362; 56: SpO2, 98.15; 56: 1min HRV, 31.490; 57: HR, 105.881; 57: RR, 17.458; 57: SpO2, 98.0; 57: 1min HRV, 14.197; 58: HR, 102.847; 58: RR, 19.966; 58: 1min HRV, 8.543; 58: 5min HRV, 22.600; 59: HR, 107.431; 59: RR, 19.397; 59: SpO2, 81.0; 59: 1min HRV, 20.253; 60: HR, 106.288; 60: RR, 18.780; 60: 1min HRV, 10.695; 61: HR, 107.103; 61: RR, 19.241; 61: 1min HRV, 14.181; 62: HR, 107.458; 62: RR, 17.695; 62: SpO2, 95.207; 62: 1min HRV, 9.273; 63: HR, 110.203; 63: RR, 19.390; 63: SpO2, 83.444; 63: 1min HRV, 26.656; 63: 5min HRV, 18.861; 64: HR, 106.690; 64: RR, 16.328; 64: SpO2, 92.0; 64: 1min HRV, 10.083; 64: SBP, 119.0; 64: DBP, 58.0; 64: MAP, 78.333; 65: HR, 104.593; 65: RR, 17.508; 65: 1min HRV, 3.740; 66: HR, 102.121; 66: RR, 19.707; 66: SpO2, 99.0; 66: 1min HRV, 7.077; 67: HR, 99.220; 67: RR, 19.254; 67: 1min HRV, 34.203; 68: HR, 97.288; 68: RR, 19.0; 68: 1min HRV, 3.403; 68: 5min HRV, 25.038; 69: HR, 98.310; 69: RR, 18.966; 69: SpO2, 97.4; 69: Perf, 0.146; 69: 1min HRV, 34.288; 70: HR, 96.864; 70: RR, 19.797; 70: SpO2, 99.0; 70: Perf, 0.18; 70: 1min HRV, 5.437; 71: HR, 97.207; 71: RR, 19.414; 71: SpO2, 98.846; 71: Perf, 0.180; 71: 1min HRV, 7.924; 72: HR, 99.136; 72: RR, 19.864; 72: SpO2, 99.492; 72: Perf, 0.511; 72: 1min HRV, 9.633; 73: HR, 101.627; 73: RR, 19.186; 73: SpO2, 99.791; 73: Perf, 0.436; 73: 1min HRV, 49.909; 73: 5min HRV, 29.921; 74: HR, 100.759; 74: RR, 18.672; 74: SpO2, 100.0; 74: Perf, 0.183; 74: 1min HRV, 20.317; 75: HR, 99.136; 75: RR, 16.932; 75: 1min HRV, 28.707; 76: HR, 98.966; 76: RR, 18.862; 76: 1min HRV, 35.558; 77: HR, 96.966; 77: RR, 18.458; 77: SpO2, 100.0; 77: Perf, 0.1; 77: 1min HRV, 10.755; 78: HR, 96.458; 78: RR, 19.746; 78: 1min HRV, 4.215; 78: 5min HRV, 25.348; 79: HR, 96.172; 79: RR, 19.155; 79: SpO2, 100.0; 79: Perf, 0.21; 79: 1min HRV, 25.924; 80: HR, 95.610; 80: RR, 19.525; 80: SpO2, 100.0; 80: Perf, 0.191; 80: 1min HRV, 10.023; 81: HR, 95.828; 81: RR, 19.931; 81: SpO2, 100.0; 81: Perf, 0.198; 81: 1min HRV, 25.357; 82: HR, 96.017; 82: RR, 20.576; 82: SpO2, 100.0; 82: Perf, 0.298; 82: 1min HRV, 8.397; 83: HR, 97.186; 83: RR, 19.932; 83: SpO2, 99.508; 83: Perf, 0.428; 83: 1min HRV, 9.429; 83: 5min HRV, 18.159; 84: HR, 98.138; 84: RR, 20.948; 84: SpO2, 99.156; 84: Perf, 0.339; 84: 1min HRV, 37.668; 85: HR, 96.661; 85: RR, 18.644; 85: SpO2, 100.0; 85: Perf, 0.201; 85: 1min HRV, 25.358; 86: HR, 96.310; 86: RR, 18.603; 86: SpO2, 100.0; 86: Perf, 0.254; 86: 1min HRV, 34.768; 87: HR, 97.373; 87: RR, 19.288; 87: SpO2, 100.0; 87: Perf, 0.271; 87: 1min HRV, 25.799; 88: HR, 98.259; 88: RR, 21.103; 88: SpO2, 99.469; 88: Perf, 0.433; 88: 1min HRV, 28.125; 88: 5min HRV, 31.007; 89: ACETAMINOPHEN, 1 000 MG/100 ML (10 MG/ML) IV SOLN; 90: NS IV BOLUS -, 30 ML/KG; 91: POC PH (V) ISTAT, 7.44; 91: POC PCO2 (V) ISTAT, 47.9 mmHg; 91: POC O2 SATURATION ISTAT VENOUS, 65 %; 91: POC HCO3 (V) ISTAT, 32.5 mmol/L; 91: POC TCO2 (V) ISTAT, 34 mmol/L; 91: POC PO2 (V) ISTAT, 33 mmHg; 91: POC BASE EXCESS ISTAT, 8 mmol/L; 91: POC LACTATE ISTAT, 0.72 mmol/L; 93: HR, 97.0; 93: RR, 19.0; 93: SpO2, 100.0; 93: SBP, 88.0; 93: DBP, 48.0; 93: MAP, 61.333; 95: WAM DIFTYP, AUTO; 95: HEMOGLOBIN (HGB), 11.5 g/dL; 95: WHITE BLOOD CELLS (WBC), 28.8 K/uL; 95: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 95: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 95: EOSINOPHIL % (AUTO DIFF), 0.0 %; 95: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.44 K/uL; 95: MEAN CORPUSCULAR VOLUME (MCV), 89.3 fL; 95: BASOPHIL % (AUTO DIFF), 0.3 %; 95: NRBC PERCENT (HEMATOLOGY), 0.0 %; 95: RED CELL DISTRIBUTION WIDTH (RDW), 13.3 %; 95: NEUTROPHIL ABSOLUTE (AUTO DIFF), 27.13 K/uL; 95: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.44 K/uL; 95: HEMATOCRIT (HCT), 35.7 %; 95: LYMPHOCYTE % (AUTO DIFF), 1.5 %; 95: RED BLOOD CELLS (RBC), 4.00 MIL/uL; 95: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.5 %; 95: MONOCYTE % (AUTO DIFF), 2.6 %; 95: NEUTROPHIL % (AUTO DIFF), 94.1 %; 95: BASOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 95: PLATELET COUNT (PLT), 255 K/uL; 95: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.8 pg; 95: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.2 g/dL; 95: MONOCYTE ABSOLUTE (AUTO DIFF), 0.75 K/uL; 104: HR, 92.0; 104: RR, 19.0; 104: SpO2, 99.0; 104: SBP, 90.0; 104: DBP, 41.0; 104: MAP, 57.333; 113: PART. THROMBOPLASTIN TIME, 37.1 seconds; 116: INR, 1.1; 116: PROTHROMBIN TIME, 14.2 seconds; 118: HR, 92.0; 118: RR, 13.0; 118: SpO2, 100.0; 118: SBP, 106.0; 118: DBP, 82.0; 118: MAP, 90.0; 0: Age, 69; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 38.1; 0: Triage HR, 110.0; 0: Triage RR, 18.0; 0: Triage SBP, 108.0; 0: Triage DBP, 51.0; 0: Triage acuity, 3-Urgent; 0: CC, ACUTE NEUROLOGICAL PROBLEM",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The data indicates several concerning signs consistent with sepsis risk. Initially, the patient exhibits tachycardia (HR consistently above 100), fever (elevated temperature), and hypotension (low DBP and SBP values). SpO2 levels also fluctuate, dropping to critically low levels on occasion. The lab results show elevated white blood cell count, primarily neutrophils, which further suggests a possible infection. Decreased blood pressure over time and the requirement for IV bolus indicates fluid resuscitation efforts, commonly associated with managing sepsis. All these factors combined suggest a high risk of developing sepsis within the next 12 hours.",
            "claims": [
                "The data indicates several concerning signs consistent with sepsis risk.",
                "The patient exhibits tachycardia.",
                "Tachycardia is defined as a heart rate consistently above 100.",
                "The patient has a fever, which is an elevated temperature.",
                "The patient has hypotension, indicated by low diastolic and systolic blood pressure values.",
                "SpO2 levels fluctuate and drop to critically low levels on occasion.",
                "Lab results show an elevated white blood cell count.",
                "The elevated white blood cell count primarily consists of neutrophils.",
                "The presence of elevated neutrophils further suggests a possible infection.",
                "There is decreased blood pressure over time.",
                "The patient requires IV bolus for fluid resuscitation efforts.",
                "Fluid resuscitation efforts are commonly associated with managing sepsis.",
                "All these factors combined suggest a high risk of developing sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The data indicates several concerning signs consistent with sepsis risk.",
                "The patient exhibits tachycardia.",
                "Tachycardia is defined as a heart rate consistently above 100.",
                "The patient has a fever, which is an elevated temperature.",
                "The patient has hypotension, indicated by low diastolic and systolic blood pressure values.",
                "SpO2 levels fluctuate and drop to critically low levels on occasion.",
                "Lab results show an elevated white blood cell count.",
                "The elevated white blood cell count primarily consists of neutrophils.",
                "The presence of elevated neutrophils further suggests a possible infection.",
                "The patient requires IV bolus for fluid resuscitation efforts.",
                "All these factors combined suggest a high risk of developing sepsis within the next 12 hours."
            ],
            "alignment_scores": [
                0.3,
                0.7,
                0.9,
                0.7,
                0.9,
                0.7,
                1.0,
                0.8,
                0.8,
                0.8,
                0.3
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "SOFA Score Increase (\u22652 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "AElevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "The claim mentions \"several concerning signs,\" which is suggestive of a composite assessment akin to the NEWS score, used for predicting clinical deterioration including sepsis risk. However, the claim doesn't specify elevated vital signs or any NEWS components, leading to a weak alignment.",
                "Tachycardia is directly mentioned as one of the criteria for SIRS, which requires a heart rate >90 bpm. This fits well with the category used to identify systemic inflammation and potential early sepsis. The alignment is strong, but without additional SIRS criteria, it's not complete, hence the rating of 0.7.",
                "Tachycardia (heart rate > 90 bpm) is one of the criteria listed under the SIRS criteria. The claim specifies a heart rate consistently above 100, which exceeds the SIRS threshold, demonstrating a strong alignment. The alignment rating of 0.9 reflects its direct relevance to this criterion.",
                "A fever indicates an elevated temperature, which is one of the criteria for SIRS. Although the exact temperature isn't specified, fever is closely related to the first SIRS criterion (temperature\u202f>\u202f38\u202f\u00b0C or\u202f<\u202f36\u202f\u00b0C). Given the link to systemic inflammation consistent with early sepsis, the category is relevant, though not enough detail is provided to confirm full SIRS adherence, thus the 0.7 rating.",
                "The claim explicitly mentions hypotension with low diastolic and systolic blood pressure values. While the claim does not provide specific numerical values or thresholds, the mention of hypotension strongly suggests an alignment with the category of sepsis-associated hypotension. Therefore, the alignment rating is high, reflecting the direct relevance to this expert category focused on identifying progression toward septic shock through hypotensive signs.",
                "The claim about fluctuating and critically low SpO2 levels suggests issues with oxygenation. This indirectly relates to the SOFA score component involving impaired oxygenation (PaO\u2082/FiO\u2082). While SpO2 isn't a direct measure in the SOFA score, it is conceptually related to the patient's respiratory status and potential organ dysfunction, hence a moderately strong alignment.",
                "An elevated white blood cell (WBC) count is explicitly listed as one of the criteria for SIRS (Systemic Inflammatory Response Syndrome), which is used to identify systemic inflammation consistent with early sepsis. This makes the alignment with the SIRS category direct and complete.",
                "An elevated white blood cell count, especially with a predominance of neutrophils, typically indicates an acute inflammatory or infectious process, which aligns with the SIRS criteria. However, the strict SIRS criteria specify WBC count >\u202f12\u202f000/\u00b5L or\u202f<\u202f4\u202f000/\u00b5L, but does not explicitly differentiate based on neutrophil predominance. Therefore, while the claim is closely related to the SIRS criteria, it isn't precisely the same criterion, which slightly reduces the alignment.",
                "Elevated neutrophils are indicative of an inflammatory response, which is commonly associated with infection. This aligns with the SIRS criteria of systemic inflammation. While elevated neutrophils aren't explicitly listed as a SIRS criterion, they are strongly linked to the concept of systemic inflammation typical of early sepsis, which is why the alignment rating is high but not perfect.",
                "The need for an IV bolus for fluid resuscitation suggests the patient may be experiencing hemodynamic instability, likely due to hypotension, which aligns with the Sepsis-Associated Hypotension category. This category highlights hypotension as a critical factor indicating progression toward septic shock. While the claim does not directly mention blood pressure readings, fluid resuscitation is a standard response to hypotensive states associated with sepsis, thus showing strong alignment.",
                "The claim refers to a combination of factors leading to a high risk of developing sepsis. This indirectly suggests a systemic evaluation akin to what the National Early Warning Score (NEWS) considers in predicting clinical deterioration. However, the claim lacks specificity about deranged vital signs necessary to directly point to an elevated NEWS score, hence a lower alignment rating."
            ],
            "final_alignment_score": 0.7181818181818181
        },
        {
            "input": "6: POC PH (V) ISTAT, 7.40; 6: POC LACTATE ISTAT, 0.71 mmol/L; 6: POC TCO2 (V) ISTAT, 19 mmol/L; 6: POC BASE EXCESS ISTAT, -7 mmol/L; 6: POC O2 SATURATION ISTAT VENOUS, 60 %; 6: POC PCO2 (V) ISTAT, 29.3 mmHg; 6: POC PO2 (V) ISTAT, 31 mmHg; 6: POC HCO3 (V) ISTAT, 18.0 mmol/L; 6: HR, 121.914; 6: RR, 17.690; 6: SpO2, 95.375; 6: 1min HRV, 1.823; 7: HR, 120.917; 7: RR, 20.717; 7: SpO2, 92.481; 7: 1min HRV, 6.958; 7: 5min HRV, 5.598; 8: HR, 119.483; 8: RR, 17.655; 8: SpO2, 96.975; 8: 1min HRV, 9.738; 9: HR, 122.0; 9: RR, 16.345; 9: SpO2, 96.294; 9: 1min HRV, 8.179; 10: HR, 120.525; 10: RR, 18.475; 10: SpO2, 88.769; 10: 1min HRV, 3.283; 10: LR IV BOLUS -, 1000 ML; 11: HR:, 119.448; 11: RR, 17.914; 11: SpO2, 89.429; 11: 1min HRV, 23.147; 11: ACETAMINOPHEN, 500 MG PO TABS; 12: HR:, 120.085; 12: RR, 14.051; 12: SpO2, 97.771; 12: 1min HRV, 7.207; 12: 5min HRV, 13.143; 12: SBP, 173.0; 12: DBP, 62.0; 12: MAP, 99.0; 13: HR, 120.966; 13: RR, 13.169; 13: SpO2, 96.971; 13: Perf, 0.165; 13: 1min HRV, 10.376; 13: Pain, 0.0; 13: Temp, 102.4; 14: HR, 120.879; 14: RR, 16.983; 14: SpO2, 98.2; 14: Perf, 0.16; 14: 1min HRV, 14.064; 15: HR, 122.356; 15: RR, 17.169; 15: SpO2, 95.0; 15: 1min HRV, 15.639; 16: HR, 122.847; 16: RR, 19.034; 16: SpO2, 98.741; 16: 1min HRV, 15.173; 17: HR, 123.085; 17: RR, 18.102; 17: 1min HRV, 11.870; 17: 5min HRV, 13.939; 18: HR, 122.052; 18: RR, 16.379; 18: SpO2, 92.308; 18: 1min HRV, 11.822; 18: SBP, 173.0; 18: DBP, 62.0; 18: MAP, 99.0; 19: HR, 121.915; 19: RR, 15.644; 19: 1min HRV, 9.792; 20: HR, 121.690; 20: RR, 15.793; 20: 1min HRV, 10.705; 21: HR, 120.695; 21: RR, 15.864; 21: SpO2, 85.457; 21: 1min HRV, 11.401; 22: HR, 121.845; 22: RR, 17.259; 22: SpO2, 94.048; 22: 1min HRV, 14.298; 22: 5min HRV, 11.833; 23: HR, 126.576; 23: RR, 18.373; 23: SpO2, 99.75; 23: 1min HRV, 11.039; 24: HR, 122.508; 24: RR, 15.559; 24: SpO2, 98.0; 24: 1min HRV, 6.847; 25: HR, 120.086; 25: RR, 19.069; 25: 1min HRV, 9.427; 26: HR, 117.763; 26: RR, 14.898; 26: 1min HRV, 11.920; 27: HR, 115.672; 27: RR, 12.552; 27: SpO2, 99.647; 27: 1min HRV, 17.602; 27: 5min HRV, 20.318; 27: SBP, 123.0; 27: DBP, 60.0; 27: MAP, 81.0; 28: HR, 113.797; 28: RR, 14.254; 28: SpO2, 99.695; 28: Perf, 0.213; 28: 1min HRV, 16.678; 29: HR, 113.186; 29: RR, 16.254; 29: SpO2, 99.711; 29: Perf, 0.238; 29: 1min HRV, 11.265; 30: HR, 111.914; 30: RR, 14.328; 30: SpO2, 98.877; 30: Perf, 0.267; 30: 1min HRV, 9.598; 30: SBP, 123.0; 30: DBP, 60.0; 30: MAP, 81.0; 31: HR, 113.254; 31: RR, 21.593; 31: SpO2, 97.136; 31: Perf, 0.297; 31: 1min HRV, 11.016; 32: HR, 113.707; 32: RR, 14.655; 32: SpO2, 96.483; 32: Perf, 0.34; 32: 1min HRV, 12.366; 32: 5min HRV, 12.877; 33: HR, 112.746; 33: RR, 14.356; 33: SpO2, 96.814; 33: Perf, 0.374; 33: 1min HRV, 14.593; 33: SBP, 139.0; 33: DBP, 65.0; 33: MAP, 89.667; 34: HR, 112.288; 34: RR, 15.492; 34: SpO2, 98.237; 34: Perf, 0.428; 34: 1min HRV, 14.612; 35: HR, 111.241; 35: RR, 16.810; 35: SpO2, 99.690; 35: Perf, 0.468; 35: 1min HRV, 17.067; 36: HR, 111.237; 36: RR, 15.220; 36: SpO2, 99.797; 36: Perf, 0.480; 36: 1min HRV, 13.064; 37: 5min HRV, 15.203; 42: HR, 109.0; 42: RR, 13.0; 42: SpO2, 99.0; 50: RBC MORPHOLOGY (SLIDE REVIEW), Abnormal; 50: RED CELL DISTRIBUTION WIDTH (RDW), 14.3 %; 50: RED BLOOD CELLS (RBC), 2.92 MIL/uL; 50: WHITE BLOOD CELLS (WBC), 1.1 K/uL; 50: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.9 g/dL; 50: HEMOGLOBIN (HGB), 9.2 g/dL; 50: MEAN CORPUSCULAR VOLUME (MCV), 92.8 fL; 50: HEMATOCRIT (HCT), 27.1 %; 50: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.5 pg; 50: PLATELET COUNT (PLT), 299 K/uL; 50: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 0.66 K/uL; 50: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 0.15 K/uL; 50: MONOCYTES % (MANUAL DIFF), 17.9 %; 50: METAMYELOCYTES ABSOLUTE (MANUAL DIFF), 0.06 K/uL; 50: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 51.7 %; 50: METAMYELOCYTES % (MANUAL DIFF), 5.4 %; 50: LYMPHOCYTES % (MANUAL DIFF), 14.3 %; 50: NEUTROPHILS BANDS % (MANUAL DIFF), 10.7 %; 50: MONOCYTES ABSOLUTE (MANUAL DIFF), 0.19 K/uL; 51: NITRITE, URINE (UA): Negative; 51: GLUCOSE, URINE (UA): Negative; 51: SPECIFIC GRAVITY, URINE (UA): 1.011; 51: KETONE, URINE (UA): Negative; 51: PH, URINE (UA): 8.0; 52: HIGH SENSITIVITY TROPONIN, 13 ng/L; 58: RSV, Not Detected; 58: SARS-COV-2 RNA, Not Detected; 58: INFLUENZA B, Not Detected; 58: INFLUENZA A, Not Detected; 90: ANION GAP, 18 mmol/L; 90: CHLORIDE, 95 mmol/L; 90: LIPASE, 15 U/L; 90: ALT (SGPT), 102 U/L; 90: CALCIUM, 8.2 mg/dL; 90: CREATININE, 5.54 mg/dL; 90: ALKALINE PHOSPHATASE, 121 U/L; 90: CO2, 16 mmol/L; 90: AST (SGOT), 27 U/L; 90: CORRECTED CALCIUM, 9.2 mg/dL; 90: GLUCOSE, 127 mg/dL; 90: BILIRUBIN TOTAL, 0.5 mg/dL; 90: SODIUM, 129 mmol/L; 90: BLOOD UREA NITROGEN (BUN), 88 mg/dL; 90: GLOBULIN, 3.0 g/dL; 90: EGFR REFIT WITHOUT RACE (2021), 10 mL/min/1.73 m2; 90: PROTEIN TOTAL, 5.8 g/dL; 90: ALBUMIN, 2.8 g/dL; 90: POTASSIUM, 4.9 mmol/L; 114: HR, 91.0; 114: RR, 12.0; 114: SpO2, 97.0; 114: SBP, 100.0; 114: DBP, 51.0; 114: MAP, 67.333; 117: CEFEPIME, 2 GRAM/20 ML IV PUSH; 0: Age:, 75; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, EMS; 0: Triage Temp, 39.1; 0: Triage HR, 123.0; 0: Triage RR, 13.0; 0: Triage SBP, 173.0; 0: Triage DBP, 62.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER",
            "answer": false,
            "llm_answer": "Yes",
            "llm_explanation": "The patient is at high risk of developing sepsis within 12 hours. Indicators include fever (39.1\u00b0C initial and 102.4\u00b0F later), elevated heart rate (consistently around 120 bpm), elevated respiratory rate, low oxygen saturation at times (as low as 85.457%), low blood pressure emerging over time, and critical lab values such as low white blood cell count (1.1 K/uL) which could indicate severe sepsis or septic shock. Additionally, the administration of a broad-spectrum antibiotic (CEFEPIME) suggests a concern for bacterial infection.",
            "claims": [
                "The patient is at high risk of developing sepsis within 12 hours.",
                "Indicators of high risk include fever.",
                "The patient's initial temperature is 39.1\u00b0C.",
                "The patient's later temperature is 102.4\u00b0F.",
                "The patient has an elevated heart rate that is consistently around 120 bpm.",
                "The patient has an elevated respiratory rate.",
                "The patient's oxygen saturation is low at times.",
                "The patient's oxygen saturation has been as low as 85.457%.",
                "The patient is experiencing low blood pressure emerging over time.",
                "The patient has critical lab values, including a low white blood cell count.",
                "The patient's white blood cell count is 1.1 K/uL.",
                "A low white blood cell count could indicate severe sepsis or septic shock.",
                "The administration of a broad-spectrum antibiotic (CEFEPIME) suggests a concern for bacterial infection."
            ],
            "relevant_claims": [
                "Indicators of high risk include fever.",
                "The patient's initial temperature is 39.1\u00b0C.",
                "The patient's later temperature is 102.4\u00b0F.",
                "The patient has an elevated heart rate that is consistently around 120 bpm.",
                "The patient has an elevated respiratory rate.",
                "The patient's oxygen saturation is low at times.",
                "The patient's oxygen saturation has been as low as 85.457%.",
                "The patient's white blood cell count is 1.1 K/uL.",
                "A low white blood cell count could indicate severe sepsis or septic shock.",
                "The administration of a broad-spectrum antibiotic (CEFEPIME) suggests a concern for bacterial infection."
            ],
            "alignment_scores": [
                0.7,
                0.9,
                0.9,
                0.8,
                0.5,
                0.5,
                0.7,
                1.0,
                0.8,
                0.8
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Early Antibiotic/Culture Orders (within 2 hours)"
            ],
            "alignment_reasonings": [
                "Fever is a component of the SIRS criteria, relevant to identifying systemic inflammation indicating potential sepsis. However, the claim references only one SIRS criterion (fever) without specifying if there are others present. Thus, the alignment is strong but not complete, as two or more criteria are required to satisfy full SIRS positivity.",
                "The claim specifies an initial temperature of 39.1\u00b0C, which exceeds the SIRS criterion of >38\u00b0C for temperature. This directly relates to one of the SIRS criteria used to identify systemic inflammation consistent with early sepsis. While this addresses only one of the needed two criteria for full SIRS positivity, the temperature overlap is clear, indicating a strong alignment though not complete SIRS positivity by itself.",
                "The claim mentions a temperature of 102.4\u00b0F, which is equivalent to approximately 39.1\u00b0C, exceeding the SIRS threshold of >38\u00b0C. This directly corresponds to one of the SIRS criteria for early sepsis detection. However, as SIRS requires the presence of \u22652 criteria and only one criterion is mentioned in the claim, the alignment is not entirely complete, resulting in a rating less than perfect.",
                "The claim identifies an elevated heart rate (120 bpm), which is a specific criterion under SIRS (heart rate > 90 bpm). This criterion is used in the identification of systemic inflammation consistent with early sepsis. The elevated heart rate aligns directly with one of the SIRS criteria, yielding a high alignment rating. However, to fully meet the SIRS criteria, additional signs would be needed, such as abnormal temperature or white blood cell count. Nevertheless, given the heart rate data alone, the alignment is quite strong.",
                "An elevated respiratory rate is specifically one of the criteria listed for SIRS positivity (respiratory rate > 20/min). While the claim suggests the presence of one SIRS criterion, it does not specify whether there are enough criteria (\u22652) to confirm SIRS positivity. The alignment is partial because it pertains to the category but is not comprehensive in itself.",
                "Low oxygen saturation can imply oxygenation issues, which is related to the PaO\u2082/FiO\u2082 component of the SOFA score. While the claim points to potential respiratory compromise, it does not specify the precise metrics used in the SOFA score; therefore, the alignment is indirect and considered moderate.",
                "The claim of an oxygen saturation as low as 85.457% suggests significant hypoxia. While not explicitly a SOFA score component, hypoxia relates to impaired oxygenation, akin to a low PaO\u2082/FiO\u2082 ratio, which can increase the SOFA score. Thus, the alignment is indirect but significant, justifying a relatively high alignment rating.",
                "A white blood cell (WBC) count of 1.1 K/uL is below the SIRS threshold of <4,000/\u00b5L, indicating one of the criteria for SIRS positivity. This category specifically identifies changes in WBC count as a marker of systemic inflammation consistent with early sepsis. Therefore, the alignment with the claim is direct and strong.",
                "The claim of a low white blood cell count aligns with the SIRS criteria, specifically the condition where WBC\u202f<\u202f4\u202f000/\u00b5L is noted as a sign of systemic inflammation consistent with early sepsis. However, the claim suggests severe sepsis or septic shock, which is why the alignment is slightly less than perfect since the SIRS criteria primarily indicate early sepsis rather than severe forms. Thus, it aligns strongly but not perfectly with the SIRS criteria.",
                "The claim explicitly mentions the administration of a broad-spectrum antibiotic, which aligns well with the category of Early Antibiotic/Culture Orders within 2 hours. This action signifies a clinician\u2019s suspicion of a serious bacterial infection. The strong alignment suggests that this is a relevant indicator for assessing sepsis risk, though the timing within 2 hours is not specified, preventing a perfect score."
            ],
            "final_alignment_score": 0.76
        },
        {
            "input": "2: HR, 118.203; 2: RR, 29.864; 2: 1min HRV, 19.480; 3: HR, 119.772; 3: RR, 31.491; 3: SpO2, 93.0; 3: 1min HRV, 13.682; 3: 5min HRV, 17.005; 3: SBP, 128.0; 3: DBP, 58.0; 3: MAP, 81.333; 3: Pain, 0.0; 3: Temp, 97.7; 4: HR, 117.932; 4: RR, 30.593; 4: 1min HRV, 5.148; 5: HR, 115.305; 5: RR, 28.949; 5: 1min HRV, 10.322; 6: HR, 114.780; 6: RR, 28.525; 6: 1min HRV, 11.839; 7: HR, 115.610; 7: RR, 31.085; 7: SpO2, 93.714; 7: 1min HRV, 2.882; 8: HR, 114.862; 8: RR, 31.190; 8: 1min HRV, 5.909; 8: 5min HRV, 9.255; 9: HR, 114.932; 9: RR, 29.610; 9: 1min HRV, 8.274; 9: LPM O2, 40.0; 10: HR, 116.534; 10: RR, 28.483; 10: 1min HRV, 4.634; 11: HR, 116.390; 11: RR, 32.288; 11: 1min HRV, 5.701; 12: HR, 117.136; 12: RR, 32.508; 12: 1min HRV, 3.381; 13: HR, 115.966; 13: RR, 31.207; 13: SpO2, 94.0; 13: 1min HRV, 6.246; 13: 5min HRV, 6.479; 13: SBP, 119.0; 13: DBP, 61.0; 13: MAP, 80.333; 14: HR, 115.288; 14: RR, 34.322; 14: 1min HRV, 5.104; 14: SBP, 119.0; 14: DBP, 61.0; 14: MAP, 80.333; 15: HR, 116.172; 15: RR, 33.034; 15: SpO2, 95.0; 15: 1min HRV, 4.809; 16: HR, 114.672; 16: RR, 28.983; 16: SpO2, 95.167; 16: 1min HRV, 5.476; 17: HR, 113.033; 17: RR, 28.733; 17: SpO2, 63.0; 17: 1min HRV, 12.735; 18: HR, 117.293; 18: RR, 34.759; 18: SpO2, 74.25; 18: 1min HRV, 2.955; 18: 5min HRV, 9.442; 19: HR, 115.559; 19: RR, 31.475; 19: 1min HRV, 4.644; 20: HR, 114.983; 20: RR, 30.534; 20: SpO2, 84.571; 20: 1min HRV, 4.050; 21: HR, 117.288; 21: RR, 32.627; 21: 1min HRV, 14.262; 22: HR, 118.254; 22: RR, 34.847; 22: 1min HRV, 5.690; 23: HR, 117.672; 23: RR, 31.603; 23: 1min HRV, 4.177; 23: 5min HRV, 9.773; 24: HR, 117.864; 24: RR, 32.729; 24: SpO2, 69.905; 24: 1min HRV, 3.418; 25: HR, 119.293; 25: RR, 32.397; 25: SpO2, 68.0; 25: 1min HRV, 4.237; 26: HR, 117.576; 26: RR, 34.339; 26: SpO2, 92.333; 26: 1min HRV, 3.865; 27: HR, 117.203; 27: RR, 32.746; 27: SpO2, 82.857; 27: 1min HRV, 7.649; 28: HR, 117.259; 28: RR, 34.845; 28: SpO2, 93.964; 28: 1min HRV, 11.532; 28: 5min HRV, 7.533; 28: SBP, 129.0; 28: DBP, 68.0; 28: MAP, 88.333; 29: HR, 117.797; 29: RR, 33.203; 29: SpO2, 93.068; 29: Perf, 1.153; 29: 1min HRV, 5.902; 29: SBP, 129.0; 29: DBP, 68.0; 29: MAP, 88.333; 29: LPM O2, 50.0; 29: CEFEPIME, 2 GRAM/20 ML IV PUSH; 30: HR:, 115.690; 30: RR, 31.655; 30: SpO2, 91.276; 30: Perf, 0.995; 30: 1min HRV, 6.757; 31: HR, 120.203; 31: RR, 35.881; 31: SpO2, 89.983; 31: Perf, 1.044; 31: 1min HRV, 5.140; 32: HR, 118.644; 32: RR, 32.746; 32: SpO2, 93.542; 32: Perf, 1.100; 32: 1min HRV, 3.802; 33: HR, 115.155; 33: RR, 26.983; 33: SpO2, 96.138; 33: Perf, 0.922; 33: 1min HRV, 11.808; 33: 5min HRV, 11.632; 37: METRONIDAZOLE IN NACL (ISO-OS), 500 MG/100 ML IV PGBK; 39: HR:, 122.0; 39: RR, 34.0; 39: SpO2, 93.0; 41: HR, 126.0; 41: RR, 36.0; 41: SpO2, 90.0; 41: LPM O2, 70.0; 43: HR, 122.0; 43: RR, 34.0; 43: SpO2, 95.0; 55: LPM O2, 50.0; 58: ALKALINE PHOSPHATASE, 72 U/L; 58: EGFR FOR AFRICAN AMERICAN, 69 mL/min/1.73 m2; 58: AST (SGOT), 127 U/L; 58: GLUCOSE, 136 mg/dL; 58: CREATININE, 1.11 mg/dL; 58: PROTEIN TOTAL, 6.9 g/dL; 58: EGFR REFIT WITHOUT RACE (2021), 60 mL/min/1.73 m2; 58: POTASSIUM, 4.1 mmol/L; 58: ALBUMIN, 3.3 g/dL; 58: ALT (SGPT), 84 U/L; 58: ANION GAP, 11 mmol/L; 58: BLOOD UREA NITROGEN (BUN), 35 mg/dL; 58: CO2, 26 mmol/L; 58: CHLORIDE, 105 mmol/L; 58: CALCIUM, 9.1 mg/dL; 58: SODIUM, 142 mmol/L; 58: GLOBULIN, 3.6 g/dL; 58: BILIRUBIN TOTAL, 0.5 mg/dL; 58: CORRECTED CALCIUM, 9.7 mg/dL; 59: INR, 1.1; 59: PROTHROMBIN TIME, 14.2 seconds; 70: WAM DIFTYP, AUTO; 70: RBC MORPHOLOGY (SLIDE REVIEW), Abnormal; 70: HEMOGLOBIN (HGB), 9.8 g/dL; 70: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 4.4 %; 70: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 1.01 K/uL; 70: MEAN CORPUSCULAR VOLUME (MCV), 94.8 fL; 70: BASOPHIL % (AUTO DIFF), 0.3 %; 70: NRBC PERCENT (HEMATOLOGY), 1.9 %; 70: RED CELL DISTRIBUTION WIDTH (RDW), 21.2 %; 70: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.90 K/uL; 70: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.8 pg; 70: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.6 g/dL; 70: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 70: WHITE BLOOD CELLS (WBC), 22.7 K/uL; 70: LYMPHOCYTE % (AUTO DIFF), 4.0 %; 70: NEUTROPHIL ABSOLUTE (AUTO DIFF), 19.79 K/uL; 70: MONOCYTE ABSOLUTE (AUTO DIFF), 0.93 K/uL; 70: HEMATOCRIT (HCT), 29.2 %; 70: BASOPHIL ABSOLUTE (AUTO DIFF), 0.07 K/uL; 70: NEUTROPHIL % (AUTO DIFF), 87.2 %; 70: EOSINOPHIL % (AUTO DIFF), 0.0 %; 70: MONOCYTE % (AUTO DIFF), 4.1 %; 70: RED BLOOD CELLS (RBC), 3.08 MIL/uL; 70: NRBC ABSOLUTE (HEMATOLOGY), 0.42 K/uL; 70: PLATELET COUNT (PLT), 500 K/uL; 89: PART. THROMBOPLASTIN TIME, 20.3 seconds; 0: Age, 86; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, EMS; 0: Triage Temp, 36.5; 0: Triage HR, 115.0; 0: Triage RR, 32.0; 0: Triage SBP, 128.0; 0: Triage DBP, 58.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient shows several signs that indicate a high risk of sepsis: he is elderly, and his vital signs reveal tachycardia (elevated heart rate), tachypnea (increased respiratory rate), and low SpO2 levels. The elevated White Blood Cell (WBC) count, high neutrophil percentage, and the presence of immature granulocytes suggest an ongoing infection or inflammatory process. The administration of antibiotics such as Cefepime also implies concern for a serious bacterial infection, which aligns with the clinical scenario of sepsis.",
            "claims": [
                "The patient is elderly.",
                "The patient shows several signs that indicate a high risk of sepsis.",
                "The patient's vital signs reveal tachycardia.",
                "Tachycardia indicates an elevated heart rate.",
                "The patient's vital signs reveal tachypnea.",
                "Tachypnea indicates an increased respiratory rate.",
                "The patient has low SpO2 levels.",
                "An elevated White Blood Cell (WBC) count suggests an ongoing infection or inflammatory process.",
                "A high neutrophil percentage suggests an ongoing infection or inflammatory process.",
                "The presence of immature granulocytes suggests an ongoing infection or inflammatory process.",
                "The administration of antibiotics such as Cefepime implies concern for a serious bacterial infection.",
                "The concern for a serious bacterial infection aligns with the clinical scenario of sepsis."
            ],
            "relevant_claims": [
                "The patient is elderly.",
                "The patient shows several signs that indicate a high risk of sepsis.",
                "The patient's vital signs reveal tachycardia.",
                "Tachycardia indicates an elevated heart rate.",
                "The patient's vital signs reveal tachypnea.",
                "Tachypnea indicates an increased respiratory rate.",
                "The patient has low SpO2 levels.",
                "An elevated White Blood Cell (WBC) count suggests an ongoing infection or inflammatory process.",
                "A high neutrophil percentage suggests an ongoing infection or inflammatory process.",
                "The presence of immature granulocytes suggests an ongoing infection or inflammatory process.",
                "The administration of antibiotics such as Cefepime implies concern for a serious bacterial infection.",
                "The concern for a serious bacterial infection aligns with the clinical scenario of sepsis."
            ],
            "alignment_scores": [
                0.9,
                0.3,
                0.7,
                0.7,
                0.8,
                0.8,
                0.6,
                1.0,
                0.8,
                0.7,
                0.9,
                0.5
            ],
            "alignment_category": [
                "Elderly Susceptibility (Age \u226565 years)",
                "Elevated NEWS Score (\u22655 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SOFA Score Increase (\u22652 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "Early Antibiotic/Culture Orders (within 2 hours)"
            ],
            "alignment_reasonings": [
                "The claim indicates that the patient is \"elderly,\" which is closely associated with the category focusing on risk due to advanced age (\u2265\u202f65 years). Although the exact age isn't specified, the term \"elderly\" typically implies an age that could markedly increase susceptibility to sepsis, indicating a strong but not absolute alignment without specific age verification.",
                "The claim generally mentions \"several signs\" indicating high sepsis risk, which conceptually aligns with NEWS score components that assess overall clinical deterioration. However, it lacks specifics such as deranged vitals or an actual score, resulting in low alignment.",
                "Tachycardia, defined as a heart rate >90 bpm, is explicitly listed as one of the SIRS criteria. While the claim mentions only one criterion (tachycardia), which is not enough to fulfill the requirement of \u22652 criteria for SIRS positivity, it is still directly relevant to the category. Therefore, the alignment is strong but not perfect.",
                "Tachycardia, or an elevated heart rate, is directly mentioned as a criterion for SIRS (heart rate\u202f>\u202f90\u202fbpm). The claim identifies this specific component of the SIRS criteria, which aligns well, although it doesn't specify whether other criteria are met, thus limiting the alignment with the full SIRS category.",
                "Tachypnea, defined as an elevated respiratory rate, is a defining element of the SIRS criteria (respiratory rate > 20/min). While the claim specifies tachypnea, it does not provide an exact respiratory rate to confirm whether it meets the SIRS threshold, so there is some slight ambiguity. However, the alignment is strong as tachypnea is indicative of systemic inflammation and early sepsis risk.",
                "Tachypnea, or increased respiratory rate, is directly referenced in the SIRS criteria, which includes a respiratory rate >20/min. This aligns closely with SIRS Positivity, indicating systemic inflammation consistent with early sepsis. However, since only one SIRS criterion is mentioned here, the alignment is strong but not complete, warranting a slightly less than full score.",
                "Low SpO2 levels indicate possible impaired oxygenation, which relates to the respiratory component of the SOFA score (i.e., PaO\u2082/FiO\u2082 ratio < 300). Although SpO2 is not a direct measure in the SOFA criteria, it is conceptually aligned with assessing respiratory function and potential organ dysfunction, which is associated with high sepsis risk. The alignment is indirect but relevant.",
                "An elevated White Blood Cell (WBC) count is explicitly mentioned as a criterion under the SIRS categories. The claim directly references this exact criterion, which is used to identify systemic inflammation consistent with early sepsis, thus perfectly aligning with the category.",
                "The claim about a high neutrophil percentage indicates systemic inflammation or an infection, closely related to the presence of SIRS criteria which would include signs of systemic inflammation or infection. While neutrophil percentage is not explicitly listed in the SIRS criteria, it is part of the white blood cell count consideration, making the alignment relatively strong.",
                "Immature granulocytes indicate an inflammatory or infectious process, which aligns conceptually with the systemic inflammation detected by SIRS criteria. While the presence of immature granulocytes isn't listed explicitly as a SIRS criterion, it strongly suggests a similar underlying process, making the alignment meaningful though indirect.",
                "The claim clearly refers to the administration of antibiotics, which is a concrete clinical action indicating serious infection. This suggests a strong alignment with the category. The alignment rating is high as antibiotic administration implies clinician suspicion of infection, closely related to sepsis risk, although it does not specify the timeframe of administration.",
                "The claim indicates a concern for serious bacterial infection, which often results in actions such as antibiotic administration or culture orders to assess for sepsis. However, the claim does not specify these actions being taken, hence partial alignment with this category."
            ],
            "final_alignment_score": 0.725
        },
        {
            "input": "5: HR, 88.0; 5: RR, 18.0; 5: SpO2, 96.0; 5: SBP, 95.0; 5: DBP, 67.0; 5: MAP, 76.333; 5: LPM O2, 2.0; 5: Temp, 98.2; 30: SpO2, 84.833; 31: SpO2, 88.586; 31: Perf, 0.691; 32: SpO2, 94.914; 32: Perf, 0.687; 33: SpO2, 95.567; 33: Perf, 0.734; 35: SpO2, 93.0; 36: SpO2, 90.449; 36: Perf, 0.51; 37: SpO2, 94.882; 37: SBP, 117.0; 37: DBP, 73.0; 37: MAP, 87.667; 38: HR, 88.9; 38: RR, 17.3; 38: SpO2, 92.897; 38: Perf, 0.577; 38: 1min HRV, 14.986; 39: HR, 89.780; 39: RR, 17.169; 39: SpO2, 93.712; 39: Perf, 0.677; 39: 1min HRV, 30.180; 40: HR, 88.407; 40: RR, 17.305; 40: SpO2, 92.434; 40: Perf, 0.698; 40: 1min HRV, 22.725; 40: 5min HRV, 24.935; 41: HR, 92.552; 41: RR, 19.276; 41: Perf, 0.7; 41: 1min HRV, 8.933; 42: HR, 88.102; 42: RR, 19.932; 42: SpO2, 96.0; 42: Perf, 0.702; 42: 1min HRV, 7.636; 43: HR, 86.175; 43: RR, 14.579; 43: SpO2, 96.807; 43: Perf, 0.838; 43: 1min HRV, 57.636; 44: HR, 86.881; 44: RR, 14.203; 44: SpO2, 95.898; 44: Perf, 0.925; 44: 1min HRV, 10.901; 45: HR, 86.288; 45: RR, 14.610; 45: SpO2, 96.373; 45: Perf, 0.903; 45: 1min HRV, 10.896; 45: 5min HRV, 31.860; 46: HR, 83.931; 46: RR, 9.255; 46: SpO2, 97.190; 46: Perf, 0.938; 46: 1min HRV, 10.150; 46: SBP, 105.0; 46: DBP, 72.0; 46: MAP, 83.0; 47: HR, 82.220; 47: RR, 7.271; 47: SpO2, 97.915; 47: Perf, 1.276; 47: 1min HRV, 9.098; 48: HR, 82.862; 48: RR, 11.793; 48: SpO2, 97.776; 48: Perf, 1.498; 48: 1min HRV, 7.660; 49: HR, 80.763; 49: RR, 13.102; 49: SpO2, 98.0; 49: Perf, 1.572; 49: 1min HRV, 8.148; 50: HR, 80.017; 50: RR, 10.203; 50: SpO2, 98.0; 50: Perf, 1.647; 50: 1min HRV, 7.351; 50: 5min HRV, 16.456; 51: HR, 80.586; 51: RR, 10.862; 51: SpO2, 98.0; 51: Perf, 1.438; 51: 1min HRV, 12.821; 52: HR, 82.186; 52: RR, 16.898; 52: SpO2, 97.780; 52: Perf, 1.173; 52: 1min HRV, 11.858; 53: HR, 83.534; 53: RR, 16.379; 53: SpO2, 97.776; 53: Perf, 1.011; 53: 1min HRV, 7.071; 54: HR, 84.121; 54: RR, 15.586; 54: SpO2, 97.586; 54: Perf, 1.138; 54: 1min HRV, 59.900; 55: HR, 83.305; 55: RR, 15.153; 55: SpO2, 97.576; 55: Perf, 1.345; 55: 1min HRV, 6.728; 55: 5min HRV, 30.099; 56: HR, 84.672; 56: RR, 17.534; 56: SpO2, 98.017; 56: Perf, 1.370; 56: 1min HRV, 8.407; 57: HR, 84.712; 57: RR, 16.559; 57: SpO2, 98.085; 57: Perf, 1.307; 57: 1min HRV, 10.786; 58: HR, 84.328; 58: RR, 14.776; 58: SpO2, 97.621; 58: Perf, 1.295; 58: 1min HRV, 8.478; 59: HR, 82.644; 59: RR, 14.407; 59: SpO2, 98.881; 59: Perf, 1.187; 59: 1min HRV, 10.463; 60: HR, 82.220; 60: RR, 14.458; 60: SpO2, 98.644; 60: Perf, 1.084; 60: 1min HRV, 8.076; 60: 5min HRV, 12.758; 60: SBP, 106.0; 60: DBP, 69.0; 60: MAP, 81.333; 60: LPM O2, 2.0; 61: POC PH (V) ISTAT, 7.44; 61: POC PO2 (V) ISTAT, 37 mmHg; 61: POC HCO3 (V) ISTAT, 29.5 mmol/L; 61: POC TCO2 (V) ISTAT, 31 mmol/L; 61: POC O2 SATURATION ISTAT VENOUS, 73 %; 61: POC BASE EXCESS ISTAT, 5 mmol/L; 61: POC PCO2 (V) ISTAT, 43.5 mmHg; 61: POC LACTATE ISTAT, 1.26 mmol/L; 61: HR, 83.241; 61: RR, 15.448; 61: SpO2, 98.086; 61: Perf, 1.09; 61: 1min HRV, 9.775; 61: SBP, 106.0; 61: DBP, nan; 61: MAP, nan; 62: HR, 82.898; 62: RR, 16.661; 62: SpO2, 98.068; 62: Perf, 1.344; 62: 1min HRV, 7.296; 63: HR, 83.569; 63: RR, 17.052; 63: SpO2, 97.897; 63: Perf, 1.436; 63: 1min HRV, 27.513; 64: HR, 81.627; 64: RR, 17.576; 64: SpO2, 98.102; 64: Perf, 1.201; 64: 1min HRV, 11.323; 65: HR, 82.053; 65: RR, 17.877; 65: SpO2, 98.754; 65: Perf, 1.020; 65: 1min HRV, 60.692; 65: 5min HRV, 31.430; 66: HR, 82.0; 66: RR, 13.407; 66: SpO2, 97.424; 66: Perf, 0.810; 66: 1min HRV, 10.620; 67: HR, 82.136; 67: RR, 11.407; 67: SpO2, 98.0; 67: Perf, 0.766; 67: 1min HRV, 8.232; 68: HR, 81.776; 68: RR, 10.862; 68: SpO2, 97.759; 68: Perf, 1.136; 68: 1min HRV, 9.964; 69: HR, 80.814; 69: RR, 10.542; 69: SpO2, 97.153; 69: Perf, 1.262; 69: 1min HRV, 12.166; 70: HR, 81.914; 70: RR, 10.534; 70: SpO2, 97.172; 70: Perf, 1.313; 70: 1min HRV, 11.149; 70: 5min HRV, 11.017; 84: HYDROMORPHONE, 1 MG/ML INJ SYRG; 85: ONDANSETRON, 4 MG PO TBDL; 89: WAM DIFTYP, AUTO; 89: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 89: BASOPHIL % (AUTO DIFF), 0.4 %; 89: LYMPHOCYTE % (AUTO DIFF), 16.8 %; 89: NEUTROPHIL ABSOLUTE (AUTO DIFF), 8.82 K/uL; 89: RED CELL DISTRIBUTION WIDTH (RDW), 18.1 %; 89: HEMOGLOBIN (HGB), 9.7 g/dL; 89: HEMATOCRIT (HCT), 30.2 %; 89: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.27 K/uL; 89: RED BLOOD CELLS (RBC), 3.17 MIL/uL; 89: WHITE BLOOD CELLS (WBC), 13.5 K/uL; 89: MEAN CORPUSCULAR VOLUME (MCV), 95.3 fL; 89: NRBC ABSOLUTE (HEMATOLOGY), 0.05 K/uL; 89: BASOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 89: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.60 K/uL; 89: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 4.5 %; 89: NEUTROPHIL % (AUTO DIFF), 65.5 %; 89: MONOCYTE ABSOLUTE (AUTO DIFF), 1.69 K/uL; 89: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.6 pg; 89: PLATELET COUNT (PLT), 153 K/uL; 89: MONOCYTE % (AUTO DIFF), 12.5 %; 89: NRBC PERCENT (HEMATOLOGY), 0.4 %; 89: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.1 g/dL; 89: EOSINOPHIL % (AUTO DIFF), 0.3 %; 111: TROPONIN I, <.017 ng/mL; 118: BNP NT-PRO, 204 pg/mL; 0: Age, 61; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.8; 0: Triage HR, 88.0; 0: Triage RR, 18.0; 0: Triage SBP, 95.0; 0: Triage DBP, 67.0; 0: Triage acuity, 2-Emergent; 0: CC, BREAST PAIN",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The patient's vital signs, such as heart rate, respiratory rate, and blood pressure, show relative stability over time, with no extreme variations typically associated with sepsis risk. The oxygen saturation levels improve with supplemental oxygen, and the blood tests, including lactate and white blood cell count, do not indicate severe suspicion of sepsis. While the elevated white blood cell count could suggest infection, other parameters like normal lactate levels and absence of signs indicating severe organ dysfunction suggest a low risk for sepsis within 12 hours.",
            "claims": [
                "The patient's vital signs show relative stability over time.",
                "There are no extreme variations in vital signs that are typically associated with sepsis risk.",
                "The oxygen saturation levels improve with supplemental oxygen.",
                "The blood tests do not indicate severe suspicion of sepsis.",
                "The lactate level is normal.",
                "The white blood cell count is elevated.",
                "An elevated white blood cell count could suggest infection.",
                "Other parameters, such as normal lactate levels, suggest a low risk for sepsis.",
                "The absence of signs indicating severe organ dysfunction suggests a low risk for sepsis within 12 hours."
            ],
            "relevant_claims": [
                "The patient's vital signs show relative stability over time.",
                "The blood tests do not indicate severe suspicion of sepsis.",
                "An elevated white blood cell count could suggest infection.",
                "The absence of signs indicating severe organ dysfunction suggests a low risk for sepsis within 12 hours."
            ],
            "alignment_scores": [
                0.3,
                0.3,
                1.0,
                0.6
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "SIRS Positivity (\u22652 Criteria)",
                "SOFA Score Increase (\u22652 points)"
            ],
            "alignment_reasonings": [
                "The claim refers to patient stability, which is indirectly relevant to the NEWS score. A NEWS score of \u22655 predicts clinical deterioration, while \"stability\" implies the opposite. Although stability may suggest a low NEWS score, the claim does not directly align with the concept of a NEWS score predicting sepsis risk, leading to a low alignment rating.",
                "The claim suggests a lower suspicion of sepsis based on blood tests. This indirectly relates to the provision of early antibiotic orders or cultures, which typically follow high suspicion. However, as this claim emphasizes a lack of severe findings rather than clinical actions taken (which are pivotal for this category), the alignment remains weak.",
                "An elevated white blood cell count is explicitly included in the SIRS criteria, which are used to detect systemic inflammation indicative of early sepsis. The claim directly aligns with one of these criteria, indicating a strong and direct relevance.",
                "The claim highlights the \"absence of signs indicating severe organ dysfunction,\" which indirectly relates to SOFA score metrics that track organ dysfunction. While it doesn't mention a specific score increase, the reference to organ dysfunction aligns with the SOFA category's purpose. The alignment is indirect since the claim lacks explicit mention of SOFA scores or its components. However, the conceptual basis of assessing organ dysfunction is well-connected to the SOFA scoring system."
            ],
            "final_alignment_score": 0.55
        },
        {
            "input": "5: HR, 62.0; 5: RR, 30.0; 5: SpO2, 82.0; 5: SBP, 140.0; 5: DBP, 65.0; 5: MAP, 90.0; 5: LPM O2, 4.0; 5: Pain, 8.0; 5: Temp, 98.1; 6: RR, 30.0; 6: SpO2, 92.0; 6: LPM O2, 6.0; 18: Pain, 7.0; 77: SARS-COV-2 RNA, Not Detected; 77: INFLUENZA B, Not Detected; 77: RSV, Not Detected; 77: INFLUENZA A, Not Detected; 84: SpO2, 93.629; 85: HR, 50.1; 85: RR, 16.686; 85: SpO2, 93.286; 85: 1min HRV, 19.687; 86: HR, 50.326; 86: RR, 20.017; 86: SpO2, 91.745; 86: 1min HRV, 21.685; 87: HR, 54.966; 87: RR, 15.881; 87: SpO2, 88.678; 87: 1min HRV, 221.895; 88: HR, 52.723; 88: RR, 17.966; 88: SpO2, 90.534; 88: 1min HRV, 28.500; 88: 5min HRV, 125.288; 89: HR, 53.562; 89: RR, 15.322; 89: SpO2, 91.017; 89: Perf, 0.56; 89: 1min HRV, 22.452; 90: HR, 52.339; 90: RR, 16.881; 90: SpO2, 87.525; 90: Perf, 0.608; 90: 1min HRV, 169.545; 91: HR, 52.568; 91: RR, 23.552; 91: SpO2, 87.121; 91: Perf, 0.798; 91: 1min HRV, 46.723; 92: HR, 50.965; 92: RR, 19.052; 92: SpO2, 86.259; 92: Perf, 1.532; 92: 1min HRV, 32.224; 93: HR, 52.169; 93: RR, 14.305; 93: SpO2, 85.390; 93: Perf, 1.841; 93: 1min HRV, 202.136; 93: 5min HRV, 136.025; 93: LPM O2, 6.0; 94: HR, 53.276; 94: RR, 19.603; 94: SpO2, 86.707; 94: Perf, 1.810; 94: 1min HRV, 243.408; 95: HR, 51.288; 95: RR, 24.085; 95: SpO2, 88.559; 95: Perf, 1.322; 95: 1min HRV, 22.266; 96: HR, 49.678; 96: RR, 19.780; 96: SpO2, 96.712; 96: Perf, 1.31; 96: 1min HRV, 63.848; 97: HR, 50.017; 97: RR, 16.690; 97: SpO2, 97.603; 97: Perf, 1.289; 97: 1min HRV, 223.779; 98: HR, 49.254; 98: RR, 16.0; 98: SpO2, 98.746; 98: Perf, 1.253; 98: 1min HRV, 18.557; 98: 5min HRV, 161.749; 99: POC PH (V) ISTAT, 7.44; 99: POC BASE EXCESS ISTAT, 7 mmol/L; 99: POC HCO3 (V) ISTAT, 30.8 mmol/L; 99: POC TCO2 (V) ISTAT, 32 mmol/L; 99: POC PCO2 (V) ISTAT, 45.7 mmHg; 99: POC LACTATE ISTAT, 1.75 mmol/L; 99: POC O2 SATURATION ISTAT VENOUS, 47 %; 99: POC PO2 (V) ISTAT, 25 mmHg; 99: HR, 48.034; 99: RR, 16.879; 99: SpO2, 98.586; 99: Perf, 1.23; 99: 1min HRV, 20.593; 100: HR, 47.783; 100: RR, 16.35; 100: SpO2, 98.733; 100: Perf, 1.227; 100: 1min HRV, 19.668; 101: HR, 47.224; 101: RR, 18.362; 101: SpO2, 99.0; 101: Perf, 1.400; 101: 1min HRV, 11.765; 102: HR, 47.278; 102: RR, 22.390; 102: SpO2, 98.203; 102: Perf, 1.942; 102: 1min HRV, 24.580; 103: HR, 47.212; 103: RR, 21.138; 103: SpO2, 97.552; 103: Perf, 2.18; 103: 1min HRV, 29.295; 103: 5min HRV, 23.281; 104: HR, 46.424; 104: RR, 21.034; 104: SpO2, 97.220; 104: Perf, 2.167; 104: 1min HRV, 34.762; 105: HR, 47.810; 105: RR, 17.345; 105: SpO2, 97.172; 105: Perf, 1.823; 105: 1min HRV, 146.607; 106: HR, 46.407; 106: RR, 20.661; 106: SpO2, 98.525; 106: Perf, 1.007; 106: 1min HRV, 18.834; 107: HR, 45.431; 107: RR, 22.707; 107: SpO2, 97.172; 107: Perf, 1.056; 107: 1min HRV, 12.632; 108: WAM DIFTYP, AUTO; 108: NRBC PERCENT (HEMATOLOGY), 0.0 %; 108: MONOCYTE ABSOLUTE (AUTO DIFF), 0.77 K/uL; 108: NEUTROPHIL % (AUTO DIFF), 81.2 %; 108: WHITE BLOOD CELLS (WBC), 9.8 K/uL; 108: NEUTROPHIL ABSOLUTE (AUTO DIFF), 7.97 K/uL; 108: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 108: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.2 %; 108: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.9 pg; 108: HEMOGLOBIN (HGB), 16.8 g/dL; 108: EOSINOPHIL % (AUTO DIFF), 3.2 %; 108: HEMATOCRIT (HCT), 54.0 %; 108: LYMPHOCYTE % (AUTO DIFF), 6.8 %; 108: MEAN CORPUSCULAR VOLUME (MCV), 96.1 fL; 108: MONOCYTE % (AUTO DIFF), 7.8 %; 108: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.1 g/dL; 108: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.31 K/uL; 108: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.67 K/uL; 108: RED BLOOD CELLS (RBC), 5.62 MIL/uL; 108: RED CELL DISTRIBUTION WIDTH (RDW), 15.4 %; 108: BASOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 108: BASOPHIL % (AUTO DIFF), 0.8 %; 108: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 108: PLATELET COUNT (PLT), 209 K/uL; 108: HR, 45.847; 108: RR, 23.475; 108: SpO2, 96.407; 108: Perf, 0.972; 108: 1min HRV, 8.665; 108: 5min HRV, 74.502; 109: HR, 46.831; 109: RR, 24.576; 109: SpO2, 95.339; 109: Perf, 1.153; 109: 1min HRV, 34.172; 110: HR, 47.483; 110: RR, 17.207; 110: SpO2, 95.138; 110: Perf, 0.853; 110: 1min HRV, 23.770; 111: HR, 47.559; 111: RR, 14.915; 111: SpO2, 97.356; 111: Perf, 0.789; 111: 1min HRV, 20.254; 112: HR, 47.897; 112: RR, 16.241; 112: SpO2, 97.724; 112: Perf, 0.800; 112: 1min HRV, 27.911; 113: HR, 45.441; 113: RR, 18.441; 113: SpO2, 97.119; 113: Perf, 0.822; 113: 1min HRV, 18.948; 113: 5min HRV, 34.415; 114: HR, 46.780; 114: RR, 20.356; 114: SpO2, 96.441; 114: Perf, 1.242; 114: 1min HRV, 177.614; 115: HR, 46.0; 115: RR, 26.828; 115: SpO2, 95.034; 115: Perf, 1.25; 115: 1min HRV, 0.0; 115: Pain, 4.0; 116: HR, 46.780; 116: RR, 19.780; 116: SpO2, 96.636; 116: Perf, 1.298; 116: 1min HRV, 177.184; 117: HR, 45.634; 117: RR, 19.305; 117: SpO2, 97.610; 117: Perf, 1.520; 117: 1min HRV, 10.559; 118: HR, 46.111; 118: RR, 17.603; 118: SpO2, 97.448; 118: Perf, 1.65; 118: 1min HRV, 0.0; 118: 5min HRV, 171.327; 119: HR, 46.958; 119: RR, 24.831; 119: SpO2, 96.695; 119: Perf, 1.619; 119: 1min HRV, 25.599; 0: Age, 62; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 62.0; 0: Triage RR, 30.0; 0: Triage SBP, 140.0; 0: Triage DBP, 65.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The patient's initial SpO2 is low (82%), but it improves steadily with oxygen supplementation over time. The respiratory rate is high initially (30) but normalizes over the course of the monitoring period. There is no evidence of abnormal lactate levels or white blood cell counts that would suggest sepsis. The patient's low HRV could indicate multiple issues, but the overall data does not present a clear, continual deterioration or typical markers indicative of a high risk of sepsis within 12 hours.",
            "claims": [
                "The patient's initial SpO2 is low at 82%.",
                "The patient's SpO2 improves steadily with oxygen supplementation over time.",
                "The initial respiratory rate is high at 30.",
                "The respiratory rate normalizes over the course of the monitoring period.",
                "There is no evidence of abnormal lactate levels that would suggest sepsis.",
                "There is no evidence of abnormal white blood cell counts that would suggest sepsis.",
                "The patient's low HRV could indicate multiple issues.",
                "The overall data does not present a clear, continual deterioration.",
                "The overall data does not present typical markers indicative of a high risk of sepsis within 12 hours."
            ],
            "relevant_claims": [
                "The patient's initial SpO2 is low at 82%.",
                "The initial respiratory rate is high at 30.",
                "There is no evidence of abnormal lactate levels that would suggest sepsis.",
                "There is no evidence of abnormal white blood cell counts that would suggest sepsis.",
                "The overall data does not present a clear, continual deterioration.",
                "The overall data does not present typical markers indicative of a high risk of sepsis within 12 hours."
            ],
            "alignment_scores": [
                0.7,
                0.8,
                0.2,
                0.7,
                0.3,
                0.3
            ],
            "alignment_category": [
                "SOFA Score Increase (\u22652 points)",
                "High qSOFA Score (\u22652)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated NEWS Score (\u22655 points)",
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "The claim about the low SpO2 level of 82% suggests potential hypoxemia, which can be associated with impaired oxygenation. While SpO2 is not explicitly listed in the SOFA criteria, hypoxemia can relate conceptually to PaO\u2082/FiO\u2082 ratio, which is part of the SOFA score components. Therefore, the claim shows an indirect but significant alignment with the SOFA score increase, which is linked to new organ dysfunction and heightened sepsis risk. The alignment is notable but not direct, leading to a rating of 0.7.",
                "The claim about the respiratory rate being high at 30 directly relates to the qSOFA Score criteria, where a respiratory rate of \u226522/min is one of the components. Although the claim does not mention the entirety of the qSOFA score, the elevated respiratory rate alone strongly suggests a high risk of sepsis-related complications, aligning significantly with this category.",
                "The claim specifically mentions lactate levels, which are directly associated with the \"Elevated Serum Lactate\" category. However, the claim indicates the absence of abnormal lactate levels, suggesting a low alignment with this sepsis risk factor, as opposed to its presence. Thus, the category is relevant but with negative findings, leading to a low alignment rating.",
                "The claim directly relates to the presence or absence of abnormal white blood cell counts, which are a component of the SIRS criteria. The absence of WBC abnormality suggests a lack of evidence for systemic inflammation consistent with early sepsis per SIRS criteria. Therefore, it is moderately aligned, as it informs about sepsis risk through the negation of a SIRS criterion.",
                "The claim's reference to a lack of clear, continual deterioration indirectly relates to the NEWS score, which is used to detect early signs of patient deterioration. However, the claim does not provide specific details about the NEWS score or vital signs, so the alignment with this category is weak.",
                "The claim indirectly suggests that typical markers of deterioration (like those captured by a NEWS score) are absent. While not directly addressing NEWS, it implies that such risk predictors are not evident, hence relating weakly to the absence of an elevated NEWS Score."
            ],
            "final_alignment_score": 0.49999999999999994
        },
        {
            "input": "6: HR, 86.0; 6: RR, 20.0; 6: SpO2, 98.0; 6: SBP, 115.0; 6: DBP, 62.0; 6: MAP, 79.667; 6: Temp, 97.3; 22: HR, 98.414; 22: RR, 31.643; 22: SpO2, 91.727; 22: 1min HRV, 110.846; 22: 5min HRV, 110.846; 23: HR, 98.136; 23: RR, 34.356; 23: SpO2, 92.0; 23: 1min HRV, 117.374; 23: SBP, 131.0; 23: DBP, 77.0; 23: MAP, 95.0; 24: HR, 95.534; 24: RR, 32.310; 24: 1min HRV, 113.171; 25: HR, 101.0; 25: RR, 29.898; 25: SpO2, 99.0; 25: 1min HRV, 162.398; 26: HR, 95.052; 26: RR, 29.517; 26: 1min HRV, 103.722; 27: HR, 100.220; 27: RR, 33.610; 27: 1min HRV, 138.512; 27: 5min HRV, 129.593; 28: HR, 95.407; 28: RR, 32.949; 28: 1min HRV, 125.817; 29: HR, 96.241; 29: RR, 34.931; 29: 1min HRV, 116.094; 30: HR, 88.407; 30: RR, 34.441; 30: 1min HRV, 109.284; 31: HR, 105.828; 31: RR, 30.397; 31: 1min HRV, 147.138; 32: HR, 98.322; 32: RR, 25.288; 32: 1min HRV, 138.014; 32: 5min HRV, 131.883; 33: HR, 90.017; 33: RR, 24.627; 33: 1min HRV, 92.595; 34: HR, 93.678; 34: RR, 29.627; 34: 1min HRV, 144.850; 35: HR, 93.828; 35: RR, 27.724; 35: 1min HRV, 120.825; 36: HR, 90.305; 36: RR, 27.576; 36: 1min HRV, 99.692; 37: HR, 92.759; 37: RR, 35.966; 37: 1min HRV, 125.839; 37: 5min HRV, 122.075; 38: HR, 92.949; 38: RR, 25.169; 38: 1min HRV, 131.881; 38: SBP, 115.0; 38: DBP, 69.0; 38: MAP, 84.333; 39: HR, 90.431; 39: RR, 28.448; 39: 1min HRV, 108.780; 40: HR, 90.356; 40: RR, 26.915; 40: 1min HRV, 135.773; 41: HR, 95.983; 41: RR, 26.407; 41: SpO2, 97.0; 41: 1min HRV, 145.704; 42: HR, 98.017; 42: RR, 33.052; 42: 1min HRV, 147.904; 42: 5min HRV, 135.808; 43: HR, 91.576; 43: RR, 32.75; 43: 1min HRV, 144.543; 44: HR, 100.644; 44: RR, 30.475; 44: 1min HRV, 99.454; 45: HR, 104.345; 45: RR, 27.672; 45: 1min HRV, 118.998; 46: HR, 102.034; 46: RR, 28.864; 46: 1min HRV, 137.662; 47: HR, 109.172; 47: RR, 29.086; 47: 1min HRV, 148.420; 47: 5min HRV, 137.077; 48: HR, 109.119; 48: RR, 23.196; 48: 1min HRV, 152.448; 49: HR, 102.559; 49: RR, 28.811; 49: 1min HRV, 167.416; 50: HR, 118.086; 50: RR, 32.224; 50: 1min HRV, 174.658; 51: HR, 96.949; 51: RR, 27.102; 51: 1min HRV, 141.684; 52: HR, 105.810; 52: RR, 23.483; 52: 1min HRV, 175.727; 52: 5min HRV, 167.496; 53: HR, 104.492; 53: RR, 22.644; 53: 1min HRV, 144.027; 53: SBP, 116.0; 53: DBP, 85.0; 53: MAP, 95.333; 54: HR, 102.931; 54: RR, 29.774; 54: 1min HRV, 146.443; 55: HR, 98.458; 55: RR, 33.310; 55: SpO2, 97.0; 55: 1min HRV, 140.776; 56: HR, 97.915; 56: RR, 35.864; 56: 1min HRV, 148.741; 57: HR, 111.828; 57: RR, 31.655; 57: 1min HRV, 154.844; 57: 5min HRV, 152.574; 58: HR, 109.508; 58: RR, 31.203; 58: 1min HRV, 160.695; 59: HR, 98.397; 59: RR, 36.534; 59: 1min HRV, 178.628; 60: HR, 91.593; 60: RR, 32.208; 60: 1min HRV, 133.466; 61: HR, 98.068; 61: RR, 40.339; 61: 1min HRV, 144.123; 62: HR, 96.810; 62: RR, 34.069; 62: 1min HRV, 146.344; 62: 5min HRV, 158.031; 63: HR, 98.593; 63: RR, 32.831; 63: 1min HRV, 156.849; 64: HR, 106.517; 64: RR, 37.741; 64: 1min HRV, 152.933; 65: HR, 97.203; 65: RR, 27.983; 65: 1min HRV, 169.895; 66: HR, 99.322; 66: RR, 29.797; 66: 1min HRV, 142.021; 67: HR, 96.966; 67: RR, 34.121; 67: 1min HRV, 128.693; 67: 5min HRV, 151.593; 68: HR, 93.492; 68: RR, 27.763; 68: 1min HRV, 119.736; 68: SBP, 103.0; 68: DBP, 67.0; 68: MAP, 79.0; 69: HR, 92.397; 69: RR, 26.690; 69: 1min HRV, 121.414; 70: HR, 88.780; 70: RR, 25.746; 70: 1min HRV, 151.117; 71: HR, 92.424; 71: RR, 29.356; 71: 1min HRV, 165.078; 72: HR, 105.810; 72: RR, 29.190; 72: 1min HRV, 177.500; 72: 5min HRV, 154.698; 73: HR, 97.508; 73: RR, 26.780; 73: 1min HRV, 174.835; 74: HR, 93.534; 74: RR, 26.534; 74: 1min HRV, 128.705; 75: HR, 97.424; 75: RR, 25.136; 75: SpO2, 98.818; 75: 1min HRV, 163.474; 76: HR, 96.661; 76: RR, 28.593; 76: SpO2, 93.4; 76: 1min HRV, 134.870; 77: ANION GAP, 12 mmol/L; 77: POTASSIUM, 4.1 mmol/L; 77: PROTEIN TOTAL, 7.2 g/dL; 77: CO2, 23 mmol/L; 77: GLUCOSE, 166 mg/dL; 77: ALBUMIN, 3.8 g/dL; 77: GLOBULIN, 3.4 g/dL; 77: ALKALINE PHOSPHATASE, 94 U/L; 77: CHLORIDE, 102 mmol/L; 77: EGFR FOR AFRICAN AMERICAN, 57 mL/min/1.73 m2; 77: AST (SGOT), 94 U/L; 77: ALT (SGPT), 76 U/L; 77: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 77: CALCIUM, 9.1 mg/dL; 77: CORRECTED CALCIUM, 9.3 mg/dL; 77: EGFR REFIT WITHOUT RACE (2021), 49 mL/min/1.73 m2; 77: SODIUM, 137 mmol/L; 77: MAGNESIUM, 2.1 mg/dL; 77: CREATININE, 1.24 mg/dL; 77: BILIRUBIN TOTAL, 0.9 mg/dL; 77: BNP NT-PRO, 2309 pg/mL; 77: HR, 91.603; 77: RR, 28.534; 77: 1min HRV, 137.927; 77: 5min HRV, 149.995; 78: HR, 96.390; 78: RR, 27.424; 78: 1min HRV, 143.471; 79: HR, 94.138; 79: RR, 26.741; 79: 1min HRV, 122.539; 80: HR, 90.627; 80: RR, 30.136; 80: 1min HRV, 126.110; 81: HR, 102.305; 81: RR, 28.525; 81: 1min HRV, 138.593; 82: HR, 91.983; 82: RR, 30.379; 82: 1min HRV, 135.501; 82: 5min HRV, 135.292; 83: HR, 104.695; 83: RR, 26.305; 83: 1min HRV, 142.713; 83: SBP, 126.0; 83: DBP, 98.0; 83: MAP, 107.333; 84: TROPONIN I, <.017 ng/mL; 84: HR, 96.435; 84: RR, 41.448; 84: 1min HRV, 111.796; 85: RR, 40.085; 86: RR, 38.724; 87: HR, 124.944; 87: RR, 32.661; 87: 1min HRV, 15.413; 87: 5min HRV, 143.679; 88: HR, 113.475; 88: RR, 20.068; 88: 1min HRV, 102.226; 89: HR, 114.949; 89: RR, 36.155; 89: 1min HRV, 96.557; 90: HR, 115.356; 90: RR, 34.237; 90: 1min HRV, 130.746; 91: HR, 117.893; 91: RR, 35.038; 91: 1min HRV, 140.391; 92: 5min HRV, 126.029; 98: D-DIMER ELISA, >10000 ng/mL FEU; 100: SARS-COV-2 RNA, Not Detected; 112: SpO2, 93.0; 113: HR, 100.0; 113: RR, 33.35; 113: 1min HRV, 112.194; 114: HR, 114.0; 114: RR, 27.379; 114: 1min HRV, 134.805; 114: SBP, 128.0; 114: DBP, 81.0; 114: MAP, 96.667; 115: HR, 108.322; 115: RR, 37.034; 115: 1min HRV, 147.034; 116: HR, 98.828; 116: RR, 24.0; 116: 1min HRV, 124.792; 117: HR, 101.136; 117: RR, 23.322; 117: 1min HRV, 117.243; 117: 5min HRV, 134.779; 118: HR, 101.879; 118: RR, 33.328; 118: 1min HRV, 102.420; 119: HR, 100.644; 119: RR, 34.458; 119: 1min HRV, 105.178; 0: Age, 90; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.3; 0: Triage HR, 86.0; 0: Triage RR, 20.0; 0: Triage SBP, 115.0; 0: Triage DBP, 62.0; 0: Triage acuity, 3-Urgent; 0: CC, DIZZINESS",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient shows several indicators of potential sepsis risk, such as elevated heart rate (reaching above 100 bpm in multiple instances), fluctuating respiratory rate (often above 30 breaths per minute), and abnormal heart rate variability. Added to this, the extremely high D-dimer levels indicate a significant coagulation status disturbance, which is a marker for severe infection or sepsis. Together, these findings suggest the patient is at high risk of developing sepsis within 12 hours.",
            "claims": [
                "The patient shows several indicators of potential sepsis risk.",
                "The patient has an elevated heart rate, reaching above 100 bpm in multiple instances.",
                "The patient has a fluctuating respiratory rate, often above 30 breaths per minute.",
                "The patient exhibits abnormal heart rate variability.",
                "The patient has extremely high D-dimer levels.",
                "High D-dimer levels indicate a significant coagulation status disturbance.",
                "A significant coagulation status disturbance is a marker for severe infection or sepsis.",
                "The findings suggest that the patient is at high risk of developing sepsis within 12 hours."
            ],
            "relevant_claims": [
                "The patient has an elevated heart rate, reaching above 100 bpm in multiple instances.",
                "The patient has a fluctuating respiratory rate, often above 30 breaths per minute.",
                "The patient exhibits abnormal heart rate variability.",
                "The patient has extremely high D-dimer levels.",
                "High D-dimer levels indicate a significant coagulation status disturbance.",
                "A significant coagulation status disturbance is a marker for severe infection or sepsis.",
                "The findings suggest that the patient is at high risk of developing sepsis within 12 hours."
            ],
            "alignment_scores": [
                0.9,
                0.8,
                0.3,
                0.2,
                0.3,
                0.7,
                0.3
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)",
                "High qSOFA Score (\u22652)",
                "Elevated Shock Index (\u22651.0)",
                "Elevated NEWS Score (\u22655 points)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "An elevated heart rate (>90 bpm) is one of the explicit criteria for SIRS. Since heart rate is a well-defined factor within the SIRS criteria and is mentioned directly in the claim as being above 100 bpm, there is a strong alignment with the SIRS Positivity category. However, SIRS requires the presence of \u22652 criteria for full identification, which slightly reduces the alignment strength from the perfect score.",
                "The claim mentions a respiratory rate often above 30 breaths per minute, which is significantly higher than the threshold of \u226522 breaths per minute used in the qSOFA score. This respiratory rate suggests a high risk of sepsis-related organ dysfunction and mortality. While the claim does not provide other components of the qSOFA score, the high respiratory rate aligns strongly with this criterion. Thus, it is a good but not complete alignment with a high qSOFA score, warranting a 0.8 rating.",
                "Abnormal heart rate variability could suggest issues with autonomic control and cardiovascular function, which might loosely relate to haemodynamic instability indicated by an elevated shock index. However, heart rate variability is not directly a measure used in evaluating the shock index, which more specifically involves the heart rate divided by systolic blood pressure. Therefore, the alignment here is indirect and weak.",
                "D-dimer levels are not specifically listed in the sepsis prediction categories provided and do not directly align with any of them. However, elevated D-dimer can suggest a state of acute illness or potential clotting dysfunction, which might indirectly relate to clinical deterioration. Thus, the only mild association might be with the NEWS score, which evaluates deranged vitals and potential clinical deterioration. This is a weak alignment, hence the low rating.",
                "High D-dimer levels suggest a disturbance in coagulation status, which can be associated with the clotting abnormalities seen in sepsis. While D-dimer is not directly a component of the SOFA score, coagulation disturbances are conceptually related to organ dysfunction, such as thrombocytopenia (platelets < 100\u202f\u00d7\u202f10\u2079/L) which is part of the SOFA criteria. However, the alignment is indirect and doesn't explicitly involve SOFA components, so the rating is low.",
                "Coagulation disturbances can relate to the platelets component in SOFA scoring. A decrease in platelet count (<100\u202f\u00d7\u202f10\u2079/L) is part of assessing organ dysfunction in high sepsis risk. While the claim is not a direct match to the SOFA criteria, it conceptually aligns with this category due to the relevance of coagulation in SOFA scoring.",
                "The claim broadly mentions a high risk of developing sepsis within 12 hours, which suggests a general state of clinical concern. While the claim does not specify NEWS or any other scoring system, the Elevated NEWS Score is used to predict imminent clinical deterioration compatible with sepsis. However, due to the lack of specificity in the claim, the alignment with any specific category is not strong. The Elevated NEWS Score is chosen because it encompasses a broad assessment that aligns with evaluating short-term risk, albeit indirectly, resulting in a moderate-to-low rating."
            ],
            "final_alignment_score": 0.5
        },
        {
            "input": "10: HR, 92.0; 10: RR, 16.0; 10: SpO2, 97.0; 10: SBP, 159.0; 10: DBP, 92.0; 10: MAP, 114.333; 10: Temp, 99.3; 67: POC, BHCG, ISTAT QUANTITATIVE: 6.9 IU/L; 71: POC PH (V) ISTAT, 7.32; 71: POC HCO3 (V) ISTAT, 20.7 mmol/L; 71: POC O2 SATURATION ISTAT VENOUS, 26 %; 71: POC PO2 (V) ISTAT, 19 mmHg; 71: POC BASE EXCESS ISTAT, -5 mmol/L; 71: POC TCO2 (V) ISTAT, 22 mmol/L; 71: POC LACTATE ISTAT, 0.69 mmol/L; 71: POC PCO2 (V) ISTAT, 40.5 mmHg; 76: POC POTASSIUM ISTAT, 6.6 mmol/L; 76: POC HGB (CALC) ISTAT, 12.9 g/dL; 76: POC SODIUM ISTAT, 134 mmol/L; 76: POC GLUCOSE ISTAT, 83 mg/dL; 76: POC HCT ISTAT, 38 %; 89: PART. THROMBOPLASTIN TIME, 35.2 seconds; 90: INR, 1.6; 90: PROTHROMBIN TIME, 18.5 seconds; 92: WAM DIFTYP, AUTO; 92: MONOCYTE ABSOLUTE (AUTO DIFF), 1.23 K/uL; 92: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.09 K/uL; 92: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.67 K/uL; 92: BASOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 92: LYMPHOCYTE % (AUTO DIFF), 18.7 %; 92: MEAN CORPUSCULAR VOLUME (MCV), 91.2 fL; 92: EOSINOPHIL % (AUTO DIFF), 1.5 %; 92: RED CELL DISTRIBUTION WIDTH (RDW), 17.4 %; 92: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.6 %; 92: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.21 K/uL; 92: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 92: NEUTROPHIL % (AUTO DIFF), 70.2 %; 92: MONOCYTE % (AUTO DIFF), 8.6 %; 92: RED BLOOD CELLS (RBC), 3.40 MIL/uL; 92: HEMATOCRIT (HCT), 31.0 %; 92: PLATELET COUNT (PLT), 378 K/uL; 92: BASOPHIL % (AUTO DIFF), 0.4 %; 92: NRBC PERCENT (HEMATOLOGY), 0.0 %; 92: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.1 pg; 92: WHITE BLOOD CELLS (WBC), 14.3 K/uL; 92: HEMOGLOBIN (HGB), 9.9 g/dL; 92: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.02 K/uL; 92: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.9 g/dL; 101: POC GLUCOSE BY METER, 98 mg/dL; 104: POC, BHCG, ISTAT QUANTITATIVE: 6.1 IU/L; 105: LIPASE, 11 U/L; 106: POC PH (V) ISTAT, 7.27; 106: POC PO2 (V) ISTAT, 22 mmHg; 106: POC BASE EXCESS ISTAT, -5 mmol/L; 106: POC LACTATE ISTAT, 1.44 mmol/L; 106: POC O2 SATURATION ISTAT VENOUS, 31 %; 106: POC PCO2 (V) ISTAT, 46.6 mmHg; 106: POC TCO2 (V) ISTAT, 23 mmol/L; 106: POC HCO3 (V) ISTAT, 21.6 mmol/L; 106: HR, 42.882; 106: RR, 17.5; 106: SpO2, 97.667; 106: Perf, 4.819; 106: 1min HRV, 16.461; 107: HR, 45.310; 107: RR, 16.966; 107: SpO2, 96.534; 107: Perf, 3.883; 107: 1min HRV, 27.125; 107: SBP, 139.0; 107: DBP, 84.0; 107: MAP, 102.333; 108: HR, 45.797; 108: RR, 13.712; 108: SpO2, 97.390; 108: Perf, 3.778; 108: 1min HRV, 27.967; 109: HR, 46.879; 109: RR, 15.5; 109: SpO2, 97.259; 109: Perf, 3.888; 109: 1min HRV, 41.979; 109: 5min HRV, 45.213; 110: HR, 44.864; 110: RR, 17.186; 110: SpO2, 97.780; 110: Perf, 4.039; 110: 1min HRV, 36.671; 111: HR, 44.729; 111: RR, 17.288; 111: SpO2, 97.475; 111: Perf, 6.292; 111: 1min HRV, 28.818; 112: HR, 44.172; 112: RR, 18.517; 112: SpO2, 96.914; 112: Perf, 6.863; 112: 1min HRV, 45.926; 113: HR, 44.356; 113: RR, 15.814; 113: SpO2, 96.322; 113: Perf, 5.662; 113: 1min HRV, 42.383; 114: SODIUM, 131 mmol/L; 114: SODIUM, 131 mmol/L; 114: POTASSIUM, 6.6 mmol/L; 114: BLOOD UREA NITROGEN (BUN), 46 mg/dL; 114: ALT (SGPT), 21 U/L; 114: CREATININE, 7.03 mg/dL; 114: EGFR REFIT WITHOUT RACE (2021), 7 mL/min/1.73 m2; 114: GLUCOSE, 88 mg/dL; 114: ALKALINE PHOSPHATASE, 342 U/L; 114: BLOOD UREA NITROGEN (BUN), 46 mg/dL; 114: EGFR FOR AFRICAN AMERICAN, 8 mL/min/1.73 m2; 114: ALT (SGPT), 21 U/L; 114: CORRECTED CALCIUM, 8.2 mg/dL; 114: ANION GAP, 14 mmol/L; 114: ALKALINE PHOSPHATASE, 342 U/L; 114: GLUCOSE, 88 mg/dL; 114: CHLORIDE, 98 mmol/L; 114: PROTEIN TOTAL, 8.2 g/dL; 114: CHLORIDE, 98 mmol/L; 114: GLOBULIN, 4.3 g/dL; 114: CALCIUM, 8.1 mg/dL; 114: CO2, 19 mmol/L; 114: AST (SGOT), 21 U/L; 114: EGFR REFIT WITHOUT RACE (2021), 7 mL/min/1.73 m2; 114: PROTEIN TOTAL, 8.2 g/dL; 114: CO2, 19 mmol/L; 114: ALBUMIN, 3.9 g/dL; 114: CALCIUM, 8.1 mg/dL; 114: GLOBULIN, 4.3 g/dL; 114: EGFR FOR AFRICAN AMERICAN, 8 mL/min/1.73 m2; 114: BILIRUBIN TOTAL, 0.7 mg/dL; 114: ANION GAP, 14 mmol/L; 114: POTASSIUM, 6.6 mmol/L; 114: AST (SGOT), 21 U/L; 114: CREATININE, 7.03 mg/dL; 114: CORRECTED CALCIUM, 8.2 mg/dL; 114: BILIRUBIN TOTAL, 0.7 mg/dL; 114: ALBUMIN, 3.9 g/dL; 114: HR, 42.052; 114: RR, 16.552; 114: SpO2, 96.707; 114: Perf, 4.959; 114: 1min HRV, 39.438; 114: 5min HRV, 47.285; 115: HR, 42.102; 115: RR, 16.525; 115: SpO2, 96.0; 115: Perf, 4.387; 115: 1min HRV, 29.882; 115: SBP, 121.0; 115: DBP, 77.0; 115: MAP, 91.667; 116: HR, 43.305; 116: RR, 15.729; 116: SpO2, 96.254; 116: Perf, 4.035; 116: 1min HRV, 46.183; 117: HR, 41.845; 117: RR, 16.276; 117: SpO2, 96.276; 117: Perf, 4.256; 117: 1min HRV, 22.321; 118: HR, 41.373; 118: RR, 17.102; 118: SpO2, 96.458; 118: Perf, 4.405; 118: 1min HRV, 38.386; 119: HR, 44.534; 119: RR, 17.276; 119: SpO2, 96.5; 119: Perf, 4.310; 119: 1min HRV, 124.121; 119: 5min HRV, 73.300; 0: Age, 28; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 37.4; 0: Triage HR, 92.0; 0: Triage RR, 16.0; 0: Triage SBP, 159.0; 0: Triage DBP, 92.0; 0: Triage acuity, 3-Urgent; 0: CC, LEG SWELLING,EMESIS,FEVER",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient presents with several concerning signs, including high blood urea nitrogen, elevated creatinine level, high potassium levels, low eGFR, and anemia, all suggestive of potential acute kidney injury. Additionally, the patient's heart rate significantly dropped over time, and low bicarbonate levels could indicate metabolic acidosis. These combined factors, along with the presenting symptoms of fever and emesis, suggest a high risk of sepsis and therefore warrant closer monitoring and immediate medical assessment.",
            "claims": [
                "The patient presents with several concerning signs.",
                "The patient's blood urea nitrogen level is high.",
                "The patient's creatinine level is elevated.",
                "The patient's potassium levels are high.",
                "The patient's estimated glomerular filtration rate (eGFR) is low.",
                "The patient has anemia.",
                "These signs are suggestive of potential acute kidney injury.",
                "The patient's heart rate significantly dropped over time.",
                "Low bicarbonate levels could indicate metabolic acidosis.",
                "These combined factors suggest a high risk of sepsis.",
                "The presenting symptoms include fever.",
                "The presenting symptoms include emesis.",
                "The patient warrants closer monitoring.",
                "The patient requires immediate medical assessment."
            ],
            "relevant_claims": [
                "The patient's blood urea nitrogen level is high.",
                "The patient's creatinine level is elevated.",
                "The patient's potassium levels are high.",
                "The patient's estimated glomerular filtration rate (eGFR) is low.",
                "These signs are suggestive of potential acute kidney injury.",
                "Low bicarbonate levels could indicate metabolic acidosis.",
                "The presenting symptoms include fever.",
                "The patient warrants closer monitoring."
            ],
            "alignment_scores": [
                0.5,
                0.7,
                0.2,
                0.7,
                0.7,
                0.7,
                0.6,
                0.2
            ],
            "alignment_category": [
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "Early Antibiotic/Culture Orders (within 2 hours)"
            ],
            "alignment_reasonings": [
                "Blood urea nitrogen (BUN) is not a direct component of the SOFA score, but it is related to renal function, which can influence SOFA scoring through creatinine levels. A high BUN indicates possible kidney dysfunction, which conceptually aligns with organ dysfunction markers used in SOFA scoring. Therefore, there is a moderate indirect alignment with the category.",
                "Elevated creatinine is listed as one of the SOFA score components, specifically linked to assessing renal function. While the claim does not indicate the degree of elevation or if it reflects a \u22652 point increase in the SOFA score, it is directly related to SOFA criteria, which assess organ dysfunction associated with sepsis. The alignment is strong, though not perfect, without more data on the degree of change in the SOFA score.",
                "High potassium levels are not directly related to any of the specified sepsis-related categories. However, electrolyte imbalances, like high potassium, can suggest organ dysfunction indirectly, as they may relate to renal impairment, which is a component of the SOFA score. The alignment is weak because the claim does not directly address any specific criteria of the SOFA score or organ dysfunction stated in the categories.",
                "A low estimated glomerular filtration rate (eGFR) indicates impaired kidney function, which is relevant to the SOFA criteria concerning renal function (specifically creatinine levels or urine output). While eGFR is not directly part of the SOFA score, it conceptually aligns with the dysfunction of organ systems that the SOFA score is used to assess. The alignment is not perfect, but it significantly relates to the category.",
                "Acute kidney injury can be related to an increase in creatinine levels, which is a component of the SOFA score. Specifically, creatinine >2 mg/dL is part of the criteria for a SOFA score increase, indicating organ dysfunction. The claim suggests a potential issue directly tied to SOFA score elements, though it does not confirm an increase in SOFA score by itself. Therefore, the alignment is strong but not perfect because it lacks specific quantitative data confirming a SOFA score change.",
                "Metabolic acidosis often reflects underlying organ dysfunction, a central focus of the SOFA scoring system. While low bicarbonate levels themselves aren't explicitly mentioned in the SOFA score, they are indicative of metabolic disturbances, such as acidosis, that can accompany sepsis-related organ dysfunction. Therefore, the alignment is indirect but relevant, warranting a moderately strong alignment rating.",
                "Fever is one of the SIRS criteria (temperature >38\u00b0C), which helps identify systemic inflammation consistent with early sepsis. However, the claim does not specify the temperature being above the threshold, so while it indicates relevance, it lacks complete information to fully satisfy the criterion.",
                "The claim mentions the need for closer monitoring, which suggests some level of concern about the patient's condition potentially related to sepsis risk. However, without specific actions such as ordering antibiotics or cultures, the connection to the risk assessment process in this category is weak. The alignment is vague and lacks direct relation to the clinical actions described in the category."
            ],
            "final_alignment_score": 0.5375
        },
        {
            "input": "10: HR, 125.0; 10: RR, 20.0; 10: SpO2, 96.0; 10: SBP, 116.0; 10: DBP, 66.0; 10: MAP, 82.667; 10: Pain, 8.0; 10: Temp, 99.1; 55: SpO2, 96.364; 56: SpO2, 97.814; 56: Perf, 3.785; 57: POC PH (V) ISTAT, 7.47; 57: POC PCO2 (V) ISTAT, 38.9 mmHg; 57: POC BASE EXCESS ISTAT, 5 mmol/L; 57: POC LACTATE ISTAT, 1.53 mmol/L; 57: POC PO2 (V) ISTAT, 44 mmHg; 57: POC HCO3 (V) ISTAT, 28.4 mmol/L; 57: POC TCO2 (V) ISTAT, 30 mmol/L; 57: POC O2 SATURATION ISTAT VENOUS, 83 %; 57: SpO2, 97.75; 57: Perf, 4.13; 58: SpO2, 97.545; 60: SpO2, 97.5; 62: SpO2, 97.892; 62: Perf, 2.504; 63: HR, 120.688; 63: RR, 29.0; 63: SpO2, 97.482; 63: Perf, 2.431; 63: 1min HRV, 4.649; 63: SBP, 115.0; 63: DBP, 74.0; 63: MAP, 87.667; 64: HR, 121.288; 64: RR, 23.593; 64: SpO2, 96.966; 64: Perf, 2.527; 64: 1min HRV, 5.019; 65: HR, 120.914; 65: RR, 23.207; 65: SpO2, 96.724; 65: Perf, 2.408; 65: 1min HRV, 5.123; 65: LR IV BOLUS -, 1000 ML; 66: HR:, 120.983; 66: RR, 24.475; 66: SpO2, 96.898; 66: Perf, 2.540; 66: 1min HRV, 9.017; 66: 5min HRV, 6.528; 66: SBP, 115.0; 66: DBP, 74.0; 66: MAP, 87.667; 67: HR, 120.172; 67: RR, 19.828; 67: SpO2, 96.603; 67: Perf, 2.773; 67: 1min HRV, 4.176; 68: HR, 117.847; 68: RR, 26.475; 68: SpO2, 96.169; 68: Perf, 3.083; 68: 1min HRV, 3.796; 69: HR, 116.424; 69: RR, 27.881; 69: SpO2, 96.763; 69: Perf, 3.132; 69: 1min HRV, 3.793; 70: HR, 115.586; 70: RR, 30.172; 70: SpO2, 96.724; 70: Perf, 2.924; 70: 1min HRV, 3.025; 71: HR, 115.458; 71: RR, 31.322; 71: SpO2, 96.508; 71: Perf, 3.087; 71: 1min HRV, 4.311; 71: 5min HRV, 7.879; 72: HR, 116.759; 72: RR, 27.810; 72: SpO2, 96.603; 72: Perf, 2.989; 72: 1min HRV, 4.088; 73: HR, 116.203; 73: RR, 26.763; 73: SpO2, 97.203; 73: Perf, 2.665; 73: 1min HRV, 7.695; 74: HR, 115.644; 74: RR, 30.881; 74: SpO2, 97.373; 74: Perf, 2.693; 74: 1min HRV, 3.287; 75: HR, 114.672; 75: RR, 31.397; 75: SpO2, 97.172; 75: Perf, 2.736; 75: 1min HRV, 3.565; 76: HR, 115.237; 76: RR, 27.085; 76: SpO2, 96.966; 76: Perf, 2.905; 76: 1min HRV, 3.617; 76: 5min HRV, 5.477; 77: HR, 115.086; 77: RR, 28.845; 77: SpO2, 96.948; 77: Perf, 2.516; 77: 1min HRV, 3.056; 78: HR, 115.169; 78: RR, 29.356; 78: SpO2, 97.492; 78: Perf, 2.126; 78: 1min HRV, 5.350; 79: HR, 114.381; 79: RR, 35.0; 79: SpO2, 97.107; 79: Perf, 1.866; 79: 1min HRV, 2.431; 81: 5min HRV, 4.226; 90: IOPAMIDOL, 76 % IV SOLN (RADIOLOGY) 500 ML; 94: INR:, 1.1; 94: PROTHROMBIN TIME, 15.1 seconds; 102: SpO2, 95.962; 103: WHITE BLOOD CELLS (WBC), 8.3 K/uL; 103: RED BLOOD CELLS (RBC), 3.10 MIL/uL; 103: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 26.8 pg; 103: MEAN CORPUSCULAR VOLUME (MCV), 84.8 fL; 103: HEMOGLOBIN (HGB), 8.3 g/dL; 103: RED CELL DISTRIBUTION WIDTH (RDW), 13.0 %; 103: HEMATOCRIT (HCT), 26.3 %; 103: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.6 g/dL; 103: PLATELET COUNT (PLT), 331 K/uL; 103: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 0.51 K/uL; 103: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 7.49 K/uL; 103: MONOCYTES % (MANUAL DIFF), 0.0 %; 103: EOSINOPHILS ABSOLUTE (MANUAL DIFF), 0.29 K/uL; 103: NEUTROPHILS BANDS % (MANUAL DIFF), 7.8 %; 103: EOSINOPHILS % (MANUAL DIFF), 3.5 %; 103: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 82.6 %; 103: LYMPHOCYTES % (MANUAL DIFF), 6.1 %; 103: HR, 112.581; 103: RR, 18.032; 103: SpO2, 97.559; 103: 1min HRV, 7.885; 104: PART. THROMBOPLASTIN TIME, 32.3 seconds; 104: HR, 112.707; 104: RR, 28.879; 104: SpO2, 97.466; 104: Perf, 1.069; 104: 1min HRV, 5.442; 105: HR, 113.780; 105: RR, 24.034; 105: SpO2, 97.305; 105: Perf, 1.174; 105: 1min HRV, 2.973; 106: HR, 113.797; 106: RR, 22.712; 106: SpO2, 97.0; 106: Perf, 1.143; 106: 1min HRV, 4.693; 106: 5min HRV, 5.928; 107: HR, 112.448; 107: RR, 27.672; 107: SpO2, 97.707; 107: Perf, 1.229; 107: 1min HRV, 4.238; 108: HR, 113.186; 108: RR, 24.390; 108: SpO2, 97.678; 108: Perf, 1.205; 108: 1min HRV, 5.694; 109: HR, 112.638; 109: RR, 26.672; 109: SpO2, 97.534; 109: Perf, 1.260; 109: 1min HRV, 4.334; 110: HR, 112.661; 110: RR, 24.373; 110: SpO2, 98.0; 110: Perf, 1.144; 110: 1min HRV, 4.286; 111: HR, 115.448; 111: RR, 21.397; 111: SpO2, 98.0; 111: Perf, 1.383; 111: 1min HRV, 4.708; 111: 5min HRV, 7.053; 112: HR, 114.949; 112: RR, 20.220; 112: SpO2, 98.339; 112: Perf, 1.131; 112: 1min HRV, 9.737; 113: HR, 114.305; 113: RR, 25.542; 113: SpO2, 97.627; 113: Perf, 1.18; 113: 1min HRV, 9.114; 114: BLOOD, URINE (UA): Negative; 114: KETONE, URINE (UA): Negative; 114: SPECIFIC GRAVITY, URINE (UA): 1.003; 114: NITRITE, URINE (UA): Negative; 114: LEUKOCYTE ESTERASE, URINE (UA): Negative; 114: PROTEIN, URINE (UA): Negative; 114: GLUCOSE, URINE (UA): Negative; 114: PH, URINE (UA): 6.0; 114: HR, 114.259; 114: RR, 24.845; 114: SpO2, 97.155; 114: Perf, 1.245; 114: 1min HRV, 7.585; 115: HR, 114.068; 115: RR, 28.017; 115: SpO2, 97.102; 115: Perf, 1.962; 115: 1min HRV, 9.362; 116: HR, 113.914; 116: RR, 25.431; 116: SpO2, 96.948; 116: Perf, 1.619; 116: 1min HRV, 5.658; 116: 5min HRV, 8.827; 117: HR, 113.034; 117: RR, 22.119; 117: SpO2, 97.797; 117: Perf, 1.397; 117: 1min HRV, 6.426; 118: HR, 112.983; 118: RR, 25.729; 118: SpO2, 97.898; 118: Perf, 1.529; 118: 1min HRV, 4.914; 119: HR, 113.845; 119: RR, 24.638; 119: SpO2, 98.0; 119: Perf, 1.743; 119: 1min HRV, 9.732; 0: Age, 45; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 37.3; 0: Triage HR, 125.0; 0: Triage RR, 20.0; 0: Triage SBP, 116.0; 0: Triage DBP, 66.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The patient's initial triage shows a high heart rate, but the blood pressure, respiratory rate, and temperature are relatively stable. Subsequent time points show slightly elevated heart rates and respiratory rates, but oxygen saturation remains relatively stable around 96-98%. Additionally, lab results, including lactate and blood gas parameters, do not suggest severe metabolic disturbances typically associated with sepsis. Overall, while there are signs of an infection (like fever), the clinical parameters do not indicate a high risk of sepsis within the next 12 hours.",
            "claims": [
                "The patient's initial triage shows a high heart rate.",
                "The blood pressure is relatively stable.",
                "The respiratory rate is relatively stable.",
                "The temperature is relatively stable.",
                "Subsequent time points show slightly elevated heart rates.",
                "Subsequent time points show slightly elevated respiratory rates.",
                "Oxygen saturation remains relatively stable around 96-98%.",
                "Lab results do not suggest severe metabolic disturbances typically associated with sepsis.",
                "Lab results include lactate and blood gas parameters.",
                "There are signs of an infection, such as fever.",
                "The clinical parameters do not indicate a high risk of sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The patient's initial triage shows a high heart rate.",
                "Subsequent time points show slightly elevated heart rates.",
                "Lab results do not suggest severe metabolic disturbances typically associated with sepsis."
            ],
            "alignment_scores": [
                0.5,
                0.3,
                0.3
            ],
            "alignment_category": [
                "Elevated Shock Index (\u22651.0)",
                "Elevated Shock Index (\u22651.0)",
                "Elevated Serum Lactate (\u22652 mmol/L)"
            ],
            "alignment_reasonings": [
                "A high heart rate is a component of the shock index (heart rate \u00f7 systolic BP), which assesses hemodynamic instability and sepsis risk. Although the claim does not mention blood pressure, the elevated heart rate partially aligns with evaluating the shock index, providing moderate relevance to this category.",
                "The claim of slightly elevated heart rates suggests potential hemodynamic instability, which is related to the Shock Index category. However, without specific values for heart rate or accompanying systolic blood pressure to calculate the shock index or confirm a rise of \u22650.3 from baseline, the alignment is weak. The connection is indirect, as only a slightly elevated heart rate is mentioned, not meeting the criteria for the category.",
                "The claim indirectly hints at normal metabolic status, implying no signs of issues like tissue hypoperfusion, which is linked to elevated serum lactate levels. However, it doesn't specifically mention lactate levels or directly address any criteria from other categories, leading to only a weak alignment."
            ],
            "final_alignment_score": 0.3666666666666667
        },
        {
            "input": "3: HR, 87.0; 3: RR, 16.0; 3: SpO2, 90.0; 3: SBP, 134.0; 3: DBP, 80.0; 3: MAP, 98.0; 3: Temp, 99.5; 6: Pain, 0.0; 29: POC PH (V) ISTAT, 7.42; 29: POC HCO3 (V) ISTAT, 37.4 mmol/L; 29: POC PCO2 (V) ISTAT, 58.4 mmHg; 29: POC TCO2 (V) ISTAT, 39 mmol/L; 29: POC PO2 (V) ISTAT, 49 mmHg; 29: POC O2 SATURATION ISTAT VENOUS, 83 %; 29: POC BASE EXCESS ISTAT, 13 mmol/L; 29: POC LACTATE ISTAT, 1.38 mmol/L; 61: INR, 1.2; 61: WAM DIFTYP, AUTO; 61: PROTHROMBIN TIME, 15.4 seconds; 61: NEUTROPHIL ABSOLUTE (AUTO DIFF), 23.28 K/uL; 61: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 61: WHITE BLOOD CELLS (WBC), 26.0 K/uL; 61: NEUTROPHIL % (AUTO DIFF), 89.4 %; 61: BASOPHIL % (AUTO DIFF), 0.2 %; 61: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 18.8 pg; 61: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 61: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.9 %; 61: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.38 K/uL; 61: HEMOGLOBIN (HGB), 9.5 g/dL; 61: MEAN CORPUSCULAR VOLUME (MCV), 66.1 fL; 61: NRBC PERCENT (HEMATOLOGY), 0.0 %; 61: MONOCYTE % (AUTO DIFF), 4.2 %; 61: RED CELL DISTRIBUTION WIDTH (RDW), 15.3 %; 61: RED BLOOD CELLS (RBC), 5.05 MIL/uL; 61: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 61: LYMPHOCYTE % (AUTO DIFF), 5.3 %; 61: PLATELET COUNT (PLT), 365 K/uL; 61: HEMATOCRIT (HCT), 33.4 %; 61: EOSINOPHIL % (AUTO DIFF), 0.0 %; 61: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 28.4 g/dL; 61: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.23 K/uL; 61: MONOCYTE ABSOLUTE (AUTO DIFF), 1.10 K/uL; 62: CHLORIDE, 94 mmol/L; 62: GLUCOSE, 129 mg/dL; 62: CALCIUM, 9.1 mg/dL; 62: ANION GAP, 7 mmol/L; 62: BLOOD UREA NITROGEN (BUN), 19 mg/dL; 62: ALBUMIN, 3.7 g/dL; 62: AST (SGOT), 15 U/L; 62: BILIRUBIN TOTAL, 0.3 mg/dL; 62: SODIUM, 136 mmol/L; 62: PROTEIN TOTAL, 7.5 g/dL; 62: CORRECTED CALCIUM, 9.3 mg/dL; 62: CREATININE, 0.33 mg/dL; 62: CO2, 35 mmol/L; 62: PART. THROMBOPLASTIN TIME, 36.4 seconds; 62: GLOBULIN, 3.8 g/dL; 62: ALKALINE PHOSPHATASE, 101 U/L; 62: EGFR FOR AFRICAN AMERICAN, 135 mL/min/1.73 m2; 62: ALT (SGPT), 12 U/L; 62: EGFR REFIT WITHOUT RACE (2021), 117 mL/min/1.73 m2; 62: POTASSIUM, 4.3 mmol/L; 85: HR, 161.0; 85: RR, 23.0; 85: SpO2, 97.0; 85: SBP, 127.0; 85: DBP, 90.0; 85: MAP, 102.333; 85: LPM O2, 2.0; 88: WAM DIFTYP, AUTO; 88: RED BLOOD CELLS (RBC), 4.88 MIL/uL; 88: HEMOGLOBIN (HGB), 9.2 g/dL; 88: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 88: NRBC PERCENT (HEMATOLOGY), 0.0 %; 88: MONOCYTE ABSOLUTE (AUTO DIFF), 1.17 K/uL; 88: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 28.6 g/dL; 88: EOSINOPHIL % (AUTO DIFF), 0.0 %; 88: MONOCYTE % (AUTO DIFF), 4.6 %; 88: MEAN CORPUSCULAR VOLUME (MCV), 66.0 fL; 88: LYMPHOCYTE % (AUTO DIFF), 5.8 %; 88: WHITE BLOOD CELLS (WBC), 25.6 K/uL; 88: PLATELET COUNT (PLT), 346 K/uL; 88: BASOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 88: BASOPHIL % (AUTO DIFF), 0.2 %; 88: NEUTROPHIL % (AUTO DIFF), 88.7 %; 88: RED CELL DISTRIBUTION WIDTH (RDW), 15.3 %; 88: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.18 K/uL; 88: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 88: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.7 %; 88: HEMATOCRIT (HCT), 32.2 %; 88: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 18.9 pg; 88: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.49 K/uL; 88: NEUTROPHIL ABSOLUTE (AUTO DIFF), 22.66 K/uL; 96: PHOSPHORUS, 2.9 mg/dL; 96: MAGNESIUM, 2.2 mg/dL; 102: LR IV BOLUS -, 500 ML; 105: CEFEPIME, 2 GRAM/20 ML IV PUSH; 110: GLUCOSE, 118 mg/dL; 110: CO2, 33 mmol/L; 110: MAGNESIUM, 2.3 mg/dL; 110: CREATININE, 0.31 mg/dL; 110: ANION GAP, 8 mmol/L; 110: EGFR FOR AFRICAN AMERICAN, 137 mL/min/1.73 m2; 110: ALKALINE PHOSPHATASE, 95 U/L; 110: CALCIUM, 9.0 mg/dL; 110: PHOSPHORUS, 2.9 mg/dL; 110: EGFR REFIT WITHOUT RACE (2021), 119 mL/min/1.73 m2; 110: PROTEIN TOTAL, 7.2 g/dL; 110: BILIRUBIN TOTAL, 0.3 mg/dL; 110: POTASSIUM, 4.1 mmol/L; 110: CORRECTED CALCIUM, 9.3 mg/dL; 110: CHLORIDE, 95 mmol/L; 110: AST (SGOT), 14 U/L; 110: SODIUM, 136 mmol/L; 110: ALBUMIN, 3.6 g/dL; 110: ALT (SGPT), 9 U/L; 110: GLOBULIN, 3.6 g/dL; 110: BLOOD UREA NITROGEN (BUN), 19 mg/dL; 110: HR, 94.0; 110: RR, 21.0; 110: SpO2, 95.0; 110: SBP, 128.0; 110: DBP, 87.0; 110: MAP, 100.667; 110: LPM O2, 2.0; 111: TROPONIN I, <.017 ng/mL; 114: MAGNESIUM SULFATE IN WATER, 2 GRAM/50 ML (4 %) IV PGBK; 0: Age:, 66; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.5; 0: Triage HR, 87.0; 0: Triage RR, 16.0; 0: Triage SBP, 134.0; 0: Triage DBP, 80.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient exhibits several signs concerning for high sepsis risk: elevated heart rate (HR: 161) at time 85.0, suggesting tachycardia, and the presence of a low oxygen saturation level (SpO2: 90.0) that may indicate hypoxia at time 3.0. Additionally, an elevated white blood cell count (WBC: 26.0 K/uL) and neutrophil percentage (Neutrophil %: 89.4%) are indicative of an inflammatory response. The administration of Cefepime, a broad-spectrum antibiotic, also suggests that the medical team suspects a serious bacterial infection. These factors combined point toward a high risk of sepsis within 12 hours.",
            "claims": [
                "The patient exhibits several signs concerning for high sepsis risk.",
                "The patient's heart rate is elevated at 161 beats per minute.",
                "An elevated heart rate of 161 suggests tachycardia.",
                "The patient has a low oxygen saturation level of 90%.",
                "A low oxygen saturation level of 90% may indicate hypoxia.",
                "The patient's white blood cell count is elevated at 26.0 K/uL.",
                "An elevated white blood cell count is indicative of an inflammatory response.",
                "The patient's neutrophil percentage is elevated at 89.4%.",
                "An elevated neutrophil percentage is indicative of an inflammatory response.",
                "The administration of Cefepime suggests that the medical team suspects a serious bacterial infection.",
                "These factors combined point toward a high risk of sepsis within 12 hours."
            ],
            "relevant_claims": [
                "The patient exhibits several signs concerning for high sepsis risk.",
                "An elevated heart rate of 161 suggests tachycardia.",
                "The patient has a low oxygen saturation level of 90%.",
                "A low oxygen saturation level of 90% may indicate hypoxia.",
                "The patient's white blood cell count is elevated at 26.0 K/uL.",
                "An elevated white blood cell count is indicative of an inflammatory response.",
                "The patient's neutrophil percentage is elevated at 89.4%.",
                "An elevated neutrophil percentage is indicative of an inflammatory response.",
                "The administration of Cefepime suggests that the medical team suspects a serious bacterial infection.",
                "These factors combined point toward a high risk of sepsis within 12 hours."
            ],
            "alignment_scores": [
                0.3,
                0.9,
                0.7,
                0.6,
                1.0,
                1.0,
                0.7,
                0.8,
                0.8,
                0.3
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "The claim is vague and does not specify which signs the patient exhibits. However, an elevated NEWS score generally consists of multiple deranged vital signs and is used to assess the overall risk of clinical deterioration, including sepsis. The alignment is weak because the claim lacks specific details that would directly match the NEWS components.",
                "The elevated heart rate (tachycardia) of 161 bpm exceeds the SIRS criterion of heart rate >90 bpm, making it highly relevant. As tachycardia is directly listed under SIRS criteria, this strongly aligns with identifying systemic inflammation and early sepsis risk, but the lack of additional SIRS criteria prevents a perfect alignment.",
                "Low oxygen saturation (90%) implies potential hypoxemia, which indirectly relates to the respiratory component of the SOFA score (PaO\u2082/FiO\u2082 < 300). While oxygen saturation isn't directly part of the SOFA criteria, it reflects potential pulmonary compromise that could contribute to organ dysfunction, thus indicating partial alignment with SOFA considerations.",
                "While a low oxygen saturation level of 90% isn't directly measured by the SOFA score, it suggests possible impaired oxygenation and hypoxia, similar to a low PaO\u2082/FiO\u2082 ratio, which is part of the SOFA score criteria. This makes the alignment indirect but relevant, as both are related to evaluating respiratory function.",
                "An elevated white blood cell count (>12,000/\u00b5L) is directly mentioned as one of the SIRS criteria. The claim explicitly provides an elevated WBC count measurement, aligning perfectly with this category's requirement for identifying systemic inflammation associated with early sepsis.",
                "An elevated white blood cell count is explicitly listed as one of the criteria for SIRS positivity. The claim directly describes an element that indicates systemic inflammation consistent with early sepsis, perfectly aligning with the SIRS criteria.",
                "An elevated neutrophil percentage suggests a strong inflammatory or infectious response, which aligns with systemic inflammation indicative of early sepsis. Although the SIRS criteria specifically list elevated WBC, an elevated neutrophil percentage generally contributes to leukocytosis, thus indirectly aligning with the systemic inflammatory response. The alignment is solid but not direct, hence the 0.7 rating.",
                "The claim about an elevated neutrophil percentage suggests an inflammatory response, which conceptually aligns with the presence of systemic inflammation as captured by SIRS criteria. While elevated neutrophils are part of the white blood cell count component of SIRS, they are not explicitly listed as a sole criterion for SIRS but often indicate a type of leukocytosis. Therefore, the alignment is strong but not perfect, as it implies inflammation without directly fulfilling the SIRS criteria.",
                "The administration of Cefepime, a broad-spectrum antibiotic, is typically indicative of suspicion of a serious bacterial infection, aligning well with this category. The claim directly relates to the category's focus on early antibiotic administration as a sign of sepsis risk. However, without explicit timing or additional context regarding how soon Cefepime was given, the alignment is slightly less than perfect, but still strong.",
                "The claim is vague and lacks specific details, but the mention of \"factors combined\" suggests an aggregation of clinical signs or scores, which aligns with the purpose of the NEWS score in predicting clinical deterioration and sepsis risk. However, without explicit reference to any particular measurements or values, the alignment is weak."
            ],
            "final_alignment_score": 0.71
        },
        {
            "input": "10: HR, 77.0; 10: RR, 26.0; 10: SpO2, 94.0; 10: SBP, 124.0; 10: DBP, 62.0; 10: MAP, 82.667; 10: Temp, 96.5; 82: SpO2, 89.0; 83: SpO2, 90.429; 84: SpO2, 90.492; 84: Perf, 4.452; 84: SBP, 154.0; 84: DBP, 70.0; 84: MAP, 98.0; 85: SpO2, 96.466; 85: Perf, 4.148; 86: HR, 71.381; 86: RR, 16.0; 86: SpO2, 97.593; 86: Perf, 2.966; 86: 1min HRV, 16.155; 86: SBP, 154.0; 86: DBP, 70.0; 86: MAP, 98.0; 86: LPM O2, 4.0; 87: HR, 71.517; 87: RR, 16.621; 87: SpO2, 97.845; 87: Perf, 2.527; 87: 1min HRV, 66.844; 88: HR, 71.068; 88: RR, 18.305; 88: SpO2, 99.102; 88: Perf, 6.147; 88: 1min HRV, 88.071; 88: 5min HRV, 71.322; 89: HR, 69.712; 89: RR, 17.373; 89: SpO2, 99.0; 89: Perf, 6.267; 89: 1min HRV, 99.938; 89: SBP, 144.0; 89: DBP, 77.0; 89: MAP, 99.333; 90: HR, 68.655; 90: RR, 19.638; 90: SpO2, 98.931; 90: Perf, 5.382; 90: 1min HRV, 93.795; 91: HR, 68.068; 91: RR, 18.051; 91: SpO2, 99.0; 91: Perf, 3.774; 91: 1min HRV, 108.446; 92: HR, 67.914; 92: RR, 19.621; 92: SpO2, 99.207; 92: Perf, 2.366; 92: 1min HRV, 144.427; 93: HR, 66.576; 93: RR, 22.169; 93: SpO2, 99.339; 93: Perf, 2.173; 93: 1min HRV, 110.827; 93: 5min HRV, 113.988; 94: HR, 65.627; 94: RR, 18.288; 94: SpO2, 98.881; 94: Perf, 2.096; 94: 1min HRV, 110.571; 95: HR, 65.172; 95: RR, 19.759; 95: SpO2, 99.379; 95: Perf, 3.281; 95: 1min HRV, 77.063; 96: POC PH (V) ISTAT, 7.31; 96: POC TCO2 (V) ISTAT, 30 mmol/L; 96: POC BASE EXCESS ISTAT, 2 mmol/L; 96: POC O2 SATURATION ISTAT VENOUS, 64 %; 96: POC PCO2 (V) ISTAT, 57.5 mmHg; 96: POC LACTATE ISTAT, 0.93 mmol/L; 96: POC PO2 (V) ISTAT, 37 mmHg; 96: POC HCO3 (V) ISTAT, 28.7 mmol/L; 96: HR, 65.542; 96: RR, 19.153; 96: SpO2, 99.102; 96: Perf, 1.754; 96: 1min HRV, 27.516; 97: HR, 68.948; 97: RR, 24.897; 97: SpO2, 98.621; 97: Perf, 1.487; 97: 1min HRV, 45.742; 98: HR, 67.034; 98: RR, 21.712; 98: SpO2, 99.085; 98: Perf, 1.493; 98: 1min HRV, 104.683; 98: 5min HRV, 81.792; 99: HR, 67.932; 99: RR, 20.525; 99: SpO2, 99.0; 99: Perf, 1.597; 99: 1min HRV, 120.171; 100: HR, 66.862; 100: RR, 19.621; 100: SpO2, 99.052; 100: Perf, 1.658; 100: 1min HRV, 94.356; 101: HR, 66.831; 101: RR, 23.169; 101: SpO2, 99.136; 101: Perf, 1.661; 101: 1min HRV, 75.248; 102: HR, 65.862; 102: RR, 19.448; 102: SpO2, 99.138; 102: Perf, 1.378; 102: 1min HRV, 32.203; 103: HR, 65.492; 103: RR, 18.424; 103: SpO2, 99.237; 103: Perf, 1.368; 103: 1min HRV, 22.240; 103: 5min HRV, 79.378; 104: HR, 66.552; 104: RR, 26.276; 104: SpO2, 99.224; 104: Perf, 1.556; 104: 1min HRV, 102.855; 105: HR, 64.949; 105: RR, 19.288; 105: SpO2, 99.237; 105: Perf, 1.84; 105: 1min HRV, 23.225; 106: HR, 65.729; 106: RR, 21.475; 106: SpO2, 99.0; 106: Perf, 1.560; 106: 1min HRV, 19.443; 107: HR, 64.603; 107: RR, 24.466; 107: SpO2, 99.776; 107: Perf, 1.227; 107: 1min HRV, 85.820; 108: HR, 63.339; 108: RR, 23.695; 108: SpO2, 99.847; 108: Perf, 1.352; 108: 1min HRV, 26.607; 108: 5min HRV, 65.054; 109: HR, 63.138; 109: RR, 25.052; 109: SpO2, 100.0; 109: Perf, 1.304; 109: 1min HRV, 111.949; 110: HR, 62.695; 110: RR, 22.966; 110: SpO2, 100.0; 110: Perf, 1.205; 110: 1min HRV, 34.180; 111: HR, 65.424; 111: RR, 24.898; 111: SpO2, 99.831; 111: Perf, 1.268; 111: 1min HRV, 76.669; 112: HR, 66.448; 112: RR, 21.948; 112: SpO2, 99.897; 112: Perf, 1.413; 112: 1min HRV, 123.017; 112: Temp, 97.9; 113: HR, 64.915; 113: RR, 23.797; 113: SpO2, 100.0; 113: Perf, 1.788; 113: 1min HRV, 99.817; 113: 5min HRV, 98.123; 114: HR, 64.741; 114: RR, 21.103; 114: SpO2, 99.828; 114: Perf, 1.588; 114: 1min HRV, 154.840; 115: HR, 64.305; 115: RR, 24.051; 115: SpO2, 99.864; 115: Perf, 1.443; 115: 1min HRV, 156.988; 116: HR, 64.797; 116: RR, 22.0; 116: SpO2, 99.949; 116: Perf, 1.362; 116: 1min HRV, 112.948; 117: HR, 64.759; 117: RR, 24.741; 117: SpO2, 99.828; 117: Perf, 1.498; 117: 1min HRV, 138.767; 117: LPM O2, 2.0; 118: SARS-COV-2 RNA, Not Detected; 118: HR, 62.881; 118: RR, 23.424; 118: SpO2, 100.0; 118: Perf, 1.646; 118: 1min HRV, 122.625; 118: 5min HRV, 139.282; 119: WAM DIFTYP, AUTO; 119: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.7 g/dL; 119: MONOCYTE ABSOLUTE (AUTO DIFF), 0.63 K/uL; 119: NRBC PERCENT (HEMATOLOGY), 0.0 %; 119: HEMATOCRIT (HCT), 35.3 %; 119: NEUTROPHIL ABSOLUTE (AUTO DIFF), 6.30 K/uL; 119: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 119: NEUTROPHIL % (AUTO DIFF), 76.3 %; 119: RED CELL DISTRIBUTION WIDTH (RDW), 14.0 %; 119: MONOCYTE % (AUTO DIFF), 7.6 %; 119: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.26 K/uL; 119: RED BLOOD CELLS (RBC), 3.82 MIL/uL; 119: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.94 K/uL; 119: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.3 pg; 119: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.08 K/uL; 119: BASOPHIL % (AUTO DIFF), 0.5 %; 119: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 119: LYMPHOCYTE % (AUTO DIFF), 11.4 %; 119: MEAN CORPUSCULAR VOLUME (MCV), 92.4 fL; 119: PLATELET COUNT (PLT), 147 K/uL; 119: EOSINOPHIL % (AUTO DIFF), 3.2 %; 119: HEMOGLOBIN (HGB), 11.2 g/dL; 119: WHITE BLOOD CELLS (WBC), 8.3 K/uL; 119: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.0 %; 119: HR, 62.966; 119: RR, 23.138; 119: SpO2, 99.603; 119: Perf, 1.539; 119: 1min HRV, 132.912; 0: Age, 72; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 35.8; 0: Triage HR, 77.0; 0: Triage RR, 26.0; 0: Triage SBP, 124.0; 0: Triage DBP, 62.0; 0: Triage acuity, 3-Urgent; 0: CC, MULTIPLE COMPLAINTS",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "While the patient presents with some risk factors for sepsis such as an elevated respiratory rate and slightly low temperature at triage, there is no evidence of significant deterioration or signs of organ dysfunction within the given time series. The heart rate variability and other vital signs stabilize or improve over time. Additionally, there are no pronounced abnormalities in laboratory results that would suggest a high risk of developing sepsis within 12 hours.",
            "claims": [
                "The patient presents with some risk factors for sepsis.",
                "The patient has an elevated respiratory rate at triage.",
                "The patient has a slightly low temperature at triage.",
                "There is no evidence of significant deterioration within the given time series.",
                "There are no signs of organ dysfunction within the given time series.",
                "The heart rate variability stabilizes or improves over time.",
                "Other vital signs stabilize or improve over time.",
                "There are no pronounced abnormalities in laboratory results.",
                "The laboratory results do not suggest a high risk of developing sepsis within 12 hours."
            ],
            "relevant_claims": [
                "The patient has an elevated respiratory rate at triage.",
                "The patient has a slightly low temperature at triage.",
                "There is no evidence of significant deterioration within the given time series.",
                "There are no pronounced abnormalities in laboratory results."
            ],
            "alignment_scores": [
                0.7,
                0.3,
                0.2,
                0.2
            ],
            "alignment_category": [
                "High qSOFA Score (\u22652)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated NEWS Score (\u22655 points)",
                "Early Antibiotic/Culture Orders (within 2 hours)"
            ],
            "alignment_reasonings": [
                "An elevated respiratory rate is included as one of the criteria for a qSOFA score (respiratory\u202frate\u202f\u2265\u202f22/min), which assesses risk for sepsis-related organ dysfunction. The claim doesn't specify the exact respiratory rate, so while it suggests a concern consistent with qSOFA, the absence of defined values and additional criteria makes the alignment strong but not perfect.",
                "A slightly low temperature may be somewhat related to one of the SIRS criteria, which includes a temperature <36\u00b0C as an indicator of systemic inflammation. However, the claim does not specify the exact temperature or whether it meets the SIRS criteria threshold. Thus, the alignment is weak, but there's a conceptual connection to early sepsis indicators.",
                "The claim refers to the lack of significant deterioration, which could relate somewhat to a NEWS score since this score is used to predict clinical deterioration. However, there is no mention of specific vital signs or scores, making this connection weak and indirect. The category alignment is therefore low.",
                "The claim indicates the absence of pronounced laboratory abnormalities, suggesting that there might not be immediate clinical evidence prompting concerns specific to sepsis risk. However, in scenarios where lab results are inconspicuous, clinicians might rely on anticipatory actions like antibiotic or culture orders to further investigate possible infections, although no direct indication of this is stated. The alignment is quite indirect, hence the low rating."
            ],
            "final_alignment_score": 0.35
        },
        {
            "input": "12: HR, 131.0; 12: RR, 26.0; 12: SpO2, 97.0; 12: SBP, 112.0; 12: DBP, 63.0; 12: MAP, 79.333; 12: Pain, 8.0; 12: Temp, 99.1; 16: HR, 130.224; 16: RR, 31.759; 16: SpO2, 96.810; 16: Perf, 2.298; 16: 1min HRV, 2.130; 17: HR, 130.271; 17: RR, 30.661; 17: SpO2, 96.169; 17: Perf, 2.430; 17: 1min HRV, 2.049; 18: HR, 129.879; 18: RR, 29.517; 18: SpO2, 96.328; 18: Perf, 2.537; 18: 1min HRV, 4.819; 19: HR, 129.661; 19: RR, 33.458; 19: SpO2, 97.0; 19: Perf, 2.426; 19: 1min HRV, 3.290; 20: HR, 128.695; 20: RR, 30.390; 20: SpO2, 96.373; 20: Perf, 2.076; 20: 1min HRV, 2.228; 20: 5min HRV, 3.789; 21: HR, 128.810; 21: RR, 30.638; 21: SpO2, 96.931; 21: Perf, 2.043; 21: 1min HRV, 2.866; 22: HR, 127.407; 22: RR, 31.864; 22: SpO2, 96.814; 22: Perf, 1.983; 22: 1min HRV, 2.082; 23: HR, 127.414; 23: RR, 31.052; 23: SpO2, 95.845; 23: Perf, 1.876; 23: 1min HRV, 2.009; 24: POC PH (V) ISTAT, 7.47; 24: POC PO2 (V) ISTAT, 47 mmHg; 24: POC LACTATE ISTAT, 1.31 mmol/L; 24: POC TCO2 (V) ISTAT, 15 mmol/L; 24: POC PCO2 (V) ISTAT, 19.9 mmHg; 24: POC O2 SATURATION ISTAT VENOUS, 87 %; 24: POC BASE EXCESS ISTAT, -9 mmol/L; 24: POC HCO3 (V) ISTAT, 14.4 mmol/L; 24: HR, 127.051; 24: RR, 32.576; 24: SpO2, 96.288; 24: Perf, 2.031; 24: 1min HRV, 2.624; 25: HR, 127.328; 25: RR, 31.345; 25: SpO2, 95.914; 25: Perf, 1.939; 25: 1min HRV, 2.888; 25: 5min HRV, 3.467; 26: HR, 127.407; 26: RR, 26.644; 26: SpO2, 95.593; 26: Perf, 1.900; 26: 1min HRV, 7.509; 27: HR, 127.932; 27: RR, 29.983; 27: SpO2, 95.780; 27: Perf, 1.887; 27: 1min HRV, 3.685; 28: HR, 127.983; 28: RR, 31.793; 28: SpO2, 94.569; 28: Perf, 2.606; 28: 1min HRV, 1.864; 29: HR, 127.542; 29: RR, 29.492; 29: SpO2, 94.0; 29: Perf, 2.147; 29: 1min HRV, 2.224; 30: 5min HRV, 4.540; 67: PROTEIN TOTAL, 7.2 g/dL; 67: ALKALINE PHOSPHATASE, 91 U/L; 67: ALT (SGPT), 13 U/L; 67: EGFR REFIT WITHOUT RACE (2021), 9 mL/min/1.73 m2; 67: CHLORIDE, 99 mmol/L; 67: GLOBULIN, 3.9 g/dL; 67: CO2, 12 mmol/L; 67: AST (SGOT), 14 U/L; 67: SODIUM, 133 mmol/L; 67: BILIRUBIN TOTAL, 0.8 mg/dL; 67: ANION GAP, 22 mmol/L; 67: ALBUMIN, 3.3 g/dL; 67: CALCIUM, 8.9 mg/dL; 67: EGFR FOR AFRICAN AMERICAN, 11 mL/min/1.73 m2; 67: GLUCOSE, 164 mg/dL; 67: CREATININE, 5.68 mg/dL; 67: CORRECTED CALCIUM, 9.5 mg/dL; 67: POTASSIUM, 4.7 mmol/L; 67: BLOOD UREA NITROGEN (BUN), 79 mg/dL; 72: INR, 1.3; 72: PROTHROMBIN TIME, 16.1 seconds; 73: PART. THROMBOPLASTIN TIME, 49.0 seconds; 73: CEFEPIME, 2 GRAM/20 ML IV PUSH; 82: HR:, 113.0; 82: RR, 27.0; 82: SpO2, 97.0; 82: Temp, 102.4; 85: VANCOMYCIN-WATER INJECT (PEG), 1.25 GRAM/250 ML IV PGBK; 86: WAM, DIFTYP: AUTO; 86: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 86: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.65 K/uL; 86: NEUTROPHIL ABSOLUTE (AUTO DIFF), 29.65 K/uL; 86: BASOPHIL % (AUTO DIFF), 0.3 %; 86: RED BLOOD CELLS (RBC), 3.66 MIL/uL; 86: EOSINOPHIL % (AUTO DIFF), 0.0 %; 86: HEMATOCRIT (HCT), 32.2 %; 86: LYMPHOCYTE % (AUTO DIFF), 2.1 %; 86: HEMOGLOBIN (HGB), 10.4 g/dL; 86: NRBC PERCENT (HEMATOLOGY), 0.0 %; 86: PLATELET COUNT (PLT), 420 K/uL; 86: MONOCYTE % (AUTO DIFF), 1.6 %; 86: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.1 %; 86: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 86: BASOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 86: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.3 g/dL; 86: MONOCYTE ABSOLUTE (AUTO DIFF), 0.49 K/uL; 86: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.4 pg; 86: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.34 K/uL; 86: NEUTROPHIL % (AUTO DIFF), 94.9 %; 86: WHITE BLOOD CELLS (WBC), 31.2 K/uL; 86: MEAN CORPUSCULAR VOLUME (MCV), 88.0 fL; 86: RED CELL DISTRIBUTION WIDTH (RDW), 14.8 %; 86: METAMYELOCYTE/MYELOCYTE/PROMYELOCYTE (SLIDE REVIEW), 54 %; 86: LR IV BOLUS -, 30 ML/KG (ED FOR BMI <= 30); 90: HR:, 116.0; 90: RR, 26.0; 90: SpO2, 97.0; 90: SBP, 95.0; 90: DBP, 56.0; 90: MAP, 69.0; 110: HR, 110.0; 110: RR, 29.0; 110: SpO2, 95.0; 110: SBP, 96.0; 110: DBP, 58.0; 110: MAP, 70.667; 0: Age, 73; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, EMS; 0: Triage Temp, 37.3; 0: Triage HR, 131.0; 0: Triage RR, 26.0; 0: Triage SBP, 112.0; 0: Triage DBP, 63.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER,ABDOMINAL PAIN,NAUSEA",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient's vitals indicate multiple signs consistent with sepsis risk: persistent tachycardia (HR consistently above 127), tachypnea (elevated RR with peaks beyond 30), and hypotension with MAP dropping to 69. Blood work shows an elevated white blood cell count (WBC at 31.2 K/uL) and high neutrophil percentage (94.9%), both suggesting an immune response to an infection. The administration of broad-spectrum antibiotics like Cefepime and Vancomycin further indicates a suspicion of severe infection, solidifying the high risk of developing sepsis.",
            "claims": [
                "The patient's vitals indicate multiple signs consistent with sepsis risk.",
                "The patient exhibits persistent tachycardia with a heart rate consistently above 127.",
                "Tachycardia is a sign consistent with sepsis risk.",
                "The patient has tachypnea with elevated respiratory rates exceeding 30.",
                "Tachypnea is a sign consistent with sepsis risk.",
                "The patient's mean arterial pressure (MAP) has dropped to 69, indicating hypotension.",
                "Hypotension is a sign consistent with sepsis risk.",
                "Blood work shows an elevated white blood cell count of 31.2 K/uL.",
                "An elevated white blood cell count suggests an immune response to an infection.",
                "Blood work shows a high neutrophil percentage of 94.9%.",
                "A high neutrophil percentage suggests an immune response to an infection.",
                "The administration of broad-spectrum antibiotics like Cefepime and Vancomycin indicates a suspicion of severe infection.",
                "The suspicion of severe infection solidifies the high risk of developing sepsis."
            ],
            "relevant_claims": [
                "The patient's vitals indicate multiple signs consistent with sepsis risk.",
                "The patient exhibits persistent tachycardia with a heart rate consistently above 127.",
                "Tachycardia is a sign consistent with sepsis risk.",
                "The patient has tachypnea with elevated respiratory rates exceeding 30.",
                "Tachypnea is a sign consistent with sepsis risk.",
                "The patient's mean arterial pressure (MAP) has dropped to 69, indicating hypotension.",
                "Hypotension is a sign consistent with sepsis risk.",
                "Blood work shows an elevated white blood cell count of 31.2 K/uL.",
                "An elevated white blood cell count suggests an immune response to an infection.",
                "Blood work shows a high neutrophil percentage of 94.9%.",
                "A high neutrophil percentage suggests an immune response to an infection.",
                "The administration of broad-spectrum antibiotics like Cefepime and Vancomycin indicates a suspicion of severe infection.",
                "The suspicion of severe infection solidifies the high risk of developing sepsis."
            ],
            "alignment_scores": [
                0.7,
                0.8,
                0.8,
                0.8,
                0.7,
                1.0,
                0.8,
                1.0,
                1.0,
                0.7,
                0.7,
                1.0,
                0.4
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "Early Antibiotic/Culture Orders (within 2 hours)"
            ],
            "alignment_reasonings": [
                "The claim mentions that the patient's vitals indicate multiple signs consistent with sepsis risk. This aligns most closely with the Elevated NEWS Score category, which is derived from multiple deranged vital signs and predicts clinical deterioration compatible with sepsis. While the claim does not directly specify a NEWS score or precise vital measurements, it captures the essence of multiple vital sign derangements elevating sepsis risk, suggesting a fairly strong, though not exact, alignment.",
                "A persistent tachycardia with a heart rate consistently above 90 bpm is one of the criteria used to identify systemic inflammation under the SIRS criteria. Since a heart rate of 127 is well above the SIRS threshold, the alignment is quite strong, although a single criterion does not fulfill the requirement for the presence of \u22652 SIRS criteria. Therefore, while it strongly suggests systemic inflammation, it does not independently confirm SIRS positivity, leading to a slightly less than perfect alignment.",
                "Tachycardia, defined as heart rate >90 bpm, is one of the criteria in the SIRS (Systemic Inflammatory Response Syndrome) list. SIRS criteria are used as a measure to identify signs of systemic inflammation indicative of early sepsis. While the claim mentions tachycardia as a sign consistent with sepsis risk, it doesn't confirm this is part of a broader SIRS positivity (\u22652 criteria), hence the rating is slightly less than full alignment.",
                "The claim states that the patient has tachypnea with respiratory rates exceeding 30, which aligns with the SIRS criterion of a respiratory rate >20/min. While this fulfills one of the criteria for SIRS positivity, SIRS requires at least 2 criteria to be met. Therefore, the alignment is strong but partial, as only one SIRS criterion is mentioned. This results in a rating of 0.8 for its direct relevance to SIRS positivity.",
                "Tachypnea, or increased respiratory rate, is directly associated with the SIRS criteria, specifically a respiratory rate >20/min. While the claim indicates tachypnea consistent with sepsis risk, it does not quantify the respiratory rate, which slightly reduces the precision of the alignment. However, the conceptual link between tachypnea and SIRS is strong.",
                "The claim specifically mentions a mean arterial pressure (MAP) of 69, which falls under the threshold for sepsis-associated hypotension (MAP < 70 mmHg), an indicator of potential progression toward septic shock. Therefore, this perfectly aligns with the category criteria.",
                "The claim directly references hypotension, which is a key part of the definition for sepsis-associated hypotension. While the claim indicates that hypotension is consistent with sepsis risk, it doesn\u2019t specify the exact parameters (such as SBP <90 mmHg or MAP <70 mmHg), so it aligns strongly but not completely perfectly with the category.",
                "The claim explicitly mentions an elevated white blood cell count (WBC), which is directly listed under the SIRS criteria. A WBC count greater than 12,000/\u00b5L is one of the criteria used to identify systemic inflammation consistent with early sepsis. The alignment is perfect, as the claim directly pertains to one of the required SIRS criteria.",
                "An elevated white blood cell count is explicitly listed as one of the criteria for SIRS (Systemic Inflammatory Response Syndrome), which indicates systemic inflammation consistent with early sepsis. The claim directly aligns with the SIRS criteria, making the alignment strong and straightforward.",
                "A high neutrophil percentage suggests an inflammatory or infectious response, aligning with the systemic inflammation detected by SIRS criteria. Although not an explicit SIRS measure, a high neutrophil level often correlates with an elevated white blood cell count, which is a criterion in SIRS. The alignment is significant, though indirect, as it indicates a likely systemic inflammatory state consistent with early sepsis.",
                "An elevated neutrophil percentage often indicates an immune response to infection, which aligns with the SIRS criteria related to systemic inflammation. While an elevated neutrophil percentage is not explicitly part of the SIRS criteria, it suggests an inflammatory response consistent with early sepsis. Therefore, the alignment is substantial but not perfect.",
                "The claim specifically mentions the administration of broad-spectrum antibiotics, which falls directly under the category of Early Antibiotic/Culture Orders. This indicates a strong suspicion of severe infection, perfectly aligning with the category criteria.",
                "The claim mentions a solidified suspicion of severe infection, which aligns with the category of early action (antibiotic administration or culture orders) in response to suspected serious infection. However, the claim does not reference any concrete actions taken to further assess or treat the suspected infection, such as ordering antibiotics or cultures, hence the moderate alignment."
            ],
            "final_alignment_score": 0.7999999999999999
        },
        {
            "input": "2: SpO2, 97.0; 2: SBP, 206.0; 2: DBP, 115.0; 2: MAP, 145.333; 3: SpO2, 97.185; 4: SpO2, 97.019; 4: Perf, 0.720; 5: SpO2, 97.491; 5: Perf, 0.742; 6: SpO2, 97.208; 6: Perf, 0.717; 7: SpO2, 98.0; 7: Perf, 0.701; 8: HR, 103.0; 8: RR, 18.0; 8: SpO2, 97.623; 8: Perf, 0.68; 8: SBP, 206.0; 8: DBP, 115.0; 8: MAP, 145.333; 8: Pain, 10.0; 9: SpO2, 97.615; 9: Perf, 0.680; 10: SpO2, 97.604; 10: Perf, 0.69; 11: SpO2, 98.0; 11: Perf, 0.772; 12: SpO2, 97.830; 12: Perf, 0.758; 13: SpO2, 97.566; 13: Perf, 0.740; 14: SpO2, 98.154; 14: Perf, 0.769; 15: SpO2, 98.189; 15: Perf, 0.763; 16: SpO2, 97.846; 16: Perf, 0.704; 17: SpO2, 97.283; 17: Perf, 0.726; 18: SpO2, 97.0; 18: Perf, 0.831; 19: SpO2, 97.242; 20: SpO2, 97.115; 20: Perf, 0.737; 21: SpO2, 96.923; 21: Perf, 0.927; 22: SpO2, 97.0; 23: SpO2, 97.586; 23: Perf, 1.114; 24: HR, 100.0; 24: RR, 18.0; 24: SpO2, 94.111; 24: SBP, 197.0; 24: DBP, 103.0; 24: MAP, 134.333; 25: SpO2, 97.0; 25: SBP, 197.0; 25: DBP, 103.0; 25: MAP, 134.333; 27: SpO2, 97.364; 28: SpO2, 97.623; 28: Perf, 1.001; 29: SpO2, 97.0; 29: Perf, 1.053; 31: SpO2, 88.0; 33: WAM DIFTYP, AUTO; 33: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.3 %; 33: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.39 K/uL; 33: LYMPHOCYTE % (AUTO DIFF), 14.0 %; 33: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.7 g/dL; 33: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.18 K/uL; 33: MEAN CORPUSCULAR VOLUME (MCV), 99.5 fL; 33: BASOPHIL % (AUTO DIFF), 0.2 %; 33: PLATELET COUNT (PLT), 376 K/uL; 33: MONOCYTE % (AUTO DIFF), 7.3 %; 33: HEMOGLOBIN (HGB), 12.5 g/dL; 33: HEMATOCRIT (HCT), 39.4 %; 33: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 33: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 33: NEUTROPHIL % (AUTO DIFF), 77.1 %; 33: RED CELL DISTRIBUTION WIDTH (RDW), 14.2 %; 33: MONOCYTE ABSOLUTE (AUTO DIFF), 0.98 K/uL; 33: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.6 pg; 33: NRBC PERCENT (HEMATOLOGY), 0.0 %; 33: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.89 K/uL; 33: EOSINOPHIL % (AUTO DIFF), 0.1 %; 33: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 33: WHITE BLOOD CELLS (WBC), 13.5 K/uL; 33: RED BLOOD CELLS (RBC), 3.96 MIL/uL; 33: SpO2, 94.0; 34: ACETAMINOPHEN, 325 MG PO TABS; 35: SpO, 2: 97.917; 36: SpO2, 97.308; 36: Perf, 0.873; 36: AMPICILLIN-SULBACTAM, 3 GRAM/100 ML MINIBAG PLUS; 37: SpO, 2: 97.170; 37: Perf, 0.920; 38: SpO2, 97.0; 38: Perf, 0.895; 39: SpO2, 97.0; 39: Perf, 0.892; 40: SpO2, 97.0; 40: Perf, 0.86; 41: SpO2, 97.0; 41: Perf, 0.827; 42: SpO2, 97.744; 43: SpO2, 98.0; 43: Perf, 0.891; 44: SpO2, 97.588; 44: Perf, 1.045; 45: SpO2, 97.0; 45: Perf, 0.975; 46: SpO2, 96.731; 46: Perf, 1.045; 47: SpO2, 96.302; 47: Perf, 1.191; 48: SpO2, 96.654; 48: Perf, 1.225; 49: SpO2, 97.0; 49: Perf, 1.303; 50: SpO2, 97.0; 50: Perf, 1.328; 51: SpO2, 97.0; 51: Perf, 1.327; 52: SpO2, 97.0; 52: Perf, 1.391; 53: SpO2, 97.0; 53: Perf, 1.318; 54: SpO2, 96.868; 54: Perf, 1.406; 55: SpO2, 96.0; 55: Perf, 1.390; 56: SpO2, 96.226; 56: Perf, 1.419; 57: SpO2, 96.327; 57: Perf, 1.422; 58: SpO2, 96.0; 58: Perf, 1.384; 59: SpO2, 95.774; 59: Perf, 1.254; 60: SpO2, 96.096; 60: Perf, 1.303; 61: SpO2, 96.264; 61: Perf, 1.389; 62: SpO2, 96.0; 62: Perf, 1.226; 63: SpO2, 95.340; 63: Perf, 1.125; 64: SpO2, 96.962; 64: Perf, 1.310; 65: SpO2, 97.0; 65: Perf, 1.818; 66: AST (SGOT), 33 U/L; 66: GLUCOSE, 102 mg/dL; 66: ALBUMIN, 4.3 g/dL; 66: PROTEIN TOTAL, 7.3 g/dL; 66: BLOOD UREA NITROGEN (BUN), 12 mg/dL; 66: BILIRUBIN TOTAL, 1.5 mg/dL; 66: EGFR FOR AFRICAN AMERICAN, 78 mL/min/1.73 m2; 66: SODIUM, 138 mmol/L; 66: CREATININE, 0.76 mg/dL; 66: GLOBULIN, 3.0 g/dL; 66: EGFR REFIT WITHOUT RACE (2021), 67 mL/min/1.73 m2; 66: ALKALINE PHOSPHATASE, 150 U/L; 66: ANION GAP, 13 mmol/L; 66: CO2, 23 mmol/L; 66: CALCIUM, 9.4 mg/dL; 66: CHLORIDE, 102 mmol/L; 66: CORRECTED CALCIUM, 9.2 mg/dL; 66: POTASSIUM, 4.3 mmol/L; 66: ALT (SGPT), 28 U/L; 66: SpO2, 96.943; 66: Perf, 1.860; 67: SpO2, 96.827; 67: Perf, 1.841; 68: SpO2, 96.0; 68: Perf, 1.759; 69: SpO2, 96.113; 69: Perf, 1.695; 70: SpO2, 95.951; 70: Perf, 1.700; 71: SpO2, 96.0; 71: Perf, 1.540; 72: SpO2, 96.173; 72: Perf, 1.488; 73: SpO2, 96.0; 73: Perf, 1.600; 74: SpO2, 95.151; 74: Perf, 1.457; 75: SpO2, 95.904; 75: Perf, 1.517; 76: SpO2, 95.925; 76: Perf, 1.477; 77: SpO2, 95.058; 77: Perf, 1.363; 78: SpO2, 96.0; 78: Perf, 1.658; 79: SpO2, 95.642; 79: Perf, 1.595; 80: SpO2, 95.327; 80: Perf, 1.426; 81: SpO2, 95.226; 81: Perf, 1.360; 82: SARS-COV-2 RNA, Not Detected; 82: SpO2, 95.0; 82: Perf, 1.314; 83: SpO2, 94.509; 83: Perf, 1.301; 84: SpO2, 94.538; 84: Perf, 1.324; 85: SpO2, 94.725; 85: Perf, 1.390; 104: SpO2, 96.365; 104: Perf, 1.140; 105: SpO2, 96.0; 105: Perf, 1.179; 106: SpO2, 96.0; 106: Perf, 1.165; 107: SpO2, 96.0; 108: SpO2, 96.721; 108: Perf, 1.267; 109: SpO2, 96.635; 109: Perf, 1.278; 110: SpO2, 96.245; 110: Perf, 1.290; 111: SpO2, 96.0; 111: Perf, 1.262; 112: SpO2, 96.282; 112: Perf, 1.303; 112: IOPAMIDOL, 76 % IV SOLN (RADIOLOGY) 500 ML; 113: SpO, 2: 97.0; 113: Perf, 1.497; 114: SpO2, 97.0; 114: Perf, 1.674; 115: SpO2, 97.189; 115: Perf, 1.635; 116: SpO2, 96.942; 116: Perf, 1.490; 117: SpO2, 97.377; 117: Perf, 1.634; 118: SpO2, 97.226; 118: Perf, 1.614; 119: SpO2, 96.635; 119: Perf, 1.432; 0: Age, 90; 0: Gender, F; 0: Race, White; 0: Means of arrival, EMS; 0: Triage Temp, 37.4; 0: Triage HR, 103.0; 0: Triage RR, 18.0; 0: Triage SBP, 206.0; 0: Triage DBP, 115.0; 0: Triage acuity, 3-Urgent; 0: CC, JAW SWELLING",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "Although the patient has high blood pressure and a high heart rate, indicating potential cardiovascular issues, the consistent oxygen saturation levels (SpO2 values typically around 96-98%), and the absence of fever suggest that the immediate risk of sepsis is low. Additionally, treatment with antibiotics indicates the healthcare providers are addressing any possible infection early. Based on this data, the patient is not at high risk of developing sepsis within the next 12 hours.",
            "claims": [
                "The patient has high blood pressure.",
                "The patient has a high heart rate.",
                "High blood pressure and a high heart rate indicate potential cardiovascular issues.",
                "The patient's oxygen saturation levels are consistent.",
                "The patient's SpO2 values are typically around 96-98%.",
                "The absence of fever suggests that the immediate risk of sepsis is low.",
                "Treatment with antibiotics indicates that healthcare providers are addressing any possible infection early.",
                "Based on the data, the patient is not at high risk of developing sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The patient has high blood pressure.",
                "Treatment with antibiotics indicates that healthcare providers are addressing any possible infection early."
            ],
            "alignment_scores": [
                0.2,
                0.9
            ],
            "alignment_category": [
                "High qSOFA Score (\u22652)",
                "Early Antibiotic/Culture Orders (within 2 hours)"
            ],
            "alignment_reasonings": [
                "High blood pressure is not explicitly part of the criteria for any of the specified expert categories, including the qSOFA score, which considers low blood pressure (systolic\u202fBP\u202f\u2264\u202f100\u202fmmHg) rather than high blood pressure. The mention of blood pressure relates somewhat weakly to qSOFA due to the involvement of blood pressure in its criteria, but the alignment is minimal. Other categories focus on low blood pressure or specific indices related to blood pressure, not high blood pressure.",
                "The claim specifically mentions treatment with antibiotics, which aligns closely with early intervention against infection indicated in the category. The statement reflects proactive management of a potential infection, strongly suggesting suspicion leading to preventive action, which closely relates but doesn't specify the timing aspect (within 2 hours). Thus, the alignment is not perfect but very strong."
            ],
            "final_alignment_score": 0.55
        },
        {
            "input": "4: HR, 106.0; 4: RR, 18.0; 4: SpO2, 95.0; 4: SBP, 118.0; 4: DBP, 57.0; 4: MAP, 77.333; 4: Temp, 100.6; 11: Pain, 10.0; 78: INFLUENZA B, Not Detected; 78: RSV, Not Detected; 78: SARS-COV-2 RNA, Not Detected; 78: INFLUENZA A, Not Detected; 86: WAM DIFTYP, AUTO; 86: MONOCYTE % (AUTO DIFF), 3.2 %; 86: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.0 %; 86: NRBC PERCENT (HEMATOLOGY), 0.0 %; 86: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.37 K/uL; 86: NEUTROPHIL ABSOLUTE (AUTO DIFF), 21.89 K/uL; 86: BASOPHIL % (AUTO DIFF), 0.2 %; 86: MONOCYTE ABSOLUTE (AUTO DIFF), 0.74 K/uL; 86: NEUTROPHIL % (AUTO DIFF), 93.9 %; 86: HEMOGLOBIN (HGB), 12.1 g/dL; 86: BASOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 86: RED CELL DISTRIBUTION WIDTH (RDW), 14.1 %; 86: PLATELET COUNT (PLT), 296 K/uL; 86: EOSINOPHIL % (AUTO DIFF), 0.1 %; 86: MEAN CORPUSCULAR VOLUME (MCV), 83.9 fL; 86: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.2 g/dL; 86: LYMPHOCYTE % (AUTO DIFF), 1.6 %; 86: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.23 K/uL; 86: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 86: WHITE BLOOD CELLS (WBC), 23.3 K/uL; 86: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 27.9 pg; 86: HEMATOCRIT (HCT), 36.4 %; 86: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 86: RED BLOOD CELLS (RBC), 4.34 MIL/uL; 89: SpO2, 96.0; 89: Perf, 4.079; 90: AST (SGOT), 114 U/L; 90: PROTEIN TOTAL, 6.9 g/dL; 90: ALT (SGPT), 110 U/L; 90: CREATININE, 0.54 mg/dL; 90: GLOBULIN, 2.9 g/dL; 90: BILIRUBIN TOTAL, 0.6 mg/dL; 90: ALBUMIN, 4.0 g/dL; 90: ALKALINE PHOSPHATASE, 96 U/L; 90: BLOOD UREA NITROGEN (BUN), 15 mg/dL; 90: POTASSIUM, 3.9 mmol/L; 90: CHLORIDE, 101 mmol/L; 90: GLUCOSE, 133 mg/dL; 90: SODIUM, 137 mmol/L; 90: ANION GAP, 15 mmol/L; 90: CO2, 21 mmol/L; 90: CORRECTED CALCIUM, 9.4 mg/dL; 90: EGFR REFIT WITHOUT RACE (2021), 101 mL/min/1.73 m2; 90: CALCIUM, 9.4 mg/dL; 90: HR, 84.517; 90: RR, 21.292; 90: SpO2, 95.458; 90: Perf, 4.041; 90: 1min HRV, 10.199; 91: HR, 83.949; 91: RR, 23.932; 91: SpO2, 95.590; 91: Perf, 3.659; 91: 1min HRV, 11.842; 91: 5min HRV, 11.409; 91: SBP, 116.0; 91: DBP, 50.0; 91: MAP, 72.0; 92: HR, 83.879; 92: RR, 27.276; 92: SpO2, 94.408; 92: Perf, 4.016; 92: 1min HRV, 9.479; 93: HR, 83.644; 93: RR, 26.017; 93: SpO2, 95.0; 93: Perf, 5.217; 93: 1min HRV, 10.131; 94: HR, 85.362; 94: RR, 23.397; 94: SpO2, 94.207; 94: Perf, 5.130; 94: 1min HRV, 10.629; 95: HR, 85.017; 95: RR, 22.847; 95: SpO2, 93.881; 95: Perf, 5.692; 95: 1min HRV, 11.154; 96: HR, 86.103; 96: RR, 22.017; 96: SpO2, 93.172; 96: Perf, 6.053; 96: 1min HRV, 6.565; 96: 5min HRV, 12.675; 97: HR, 88.797; 97: RR, 23.356; 97: SpO2, 91.763; 97: Perf, 5.578; 97: 1min HRV, 7.669; 98: HR, 88.475; 98: RR, 24.407; 98: SpO2, 92.407; 98: Perf, 5.426; 98: 1min HRV, 9.469; 99: HR, 89.207; 99: RR, 25.948; 99: SpO2, 92.172; 99: Perf, 5.348; 99: 1min HRV, 6.386; 100: HR, 86.966; 100: RR, 25.237; 100: SpO2, 92.068; 100: Perf, 5.777; 100: 1min HRV, 9.830; 101: HR, 86.914; 101: RR, 23.397; 101: SpO2, 94.155; 101: Perf, 6.101; 101: 1min HRV, 9.211; 101: 5min HRV, 11.822; 102: HR, 86.542; 102: RR, 24.0; 102: SpO2, 92.156; 102: Perf, 5.225; 102: 1min HRV, 5.188; 102: SBP, 110.0; 102: DBP, 58.0; 102: MAP, 75.333; 103: HR, 87.780; 103: RR, 23.678; 103: SpO2, 91.780; 103: Perf, 4.880; 103: 1min HRV, 7.196; 104: HR, 87.845; 104: RR, 25.397; 104: SpO2, 91.707; 104: Perf, 4.783; 104: 1min HRV, 8.222; 105: HR, 88.525; 105: RR, 26.814; 105: SpO2, 92.051; 105: Perf, 4.338; 105: 1min HRV, 7.789; 106: HIGH SENSITIVITY TROPONIN, 4 ng/L; 106: HR, 88.931; 106: RR, 25.759; 106: SpO2, 92.517; 106: Perf, 4.301; 106: 1min HRV, 8.454; 106: 5min HRV, 10.096; 107: HR, 88.847; 107: RR, 28.763; 107: SpO2, 92.712; 107: Perf, 4.237; 107: 1min HRV, 8.968; 108: HR, 88.322; 108: RR, 27.695; 108: SpO2, 94.831; 108: Perf, 4.0; 108: 1min HRV, 12.599; 109: HR, 88.897; 109: RR, 25.276; 109: SpO2, 96.0; 109: Perf, 4.164; 109: 1min HRV, 19.491; 110: HR, 86.797; 110: RR, 25.288; 110: SpO2, 96.0; 110: Perf, 4.062; 110: 1min HRV, 18.006; 111: HR, 85.241; 111: RR, 25.534; 111: SpO2, 95.534; 111: Perf, 4.561; 111: 1min HRV, 11.685; 111: 5min HRV, 18.796; 112: HR, 86.254; 112: RR, 25.847; 112: SpO2, 95.0; 112: Perf, 4.068; 112: 1min HRV, 14.892; 113: HR, 85.492; 113: RR, 26.373; 113: SpO2, 94.492; 113: Perf, 4.149; 113: 1min HRV, 12.022; 114: HR, 85.155; 114: RR, 23.362; 114: SpO2, 94.759; 114: Perf, 4.107; 114: 1min HRV, 17.338; 114: CEFTRIAXONE, 1 GRAM/10 ML IV PUSH (VIAL ONLY); 115: HR:, 85.966; 115: RR, 25.119; 115: SpO2, 94.932; 115: Perf, 3.909; 115: 1min HRV, 18.567; 115: SBP, 110.0; 115: DBP, 58.0; 115: MAP, 75.333; 115: Pain, 10.0; 116: HR, 94.586; 116: RR, 23.483; 116: SpO2, 95.224; 116: Perf, 2.791; 116: 1min HRV, 9.841; 116: 5min HRV, 32.305; 117: HR, 93.407; 117: RR, 20.458; 117: SpO2, 95.912; 117: Perf, 2.549; 117: 1min HRV, 28.365; 117: SBP, 132.0; 117: DBP, 60.0; 117: MAP, 84.0; 118: HR, 85.695; 118: RR, 26.695; 118: SpO2, 96.424; 118: Perf, 3.112; 118: 1min HRV, 16.910; 119: HR, 88.931; 119: RR, 22.603; 119: SpO2, 97.362; 119: Perf, 4.151; 119: 1min HRV, 14.827; 0: Age, 68; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 38.1; 0: Triage HR, 106.0; 0: Triage RR, 18.0; 0: Triage SBP, 118.0; 0: Triage DBP, 57.0; 0: Triage acuity, 3-Urgent; 0: CC, CHEST PAIN",
            "answer": true,
            "llm_answer": "No",
            "llm_explanation": "Based on the provided data, while there are some concerning factors such as elevated heart rate and respiratory rate and a high white blood cell (WBC) count, the patient's vital signs remain relatively stable, with adequate blood pressure, acceptable oxygen saturation levels, and no abnormal chest imaging findings typical for sepsis. Moreover, there's no detection of influenza, RSV, or SARS-COV-2 and no other strong indicators of infection or organ dysfunction within the first two hours. Hence, the risk of developing sepsis within the next 12 hours is not high.",
            "claims": [
                "The patient's heart rate is elevated.",
                "The patient's respiratory rate is elevated.",
                "The patient's white blood cell (WBC) count is high.",
                "The patient's vital signs remain relatively stable.",
                "The patient's blood pressure is adequate.",
                "The patient's oxygen saturation levels are acceptable.",
                "There are no abnormal chest imaging findings typical for sepsis.",
                "There is no detection of influenza in the patient.",
                "There is no detection of RSV in the patient.",
                "There is no detection of SARS-COV-2 in the patient.",
                "There are no strong indicators of infection within the first two hours.",
                "There are no strong indicators of organ dysfunction within the first two hours.",
                "The risk of developing sepsis within the next 12 hours is not high."
            ],
            "relevant_claims": [
                "The patient's heart rate is elevated.",
                "The patient's white blood cell (WBC) count is high."
            ],
            "alignment_scores": [
                0.7,
                1.0
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)"
            ],
            "alignment_reasonings": [
                "An elevated heart rate is explicitly listed under SIRS criteria (heart rate >90 bpm), which indicates systemic inflammation consistent with early sepsis. However, since the claim does not provide the exact heart rate or confirm that it's over the specified threshold, the alignment is not absolute, resulting in a rating of 0.7.",
                "Elevated white blood cell (WBC) count is explicitly part of the SIRS criteria, which are used to identify systemic inflammation indicative of potential early sepsis. The claim directly aligns with one of the SIRS criteria, leading to a perfect alignment rating."
            ],
            "final_alignment_score": 0.85
        },
        {
            "input": "5: HR, 89.0; 5: RR, 26.0; 5: SpO2, 99.422; 5: SBP, 134.0; 5: DBP, 89.0; 5: MAP, 104.0; 5: Temp, 98.0; 6: HR, 82.0; 6: RR, 25.0; 6: SpO2, 100.0; 6: Perf, 1.743; 6: 1min HRV, 8.815; 7: HR, 82.441; 7: RR, 24.983; 7: SpO2, 100.0; 7: Perf, 1.750; 7: 1min HRV, 13.853; 8: HR, 87.914; 8: RR, 19.672; 8: SpO2, 100.0; 8: Perf, 1.710; 8: 1min HRV, 19.853; 9: HR, 87.593; 9: RR, 24.797; 9: SpO2, 100.0; 9: Perf, 1.685; 9: 1min HRV, 11.920; 10: HR, 86.186; 10: RR, 20.915; 10: SpO2, 100.0; 10: Perf, 1.863; 10: 1min HRV, 15.067; 10: 5min HRV, 23.610; 11: HR, 82.586; 11: RR, 28.431; 11: SpO2, 100.0; 11: Perf, 2.261; 11: 1min HRV, 49.671; 12: HR, 84.254; 12: RR, 25.051; 12: SpO2, 100.0; 12: Perf, 2.640; 12: 1min HRV, 23.906; 13: HR, 82.707; 13: RR, 27.845; 13: SpO2, 100.0; 13: Perf, 2.562; 13: 1min HRV, 14.888; 14: HR, 83.051; 14: RR, 23.678; 14: SpO2, 100.0; 14: Perf, 2.033; 14: 1min HRV, 64.432; 15: HR, 81.288; 15: RR, 24.712; 15: SpO2, 100.0; 15: Perf, 1.790; 15: 1min HRV, 14.575; 15: 5min HRV, 40.136; 15: SBP, 127.0; 15: DBP, 77.0; 15: MAP, 93.667; 16: HR, 81.0; 16: RR, 24.5; 16: SpO2, 100.0; 16: Perf, 1.82; 16: 1min HRV, 0.0; 18: POC PH (V) ISTAT, 7.29; 18: POC PO2 (V) ISTAT, 19 mmHg; 18: POC PCO2 (V) ISTAT, 68.2 mmHg; 18: POC LACTATE ISTAT, 0.77 mmol/L; 18: POC HCO3 (V) ISTAT, 33.0 mmol/L; 18: POC TCO2 (V) ISTAT, 35 mmol/L; 18: POC BASE EXCESS ISTAT, 6 mmol/L; 18: POC O2 SATURATION ISTAT VENOUS, 22 %; 20: HR, 83.0; 20: RR, 27.0; 20: SpO2, 100.0; 20: 5min HRV, 0.0; 20: SBP, 132.0; 20: DBP, 77.0; 20: MAP, 95.333; 23: HR, 81.0; 23: RR, 22.0; 23: SpO2, 100.0; 23: SBP, 132.0; 23: DBP, 77.0; 23: MAP, 95.333; 23: LPM O2, 15.0; 24: METHYLPREDNISOLONE SOD SUC(PF), 125 MG/2 ML INJ SOLR; 25: HR:, 85.0; 25: RR, 27.0; 25: SpO2, 100.0; 59: ALBUTEROL SULFATE, 90 MCG/ACTUATION INH HFAA; 66: RR:, 25.0; 66: SpO2, 100.0; 66: LPM O2, 12.0; 80: HR, 81.0; 80: RR, 23.0; 80: SpO2, 100.0; 80: LPM O2, 3.0; 90: INR, 1.1; 90: PROTHROMBIN TIME, 13.6 seconds; 91: PART. THROMBOPLASTIN TIME, 29.2 seconds; 99: WAM DIFTYP, AUTO; 99: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.5 pg; 99: NEUTROPHIL ABSOLUTE (AUTO DIFF), 5.43 K/uL; 99: MEAN CORPUSCULAR VOLUME (MCV), 95.1 fL; 99: RED CELL DISTRIBUTION WIDTH (RDW), 13.6 %; 99: EOSINOPHIL % (AUTO DIFF), 2.0 %; 99: PLATELET COUNT (PLT), 136 K/uL; 99: MONOCYTE ABSOLUTE (AUTO DIFF), 0.87 K/uL; 99: MONOCYTE % (AUTO DIFF), 9.3 %; 99: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 99: HEMOGLOBIN (HGB), 14.2 g/dL; 99: BASOPHIL % (AUTO DIFF), 0.4 %; 99: NEUTROPHIL % (AUTO DIFF), 58.2 %; 99: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 99: LYMPHOCYTE % (AUTO DIFF), 29.8 %; 99: WHITE BLOOD CELLS (WBC), 9.3 K/uL; 99: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.78 K/uL; 99: NRBC PERCENT (HEMATOLOGY), 0.0 %; 99: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 99: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.19 K/uL; 99: HEMATOCRIT (HCT), 44.3 %; 99: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.1 g/dL; 99: RED BLOOD CELLS (RBC), 4.66 MIL/uL; 99: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 105: D-DIMER ELISA, 522 ng/mL FEU; 105: HR, 82.0; 105: RR, 20.0; 105: SpO2, 100.0; 105: SBP, 119.0; 105: DBP, 74.0; 105: MAP, 89.0; 105: LPM O2, 3.0; 107: POTASSIUM, 3.9 mmol/L; 107: ALT (SGPT), 23 U/L; 107: BLOOD UREA NITROGEN (BUN), 12 mg/dL; 107: EGFR REFIT WITHOUT RACE (2021), 92 mL/min/1.73 m2; 107: EGFR FOR AFRICAN AMERICAN, 106 mL/min/1.73 m2; 107: GLOBULIN, 2.6 g/dL; 107: ANION GAP, 9 mmol/L; 107: SODIUM, 144 mmol/L; 107: BILIRUBIN TOTAL, 0.6 mg/dL; 107: MAGNESIUM, 2.1 mg/dL; 107: AST (SGOT), 25 U/L; 107: CALCIUM, 9.0 mg/dL; 107: ALBUMIN, 4.4 g/dL; 107: CORRECTED CALCIUM, 8.7 mg/dL; 107: ALKALINE PHOSPHATASE, 65 U/L; 107: CREATININE, 0.88 mg/dL; 107: CHLORIDE, 103 mmol/L; 107: PROTEIN TOTAL, 7.0 g/dL; 107: GLUCOSE, 128 mg/dL; 107: CO2, 32 mmol/L; 107: HR, 70.55; 107: RR, 20.2; 107: SpO2, 98.0; 107: 1min HRV, 16.197; 108: HR, 69.717; 108: RR, 21.483; 108: SpO2, 98.45; 108: Perf, 10.850; 108: 1min HRV, 18.305; 108: SBP, 162.0; 108: DBP, 70.0; 108: MAP, 100.667; 109: HR, 70.741; 109: RR, 23.603; 109: SpO2, 98.0; 109: Perf, 10.095; 109: 1min HRV, 14.727; 110: HR, 70.525; 110: RR, 23.678; 110: SpO2, 97.729; 110: Perf, 10.250; 110: 1min HRV, 18.191; 110: 5min HRV, 17.916; 111: HR, 69.593; 111: RR, 21.678; 111: SpO2, 98.0; 111: Perf, 11.894; 111: 1min HRV, 17.194; 112: HR, 68.845; 112: RR, 22.069; 112: SpO2, 98.172; 112: Perf, 11.066; 112: 1min HRV, 18.784; 113: HR, 68.932; 113: RR, 23.898; 113: SpO2, 98.0; 113: Perf, 11.114; 113: 1min HRV, 17.758; 114: HR, 68.983; 114: RR, 19.983; 114: SpO2, 98.034; 114: Perf, 9.912; 114: 1min HRV, 17.644; 115: HR, 68.881; 115: RR, 21.441; 115: SpO2, 98.0; 115: Perf, 10.051; 115: 1min HRV, 14.015; 115: 5min HRV, 17.415; 116: HR, 67.797; 116: RR, 21.915; 116: SpO2, 97.881; 116: Perf, 10.571; 116: 1min HRV, 19.510; 117: HR, 68.259; 117: RR, 23.586; 117: SpO2, 98.0; 117: Perf, 10.108; 117: 1min HRV, 37.164; 118: HR, 68.525; 118: RR, 23.627; 118: SpO2, 98.0; 118: Perf, 9.978; 118: 1min HRV, 14.901; 119: HR, 68.138; 119: RR, 17.828; 119: SpO2, 98.362; 119: Perf, 9.379; 119: 1min HRV, 11.541; 0: Age, 64; 0: Gender, M; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 36.7; 0: Triage HR, 89.0; 0: Triage RR, 26.0; 0: Triage SBP, 134.0; 0: Triage DBP, 89.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The patient\u2019s vital signs such as heart rate, blood pressure, respiratory rate, and SpO2 remain relatively stable throughout the time series, showing no sudden or severe fluctuations suggestive of sepsis. The lactate level at 0.77 mmol/L is within normal range, and the blood gas analysis does not indicate acidosis or other significant abnormalities often associated with sepsis. Despite the initial elevated respiratory rate, there are no trends in the data indicating a high risk of sepsis developing within the next 12 hours.",
            "claims": [
                "The patient\u2019s vital signs remain relatively stable throughout the time series.",
                "The patient\u2019s vital signs include heart rate, blood pressure, respiratory rate, and SpO2.",
                "There are no sudden or severe fluctuations in the vital signs suggestive of sepsis.",
                "The lactate level is 0.77 mmol/L.",
                "A lactate level of 0.77 mmol/L is within normal range.",
                "The blood gas analysis does not indicate acidosis.",
                "The blood gas analysis does not indicate other significant abnormalities often associated with sepsis.",
                "Despite the initial elevated respiratory rate, there are no trends in the data indicating a high risk of sepsis developing within the next 12 hours."
            ],
            "relevant_claims": [
                "The patient\u2019s vital signs remain relatively stable throughout the time series.",
                "The lactate level is 0.77 mmol/L.",
                "The blood gas analysis does not indicate acidosis.",
                "The blood gas analysis does not indicate other significant abnormalities often associated with sepsis.",
                "Despite the initial elevated respiratory rate, there are no trends in the data indicating a high risk of sepsis developing within the next 12 hours."
            ],
            "alignment_scores": [
                0.2,
                0.2,
                0.2,
                0.3,
                0.5
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "SOFA Score Increase (\u22652 points)",
                "High qSOFA Score (\u22652)"
            ],
            "alignment_reasonings": [
                "The claim about stable vital signs suggests an absence of deranged vital measurements. Elevated NEWS Score is based on deranged vital signs indicating clinical deterioration. The stable vitals imply a lack of significant deterioration, weakly relating to the absence of a high NEWS score.",
                "The claim references the lactate level, which relates to the category of Elevated Serum Lactate. However, the value of 0.77 mmol/L is significantly below the 2 mmol/L threshold that indicates a marked increase in sepsis mortality risk. Thus, while the category is somewhat related, the specific lactate level mentioned does not align closely with the criteria for elevated risk.",
                "Blood gas analysis typically assesses for conditions like acidosis, which can indirectly relate to elevated serum lactate levels indicating tissue hypoperfusion. However, the claim explicitly states there is no acidosis, suggesting normal lactate levels. Thus, while blood gas analysis might be associated with lactate assessments, the absence of acidosis aligns very weakly with concerns for elevated lactate in sepsis.",
                "The claim suggests that the blood gas analysis does not show significant abnormalities, implying no deterioration in parameters like PaO\u2082/FiO\u2082 ratio, which could affect the SOFA score. While the absence of abnormalities indirectly relates to not having an increased SOFA score, it does not actively contribute to assessing the risk of sepsis. Thus, the alignment is weak and indirect.",
                "The claim mentions an \"elevated respiratory rate,\" which is a component of the qSOFA score. However, the claim also indicates that there are no trends suggesting a high risk of sepsis, implying that the elevated respiratory rate alone doesn't align strongly with a high sepsis risk prediction according to the qSOFA criteria. This gives a moderate alignment due to the mention of a qSOFA-related symptom, but without additional supportive data, the alignment is not strong."
            ],
            "final_alignment_score": 0.28
        },
        {
            "input": "5: HR, 116.0; 5: RR, 18.0; 5: SpO2, 99.0; 5: SBP, 100.0; 5: DBP, 53.0; 5: MAP, 68.667; 5: Temp, 98.8; 10: Pain, 0.0; 51: SpO2, 97.0; 51: Perf, 4.984; 52: SpO2, 97.089; 52: Perf, 4.915; 53: SpO2, 98.595; 54: SpO2, 96.5; 54: Perf, 4.248; 55: SpO2, 96.102; 55: Perf, 4.384; 55: SBP, 131.0; 55: DBP, 110.0; 55: MAP, 117.0; 56: HR, 131.0; 56: RR, 18.0; 56: SpO2, 94.517; 56: Perf, 4.223; 57: SpO2, 97.086; 57: Perf, 4.379; 58: SpO2, 96.390; 58: Perf, 5.404; 58: SBP, 136.0; 58: DBP, 73.0; 58: MAP, 94.0; 59: SpO2, 96.397; 59: Perf, 5.06; 60: SpO2, 95.729; 60: Perf, 5.474; 61: SpO2, 95.542; 61: Perf, 5.584; 62: SpO2, 94.190; 62: Perf, 6.141; 63: SpO2, 93.339; 63: Perf, 6.243; 64: SpO2, 92.707; 64: Perf, 6.196; 65: SpO2, 92.831; 65: Perf, 5.624; 66: SpO2, 93.655; 66: Perf, 5.275; 67: SpO2, 93.466; 67: Perf, 5.632; 68: SpO2, 92.0; 68: Perf, 5.250; 69: SpO2, 94.483; 69: Perf, 5.079; 70: SpO2, 95.644; 70: Perf, 4.544; 71: WAM DIFTYP, AUTO; 71: MONOCYTE % (AUTO DIFF), 12.4 %; 71: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.17 K/uL; 71: HEMATOCRIT (HCT), 29.4 %; 71: NEUTROPHIL ABSOLUTE (AUTO DIFF), 13.60 K/uL; 71: EOSINOPHIL % (AUTO DIFF), 0.7 %; 71: PLATELET COUNT (PLT), 194 K/uL; 71: MEAN CORPUSCULAR VOLUME (MCV), 90.2 fL; 71: BASOPHIL % (AUTO DIFF), 0.2 %; 71: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.0 %; 71: LYMPHOCYTE % (AUTO DIFF), 7.3 %; 71: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 71: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.13 K/uL; 71: RED CELL DISTRIBUTION WIDTH (RDW), 19.4 %; 71: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 35.0 g/dL; 71: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.27 K/uL; 71: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.6 pg; 71: NRBC PERCENT (HEMATOLOGY), 0.0 %; 71: HEMOGLOBIN (HGB), 10.3 g/dL; 71: MONOCYTE ABSOLUTE (AUTO DIFF), 2.16 K/uL; 71: WHITE BLOOD CELLS (WBC), 17.4 K/uL; 71: RED BLOOD CELLS (RBC), 3.26 MIL/uL; 71: NEUTROPHIL % (AUTO DIFF), 78.4 %; 71: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 71: SpO2, 96.627; 71: Perf, 3.934; 72: HR, 128.0; 72: RR, 15.0; 72: SpO2, 96.948; 72: Perf, 3.796; 72: SBP, 111.0; 72: DBP, 58.0; 72: MAP, 75.667; 73: SpO2, 95.169; 73: Perf, 3.323; 74: SpO2, 95.862; 74: Perf, 3.46; 75: SpO2, 95.949; 75: Perf, 4.404; 76: SpO2, 96.424; 76: Perf, 4.125; 77: SpO2, 95.386; 77: Perf, 4.499; 78: SpO2, 95.847; 78: Perf, 4.029; 79: SpO2, 93.931; 79: Perf, 5.616; 80: SpO2, 93.712; 80: Perf, 5.950; 81: SpO2, 92.576; 81: Perf, 6.079; 82: SpO2, 91.5; 82: Perf, 6.108; 83: SpO2, 91.288; 83: Perf, 5.687; 84: SpO2, 92.759; 84: Perf, 4.941; 85: SpO2, 91.695; 85: Perf, 4.881; 86: SpO2, 94.155; 86: Perf, 4.166; 87: SpO2, 92.356; 87: Perf, 5.018; 88: SpO2, 92.017; 88: Perf, 4.251; 89: SARS-COV-2 RNA, Not Detected; 89: SpO2, 92.678; 89: Perf, 4.758; 90: SpO2, 93.431; 90: Perf, 4.360; 91: SpO2, 93.085; 91: Perf, 4.184; 92: SpO2, 92.138; 92: Perf, 4.353; 93: SpO2, 93.15; 93: Perf, 3.918; 94: SpO2, 92.982; 94: Perf, 4.616; 95: SpO2, 91.458; 95: Perf, 4.198; 96: SpO2, 92.508; 96: Perf, 3.947; 97: SpO2, 95.017; 97: Perf, 2.862; 98: SpO2, 95.172; 98: Perf, 3.838; 99: SpO2, 95.103; 99: Perf, 4.120; 100: SpO2, 95.155; 100: Perf, 3.586; 101: SpO2, 95.847; 101: Perf, 3.316; 102: SpO2, 96.483; 102: Perf, 3.631; 103: SpO2, 96.525; 103: Perf, 4.056; 104: SpO2, 95.339; 104: Perf, 4.778; 105: SpO2, 95.741; 105: Perf, 4.193; 106: SpO2, 95.305; 106: Perf, 4.879; 107: SpO2, 95.390; 107: Perf, 4.927; 108: HIGH SENSITIVITY TROPONIN, 12 ng/L; 108: SpO2, 94.627; 108: Perf, 5.704; 117: HR, 129.0; 117: RR, 17.0; 117: SpO2, 98.0; 117: SBP, 131.0; 117: DBP, 69.0; 117: MAP, 89.667; 119: ALKALINE PHOSPHATASE, 557 U/L; 119: ALBUMIN, 1.9 g/dL; 119: CALCIUM, 7.5 mg/dL; 119: EGFR REFIT WITHOUT RACE (2021), 92 mL/min/1.73 m2; 119: ANION GAP, 13 mmol/L; 119: ALT (SGPT), 63 U/L; 119: BLOOD UREA NITROGEN (BUN), 15 mg/dL; 119: CHLORIDE, 92 mmol/L; 119: POTASSIUM, 4.0 mmol/L; 119: PROTEIN TOTAL, 4.6 g/dL; 119: GLUCOSE, 110 mg/dL; 119: CORRECTED CALCIUM, 9.2 mg/dL; 119: SODIUM, 128 mmol/L; 119: GLOBULIN, 2.7 g/dL; 119: AST (SGOT), 64 U/L; 119: CO2, 23 mmol/L; 119: BILIRUBIN TOTAL, 5.7 mg/dL; 119: CREATININE, 0.72 mg/dL; 119: LIPASE, 48 U/L; 0: Age, 66; 0: Gender, F; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 37.1; 0: Triage HR, 116.0; 0: Triage RR, 18.0; 0: Triage SBP, 100.0; 0: Triage DBP, 53.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient exhibits multiple indicators of potential sepsis, such as elevated heart rate (tachycardia) and low diastolic blood pressure, which can be suggestive of early signs of shock. The lab results show high white blood cell count (leukocytosis) and very low albumin levels, indicating possible inflammation and liver dysfunction. Additionally, the presence of hypoxia as indicated by fluctuating SpO2 levels, and abnormal liver function tests support the assessment of high sepsis risk. These factors suggest that the patient is at risk of developing sepsis within the next 12 hours.",
            "claims": [
                "The patient exhibits multiple indicators of potential sepsis.",
                "One indicator of potential sepsis is an elevated heart rate (tachycardia).",
                "An elevated heart rate (tachycardia) can be suggestive of early signs of shock.",
                "Another indicator of potential sepsis is low diastolic blood pressure.",
                "The lab results show high white blood cell count (leukocytosis).",
                "A high white blood cell count (leukocytosis) indicates possible inflammation.",
                "The lab results show very low albumin levels.",
                "Very low albumin levels indicate possible liver dysfunction.",
                "The presence of hypoxia is indicated by fluctuating SpO2 levels.",
                "Abnormal liver function tests support the assessment of high sepsis risk.",
                "These factors suggest that the patient is at risk of developing sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The patient exhibits multiple indicators of potential sepsis.",
                "One indicator of potential sepsis is an elevated heart rate (tachycardia).",
                "An elevated heart rate (tachycardia) can be suggestive of early signs of shock.",
                "Another indicator of potential sepsis is low diastolic blood pressure.",
                "The lab results show high white blood cell count (leukocytosis).",
                "A high white blood cell count (leukocytosis) indicates possible inflammation.",
                "The lab results show very low albumin levels.",
                "Very low albumin levels indicate possible liver dysfunction.",
                "The presence of hypoxia is indicated by fluctuating SpO2 levels.",
                "Abnormal liver function tests support the assessment of high sepsis risk.",
                "These factors suggest that the patient is at risk of developing sepsis within the next 12 hours."
            ],
            "alignment_scores": [
                0.3,
                0.8,
                0.7,
                0.7,
                1.0,
                1.0,
                0.3,
                0.6,
                0.6,
                0.7,
                0.3
            ],
            "alignment_category": [
                "SOFA Score Increase (\u22652 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated Shock Index (\u22651.0)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "The claim is somewhat ambiguous and lacks specific detail. The reference to \"multiple indicators\" of potential sepsis suggests potential organ dysfunction, but it does not specify which indicators are present. The SOFA score covers various aspects of organ dysfunction indicative of sepsis. However, the alignment is weak due to the lack of specificity, as it doesn't confirm an increase in SOFA score or specify which components might be contributing.",
                "An elevated heart rate (tachycardia) is explicitly mentioned as one of the SIRS criteria (heart rate >90 bpm). This criterion is used to identify systemic inflammation associated with early sepsis. The alignment is strong because the claim directly references a SIRS criterion, but it is not a complete identification of SIRS since it involves multiple factors.",
                "Tachycardia (elevated heart rate) is a component used in the calculation of the shock index, which indicates hemodynamic instability suggestive of shock or severe sepsis. While the claim mentions tachycardia's potential link to early signs of shock, it does not provide information on systolic blood pressure, which is necessary to directly assess the shock index. Therefore, the alignment is relevant but incomplete without additional data on blood pressure.",
                "The claim references low diastolic blood pressure, which can be an aspect of hypotensive states often associated with sepsis. Although the expert category specifically mentions sepsis-associated hypotension in terms of systolic blood pressure or mean arterial pressure, diastolic blood pressure is a component of blood pressure assessment and can contribute to overall hypotension context. However, the alignment is not direct since diastolic BP is not explicitly mentioned in the category definition, thus the alignment rating is set at 0.7.",
                "Elevated white blood cell count is explicitly one of the SIRS criteria, which are used to identify systemic inflammation consistent with early sepsis. The claim directly mentions leukocytosis, confirming a strong alignment with this category.",
                "A high white blood cell count (leukocytosis) is explicitly one of the criteria listed under SIRS, which is used to identify systemic inflammation consistent with early sepsis. Therefore, the alignment with the category is direct and complete.",
                "Low albumin levels are not directly mentioned in any listed category, but they can suggest impaired liver function or malnutrition, which relates conceptually to SOFA criteria (such as bilirubin >2 mg/dL for liver dysfunction). The alignment is indirect and not strong, as it requires interpretive correlation rather than categorical match.",
                "While albumin levels are not directly part of the SOFA scoring criteria, a very low albumin level can indicate liver dysfunction\u2014related to one of the SOFA score components (bilirubin >2 mg/dL) that measures hepatic function. The alignment is indirect but conceptually related to assessing organ dysfunction as part of sepsis risk.",
                "Fluctuating SpO2 levels suggest possible hypoxia, which relates conceptually to impaired oxygenation and organ dysfunction, factors considered in the SOFA score. Although SpO2 is not directly a component of the SOFA score, it is indirectly associated with the potential for increased sepsis risk through oxygenation issues. The alignment is indirect but meaningful.",
                "Impaired liver function is relevant to the SOFA score, which includes bilirubin >2 mg/dL as a criterion. While the claim does not specify bilirubin levels, abnormal liver function is conceptually related, suggesting possible organ dysfunction aligned with SOFA criteria. Since the specific SOFA threshold isn't mentioned, the alignment isn't complete but is still significant.",
                "The claim is generic and lacks specifics about what factors are indicating the risk. However, a NEWS score is derived from multiple deranged vital signs and is used to predict clinical deterioration like sepsis. This broad applicability to various risk factors provides minimal but potential relevance, though without specific details the alignment is weak."
            ],
            "final_alignment_score": 0.6363636363636364
        },
        {
            "input": "2: HR, 84.0; 2: RR, 18.0; 2: SpO2, 100.0; 2: SBP, 149.0; 2: DBP, 90.0; 2: MAP, 109.667; 2: Temp, 97.5; 9: Pain, 7.0; 29: SpO2, 99.615; 29: SBP, 133.0; 29: DBP, 66.0; 29: MAP, 88.333; 30: SpO2, 99.052; 30: Perf, 1.447; 31: SpO2, 99.136; 31: Perf, 1.132; 32: SpO2, 98.864; 32: Perf, 1.162; 33: SpO2, 98.678; 33: Perf, 1.168; 34: SpO2, 98.172; 34: Perf, 1.263; 35: SpO2, 97.729; 35: Perf, 1.112; 36: SpO2, 98.793; 36: Perf, 1.055; 37: SpO2, 99.932; 37: Perf, 2.007; 38: SpO2, 99.475; 38: Perf, 1.981; 39: SpO2, 100.0; 39: Perf, 1.991; 40: SpO2, 100.0; 40: Perf, 2.05; 40: SBP, 134.0; 40: DBP, 64.0; 40: MAP, 87.333; 41: SpO2, 100.0; 41: Perf, 1.834; 42: SpO2, 100.0; 42: Perf, 2.230; 43: SpO2, 100.0; 43: Perf, 2.98; 44: SpO2, 100.0; 44: Perf, 2.706; 45: SpO2, 100.0; 45: Perf, 2.465; 46: SpO2, 100.0; 46: Perf, 1.636; 47: SpO2, 100.0; 47: Perf, 1.171; 48: SpO2, 100.0; 48: Perf, 1.506; 49: SpO2, 100.0; 49: Perf, 1.302; 50: SpO2, 100.0; 50: Perf, 1.425; 51: SpO2, 100.0; 51: Perf, 1.422; 52: SpO2, 100.0; 52: Perf, 1.737; 53: SpO2, 99.949; 53: Perf, 1.718; 54: HR, 89.0; 54: SpO2, 99.776; 54: Perf, 2.102; 54: SBP, 149.0; 54: DBP, 87.0; 54: MAP, 107.667; 55: SpO2, 100.0; 55: Perf, 2.118; 55: SBP, 149.0; 55: DBP, 87.0; 55: MAP, 107.667; 56: SpO2, 99.948; 56: Perf, 1.947; 57: SpO2, 100.0; 57: Perf, 1.568; 58: SpO2, 100.0; 58: Perf, 1.255; 59: SpO2, 100.0; 59: Perf, 1.162; 60: SpO2, 100.0; 60: Perf, 1.636; 61: SpO2, 100.0; 61: Perf, 2.113; 62: SpO2, 100.0; 62: Perf, 2.164; 63: SpO2, 100.0; 63: Perf, 2.545; 64: SpO2, 100.0; 64: Perf, 1.976; 65: SpO2, 100.0; 65: Perf, 2.252; 66: SpO2, 100.0; 66: Perf, 2.494; 67: SpO2, 100.0; 67: Perf, 3.019; 68: SpO2, 100.0; 68: Perf, 2.882; 69: SpO2, 100.0; 69: Perf, 2.967; 70: SpO2, 100.0; 70: Perf, 2.846; 70: SBP, 161.0; 70: DBP, 59.0; 70: MAP, 93.0; 71: SpO2, 100.0; 71: Perf, 3.402; 72: SpO2, 100.0; 72: Perf, 3.417; 73: SpO2, 100.0; 73: Perf, 4.680; 74: SpO2, 100.0; 74: Perf, 4.734; 75: SpO2, 100.0; 75: Perf, 4.657; 76: SpO2, 100.0; 76: Perf, 4.039; 77: SpO2, 100.0; 77: Perf, 5.079; 78: SpO2, 100.0; 78: Perf, 6.706; 79: SpO2, 100.0; 79: Perf, 6.602; 80: SpO2, 100.0; 80: Perf, 2.713; 81: SpO2, 100.0; 81: Perf, 2.343; 82: SpO2, 100.0; 82: Perf, 4.020; 83: SARS-COV-2 RNA, Not Detected; 83: SpO2, 100.0; 83: Perf, 4.951; 84: SpO2, 100.0; 84: Perf, 4.196; 85: SpO2, 100.0; 85: Perf, 3.677; 85: SBP, 143.0; 85: DBP, 68.0; 85: MAP, 93.0; 85: HYDROMORPHONE, 1 MG/ML INJ SYRG; 85: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 86: SpO2, 100.0; 86: Perf, 4.171; 87: SpO2, 100.0; 87: Perf, 4.629; 88: SpO2, 100.0; 88: Perf, 6.049; 89: SpO2, 100.0; 89: Perf, 6.075; 90: HIGH SENSITIVITY TROPONIN, <4 ng/L; 90: SpO2, 100.0; 90: Perf, 5.209; 91: SpO2, 100.0; 91: Perf, 4.779; 92: SpO2, 100.0; 92: Perf, 4.859; 93: SpO2, 100.0; 93: Perf, 6.634; 94: SpO2, 100.0; 94: Perf, 5.851; 95: SpO2, 99.966; 95: Perf, 6.213; 96: SpO2, 99.797; 96: Perf, 5.211; 97: GLOBULIN, 4.5 g/dL; 97: CORRECTED CALCIUM, 9.1 mg/dL; 97: CALCIUM, 8.4 mg/dL; 97: EGFR REFIT WITHOUT RACE (2021), 79 mL/min/1.73 m2; 97: PROTEIN TOTAL, 7.6 g/dL; 97: CREATININE, 0.78 mg/dL; 97: ALT (SGPT), 92 U/L; 97: ALBUMIN, 3.1 g/dL; 97: GLUCOSE, 88 mg/dL; 97: CO2, 24 mmol/L; 97: AST (SGOT), 182 U/L; 97: SODIUM, 139 mmol/L; 97: BLOOD UREA NITROGEN (BUN), 15 mg/dL; 97: ALKALINE PHOSPHATASE, 593 U/L; 97: BILIRUBIN TOTAL, 3.1 mg/dL; 97: POTASSIUM, 3.9 mmol/L; 97: CHLORIDE, 103 mmol/L; 97: ANION GAP, 12 mmol/L; 97: C-REACTIVE PROTEIN (CRP), 2.4 mg/dL; 97: SpO2, 100.0; 97: Perf, 3.267; 98: SpO2, 100.0; 98: Perf, 4.380; 99: HR, 89.0; 99: RR, 17.0; 99: SpO2, 100.0; 99: Perf, 3.140; 99: SBP, 148.0; 99: DBP, 75.0; 99: MAP, 99.333; 100: SpO2, 100.0; 100: Perf, 2.549; 100: SBP, 148.0; 100: DBP, 75.0; 100: MAP, 99.333; 101: SpO2, 100.0; 101: Perf, 2.340; 102: SpO2, 100.0; 102: Perf, 3.034; 103: SpO2, 99.897; 103: Perf, 3.312; 104: SpO2, 100.0; 104: Perf, 3.47; 115: Pain, 4.0; 118: WAM DIFTYP, AUTO; 118: LYMPHOCYTE % (AUTO DIFF), 31.0 %; 118: HEMATOCRIT (HCT), 34.7 %; 118: BASOPHIL % (AUTO DIFF), 1.0 %; 118: PLATELET COUNT (PLT), 65 K/uL; 118: NEUTROPHIL % (AUTO DIFF), 51.8 %; 118: WHITE BLOOD CELLS (WBC), 2.9 K/uL; 118: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 118: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.0 g/dL; 118: MEAN CORPUSCULAR VOLUME (MCV), 97.2 fL; 118: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.1 pg; 118: RED BLOOD CELLS (RBC), 3.57 MIL/uL; 118: NEUTROPHIL ABSOLUTE (AUTO DIFF), 1.50 K/uL; 118: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 118: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 118: NRBC PERCENT (HEMATOLOGY), 0.0 %; 118: HEMOGLOBIN (HGB), 11.1 g/dL; 118: EOSINOPHIL % (AUTO DIFF), 3.8 %; 118: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.90 K/uL; 118: MONOCYTE ABSOLUTE (AUTO DIFF), 0.35 K/uL; 118: RED CELL DISTRIBUTION WIDTH (RDW), 15.2 %; 118: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 118: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.11 K/uL; 118: MONOCYTE % (AUTO DIFF), 12.1 %; 0: Age, 78; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.4; 0: Triage HR, 84.0; 0: Triage RR, 18.0; 0: Triage SBP, 149.0; 0: Triage DBP, 90.0; 0: Triage acuity, 3-Urgent; 0: CC, KNEE PAIN",
            "answer": false,
            "llm_answer": "Yes",
            "llm_explanation": "The patient presents with several clinical indicators that suggest an increased risk for sepsis: advanced age (78 years), high pain levels (evolving from 7 to 4), and significant changes in blood pressure and perfusion over time. Importantly, the lab results exhibit abnormalities such as elevated liver enzymes (AST, ALT), total bilirubin, and severe thrombocytopenia (platelet count of 65 K/uL), along with a low white blood cell count (2.9 K/uL), all of which may indicate systemic inflammation or infection. This combination of factors suggests a heightened risk for developing sepsis within the next 12 hours.",
            "claims": [
                "The patient is 78 years old.",
                "The patient's age (78 years) suggests an increased risk for sepsis.",
                "The patient has high pain levels that evolved from 7 to 4.",
                "High pain levels may contribute to an increased risk for sepsis.",
                "There are significant changes in the patient's blood pressure and perfusion over time.",
                "Changes in blood pressure and perfusion may indicate an increased risk for sepsis.",
                "Lab results show elevated liver enzymes (AST, ALT).",
                "Elevated liver enzymes may indicate systemic inflammation or infection.",
                "Lab results show elevated total bilirubin.",
                "Elevated total bilirubin may indicate systemic inflammation or infection.",
                "The patient has severe thrombocytopenia with a platelet count of 65 K/uL.",
                "Severe thrombocytopenia may indicate systemic inflammation or infection.",
                "Lab results reveal a low white blood cell count of 2.9 K/uL.",
                "A low white blood cell count may indicate systemic inflammation or infection.",
                "The combination of these clinical indicators suggests a heightened risk for developing sepsis.",
                "The patient is at heightened risk for developing sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The patient is 78 years old.",
                "The patient's age (78 years) suggests an increased risk for sepsis.",
                "High pain levels may contribute to an increased risk for sepsis.",
                "There are significant changes in the patient's blood pressure and perfusion over time.",
                "Changes in blood pressure and perfusion may indicate an increased risk for sepsis.",
                "Elevated liver enzymes may indicate systemic inflammation or infection.",
                "The patient has severe thrombocytopenia with a platelet count of 65 K/uL.",
                "Severe thrombocytopenia may indicate systemic inflammation or infection.",
                "A low white blood cell count may indicate systemic inflammation or infection.",
                "The patient is at heightened risk for developing sepsis within the next 12 hours."
            ],
            "alignment_scores": [
                1.0,
                1.0,
                0.2,
                0.7,
                0.7,
                0.7,
                0.9,
                0.7,
                0.8,
                0.3
            ],
            "alignment_category": [
                "Elderly Susceptibility (Age \u226565 years)",
                "Elderly Susceptibility (Age \u226565 years)",
                "High qSOFA Score (\u22652)",
                "Elevated Shock Index (\u22651.0)",
                "Elevated Shock Index (\u22651.0)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "The claim provides the patient's age as 78, which falls within the category's definition of advanced age (\u2265\u202f65\u202fyears). This is a direct indication of increased susceptibility to sepsis, leading to a perfect alignment with the Elderly Susceptibility category.",
                "The claim directly references the patient's age, which is 78 years, as a factor that increases the risk for sepsis. This aligns perfectly with the \"Elderly Susceptibility\" category, which states that advanced age (\u2265 65 years) markedly increases susceptibility to rapid sepsis progression and higher mortality after infection.",
                "The claim about \"high pain levels\" is not directly linked to any sepsis prediction category. However, in the context of qSOFA, altered mentation due to pain could be conceptually related, albeit indirectly, to patient distress or altered physiological states seen in acute conditions. The alignment is weak because pain is not a specific qSOFA component or direct sepsis marker.",
                "The claim about significant changes in blood pressure and perfusion suggests hemodynamic instability, which aligns with the concept of elevated shock index. While it doesn\u2019t provide specific numbers to confirm an elevated shock index (\u22651.0) exactly, the mention of significant changes in perfusion is related to the concerns within this category, indicating moderately strong alignment.",
                "The claim refers to changes in blood pressure and perfusion, which are central to the concept of the Shock Index and are indicative of hemodynamic instability. While the claim does not explicitly mention the Shock Index, which is a specific calculation based on heart rate and systolic blood pressure, the reference to blood pressure and perfusion changes suggests potential alignment with this category. The alignment is strong but not perfect, as it lacks the specificity of mentioning a Shock Index of \u22651.0 or a specific numerical change.",
                "Elevated liver enzymes might indicate systemic inflammation or infection, but they also suggest possible liver dysfunction. In the SOFA score, bilirubin levels are used to assess liver impairment, which aligns with the idea of systemic inflammation affecting liver function. Although liver enzymes are not explicitly listed in the SOFA criteria, changes in liver function are conceptually relevant. Therefore, the alignment is indirect but significant.",
                "Severe thrombocytopenia, reflected in a platelet count of 65 K/uL, is directly related to one of the components of the SOFA score, which considers platelets < 100 x 10\u2079/L as indicative of organ dysfunction. This claim aligns strongly with the SOFA criteria as it indicates a significant decrease in platelet count, which reflects a marked risk of sepsis. However, it does not mention the exact increase in SOFA points, so the alignment is not perfect but very strong.",
                "Severe thrombocytopenia (low platelet count) can suggest systemic issues like inflammation or infection and is relevant to the SOFA score, specifically the component related to platelets <100 \u00d7 10\u2079/L. This indicates potential organ dysfunction associated with sepsis. While thrombocytopenia is directly referenced in the SOFA criteria, the claim does not provide specific platelet counts or SOFA score data, resulting in a strong but not perfect alignment.",
                "A low white blood cell count (<4,000/\u00b5L) is explicitly one of the criteria for SIRS, which is used to identify systemic inflammation consistent with early sepsis. While the claim mentions the possibility without specific numerical values, it aligns well with the SIRS criteria that assess sepsis risk based on white blood cell counts.",
                "The claim vaguely suggests increased risk for sepsis, which aligns slightly with the notion of clinical deterioration predicted by an elevated NEWS score. However, the claim lacks specificity about any deranged vital signs or specific NEWS score, resulting in low alignment."
            ],
            "final_alignment_score": 0.7
        },
        {
            "input": "8: HR, 112.0; 8: RR, 22.0; 8: SpO2, 92.0; 8: SBP, 120.0; 8: DBP, 73.0; 8: MAP, 88.667; 8: Pain, 10.0; 8: Temp, 102.4; 17: SpO2, 96.0; 17: LPM O2, 2.0; 66: SpO2, 98.478; 67: SpO2, 98.387; 67: SBP, 117.0; 67: DBP, 82.0; 67: MAP, 93.667; 68: SpO2, 98.891; 68: Perf, 0.407; 69: HR, 108.325; 69: RR, 44.0; 69: SpO2, 98.638; 69: Perf, 0.381; 69: 1min HRV, 41.156; 70: HR, 108.559; 70: RR, 45.661; 70: SpO2, 98.915; 70: Perf, 0.297; 70: 1min HRV, 5.363; 70: 5min HRV, 28.514; 71: HR, 108.068; 71: RR, 37.729; 71: SpO2, 98.780; 71: Perf, 0.294; 71: 1min HRV, 13.637; 72: POC PH (V) ISTAT, 7.36; 72: POC TCO2 (V) ISTAT, 23 mmol/L; 72: POC O2 SATURATION ISTAT VENOUS, 19 %; 72: POC PCO2 (V) ISTAT, 38.5 mmHg; 72: POC BASE EXCESS ISTAT, -4 mmol/L; 72: POC HCO3 (V) ISTAT, 21.5 mmol/L; 72: POC LACTATE ISTAT, 1.65 mmol/L; 72: POC PO2 (V) ISTAT, 15 mmHg; 72: HR, 109.293; 72: RR, 37.052; 72: SpO2, 98.310; 72: Perf, 0.303; 72: 1min HRV, 11.081; 73: HR, 108.983; 73: RR, 40.966; 73: SpO2, 98.593; 73: Perf, 0.307; 73: 1min HRV, 6.493; 74: HR, 109.741; 74: RR, 38.379; 74: SpO2, 98.603; 74: Perf, 0.296; 74: 1min HRV, 18.011; 75: HR, 110.949; 75: RR, 37.576; 75: SpO2, 98.475; 75: Perf, 0.286; 75: 1min HRV, 9.440; 75: 5min HRV, 13.032; 76: HR, 109.644; 76: RR, 36.441; 76: SpO2, 97.741; 76: Perf, 0.28; 76: 1min HRV, 7.183; 77: HR, 110.276; 77: RR, 35.690; 77: SpO2, 98.448; 77: Perf, 0.281; 77: 1min HRV, 7.025; 78: HR, 110.237; 78: RR, 43.407; 78: SpO2, 98.525; 78: Perf, 0.269; 78: 1min HRV, 7.783; 79: HR, 111.241; 79: RR, 38.638; 79: SpO2, 98.482; 79: Perf, 0.259; 79: 1min HRV, 10.516; 80: HR, 110.592; 80: RR, 37.695; 80: SpO2, 99.352; 80: Perf, 0.258; 80: 1min HRV, 10.900; 80: 5min HRV, 8.904; 81: HR, 109.362; 81: RR, 39.776; 81: SpO2, 99.583; 81: Perf, 0.230; 81: 1min HRV, 13.018; 81: Pain, 0.0; 82: HR, 110.339; 82: RR, 40.542; 82: SpO2, 99.814; 82: Perf, 0.247; 82: 1min HRV, 8.560; 83: HR, 109.763; 83: RR, 39.017; 83: SpO2, 100.0; 83: Perf, 0.238; 83: 1min HRV, 13.194; 84: HR, 111.088; 84: RR, 36.879; 84: SpO2, 99.878; 84: Perf, 0.246; 84: 1min HRV, 10.999; 85: HR, 113.475; 85: RR, 38.644; 85: SpO2, 99.508; 85: Perf, 0.278; 85: 1min HRV, 9.971; 85: 5min HRV, 12.858; 86: HR, 111.155; 86: RR, 33.845; 86: SpO2, 99.259; 86: Perf, 0.383; 86: 1min HRV, 14.009; 87: HR, 110.508; 87: RR, 41.932; 87: SpO2, 99.254; 87: Perf, 0.294; 87: 1min HRV, 5.862; 88: HR, 111.424; 88: RR, 40.847; 88: SpO2, 98.966; 88: Perf, 0.262; 88: 1min HRV, 4.613; 89: HR, 110.741; 89: RR, 41.483; 89: SpO2, 98.414; 89: Perf, 0.271; 89: 1min HRV, 2.881; 90: HR, 110.458; 90: RR, 40.831; 90: SpO2, 98.322; 90: Perf, 0.288; 90: 1min HRV, 4.093; 90: 5min HRV, 7.499; 91: HR, 111.466; 91: RR, 39.552; 91: SpO2, 98.155; 91: Perf, 0.272; 91: 1min HRV, 4.415; 92: HR, 111.220; 92: RR, 39.102; 92: SpO2, 98.356; 92: Perf, 0.274; 92: 1min HRV, 12.221; 93: HR, 111.627; 93: RR, 39.915; 93: SpO2, 98.966; 93: Perf, 0.280; 93: 1min HRV, 2.886; 94: HR, 111.414; 94: RR, 41.983; 94: SpO2, 99.448; 94: Perf, 0.296; 94: 1min HRV, 2.454; 95: HR, 110.814; 95: RR, 40.644; 95: SpO2, 98.966; 95: Perf, 0.308; 95: 1min HRV, 3.129; 95: 5min HRV, 6.370; 96: HR, 111.224; 96: RR, 39.759; 96: SpO2, 99.483; 96: Perf, 0.332; 96: 1min HRV, 2.579; 97: HR, 110.932; 97: RR, 39.932; 97: SpO2, 99.695; 97: Perf, 0.334; 97: 1min HRV, 49.577; 98: HR, 111.559; 98: RR, 39.983; 98: SpO2, 99.780; 98: Perf, 0.330; 98: 1min HRV, 3.696; 99: HR, 113.172; 99: RR, 42.103; 99: SpO2, 98.707; 99: Perf, 0.323; 99: 1min HRV, 5.145; 99: PIPERACILLIN-TAZOBACTAM-DEXTRS, 3.375 GRAM/50 ML IV PGBK; 100: HR:, 112.746; 100: RR, 43.661; 100: SpO2, 99.102; 100: Perf, 0.328; 100: 1min HRV, 6.513; 100: 5min HRV, 23.550; 101: HR, 114.190; 101: RR, 41.603; 101: SpO2, 99.190; 101: Perf, 0.33; 101: 1min HRV, 5.972; 102: HR, 114.695; 102: RR, 41.492; 102: SpO2, 98.552; 102: Perf, 0.33; 102: 1min HRV, 11.769; 103: HR, 114.373; 103: RR, 44.847; 103: SpO2, 99.843; 103: Perf, 0.338; 103: 1min HRV, 10.364; 104: HR, 114.310; 104: RR, 42.603; 104: SpO2, 99.862; 104: Perf, 0.327; 104: 1min HRV, 8.266; 105: INR, 1.3; 105: PROTHROMBIN TIME, 16.5 seconds; 105: HR, 114.186; 105: RR, 38.407; 105: SpO2, 99.169; 105: Perf, 0.3; 105: 1min HRV, 13.973; 105: 5min HRV, 10.070; 106: PART. THROMBOPLASTIN TIME, 34.9 seconds; 106: HR, 113.776; 106: RR, 42.138; 106: SpO2, 99.172; 106: Perf, 0.3; 106: 1min HRV, 7.621; 107: HR, 112.085; 107: RR, 39.305; 107: SpO2, 98.746; 107: Perf, 0.306; 107: 1min HRV, 54.041; 108: HR, 113.746; 108: RR, 41.508; 108: SpO2, 99.169; 108: Perf, 0.313; 108: 1min HRV, 54.108; 109: HR, 111.966; 109: RR, 40.017; 109: SpO2, 99.143; 109: Perf, 0.32; 109: 1min HRV, 9.468; 110: HR, 113.746; 110: RR, 39.746; 110: SpO2, 98.562; 110: Perf, 0.318; 110: 1min HRV, 4.468; 110: 5min HRV, 35.284; 111: HR, 113.897; 111: RR, 42.293; 111: SpO2, 99.103; 111: Perf, 0.327; 111: 1min HRV, 4.217; 112: HR, 112.932; 112: RR, 42.305; 112: SpO2, 98.831; 112: Perf, 0.343; 112: 1min HRV, 4.204; 113: HR, 112.207; 113: RR, 41.569; 113: SpO2, 99.466; 113: Perf, 0.396; 113: 1min HRV, 5.945; 114: HR, 112.831; 114: RR, 41.407; 114: SpO2, 99.305; 114: Perf, 0.383; 114: 1min HRV, 3.358; 115: HR, 113.017; 115: RR, 42.136; 115: SpO2, 99.475; 115: Perf, 0.405; 115: 1min HRV, 6.819; 115: 5min HRV, 5.540; 116: HR, 112.155; 116: RR, 41.862; 116: SpO2, 99.569; 116: Perf, 0.380; 116: 1min HRV, 3.962; 117: HR, 112.797; 117: RR, 42.576; 117: SpO2, 99.847; 117: Perf, 0.382; 117: 1min HRV, 2.799; 118: HR, 112.224; 118: RR, 41.310; 118: SpO2, 99.517; 118: Perf, 0.397; 118: 1min HRV, 4.919; 119: HR, 112.254; 119: RR, 44.492; 119: SpO2, 99.593; 119: Perf, 0.429; 119: 1min HRV, 2.948; 0: Age, 75; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 39.1; 0: Triage HR, 112.0; 0: Triage RR, 22.0; 0: Triage SBP, 120.0; 0: Triage DBP, 73.0; 0: Triage acuity, 2-Emergent; 0: CC, FATIGUE",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient presents with several concerning signs. Initial high fever (39.1\u00b0C) persists with elevated heart rate (HR consistently above 110) and respiratory rate (RR peaks at 45.661), coupled with low SpO2, indicating potential respiratory distress or sepsis. Additionally, the presence of piperacillin-tazobactam, an antibiotic for severe infections, suggests a high suspicion of sepsis by medical staff. These factors, along with the high lactate level earlier on and changes in HRV, support a high risk of sepsis within 12 hours.",
            "claims": [
                "The patient presents with several concerning signs.",
                "The patient has an initial high fever of 39.1\u00b0C.",
                "The patient's heart rate is consistently above 110.",
                "The patient's respiratory rate peaks at 45.661.",
                "The patient has low SpO2 levels.",
                "Low SpO2 levels indicate potential respiratory distress or sepsis.",
                "The presence of piperacillin-tazobactam suggests a high suspicion of sepsis by medical staff.",
                "Piperacillin-tazobactam is an antibiotic used for severe infections.",
                "The patient has a high lactate level earlier on.",
                "Changes in heart rate variability (HRV) support a high risk of sepsis.",
                "These factors support a high risk of sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The patient has an initial high fever of 39.1\u00b0C.",
                "The patient's heart rate is consistently above 110.",
                "The patient's respiratory rate peaks at 45.661.",
                "Low SpO2 levels indicate potential respiratory distress or sepsis.",
                "The presence of piperacillin-tazobactam suggests a high suspicion of sepsis by medical staff.",
                "Piperacillin-tazobactam is an antibiotic used for severe infections.",
                "The patient has a high lactate level earlier on.",
                "Changes in heart rate variability (HRV) support a high risk of sepsis.",
                "These factors support a high risk of sepsis within the next 12 hours."
            ],
            "alignment_scores": [
                0.8,
                0.8,
                1.0,
                0.6,
                0.9,
                0.7,
                1.0,
                0.3,
                0.3
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "High qSOFA Score (\u22652)",
                "SOFA Score Increase (\u22652 points)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "Elevated NEWS Score (\u22655 points)",
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "The claim directly references a fever of 39.1\u00b0C, which exceeds the temperature criterion (>38\u00b0C) listed under SIRS Positivity. This aligns strongly with SIRS Positivity, but without additional criteria met, it does not reach perfect alignment.",
                "The heart rate being consistently above 110 bpm aligns well with the SIRS criterion of heart rate >90 bpm, indicating systemic inflammation consistent with early sepsis. Although the claim does not provide information about additional SIRS criteria, the elevated heart rate strongly aligns with this category\u2019s list of criteria.",
                "The claim mentions a high respiratory rate (45.661), which significantly surpasses the threshold of \u226522 breaths per minute listed for qSOFA. This directly points to a high risk of sepsis-related organ dysfunction and mortality as flagged by a high qSOFA score. The alignment is perfect because the respiratory rate is explicitly used in the qSOFA criteria.",
                "Low SpO2 levels can be associated with respiratory distress and potentially indicate impaired oxygenation, which indirectly relates to the PaO\u2082/FiO\u2082 ratio component in the SOFA score. The alignment is not direct but meaningful, as low oxygen saturation could signify a risk of respiratory dysfunction associated with sepsis.",
                "The claim highlights the use of piperacillin-tazobactam, a broad-spectrum antibiotic, indicating a strong likelihood that medical staff suspects a serious infection, such as sepsis. This aligns well with the category of early administration of antibiotics, which shows high suspicion of sepsis. Although it doesn't specify the timing within the first two hours, the use of piperacillin-tazobactam itself strongly implies the relevance to this category.",
                "The claim mentions piperacillin-tazobactam, a broad-spectrum antibiotic commonly used to treat severe infections. While it doesn't specify the timing of administration or ordering of cultures, it implies a high level of clinical suspicion for serious infection, aligning closely with a key part of the category. The alignment is strong due to the type of antibiotic mentioned, indicating a typical response for suspected sepsis, but not complete given the lack of specific timing information.",
                "The claim directly references a high lactate level, which this category identifies as a specific marker indicating an elevated risk of sepsis mortality due to tissue hypoperfusion. The alignment is perfect as \"elevated serum lactate\" is explicitly what this category is concerned with.",
                "Heart rate variability (HRV) changes can suggest autonomic instability, which might indicate clinical deterioration. This aligns with the intent of the NEWS score, which assesses clinical deterioration using vital signs, including heart rate. However, HRV is not a direct component of the NEWS score, nor any category provided, so the alignment is indirect and weak.",
                "The claim doesn't provide specific information to match strongly with any category, only indicating the perception of a high sepsis risk. The Elevated NEWS Score category involves comprehensive vitals assessments to predict clinical deterioration compatible with sepsis, which is somewhat aligned with assessing general risk. However, the lack of specific details results in low alignment."
            ],
            "final_alignment_score": 0.7111111111111111
        },
        {
            "input": "6: HR, 118.0; 6: RR, 22.0; 6: SpO2, 100.0; 6: SBP, 132.0; 6: DBP, 94.0; 6: MAP, 106.667; 6: Pain, 5.0; 6: Temp, 98.1; 43: METOCLOPRAMIDE HCL, 5 MG/ML INJ SOLN; 52: SpO, 2: 95.903; 53: SpO2, 100.0; 53: SBP, 144.0; 53: DBP, 114.0; 53: MAP, 124.0; 54: SpO2, 100.0; 54: Perf, 0.382; 55: SpO2, 100.0; 55: Perf, 0.570; 56: SpO2, 100.0; 56: Perf, 1.475; 56: LR IV BOLUS -, 1000 ML; 57: SpO, 2: 99.898; 57: Perf, 1.808; 57: Pain, 0.0; 58: SpO2, 99.707; 58: Perf, 1.647; 59: SpO2, 100.0; 59: Perf, 1.412; 60: SpO2, 100.0; 60: Perf, 1.091; 61: SpO2, 100.0; 61: Perf, 0.924; 61: SBP, 125.0; 61: DBP, nan; 61: MAP, nan; 62: HR, 87.0; 62: RR, 18.0; 62: SpO2, 100.0; 62: Perf, 0.791; 62: SBP, 133.0; 62: DBP, 92.0; 62: MAP, 105.667; 62: Pain, 5.0; 63: SpO2, 100.0; 63: Perf, 0.720; 63: SBP, 133.0; 63: DBP, 92.0; 63: MAP, 105.667; 64: SARS-COV-2 RNA, Not Detected; 64: SpO2, 99.690; 64: Perf, 0.582; 65: SpO2, 99.897; 65: Perf, 0.660; 66: POC PH (V) ISTAT, 7.43; 66: POC LACTATE ISTAT, 2.70 mmol/L; 66: POC O2 SATURATION ISTAT VENOUS, 55 %; 66: POC PO2 (V) ISTAT, 28 mmHg; 66: POC HCO3 (V) ISTAT, 23.1 mmol/L; 66: POC TCO2 (V) ISTAT, 24 mmol/L; 66: POC PCO2 (V) ISTAT, 35.1 mmHg; 66: POC BASE EXCESS ISTAT, -1 mmol/L; 66: SpO2, 99.915; 66: Perf, 0.674; 67: SpO2, 100.0; 67: Perf, 0.690; 68: SpO2, 99.879; 68: Perf, 0.710; 69: SpO2, 100.0; 69: Perf, 0.765; 70: SpO2, 99.878; 70: Perf, 0.725; 71: SpO2, 99.830; 71: Perf, 0.598; 72: WAM DIFTYP, AUTO; 72: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 72: NEUTROPHIL % (AUTO DIFF), 83.7 %; 72: RED CELL DISTRIBUTION WIDTH (RDW), 12.3 %; 72: MONOCYTE % (AUTO DIFF), 4.1 %; 72: NRBC PERCENT (HEMATOLOGY), 0.0 %; 72: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 72: RED BLOOD CELLS (RBC), 4.89 MIL/uL; 72: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 72: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 72: HEMATOCRIT (HCT), 42.2 %; 72: NEUTROPHIL ABSOLUTE (AUTO DIFF), 9.84 K/uL; 72: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.7 pg; 72: PLATELET COUNT (PLT), 323 K/uL; 72: EOSINOPHIL % (AUTO DIFF), 0.1 %; 72: MONOCYTE ABSOLUTE (AUTO DIFF), 0.48 K/uL; 72: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 72: MEAN CORPUSCULAR VOLUME (MCV), 86.3 fL; 72: BASOPHIL % (AUTO DIFF), 0.3 %; 72: WHITE BLOOD CELLS (WBC), 11.8 K/uL; 72: LYMPHOCYTE % (AUTO DIFF), 11.4 %; 72: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.34 K/uL; 72: HEMOGLOBIN (HGB), 14.5 g/dL; 72: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.4 g/dL; 72: SpO2, 100.0; 72: Perf, 0.590; 73: SpO2, 100.0; 73: Perf, 0.597; 74: SpO2, 100.0; 74: Perf, 0.607; 75: SpO2, 100.0; 75: Perf, 0.565; 76: SpO2, 100.0; 76: Perf, 0.524; 77: SpO2, 100.0; 77: Perf, 0.508; 78: SpO2, 100.0; 78: Perf, 0.520; 78: SBP, 114.0; 78: DBP, 75.0; 78: MAP, 88.0; 79: SpO2, 100.0; 79: Perf, 0.482; 80: SpO2, 100.0; 80: Perf, 0.443; 81: SpO2, 100.0; 81: Perf, 0.402; 82: HR, 100.0; 82: RR, 17.0; 82: SpO2, 100.0; 82: Perf, 0.384; 82: SBP, 114.0; 82: DBP, 75.0; 82: MAP, 88.0; 82: Pain, 5.0; 82: ACETAMINOPHEN, 500 MG PO TABS; 83: SpO, 2: 100.0; 83: Perf, 0.38; 84: SpO2, 100.0; 84: Perf, 0.38; 85: SpO2, 100.0; 85: Perf, 0.389; 86: Perf, 0.39; 87: SpO2, 100.0; 87: Perf, 0.39; 88: SpO2, 100.0; 88: Perf, 0.39; 89: Perf, 0.39; 90: Perf, 0.396; 91: Perf, 0.401; 92: SpO2, 100.0; 92: Perf, 0.375; 93: SpO2, 100.0; 93: Perf, 0.38; 93: SBP, 133.0; 93: DBP, 91.0; 93: MAP, 105.0; 94: SpO2, 100.0; 94: Perf, 0.384; 95: SpO2, 100.0; 95: Perf, 0.397; 96: SpO2, 100.0; 96: Perf, 0.4; 97: SpO2, 100.0; 97: Perf, 0.392; 98: SpO2, 100.0; 98: Perf, 0.361; 99: ALT (SGPT), 17 U/L; 99: BLOOD UREA NITROGEN (BUN), 11 mg/dL; 99: SODIUM, 137 mmol/L; 99: CHLORIDE, 102 mmol/L; 99: AST (SGOT), 19 U/L; 99: BILIRUBIN TOTAL, 0.6 mg/dL; 99: GLUCOSE, 110 mg/dL; 99: CREATININE, 0.61 mg/dL; 99: CO2, 21 mmol/L; 99: ANION GAP, 14 mmol/L; 99: ALBUMIN, 4.3 g/dL; 99: POTASSIUM, 3.9 mmol/L; 99: GLOBULIN, 3.0 g/dL; 99: EGFR REFIT WITHOUT RACE (2021), 127 mL/min/1.73 m2; 99: CORRECTED CALCIUM, 9.0 mg/dL; 99: CALCIUM, 9.2 mg/dL; 99: EGFR FOR AFRICAN AMERICAN, 147 mL/min/1.73 m2; 99: PROTEIN TOTAL, 7.3 g/dL; 99: ALKALINE PHOSPHATASE, 57 U/L; 99: MAGNESIUM, 1.9 mg/dL; 99: SpO2, 100.0; 99: Perf, 0.359; 100: SpO2, 100.0; 100: Perf, 0.337; 101: SpO2, 100.0; 101: Perf, 0.28; 102: SpO2, 100.0; 102: Perf, 0.252; 103: SpO2, 100.0; 103: Perf, 0.26; 104: Perf, 0.26; 105: Perf, 0.26; 106: Perf, 0.26; 107: SpO2, 97.575; 107: Perf, 0.391; 108: SpO2, 100.0; 108: Perf, 0.39; 108: SBP, 115.0; 108: DBP, 70.0; 108: MAP, 85.0; 108: LR IV BOLUS -, 1000 ML; 109: SpO, 2: 100.0; 109: Perf, 0.398; 110: SpO2, 100.0; 110: Perf, 0.407; 111: SpO2, 100.0; 111: Perf, 0.396; 112: HR, 85.0; 112: RR, 16.0; 112: SpO2, 100.0; 112: Perf, 0.473; 112: SBP, 115.0; 112: DBP, 70.0; 112: MAP, 85.0; 112: Pain, 3.0; 113: SpO2, 100.0; 113: Perf, 0.453; 114: SpO2, 100.0; 114: Perf, 0.429; 115: SpO2, 100.0; 115: Perf, 0.413; 116: SpO2, 100.0; 116: Perf, 0.377; 117: SpO2, 100.0; 117: Perf, 0.364; 118: BETA HCG, 50897 mIU/mL; 118: SpO2, 100.0; 118: Perf, 0.364; 119: SpO2, 100.0; 119: Perf, 0.559; 0: Age, 26; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 118.0; 0: Triage RR, 22.0; 0: Triage SBP, 132.0; 0: Triage DBP, 94.0; 0: Triage acuity, 3-Urgent; 0: CC, EMESIS,HEADACHE",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The patient shows elevated heart rate and respiratory rate initially, which could hint at a stress response, but these parameters later normalize. The patient's blood pressure remains stable, and blood tests, including lactate levels, are not critically abnormal. The administration of medication and IV fluids appears to manage symptoms effectively. Overall, without critical signs of organ dysfunction or persistently abnormal vital signs, the patient doesn't meet high-risk criteria for sepsis within the next 12 hours.",
            "claims": [
                "The patient shows an elevated heart rate initially.",
                "The patient shows an elevated respiratory rate initially.",
                "Elevated heart rate and respiratory rate could hint at a stress response.",
                "The heart rate and respiratory rate later normalize.",
                "The patient's blood pressure remains stable.",
                "Blood tests, including lactate levels, are not critically abnormal.",
                "The administration of medication and IV fluids appears to manage symptoms effectively.",
                "The patient does not have critical signs of organ dysfunction.",
                "The patient does not have persistently abnormal vital signs.",
                "The patient does not meet high-risk criteria for sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The patient shows an elevated heart rate initially.",
                "Blood tests, including lactate levels, are not critically abnormal."
            ],
            "alignment_scores": [
                0.5,
                0.3
            ],
            "alignment_category": [
                "Elevated Shock Index (\u22651.0)",
                "Elevated Serum Lactate (\u22652 mmol/L)"
            ],
            "alignment_reasonings": [
                "An elevated heart rate can be associated with an elevated shock index if there is concurrent hypotension or a specific heart rate to blood pressure ratio. It suggests potential haemodynamic instability, aligning with the elevated shock index category. However, without information on blood pressure, the alignment is partial but not definitive, hence the moderate rating.",
                "The claim references lactate levels, which are relevant to the elevated serum lactate category, although it notes that these levels are not critically abnormal. While it directly pertains to lactate and has some relevance, the lack of critical abnormality means the alignment with the significant risk indicator of elevated lactate is weak."
            ],
            "final_alignment_score": 0.4
        },
        {
            "input": "5: HR, 104.0; 5: RR, 18.0; 5: SpO2, 98.0; 5: SBP, 126.0; 5: DBP, 78.0; 5: MAP, 94.0; 5: Pain, 7.0; 5: Temp, 99.9; 18: SBP, 126.0; 18: DBP, 86.0; 18: MAP, 99.333; 20: HR, 129.333; 20: 1min HRV, 10.333; 21: HR, 124.169; 21: RR, 20.098; 21: SpO2, 99.711; 21: 1min HRV, 33.530; 22: HR, 122.707; 22: RR, 11.466; 22: SpO2, 98.571; 22: 1min HRV, 17.122; 23: HR, 122.085; 23: RR, 14.085; 23: SpO2, 97.219; 23: 1min HRV, 24.052; 24: HR, 117.914; 24: RR, 17.724; 24: SpO2, 100.0; 24: 1min HRV, 21.285; 24: 5min HRV, 25.823; 25: HR, 122.220; 25: RR, 16.627; 25: SpO2, 99.808; 25: Perf, 0.192; 25: 1min HRV, 24.577; 25: SBP, 116.0; 25: DBP, 78.0; 25: MAP, 90.667; 26: HR, 117.746; 26: RR, 18.153; 26: SpO2, 99.679; 26: Perf, 0.206; 26: 1min HRV, 20.401; 27: HR, 124.672; 27: RR, 26.879; 27: SpO2, 99.552; 27: Perf, 0.2; 27: 1min HRV, 26.780; 28: HR, 123.627; 28: RR, 25.542; 28: SpO2, 96.894; 28: Perf, 0.2; 28: 1min HRV, 23.114; 29: HR, 123.052; 29: RR, 20.724; 29: SpO2, 99.707; 29: 1min HRV, 29.700; 29: 5min HRV, 26.483; 30: HR, 124.593; 30: RR, 16.186; 30: SpO2, 99.949; 30: 1min HRV, 22.922; 31: HR, 125.559; 31: RR, 19.305; 31: SpO2, 99.909; 31: 1min HRV, 28.814; 32: HR, 129.931; 32: RR, 28.155; 32: SpO2, 99.875; 32: Perf, 0.214; 32: 1min HRV, 28.843; 33: HR, 129.712; 33: RR, 26.254; 33: SpO2, 99.947; 33: Perf, 0.22; 33: 1min HRV, 25.706; 34: HR, 146.724; 34: RR, 30.155; 34: Perf, 0.22; 34: 1min HRV, 32.094; 34: 5min HRV, 35.024; 35: HR, 133.554; 35: RR, 27.847; 35: 1min HRV, 32.280; 36: HR, 123.441; 36: RR, 15.797; 36: 1min HRV, 35.801; 37: HR, 128.879; 37: RR, 24.828; 37: 1min HRV, 28.475; 38: HR, 132.051; 38: RR, 20.542; 38: 1min HRV, 16.376; 39: HR, 128.603; 39: RR, 20.069; 39: 1min HRV, 16.487; 39: 5min HRV, 30.643; 40: HR, 128.610; 40: RR, 16.712; 40: 1min HRV, 15.154; 40: SBP, 107.0; 40: DBP, 84.0; 40: MAP, 91.667; 41: HR, 121.483; 41: RR, 21.397; 41: 1min HRV, 19.597; 42: HR, 124.068; 42: RR, 20.373; 42: 1min HRV, 22.711; 43: HR, 116.780; 43: RR, 21.153; 43: 1min HRV, 16.104; 44: HR, 116.379; 44: RR, 19.914; 44: 1min HRV, 15.746; 44: 5min HRV, 25.775; 45: HR, 114.356; 45: RR, 20.746; 45: 1min HRV, 14.980; 46: HR, 113.724; 46: RR, 20.293; 46: 1min HRV, 22.211; 47: HR, 111.797; 47: RR, 21.017; 47: 1min HRV, 12.082; 48: HR, 111.288; 48: RR, 19.559; 48: 1min HRV, 19.268; 49: HR, 109.017; 49: RR, 18.345; 49: 1min HRV, 23.235; 49: 5min HRV, 20.667; 50: HR, 110.898; 50: RR, 18.576; 50: 1min HRV, 14.002; 51: HR, 115.966; 51: RR, 16.397; 51: 1min HRV, 18.354; 52: HR, 113.254; 52: RR, 19.898; 52: 1min HRV, 30.575; 53: HR, 111.898; 53: RR, 24.644; 53: 1min HRV, 22.842; 54: HR, 111.172; 54: RR, 23.534; 54: 1min HRV, 20.992; 54: 5min HRV, 24.145; 55: HR, 111.644; 55: RR, 17.237; 55: 1min HRV, 16.907; 56: HR, 115.121; 56: RR, 21.845; 56: 1min HRV, 29.425; 57: HR, 113.305; 57: RR, 19.746; 57: 1min HRV, 21.649; 58: HR, 116.712; 58: RR, 24.169; 58: 1min HRV, 28.961; 59: HR, 112.948; 59: RR, 21.069; 59: 1min HRV, 33.231; 59: 5min HRV, 27.756; 60: HR, 112.576; 60: RR, 22.441; 60: 1min HRV, 27.150; 61: HR, 114.328; 61: RR, 18.259; 61: 1min HRV, 29.118; 62: HR, 107.780; 62: RR, 18.492; 62: 1min HRV, 21.263; 63: HR, 105.661; 63: RR, 17.847; 63: 1min HRV, 15.294; 64: HR, 107.259; 64: RR, 17.793; 64: 1min HRV, 17.259; 64: 5min HRV, 29.527; 65: HR, 103.119; 65: RR, 20.339; 65: 1min HRV, 13.472; 66: HR, 104.931; 66: RR, 18.5; 66: 1min HRV, 11.080; 67: HR, 105.661; 67: RR, 19.186; 67: 1min HRV, 11.420; 68: HR, 104.678; 68: RR, 19.373; 68: 1min HRV, 12.364; 69: HR, 104.5; 69: RR, 17.828; 69: 1min HRV, 12.741; 69: 5min HRV, 13.261; 70: HR, 103.593; 70: RR, 16.898; 70: 1min HRV, 15.759; 71: HR, 103.172; 71: RR, 19.5; 71: 1min HRV, 18.602; 72: HR, 103.0; 72: RR, 18.203; 72: 1min HRV, 23.638; 73: HR, 102.190; 73: RR, 15.741; 73: 1min HRV, 18.132; 74: HR, 102.305; 74: RR, 20.254; 74: 1min HRV, 32.681; 74: 5min HRV, 23.049; 75: HR, 101.475; 75: RR, 16.881; 75: 1min HRV, 21.624; 76: HR, 100.534; 76: RR, 19.810; 76: 1min HRV, 16.212; 77: HR, 100.017; 77: RR, 17.949; 77: 1min HRV, 17.357; 78: HR, 102.121; 78: RR, 18.190; 78: 1min HRV, 13.711; 79: HR, 99.153; 79: RR, 17.661; 79: 1min HRV, 17.442; 79: 5min HRV, 18.412; 80: HR, 99.102; 80: RR, 18.763; 80: 1min HRV, 14.854; 81: HR, 97.5; 81: RR, 20.966; 81: 1min HRV, 12.589; 82: HR, 98.814; 82: RR, 18.475; 82: 1min HRV, 18.978; 83: HR, 96.672; 83: RR, 19.0; 83: 1min HRV, 13.628; 84: HR, 101.678; 84: RR, 21.288; 84: 1min HRV, 22.110; 84: 5min HRV, 20.979; 85: HR, 102.508; 85: RR, 20.085; 85: 1min HRV, 18.928; 85: LR IV BOLUS -, 1000 ML; 86: SARS-COV-, 2 RNA: Not Detected; 86: HR, 102.397; 86: RR, 17.707; 86: 1min HRV, 24.139; 87: HR, 101.610; 87: RR, 19.661; 87: 1min HRV, 30.701; 88: HR, 110.259; 88: RR, 19.207; 88: 1min HRV, 29.053; 89: HR, 115.8; 89: RR, 19.870; 89: 1min HRV, 31.107; 89: 5min HRV, 35.486; 0: Age, 25; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 37.7; 0: Triage HR, 104.0; 0: Triage RR, 18.0; 0: Triage SBP, 126.0; 0: Triage DBP, 78.0; 0: Triage acuity, 3-Urgent; 0: CC, FEVER,FEMALE GENITAL PROBLEM",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The patient's vital signs such as heart rate and respiratory rate are elevated but not critically high, and there is no significant decrease in blood oxygen saturation (SpO2) to indicate organ dysfunction. The heart rate variability (HRV) shows fluctuation but remains within a relatively stable range. The absence of extreme deviations in vital signs or clinical indicators typically associated with sepsis, such as hypotension or severe hypoxemia, suggests that the risk of sepsis is not high within the next 12 hours.",
            "claims": [
                "The patient's vital signs are elevated.",
                "The heart rate and respiratory rate are elevated but not critically high.",
                "There is no significant decrease in blood oxygen saturation (SpO2).",
                "The absence of a significant decrease in SpO2 indicates no organ dysfunction.",
                "The heart rate variability (HRV) shows fluctuation.",
                "The HRV remains within a relatively stable range.",
                "There are no extreme deviations in vital signs or clinical indicators typically associated with sepsis.",
                "Hypotension is typically associated with sepsis.",
                "Severe hypoxemia is typically associated with sepsis.",
                "The absence of extreme deviations suggests that the risk of sepsis is not high.",
                "The risk of sepsis is not high within the next 12 hours."
            ],
            "relevant_claims": [
                "The heart rate and respiratory rate are elevated but not critically high.",
                "There is no significant decrease in blood oxygen saturation (SpO2).",
                "There are no extreme deviations in vital signs or clinical indicators typically associated with sepsis."
            ],
            "alignment_scores": [
                0.7,
                0.3,
                0.2
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)",
                "SOFA Score Increase (\u22652 points)",
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "Elevated heart rate and respiratory rate are components of the SIRS criteria, which assess systemic inflammation potentially indicative of early sepsis. While the claim specifies that these rates are elevated but not critically high, this suggests partial fulfillment of SIRS criteria and a moderate relevance to this category.",
                "The claim references blood oxygen saturation (SpO2), which is somewhat related to the SOFA score's evaluation of respiratory function through the PaO\u2082/FiO\u2082 ratio. However, it does not directly address any specific criteria for SOFA score increase. The lack of significant decrease in SpO2 suggests stable respiratory function, offering a loose and indirect connection to this category.",
                "The claim indicates an absence of extreme deviations in vital signs or clinical indicators, which contrasts the elevated NEWS Score category that focuses on deranged vitals predicting clinical deterioration. This suggests a low risk of sepsis, aligning weakly with the concept of an elevated NEWS score, as there isn\u2019t enough evidence of vital sign distortion to predict sepsis."
            ],
            "final_alignment_score": 0.39999999999999997
        },
        {
            "input": "7: HR, 100.0; 7: RR, 16.0; 7: SpO2, 93.364; 7: Pain, 10.0; 7: Temp, 97.5; 8: SpO2, 96.0; 9: HR, 97.714; 9: 1min HRV, 46.887; 9: 5min HRV, 46.887; 9: SBP, 80.0; 9: DBP, 56.0; 9: MAP, 64.0; 10: HR, 99.339; 10: 1min HRV, 38.734; 11: HR, 98.414; 11: SpO2, 98.476; 11: 1min HRV, 37.015; 12: HR, 97.763; 12: 1min HRV, 37.484; 13: HR, 97.458; 13: SpO2, 100.0; 13: Perf, 0.11; 13: 1min HRV, 27.611; 14: HR, 97.018; 14: SpO2, 100.0; 14: Perf, 0.11; 14: 1min HRV, 22.578; 14: 5min HRV, 33.647; 15: HR, 97.034; 15: 1min HRV, 29.255; 16: HR, 95.672; 16: 1min HRV, 29.521; 17: HR, 94.644; 17: SpO2, 95.667; 17: 1min HRV, 20.008; 18: HR, 97.034; 18: SpO2, 97.474; 18: 1min HRV, 39.668; 19: HR, 95.75; 19: SpO2, 98.733; 19: 1min HRV, 26.890; 19: 5min HRV, 30.244; 19: SBP, 93.0; 19: DBP, 67.0; 19: MAP, 75.667; 20: HR, 96.153; 20: SpO2, 85.5; 20: 1min HRV, 29.099; 20: SBP, 93.0; 20: DBP, 67.0; 20: MAP, 75.667; 21: HR, 98.155; 21: SpO2, 100.0; 21: 1min HRV, 16.114; 22: HR, 95.508; 22: SpO2, 99.966; 22: 1min HRV, 19.910; 23: HR, 95.424; 23: SpO2, 100.0; 23: 1min HRV, 23.032; 24: HR, 94.810; 24: SpO2, 100.0; 24: 1min HRV, 13.884; 24: 5min HRV, 22.364; 25: HR, 92.966; 25: SpO2, 100.0; 25: 1min HRV, 9.650; 26: HR, 93.138; 26: SpO2, 100.0; 26: 1min HRV, 5.931; 27: HR, 94.695; 27: 1min HRV, 32.017; 28: HR, 93.5; 28: SpO2, 99.4; 28: 1min HRV, 36.406; 29: HR, 96.881; 29: SpO2, 99.0; 29: 1min HRV, 39.831; 29: 5min HRV, 30.991; 30: HR, 96.627; 30: SpO2, 100.0; 30: 1min HRV, 28.922; 31: HR, 95.796; 31: SpO2, 100.0; 31: 1min HRV, 28.161; 32: HR, 95.746; 32: SpO2, 96.556; 32: 1min HRV, 15.114; 33: HR, 95.293; 33: SpO2, 91.8; 33: 1min HRV, 18.812; 34: HR, 97.448; 34: SpO2, 93.95; 34: 1min HRV, 10.198; 34: 5min HRV, 22.786; 35: HR, 97.085; 35: SpO2, 94.5; 35: 1min HRV, 15.337; 35: ASPIRIN, 81 MG PO CHEW; 35: ACETAMINOPHEN, 500 MG PO TABS; 36: HR, 98.241; 36: SpO2, 95.518; 36: 1min HRV, 24.382; 37: HR, 97.492; 37: SpO2, 93.096; 37: 1min HRV, 45.606; 38: HR, 97.310; 38: SpO2, 93.85; 38: Perf, 0.24; 38: 1min HRV, 44.786; 39: HR, 97.305; 39: SpO2, 95.474; 39: Perf, 0.24; 39: 1min HRV, 40.561; 39: 5min HRV, 38.341; 40: HR, 97.0; 40: SpO2, 99.2; 40: Perf, 0.24; 40: 1min HRV, 39.062; 41: HR, 96.983; 41: SpO2, 100.0; 41: 1min HRV, 48.266; 42: HR, 97.356; 42: SpO2, 99.0; 42: 1min HRV, 40.408; 43: HR, 95.621; 43: SpO2, 100.0; 43: 1min HRV, 42.188; 44: HR, 96.5; 44: SpO2, 100.0; 44: 1min HRV, 37.516; 44: 5min HRV, 42.290; 45: HR, 92.847; 45: SpO2, 100.0; 45: 1min HRV, 23.501; 46: HR, 94.397; 46: SpO2, 100.0; 46: 1min HRV, 29.513; 47: HR, 93.034; 47: SpO2, 98.647; 47: 1min HRV, 32.125; 48: HR, 95.667; 48: SpO2, 99.143; 48: 1min HRV, 14.480; 49: HR, 93.831; 49: SpO2, 99.531; 49: 1min HRV, 16.465; 49: 5min HRV, 25.851; 50: HR, 93.661; 50: SpO2, 98.571; 50: 1min HRV, 13.106; 51: HR, 93.207; 51: 1min HRV, 11.248; 52: HR, 92.525; 52: 1min HRV, 12.237; 53: HR, 92.534; 53: SpO2, 100.0; 53: 1min HRV, 11.557; 54: HR, 92.508; 54: SpO2, 96.143; 54: 1min HRV, 6.789; 54: 5min HRV, 11.654; 54: Pain, 10.0; 55: HR, 92.559; 55: SpO2, 100.0; 55: 1min HRV, 9.271; 56: HR, 92.862; 56: SpO2, 99.853; 56: 1min HRV, 8.397; 57: HR, 92.237; 57: SpO2, 100.0; 57: 1min HRV, 9.517; 58: HR, 92.655; 58: SpO2, 99.955; 58: Perf, 0.15; 58: 1min HRV, 9.605; 59: HR, 93.0; 59: SpO2, 100.0; 59: Perf, 0.15; 59: 1min HRV, 6.399; 59: 5min HRV, 8.951; 60: HR, 92.897; 60: SpO2, 100.0; 60: Perf, 0.2; 60: 1min HRV, 7.052; 61: HR, 92.949; 61: SpO2, 100.0; 61: Perf, 0.21; 61: 1min HRV, 6.408; 62: HR, 92.492; 62: SpO2, 100.0; 62: Perf, 0.229; 62: 1min HRV, 7.471; 63: HR, 92.138; 63: 1min HRV, 8.428; 64: HR, 93.305; 64: SpO2, 100.0; 64: Perf, 0.216; 64: 1min HRV, 18.790; 64: 5min HRV, 10.843; 65: HR, 88.298; 65: SpO2, 100.0; 65: Perf, 0.23; 65: 1min HRV, 14.646; 66: HR, 91.559; 66: SpO2, 100.0; 66: 1min HRV, 13.013; 67: HR, 92.644; 67: SpO2, 100.0; 67: 1min HRV, 24.961; 68: HR, 91.724; 68: SpO2, 100.0; 68: 1min HRV, 43.105; 69: HR, 92.655; 69: SpO2, 96.95; 69: 1min HRV, 33.333; 69: 5min HRV, 28.986; 70: HR, 91.552; 70: SpO2, 93.75; 70: 1min HRV, 51.283; 71: HR, 90.492; 71: SpO2, 99.933; 71: Perf, 0.15; 71: 1min HRV, 22.465; 72: HR, 91.153; 72: SpO2, 99.867; 72: Perf, 0.155; 72: 1min HRV, 5.308; 73: HR, 91.741; 73: SpO2, 99.848; 73: Perf, 0.159; 73: 1min HRV, 22.532; 74: HR, 89.729; 74: SpO2, 99.595; 74: Perf, 0.160; 74: 1min HRV, 24.310; 74: 5min HRV, 26.494; 75: HR, 90.667; 75: SpO2, 100.0; 75: Perf, 0.165; 75: 1min HRV, 23.716; 76: HR, 91.729; 76: SpO2, 100.0; 76: Perf, 0.178; 76: 1min HRV, 22.482; 77: HR, 93.135; 77: SpO2, 97.852; 77: Perf, 0.18; 77: 1min HRV, 3.623; 78: HR, 97.52; 78: SpO2, 97.167; 78: 1min HRV, 37.103; 78: SBP, 72.0; 78: DBP, 54.0; 78: MAP, 60.0; 79: HR, 98.288; 79: SpO2, 98.667; 79: 1min HRV, 25.253; 79: 5min HRV, 35.545; 79: SBP, 72.0; 79: DBP, nan; 79: MAP, nan; 80: HR, 98.034; 80: SpO2, 100.0; 80: Perf, 0.22; 80: 1min HRV, 30.413; 80: SBP, 69.0; 80: DBP, 52.0; 80: MAP, 57.667; 81: HR, 97.949; 81: SpO2, 100.0; 81: Perf, 0.255; 81: 1min HRV, 28.517; 81: SBP, 69.0; 81: DBP, 52.0; 81: MAP, 57.667; 82: HR, 98.068; 82: SpO2, 100.0; 82: Perf, 0.279; 82: 1min HRV, 31.266; 83: HR, 97.621; 83: SpO2, 100.0; 83: Perf, 0.299; 83: 1min HRV, 23.406; 84: 5min HRV, 28.597; 86: NS IV BOLUS -, 250 ML; 94: HR:, 93.0; 94: SpO2, 100.0; 94: SBP, 86.0; 94: DBP, 68.0; 94: MAP, 74.0; 100: SARS-COV-2 RNA, Not Detected; 109: HR, 87.0; 109: SpO2, 100.0; 109: SBP, 76.0; 109: DBP, 48.0; 109: MAP, 57.333; 117: INR, 1.2; 117: PROTHROMBIN TIME, 15.1 seconds; 118: PART. THROMBOPLASTIN TIME, 47.1 seconds; 118: NS IV BOLUS -, 250 ML; 0: Age:, 65; 0: Gender, F; 0: Race, Black or African American; 0: Means of arrival, EMS; 0: Triage Temp, 36.4; 0: Triage HR, 100.0; 0: Triage RR, 16.0; 0: Triage SBP, 93.0; 0: Triage DBP, 67.0; 0: Triage acuity, 3-Urgent; 0: CC, CHEST PAIN",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient's declining blood pressure (evidenced by repeated low SBP and DBP measurements) and the administration of intravenous fluid boluses indicate potential hemodynamic instability, a hallmark of sepsis. Additionally, high heart rate (tachycardia) and low MAP further support this risk. Despite SpO2 levels appearing stable, the combination of these factors, coupled with severe chest pain and urgent triage acuity, suggests a high risk of sepsis developing within the next 12 hours.",
            "claims": [
                "The patient has a declining blood pressure.",
                "The declining blood pressure is evidenced by repeated low SBP measurements.",
                "The declining blood pressure is evidenced by repeated low DBP measurements.",
                "The administration of intravenous fluid boluses indicates potential hemodynamic instability.",
                "Hemodynamic instability is a hallmark of sepsis.",
                "The patient has a high heart rate.",
                "A high heart rate is also known as tachycardia.",
                "The patient has a low MAP.",
                "Low MAP further supports the risk of sepsis.",
                "SpO2 levels appear stable.",
                "The combination of declining blood pressure, high heart rate, low MAP, severe chest pain, and urgent triage acuity suggests a high risk of sepsis.",
                "The patient is at high risk of sepsis developing within the next 12 hours."
            ],
            "relevant_claims": [
                "The patient has a declining blood pressure.",
                "The declining blood pressure is evidenced by repeated low SBP measurements.",
                "The declining blood pressure is evidenced by repeated low DBP measurements.",
                "The administration of intravenous fluid boluses indicates potential hemodynamic instability.",
                "Hemodynamic instability is a hallmark of sepsis.",
                "The patient has a high heart rate.",
                "The patient has a low MAP.",
                "Low MAP further supports the risk of sepsis.",
                "The combination of declining blood pressure, high heart rate, low MAP, severe chest pain, and urgent triage acuity suggests a high risk of sepsis."
            ],
            "alignment_scores": [
                0.8,
                0.8,
                0.8,
                0.7,
                0.7,
                0.5,
                0.9,
                1.0,
                0.8
            ],
            "alignment_category": [
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Elevated Shock Index (\u22651.0)",
                "Elevated Shock Index (\u22651.0)",
                "Elevated Shock Index (\u22651.0)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)"
            ],
            "alignment_reasonings": [
                "The claim mentions declining blood pressure, which is indicative of progressing hypotension often seen in sepsis. The Sepsis-Associated Hypotension category focuses specifically on low blood pressure as a sign of septic shock. While the claim doesn't specify if the blood pressure has fallen below a particular threshold (e.g., SBP <90 mmHg), it suggests a concerning trend. This gives it a strong, but not perfect, alignment with the category.",
                "The claim suggests a pattern of low systolic blood pressure (SBP), which aligns with the category of sepsis-associated hypotension. However, specific numeric thresholds (e.g., SBP <90 mmHg) or a precise drop in SBP (\u226540 mmHg) are not provided in the claim, slightly reducing the alignment certainty.",
                "The claim focuses on declining blood pressure, which correlates with the \"Sepsis-Associated Hypotension\" category. Although the claim specifies low diastolic blood pressure (DBP) rather than systolic blood pressure (SBP) or mean arterial pressure (MAP) explicitly mentioned in the category, it suggests developing hypotension. The alignment is strong as hypotension is a critical component in assessing the progression to septic shock, but it does not precisely match the category criteria related to SBP, MAP, or a \u226540 mmHg drop.",
                "The claim refers to the administration of intravenous fluid boluses, which is commonly used to address hemodynamic instability\u2014a core concept linked to the Elevated Shock Index category. Although the claim does not explicitly quantify the shock index or mention heart rate and blood pressure measurements, the implication of hemodynamic instability aligns well with this category. The alignment is strong due to the significant overlap in concepts, though not perfectly direct as specific metrics are not detailed.",
                "Hemodynamic instability directly implies issues with cardiovascular stability, which is closely related to the shock index\u2014a measure of heart rate over systolic blood pressure indicating haemodynamic instability. While the claim doesn't specify a shock index value or change, the concept aligns with this category\u2019s focus on cardiovascular dynamics during severe sepsis. Hence, the alignment is moderate but not specific.",
                "A high heart rate is one component used to calculate the shock index, where it is divided by systolic blood pressure (SBP) to assess haemodynamic stability. While the claim does not provide information on SBP to confirm an elevated shock index, a high heart rate is relevant for considering this category. Thus, the alignment is moderate but incomplete without full data.",
                "The claim directly mentions a low mean arterial pressure (MAP), which is a key component in defining sepsis-associated hypotension and indicates progression towards septic shock. The strong connection to the definition in this category results in a high alignment rating. However, without specific values, there is a slight uncertainty, which prevents a perfect score of 1.0.",
                "The claim explicitly mentions \"Low MAP,\" which directly aligns with the category of Sepsis-Associated Hypotension. A low mean arterial pressure (MAP) is specifically noted in this category as an indicator of progression toward septic shock, making the alignment perfect.",
                "The claim specifically mentions declining blood pressure and low mean arterial pressure (MAP), which are key elements of the Sepsis-Associated Hypotension category. The high heart rate further supports hemodynamic instability, and though severe chest pain and urgent triage acuity are not directly mentioned in the category, they suggest an acute and serious clinical situation that aligns with the concept of a progressing to septic shock. Overall, the alignment is strong but not perfect, as not all elements directly match the criteria listed under Sepsis-Associated Hypotension."
            ],
            "final_alignment_score": 0.7777777777777777
        },
        {
            "input": "3: HR, 121.0; 3: RR, 22.0; 3: SpO2, 97.0; 3: SBP, 129.0; 3: DBP, 87.0; 3: MAP, 101.0; 3: Temp, 99.3; 16: SpO2, 96.45; 16: Perf, 0.6; 17: HR, 133.538; 17: RR, 22.158; 17: SpO2, 97.130; 17: Perf, 0.471; 17: 1min HRV, 16.532; 18: HR, 133.305; 18: RR, 21.966; 18: SpO2, 96.625; 18: Perf, 0.406; 18: 1min HRV, 19.165; 18: SBP, 114.0; 18: DBP, 76.0; 18: MAP, 88.667; 19: HR, 139.339; 19: RR, 18.746; 19: SpO2, 97.186; 19: Perf, 0.443; 19: 1min HRV, 20.527; 19: 5min HRV, 20.534; 20: HR, 131.103; 20: RR, 23.862; 20: SpO2, 96.793; 20: Perf, 0.505; 20: 1min HRV, 16.418; 21: HR, 130.086; 21: RR, 22.190; 21: SpO2, 97.138; 21: Perf, 0.542; 21: 1min HRV, 12.962; 22: HR, 129.103; 22: RR, 20.5; 22: SpO2, 96.931; 22: Perf, 0.499; 22: 1min HRV, 9.228; 23: HR, 131.356; 23: RR, 21.898; 23: SpO2, 97.356; 23: Perf, 0.426; 23: 1min HRV, 11.118; 24: HR, 131.390; 24: RR, 21.932; 24: SpO2, 97.441; 24: Perf, 0.427; 24: 1min HRV, 12.103; 24: 5min HRV, 13.005; 25: HR, 131.948; 25: RR, 21.914; 25: SpO2, 97.276; 25: Perf, 0.387; 25: 1min HRV, 10.485; 26: HR, 133.322; 26: RR, 22.390; 26: SpO2, 97.695; 26: Perf, 0.369; 26: 1min HRV, 13.968; 27: HR, 133.121; 27: RR, 22.517; 27: SpO2, 98.034; 27: Perf, 0.367; 27: 1min HRV, 16.834; 28: HR, 130.119; 28: RR, 22.068; 28: SpO2, 97.279; 28: Perf, 0.408; 28: 1min HRV, 10.430; 29: HR, 129.169; 29: RR, 20.814; 29: SpO2, 97.424; 29: Perf, 0.623; 29: 1min HRV, 5.235; 29: 5min HRV, 13.384; 29: SBP, 113.0; 29: DBP, 72.0; 29: MAP, 85.667; 30: HR, 129.017; 30: RR, 21.931; 30: SpO2, 98.023; 30: Perf, 0.61; 30: 1min HRV, 8.060; 30: SBP, 113.0; 30: DBP, 72.0; 30: MAP, 85.667; 31: HR, 130.0; 31: RR, 22.655; 31: SpO2, 98.0; 31: Perf, 0.628; 31: 1min HRV, 7.261; 32: HR, 130.810; 32: RR, 21.621; 32: SpO2, 98.0; 32: Perf, 0.555; 32: 1min HRV, 5.514; 33: HR, 130.661; 33: RR, 25.169; 33: SpO2, 98.0; 33: Perf, 0.507; 33: 1min HRV, 10.328; 34: 5min HRV, 8.431; 61: POC PH (V) ISTAT, 7.41; 61: POC LACTATE ISTAT, 1.49 mmol/L; 61: POC O2 SATURATION ISTAT VENOUS, 77 %; 61: POC PO2 (V) ISTAT, 41 mmHg; 61: POC TCO2 (V) ISTAT, 24 mmol/L; 61: POC BASE EXCESS ISTAT, -2 mmol/L; 61: POC PCO2 (V) ISTAT, 36.8 mmHg; 61: POC HCO3 (V) ISTAT, 23.1 mmol/L; 66: POC CREATININE ISTAT, 0.2 mg/dL; 66: POC EGFR REFIT WITHOUT RACE (2021), 169 mL/min/1.73 m2; 78: RSV, Not Detected; 78: INFLUENZA B, Not Detected; 78: SARS-COV-2 RNA, Not Detected; 78: INFLUENZA A, Not Detected; 84: WAM DIFTYP, AUTO; 84: NEUTROPHIL % (AUTO DIFF), 70.3 %; 84: PLATELET COUNT (PLT), 275 K/uL; 84: WHITE BLOOD CELLS (WBC), 7.6 K/uL; 84: EOSINOPHIL % (AUTO DIFF), 1.1 %; 84: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.3 g/dL; 84: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 84: BASOPHIL % (AUTO DIFF), 0.4 %; 84: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 84: NRBC PERCENT (HEMATOLOGY), 0.0 %; 84: MONOCYTE ABSOLUTE (AUTO DIFF), 0.52 K/uL; 84: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.60 K/uL; 84: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 84: HEMATOCRIT (HCT), 47.6 %; 84: NEUTROPHIL ABSOLUTE (AUTO DIFF), 5.35 K/uL; 84: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 84: LYMPHOCYTE % (AUTO DIFF), 21.1 %; 84: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 84: RED BLOOD CELLS (RBC), 5.91 MIL/uL; 84: MONOCYTE % (AUTO DIFF), 6.8 %; 84: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 25.2 pg; 84: RED CELL DISTRIBUTION WIDTH (RDW), 17.4 %; 84: HEMOGLOBIN (HGB), 14.9 g/dL; 84: MEAN CORPUSCULAR VOLUME (MCV), 80.5 fL; 97: INR, 1.0; 97: PROTHROMBIN TIME, 13.8 seconds; 98: PART. THROMBOPLASTIN TIME, 32.9 seconds; 111: HIGH SENSITIVITY TROPONIN, <4 ng/L; 112: SODIUM, 137 mmol/L; 112: AST (SGOT), 57 U/L; 112: PROTEIN TOTAL, 8.1 g/dL; 112: BILIRUBIN TOTAL, 0.5 mg/dL; 112: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 112: ALKALINE PHOSPHATASE, 165 U/L; 112: GLUCOSE, 146 mg/dL; 112: CHLORIDE, 107 mmol/L; 112: GLOBULIN, 4.1 g/dL; 112: ANION GAP, 10 mmol/L; 112: POTASSIUM, 4.1 mmol/L; 112: EGFR REFIT WITHOUT RACE (2021), 181 mL/min/1.73 m2; 112: CREATININE, 0.16 mg/dL; 112: CALCIUM, 9.4 mg/dL; 112: CORRECTED CALCIUM, 9.4 mg/dL; 112: ALBUMIN, 4.0 g/dL; 112: ALT (SGPT), 122 U/L; 112: C-REACTIVE PROTEIN (CRP), 2.1 mg/dL; 112: CO2, 20 mmol/L; 119: HR, 120.0; 119: RR, 20.0; 119: SpO2, 96.0; 119: SBP, 120.0; 119: DBP, 90.0; 119: MAP, 100.0; 119: Pain, 0.0; 0: Age, 47; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.4; 0: Triage HR, 121.0; 0: Triage RR, 22.0; 0: Triage SBP, 129.0; 0: Triage DBP, 87.0; 0: Triage acuity, 3-Urgent; 0: CC, VASCULAR ACCESS PROBLEM",
            "answer": true,
            "llm_answer": "No",
            "llm_explanation": "While the patient presents with tachycardia (high heart rate) and has been assessed with urgent triage, other vital signs are relatively stable, and lab results do not indicate signs of sepsis like lactate elevation or organ dysfunction. Oxygen saturation remains within a normal range, and there are no significant abnormalities in laboratory values such as white blood cell count, lactate, or inflammatory markers like CRP. Thus, based on the available EHR data, there is no high risk of developing sepsis within 12 hours.",
            "claims": [
                "The patient presents with tachycardia (high heart rate).",
                "The patient has been assessed with urgent triage.",
                "Other vital signs are relatively stable.",
                "Lab results do not indicate signs of sepsis.",
                "Lactate levels are not elevated.",
                "There is no evidence of organ dysfunction.",
                "Oxygen saturation remains within a normal range.",
                "There are no significant abnormalities in laboratory values.",
                "Laboratory values include white blood cell count, lactate, and inflammatory markers like CRP.",
                "Based on the available EHR data, there is no high risk of developing sepsis within 12 hours."
            ],
            "relevant_claims": [
                "The patient presents with tachycardia (high heart rate)."
            ],
            "alignment_scores": [
                0.7
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)"
            ],
            "alignment_reasonings": [
                "The claim of tachycardia (high heart rate) is directly related to the SIRS criteria, which include a heart rate >90 bpm. While the claim aligns with one specific criterion of the SIRS positivity category, it does not fulfill the requirement of having \u22652 SIRS criteria. Therefore, the alignment is strong, but not complete."
            ],
            "final_alignment_score": 0.7
        },
        {
            "input": "4: HR, 95.0; 4: RR, 18.0; 4: SpO2, 97.0; 4: SBP, 92.0; 4: DBP, 64.0; 4: MAP, 73.333; 4: Temp, 97.5; 5: SBP, 86.0; 5: DBP, 59.0; 5: MAP, 68.0; 8: Pain, 2.0; 38: POC PH (V) ISTAT, 7.36; 38: POC LACTATE ISTAT, 2.34 mmol/L; 38: POC TCO2 (V) ISTAT, 31 mmol/L; 38: POC HCO3 (V) ISTAT, 29.3 mmol/L; 38: POC BASE EXCESS ISTAT, 4 mmol/L; 38: POC PO2 (V) ISTAT, 24 mmHg; 38: POC PCO2 (V) ISTAT, 51.6 mmHg; 38: POC O2 SATURATION ISTAT VENOUS, 40 %; 44: WAM DIFTYP, AUTO; 44: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 44: NEUTROPHIL % (AUTO DIFF), 58.6 %; 44: MONOCYTE ABSOLUTE (AUTO DIFF), 0.46 K/uL; 44: RED CELL DISTRIBUTION WIDTH (RDW), 15.0 %; 44: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.38 K/uL; 44: HEMOGLOBIN (HGB), 11.4 g/dL; 44: EOSINOPHIL % (AUTO DIFF), 4.4 %; 44: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 44: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 44: NRBC PERCENT (HEMATOLOGY), 0.0 %; 44: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.66 K/uL; 44: NEUTROPHIL ABSOLUTE (AUTO DIFF), 5.03 K/uL; 44: MONOCYTE % (AUTO DIFF), 5.3 %; 44: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 25.7 pg; 44: BASOPHIL % (AUTO DIFF), 0.5 %; 44: HEMATOCRIT (HCT), 38.3 %; 44: MEAN CORPUSCULAR VOLUME (MCV), 86.5 fL; 44: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 29.8 g/dL; 44: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 44: LYMPHOCYTE % (AUTO DIFF), 30.9 %; 44: PLATELET COUNT (PLT), 425 K/uL; 44: WHITE BLOOD CELLS (WBC), 8.6 K/uL; 44: RED BLOOD CELLS (RBC), 4.43 MIL/uL; 45: SpO2, 97.435; 46: SpO2, 95.0; 46: Perf, 0.797; 47: SpO2, 94.949; 47: Perf, 0.570; 48: SpO2, 97.222; 48: Perf, 0.413; 48: SBP, 106.0; 48: DBP, 63.0; 48: MAP, 77.333; 49: SpO2, 96.627; 49: Perf, 0.574; 50: SpO2, 95.379; 50: Perf, 0.486; 51: SpO2, 95.356; 51: Perf, 0.394; 52: SpO2, 95.759; 52: Perf, 0.377; 53: SpO2, 96.949; 53: Perf, 0.411; 54: SpO2, 97.0; 54: Perf, 0.439; 55: SpO2, 96.586; 55: Perf, 0.461; 56: SpO2, 97.0; 56: Perf, 0.387; 57: INR, 1.0; 57: PROTHROMBIN TIME, 13.5 seconds; 57: PART. THROMBOPLASTIN TIME, 27.1 seconds; 57: SpO2, 97.0; 57: Perf, 0.376; 58: HR, 79.0; 58: SpO2, 96.475; 58: Perf, 0.393; 59: HR, 79.0; 59: SpO2, 97.0; 59: Perf, 0.442; 59: SBP, 102.0; 59: DBP, 64.0; 59: MAP, 76.667; 60: SpO2, 97.333; 60: Perf, 0.45; 60: SBP, 102.0; 60: DBP, 64.0; 60: MAP, 76.667; 61: SpO2, 96.627; 61: Perf, 0.591; 62: SpO2, 96.207; 62: Perf, 0.531; 63: SpO2, 97.017; 63: Perf, 0.563; 64: SpO2, 96.678; 64: Perf, 0.502; 65: SpO2, 96.860; 65: Perf, 0.598; 66: SpO2, 96.483; 66: Perf, 0.573; 67: SpO2, 95.759; 67: Perf, 0.473; 68: SpO2, 94.576; 68: Perf, 0.374; 69: SpO2, 95.136; 69: Perf, 0.384; 70: SpO2, 95.397; 70: Perf, 0.361; 71: SpO2, 96.644; 71: Perf, 0.393; 72: SpO2, 96.879; 72: Perf, 0.448; 73: SpO2, 96.898; 73: Perf, 0.455; 74: SpO2, 97.0; 74: Perf, 0.478; 75: EGFR REFIT WITHOUT RACE (2021), 76 mL/min/1.73 m2; 75: CALCIUM, 9.7 mg/dL; 75: GLUCOSE, 133 mg/dL; 75: CO2, 26 mmol/L; 75: AST (SGOT), 24 U/L; 75: ALBUMIN, 4.1 g/dL; 75: CORRECTED CALCIUM, 9.6 mg/dL; 75: PROTEIN TOTAL, 7.8 g/dL; 75: ANION GAP, 10 mmol/L; 75: BLOOD UREA NITROGEN (BUN), 18 mg/dL; 75: CREATININE, 0.74 mg/dL; 75: GLOBULIN, 3.7 g/dL; 75: ALT (SGPT), 11 U/L; 75: BILIRUBIN TOTAL, 0.3 mg/dL; 75: SODIUM, 136 mmol/L; 75: ALKALINE PHOSPHATASE, 86 U/L; 75: CHLORIDE, 100 mmol/L; 75: POTASSIUM, 4.9 mmol/L; 75: SpO2, 97.190; 75: Perf, 0.538; 76: SpO2, 97.305; 76: Perf, 0.482; 77: SpO2, 96.897; 77: Perf, 0.432; 78: SpO2, 97.155; 78: Perf, 0.404; 79: SpO2, 97.661; 79: Perf, 0.421; 80: SARS-COV-2 RNA, Not Detected; 80: SpO2, 96.525; 80: Perf, 0.404; 81: SpO2, 96.695; 81: Perf, 0.383; 82: SpO2, 96.603; 82: Perf, 0.349; 82: LR IV BOLUS -, 1000 ML; 83: SpO, 2: 96.704; 83: Perf, 0.351; 84: SpO2, 96.604; 85: SpO2, 95.845; 86: SpO2, 96.576; 86: Perf, 0.305; 87: SpO2, 96.707; 87: Perf, 0.307; 88: SpO2, 96.522; 88: Perf, 0.3; 89: SpO2, 97.537; 89: Perf, 0.3; 90: SpO2, 97.0; 90: Perf, 0.382; 91: SpO2, 96.288; 91: Perf, 0.401; 92: SpO2, 94.915; 92: Perf, 0.369; 93: SpO2, 96.949; 93: Perf, 0.290; 94: SpO2, 95.310; 94: Perf, 0.277; 95: SpO2, 96.644; 95: Perf, 0.301; 96: SpO2, 95.537; 96: Perf, 0.269; 97: SpO2, 96.064; 97: Perf, 0.260; 98: SpO2, 97.091; 98: Perf, 0.255; 99: SpO2, 96.612; 99: Perf, 0.264; 100: SpO2, 96.409; 100: Perf, 0.242; 101: SpO2, 96.231; 101: Perf, 0.246; 102: SpO2, 96.735; 102: Perf, 0.238; 103: SpO2, 97.0; 103: Perf, 0.235; 104: SpO2, 97.217; 104: Perf, 0.236; 105: SpO2, 96.6; 105: Perf, 0.217; 106: SpO2, 96.675; 106: Perf, 0.224; 107: SpO2, 96.081; 107: Perf, 0.240; 108: SpO2, 96.806; 108: Perf, 0.232; 109: SpO2, 96.25; 109: Perf, 0.225; 110: SpO2, 96.759; 110: Perf, 0.220; 111: SpO2, 96.379; 111: Perf, 0.216; 112: SpO2, 96.455; 112: Perf, 0.222; 113: SpO2, 97.125; 113: Perf, 0.221; 114: SpO2, 96.318; 114: Perf, 0.227; 115: SpO2, 96.241; 115: Perf, 0.227; 116: SpO2, 96.714; 116: Perf, 0.216; 117: SpO2, 97.135; 117: Perf, 0.224; 118: SpO2, 97.318; 118: Perf, 0.227; 119: SpO2, 97.467; 119: Perf, 0.21; 0: Age, 90; 0: Gender, F; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.4; 0: Triage HR, 95.0; 0: Triage RR, 18.0; 0: Triage SBP, 92.0; 0: Triage DBP, 64.0; 0: Triage acuity, 2-Emergent; 0: CC, WOUND CHECK",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The patient's vital signs show some fluctuations, such as low blood pressure and a temporary elevated heart rate, but the SpO2 levels remain mostly stable and adequate. The lab results do not indicate severe abnormalities commonly associated with sepsis, like significantly elevated lactate or marked signs of infection. Additionally, supportive measures such as IV fluids appear to help stabilize the patient. Therefore, the patient is not at high risk of developing sepsis within 12 hours based on the available data.",
            "claims": [
                "The patient's vital signs show fluctuations.",
                "The patient has low blood pressure.",
                "The patient has a temporary elevated heart rate.",
                "The SpO2 levels remain mostly stable and adequate.",
                "The lab results do not indicate severe abnormalities commonly associated with sepsis.",
                "The lab results do not show significantly elevated lactate.",
                "The lab results do not show marked signs of infection.",
                "Supportive measures such as IV fluids appear to help stabilize the patient.",
                "The patient is not at high risk of developing sepsis within 12 hours based on the available data."
            ],
            "relevant_claims": [
                "The patient has low blood pressure.",
                "The lab results do not indicate severe abnormalities commonly associated with sepsis.",
                "The lab results do not show significantly elevated lactate.",
                "The lab results do not show marked signs of infection."
            ],
            "alignment_scores": [
                0.8,
                0.2,
                0.3,
                0.2
            ],
            "alignment_category": [
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "Early Antibiotic/Culture Orders (within 2 hours)"
            ],
            "alignment_reasonings": [
                "Low blood pressure directly aligns with the concept of sepsis-associated hypotension, which includes conditions such as SBP <90 mmHg, MAP <70 mmHg, or a significant drop in blood pressure, as defining sepsis progression. However, without specific numerical values, the link is strong but not entirely specific to all thresholds defined in the category.",
                "The claim mentions that lab results do not indicate severe abnormalities, which indirectly suggests that key abnormal lab findings associated with sepsis, such as elevated serum lactate, are not present. Although the claim does not directly relate to a specific category, the absence of severe abnormalities suggests no indications of tissue hypoperfusion, which elevated serum lactate would signal. The alignment is weak because the claim does not directly address any specific measurement typically used in sepsis prediction.",
                "The claim references lactate levels, which directly pertains to the category of elevated serum lactate. However, since it states lactate is not significantly elevated, this does not align with the criteria for high sepsis risk (\u22652 mmol/L). The alignment is minor, acknowledging the consideration of lactate levels in sepsis assessment, but indicating low risk in this context.",
                "The claim about lab results not showing marked signs of infection suggests a low clinical suspicion of infection, which typically relates to the decision against early antibiotic administration or culture draws. This indirectly connects to the assessment of infection risk by suggesting a low likelihood of a need for such immediate actions. However, it contrasts rather than aligns directly, hence the low alignment rating."
            ],
            "final_alignment_score": 0.375
        },
        {
            "input": "4: HR, 94.0; 4: RR, 18.0; 4: SpO2, 99.0; 4: SBP, 141.0; 4: DBP, 92.0; 4: MAP, 108.333; 4: Pain, 6.0; 4: Temp, 97.9; 9: Pain, 7.0; 28: HR, 97.0; 28: RR, 15.0; 28: SpO2, 99.0; 28: SBP, 149.0; 28: DBP, 99.0; 28: MAP, 115.667; 28: Pain, 7.0; 29: SBP, 149.0; 29: DBP, 99.0; 29: MAP, 115.667; 30: SpO2, 98.833; 30: Perf, 2.51; 31: SpO2, 98.847; 31: Perf, 2.238; 32: SpO2, 98.103; 32: Perf, 1.899; 33: SpO2, 96.763; 33: Perf, 2.299; 34: SpO2, 97.034; 34: Perf, 2.379; 35: SpO2, 96.593; 35: Perf, 2.486; 36: SpO2, 98.322; 36: Perf, 2.368; 37: SpO2, 98.569; 37: Perf, 2.020; 38: SpO2, 97.0; 38: Perf, 2.242; 39: SpO2, 96.793; 39: Perf, 2.375; 40: SpO2, 97.814; 40: Perf, 2.22; 41: SpO2, 98.898; 41: Perf, 1.982; 42: SpO2, 98.983; 42: Perf, 1.713; 43: SpO2, 99.034; 43: Perf, 1.991; 44: SpO2, 97.5; 44: Perf, 2.662; 45: SpO2, 97.814; 45: Perf, 2.922; 46: SpO2, 98.322; 46: Perf, 2.619; 47: SpO2, 98.793; 47: Perf, 2.243; 48: SpO2, 97.407; 48: Perf, 1.931; 49: SpO2, 97.724; 49: Perf, 1.593; 50: SpO2, 97.898; 50: Perf, 1.594; 51: SpO2, 97.915; 51: Perf, 1.571; 52: SpO2, 98.776; 52: Perf, 1.957; 53: SpO2, 98.661; 53: Perf, 2.086; 54: SpO2, 98.328; 54: Perf, 1.897; 55: SpO2, 98.102; 55: Perf, 1.603; 56: SpO2, 98.322; 56: Perf, 1.592; 57: SpO2, 98.534; 57: Perf, 1.642; 58: SpO2, 99.237; 58: Perf, 1.675; 59: SpO2, 97.810; 59: Perf, 1.644; 60: SpO2, 97.729; 60: Perf, 1.421; 61: SpO2, 97.729; 61: Perf, 1.236; 62: SpO2, 98.103; 62: Perf, 1.116; 63: SpO2, 98.102; 63: Perf, 1.111; 64: SpO2, 98.862; 64: Perf, 1.314; 65: SpO2, 98.288; 65: Perf, 1.637; 66: SpO2, 98.810; 66: Perf, 1.958; 67: SpO2, 98.780; 67: Perf, 1.529; 68: SpO2, 97.831; 68: Perf, 1.272; 69: SpO2, 98.379; 69: Perf, 1.351; 70: SpO2, 98.254; 70: Perf, 1.663; 71: SpO2, 97.879; 71: Perf, 1.607; 72: SpO2, 98.746; 72: Perf, 1.151; 73: SpO2, 97.475; 73: Perf, 1.061; 74: SpO2, 97.466; 74: Perf, 1.162; 75: SpO2, 97.661; 75: Perf, 1.278; 76: SpO2, 98.155; 76: Perf, 1.366; 77: SpO2, 98.0; 77: Perf, 1.219; 78: SpO2, 99.034; 78: Perf, 0.794; 79: SpO2, 98.707; 79: Perf, 0.774; 80: SpO2, 97.254; 80: Perf, 1.277; 81: SpO2, 97.138; 81: Perf, 1.397; 82: SpO2, 96.949; 82: Perf, 1.276; 83: SpO2, 97.254; 83: Perf, 0.825; 84: SpO2, 97.483; 84: Perf, 1.056; 85: SpO2, 98.441; 85: Perf, 1.759; 86: SpO2, 98.086; 86: Perf, 1.750; 87: SpO2, 98.627; 87: Perf, 1.313; 88: SpO2, 98.051; 88: Perf, 1.599; 89: SpO2, 98.672; 89: Perf, 1.206; 89: SBP, 151.0; 89: DBP, 87.0; 89: MAP, 108.333; 90: SpO2, 98.864; 90: Perf, 1.203; 91: SpO2, 99.431; 91: Perf, 1.215; 92: SpO2, 98.881; 92: Perf, 1.043; 93: CHLORIDE, 105 mmol/L; 93: GLOBULIN, 2.6 g/dL; 93: ALKALINE PHOSPHATASE, 89 U/L; 93: CREATININE, 1.25 mg/dL; 93: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 93: ALT (SGPT), 29 U/L; 93: EGFR REFIT WITHOUT RACE (2021), 68 mL/min/1.73 m2; 93: AST (SGOT), 29 U/L; 93: CO2, 21 mmol/L; 93: POTASSIUM, 3.6 mmol/L; 93: GLUCOSE, 109 mg/dL; 93: ALBUMIN, 4.3 g/dL; 93: CORRECTED CALCIUM, 8.6 mg/dL; 93: PROTEIN TOTAL, 6.9 g/dL; 93: CALCIUM, 8.8 mg/dL; 93: ANION GAP, 13 mmol/L; 93: SODIUM, 139 mmol/L; 93: BILIRUBIN TOTAL, 0.6 mg/dL; 93: LIPASE, 23 U/L; 93: SpO2, 99.136; 93: Perf, 0.841; 94: SpO2, 98.931; 94: Perf, 0.738; 95: SpO2, 98.203; 95: Perf, 1.045; 96: SpO2, 98.293; 96: Perf, 1.207; 97: SARS-COV-2 RNA, Not Detected; 97: SpO2, 99.458; 97: Perf, 1.211; 98: SpO2, 99.259; 98: Perf, 1.108; 99: SpO2, 100.0; 99: Perf, 0.684; 100: SpO2, 99.932; 100: Perf, 0.549; 101: SpO2, 99.276; 101: Perf, 0.588; 102: SpO2, 98.780; 102: Perf, 0.494; 103: SpO2, 99.052; 103: Perf, 0.49; 104: SpO2, 98.424; 104: Perf, 0.535; 105: SpO2, 98.305; 105: Perf, 0.428; 106: SpO2, 98.897; 106: Perf, 0.391; 107: SpO2, 97.763; 107: Perf, 0.546; 108: SpO2, 98.483; 108: Perf, 0.491; 109: SpO2, 96.593; 109: Perf, 0.523; 110: SpO2, 97.627; 110: Perf, 0.64; 111: SpO2, 97.707; 111: Perf, 0.719; 112: SpO2, 98.525; 112: Perf, 0.737; 113: SpO2, 98.155; 113: Perf, 0.561; 114: SpO2, 97.525; 114: Perf, 0.627; 115: SpO2, 98.085; 115: Perf, 0.650; 116: PLATELET COUNT (PLT), 215 K/uL; 116: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.0 g/dL; 116: RED CELL DISTRIBUTION WIDTH (RDW), 12.6 %; 116: HEMATOCRIT (HCT), 37.6 %; 116: WHITE BLOOD CELLS (WBC), 3.3 K/uL; 116: RED BLOOD CELLS (RBC), 4.01 MIL/uL; 116: MEAN CORPUSCULAR VOLUME (MCV), 93.8 fL; 116: HEMOGLOBIN (HGB), 12.8 g/dL; 116: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.9 pg; 116: NEUTROPHILS BANDS % (MANUAL DIFF), 10.4 %; 116: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 2.68 K/uL; 116: LYMPHOCYTES % (MANUAL DIFF), 8.7 %; 116: MONOCYTES ABSOLUTE (MANUAL DIFF), 0.17 K/uL; 116: EOSINOPHILS ABSOLUTE (MANUAL DIFF), 0.09 K/uL; 116: BASOPHILS % (MANUAL DIFF), 1.7 %; 116: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 71.4 %; 116: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 0.29 K/uL; 116: MONOCYTES % (MANUAL DIFF), 5.2 %; 116: EOSINOPHILS % (MANUAL DIFF), 2.6 %; 116: BASOPHILS ABSOLUTE (MANUAL DIFF), 0.06 K/uL; 116: SpO2, 99.069; 116: Perf, 0.680; 117: SpO2, 98.864; 117: Perf, 0.548; 118: SpO2, 99.439; 118: Perf, 0.634; 119: SpO2, 98.75; 119: Perf, 0.77; 0: Age, 54; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 94.0; 0: Triage RR, 18.0; 0: Triage SBP, 141.0; 0: Triage DBP, 92.0; 0: Triage acuity, 3-Urgent; 0: CC, FLANK PAIN",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The patient's vital signs are largely within normal ranges, with stable blood pressure, heart rate, temperature, respiratory rate, and oxygen saturation (SpO2) levels. Laboratory results show no significant elevations in inflammatory markers typically associated with sepsis, such as white blood cell count\u2013which is low but not concerningly so\u2013and no derangement in renal or liver function tests. Despite mild pain reported early on, these factors collectively suggest a low risk of sepsis.",
            "claims": [
                "The patient's vital signs are largely within normal ranges.",
                "The patient's blood pressure is stable.",
                "The patient's heart rate is stable.",
                "The patient's temperature is stable.",
                "The patient's respiratory rate is stable.",
                "The patient's oxygen saturation (SpO2) levels are stable.",
                "Laboratory results show no significant elevations in inflammatory markers typically associated with sepsis.",
                "The white blood cell count is low but not concerningly so.",
                "There is no derangement in renal function tests.",
                "There is no derangement in liver function tests.",
                "The patient reported mild pain early on.",
                "These factors collectively suggest a low risk of sepsis."
            ],
            "relevant_claims": [
                "The patient's vital signs are largely within normal ranges.",
                "Laboratory results show no significant elevations in inflammatory markers typically associated with sepsis."
            ],
            "alignment_scores": [
                0.2,
                0.3
            ],
            "alignment_category": [
                "AElevated NEWS Score (\u22655 points)",
                "SIRS Positivity (\u22652 Criteria)"
            ],
            "alignment_reasonings": [
                "The claim that the patient's vital signs are largely within normal ranges suggests that the NEWS score is likely to be low, as it relies on deranged vitals for scoring. While this observation doesn't directly align with any specific sepsis criteria, it contrasts with the conditions that would lead to an elevated NEWS score, which is an important predictive category for sepsis. Therefore, the alignment is present due to the contrast but is weak.",
                "The claim involves the absence of elevated inflammatory markers, which are relevant to SIRS criteria that concern systemic inflammation. While this claim directly contradicts the presence of such criteria, it indirectly aligns with assessing whether SIRS positivity is present. The alignment is weak because it's based on a lack of findings rather than meeting any SIRS criteria."
            ],
            "final_alignment_score": 0.25
        },
        {
            "input": "7: Pain, 7.0; 32: HR, 117.0; 32: RR, 32.0; 32: SpO2, 86.0; 32: SBP, 109.0; 32: DBP, 68.0; 32: MAP, 81.667; 32: Pain, 10.0; 32: Temp, 100.9; 36: SpO2, 96.0; 36: LPM O2, 4.0; 68: WAM DIFTYP, AUTO; 68: RED BLOOD CELLS (RBC), 5.46 MIL/uL; 68: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 24.9 pg; 68: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.1 %; 68: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 68: NEUTROPHIL % (AUTO DIFF), 80.3 %; 68: NEUTROPHIL ABSOLUTE (AUTO DIFF), 6.20 K/uL; 68: MONOCYTE ABSOLUTE (AUTO DIFF), 0.40 K/uL; 68: RED CELL DISTRIBUTION WIDTH (RDW), 14.6 %; 68: MONOCYTE % (AUTO DIFF), 5.2 %; 68: MEAN CORPUSCULAR VOLUME (MCV), 74.0 fL; 68: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.05 K/uL; 68: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 68: EOSINOPHIL % (AUTO DIFF), 0.4 %; 68: NRBC PERCENT (HEMATOLOGY), 0.0 %; 68: HEMOGLOBIN (HGB), 13.6 g/dL; 68: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 68: PLATELET COUNT (PLT), 312 K/uL; 68: HEMATOCRIT (HCT), 40.4 %; 68: LYMPHOCYTE % (AUTO DIFF), 13.6 %; 68: BASOPHIL % (AUTO DIFF), 0.4 %; 68: WHITE BLOOD CELLS (WBC), 7.7 K/uL; 68: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.7 g/dL; 68: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 85: SpO2, 98.0; 86: SpO2, 98.625; 86: Perf, 2.463; 86: SBP, 109.0; 86: DBP, 73.0; 86: MAP, 85.0; 87: HR, 113.469; 87: RR, 27.0; 87: SpO2, 99.155; 87: Perf, 2.662; 87: 1min HRV, 19.790; 87: 5min HRV, 19.790; 88: HR, 112.390; 88: RR, 21.492; 88: SpO2, 98.644; 88: Perf, 2.950; 88: 1min HRV, 20.380; 89: HR, 110.603; 89: RR, 27.207; 89: SpO2, 98.586; 89: Perf, 2.988; 89: 1min HRV, 18.547; 90: HR, 107.508; 90: RR, 27.237; 90: SpO2, 98.797; 90: Perf, 4.969; 90: 1min HRV, 11.911; 91: HR, 106.559; 91: RR, 22.780; 91: SpO2, 99.0; 91: Perf, 5.491; 91: 1min HRV, 7.818; 92: HR, 107.448; 92: RR, 21.603; 92: SpO2, 98.931; 92: Perf, 5.781; 92: 1min HRV, 17.544; 92: 5min HRV, 19.342; 92: SBP, 105.0; 92: DBP, 77.0; 92: MAP, 86.333; 92: LPM O2, 4.0; 93: HR, 106.458; 93: RR, 27.153; 93: SpO2, 99.152; 93: Perf, 5.267; 93: 1min HRV, 9.148; 93: SBP, 105.0; 93: DBP, 77.0; 93: MAP, 86.333; 94: HR, 105.397; 94: RR, 27.448; 94: SpO2, 98.931; 94: Perf, 4.354; 94: 1min HRV, 11.650; 95: HR, 105.983; 95: RR, 24.458; 95: SpO2, 98.475; 95: Perf, 5.262; 95: 1min HRV, 7.859; 96: HR, 104.966; 96: RR, 26.254; 96: SpO2, 98.0; 96: Perf, 5.722; 96: 1min HRV, 9.993; 97: HR, 104.759; 97: RR, 28.569; 97: SpO2, 98.345; 97: Perf, 5.849; 97: 1min HRV, 26.592; 97: 5min HRV, 15.220; 98: HR, 106.051; 98: RR, 28.017; 98: SpO2, 98.475; 98: Perf, 4.902; 98: 1min HRV, 13.398; 99: POC PH (V) ISTAT, 7.44; 99: POC LACTATE ISTAT, 0.97 mmol/L; 99: POC TCO2 (V) ISTAT, 36 mmol/L; 99: POC PCO2 (V) ISTAT, 51.2 mmHg; 99: POC O2 SATURATION ISTAT VENOUS, 86 %; 99: POC BASE EXCESS ISTAT, 10 mmol/L; 99: POC HCO3 (V) ISTAT, 34.4 mmol/L; 99: POC PO2 (V) ISTAT, 51 mmHg; 99: HR, 102.362; 99: RR, 23.259; 99: SpO2, 98.0; 99: Perf, 5.626; 99: 1min HRV, 9.641; 100: HR, 103.119; 100: RR, 26.407; 100: SpO2, 98.0; 100: Perf, 6.064; 100: 1min HRV, 9.006; 101: HR, 105.552; 101: RR, 21.793; 101: SpO2, 98.017; 101: Perf, 6.432; 101: 1min HRV, 26.363; 102: HR, 105.746; 102: RR, 21.576; 102: SpO2, 98.492; 102: Perf, 6.412; 102: 1min HRV, 15.509; 102: 5min HRV, 18.497; 103: LIPASE, 7 U/L; 103: HR, 103.559; 103: RR, 21.322; 103: SpO2, 97.966; 103: Perf, 7.953; 103: 1min HRV, 10.207; 103: HYDROMORPHONE, 1 MG/ML INJ SYRG; 104: HR:, 103.966; 104: RR, 22.931; 104: SpO2, 98.190; 104: Perf, 6.394; 104: 1min HRV, 12.384; 105: HR, 102.797; 105: RR, 22.898; 105: SpO2, 98.0; 105: Perf, 7.407; 105: 1min HRV, 9.324; 106: HR, 106.552; 106: RR, 26.207; 106: SpO2, 97.638; 106: Perf, 6.102; 106: 1min HRV, 22.177; 107: HR, 105.051; 107: RR, 20.458; 107: SpO2, 97.542; 107: Perf, 7.189; 107: 1min HRV, 15.540; 107: 5min HRV, 16.297; 108: HR, 102.203; 108: RR, 26.271; 108: SpO2, 98.0; 108: Perf, 8.579; 108: 1min HRV, 8.521; 108: SBP, 104.0; 108: DBP, 68.0; 108: MAP, 80.0; 109: HR, 102.862; 109: RR, 19.431; 109: SpO2, 98.0; 109: Perf, 7.502; 109: 1min HRV, 7.261; 110: HR, 102.322; 110: RR, 22.508; 110: SpO2, 98.0; 110: Perf, 8.154; 110: 1min HRV, 11.387; 111: HR, 100.224; 111: RR, 23.552; 111: SpO2, 98.0; 111: Perf, 7.929; 111: 1min HRV, 13.069; 112: HR, 100.729; 112: RR, 22.237; 112: SpO2, 98.0; 112: Perf, 7.754; 112: 1min HRV, 10.293; 112: 5min HRV, 11.824; 113: HR, 99.966; 113: RR, 24.864; 113: SpO2, 98.0; 113: Perf, 7.96; 113: 1min HRV, 13.281; 114: HR, 99.586; 114: RR, 24.603; 114: SpO2, 98.0; 114: Perf, 8.212; 114: 1min HRV, 12.548; 115: HR, 98.763; 115: RR, 22.390; 115: SpO2, 98.0; 115: Perf, 8.311; 115: 1min HRV, 10.531; 116: HR, 100.362; 116: RR, 22.362; 116: SpO2, 98.0; 116: Perf, 7.152; 116: 1min HRV, 24.455; 117: HR, 98.441; 117: RR, 21.373; 117: SpO2, 98.0; 117: Perf, 7.441; 117: 1min HRV, 13.903; 117: 5min HRV, 16.747; 118: HR, 97.034; 118: RR, 24.085; 118: SpO2, 98.0; 118: Perf, 7.582; 118: 1min HRV, 11.218; 119: HR, 96.879; 119: RR, 22.638; 119: SpO2, 98.0; 119: Perf, 8.531; 119: 1min HRV, 11.097; 0: Age, 23; 0: Gender, M; 0: Race, Black or African American; 0: Means of arrival, Self; 0: Triage Temp, 38.3; 0: Triage HR, 117.0; 0: Triage RR, 32.0; 0: Triage SBP, 109.0; 0: Triage DBP, 68.0; 0: Triage acuity, 3-Urgent; 0: CC, CHEST PAIN,ABDOMINAL PAIN",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient exhibits several indicators that suggest a high risk of developing sepsis within 12 hours. Initially, the patient has a high heart rate (over 100 bpm) and respiratory rate (over 20 breaths per minute), coupled with a fever (temperature of 38.3\u00b0C), which are signs of systemic inflammation or infection. Additionally, low oxygen saturation levels (SpO2) were observed early on, and although they improved with supplemental oxygen, they initially indicated potential respiratory compromise. Despite the absence of significantly elevated lactate levels, the combination of tachycardia, tachypnea, fever, and abnormal initial oxygen saturation levels suggests an elevated risk of sepsis.",
            "claims": [
                "The patient exhibits several indicators that suggest a high risk of developing sepsis within 12 hours.",
                "The patient has a high heart rate of over 100 bpm.",
                "The patient has a respiratory rate of over 20 breaths per minute.",
                "The patient has a fever with a temperature of 38.3\u00b0C.",
                "High heart rate, high respiratory rate, and fever are signs of systemic inflammation or infection.",
                "Low oxygen saturation levels (SpO2) were observed early on.",
                "The low oxygen saturation levels improved with supplemental oxygen.",
                "Initially low oxygen saturation levels indicated potential respiratory compromise.",
                "There are no significantly elevated lactate levels in the patient.",
                "The combination of tachycardia, tachypnea, fever, and abnormal initial oxygen saturation levels suggests an elevated risk of sepsis."
            ],
            "relevant_claims": [
                "The patient exhibits several indicators that suggest a high risk of developing sepsis within 12 hours.",
                "The patient has a high heart rate of over 100 bpm.",
                "The patient has a respiratory rate of over 20 breaths per minute.",
                "The patient has a fever with a temperature of 38.3\u00b0C.",
                "High heart rate, high respiratory rate, and fever are signs of systemic inflammation or infection.",
                "Low oxygen saturation levels (SpO2) were observed early on.",
                "The low oxygen saturation levels improved with supplemental oxygen.",
                "Initially low oxygen saturation levels indicated potential respiratory compromise.",
                "The combination of tachycardia, tachypnea, fever, and abnormal initial oxygen saturation levels suggests an elevated risk of sepsis."
            ],
            "alignment_scores": [
                0.5,
                0.7,
                0.8,
                0.8,
                1.0,
                0.7,
                0.6,
                0.5,
                0.8
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "SIRS Positivity (\u22652 Criteria)"
            ],
            "alignment_reasonings": [
                "The claim is vague and does not specify particular indicators or measurements. However, the description of \"several indicators\" suggesting a high risk of developing sepsis within 12 hours aligns conceptually with indicators of clinical deterioration, like those used in the NEWS score category. While the claim does not specify which specific indicators or scores are present, the implication of severe or multiple warning signs aligns generally with the use of NEWS\u2014which tracks a combination of vital signs to predict clinical deterioration. The alignment is moderately strong due to its generality and the broad interpretation of \"several indicators.\"",
                "The claim of a high heart rate (>90 bpm) directly relates to one of the SIRS criteria used to identify systemic inflammation associated with early sepsis. While the claim mentions a high heart rate, it does not confirm the presence of the full SIRS definition (i.e., it requires at least two criteria), leading to a strong, but not complete, alignment.",
                "The claim directly references a respiratory rate over 20 breaths per minute, which aligns with one of the SIRS criteria (respiratory rate > 20 breaths/min). Although it aligns well with the category, the SIRS criteria require the presence of at least two elements to fully identify systemic inflammation. Since only one criterion is mentioned, the alignment is high but not complete.",
                "The claim specifically identifies a fever with a temperature of 38.3\u00b0C, which exceeds the SIRS criterion of >38\u00b0C for systemic inflammation. This is a direct match with the SIRS criteria for identifying early sepsis. However, there is only one SIRS criterion provided in the claim, so it doesn't fully meet the SIRS Positivity requirement of \u22652 criteria. Thus, the alignment rating is less than perfect.",
                "The claim mentions a high heart rate, high respiratory rate, and fever, all of which are specific components of the SIRS criteria used to identify systemic inflammation consistent with early sepsis. The presence of these factors matches the SIRS Positivity category directly, indicating perfect alignment.",
                "Low oxygen saturation (SpO2) suggests potential issues with oxygenation, which indirectly relates to impaired lung function, an element of the SOFA score (PaO\u2082/FiO\u2082). While SpO2 is not a direct SOFA measure, it is conceptually related to the organ dysfunction that the SOFA score evaluates, indicating moderate alignment.",
                "Improvement in oxygen saturation levels with supplemental oxygen suggests issues with oxygenation, which is conceptually linked to the impaired oxygenation component of the SOFA score (PaO\u2082/FiO\u2082). While not directly measuring SOFA components, the claim indicates a scenario that could relate to sepsis and requires further monitoring. The alignment is indirect but notable.",
                "The claim regarding low oxygen saturation levels suggests potential respiratory compromise, which relates conceptually to impaired oxygenation\u2014a component potentially affecting the SOFA score, specifically PaO\u2082/FiO\u2082 ratio. Although low oxygen saturation isn\u2019t directly a SOFA criterion, it is associated with respiratory issues that could lead to increased SOFA scores indirectly. The alignment is indirect but relevant.",
                "The claim mentions tachycardia, tachypnea, and fever, all of which are elements of the SIRS criteria (temperature\u202f>\u202f38\u202f\u00b0C or\u202f<\u202f36\u202f\u00b0C, heart\u202frate\u202f>\u202f90\u202fbpm, respiratory\u202frate\u202f>\u202f20\u202f/min), aligning well with the category. Additionally, the reference to abnormal oxygen saturation aligns indirectly with SIRS, as it suggests a state of systemic stress. While the claim strongly relates to SIRS positivity, it doesn't directly refer to specific SIRS cutoffs, accounting for a slightly less than perfect alignment."
            ],
            "final_alignment_score": 0.711111111111111
        },
        {
            "input": "12: SpO2, 98.026; 13: HR, 117.0; 13: RR, 18.0; 13: SpO2, 97.0; 13: SBP, 148.0; 13: DBP, 99.0; 13: MAP, 115.333; 13: Pain, 0.0; 13: Temp, 97.9; 14: SpO2, 96.877; 14: SBP, 148.0; 14: DBP, 99.0; 14: MAP, 115.333; 15: SpO2, 96.559; 15: Perf, 0.549; 16: SpO2, 96.121; 16: Perf, 0.543; 17: SpO2, 95.717; 17: Perf, 0.54; 18: SpO2, 96.339; 18: Perf, 0.569; 19: SpO2, 96.155; 19: Perf, 0.618; 20: SpO2, 94.929; 20: Perf, 0.62; 21: SpO2, 94.312; 21: Perf, 0.62; 22: SpO2, 94.214; 22: Perf, 0.631; 23: SpO2, 95.489; 23: Perf, 0.899; 24: SpO2, 94.466; 24: Perf, 0.986; 25: SpO2, 95.390; 25: Perf, 0.890; 26: SpO2, 95.707; 26: Perf, 0.893; 27: SpO2, 95.339; 27: Perf, 0.886; 28: SpO2, 95.932; 28: Perf, 0.794; 29: SpO2, 95.476; 29: Perf, 0.73; 30: SpO2, 95.695; 31: SpO2, 95.121; 31: Perf, 0.726; 32: SpO2, 95.881; 32: Perf, 0.751; 33: SpO2, 95.593; 33: Perf, 0.769; 34: SpO2, 95.828; 34: Perf, 0.635; 35: SpO2, 95.932; 35: Perf, 0.645; 36: SpO2, 96.517; 36: Perf, 0.65; 37: SpO2, 95.746; 37: Perf, 0.65; 37: Temp, 99.9; 38: SpO2, 95.1; 38: Perf, 0.65; 39: SpO2, 97.0; 39: Perf, 0.65; 40: Perf, 0.65; 41: SpO2, 95.769; 41: Perf, 0.654; 42: SpO2, 97.0; 42: Perf, 0.67; 43: SpO2, 95.35; 43: Perf, 0.704; 44: SpO2, 94.288; 44: Perf, 0.715; 45: SpO2, 93.421; 45: Perf, 0.72; 46: SpO2, 94.0; 46: Perf, 0.727; 47: SpO2, 94.458; 47: Perf, 0.74; 48: SpO2, 94.379; 48: Perf, 0.741; 49: SpO2, 94.153; 49: Perf, 0.844; 50: SpO2, 94.356; 50: Perf, 1.115; 51: SpO2, 94.524; 51: Perf, 1.12; 51: LR IV BOLUS -, 500 ML; 52: SpO, 2: 94.373; 52: Perf, 1.12; 53: SpO2, 94.569; 53: Perf, 1.139; 54: SpO2, 93.830; 54: Perf, 1.238; 55: SpO2, 93.714; 55: Perf, 1.176; 56: SpO2, 95.190; 56: Perf, 0.968; 57: SpO2, 94.169; 57: Perf, 0.96; 58: SpO2, 94.466; 58: Perf, 0.96; 59: SpO2, 93.712; 59: Perf, 0.946; 60: SpO2, 95.0; 60: Perf, 0.894; 61: SpO2, 95.017; 61: Perf, 0.882; 62: SpO2, 95.441; 62: Perf, 0.883; 63: SpO2, 94.707; 63: Perf, 0.87; 64: SpO2, 95.017; 64: Perf, 0.861; 65: SpO2, 94.644; 65: Perf, 0.857; 66: SpO2, 95.310; 66: Perf, 0.742; 67: SpO2, 94.824; 67: Perf, 0.69; 68: INR, 1.9; 68: PROTHROMBIN TIME, 21.2 seconds; 68: SpO2, 94.655; 69: PART. THROMBOPLASTIN TIME, 79.5 seconds; 69: SpO2, 96.525; 69: Perf, 0.725; 70: SpO2, 96.822; 70: Perf, 0.7; 71: SpO2, 95.085; 72: SpO2, 94.644; 72: Perf, 0.757; 73: WAM DIFTYP, AUTO; 73: POTASSIUM, 5.2 mmol/L; 73: CO2, 21 mmol/L; 73: GLUCOSE, 115 mg/dL; 73: BLOOD UREA NITROGEN (BUN), 51 mg/dL; 73: CALCIUM, 8.8 mg/dL; 73: CHLORIDE, 103 mmol/L; 73: EGFR REFIT WITHOUT RACE (2021), 55 mL/min/1.73 m2; 73: ANION GAP, 14 mmol/L; 73: SODIUM, 138 mmol/L; 73: CREATININE, 1.15 mg/dL; 73: EGFR FOR AFRICAN AMERICAN, 64 mL/min/1.73 m2; 73: MONOCYTE ABSOLUTE (AUTO DIFF), 0.02 K/uL; 73: NRBC PERCENT (HEMATOLOGY), 0.0 %; 73: RED CELL DISTRIBUTION WIDTH (RDW), 15.8 %; 73: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 73: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.4 pg; 73: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 73: WHITE BLOOD CELLS (WBC), 7.1 K/uL; 73: NEUTROPHIL ABSOLUTE (AUTO DIFF), 6.15 K/uL; 73: EOSINOPHIL % (AUTO DIFF), 0.1 %; 73: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 73: MONOCYTE % (AUTO DIFF), 0.3 %; 73: NEUTROPHIL % (AUTO DIFF), 87.1 %; 73: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.1 g/dL; 73: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 73: PLATELET COUNT (PLT), 106 K/uL; 73: RED BLOOD CELLS (RBC), 3.70 MIL/uL; 73: LYMPHOCYTE % (AUTO DIFF), 11.8 %; 73: BASOPHIL % (AUTO DIFF), 0.3 %; 73: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 73: HEMATOCRIT (HCT), 33.8 %; 73: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.83 K/uL; 73: MEAN CORPUSCULAR VOLUME (MCV), 91.4 fL; 73: HEMOGLOBIN (HGB), 10.5 g/dL; 73: SpO2, 94.759; 73: Perf, 0.619; 74: SpO2, 95.083; 74: Perf, 0.627; 74: SBP, 127.0; 74: DBP, 67.0; 74: MAP, 87.0; 75: Perf, 0.63; 76: SpO2, 93.6; 76: Perf, 0.617; 77: SpO2, 94.621; 77: Perf, 0.6; 78: SpO2, 95.179; 78: Perf, 0.6; 79: SpO2, 95.542; 79: Perf, 0.6; 80: SpO2, 92.625; 80: Perf, 0.6; 81: SpO2, 91.722; 82: SpO2, 92.1; 83: SpO2, 95.957; 84: SpO2, 94.797; 85: SpO2, 95.552; 86: SpO2, 96.4; 87: SpO2, 99.4; 88: SpO2, 97.308; 90: SpO2, 95.739; 91: SpO2, 94.356; 92: SpO2, 94.293; 93: SpO2, 94.831; 94: SpO2, 95.220; 95: SpO2, 94.5; 95: Perf, 0.516; 96: SpO2, 94.780; 96: Perf, 0.531; 97: SpO2, 95.172; 97: Perf, 0.547; 98: SpO2, 95.390; 98: Perf, 0.573; 99: SpO2, 95.085; 99: Perf, 0.603; 100: SpO2, 94.845; 100: Perf, 0.638; 101: SpO2, 94.525; 101: Perf, 0.655; 102: SpO2, 93.333; 102: Perf, 0.66; 111: SpO2, 83.875; 112: SpO2, 94.931; 112: Perf, 0.38; 113: SpO2, 95.0; 113: Perf, 0.352; 114: SpO2, 95.746; 114: Perf, 0.358; 115: SpO2, 95.897; 115: Perf, 0.361; 116: SpO2, 94.830; 116: Perf, 0.274; 117: HR, 130.0; 117: SpO2, 94.0; 117: Temp, 103.1; 0: Age, 90; 0: Gender, M; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 36.6; 0: Triage HR, 117.0; 0: Triage RR, 18.0; 0: Triage SBP, 148.0; 0: Triage DBP, 99.0; 0: Triage acuity, 3-Urgent; 0: CC, MALE GENITAL PROBLEM",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient is at high risk of developing sepsis. This conclusion is drawn from several concerning factors: the patient is elderly, with a high heart rate that increases over time, indicating potential cardiovascular stress. The patient's temperature rises significantly, indicating a fever, which could suggest an infection. Additionally, the patient receives a large volume bolus, indicating a systemic issue like sepsis. The fluctuating SpO2 levels and low perfusion also suggest compromised circulation. Furthermore, lab results indicating prolonged prothrombin and partial thromboplastin times, along with elevated INR, suggest compromised coagulation, often related to sepsis.",
            "claims": [
                "The patient is at high risk of developing sepsis.",
                "The patient is elderly.",
                "The patient has a high heart rate that increases over time.",
                "An increasing heart rate indicates potential cardiovascular stress.",
                "The patient's temperature rises significantly.",
                "A rising temperature indicates a fever.",
                "A fever could suggest an infection.",
                "The patient receives a large volume bolus.",
                "Receiving a large volume bolus indicates a systemic issue like sepsis.",
                "The patient has fluctuating SpO2 levels.",
                "Fluctuating SpO2 levels suggest compromised circulation.",
                "The patient has low perfusion.",
                "Low perfusion also suggests compromised circulation.",
                "Lab results indicate prolonged prothrombin times.",
                "Lab results indicate prolonged partial thromboplastin times.",
                "Lab results show elevated INR.",
                "Prolonged prothrombin and partial thromboplastin times suggest compromised coagulation.",
                "Compromised coagulation is often related to sepsis."
            ],
            "relevant_claims": [
                "The patient is at high risk of developing sepsis.",
                "The patient has a high heart rate that increases over time.",
                "An increasing heart rate indicates potential cardiovascular stress.",
                "The patient's temperature rises significantly.",
                "A rising temperature indicates a fever.",
                "A fever could suggest an infection.",
                "The patient receives a large volume bolus.",
                "Receiving a large volume bolus indicates a systemic issue like sepsis.",
                "The patient has fluctuating SpO2 levels.",
                "Fluctuating SpO2 levels suggest compromised circulation.",
                "The patient has low perfusion.",
                "Low perfusion also suggests compromised circulation.",
                "Lab results indicate prolonged prothrombin times.",
                "Lab results indicate prolonged partial thromboplastin times.",
                "Lab results show elevated INR.",
                "Prolonged prothrombin and partial thromboplastin times suggest compromised coagulation.",
                "Compromised coagulation is often related to sepsis."
            ],
            "alignment_scores": [
                0.3,
                0.7,
                0.6,
                0.7,
                0.7,
                0.3,
                0.7,
                0.6,
                0.5,
                0.5,
                0.7,
                0.7,
                0.7,
                0.4,
                0.3,
                0.7,
                0.6
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "Elevated Shock Index (\u22651.0)",
                "Elevated Shock Index (\u22651.0)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)"
            ],
            "alignment_reasonings": [
                "The claim is very general and doesn't provide specifics, but it implies a high risk of sepsis which can be associated with an elevated NEWS score indicating clinical deterioration. Without precise details, the alignment is weak, but the category reflects an overall assessment of risk.",
                "The claim mentions a high heart rate that increases over time, which suggests a hemodynamic imbalance indicative of possible sepsis-related issues. While the shock index includes both heart rate and systolic blood pressure, an increasing heart rate can signal hemodynamic instability. However, without information on blood pressure, the alignment is not perfect, but there is significant relevance to the concept of an elevated shock index.",
                "An increasing heart rate is a component of the shock index, which is calculated by heart rate divided by systolic blood pressure. While the claim does not provide specific values for shock index or blood pressure, a rising heart rate suggests potential hemodynamic instability, which relates to the elevated shock index category. The alignment is indirect because the claim does not specify blood pressure values or complete calculations, but the link to cardiovascular stress and potential sepsis risk is meaningful.",
                "A significant rise in temperature could indicate a fever, which is a component of the SIRS criteria (>38\u00b0C). However, the claim does not provide specific temperature values to confirm it meets this criterion completely. Therefore, the alignment is suggestive but lacks full confirmation, resulting in a moderate alignment score.",
                "A rising temperature indicating fever is relevant to the SIRS criteria, which includes temperature >38\u00b0C as one of its factors. While the claim does not specify the exact temperature, the implication of fever suggests that it could meet or be approaching this specific criterion. The alignment is strong due to the relevance of temperature in SIRS, but it is not perfect because the claim does not confirm that the threshold has been met.",
                "The claim mentions fever, which is part of the SIRS criteria (>38\u00b0C). However, it is vague and only suggests a possible infection without specifying the temperature or meeting the explicit criteria for SIRS. The alignment is weak due to the lack of specific detail or additional SIRS criteria.",
                "Administration of a large volume bolus often indicates an attempt to manage hypotension, which aligns with sepsis-associated hypotension characterized by low blood pressure or significant drops from baseline. While the claim does not directly mention blood pressure, the need for volume resuscitation suggests possible hemodynamic instability related to this category. However, without specific blood pressure values, the alignment cannot be considered perfect.",
                "Administering a large volume bolus often addresses low blood pressure, which might be related to sepsis-associated hypotension. While this does not directly indicate hypotension, it suggests concern for fluid imbalance or circulatory compromise typical of sepsis, leading to a moderate alignment with hypotension in sepsis.",
                "While SpO2 fluctuation is not directly measured in the SOFA score, it relates to potential issues with oxygenation, which could lead to a PaO\u2082/FiO\u2082 ratio concern\u2014a component of the SOFA score. Thus, the alignment is indirect, indicating some relation to possible organ dysfunction.",
                "The claim regarding fluctuating SpO2 levels hints at potential compromised oxygen delivery to tissues, which aligns with concepts in the SOFA Score related to respiratory impairment (PaO\u2082/FiO\u2082\u202f<\u202f300) and overall organ dysfunction. Although SpO2 itself is not a direct SOFA measure, the condition it implies could contribute to an increased SOFA score when severe, indicating moderate alignment.",
                "Low perfusion suggests tissue hypoperfusion, which is closely associated with elevated serum lactate levels, a key indicator for sepsis risk. The claim does not directly mention serum lactate, but the conceptual link to the effects of low perfusion aligns well with this category. Since the connection is strong but not direct, the alignment rating is moderately high.",
                "The claim regarding low perfusion is related to compromised circulation, which is conceptually linked to tissue hypoperfusion. Elevated serum lactate is a marker for tissue hypoperfusion, showing that the circulatory system is not delivering sufficient oxygen to tissues, which aligns with the idea of \"compromised circulation.\" Although the claim does not specifically mention elevated serum lactate levels, the correlation justifies a moderate alignment rating.",
                "Prolonged prothrombin time indicates potential coagulation abnormalities, which often relate to liver dysfunction. Although not explicitly mentioned, this may align with the SOFA marker for elevated bilirubin levels or other liver-related dysfunctions, both indicative of organ dysfunction associated with sepsis. The alignment is somewhat indirect but relevant when considering overall organ dysfunction monitoring in sepsis.",
                "Prolonged partial thromboplastin times suggest coagulation abnormalities, which are related to organ dysfunction\u2014an aspect of the SOFA score. While prolonged clotting times are not a direct component of SOFA, they hint at underlying organ dysfunction correlating with sepsis risk. The alignment with the SOFA score is somewhat indirect, leading to a moderate rating.",
                "Elevated INR relates to coagulation abnormalities, which can be a component of liver dysfunction. While not directly mentioned in the SOFA criteria, liver function impairment could lead to an increased bilirubin level, reflecting some alignment. However, the link to the SOFA score is indirect and weak without further specific context or additional SOFA-related symptoms.",
                "Compromised coagulation is related to overt organ dysfunction, which aligns closely with the SOFA score's emphasis on organ function assessment. Although prolonged prothrombin and partial thromboplastin times are not directly listed in SOFA categories, they suggest potential organ dysfunction (e.g., liver), fitting the intent of an elevated SOFA score indicating high sepsis risk. Hence, the category and the claim have a moderately high alignment.",
                "Compromised coagulation could imply low platelet counts, which aligns with the SOFA score criteria (platelets\u202f<\u202f100\u202f\u00d7\u202f10\u2079/L) that relate to organ dysfunction in sepsis. The alignment is indirect as the claim does not specify numbers, but it is conceptually relevant to SOFA score increase."
            ],
            "final_alignment_score": 0.5705882352941175
        },
        {
            "input": "11: HR, 124.0; 11: RR, 24.0; 11: SpO2, 96.0; 11: SBP, 110.0; 11: DBP, 65.0; 11: MAP, 80.0; 11: Temp, 97.9; 32: HR, 123.588; 32: RR, 18.0; 32: SpO2, 96.067; 32: Perf, 0.2; 32: 1min HRV, 6.990; 32: SBP, 117.0; 32: DBP, 73.0; 32: MAP, 87.667; 33: HR, 120.208; 33: RR, 19.604; 33: 1min HRV, 2.968; 34: HR, 119.173; 34: RR, 17.942; 34: SpO2, 97.0; 34: Perf, 0.15; 34: 1min HRV, 4.574; 35: HR, 117.981; 35: RR, 16.547; 35: SpO2, 96.5; 35: Perf, 0.14; 35: 1min HRV, 2.616; 35: 5min HRV, 7.779; 35: SBP, 113.0; 35: DBP, 69.0; 35: MAP, 83.667; 36: HR, 118.132; 36: RR, 15.736; 36: 1min HRV, 5.070; 36: SBP, 113.0; 36: DBP, 69.0; 36: MAP, 83.667; 37: HR, 117.0; 37: RR, 16.0; 37: 1min HRV, 1.732; 38: HR, 117.113; 38: RR, 15.434; 38: SpO2, 95.0; 38: Perf, 0.207; 38: 1min HRV, 2.010; 39: HR, 116.019; 39: RR, 15.038; 39: SpO2, 95.0; 39: Perf, 0.21; 39: 1min HRV, 2.276; 40: HR, 116.075; 40: RR, 15.642; 40: 1min HRV, 2.121; 40: 5min HRV, 4.496; 41: HR, 115.623; 41: RR, 15.415; 41: SpO2, 95.0; 41: Perf, 0.233; 41: 1min HRV, 1.634; 42: HR, 115.717; 42: RR, 15.396; 42: SpO2, 95.333; 42: Perf, 0.22; 42: 1min HRV, 2.719; 43: HR, 115.755; 43: RR, 15.717; 43: SpO2, 95.963; 43: Perf, 0.226; 43: 1min HRV, 1.995; 44: HR, 115.462; 44: RR, 15.0; 44: SpO2, 94.288; 44: Perf, 0.281; 44: 1min HRV, 2.2; 45: HR, 115.340; 45: RR, 14.075; 45: SpO2, 94.472; 45: Perf, 0.278; 45: 1min HRV, 1.998; 45: 5min HRV, 2.160; 46: HR, 115.340; 46: RR, 13.660; 46: SpO2, 94.038; 46: Perf, 0.276; 46: 1min HRV, 2.547; 47: HR, 115.0; 47: RR, 13.923; 47: SpO2, 94.135; 47: Perf, 0.275; 47: 1min HRV, 3.042; 48: HR, 115.245; 48: RR, 14.019; 48: SpO2, 94.617; 48: Perf, 0.266; 48: 1min HRV, 2.396; 49: HR, 117.808; 49: RR, 17.981; 49: SpO2, 95.432; 49: Perf, 0.238; 49: 1min HRV, 5.660; 50: HR, 119.849; 50: RR, 18.453; 50: SpO2, 96.208; 50: Perf, 0.328; 50: 1min HRV, 2.571; 50: 5min HRV, 9.206; 51: HR, 119.170; 51: RR, 17.321; 51: SpO2, 95.264; 51: Perf, 0.421; 51: 1min HRV, 2.345; 52: HR, 118.288; 52: RR, 17.577; 52: SpO2, 95.08; 52: Perf, 0.331; 52: 1min HRV, 2.746; 53: HR, 118.519; 53: RR, 18.759; 53: SpO2, 95.630; 53: Perf, 0.334; 53: 1min HRV, 3.235; 54: HR, 118.519; 54: RR, 19.385; 54: SpO2, 94.212; 54: Perf, 0.363; 54: 1min HRV, 1.890; 55: HR, 117.547; 55: RR, 18.566; 55: SpO2, 95.0; 55: Perf, 0.332; 55: 1min HRV, 2.645; 55: 5min HRV, 3.315; 56: HR, 116.769; 56: RR, 18.385; 56: SpO2, 95.0; 56: Perf, 0.333; 56: 1min HRV, 4.047; 57: HR, 118.472; 57: RR, 21.830; 57: SpO2, 95.774; 57: Perf, 0.297; 57: 1min HRV, 8.639; 58: HR, 118.321; 58: RR, 20.208; 58: SpO2, 96.302; 58: Perf, 0.278; 58: 1min HRV, 4.660; 59: HR, 117.5; 59: RR, 16.981; 59: SpO2, 95.865; 59: Perf, 0.261; 59: 1min HRV, 4.249; 60: HR, 115.981; 60: RR, 15.962; 60: SpO2, 94.604; 60: Perf, 0.295; 60: 1min HRV, 1.728; 60: 5min HRV, 6.621; 61: HR, 115.558; 61: RR, 16.077; 61: SpO2, 94.404; 61: Perf, 0.293; 61: 1min HRV, 3.394; 62: HR, 115.509; 62: RR, 16.547; 62: SpO2, 95.0; 62: Perf, 0.267; 62: 1min HRV, 1.862; 63: HR, 115.981; 63: RR, 16.792; 63: SpO2, 95.115; 63: Perf, 0.258; 63: 1min HRV, 1.911; 64: HR, 116.654; 64: RR, 17.404; 64: SpO2, 95.654; 64: Perf, 0.279; 64: 1min HRV, 3.281; 65: HR, 118.889; 65: RR, 18.037; 65: SpO2, 95.0; 65: Perf, 0.319; 65: 1min HRV, 8.971; 65: 5min HRV, 7.523; 66: HR, 119.481; 66: RR, 19.615; 66: SpO2, 95.385; 66: Perf, 0.316; 66: 1min HRV, 3.115; 66: SBP, 108.0; 66: DBP, 76.0; 66: MAP, 86.667; 67: HR, 118.943; 67: RR, 18.264; 67: SpO2, 95.264; 67: Perf, 0.389; 67: 1min HRV, 2.462; 68: HR, 118.868; 68: RR, 18.019; 68: SpO2, 95.0; 68: Perf, 0.353; 68: 1min HRV, 3.067; 69: HR, 117.904; 69: RR, 18.192; 69: SpO2, 95.0; 69: Perf, 0.343; 69: 1min HRV, 2.331; 70: HR, 117.415; 70: RR, 17.057; 70: SpO2, 95.0; 70: Perf, 0.326; 70: 1min HRV, 2.257; 70: 5min HRV, 3.951; 71: HR, 118.788; 71: RR, 18.25; 71: SpO2, 95.0; 71: Perf, 0.294; 71: 1min HRV, 5.300; 72: HR, 120.094; 72: RR, 18.377; 72: SpO2, 95.340; 72: Perf, 0.285; 72: 1min HRV, 1.663; 73: HR, 119.283; 73: RR, 18.094; 73: SpO2, 95.528; 73: Perf, 0.277; 73: 1min HRV, 6.112; 74: HR, 118.692; 74: RR, 16.962; 74: SpO2, 95.385; 74: Perf, 0.294; 74: 1min HRV, 4.186; 75: HR, 118.075; 75: RR, 16.528; 75: SpO2, 95.811; 75: Perf, 0.311; 75: 1min HRV, 3.037; 75: 5min HRV, 5.208; 76: HR, 119.308; 76: RR, 17.538; 76: SpO2, 94.173; 76: Perf, 0.370; 76: 1min HRV, 5.686; 77: HR, 117.396; 77: RR, 15.623; 77: SpO2, 93.925; 77: Perf, 0.396; 77: 1min HRV, 2.105; 78: HR, 118.321; 78: RR, 16.755; 78: SpO2, 94.0; 78: Perf, 0.371; 78: 1min HRV, 3.661; 79: HR, 118.151; 79: RR, 16.623; 79: SpO2, 94.0; 79: Perf, 0.396; 79: 1min HRV, 2.929; 80: HR, 117.463; 80: RR, 15.056; 80: SpO2, 94.0; 80: Perf, 0.372; 80: 1min HRV, 1.731; 80: 5min HRV, 4.406; 81: HR, 117.5; 81: RR, 15.0; 81: SpO2, 93.923; 81: Perf, 0.317; 81: 1min HRV, 2.825; 82: HR, 119.370; 82: RR, 15.630; 82: SpO2, 93.833; 82: Perf, 0.315; 82: 1min HRV, 6.033; 83: HR, 117.679; 83: RR, 15.830; 83: SpO2, 94.0; 83: Perf, 0.320; 83: 1min HRV, 2.040; 84: HR, 116.788; 84: RR, 15.077; 84: SpO2, 93.423; 84: Perf, 0.391; 84: 1min HRV, 2.008; 85: 5min HRV, 5.663; 95: HR, 119.0; 95: RR, 17.0; 95: SpO2, 95.0; 95: SBP, 115.0; 95: DBP, 73.0; 95: MAP, 87.0; 116: POC PH (V) ISTAT, 7.43; 116: POC PCO2 (V) ISTAT, 46.2 mmHg; 116: POC LACTATE ISTAT, 2.90 mmol/L; 116: POC HCO3 (V) ISTAT, 30.7 mmol/L; 116: POC PO2 (V) ISTAT, 38 mmHg; 116: POC TCO2 (V) ISTAT, 32 mmol/L; 116: POC BASE EXCESS ISTAT, 6 mmol/L; 116: POC O2 SATURATION ISTAT VENOUS, 73 %; 118: POC, HCG, ISTAT QUALITATIVE: Negative; 118: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 0: Age, 52; 0: Gender, F; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 124.0; 0: Triage RR, 24.0; 0: Triage SBP, 110.0; 0: Triage DBP, 65.0; 0: Triage acuity, 2-Emergent; 0: CC, EDEMA,JAUNDICE,ABNORMAL LAB",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient presents with initial signs that raise concern for sepsis risk: an elevated heart rate (HR) consistently over 115 BPM, increased respiratory rate (RR) between 24-19 BPM, and a history of jaundice which can suggest liver dysfunction. The triage category is '2-Emergent,' indicating the patient is already in a critical state. The POC lactate at 2.90 mmol/L is elevated, suggesting tissue hypoxia or poor perfusion. Additionally, the recorded hypotensive episodes (DBP around 65-76 mmHg) and persistent tachycardia could predispose this patient to sepsis. Consequently, the vital sign trends and clinical picture suggest a high risk of developing sepsis within the given timeframe.",
            "claims": [
                "The patient presents with initial signs that raise concern for sepsis risk.",
                "The patient has an elevated heart rate (HR) consistently over 115 BPM.",
                "An elevated heart rate (HR) over 115 BPM raises concern for sepsis risk.",
                "The patient has an increased respiratory rate (RR) between 24-19 BPM.",
                "An increased respiratory rate (RR) between 24-19 BPM raises concern for sepsis risk.",
                "The patient has a history of jaundice.",
                "A history of jaundice can suggest liver dysfunction.",
                "The triage category for the patient is '2-Emergent.'",
                "A triage category of '2-Emergent' indicates the patient is already in a critical state.",
                "The POC lactate level is 2.90 mmol/L.",
                "A POC lactate level of 2.90 mmol/L is elevated.",
                "An elevated POC lactate level suggests tissue hypoxia or poor perfusion.",
                "The patient has recorded hypotensive episodes with a DBP around 65-76 mmHg.",
                "Recorded hypotensive episodes could predispose this patient to sepsis.",
                "The patient has persistent tachycardia.",
                "Persistent tachycardia could predispose this patient to sepsis.",
                "The vital sign trends and clinical picture suggest a high risk of developing sepsis within the given timeframe."
            ],
            "relevant_claims": [
                "The patient presents with initial signs that raise concern for sepsis risk.",
                "The patient has an elevated heart rate (HR) consistently over 115 BPM.",
                "An elevated heart rate (HR) over 115 BPM raises concern for sepsis risk.",
                "The patient has an increased respiratory rate (RR) between 24-19 BPM.",
                "An increased respiratory rate (RR) between 24-19 BPM raises concern for sepsis risk.",
                "A history of jaundice can suggest liver dysfunction.",
                "A triage category of '2-Emergent' indicates the patient is already in a critical state.",
                "The POC lactate level is 2.90 mmol/L.",
                "A POC lactate level of 2.90 mmol/L is elevated.",
                "An elevated POC lactate level suggests tissue hypoxia or poor perfusion.",
                "The patient has recorded hypotensive episodes with a DBP around 65-76 mmHg.",
                "The patient has persistent tachycardia.",
                "Persistent tachycardia could predispose this patient to sepsis.",
                "The vital sign trends and clinical picture suggest a high risk of developing sepsis within the given timeframe."
            ],
            "alignment_scores": [
                0.3,
                0.8,
                0.4,
                0.7,
                0.7,
                0.3,
                0.5,
                1.0,
                1.0,
                1.0,
                0.7,
                0.8,
                0.7,
                0.6
            ],
            "alignment_category": [
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated Shock Index (\u22651.0)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SOFA Score Increase (\u22652 points)",
                "Elevated NEWS Score (\u22655 points)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "AElevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "The claim indicates concern for sepsis risk, which suggests potential clinician suspicion of serious infection. However, it lacks specific details or actions, such as ordering antibiotics or cultures, which would strongly align with this category. The reference to initial signs is vague and does not provide precise clinical information to accurately align with one of the defined expert categories.",
                "An elevated heart rate (>90 BPM) is one of the criteria for SIRS positivity, which signals systemic inflammation consistent with early sepsis. The claim specifies a heart rate over 115 BPM, which exceeds the SIRS criterion substantially, aligning well with this category. However, because more than one SIRS criterion is needed for definitive SIRS positivity, the alignment is strong but not complete.",
                "While an elevated heart rate is a component of the Shock Index (which considers the ratio of heart rate to systolic blood pressure), the claim only mentions the heart rate itself. It doesn't provide enough information about blood pressure to determine the Shock Index. The elevated heart rate could hint at potential hemodynamic instability, making the alignment indirect but somewhat relevant.",
                "An increased respiratory rate of more than 20 BPM is a direct component of the SIRS criteria. The claim states a respiratory rate between 24-19 BPM, which includes values at or above the 20 BPM threshold necessary to meet one of the criteria for systemic inflammatory response syndrome. This suggests a strong indication of early sepsis. The alignment is not perfect due to a lack of information about other SIRS criteria being met, but the elevated respiratory rate aligns closely with the SIRS criterion.",
                "The claim mentions an increased respiratory rate (RR), which fits under SIRS criteria when RR is greater than 20 breaths per minute. Although the claim specifies a range between 24-19 BPM, which is not entirely above the threshold, the mention of concern strongly aligns with SIRS as increased RR is directly related. Thus, the claim partially aligns with the SIRS criteria for systemic inflammation and potential sepsis risk.",
                "Jaundice, characterized by yellowing of the skin and eyes, is related to elevated bilirubin levels, which can indicate liver dysfunction. Liver dysfunction is a component of the SOFA score (bilirubin >2 mg/dL). However, the claim does not provide specific details about bilirubin levels or a definitive SOFA score increase, so the alignment is indirect and weak.",
                "The claim refers to the patient being in a critical state, akin to circumstances where immediate medical attention is needed. The NEWS score is designed to reflect the urgency of a patient's condition based on vital signs, similar to what might be inferred from an emergent triage category. However, the claim does not explicitly mention the news score or any vital signs that make up the score, leading to a moderate alignment rating rather than perfect.",
                "The claim directly provides the point-of-care (POC) lactate level of 2.90 mmol/L, which is above the threshold of 2 mmol/L as specified in the category. This level indicates tissue hypoperfusion and an elevated risk of sepsis mortality, hence it aligns perfectly with the given category criteria.",
                "The claim directly mentions an elevated POC lactate level of 2.90 mmol/L, which is above the specified threshold (\u22652 mmol/L) for elevated serum lactate. This category explicitly correlates high lactate levels with increased sepsis risk, indicating strong alignment with the claim.",
                "The claim directly references an elevated POC (point-of-care) lactate level, which is explicitly aligned with the category focused on elevated serum lactate as a marker of tissue hypoperfusion. This strongly indicates an elevated risk of sepsis, showing perfect alignment with the specified category.",
                "The claim refers to hypotensive episodes with a diastolic blood pressure (DBP) between 65-76 mmHg. Although the claim specifically mentions DBP rather than systolic blood pressure (SBP), hypotension generally indicates instability, which aligns with the category of Sepsis-Associated Hypotension. However, the SBP and mean arterial pressure (MAP) values required to precisely identify sepsis-associated hypotension are not provided. Thus, while there's a significant relevance given the hypotensive episodes, the information does not fully match the specific criteria of the category, resulting in a partial alignment rating.",
                "Persistent tachycardia (heart rate\u202f>\u202f90\u202fbpm) is one of the specific criteria for SIRS. Tachycardia alone does not meet the requirement for SIRS positivity, which requires two or more criteria, but it is directly relevant to this category as it suggests systemic inflammation or a response to infection, which are consistent with early sepsis. The alignment is strong but not complete as it partially fulfills the criteria.",
                "Persistent tachycardia relates to one of the SIRS criteria (heart rate >90 bpm), which indicates systemic inflammation associated with early sepsis. The claim doesn't specify whether the patient meets additional SIRS criteria, which prevents a perfect alignment but indicates a significant level of relevance.",
                "The claim references \"vital sign trends and clinical picture,\" which aligns with the assessment dynamics captured by the NEWS system. This system aggregates scores from deranged vitals to predict clinical deterioration, akin to the situation described. However, the claim is somewhat vague and doesn't specify NEWS scores or similar metrics, reducing alignment certainty. Thus, the alignment is indirect but notable, warranting an intermediate rating."
            ],
            "final_alignment_score": 0.6785714285714286
        },
        {
            "input": "4: SBP, 87.0; 4: DBP, 67.0; 4: MAP, 73.667; 5: HR, 122.0; 5: RR, 20.0; 5: SpO2, 96.0; 5: 1min HRV, 35.0; 5: SBP, 87.0; 5: DBP, 67.0; 5: MAP, 73.667; 5: Pain, 0.0; 5: Temp, 97.6; 6: HR, 120.811; 6: 1min HRV, 27.447; 7: HR, 122.915; 7: SpO2, 100.0; 7: Perf, 0.11; 7: 1min HRV, 14.483; 7: 5min HRV, 22.525; 8: HR, 121.707; 8: SpO2, 100.0; 8: Perf, 0.087; 8: 1min HRV, 18.467; 9: HR, 121.949; 9: SpO2, 100.0; 9: Perf, 0.08; 9: 1min HRV, 20.872; 10: HR, 122.724; 10: SpO2, 100.0; 10: Perf, 0.08; 10: 1min HRV, 14.636; 11: POC GLUCOSE BY METER, 93 mg/dL; 11: HR, 124.707; 11: SpO2, 99.8; 11: Perf, 0.073; 11: 1min HRV, 16.397; 12: 5min HRV, 18.206; 18: POC, BHCG, ISTAT QUANTITATIVE: 7.1 IU/L; 20: POC PH (V) ISTAT, 7.47; 20: POC LACTATE ISTAT, 0.77 mmol/L; 20: POC PCO2 (V) ISTAT, 23.4 mmHg; 20: POC PO2 (V) ISTAT, 47 mmHg; 20: POC HCO3 (V) ISTAT, 16.9 mmol/L; 20: POC TCO2 (V) ISTAT, 18 mmol/L; 20: POC BASE EXCESS ISTAT, -7 mmol/L; 20: POC O2 SATURATION ISTAT VENOUS, 86 %; 27: HR, 59.0; 27: RR, 16.0; 27: SpO2, 71.0; 27: SBP, 94.0; 27: DBP, 70.0; 27: MAP, 78.0; 27: Pain, 0.0; 30: LR IV BOLUS -, 1000 ML; 40: ABO/RH, (AUTOMATION): B Positive; 40: ANTIBODY SCREEN 3, NEG; 46: METRONIDAZOLE IN NACL (ISO-OS), 500 MG/100 ML IV PGBK; 47: PART. THROMBOPLASTIN TIME:, 37.6 seconds; 47: LEVOFLOXACIN IN D, 5W 750 MG/150 ML IV PGBK; 54: INR:, 1.7; 54: PROTHROMBIN TIME, 19.5 seconds; 64: LIPASE, 5 U/L; 83: DIPHENHYDRAMINE HCL, 50 MG/ML INJ SOLN; 86: TROPONIN I: <., 017 ng/mL; 92: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 86.9 %; 92: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 11.57 K/uL; 92: MONOCYTES % (MANUAL DIFF), 2.6 %; 92: LYMPHOCYTES % (MANUAL DIFF), 0.9 %; 92: MONOCYTES ABSOLUTE (MANUAL DIFF), 0.31 K/uL; 92: NEUTROPHILS BANDS % (MANUAL DIFF), 9.6 %; 92: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 0.11 K/uL; 94: HEMOGLOBIN (HGB), 4.2 g/dL; 94: HEMATOCRIT (HCT), 12.2 %; 94: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.4 g/dL; 94: MEAN CORPUSCULAR VOLUME (MCV), 84.7 fL; 94: HEMOGLOBIN (HGB), 4.2 g/dL; 94: RED CELL DISTRIBUTION WIDTH (RDW), 14.5 %; 94: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.4 g/dL; 94: WHITE BLOOD CELLS (WBC), 12.0 K/uL; 94: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.2 pg; 94: MEAN CORPUSCULAR VOLUME (MCV), 84.7 fL; 94: PLATELET COUNT (PLT), 27 K/uL; 94: RED BLOOD CELLS (RBC), 1.44 MIL/uL; 94: WHITE BLOOD CELLS (WBC), 12.0 K/uL; 94: RED CELL DISTRIBUTION WIDTH (RDW), 14.5 %; 94: HEMATOCRIT (HCT), 12.2 %; 94: RED BLOOD CELLS (RBC), 1.44 MIL/uL; 94: PLATELET COUNT (PLT), 27 K/uL; 94: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.2 pg; 95: HR, 103.0; 95: RR, 24.0; 95: SpO2, 100.0; 95: SBP, 96.0; 95: DBP, 59.0; 95: MAP, 71.333; 95: Temp, 97.6; 102: HR, 123.0; 102: SpO2, 100.0; 102: SBP, 96.0; 102: DBP, 59.0; 102: MAP, 71.333; 111: HR, 114.0; 111: RR, 28.0; 111: SpO2, 100.0; 111: SBP, 94.0; 111: DBP, 55.0; 111: MAP, 68.0; 111: Temp, 97.7; 117: HR, 127.0; 117: SpO2, 100.0; 119: BLOOD UREA NITROGEN (BUN), 35 mg/dL; 119: GLUCOSE, 89 mg/dL; 119: GLUCOSE, 89 mg/dL; 119: AST (SGOT), 15 U/L; 119: ALT (SGPT), 10 U/L; 119: ANION GAP, 15 mmol/L; 119: EGFR REFIT WITHOUT RACE (2021), 17 mL/min/1.73 m2; 119: PROTEIN TOTAL, 5.3 g/dL; 119: POTASSIUM, 3.1 mmol/L; 119: BILIRUBIN TOTAL, 0.3 mg/dL; 119: CORRECTED CALCIUM, 8.8 mg/dL; 119: ALBUMIN, 2.4 g/dL; 119: CHLORIDE, 88 mmol/L; 119: EGFR REFIT WITHOUT RACE (2021), 17 mL/min/1.73 m2; 119: CHLORIDE, 88 mmol/L; 119: PROTEIN TOTAL, 5.3 g/dL; 119: GLOBULIN, 2.9 g/dL; 119: AST (SGOT), 15 U/L; 119: CORRECTED CALCIUM, 8.8 mg/dL; 119: POTASSIUM, 3.1 mmol/L; 119: BLOOD UREA NITROGEN (BUN), 35 mg/dL; 119: ALT (SGPT), 10 U/L; 119: SODIUM, 119 mmol/L; 119: ANION GAP, 15 mmol/L; 119: SODIUM, 119 mmol/L; 119: CALCIUM, 7.5 mg/dL; 119: CO2, 16 mmol/L; 119: ALKALINE PHOSPHATASE, 129 U/L; 119: CO2, 16 mmol/L; 119: GLOBULIN, 2.9 g/dL; 119: BILIRUBIN TOTAL, 0.3 mg/dL; 119: EGFR FOR AFRICAN AMERICAN, 20 mL/min/1.73 m2; 119: CREATININE, 3.12 mg/dL; 119: ALBUMIN, 2.4 g/dL; 119: EGFR FOR AFRICAN AMERICAN, 20 mL/min/1.73 m2; 119: ALKALINE PHOSPHATASE, 129 U/L; 119: CALCIUM, 7.5 mg/dL; 119: CREATININE, 3.12 mg/dL; 0: Age, 44; 0: Gender, F; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 36.4; 0: Triage HR, 122.0; 0: Triage RR, 20.0; 0: Triage SBP, 87.0; 0: Triage DBP, 67.0; 0: Triage acuity, 1-Resuscitation; 0: CC, BLOOD IN URINE",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient shows several concerning signs that suggest a high risk of sepsis. Initially, the patient presents with tachycardia (elevated heart rate), hypotension (low blood pressure), and requires resuscitation. Throughout the timeline, the patient continues to have low blood pressure and high heart rate, alongside receiving treatments like antibiotics and IV fluids, indicating suspected infection and possible sepsis management. Additionally, lab results reveal significant abnormalities, including low hemoglobin and hematocrit, low platelet count, and elevated white blood cell count, further indicating systemic infection and a deteriorating condition typical of sepsis onset.",
            "claims": [
                "The patient shows several concerning signs that suggest a high risk of sepsis.",
                "The patient presents with tachycardia.",
                "Tachycardia indicates an elevated heart rate.",
                "The patient also presents with hypotension.",
                "Hypotension indicates low blood pressure.",
                "The patient requires resuscitation.",
                "The patient continues to have low blood pressure.",
                "The patient continues to have a high heart rate.",
                "The patient is receiving treatments like antibiotics.",
                "The patient is receiving IV fluids.",
                "Treatments like antibiotics indicate suspected infection.",
                "Treatments like IV fluids indicate possible sepsis management.",
                "Lab results reveal significant abnormalities.",
                "The lab results show low hemoglobin and hematocrit.",
                "The lab results show a low platelet count.",
                "The lab results show an elevated white blood cell count.",
                "An elevated white blood cell count further indicates systemic infection.",
                "The patient's condition is deteriorating.",
                "A deteriorating condition is typical of sepsis onset."
            ],
            "relevant_claims": [
                "The patient shows several concerning signs that suggest a high risk of sepsis.",
                "The patient presents with tachycardia.",
                "Tachycardia indicates an elevated heart rate.",
                "The patient also presents with hypotension.",
                "Hypotension indicates low blood pressure.",
                "The patient requires resuscitation.",
                "The patient continues to have low blood pressure.",
                "The patient continues to have a high heart rate.",
                "The patient is receiving treatments like antibiotics.",
                "The patient is receiving IV fluids.",
                "Treatments like antibiotics indicate suspected infection.",
                "Treatments like IV fluids indicate possible sepsis management.",
                "Lab results reveal significant abnormalities.",
                "The lab results show low hemoglobin and hematocrit.",
                "The lab results show a low platelet count.",
                "An elevated white blood cell count further indicates systemic infection.",
                "The patient's condition is deteriorating.",
                "A deteriorating condition is typical of sepsis onset."
            ],
            "alignment_scores": [
                0.3,
                0.6,
                0.7,
                1.0,
                0.7,
                0.7,
                0.9,
                0.4,
                0.8,
                0.3,
                0.6,
                0.5,
                0.3,
                0.2,
                0.8,
                1.0,
                0.4,
                0.5
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Elevated Shock Index (\u22651.0)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Elevated Shock Index (\u22651.0)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated NEWS Score (\u22655 points)",
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "The claim broadly mentions \"several concerning signs\" suggesting a high risk of sepsis. This could imply a collection of deranged vital signs and clinical indicators, which is conceptually similar to an elevated NEWS score that predicts deterioration. However, without specific details on the actual signs or measurements, the alignment is quite vague and indirect, resulting in a low rating.",
                "Tachycardia, defined as a heart rate >90 bpm, is explicitly one of the criteria under SIRS positivity. While the claim identifies tachycardia, it does not mention other SIRS criteria being met, thus the alignment is partial but significant.",
                "Tachycardia, or an elevated heart rate, is directly mentioned as a criterion for SIRS (heart rate\u202f>\u202f90\u202fbpm). The claim identifies this specific component of the SIRS criteria, which aligns well, although it doesn't specify whether other criteria are met, thus limiting the alignment with the full SIRS category.",
                "The claim directly refers to hypotension, which is explicitly listed as an indicator in the Sepsis-Associated Hypotension category. Both SBP <90 mmHg or a significant drop in SBP are key components of this category, making the alignment perfect.",
                "The claim mentions hypotension, which is directly related to the category of sepsis-associated hypotension. However, the claim lacks specific details (e.g., exact blood pressure values) that would provide full alignment. Hence, the rating reflects substantial relevance but is not complete without further specifics.",
                "The need for resuscitation generally indicates haemodynamic instability, which is closely related to the concept of an elevated shock index (heart rate \u00f7 systolic BP \u2265 1.0 or a significant rise from baseline). While the claim does not explicitly mention specific indicators like heart rate or blood pressure, the implication of significant instability aligns with this category. The alignment is strong conceptually but lacks direct reference to the specific metrics (shock index), thus the less-than-perfect rating.",
                "The claim mentions continuous low blood pressure, which directly relates to sepsis-associated hypotension, a key indicator of sepsis progression toward shock. While the claim does not provide specific values (e.g., SBP <90 mmHg or MAP <70 mmHg), the continuation of low blood pressure strongly implies significant hemodynamic instability. Therefore, the alignment is strong, though slightly less than perfect due to the lack of specific numeric thresholds.",
                "A high heart rate can contribute to a high Shock Index since this index is calculated as heart rate divided by systolic blood pressure. While the claim does not provide direct information on blood pressure to confirm an elevated Shock Index, the persistent high heart rate suggests the possibility of haemodynamic instability. Therefore, there is some alignment with the Elevated Shock Index category, but not enough specific information to consider the alignment strong.",
                "The claim refers to the patient receiving antibiotics, which is a key component of this category that signifies clinician suspicion of a serious infection and is a strong indicator for assessing sepsis risk. The claim notably aligns with this category, though it's not clear if the antibiotics were initiated within the first 2 hours, hence a slightly less than perfect alignment.",
                "The administration of IV fluids is often associated with the treatment of hypotension, which corresponds with sepsis-associated hypotension. However, the claim does not specify if the IV fluids are actually being administered because of low blood pressure or sepsis-related hypotension. Furthermore, the claim lacks specific details such as blood pressure readings or changes that would directly align it with the sepsis-associated hypotension category. Therefore, the alignment is suggested but not strongly supported by details, leading to a low alignment rating.",
                "The claim mentions treatments like antibiotics, which align with early actions a clinician might take when suspecting a serious infection\u2014a key element in assessing sepsis risk. Although the time frame (\"within 2 hours\") isn't specified in the claim, the mention of antibiotics is a direct reference to sepsis management actions, suggesting a moderate alignment.",
                "The administration of IV fluids is often associated with managing hypotension, a critical element in sepsis management. The category \"Sepsis-Associated Hypotension\" includes hypotension as part of its criteria for indicating sepsis progression. While the claim does not directly mention hypotension, the reference to treatment with IV fluids suggests potential management of hemodynamic instability, which partially aligns with this category. Therefore, the alignment is indirect but relevant, resulting in a moderate alignment rating.",
                "The claim mentions \"significant abnormalities\" in lab results, which could suggest changes in the parameters used in the SOFA score to indicate organ dysfunction. However, it lacks specific details to directly connect to SOFA measures such as altered platelet counts, bilirubin, or creatinine levels. The alignment is weak due to the lack of specific data that conforms to the SOFA criteria.",
                "While low hemoglobin and hematocrit are not direct measures in the SOFA score, they can indicate anemia, which might indirectly relate to potential organ dysfunction and thus have some conceptual overlap with SOFA components. However, hemoglobin and hematocrit aren't direct markers for sepsis as defined by SOFA or any explicit sepsis category; hence, the alignment is weak.",
                "A low platelet count is explicitly listed as a factor in the SOFA score criteria, which is used to assess organ dysfunction and sepsis risk. While the exact level of platelet count reduction isn't provided, the mention closely aligns with the criteria for a SOFA score increase. Therefore, it is relevant and significantly aligned with this category, justifying a high rating.",
                "An elevated white blood cell count is explicitly listed as one of the SIRS criteria used to identify systemic inflammation associated with early sepsis. The claim directly aligns with this category, as it highlights a specific indicator (WBC count) that is part of the SIRS criteria.",
                "The claim \"The patient's condition is deteriorating\" is vague but suggests a worsening clinical status, which can correlate with an elevated NEWS score since NEWS scores are used to predict clinical deterioration. However, without specific details on the NEWS score or the specific vital signs, the alignment is indirect and only moderately aligned.",
                "The claim refers to a \"deteriorating condition,\" which aligns with the concept of clinical deterioration captured by an elevated NEWS score. However, it does not directly reference specific vitals or NEWS scoring, providing only a general indication of worsening health. Thus, the alignment is partial but not definitive."
            ],
            "final_alignment_score": 0.5944444444444446
        },
        {
            "input": "4: HR, 97.746; 4: RR, 22.186; 4: SpO2, 94.559; 4: Perf, 0.646; 4: 1min HRV, 11.968; 4: SBP, 92.0; 4: DBP, 66.0; 4: MAP, 74.667; 5: HR, 98.759; 5: RR, 23.724; 5: SpO2, 94.862; 5: Perf, 0.741; 5: 1min HRV, 8.708; 6: HR, 100.746; 6: RR, 26.729; 6: SpO2, 90.763; 6: Perf, 0.651; 6: 1min HRV, 5.674; 7: HR, 100.644; 7: RR, 28.102; 7: SpO2, 89.068; 7: Perf, 0.558; 7: 1min HRV, 12.144; 8: HR, 99.017; 8: RR, 27.690; 8: SpO2, 90.66; 8: Perf, 0.624; 8: 1min HRV, 8.066; 8: 5min HRV, 11.353; 9: HR, 97.288; 9: RR, 24.424; 9: SpO2, 91.576; 9: Perf, 0.602; 9: 1min HRV, 7.119; 9: SBP, 83.0; 9: DBP, 64.0; 9: MAP, 70.333; 10: HR, 96.627; 10: RR, 26.712; 10: SpO2, 92.0; 10: Perf, 0.704; 10: 1min HRV, 9.393; 10: SBP, 83.0; 10: DBP, 64.0; 10: MAP, 70.333; 10: Temp, 100.9; 11: HR, 96.776; 11: RR, 22.207; 11: SpO2, 92.621; 11: Perf, 0.637; 11: 1min HRV, 9.644; 12: HR, 97.034; 12: RR, 22.847; 12: SpO2, 92.017; 12: Perf, 0.600; 12: 1min HRV, 5.245; 13: HR, 96.879; 13: RR, 22.034; 13: SpO2, 92.088; 13: Perf, 0.632; 13: 1min HRV, 14.753; 13: 5min HRV, 9.971; 14: HR, 96.339; 14: RR, 21.119; 14: SpO2, 94.339; 14: Perf, 0.657; 14: 1min HRV, 10.121; 14: SBP, 90.0; 14: DBP, 60.0; 14: MAP, 70.0; 15: HR, 95.949; 15: RR, 22.492; 15: SpO2, 94.763; 15: Perf, 0.840; 15: 1min HRV, 4.013; 15: SBP, 90.0; 15: DBP, 60.0; 15: MAP, 70.0; 16: HR, 96.845; 16: RR, 22.259; 16: SpO2, 94.569; 16: Perf, 0.876; 16: 1min HRV, 3.703; 17: HR, 96.237; 17: RR, 22.627; 17: SpO2, 94.881; 17: Perf, 0.765; 17: 1min HRV, 6.290; 18: HR, 96.690; 18: RR, 21.793; 18: SpO2, 94.795; 18: Perf, 0.773; 18: 1min HRV, 4.852; 18: 5min HRV, 6.426; 19: HR, 97.254; 19: RR, 22.339; 19: SpO2, 94.526; 19: Perf, 0.814; 19: 1min HRV, 3.623; 19: SBP, 85.0; 19: DBP, 61.0; 19: MAP, 69.0; 20: HR, 96.186; 20: RR, 20.678; 20: SpO2, 94.0; 20: Perf, 0.843; 20: 1min HRV, 4.718; 21: HR, 96.052; 21: RR, 22.172; 21: SpO2, 94.0; 21: Perf, 0.719; 21: 1min HRV, 5.543; 22: HR, 96.593; 22: RR, 25.831; 22: SpO2, 94.0; 22: Perf, 0.723; 22: 1min HRV, 6.151; 23: HR, 97.552; 23: RR, 25.569; 23: SpO2, 95.672; 23: Perf, 0.807; 23: 1min HRV, 44.425; 23: 5min HRV, 20.809; 24: HR, 95.424; 24: RR, 24.492; 24: SpO2, 92.644; 24: Perf, 0.812; 24: 1min HRV, 4.431; 24: SBP, 94.0; 24: DBP, 84.0; 24: MAP, 87.333; 25: HR, 95.932; 25: RR, 23.441; 25: SpO2, 90.424; 25: Perf, 0.442; 25: 1min HRV, 7.390; 26: HR, 96.586; 26: RR, 23.5; 26: SpO2, 92.793; 26: Perf, 0.369; 26: 1min HRV, 7.642; 27: HR, 95.898; 27: RR, 22.407; 27: SpO2, 92.542; 27: Perf, 0.37; 27: 1min HRV, 10.837; 28: HR, 95.948; 28: RR, 23.241; 28: SpO2, 92.086; 28: Perf, 0.37; 28: 1min HRV, 2.685; 28: 5min HRV, 7.882; 29: SBP, 82.0; 29: DBP, 67.0; 29: MAP, 72.0; 44: POC PH (V) ISTAT, 7.45; 44: POC LACTATE ISTAT, 0.79 mmol/L; 44: POC PCO2 (V) ISTAT, 49.2 mmHg; 44: POC HCO3 (V) ISTAT, 34.0 mmol/L; 44: POC O2 SATURATION ISTAT VENOUS, 72 %; 44: POC BASE EXCESS ISTAT, 10 mmol/L; 44: POC TCO2 (V) ISTAT, 35 mmol/L; 44: POC PO2 (V) ISTAT, 37 mmHg; 47: SpO2, 94.0; 47: LPM O2, 15.0; 53: HR, 86.0; 53: RR, 34.0; 53: SpO2, 98.0; 53: SBP, 102.0; 53: DBP, 61.0; 53: MAP, 74.667; 57: LR IV BOLUS -, 500 ML; 58: HR:, 88.0; 58: RR, 20.0; 58: SpO2, 98.0; 58: SBP, 86.0; 58: DBP, 61.0; 58: MAP, 69.333; 58: Temp, 100.2; 68: HR, 87.0; 68: RR, 27.0; 68: SpO2, 93.0; 68: SBP, 92.0; 68: DBP, 66.0; 68: MAP, 74.667; 68: Temp, 100.2; 83: HR, 85.0; 83: RR, 20.0; 83: SpO2, 94.0; 83: Temp, 100.2; 88: HR, 85.0; 88: RR, 20.0; 88: SpO2, 96.0; 88: SBP, 84.0; 88: DBP, 59.0; 88: MAP, 67.333; 88: Temp, 100.2; 88: LR IV BOLUS -, 500 ML; 94: SODIUM:, 131 mmol/L; 94: GLOBULIN, 4.0 g/dL; 94: EGFR REFIT WITHOUT RACE (2021), 116 mL/min/1.73 m2; 94: GLUCOSE, 128 mg/dL; 94: POTASSIUM, 4.3 mmol/L; 94: ALKALINE PHOSPHATASE, 159 U/L; 94: ALT (SGPT), 31 U/L; 94: CALCIUM, 8.5 mg/dL; 94: PROTEIN TOTAL, 7.1 g/dL; 94: ANION GAP, 10 mmol/L; 94: CREATININE, 0.55 mg/dL; 94: AST (SGOT), 51 U/L; 94: CHLORIDE, 94 mmol/L; 94: ALBUMIN, 3.1 g/dL; 94: CO2, 27 mmol/L; 94: BILIRUBIN TOTAL, 0.3 mg/dL; 94: BLOOD UREA NITROGEN (BUN), 5 mg/dL; 94: CORRECTED CALCIUM, 9.2 mg/dL; 94: ACETAMINOPHEN, 1 000 MG/100 ML (10 MG/ML) IV SOLN; 98: HR:, 84.0; 98: RR, 22.0; 98: SpO2, 96.0; 98: SBP, 86.0; 98: DBP, 58.0; 98: MAP, 67.333; 98: Temp, 100.0; 113: HR, 80.0; 113: RR, 17.0; 113: SpO2, 96.0; 113: SBP, 84.0; 113: DBP, 57.0; 113: MAP, 66.0; 113: Temp, 99.7; 0: Age, 56; 0: Gender, M; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 38.3; 0: Triage HR, 97.0; 0: Triage RR, 21.0; 0: Triage SBP, 83.0; 0: Triage DBP, 64.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "Several clinical indicators suggest a high risk of developing sepsis: the patient presents with shortness of breath, hypotension (SBP as low as 83 mmHg), persistent fever (Temp between 38.3\u00b0C and 100.9\u00b0F), elevated respiratory rate (often exceeding 22 breaths per minute), low SpO2 levels, and some episodes of low HRV, which may indicate autonomic instability. Additionally, interventions like administration of oxygen and IV fluids suggest clinical concern for hemodynamic instability. These elements collectively indicate a high risk for sepsis within 12 hours.",
            "claims": [
                "Several clinical indicators suggest a high risk of developing sepsis.",
                "The patient presents with shortness of breath.",
                "The patient exhibits hypotension with a systolic blood pressure (SBP) as low as 83 mmHg.",
                "The patient has a persistent fever, with a temperature between 38.3\u00b0C and 100.9\u00b0F.",
                "The patient has an elevated respiratory rate, often exceeding 22 breaths per minute.",
                "The patient exhibits low SpO2 levels.",
                "The patient has episodes of low heart rate variability (HRV).",
                "Low HRV may indicate autonomic instability.",
                "Interventions like administration of oxygen and IV fluids indicate clinical concern for hemodynamic instability.",
                "These clinical elements collectively indicate a high risk for sepsis within 12 hours."
            ],
            "relevant_claims": [
                "Several clinical indicators suggest a high risk of developing sepsis.",
                "The patient presents with shortness of breath.",
                "The patient exhibits hypotension with a systolic blood pressure (SBP) as low as 83 mmHg.",
                "The patient has a persistent fever, with a temperature between 38.3\u00b0C and 100.9\u00b0F.",
                "The patient has an elevated respiratory rate, often exceeding 22 breaths per minute.",
                "The patient exhibits low SpO2 levels.",
                "The patient has episodes of low heart rate variability (HRV).",
                "Low HRV may indicate autonomic instability.",
                "Interventions like administration of oxygen and IV fluids indicate clinical concern for hemodynamic instability.",
                "These clinical elements collectively indicate a high risk for sepsis within 12 hours."
            ],
            "alignment_scores": [
                0.3,
                0.4,
                1.0,
                0.8,
                0.8,
                0.6,
                0.3,
                0.3,
                0.7,
                0.4
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "High qSOFA Score (\u22652)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "SIRS Positivity (\u22652 Criteria)",
                "High qSOFA Score (\u22652)",
                "SOFA Score Increase (\u22652 points)",
                "Elevated Shock Index (\u22651.0)",
                "Elevated Shock Index (\u22651.0)",
                "Elevated Shock Index (\u22651.0)",
                "Early Antibiotic/Culture Orders (within 2 hours)"
            ],
            "alignment_reasonings": [
                "The claim is vague and does not specify any particular clinical indicators that align directly with the expert categories. However, the mention of \"several clinical indicators\" could tangentially suggest a systematic method of assessment like the NEWS score, which aggregates various vitals and clinical signs to predict clinical deterioration related to sepsis. However, because the claim lacks specifics, the alignment is weak.",
                "Shortness of breath can be related to an increased respiratory rate, one of the components of the qSOFA score (respiratory rate\u202f\u2265\u202f22\u202f/min). However, shortness of breath alone does not confirm a high qSOFA score nor provides the complete information needed to fully assess it. The alignment is partial and indirect, hence the moderate rating.",
                "The claim directly mentions hypotension with a systolic blood pressure of 83 mmHg, which falls below the threshold of SBP < 90 mmHg as defined by the Sepsis-Associated Hypotension category. This specific value indicates a significant alignment with that category, as it suggests progression toward septic shock.",
                "The claim describes a persistent fever with a temperature of 38.3\u00b0C, which exceeds the SIRS criterion of >38\u00b0C for temperature and indicates systemic inflammation consistent with early sepsis. However, because SIRS requires at least two criteria, and only one criterion is mentioned here, the alignment is strong but not complete, which justifies a 0.8 rating.",
                "The claim mentions an elevated respiratory rate often exceeding 22 breaths per minute, which is one of the specific criteria for a high qSOFA score (respiratory rate\u202f\u2265\u202f22\u202f/min). The alignment is strong because it directly relates to one of the listed criteria in the qSOFA, indicating a heightened risk of sepsis-related organ dysfunction and mortality. However, the alignment isn't perfect (1.0) because a complete high qSOFA score also requires at least one other criterion (systolic BP\u202f\u2264\u202f100\u202fmmHg or altered mentation), which is not mentioned in the claim.",
                "Low SpO2 levels suggest possible hypoxia, which conceptually relates to impaired oxygenation (PaO\u2082/FiO\u2082), a component of the SOFA score. While SpO2 is not directly a SOFA measure, the implication of potential oxygenation issues aligns conceptually with increased SOFA components. Hence, the alignment is indirect but meaningful.",
                "Heart rate variability (HRV) is not directly related to any outlined category, but it can correlate to autonomic instability, which can conceptually relate to hemodynamic stability, similar to the shock index. While HRV episodes suggest possible instability, they don't directly contribute to the shock index calculation or other categories but provide some indirect relevance to the concept of hemodynamic monitoring. Hence, the alignment is weak.",
                "The claim about low heart rate variability (HRV) suggesting autonomic instability indirectly relates to haemodynamic instability, which is the focus of the Shock Index category. However, HRV is not mentioned specifically in any of the categories and does not directly tie into the Shock Index criteria, which are based on heart rate and blood pressure measurements. Hence, the alignment is indirect and weak, reflecting a potential but not explicit connection to the category.",
                "The administration of oxygen and IV fluids suggests concern for hemodynamic instability, which aligns with the category of Elevated Shock Index. This is because both treatments are commonly employed to stabilize patients experiencing or at risk of shock, a key consideration of the Elevated Shock Index category. Although no explicit shock index value is given, the clinical actions indicating hemodynamic concerns relate conceptually to this category.",
                "The claim is vague and refers generally to a prediction of high sepsis risk within a timeframe, but it lacks specific measures or scores that could clearly align with other categories like SIRS, qSOFA, or NEWS. The reference to a prediction suggests a general clinical suspicion similar to that when early antibiotic or culture orders occur. However, the alignment lacks specificity concerning an actual clinical action or a stated suspicion of infection, which decreases the alignment strength."
            ],
            "final_alignment_score": 0.56
        },
        {
            "input": "5: HR, 106.0; 5: RR, 32.0; 5: SpO2, 99.0; 5: SBP, 123.0; 5: DBP, 78.0; 5: MAP, 93.0; 5: Pain, 0.0; 5: Temp, 98.8; 27: SpO2, 95.804; 27: Perf, 0.518; 28: SpO2, 95.915; 28: Perf, 0.875; 29: SpO2, 93.810; 29: Perf, 0.93; 30: SpO2, 93.731; 30: Perf, 0.93; 31: HR, 105.0; 31: SpO2, 95.5; 31: Perf, 0.921; 31: SBP, 118.0; 31: DBP, 88.0; 31: MAP, 98.0; 32: SpO2, 94.926; 32: Perf, 0.769; 33: SpO2, 94.895; 33: Perf, 0.76; 34: SpO2, 95.0; 34: Perf, 0.76; 35: SpO2, 97.0; 35: Perf, 0.603; 36: HR, 101.952; 36: SpO2, 97.103; 36: Perf, 0.532; 36: 1min HRV, 35.120; 37: HR, 105.542; 37: SpO2, 96.441; 37: Perf, 0.586; 37: 1min HRV, 22.801; 38: HR, 104.845; 38: SpO2, 95.776; 38: Perf, 0.601; 38: 1min HRV, 17.379; 39: HR, 103.475; 39: SpO2, 95.881; 39: Perf, 0.698; 39: 1min HRV, 21.945; 39: 5min HRV, 25.526; 40: HR, 104.776; 40: SpO2, 95.259; 40: Perf, 0.889; 40: 1min HRV, 23.186; 41: HR, 107.186; 41: SpO2, 94.458; 41: Perf, 0.937; 41: 1min HRV, 27.290; 42: HR, 102.814; 42: SpO2, 94.712; 42: Perf, 1.16; 42: 1min HRV, 26.491; 43: HR, 104.983; 43: SpO2, 93.897; 43: Perf, 1.168; 43: 1min HRV, 19.577; 44: HR, 106.0; 44: SpO2, 95.085; 44: Perf, 0.625; 44: 1min HRV, 22.391; 44: 5min HRV, 24.972; 45: HR, 101.517; 45: SpO2, 94.690; 45: Perf, 0.590; 45: 1min HRV, 36.524; 46: HR, 106.186; 46: SpO2, 96.339; 46: Perf, 0.64; 46: 1min HRV, 41.338; 47: HR, 106.034; 47: SpO2, 95.576; 47: Perf, 0.64; 47: 1min HRV, 24.015; 48: HR, 101.431; 48: SpO2, 97.017; 48: Perf, 0.638; 48: 1min HRV, 27.987; 49: HR, 105.271; 49: SpO2, 96.026; 49: Perf, 0.623; 49: 1min HRV, 27.465; 49: 5min HRV, 36.044; 50: HR, 105.475; 50: SpO2, 95.458; 50: Perf, 0.709; 50: 1min HRV, 32.442; 51: HR, 104.569; 51: SpO2, 95.414; 51: Perf, 0.74; 51: 1min HRV, 29.709; 52: HR, 104.508; 52: SpO2, 94.0; 52: Perf, 0.74; 52: 1min HRV, 29.782; 53: HR, 109.086; 53: Perf, 0.74; 53: 1min HRV, 21.648; 54: HR, 108.237; 54: Perf, 0.74; 54: 1min HRV, 29.355; 54: 5min HRV, 30.426; 55: HR, 106.305; 55: SpO2, 91.417; 55: Perf, 0.74; 55: 1min HRV, 28.756; 56: HR, 100.034; 56: SpO2, 90.0; 56: 1min HRV, 30.972; 57: HR, 103.593; 57: 1min HRV, 26.173; 58: HR, 100.0; 58: 1min HRV, 36.792; 59: HR, 109.305; 59: 1min HRV, 33.558; 59: 5min HRV, 36.879; 60: HR, 102.017; 60: 1min HRV, 32.222; 61: HR, 107.780; 61: 1min HRV, 25.075; 62: HR, 109.136; 62: 1min HRV, 18.568; 63: HR, 107.483; 63: 1min HRV, 39.046; 64: HR, 109.356; 64: 1min HRV, 32.715; 64: 5min HRV, 33.510; 65: HR, 96.627; 65: SpO2, 91.484; 65: 1min HRV, 30.208; 66: HR, 102.293; 66: SpO2, 94.64; 66: 1min HRV, 31.751; 67: HR, 100.339; 67: SpO2, 96.913; 67: Perf, 0.65; 67: 1min HRV, 34.148; 68: HR, 106.034; 68: SpO2, 96.833; 68: Perf, 0.65; 68: 1min HRV, 31.407; 69: HR, 101.153; 69: SpO2, 97.0; 69: Perf, 0.402; 69: 1min HRV, 29.794; 69: 5min HRV, 36.688; 70: HR, 98.627; 70: SpO2, 96.949; 70: Perf, 0.405; 70: 1min HRV, 26.562; 71: HR, 111.034; 71: SpO2, 97.25; 71: Perf, 0.41; 71: 1min HRV, 20.913; 72: HR, 109.644; 72: SpO2, 94.857; 72: 1min HRV, 36.253; 73: POC, HCG, ISTAT QUALITATIVE: Negative; 73: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 73: HR, 101.759; 73: 1min HRV, 34.292; 74: HR, 105.780; 74: 1min HRV, 41.076; 74: 5min HRV, 41.376; 75: POC PH (V) ISTAT, 7.38; 75: POC LACTATE ISTAT, <.30 mmol/L; 75: POC HCO3 (V) ISTAT, 19.6 mmol/L; 75: POC O2 SATURATION ISTAT VENOUS, 86 %; 75: POC PCO2 (V) ISTAT, 33.3 mmHg; 75: POC TCO2 (V) ISTAT, 21 mmol/L; 75: POC PO2 (V) ISTAT, 53 mmHg; 75: POC BASE EXCESS ISTAT, -6 mmol/L; 75: HR, 107.724; 75: SpO2, 96.0; 75: 1min HRV, 29.352; 76: HR, 109.695; 76: SpO2, 96.0; 76: 1min HRV, 30.434; 77: HR, 106.627; 77: SpO2, 96.2; 77: 1min HRV, 24.569; 78: HR, 104.724; 78: SpO2, 96.0; 78: 1min HRV, 28.498; 79: HR, 110.661; 79: 1min HRV, 27.035; 79: 5min HRV, 30.151; 80: HR, 108.207; 80: 1min HRV, 18.073; 81: HR, 108.407; 81: SpO2, 99.0; 81: 1min HRV, 21.980; 82: HR, 106.983; 82: SpO2, 98.0; 82: 1min HRV, 26.322; 83: HR, 110.776; 83: 1min HRV, 24.902; 84: HR, 105.169; 84: 1min HRV, 25.793; 84: 5min HRV, 24.952; 85: HR, 107.724; 85: 1min HRV, 25.418; 86: HR, 107.661; 86: 1min HRV, 29.177; 87: HR, 107.220; 87: 1min HRV, 22.764; 88: SARS-COV-2 RNA, Not Detected; 88: HR, 108.845; 88: 1min HRV, 34.501; 89: HR, 105.915; 89: SpO2, 100.0; 89: 1min HRV, 23.263; 89: 5min HRV, 27.878; 90: HR, 105.138; 90: SpO2, 100.0; 90: 1min HRV, 21.307; 91: HR, 106.068; 91: SpO2, 99.0; 91: Perf, 1.246; 91: 1min HRV, 39.280; 92: HR, 107.915; 92: SpO2, 99.0; 92: Perf, 0.983; 92: 1min HRV, 27.151; 93: HR, 106.810; 93: SpO2, 99.0; 93: Perf, 0.870; 93: 1min HRV, 21.717; 94: HR, 107.0; 94: SpO2, 99.0; 94: Perf, 0.943; 94: 1min HRV, 17.297; 94: 5min HRV, 27.470; 118: WAM DIFTYP, AUTO; 118: BASOPHIL % (AUTO DIFF), 0.3 %; 118: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 118: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.26 K/uL; 118: RED CELL DISTRIBUTION WIDTH (RDW), 13.3 %; 118: MONOCYTE ABSOLUTE (AUTO DIFF), 0.70 K/uL; 118: PLATELET COUNT (PLT), 279 K/uL; 118: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.2 pg; 118: HEMOGLOBIN (HGB), 10.6 g/dL; 118: RED BLOOD CELLS (RBC), 3.40 MIL/uL; 118: MONOCYTE % (AUTO DIFF), 7.3 %; 118: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.6 g/dL; 118: NEUTROPHIL % (AUTO DIFF), 76.0 %; 118: EOSINOPHIL % (AUTO DIFF), 2.7 %; 118: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 118: HEMATOCRIT (HCT), 33.5 %; 118: WHITE BLOOD CELLS (WBC), 9.6 K/uL; 118: LYMPHOCYTE % (AUTO DIFF), 13.3 %; 118: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.04 K/uL; 118: MEAN CORPUSCULAR VOLUME (MCV), 98.5 fL; 118: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.28 K/uL; 118: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 118: NEUTROPHIL ABSOLUTE (AUTO DIFF), 7.31 K/uL; 118: NRBC PERCENT (HEMATOLOGY), 0.0 %; 0: Age, 23; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.1; 0: Triage HR, 106.0; 0: Triage RR, 32.0; 0: Triage SBP, 123.0; 0: Triage DBP, 78.0; 0: Triage acuity, 2-Emergent; 0: CC, COUGH",
            "answer": true,
            "llm_answer": "No",
            "llm_explanation": "The patient presents with a high heart rate and respiratory rate, which can be indicative of sepsis, but other critical vital signs such as blood pressure, oxygen saturation, and temperature are within normal limits. The patient's laboratory results do not show any alarming values that would strongly suggest an imminent risk of sepsis, such as elevated lactate levels or significantly abnormal white blood cell count. These factors, along with the absence of any dramatic changes in vital signs over time, suggest that the patient is not at a high risk of developing sepsis within 12 hours.",
            "claims": [
                "The patient presents with a high heart rate.",
                "The patient presents with a high respiratory rate.",
                "A high heart rate can be indicative of sepsis.",
                "A high respiratory rate can be indicative of sepsis.",
                "Other critical vital signs such as blood pressure are within normal limits.",
                "Oxygen saturation is within normal limits.",
                "Temperature is within normal limits.",
                "The patient's laboratory results do not show any alarming values.",
                "Alarming values would include elevated lactate levels.",
                "Alarming values would include a significantly abnormal white blood cell count.",
                "These factors suggest the patient is not at a high risk of developing sepsis within 12 hours.",
                "The absence of any dramatic changes in vital signs over time supports the conclusion that the patient is not at high risk of sepsis."
            ],
            "relevant_claims": [
                "The patient presents with a high heart rate.",
                "The patient presents with a high respiratory rate.",
                "A high heart rate can be indicative of sepsis.",
                "A high respiratory rate can be indicative of sepsis.",
                "Alarming values would include elevated lactate levels."
            ],
            "alignment_scores": [
                0.7,
                1.0,
                0.8,
                0.8,
                0.8
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated Serum Lactate (\u22652 mmol/L)"
            ],
            "alignment_reasonings": [
                "The claim refers to a high heart rate, which is one of the criteria under the SIRS category (heart rate >90 bpm). This criterion is directly linked to identifying systemic inflammation related to early sepsis, suggesting a strong alignment. However, without the presence of at least one other SIRS criterion, the alignment is not complete, thus the rating is not maximal.",
                "A high respiratory rate is explicitly listed as one of the criteria (respiratory rate > 20/min) for the SIRS (Systemic Inflammatory Response Syndrome) positivity, which is used to identify systemic inflammation consistent with early sepsis. Therefore, it directly aligns with the SIRS criteria and strongly indicates the presence of systemic inflammation.",
                "A high heart rate is directly mentioned as one of the SIRS criteria (>90 bpm) for identifying systemic inflammation and potential early sepsis. The claim specifically refers to a high heart rate as an indicator of sepsis, which aligns with the SIRS criteria, though it does not specify the exact heart rate value. Therefore, the alignment is very strong but not perfect due to this lack of specificity.",
                "A high respiratory rate is explicitly one of the criteria used to identify SIRS, which is associated with early sepsis. The claim directly references an elevated respiratory rate (respiratory rate >20/min), aligning closely with the SIRS criteria, though it would need one additional criterion to fully confirm SIRS positivity. Thus, the alignment is strong but slightly short of perfect.",
                "The claim refers to \"elevated lactate levels,\" which directly relate to the category concerning serum lactate. While the claim does not specify the exact value (\u22652 mmol/L), it describes lactate as an alarming value, thereby aligning closely with the category's focus on elevated lactate signifying hypoperfusion and increased sepsis risk. The conceptual alignment is strong but lacks specific numeric confirmation, meriting a rating of 0.8."
            ],
            "final_alignment_score": 0.82
        },
        {
            "input": "3: SpO2, 95.566; 3: Perf, 1.128; 4: SpO2, 94.811; 4: Perf, 0.859; 5: RR, 28.667; 5: SpO2, 88.321; 5: Perf, 0.710; 5: 1min HRV, 192.045; 6: HR, 87.510; 6: RR, 18.358; 6: SpO2, 86.736; 6: Perf, 0.617; 6: 1min HRV, 190.778; 7: HR, 84.615; 7: RR, 24.756; 7: SpO2, 94.173; 7: Perf, 0.719; 7: 1min HRV, 151.921; 7: 5min HRV, 200.315; 8: HR, 79.667; 8: RR, 17.333; 8: SpO2, 97.551; 8: Perf, 0.640; 8: SBP, 81.0; 8: DBP, 67.0; 8: MAP, 71.667; 8: LPM O2, 15.0; 8: Pain, 0.0; 8: Temp, 95.5; 9: HR, 80.896; 9: SpO2, 97.698; 9: Perf, 0.721; 9: 1min HRV, 123.937; 10: HR, 73.521; 10: SpO2, 95.0; 10: Perf, 0.766; 10: 1min HRV, 345.717; 10: SBP, 103.0; 10: DBP, 61.0; 10: MAP, 75.0; 11: HR, 54.913; 11: SpO2, 95.887; 11: Perf, 0.672; 11: 1min HRV, 55.263; 12: HR, 0.0; 12: SpO2, 96.472; 12: Perf, 0.808; 12: 5min HRV, 222.786; 13: POC PH (V) ISTAT, 7.34; 13: POC PO2 (V) ISTAT, 26 mmHg; 13: POC TCO2 (V) ISTAT, 39 mmol/L; 13: POC LACTATE ISTAT, 1.75 mmol/L; 13: POC HCO3 (V) ISTAT, 36.6 mmol/L; 13: POC PCO2 (V) ISTAT, 68.0 mmHg; 13: POC O2 SATURATION ISTAT VENOUS, 40 %; 13: POC BASE EXCESS ISTAT, 11 mmol/L; 13: HR, 0.0; 13: SpO2, 96.623; 13: Perf, 0.706; 13: 1min HRV, 178.75; 14: HR, 0.0; 14: SpO2, 97.852; 14: Perf, 0.518; 14: 1min HRV, 3.583; 15: HR, 0.0; 15: SpO2, 97.135; 15: Perf, 0.586; 15: 1min HRV, 8.225; 16: HR, 0.0; 16: SpO2, 97.585; 16: Perf, 0.585; 17: HR, 0.0; 17: SpO2, 97.774; 17: Perf, 0.55; 17: 1min HRV, 133.625; 17: 5min HRV, 125.316; 18: HR, 0.0; 18: SpO2, 96.925; 18: Perf, 0.553; 18: 1min HRV, 213.992; 19: HR, 6.276; 19: SpO2, 97.132; 19: Perf, 0.56; 19: 1min HRV, 93.679; 20: HR, 0.0; 20: SpO2, 97.596; 20: Perf, 0.56; 20: 1min HRV, 0.0; 21: HR, 0.0; 21: SpO2, 98.0; 21: Perf, 0.564; 21: 1min HRV, 0.0; 22: HR, 0.0; 22: SpO2, 97.269; 22: Perf, 0.574; 22: 5min HRV, 167.366; 23: HR, 0.0; 23: SpO2, 96.415; 23: Perf, 0.59; 23: SBP, 103.0; 23: DBP, 74.0; 23: MAP, 83.667; 24: HR, 0.0; 24: SpO2, 97.811; 24: Perf, 0.619; 25: HR, 0.0; 25: SpO2, 98.0; 25: Perf, 0.63; 26: HR, 0.0; 26: SpO2, 97.755; 26: Perf, 0.675; 27: HR, 0.0; 27: SpO2, 97.442; 27: Perf, 0.749; 28: HR, 14.6; 28: RR, 7.286; 28: SpO2, 98.113; 28: Perf, 0.786; 28: 1min HRV, 126.031; 29: HR, 0.0; 29: RR, 13.510; 29: SpO2, 98.019; 29: Perf, 0.809; 29: 1min HRV, 100.75; 30: HR, 0.0; 30: RR, 18.885; 30: SpO2, 97.885; 30: Perf, 0.8; 30: 1min HRV, 258.922; 31: HR, 33.793; 31: RR, 15.574; 31: SpO2, 97.704; 31: Perf, 0.790; 31: 1min HRV, 99.035; 32: HR, 15.778; 32: RR, 17.615; 32: SpO2, 96.942; 32: Perf, 0.688; 32: 1min HRV, 79.568; 32: 5min HRV, 173.597; 33: HR, 63.727; 33: RR, 32.547; 33: SpO2, 97.642; 33: Perf, 0.56; 33: 1min HRV, 59.396; 34: HR, 23.1; 34: RR, 23.788; 34: SpO2, 97.0; 34: Perf, 0.635; 34: 1min HRV, 20.603; 35: HR, 0.0; 35: RR, 24.767; 35: SpO2, 96.870; 35: Perf, 0.611; 36: HR, 16.818; 36: RR, 16.923; 36: SpO2, 96.717; 36: Perf, 0.6; 36: 1min HRV, 56.853; 37: HR, 31.882; 37: RR, 27.673; 37: SpO2, 95.308; 37: Perf, 0.601; 37: 1min HRV, 53.233; 37: 5min HRV, 56.500; 38: HR, 41.0; 38: RR, 28.075; 38: SpO2, 96.522; 38: Perf, 0.61; 38: 1min HRV, 65.923; 38: SBP, 100.0; 38: DBP, 63.0; 38: MAP, 75.333; 42: 5min HRV, 65.923; 46: WAM DIFTYP, AUTO; 46: NEUTROPHIL % (AUTO DIFF), 88.2 %; 46: HEMATOCRIT (HCT), 44.5 %; 46: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 46: BASOPHIL % (AUTO DIFF), 0.3 %; 46: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.6 pg; 46: NRBC PERCENT (HEMATOLOGY), 0.0 %; 46: RED BLOOD CELLS (RBC), 4.53 MIL/uL; 46: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 46: HEMOGLOBIN (HGB), 14.3 g/dL; 46: MONOCYTE % (AUTO DIFF), 3.2 %; 46: EOSINOPHIL % (AUTO DIFF), 0.3 %; 46: WHITE BLOOD CELLS (WBC), 11.8 K/uL; 46: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.1 g/dL; 46: LYMPHOCYTE % (AUTO DIFF), 7.6 %; 46: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.90 K/uL; 46: MEAN CORPUSCULAR VOLUME (MCV), 98.2 fL; 46: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 46: RED CELL DISTRIBUTION WIDTH (RDW), 16.1 %; 46: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 46: PLATELET COUNT (PLT), 113 K/uL; 46: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.43 K/uL; 46: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 46: MONOCYTE ABSOLUTE (AUTO DIFF), 0.38 K/uL; 54: RR, 30.0; 54: SpO2, 97.0; 61: PROTEIN TOTAL, 7.9 g/dL; 61: CREATININE, 0.64 mg/dL; 61: ALT (SGPT), 17 U/L; 61: EGFR FOR AFRICAN AMERICAN, 111 mL/min/1.73 m2; 61: BILIRUBIN TOTAL, 0.3 mg/dL; 61: SODIUM, 138 mmol/L; 61: CORRECTED CALCIUM, 9.8 mg/dL; 61: ANION GAP, 8 mmol/L; 61: GLUCOSE, 78 mg/dL; 61: AST (SGOT), 40 U/L; 61: POTASSIUM, 5.2 mmol/L; 61: CO2, 27 mmol/L; 61: BLOOD UREA NITROGEN (BUN), 19 mg/dL; 61: ALBUMIN, 2.6 g/dL; 61: GLOBULIN, 5.3 g/dL; 61: BNP NT-PRO, 2199 pg/mL; 61: CHLORIDE, 103 mmol/L; 61: EGFR REFIT WITHOUT RACE (2021), 96 mL/min/1.73 m2; 61: CALCIUM, 8.7 mg/dL; 61: ALKALINE PHOSPHATASE, 115 U/L; 67: HR, 71.0; 67: RR, 28.0; 67: SpO2, 99.0; 67: SBP, 104.0; 67: DBP, 51.0; 67: MAP, 68.667; 72: TROPONIN I, <.017 ng/mL; 83: SARS-COV-2 RNA, Not Detected; 105: METHYLPREDNISOLONE SOD SUC(PF), 125 MG/2 ML INJ SOLR; 110: NORMOSOL-R IV BOLUS -, 500 ML; 0: Age, 75; 0: Gender, M; 0: Race, White; 0: Means of arrival, EMS; 0: Triage Temp, 35.3; 0: Triage HR, 72.0; 0: Triage RR, 28.0; 0: Triage SBP, 103.0; 0: Triage DBP, 61.0; 0: Triage acuity, 2-Emergent; 0: CC, RESPIRATORY DISTRESS",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient is at high risk of developing sepsis as indicated by several clinical markers. Initially, the patient presents with respiratory distress, hypothermia (triage temperature of 35.3\u02daC), and elevated respiratory rate, which are potential sepsis indicators. Throughout the time series, the patient consistently shows low blood pressure (with significant hypotension at times), significantly fluctuating heart rate variability, decreasing perfusion index, and low heart rate, all suggestive of hemodynamic instability. The high neutrophil percentage and elevated BNP NT-PRO further support the risk of sepsis. Early and consistent signs of potential organ dysfunction reinforce the high sepsis risk.",
            "claims": [
                "The patient is at high risk of developing sepsis as indicated by several clinical markers.",
                "The patient presents with respiratory distress.",
                "The patient has hypothermia, with a triage temperature of 35.3\u02daC.",
                "The patient has an elevated respiratory rate.",
                "Respiratory distress, hypothermia, and elevated respiratory rate are potential sepsis indicators.",
                "The patient consistently shows low blood pressure.",
                "The patient experiences significant hypotension at times.",
                "The patient has significantly fluctuating heart rate variability.",
                "The patient has a decreasing perfusion index.",
                "The patient has a low heart rate.",
                "Low blood pressure, fluctuating heart rate variability, decreasing perfusion index, and low heart rate are suggestive of hemodynamic instability.",
                "The patient has a high neutrophil percentage.",
                "The patient has elevated BNP NT-PRO levels.",
                "A high neutrophil percentage and elevated BNP NT-PRO further support the risk of sepsis.",
                "Early and consistent signs of potential organ dysfunction reinforce the high sepsis risk."
            ],
            "relevant_claims": [
                "The patient is at high risk of developing sepsis as indicated by several clinical markers.",
                "The patient presents with respiratory distress.",
                "The patient has hypothermia, with a triage temperature of 35.3\u02daC.",
                "The patient has an elevated respiratory rate.",
                "Respiratory distress, hypothermia, and elevated respiratory rate are potential sepsis indicators.",
                "The patient experiences significant hypotension at times.",
                "The patient has significantly fluctuating heart rate variability.",
                "The patient has a decreasing perfusion index.",
                "Low blood pressure, fluctuating heart rate variability, decreasing perfusion index, and low heart rate are suggestive of hemodynamic instability.",
                "The patient has a high neutrophil percentage.",
                "The patient has elevated BNP NT-PRO levels.",
                "A high neutrophil percentage and elevated BNP NT-PRO further support the risk of sepsis.",
                "Early and consistent signs of potential organ dysfunction reinforce the high sepsis risk."
            ],
            "alignment_scores": [
                0.5,
                0.5,
                0.8,
                0.5,
                0.9,
                0.9,
                0.3,
                0.6,
                0.7,
                0.5,
                0.2,
                0.4,
                0.8
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "High qSOFA Score (\u22652)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Elevated Shock Index (\u22651.0)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "Elevated Shock Index (\u22651.0)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated NEWS Score (\u22655 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SOFA Score Increase (\u22652 points)"
            ],
            "alignment_reasonings": [
                "The claim mentions that several clinical markers indicate a high risk of sepsis. While it does not specify which markers are involved, this aligns with the concept of the Elevated NEWS Score, which aggregates different vital signs to predict deterioration. However, without specific markers provided, the alignment is somewhat general, leading to a moderate rating.",
                "Respiratory distress can potentially be related to a high respiratory rate, one of the components of the qSOFA score. However, the claim is not explicit that the respiratory rate meets or exceeds the threshold for qSOFA (\u226522\u202f/min), hence it suggests a possible connection without confirming it. Therefore, it partially aligns with the indication of sepsis risk through the qSOFA score but lacks sufficient detail for a higher rating.",
                "The claim mentions hypothermia with a temperature of 35.3\u02daC, which falls below the SIRS criteria threshold of <36\u02daC for sepsis-related systemic inflammation. While the category requires the presence of at least two SIRS criteria for full alignment, the temperature condition strongly aligns with one of the specific SIRS criteria, warranting a high, but not perfect, alignment rating.",
                "An elevated respiratory rate is specifically one of the criteria listed for SIRS positivity (respiratory rate > 20/min). While the claim suggests the presence of one SIRS criterion, it does not specify whether there are enough criteria (\u22652) to confirm SIRS positivity. The alignment is partial because it pertains to the category but is not comprehensive in itself.",
                "The claim includes \"respiratory distress\" and \"elevated respiratory rate,\" which directly correlate with the SIRS criteria involving the respiratory rate (>20/min). \"Hypothermia\" is also listed under SIRS criteria (<36\u00b0C), making this a strong alignment. The presence of multiple factors related to systemic inflammation suggests the risk of early sepsis, but the claim does not provide specific values to confirm the exact criteria thresholds, which slightly reduces the rating from a perfect score.",
                "The claim mentioning \"significant hypotension\" is directly related to the Sepsis-Associated Hypotension category, which identifies hypotension as indicative of the progression toward septic shock. The wording \"at times\" suggests variability or intermittency in the hypotension, which slightly softens the correlation with the specific numeric thresholds mentioned in the category (e.g., SBP <90 mmHg). However, it still aligns strongly with the sepsis risk factor of hypotension, resulting in a high alignment rating.",
                "Heart rate variability is not directly listed under any expert sepsis categories, and it does not precisely fit into any one criterion. However, fluctuating heart rate might relate to hemodynamic instability, which is captured by the Elevated Shock Index category. The connection is indirect since heart rate variability itself does not translate directly to a shock index calculation, indicating a weak alignment.",
                "A decreasing perfusion index can be associated with tissue hypoperfusion, which is conceptually related to elevated serum lactate levels, a marker used to assess inadequate oxygen delivery to tissues. While decreasing perfusion index isn't explicitly listed as a sepsis marker, it suggests circulatory compromise, making it moderately aligned with the category of Elevated Serum Lactate.",
                "The claim mentions several aspects indicative of hemodynamic instability, notably low blood pressure and fluctuating heart rate variability. While it does not directly calculate the shock index, which requires heart rate divided by systolic blood pressure, the described symptoms are closely related to the concept. The alignment is strong but not perfect because the actual shock index value is not provided.",
                "A high neutrophil percentage often indicates an inflammatory or infectious process, which can relate to the SIRS criteria, specifically the white blood cell (WBC) count component. However, the claim does not indicate the WBC count thresholds (>12,000/\u00b5L or <4,000/\u00b5L) required for full alignment with SIRS. Therefore, the alignment is moderate because the high neutrophil percentage suggests systemic inflammation akin to that flagged by elevated WBCs, but does not confirm the SIRS criteria are fully met.",
                "Elevated BNP NT-PRO levels are not directly linked to any of the expert categories related to sepsis prediction. However, they can indicate heart strain and are often elevated in conditions such as heart failure, which could indirectly contribute to higher NEWS scores due to associated deranged vitals like respiratory rate or systolic BP. This provides a tenuous connection at best, hence the low alignment rating.",
                "A high neutrophil percentage can be associated with systemic inflammation and could suggest an infectious process, which is related to SIRS criteria. However, BNP NT-PRO is not part of the traditional SIRS criteria, as it is more commonly related to cardiac function. Therefore, the alignment with SIRS is indirect and less strong due to the inclusion of BNP. Thus, the alignment rating is moderate.",
                "The claim about early and consistent signs of potential organ dysfunction strongly relates to the SOFA score, which measures organ dysfunction across multiple systems. However, the claim is somewhat vague without specifying a \u22652 points increase in any SOFA component, which is why the rating is not the highest possible. Nevertheless, the reference to organ dysfunction aligns well with this category."
            ],
            "final_alignment_score": 0.5846153846153846
        },
        {
            "input": "4: HR, 152.0; 4: RR, 16.0; 4: SpO2, 100.0; 4: SBP, 150.0; 4: DBP, 102.0; 4: MAP, 118.0; 4: Temp, 97.2; 24: Pain, 5.0; 57: SpO2, 100.0; 57: Perf, 0.247; 58: SpO2, 100.0; 58: Perf, 0.346; 59: SpO2, 100.0; 59: Perf, 0.383; 60: SpO2, 100.0; 60: Perf, 0.339; 61: SpO2, 100.0; 61: Perf, 0.721; 62: SpO2, 100.0; 62: Perf, 1.018; 63: SpO2, 100.0; 63: Perf, 0.941; 64: SpO2, 100.0; 64: Perf, 0.551; 65: SpO2, 100.0; 65: Perf, 0.336; 66: HR, 142.0; 66: RR, 11.0; 66: SpO2, 100.0; 66: Perf, 0.311; 67: SpO2, 100.0; 67: Perf, 0.243; 68: HR, 142.444; 68: RR, 30.6; 68: SpO2, 100.0; 68: Perf, 0.229; 68: 1min HRV, 12.486; 69: HR, 143.678; 69: RR, 14.271; 69: SpO2, 100.0; 69: Perf, 0.249; 69: 1min HRV, 7.575; 70: HR, 142.069; 70: RR, 20.431; 70: SpO2, 100.0; 70: Perf, 0.267; 70: 1min HRV, 5.002; 71: HR, 143.068; 71: RR, 16.136; 71: SpO2, 100.0; 71: Perf, 0.304; 71: 1min HRV, 6.348; 71: 5min HRV, 7.438; 72: HR, 141.569; 72: RR, 15.552; 72: SpO2, 100.0; 72: Perf, 0.481; 72: 1min HRV, 5.429; 73: HR, 141.559; 73: RR, 15.983; 73: SpO2, 100.0; 73: Perf, 0.340; 73: 1min HRV, 11.586; 74: HR, 146.741; 74: RR, 19.931; 74: SpO2, 100.0; 74: Perf, 0.334; 74: 1min HRV, 7.123; 75: HR, 142.169; 75: RR, 17.186; 75: SpO2, 100.0; 75: Perf, 0.285; 75: 1min HRV, 16.123; 76: HR, 148.475; 76: RR, 22.847; 76: SpO2, 100.0; 76: Perf, 0.271; 76: 1min HRV, 10.443; 76: 5min HRV, 12.894; 77: HR, 143.0; 77: RR, 18.241; 77: SpO2, 100.0; 77: Perf, 0.218; 77: 1min HRV, 8.013; 78: HR, 141.678; 78: RR, 13.186; 78: SpO2, 100.0; 78: Perf, 0.204; 78: 1min HRV, 7.869; 79: HR, 143.322; 79: RR, 17.186; 79: SpO2, 100.0; 79: Perf, 0.191; 79: 1min HRV, 5.016; 80: HR, 145.862; 80: RR, 21.483; 80: SpO2, 100.0; 80: Perf, 0.19; 80: 1min HRV, 14.273; 81: HR, 150.593; 81: RR, 24.136; 81: SpO2, 100.0; 81: Perf, 0.220; 81: 1min HRV, 4.908; 81: 5min HRV, 12.638; 82: HR, 147.724; 82: RR, 20.155; 82: SpO2, 100.0; 82: Perf, 0.193; 82: 1min HRV, 6.422; 83: HR, 145.864; 83: RR, 19.610; 83: SpO2, 100.0; 83: Perf, 0.198; 83: 1min HRV, 16.707; 84: HR, 146.103; 84: RR, 15.379; 84: SpO2, 100.0; 84: Perf, 0.203; 84: 1min HRV, 5.428; 85: HR, 146.881; 85: RR, 19.746; 85: SpO2, 100.0; 85: Perf, 0.2; 85: 1min HRV, 5.309; 86: HR, 147.690; 86: RR, 17.586; 86: SpO2, 100.0; 86: Perf, 0.2; 86: 1min HRV, 6.579; 86: 5min HRV, 9.290; 87: HR, 147.831; 87: RR, 16.932; 87: 1min HRV, 6.513; 88: HR, 146.373; 88: RR, 17.644; 88: 1min HRV, 5.914; 89: HR, 146.345; 89: RR, 18.966; 89: SpO2, 100.0; 89: Perf, 0.19; 89: 1min HRV, 4.308; 90: HR, 144.763; 90: RR, 19.559; 90: SpO2, 100.0; 90: Perf, 0.172; 90: 1min HRV, 6.645; 91: HR, 143.510; 91: RR, 16.830; 91: SpO2, 100.0; 91: Perf, 0.177; 91: 1min HRV, 6.265; 91: 5min HRV, 7.416; 92: HR, 143.94; 92: RR, 16.6; 92: SpO2, 100.0; 92: Perf, 0.177; 92: 1min HRV, 5.722; 93: HR, 145.458; 93: RR, 19.203; 93: SpO2, 100.0; 93: Perf, 0.179; 93: 1min HRV, 12.575; 94: HR, 145.466; 94: RR, 19.914; 94: SpO2, 100.0; 94: Perf, 0.276; 94: 1min HRV, 3.769; 95: HR, 140.983; 95: RR, 28.966; 95: SpO2, 100.0; 95: Perf, 0.435; 95: 1min HRV, 7.861; 96: HR, 141.915; 96: RR, 19.475; 96: SpO2, 100.0; 96: Perf, 0.645; 96: 1min HRV, 7.151; 96: 5min HRV, 9.919; 97: HR, 141.207; 97: RR, 15.810; 97: SpO2, 100.0; 97: Perf, 0.418; 97: 1min HRV, 8.263; 98: HR, 141.441; 98: RR, 15.542; 98: SpO2, 100.0; 98: Perf, 0.271; 98: 1min HRV, 5.571; 99: HR, 140.879; 99: RR, 16.121; 99: SpO2, 100.0; 99: Perf, 0.212; 99: 1min HRV, 6.727; 100: HR, 141.542; 100: RR, 17.492; 100: SpO2, 100.0; 100: Perf, 0.225; 100: 1min HRV, 6.407; 101: HR, 141.831; 101: RR, 17.068; 101: SpO2, 100.0; 101: Perf, 0.186; 101: 1min HRV, 8.050; 101: 5min HRV, 7.225; 102: HR, 135.224; 102: RR, 22.741; 102: SpO2, 100.0; 102: Perf, 0.207; 102: 1min HRV, 18.650; 103: HR, 137.288; 103: RR, 17.932; 103: SpO2, 100.0; 103: Perf, 0.205; 103: 1min HRV, 10.367; 104: HR, 139.483; 104: RR, 18.828; 104: SpO2, 100.0; 104: Perf, 0.205; 104: 1min HRV, 10.576; 105: HR, 139.983; 105: RR, 19.322; 105: SpO2, 100.0; 105: Perf, 0.185; 105: 1min HRV, 6.975; 106: SARS-COV-2 RNA, Not Detected; 106: HR, 139.864; 106: RR, 19.203; 106: SpO2, 100.0; 106: Perf, 0.192; 106: 1min HRV, 7.106; 106: 5min HRV, 12.724; 107: HR, 137.103; 107: RR, 15.759; 107: SpO2, 100.0; 107: Perf, 0.256; 107: 1min HRV, 6.563; 108: HR, 139.525; 108: RR, 18.593; 108: SpO2, 100.0; 108: Perf, 0.316; 108: 1min HRV, 5.620; 109: HR, 142.172; 109: RR, 19.672; 109: SpO2, 100.0; 109: Perf, 0.279; 109: 1min HRV, 7.703; 110: HR, 143.797; 110: RR, 15.898; 110: SpO2, 100.0; 110: Perf, 0.261; 110: 1min HRV, 5.670; 111: HR, 142.763; 111: RR, 17.085; 111: SpO2, 100.0; 111: Perf, 0.269; 111: 1min HRV, 6.064; 111: 5min HRV, 9.558; 112: HR, 143.172; 112: RR, 24.379; 112: SpO2, 100.0; 112: Perf, 0.222; 112: 1min HRV, 6.416; 113: HR, 146.136; 113: RR, 20.525; 113: SpO2, 100.0; 113: Perf, 0.214; 113: 1min HRV, 10.223; 114: HR, 142.983; 114: RR, 21.0; 114: SpO2, 100.0; 114: Perf, 0.235; 114: 1min HRV, 6.139; 115: HR, 146.153; 115: RR, 21.203; 115: SpO2, 100.0; 115: Perf, 0.246; 115: 1min HRV, 4.909; 116: HR, 148.845; 116: RR, 28.776; 116: SpO2, 100.0; 116: Perf, 0.22; 116: 1min HRV, 5.657; 116: 5min HRV, 9.084; 117: HR, 149.305; 117: RR, 22.729; 117: SpO2, 100.0; 117: Perf, 0.22; 117: 1min HRV, 4.460; 118: HR, 145.949; 118: RR, 20.814; 118: SpO2, 100.0; 118: Perf, 0.213; 118: 1min HRV, 5.542; 119: HR, 149.362; 119: RR, 19.431; 119: SpO2, 100.0; 119: Perf, 0.245; 119: 1min HRV, 6.651; 0: Age, 32; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.2; 0: Triage HR, 152.0; 0: Triage RR, 16.0; 0: Triage SBP, 150.0; 0: Triage DBP, 102.0; 0: Triage acuity, 2-Emergent; 0: CC, EMESIS,DIZZINESS,CHEST PRESSURE",
            "answer": true,
            "llm_answer": "No",
            "llm_explanation": "The patient's vitals show elevated heart rate (HR) and diastolic blood pressure (DBP), which could be concerning, but their oxygen saturation (SpO2) remains at 100%, suggesting adequate respiratory function. The temperature appears normal, and there's no indication of infection from the provided data, such as fever or positive SARS-COV-2 RNA. While the chief complaints include symptoms like chest pressure and dizziness, there is no notable increase in RR or significant drop in perfusion metrics. Additionally, variability in HR (HRV) appears typical. Overall, the data does not strongly indicate a high risk for developing sepsis within 12 hours.",
            "claims": [
                "The patient's vitals show an elevated heart rate (HR).",
                "The patient's vitals show elevated diastolic blood pressure (DBP).",
                "An elevated heart rate and diastolic blood pressure could be concerning.",
                "The patient's oxygen saturation (SpO2) remains at 100%.",
                "An oxygen saturation reading of 100% suggests adequate respiratory function.",
                "The patient's temperature appears normal.",
                "There is no indication of infection from the provided data.",
                "The provided data shows no fever.",
                "The provided data shows no positive SARS-COV-2 RNA.",
                "The chief complaints include symptoms like chest pressure and dizziness.",
                "There is no notable increase in respiratory rate (RR).",
                "There is no significant drop in perfusion metrics.",
                "Variability in heart rate (HRV) appears typical.",
                "Overall, the data does not strongly indicate a high risk for developing sepsis within 12 hours."
            ],
            "relevant_claims": [
                "The patient's vitals show an elevated heart rate (HR).",
                "The patient's vitals show elevated diastolic blood pressure (DBP).",
                "An elevated heart rate and diastolic blood pressure could be concerning.",
                "There is no indication of infection from the provided data.",
                "The provided data shows no fever.",
                "There is no significant drop in perfusion metrics."
            ],
            "alignment_scores": [
                0.5,
                0.3,
                0.7,
                0.3,
                0.3,
                0.3
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated NEWS Score (\u22655 points)",
                "Elevated Shock Index (\u22651.0)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated Serum Lactate (\u22652 mmol/L)"
            ],
            "alignment_reasonings": [
                "An elevated heart rate is part of the SIRS criteria, which identifies systemic inflammation consistent with early sepsis. However, the claim only mentions one SIRS criterion (elevated HR), and SIRS positivity requires the presence of \u22652 criteria. Therefore, while relevant, it only partially aligns, resulting in a moderate alignment rating.",
                "Elevated diastolic blood pressure is not directly mentioned in any of the expert categories. However, vital sign changes can contribute to the NEWS score, which considers multiple vital parameters, though specifically not diastolic blood pressure by itself. Since NEWS does relate to overall vital sign abnormalities, there\u2019s a low indirect alignment with this category based on the idea of clinically relevant changes in vitals.",
                "The claim mentions elevated heart rate and blood pressure features, which aligns with the concept of the shock index (heart rate \u00f7 systolic BP). While the claim specifically mentions diastolic blood pressure rather than the systolic BP needed for the index, it still signals potential hemodynamic instability that the shock index evaluates. This provides a moderate alignment with the category.",
                "The absence of infection indication relates to clinical suspicion of infection and decisions regarding further action (e.g., antibiotics or culture orders). However, since this claim specifies no indication of infection, there's only a marginal alignment based on negating the typical actions of this category.",
                "The absence of fever is indirectly related to SIRS criteria, where temperature deviations (either >38\u00b0C or <36\u00b0C) are important for identifying systemic inflammation in early sepsis. However, the claim only notes the absence of fever without providing the full temperature context or other criteria, thus offering a weak alignment with identifying SIRS positivity.",
                "The claim discusses the absence of a significant drop in perfusion metrics, which relates to tissue perfusion. Elevated serum lactate indicates tissue hypoperfusion, aligning it conceptually with the category concerning perfusion but also implying an absence of high risk. Since it mentions the absence of perfusion issues rather than confirming their presence, the alignment is indirect and weak, warranting a lower rating."
            ],
            "final_alignment_score": 0.39999999999999997
        },
        {
            "input": "5: HR, 109.0; 5: RR, 18.0; 5: SpO2, 100.0; 5: SBP, 127.0; 5: DBP, 69.0; 5: MAP, 88.333; 5: Pain, 6.0; 5: Temp, 98.2; 81: WAM DIFTYP, AUTO; 81: RED CELL DISTRIBUTION WIDTH (RDW), 14.9 %; 81: NEUTROPHIL ABSOLUTE (AUTO DIFF), 4.34 K/uL; 81: BASOPHIL % (AUTO DIFF), 0.9 %; 81: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 81: MONOCYTE ABSOLUTE (AUTO DIFF), 0.53 K/uL; 81: HEMATOCRIT (HCT), 43.5 %; 81: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 81: PLATELET COUNT (PLT), 241 K/uL; 81: NEUTROPHIL % (AUTO DIFF), 64.0 %; 81: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.78 K/uL; 81: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 81: MONOCYTE % (AUTO DIFF), 7.8 %; 81: MEAN CORPUSCULAR VOLUME (MCV), 104.6 fL; 81: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 81: NRBC PERCENT (HEMATOLOGY), 0.0 %; 81: EOSINOPHIL % (AUTO DIFF), 0.7 %; 81: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.3 pg; 81: RED BLOOD CELLS (RBC), 4.16 MIL/uL; 81: LYMPHOCYTE % (AUTO DIFF), 26.3 %; 81: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 29.9 g/dL; 81: BASOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 81: HEMOGLOBIN (HGB), 13.0 g/dL; 81: WHITE BLOOD CELLS (WBC), 6.8 K/uL; 86: SpO2, 99.32; 87: SpO2, 99.552; 87: Perf, 2.687; 88: HR, 98.8; 88: RR, 19.467; 88: SpO2, 99.525; 88: Perf, 1.823; 88: 1min HRV, 17.223; 89: HR, 103.483; 89: RR, 18.948; 89: SpO2, 98.983; 89: Perf, 1.419; 89: 1min HRV, 28.598; 90: HR, 99.322; 90: RR, 22.068; 90: SpO2, 98.862; 90: Perf, 2.159; 90: 1min HRV, 16.204; 90: 5min HRV, 24.694; 91: HR, 96.356; 91: RR, 15.966; 91: SpO2, 98.983; 91: Perf, 2.292; 91: 1min HRV, 22.544; 91: SBP, 115.0; 91: DBP, 79.0; 91: MAP, 91.0; 92: HR, 95.0; 92: RR, 19.052; 92: SpO2, 98.879; 92: Perf, 3.058; 92: 1min HRV, 14.133; 93: HR, 95.932; 93: RR, 16.966; 93: SpO2, 98.746; 93: Perf, 4.128; 93: 1min HRV, 18.879; 94: HR, 96.397; 94: RR, 17.466; 94: SpO2, 98.052; 94: Perf, 4.146; 94: 1min HRV, 17.535; 95: HR, 96.424; 95: RR, 15.492; 95: SpO2, 98.627; 95: Perf, 3.096; 95: 1min HRV, 40.939; 95: 5min HRV, 25.220; 96: HR, 91.881; 96: RR, 11.475; 96: SpO2, 98.441; 96: Perf, 4.773; 96: 1min HRV, 19.820; 97: HR, 93.448; 97: RR, 13.672; 97: SpO2, 98.517; 97: Perf, 4.844; 97: 1min HRV, 17.150; 98: HR, 95.034; 98: RR, 9.695; 98: SpO2, 98.627; 98: Perf, 3.999; 98: 1min HRV, 20.632; 99: HR, 93.207; 99: RR, 12.017; 99: SpO2, 98.414; 99: Perf, 4.606; 99: 1min HRV, 19.888; 100: HR, 95.136; 100: RR, 11.525; 100: SpO2, 98.085; 100: Perf, 4.079; 100: 1min HRV, 21.264; 100: 5min HRV, 21.607; 101: HR, 94.678; 101: RR, 11.169; 101: SpO2, 98.729; 101: Perf, 2.924; 101: 1min HRV, 17.756; 102: HR, 94.517; 102: RR, 12.276; 102: SpO2, 98.741; 102: Perf, 3.257; 102: 1min HRV, 18.186; 103: HR, 94.288; 103: RR, 16.644; 103: SpO2, 98.797; 103: Perf, 2.705; 103: 1min HRV, 12.102; 104: HR, 95.414; 104: RR, 15.724; 104: SpO2, 98.207; 104: Perf, 1.763; 104: 1min HRV, 8.317; 105: HR, 94.797; 105: RR, 14.169; 105: SpO2, 99.068; 105: Perf, 1.365; 105: 1min HRV, 17.161; 105: 5min HRV, 15.655; 106: HR, 93.729; 106: RR, 13.593; 106: SpO2, 98.729; 106: Perf, 1.404; 106: 1min HRV, 12.790; 106: SBP, 126.0; 106: DBP, nan; 106: MAP, nan; 107: HR, 94.759; 107: RR, 13.276; 107: SpO2, 98.776; 107: Perf, 2.192; 107: 1min HRV, 34.534; 108: HR, 93.305; 108: RR, 16.305; 108: SpO2, 98.893; 108: Perf, 2.48; 108: 1min HRV, 38.104; 109: HR, 94.155; 109: RR, 11.897; 109: SpO2, 98.522; 109: Perf, 1.763; 109: 1min HRV, 21.272; 110: HR, 96.153; 110: RR, 11.661; 110: SpO2, 98.305; 110: Perf, 1.962; 110: 1min HRV, 20.947; 110: 5min HRV, 28.704; 111: HR, 98.356; 111: RR, 17.695; 111: SpO2, 98.627; 111: Perf, 1.963; 111: 1min HRV, 19.384; 112: HR, 98.379; 112: RR, 15.914; 112: SpO2, 98.534; 112: Perf, 1.66; 112: 1min HRV, 23.370; 113: HR, 96.068; 113: RR, 13.627; 113: SpO2, 98.661; 113: Perf, 1.335; 113: 1min HRV, 19.161; 114: CHLORIDE, 105 mmol/L; 114: GLOBULIN, 3.0 g/dL; 114: CO2, 23 mmol/L; 114: GLUCOSE, 126 mg/dL; 114: ALKALINE PHOSPHATASE, 91 U/L; 114: SODIUM, 140 mmol/L; 114: ALT (SGPT), 32 U/L; 114: BLOOD UREA NITROGEN (BUN), 9 mg/dL; 114: PROTEIN TOTAL, 6.8 g/dL; 114: ANION GAP, 12 mmol/L; 114: CREATININE, 0.82 mg/dL; 114: EGFR REFIT WITHOUT RACE (2021), 89 mL/min/1.73 m2; 114: POTASSIUM, 4.6 mmol/L; 114: CORRECTED CALCIUM, 9.2 mg/dL; 114: CALCIUM, 9.0 mg/dL; 114: AST (SGOT), 40 U/L; 114: BILIRUBIN TOTAL, 0.3 mg/dL; 114: ALBUMIN, 3.8 g/dL; 114: HR, 94.655; 114: RR, 13.293; 114: SpO2, 99.241; 114: Perf, 1.235; 114: 1min HRV, 19.096; 115: HR, 94.017; 115: RR, 14.356; 115: SpO2, 99.322; 115: Perf, 1.177; 115: 1min HRV, 19.983; 115: 5min HRV, 23.273; 116: HR, 94.881; 116: RR, 19.356; 116: SpO2, 99.288; 116: Perf, 1.171; 116: 1min HRV, 23.524; 117: HR, 94.241; 117: RR, 14.534; 117: SpO2, 99.138; 117: Perf, 1.404; 117: 1min HRV, 19.643; 118: HR, 94.339; 118: RR, 19.746; 118: SpO2, 98.051; 118: Perf, 1.309; 118: 1min HRV, 33.339; 119: HR, 93.017; 119: RR, 15.897; 119: SpO2, 97.857; 119: Perf, 1.16; 119: 1min HRV, 24.704; 0: Age, 48; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.8; 0: Triage HR, 109.0; 0: Triage RR, 18.0; 0: Triage SBP, 127.0; 0: Triage DBP, 69.0; 0: Triage acuity, 3-Urgent; 0: CC, DIZZINESS",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The patient's vital signs, including heart rate (HR), respiratory rate (RR), blood pressure (BP), and oxygen saturation (SpO2), are relatively stable and generally within the normal range. The patient's HR is slightly elevated initially, but later measurements show an improvement and stabilization. Blood test results do not indicate significant abnormalities typically associated with sepsis, such as significant leukocytosis or left shift. Overall, there are no strong indicators of an immediate high risk for sepsis, leading to a \"No\" label for high sepsis risk within 12 hours.",
            "claims": [
                "The patient's vital signs are relatively stable.",
                "The patient's vital signs are generally within the normal range.",
                "The patient's heart rate (HR) is slightly elevated initially.",
                "Later measurements show an improvement and stabilization in the patient's heart rate.",
                "Blood test results do not indicate significant abnormalities typically associated with sepsis.",
                "There is no significant leukocytosis in the blood test results.",
                "There is no left shift in the blood test results.",
                "Overall, there are no strong indicators of an immediate high risk for sepsis.",
                "The patient has been labeled \"No\" for high sepsis risk within 12 hours."
            ],
            "relevant_claims": [
                "Blood test results do not indicate significant abnormalities typically associated with sepsis.",
                "There is no significant leukocytosis in the blood test results."
            ],
            "alignment_scores": [
                0.0,
                0.4
            ],
            "alignment_category": [
                "No specific category alignment",
                "SIRS Positivity (\u22652 Criteria)"
            ],
            "alignment_reasonings": [
                "The claim states that blood test results do not show significant abnormalities typical of sepsis. None of the expert sepsis categories specifically deals with the absence of findings as a predictor for sepsis risk. Since none of the categories focus on the lack of abnormalities, there is no alignment here.",
                "Leukocytosis (elevated white blood cell count) is a direct component of SIRS criteria used to identify systemic inflammation consistent with early sepsis. The absence of leukocytosis suggests that one of the SIRS criteria is not met, indicating a lower risk of sepsis. Although the claim is related to a SIRS criterion, it aligns less strongly because it indicates what is not present rather than what is, making the alignment somewhat indirect."
            ],
            "final_alignment_score": 0.2
        },
        {
            "input": "4: HR, 91.0; 4: RR, 16.0; 4: SpO2, 99.0; 4: SBP, 168.0; 4: DBP, 100.0; 4: MAP, 122.667; 4: Pain, 6.0; 4: Temp, 97.9; 5: SBP, 159.0; 5: DBP, 100.0; 5: MAP, 119.667; 37: SpO2, 99.0; 38: SpO2, 98.932; 38: Perf, 3.107; 38: SBP, 158.0; 38: DBP, 127.0; 38: MAP, 137.333; 39: SpO2, 98.898; 39: Perf, 2.952; 40: SpO2, 98.638; 40: Perf, 2.714; 41: SpO2, 98.373; 41: Perf, 2.238; 42: SpO2, 98.552; 42: Perf, 2.528; 43: SpO2, 98.695; 43: Perf, 2.543; 44: SpO2, 98.322; 44: Perf, 2.768; 45: HR, 90.0; 45: SpO2, 98.741; 45: Perf, 2.907; 45: SBP, 163.0; 45: DBP, 113.0; 45: MAP, 129.667; 46: SpO2, 98.898; 46: Perf, 2.837; 46: SBP, 163.0; 46: DBP, 113.0; 46: MAP, 129.667; 47: SpO2, 98.621; 47: Perf, 2.756; 48: SpO2, 98.661; 48: Perf, 2.652; 49: SpO2, 98.085; 49: Perf, 2.790; 50: SpO2, 98.121; 50: Perf, 2.636; 51: SpO2, 98.356; 51: Perf, 2.65; 52: SpO2, 98.224; 52: Perf, 2.656; 53: SpO2, 98.119; 53: Perf, 2.71; 54: SpO2, 98.305; 54: Perf, 2.71; 55: SpO2, 98.621; 55: Perf, 2.71; 56: SpO2, 98.322; 56: Perf, 2.71; 57: SpO2, 98.328; 57: Perf, 2.71; 58: SpO2, 97.237; 58: Perf, 2.663; 59: SpO2, 98.373; 59: Perf, 2.71; 60: SpO2, 98.310; 60: Perf, 2.456; 60: KETOROLAC, 15 MG/ML INJ SOLN; 60: METOCLOPRAMIDE HCL, 5 MG/ML INJ SOLN; 60: DEXAMETHASONE SODIUM PHOSPHATE, 4 MG/ML INJ SOLN; 61: SpO, 2: 98.780; 61: Perf, 1.355; 61: SBP, 177.0; 61: DBP, 119.0; 61: MAP, 138.333; 61: DIPHENHYDRAMINE HCL, 50 MG/ML INJ SOLN; 62: SpO, 2: 98.362; 62: Perf, 1.539; 63: SpO2, 98.525; 63: Perf, 2.468; 64: SpO2, 98.136; 64: Perf, 2.768; 65: SpO2, 98.190; 65: Perf, 3.867; 65: NS IV BOLUS -, 1000 ML; 66: SpO, 2: 98.085; 66: Perf, 2.609; 67: SpO2, 97.517; 67: Perf, 2.276; 68: SpO2, 97.897; 68: Perf, 3.014; 69: SpO2, 97.051; 69: Perf, 2.980; 70: SpO2, 97.407; 70: Perf, 3.188; 71: WAM DIFTYP, AUTO; 71: NEUTROPHIL ABSOLUTE (AUTO DIFF), 3.18 K/uL; 71: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.3 pg; 71: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 71: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.2 g/dL; 71: BASOPHIL % (AUTO DIFF), 1.1 %; 71: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.35 K/uL; 71: MEAN CORPUSCULAR VOLUME (MCV), 88.6 fL; 71: RED BLOOD CELLS (RBC), 4.58 MIL/uL; 71: EOSINOPHIL % (AUTO DIFF), 3.3 %; 71: HEMATOCRIT (HCT), 40.6 %; 71: LYMPHOCYTE % (AUTO DIFF), 37.4 %; 71: NEUTROPHIL % (AUTO DIFF), 50.7 %; 71: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.2 %; 71: MONOCYTE ABSOLUTE (AUTO DIFF), 0.46 K/uL; 71: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.21 K/uL; 71: MONOCYTE % (AUTO DIFF), 7.3 %; 71: RED CELL DISTRIBUTION WIDTH (RDW), 12.6 %; 71: BASOPHIL ABSOLUTE (AUTO DIFF), 0.07 K/uL; 71: HEMOGLOBIN (HGB), 13.9 g/dL; 71: WHITE BLOOD CELLS (WBC), 6.3 K/uL; 71: NRBC PERCENT (HEMATOLOGY), 0.0 %; 71: PLATELET COUNT (PLT), 218 K/uL; 71: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 71: HR, 76.0; 71: SpO2, 96.672; 71: Perf, 4.325; 71: SBP, 177.0; 71: DBP, 119.0; 71: MAP, 138.333; 71: AMOXICILLIN-POT CLAVULANATE, 875-125 MG PO TABS; 71: LOSARTAN, 50 MG PO TABS; 72: SpO2, 96.847; 72: Perf, 4.581; 73: SpO2, 98.052; 73: Perf, 3.920; 74: SpO2, 97.390; 74: Perf, 3.688; 74: MAGNESIUM SULFATE IN D, 5W 1 GRAM/100 ML IV PGBK; 75: SpO, 2: 96.576; 75: Perf, 4.164; 76: SpO2, 97.119; 76: Perf, 4.159; 76: SBP, 138.0; 76: DBP, 85.0; 76: MAP, 102.667; 77: SpO2, 97.776; 77: Perf, 3.844; 78: HR, 78.0; 78: RR, 18.0; 78: SpO2, 96.948; 78: Perf, 4.500; 78: SBP, 138.0; 78: DBP, 85.0; 78: MAP, 102.667; 79: SpO2, 97.271; 79: Perf, 4.525; 80: SpO2, 97.914; 80: Perf, 4.377; 81: SpO2, 97.917; 81: Perf, 4.162; 82: SpO2, 97.828; 82: Perf, 4.318; 83: SpO2, 97.293; 83: Perf, 4.348; 84: SpO2, 97.0; 84: Perf, 4.549; 85: SpO2, 97.0; 85: Perf, 4.268; 86: SpO2, 97.153; 86: Perf, 3.840; 87: SpO2, 97.644; 87: Perf, 3.567; 88: SpO2, 97.655; 88: Perf, 3.958; 89: EGFR FOR AFRICAN AMERICAN, 111 mL/min/1.73 m2; 89: EGFR REFIT WITHOUT RACE (2021), 96 mL/min/1.73 m2; 89: ALT (SGPT), 71 U/L; 89: CHLORIDE, 103 mmol/L; 89: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 89: SODIUM, 138 mmol/L; 89: ALBUMIN, 4.4 g/dL; 89: ANION GAP, 10 mmol/L; 89: CREATININE, 1.03 mg/dL; 89: POTASSIUM, 4.0 mmol/L; 89: ALKALINE PHOSPHATASE, 61 U/L; 89: GLUCOSE, 122 mg/dL; 89: AST (SGOT), 42 U/L; 89: CORRECTED CALCIUM, 9.2 mg/dL; 89: CO2, 25 mmol/L; 89: GLOBULIN, 2.4 g/dL; 89: MAGNESIUM, 2.1 mg/dL; 89: BILIRUBIN TOTAL, <.2 mg/dL; 89: CALCIUM, 9.5 mg/dL; 89: PROTEIN TOTAL, 6.8 g/dL; 89: SpO2, 97.864; 89: Perf, 4.193; 90: SpO2, 97.881; 90: Perf, 3.909; 91: SpO2, 98.390; 91: Perf, 4.445; 91: SBP, 130.0; 91: DBP, 81.0; 91: MAP, 97.333; 92: SpO2, 98.259; 92: Perf, 4.703; 93: SpO2, 98.0; 93: Perf, 3.96; 94: SpO2, 97.845; 94: Perf, 4.029; 95: SpO2, 97.593; 95: Perf, 3.823; 96: SpO2, 98.305; 96: Perf, 2.939; 97: SpO2, 98.224; 97: Perf, 3.344; 98: SpO2, 98.610; 98: Perf, 3.357; 99: SpO2, 97.879; 99: Perf, 4.154; 100: SpO2, 98.458; 100: Perf, 3.910; 101: SpO2, 98.5; 101: Perf, 3.063; 102: SpO2, 98.814; 102: Perf, 5.818; 103: SpO2, 98.128; 103: Perf, 7.793; 104: SpO2, 98.776; 105: SpO2, 98.881; 105: Perf, 3.678; 106: SpO2, 97.310; 106: Perf, 3.918; 106: SBP, 139.0; 106: DBP, 102.0; 106: MAP, 114.333; 107: SpO2, 97.746; 107: Perf, 3.92; 108: SpO2, 97.746; 108: Perf, 3.92; 0: Age, 34; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 91.0; 0: Triage RR, 16.0; 0: Triage SBP, 168.0; 0: Triage DBP, 100.0; 0: Triage acuity, 3-Urgent; 0: CC, HEADACHE",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "Despite the elevated blood pressure (DBP and SBP) at several time points, other key indicators such as heart rate, respiratory rate, temperature, and oxygen saturation remain within normal ranges. Moreover, there are no substantial fluctuations or concerning trends in these vital signs that suggest a heightened risk of sepsis within the next 12 hours. Additionally, the patient's lab values and administered medications do not indicate a pattern consistent with sepsis risk, supporting a \"No\" label for high sepsis risk prediction.",
            "claims": [
                "The blood pressure is elevated at several time points.",
                "Both diastolic blood pressure (DBP) and systolic blood pressure (SBP) are elevated.",
                "The heart rate remains within normal ranges.",
                "The respiratory rate remains within normal ranges.",
                "The temperature remains within normal ranges.",
                "The oxygen saturation remains within normal ranges.",
                "There are no substantial fluctuations in these vital signs.",
                "There are no concerning trends in these vital signs.",
                "The absence of concerning trends suggests a lowered risk of sepsis.",
                "The patient's lab values do not indicate a pattern consistent with sepsis risk.",
                "The medications administered do not indicate a pattern consistent with sepsis risk.",
                "These factors support a \"No\" label for high sepsis risk prediction."
            ],
            "relevant_claims": [
                "The blood pressure is elevated at several time points.",
                "Both diastolic blood pressure (DBP) and systolic blood pressure (SBP) are elevated.",
                "The medications administered do not indicate a pattern consistent with sepsis risk."
            ],
            "alignment_scores": [
                0.3,
                0.3,
                0.3
            ],
            "alignment_category": [
                "Elevated Shock Index (\u22651.0)",
                "Elevated Shock Index (\u22651.0)",
                "Early Antibiotic/Culture Orders (within 2 hours)"
            ],
            "alignment_reasonings": [
                "While the claim refers to elevated blood pressure rather than low blood pressure or a drop in blood pressure that is characteristic of sepsis-associated hypotension or shock, it does relate to the concept of hemodynamic status, which is pertinent to Elevated Shock Index. However, elevated blood pressure alone doesn't directly indicate the risk of sepsis or the presence of shock, leading to the low alignment rating. Elevated blood pressure could be a compensatory response and does not signal the typical hypotension seen in sepsis, resulting in only indirect conceptual relevance.",
                "The claim mentions elevated diastolic and systolic blood pressure, which is not directly linked to any listed categories. However, blood pressure is part of the Shock Index calculation (heart rate \u00f7 systolic BP), which assesses hemodynamic instability. Elevated BP could indirectly suggest changes in hemodynamic status, although it doesn't directly align with the concept of a high or rising Shock Index indicating severe sepsis. Thus, the connection is weak, leading to a low alignment rating.",
                "The claim suggests that medication patterns do not indicate a risk of sepsis, implying a lack of early antibiotic administration or culture orders, which this category captures. However, the claim is more about absence rather than presence of actions, leading to a weaker alignment."
            ],
            "final_alignment_score": 0.3
        },
        {
            "input": "8: HR, 114.0; 8: RR, 18.0; 8: SpO2, 98.0; 8: SBP, 100.0; 8: DBP, 62.0; 8: MAP, 74.667; 8: Temp, 101.9; 54: POC PH (V) ISTAT, 7.45; 54: POC PCO2 (V) ISTAT, 41.3 mmHg; 54: POC TCO2 (V) ISTAT, 30 mmol/L; 54: POC PO2 (V) ISTAT, 28 mmHg; 54: POC BASE EXCESS ISTAT, 5 mmol/L; 54: POC O2 SATURATION ISTAT VENOUS, 55 %; 54: POC HCO3 (V) ISTAT, 28.8 mmol/L; 54: POC LACTATE ISTAT, 1.14 mmol/L; 61: SpO2, 96.667; 61: SBP, 106.0; 61: DBP, 75.0; 61: MAP, 85.333; 62: SpO2, 95.780; 63: SpO2, 96.729; 63: Perf, 1.77; 64: SpO2, 97.0; 64: Perf, 1.786; 64: NORMOSOL-R IV BOLUS -, 1000 ML; 65: HR:, 112.0; 65: SpO2, 97.271; 65: Perf, 1.638; 65: SBP, 115.0; 65: DBP, 84.0; 65: MAP, 94.333; 65: ACETAMINOPHEN, 500 MG PO TABS; 66: SpO, 2: 98.293; 66: Perf, 1.373; 66: SBP, 115.0; 66: DBP, 84.0; 66: MAP, 94.333; 67: SpO2, 96.085; 67: Perf, 1.177; 68: SpO2, 95.678; 68: Perf, 1.127; 69: SpO2, 96.5; 69: Perf, 0.956; 70: SpO2, 95.356; 70: Perf, 0.855; 71: SpO2, 95.828; 71: Perf, 0.802; 72: SpO2, 95.559; 72: Perf, 0.764; 73: SpO2, 96.254; 73: Perf, 0.803; 74: SpO2, 96.931; 74: Perf, 0.899; 74: AMOXICILLIN, 500 MG PO CAPS; 74: AZITHROMYCIN, 250 MG PO TABS; 75: SpO2, 96.339; 75: Perf, 0.968; 76: SpO2, 96.052; 76: Perf, 0.902; 77: HR, 110.528; 77: RR, 13.625; 77: SpO2, 95.780; 77: Perf, 0.899; 77: 1min HRV, 2.757; 78: HR, 109.741; 78: RR, 19.190; 78: SpO2, 95.638; 78: Perf, 0.769; 78: 1min HRV, 3.116; 79: HR, 109.322; 79: RR, 23.814; 79: SpO2, 96.0; 79: Perf, 0.738; 79: 1min HRV, 2.266; 80: HR, 111.475; 80: RR, 21.068; 80: SpO2, 96.153; 80: Perf, 0.685; 80: 1min HRV, 3.989; 80: 5min HRV, 5.418; 80: SBP, 102.0; 80: DBP, 90.0; 80: MAP, 94.0; 81: HR, 114.534; 81: RR, 21.552; 81: SpO2, 95.455; 81: Perf, 0.641; 81: 1min HRV, 5.618; 81: SBP, 102.0; 81: DBP, 90.0; 81: MAP, 94.0; 82: HR, 117.169; 82: RR, 25.864; 82: SpO2, 95.508; 82: Perf, 0.54; 82: 1min HRV, 9.593; 83: HR, 121.276; 83: RR, 26.914; 83: SpO2, 94.328; 83: Perf, 0.548; 83: 1min HRV, 5.129; 84: HR, 124.678; 84: RR, 30.169; 84: SpO2, 93.492; 84: Perf, 0.55; 84: 1min HRV, 7.047; 85: HR, 127.04; 85: RR, 26.220; 85: SpO2, 93.136; 85: Perf, 0.55; 85: 1min HRV, 7.672; 85: 5min HRV, 18.936; 86: HR, 132.0; 86: RR, 28.845; 86: SpO2, 94.103; 86: Perf, 0.55; 86: 1min HRV, 9.623; 87: RR, 31.966; 87: SpO2, 94.0; 87: Perf, 0.55; 88: HR, 136.0; 88: RR, 35.690; 88: SpO2, 94.897; 88: Perf, 0.55; 88: 1min HRV, 0.0; 89: HR, 133.906; 89: RR, 30.373; 89: SpO2, 94.085; 89: Perf, 0.55; 89: 1min HRV, 173.207; 90: HR, 125.0; 90: RR, 33.390; 90: SpO2, 95.05; 90: Perf, 0.55; 90: 5min HRV, 97.885; 91: HR, 149.054; 91: RR, 31.534; 91: SpO2, 97.679; 91: Perf, 0.55; 91: 1min HRV, 10.808; 92: HR, 156.712; 92: RR, 30.0; 92: SpO2, 98.271; 92: Perf, 0.55; 92: 1min HRV, 60.644; 93: HR, 161.025; 93: RR, 33.034; 93: SpO2, 98.6; 93: Perf, 0.55; 93: 1min HRV, 22.283; 94: HR, 156.370; 94: RR, 36.712; 94: SpO2, 98.2; 94: Perf, 0.55; 94: 1min HRV, 94.293; 95: HR, 157.196; 95: RR, 34.339; 95: SpO2, 96.737; 95: Perf, 0.55; 95: 1min HRV, 16.234; 95: 5min HRV, 49.010; 95: SBP, 111.0; 95: DBP, 53.0; 95: MAP, 72.333; 96: PROTEIN, URINE (UA): Negative; 96: SPECIFIC GRAVITY, URINE (UA): 1.001; 96: NITRITE, URINE (UA): Negative; 96: KETONE, URINE (UA): Negative; 96: LEUKOCYTE ESTERASE, URINE (UA): Negative; 96: PH, URINE (UA): 7.0; 96: HR, 164.089; 96: RR, 36.5; 96: SpO2, 97.32; 96: Perf, 0.55; 96: 1min HRV, 26.799; 97: INR, 1.2; 97: PART. THROMBOPLASTIN TIME, 38.8 seconds; 97: PROTHROMBIN TIME, 15.3 seconds; 97: HR, 163.871; 97: RR, 36.424; 97: SpO2, 96.475; 97: Perf, 0.55; 97: 1min HRV, 13.300; 98: HR, 153.0; 98: RR, 40.224; 98: SpO2, 96.771; 98: Perf, 0.55; 98: 1min HRV, 124.873; 99: HR, 144.982; 99: RR, 34.576; 99: SpO2, 95.875; 99: Perf, 0.55; 99: 1min HRV, 12.892; 100: HR, 162.524; 100: RR, 33.407; 100: SpO2, 96.271; 100: Perf, 0.55; 100: 1min HRV, 1.961; 100: 5min HRV, 75.241; 101: HR, 165.897; 101: RR, 36.362; 101: SpO2, 97.0; 101: Perf, 0.55; 101: 1min HRV, 13.371; 102: HR, 166.962; 102: RR, 41.898; 102: SpO2, 96.746; 102: Perf, 0.55; 102: 1min HRV, 15.235; 103: HR, 164.707; 103: RR, 34.897; 103: SpO2, 97.155; 103: Perf, 0.55; 103: 1min HRV, 13.524; 104: HR, 166.322; 104: RR, 36.576; 104: SpO2, 97.492; 104: Perf, 0.55; 104: 1min HRV, 16.295; 105: HR, 165.821; 105: RR, 37.136; 105: SpO2, 97.0; 105: Perf, 0.55; 105: 1min HRV, 16.144; 105: 5min HRV, 15.305; 106: CREATININE, 1.17 mg/dL; 106: ALT (SGPT), 56 U/L; 106: BILIRUBIN TOTAL, 0.7 mg/dL; 106: AST (SGOT), 53 U/L; 106: CALCIUM, 8.8 mg/dL; 106: SODIUM, 129 mmol/L; 106: EGFR FOR AFRICAN AMERICAN, 93 mL/min/1.73 m2; 106: ALBUMIN, 3.9 g/dL; 106: GLOBULIN, 3.0 g/dL; 106: GLUCOSE, 298 mg/dL; 106: POTASSIUM, 3.1 mmol/L; 106: ALKALINE PHOSPHATASE, 76 U/L; 106: CORRECTED CALCIUM, 8.9 mg/dL; 106: CHLORIDE, 96 mmol/L; 106: CO2, 24 mmol/L; 106: ANION GAP, 9 mmol/L; 106: EGFR REFIT WITHOUT RACE (2021), 80 mL/min/1.73 m2; 106: BLOOD UREA NITROGEN (BUN), 7 mg/dL; 106: PROTEIN TOTAL, 6.9 g/dL; 106: HR, 166.759; 106: RR, 37.879; 106: SpO2, 97.741; 106: Perf, 0.55; 106: 1min HRV, 18.752; 107: HR, 166.305; 107: RR, 35.915; 107: SpO2, 97.339; 107: Perf, 0.55; 107: 1min HRV, 13.251; 108: HR, 161.741; 108: RR, 39.034; 108: SpO2, 97.190; 108: Perf, 0.55; 108: 1min HRV, 70.909; 109: HR, 159.644; 109: RR, 38.186; 109: SpO2, 97.254; 109: Perf, 0.55; 109: 1min HRV, 59.905; 110: HR, 165.724; 110: RR, 34.431; 110: SpO2, 97.310; 110: Perf, 0.55; 110: 1min HRV, 11.562; 110: 5min HRV, 46.894; 111: HR, 164.068; 111: RR, 31.051; 111: SpO2, 97.085; 111: Perf, 0.55; 111: 1min HRV, 8.139; 112: HR, 161.678; 112: RR, 32.475; 112: SpO2, 97.533; 112: Perf, 0.55; 112: 1min HRV, 10.966; 113: HR, 161.448; 113: RR, 36.655; 113: SpO2, 98.0; 113: 1min HRV, 34.426; 114: HR, 159.678; 114: RR, 29.136; 114: SpO2, 97.683; 114: 1min HRV, 11.619; 115: HR, 155.552; 115: RR, 22.431; 115: SpO2, 98.0; 115: 1min HRV, 13.881; 115: 5min HRV, 19.683; 116: HR, 153.390; 116: RR, 21.559; 116: SpO2, 98.0; 116: 1min HRV, 15.817; 117: HR, 151.356; 117: RR, 20.356; 117: SpO2, 98.0; 117: 1min HRV, 17.470; 117: CEFTRIAXONE, 1 GRAM/10 ML IV PUSH (VIAL ONLY); 118: HR:, 150.379; 118: RR, 20.672; 118: SpO2, 97.845; 118: 1min HRV, 17.041; 119: HR, 149.695; 119: RR, 23.661; 119: SpO2, 97.0; 119: 1min HRV, 18.899; 0: Age, 33; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 38.8; 0: Triage HR, 114.0; 0: Triage RR, 18.0; 0: Triage SBP, 100.0; 0: Triage DBP, 62.0; 0: Triage acuity, 3-Urgent; 0: CC, FEVER",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient exhibits several indicators of sepsis: elevated heart rate (HR consistently above 110 bpm, peaking at 166 bpm), tachypnea (respiratory rate sometimes exceeding 30 breaths per minute), and fever (temperature of 101.9\u00b0F). Additionally, the decreasing perfusion and fluctuating HRV values suggest poor hemodynamic stability. The administration of antibiotics also indicates a clinical concern for infection. These factors suggest a high risk of developing sepsis within the next 12 hours.",
            "claims": [
                "The patient exhibits several indicators of sepsis.",
                "The patient's heart rate is consistently above 110 bpm.",
                "The patient's heart rate has peaked at 166 bpm.",
                "The patient is experiencing tachypnea.",
                "The patient's respiratory rate sometimes exceeds 30 breaths per minute.",
                "The patient has a fever.",
                "The patient's temperature is 101.9\u00b0F.",
                "The patient shows decreasing perfusion.",
                "The patient has fluctuating heart rate variability (HRV) values.",
                "Decreasing perfusion and fluctuating HRV suggest poor hemodynamic stability.",
                "The administration of antibiotics indicates a clinical concern for infection.",
                "These factors suggest a high risk of developing sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The patient exhibits several indicators of sepsis.",
                "The patient's heart rate is consistently above 110 bpm.",
                "The patient's heart rate has peaked at 166 bpm.",
                "The patient is experiencing tachypnea.",
                "The patient's respiratory rate sometimes exceeds 30 breaths per minute.",
                "The patient has a fever.",
                "The patient's temperature is 101.9\u00b0F.",
                "The patient shows decreasing perfusion.",
                "The patient has fluctuating heart rate variability (HRV) values.",
                "Decreasing perfusion and fluctuating HRV suggest poor hemodynamic stability.",
                "The administration of antibiotics indicates a clinical concern for infection.",
                "These factors suggest a high risk of developing sepsis within the next 12 hours."
            ],
            "alignment_scores": [
                0.3,
                0.8,
                0.7,
                0.7,
                0.8,
                0.8,
                0.9,
                0.7,
                0.3,
                0.7,
                0.7,
                0.3
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated Shock Index (\u22651.0)",
                "SIRS Positivity (\u22652 Criteria)",
                "High qSOFA Score (\u22652)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "Elevated Shock Index (\u22651.0)",
                "Elevated Shock Index (\u22651.0)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "The claim is vague, mentioning \"several indicators of sepsis\" without specifying which ones. The National Early Warning Score (NEWS) aggregates various vital signs and clinical parameters, which could encompass multiple indicators of sepsis. However, without specific parameters identified (e.g., vital signs), the alignment is somewhat speculative and weak, suggesting a very mild connection.",
                "The claim mentions a high heart rate (>110 bpm), which satisfies the SIRS criterion of a heart rate >90 bpm. This aligns strongly with the SIRS Positivity category for identifying systemic inflammation consistent with early sepsis, but it's only one part of the SIRS criteria, not a complete diagnosis, so the alignment is high but not perfect.",
                "The claim highlights a very high heart rate, which can indicate hemodynamic instability\u2014a key aspect of the Shock Index category. While the Shock Index specifically requires the ratio of heart rate to systolic BP, a heart rate this high strongly suggests a potential Shock Index over 1.0. However, without the accompanying BP measurement, the alignment is suggestive rather than definitive. Thus, while plausible, it's not a complete match.",
                "Tachypnea, defined as an increased respiratory rate (>20/min), is directly listed as one of the criteria for SIRS positivity. This implies systemic inflammation that is consistent with early sepsis. The alignment is quite strong as tachypnea is a clear SIRS criterion; however, since the claim does not state whether other SIRS criteria are present, full alignment (1.0) isn't achieved.",
                "A respiratory rate\u202f\u2265\u202f22\u202f/min is a direct component of the qSOFA score. The claim mentions a respiratory rate exceeding 30 breaths per minute, which comfortably exceeds the qSOFA threshold, making it highly relevant to this category. While the claim does not provide a complete qSOFA score of \u22652, the respiratory rate mentioned strongly suggests risk.",
                "A fever is directly related to the SIRS criteria, where a temperature >38 \u00b0C (100.4 \u00b0F) is one of the thresholds indicating systemic inflammation. The claim aligns well with this category since a fever often signals such inflammation, but without the specific temperature data, it does not fully confirm meeting the criterion. However, the concept of fever strongly suggests a potential alignment with early sepsis identification, warranting a high alignment rating.",
                "The patient's temperature is above 38\u00b0C (100.4\u00b0F), which directly meets one of the SIRS criteria for systemic inflammation indicative of potential early sepsis. While the claim only provides one SIRS criterion out of the required two or more, it aligns strongly with identifying systemic inflammation.",
                "Decreasing perfusion is closely associated with tissue hypoperfusion, a key factor that elevated serum lactate levels often indicate in sepsis. While the claim does not directly mention serum lactate levels, the physiological symptoms described strongly suggest issues with perfusion and potential hypoxia, aligning with the elevated serum lactate category conceptually.",
                "Fluctuating heart rate variability (HRV) can imply instability in the cardiovascular system, reminiscent of the haemodynamic concerns captured by the Elevated Shock Index category. However, HRV is not directly related to parameters used in calculating the Shock Index, which involves heart rate and systolic blood pressure. Therefore, the alignment is weak and indirect.",
                "The claim about decreasing perfusion and fluctuating heart rate variability (HRV) suggests issues with hemodynamic stability. The Elevated Shock Index category concerns hemodynamic instability due to its calculation involving the heart rate and systolic blood pressure. Although the claim does not provide explicit values to calculate the shock index, it describes concepts closely related to this category, indicating a meaningful but not perfect alignment.",
                "The claim mentions the administration of antibiotics, which aligns with the category suggesting suspicion of serious infection. However, the claim does not specify whether this occurred within the critical 2-hour window, slightly reducing the alignment strength.",
                "The claim is general and unspecific, referring broadly to a \"high risk of developing sepsis.\" While it suggests imminent deterioration, it doesn't specify which clinical data or risk factor leads to this risk. The Elevated NEWS Score, a general indicator predicting imminent clinical deterioration, aligns best, albeit weakly due to lack of specificity or explicit mention of NEWS-related clinical features. There is an indirect relationship as both involve predicting risk based on general clinical status."
            ],
            "final_alignment_score": 0.6416666666666667
        },
        {
            "input": "4: HR, 77.0; 4: RR, 16.0; 4: SpO2, 100.0; 4: SBP, 111.0; 4: DBP, 62.0; 4: MAP, 78.333; 4: Temp, 98.1; 30: SpO2, 95.364; 31: SpO2, 98.15; 31: Perf, 1.224; 31: SBP, 141.0; 31: DBP, 64.0; 31: MAP, 89.667; 32: SpO2, 99.776; 32: Perf, 0.976; 33: SpO2, 99.847; 33: Perf, 0.968; 34: SpO2, 98.625; 34: SBP, 126.0; 34: DBP, 74.0; 34: MAP, 91.333; 35: SpO2, 99.086; 35: Perf, 0.972; 36: SpO2, 99.542; 36: Perf, 0.932; 37: SpO2, 99.086; 37: Perf, 0.882; 38: SpO2, 99.172; 38: Perf, 0.910; 39: SpO2, 99.917; 39: Perf, 0.988; 40: SpO2, 99.707; 40: Perf, 0.895; 41: SpO2, 99.271; 41: Perf, 0.855; 42: SpO2, 99.517; 42: Perf, 0.907; 43: POC, HCG, ISTAT QUALITATIVE: Negative; 43: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 43: SpO2, 100.0; 43: Perf, 0.995; 44: SpO2, 98.831; 44: Perf, 0.989; 45: SpO2, 98.034; 45: Perf, 0.958; 46: SpO2, 99.305; 46: Perf, 0.772; 47: SpO2, 98.897; 47: Perf, 0.843; 48: SpO2, 99.593; 48: Perf, 0.885; 49: SpO2, 99.0; 49: SBP, 122.0; 49: DBP, 85.0; 49: MAP, 97.333; 50: SpO2, 98.831; 50: Perf, 0.945; 51: SpO2, 99.310; 51: Perf, 0.891; 52: SpO2, 99.237; 52: Perf, 0.859; 53: SpO2, 99.644; 53: Perf, 0.846; 54: SpO2, 97.429; 54: Perf, 0.83; 55: SpO2, 99.322; 55: Perf, 0.887; 56: SpO2, 99.305; 56: Perf, 0.819; 57: SpO2, 99.379; 57: Perf, 0.925; 58: SpO2, 98.271; 58: Perf, 0.880; 59: SpO2, 97.727; 59: Perf, 0.86; 60: SpO2, 98.362; 60: Perf, 0.852; 61: SpO2, 99.085; 61: Perf, 0.805; 62: SpO2, 97.741; 62: Perf, 0.81; 63: SpO2, 97.636; 63: Perf, 0.811; 64: SpO2, 98.1; 64: SBP, 120.0; 64: DBP, 100.0; 64: MAP, 106.667; 65: SpO2, 96.872; 66: SpO2, 98.068; 66: Perf, 0.520; 67: SpO2, 98.707; 67: Perf, 0.486; 68: SpO2, 98.559; 68: Perf, 0.544; 69: WAM DIFTYP, AUTO; 69: RED BLOOD CELLS (RBC), 4.54 MIL/uL; 69: HEMATOCRIT (HCT), 43.4 %; 69: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 69: HEMOGLOBIN (HGB), 14.1 g/dL; 69: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 69: MONOCYTE ABSOLUTE (AUTO DIFF), 0.32 K/uL; 69: RED CELL DISTRIBUTION WIDTH (RDW), 12.2 %; 69: MEAN CORPUSCULAR VOLUME (MCV), 95.6 fL; 69: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 69: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 69: NRBC PERCENT (HEMATOLOGY), 0.0 %; 69: PLATELET COUNT (PLT), 241 K/uL; 69: BASOPHIL % (AUTO DIFF), 0.9 %; 69: MONOCYTE % (AUTO DIFF), 9.2 %; 69: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.1 pg; 69: LYMPHOCYTE % (AUTO DIFF), 38.6 %; 69: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.5 g/dL; 69: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 69: EOSINOPHIL % (AUTO DIFF), 1.7 %; 69: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.34 K/uL; 69: NEUTROPHIL % (AUTO DIFF), 49.3 %; 69: WHITE BLOOD CELLS (WBC), 3.5 K/uL; 69: NEUTROPHIL ABSOLUTE (AUTO DIFF), 1.71 K/uL; 69: SpO2, 98.724; 69: Perf, 0.638; 70: SARS-COV-2 RNA, Not Detected; 70: SpO2, 97.845; 70: Perf, 0.540; 71: SpO2, 98.0; 71: Perf, 0.48; 72: SpO2, 96.611; 72: Perf, 0.48; 73: SpO2, 94.722; 73: Perf, 0.48; 74: SpO2, 98.588; 74: Perf, 0.488; 75: SpO2, 95.053; 75: Perf, 0.52; 76: GLUCOSE, URINE (UA): Negative; 76: PROTEIN, URINE (UA): Negative; 76: NITRITE, URINE (UA): Negative; 76: PH, URINE (UA): 6.0; 76: KETONE, URINE (UA): Negative; 76: SPECIFIC GRAVITY, URINE (UA): 1.013; 76: SpO2, 97.562; 77: SpO2, 88.5; 78: SpO2, 95.889; 79: SpO2, 94.88; 79: SBP, 115.0; 79: DBP, 75.0; 79: MAP, 88.333; 80: SpO2, 97.727; 80: Perf, 0.173; 81: SpO2, 94.140; 83: SpO2, 91.75; 84: SpO2, 91.464; 86: SpO2, 90.294; 87: SpO2, 92.613; 88: SpO2, 97.147; 89: SpO2, 96.1; 90: SpO2, 91.103; 91: SpO2, 93.606; 92: SpO2, 92.714; 93: CREATININE, 0.85 mg/dL; 93: POTASSIUM, 4.1 mmol/L; 93: GLUCOSE, 100 mg/dL; 93: CORRECTED CALCIUM, 8.8 mg/dL; 93: ALBUMIN, 4.8 g/dL; 93: CALCIUM, 9.4 mg/dL; 93: ANION GAP, 9 mmol/L; 93: BLOOD UREA NITROGEN (BUN), 12 mg/dL; 93: EGFR REFIT WITHOUT RACE (2021), 80 mL/min/1.73 m2; 93: BILIRUBIN TOTAL, 0.5 mg/dL; 93: LIPASE, 46 U/L; 93: ALKALINE PHOSPHATASE, 70 U/L; 93: AST (SGOT), 23 U/L; 93: CHLORIDE, 103 mmol/L; 93: SODIUM, 137 mmol/L; 93: EGFR FOR AFRICAN AMERICAN, 92 mL/min/1.73 m2; 93: CO2, 25 mmol/L; 93: PROTEIN TOTAL, 7.6 g/dL; 93: GLOBULIN, 2.8 g/dL; 93: ALT (SGPT), 18 U/L; 93: TSH, 2.77 uIU/mL; 93: SpO2, 88.762; 94: SpO2, 98.105; 94: SBP, 125.0; 94: DBP, 98.0; 94: MAP, 107.0; 95: SpO2, 95.966; 95: Perf, 0.92; 96: SpO2, 98.672; 96: Perf, 0.845; 97: SpO2, 98.169; 97: Perf, 0.894; 98: SpO2, 96.966; 98: Perf, 0.907; 99: SpO2, 96.175; 99: Perf, 0.898; 100: SpO2, 97.276; 100: Perf, 0.873; 101: SpO2, 98.288; 101: Perf, 0.865; 102: SpO2, 96.390; 102: Perf, 0.899; 103: SpO2, 98.508; 103: Perf, 1.044; 104: SpO2, 98.086; 104: Perf, 0.951; 105: SpO2, 96.68; 105: Perf, 0.95; 106: SpO2, 96.0; 106: Perf, 0.95; 107: SpO2, 97.746; 107: Perf, 0.898; 108: SpO2, 96.929; 108: Perf, 0.859; 109: SpO2, 96.611; 109: SBP, 114.0; 109: DBP, 72.0; 109: MAP, 86.0; 110: SpO2, 96.525; 110: Perf, 1.736; 111: SpO2, 98.786; 111: Perf, 1.821; 112: SpO2, 98.017; 112: Perf, 2.042; 113: SpO2, 98.153; 113: Perf, 1.672; 114: SpO2, 97.581; 114: Perf, 1.112; 0: Age, 48; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 77.0; 0: Triage RR, 16.0; 0: Triage SBP, 111.0; 0: Triage DBP, 62.0; 0: Triage acuity, 3-Urgent; 0: CC, ABDOMINAL PAIN",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The patient's vital signs and lab results remain generally stable throughout the time series, with blood pressure and heart rate in normal ranges, and no significant indication of infection or systemic instability. Although there were some fluctuations in SpO2, the values remained mostly within a manageable range, indicating stable oxygenation. The laboratory findings don't show elevated white blood cell count often associated with infection. There is no clear evidence pointing towards a high risk of sepsis within the next 12 hours.",
            "claims": [
                "The patient's vital signs and lab results remain generally stable throughout the time series.",
                "Blood pressure is in the normal range.",
                "Heart rate is in the normal range.",
                "There is no significant indication of infection.",
                "There is no significant indication of systemic instability.",
                "There were some fluctuations in SpO2.",
                "The SpO2 values remained mostly within a manageable range.",
                "The stable SpO2 values indicate stable oxygenation.",
                "The laboratory findings do not show elevated white blood cell count.",
                "Elevated white blood cell count is often associated with infection.",
                "There is no clear evidence pointing towards a high risk of sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The patient's vital signs and lab results remain generally stable throughout the time series.",
                "There is no significant indication of infection.",
                "There is no significant indication of systemic instability.",
                "The laboratory findings do not show elevated white blood cell count.",
                "There is no clear evidence pointing towards a high risk of sepsis within the next 12 hours."
            ],
            "alignment_scores": [
                0.2,
                0.2,
                0.2,
                0.2,
                0.0
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "Elevated Shock Index (\u22651.0)",
                "SIRS Positivity (\u22652 Criteria)",
                "N/A (No specific category)"
            ],
            "alignment_reasonings": [
                "The NEWS score is typically used to identify clinical instability and deterioration. The claim states that the patient's vital signs and lab results remain generally stable, opposing the idea of a high NEWS score. This suggests that the alignment is weak; however, stability in vital signs does relate to the absence of what the NEWS score measures, which is why a minimal alignment is acknowledged.",
                "The claim suggests a lack of significant infection. The category relevant to assessing infection suspicion\u2014though opposite in this context\u2014is \"Early Antibiotic/Culture Orders.\" Since there is no indication of sepsis or an impending infection, it aligns weakly in a reverse manner as the absence of action that would otherwise indicate such suspicion. Hence, the alignment rating is low.",
                "The claim mentions \"no significant indication of systemic instability,\" which is somewhat relevant to the Elevated Shock Index category, as a shock index \u22651.0 denotes hemodynamic instability. However, this is more a statement of absence rather than evidence of meeting or approaching the criteria of an elevated shock index. Hence, the alignment is weak but conceptually related.",
                "The claim refers to the absence of an elevated white blood cell count, which is one of the SIRS criteria. Although it is relevant to the SIRS category, it does not fulfill the requirement for systemic inflammation or sepsis risk, leading to a low alignment score.",
                "The claim states that there is no clear evidence of high sepsis risk, which does not specifically align with any of the expert categories that identify or predict sepsis risk. There are no clinical indicators, such as elevated scores or measurements, presented which correlate with the expert categories. The alignment is therefore nonexistent, hence a rating of 0.0."
            ],
            "final_alignment_score": 0.16
        },
        {
            "input": "15: HR, 100.0; 15: RR, 22.0; 15: SpO2, 94.0; 15: SBP, 107.0; 15: DBP, 55.0; 15: MAP, 72.333; 15: Pain, 3.0; 15: Temp, 101.8; 28: SpO2, 87.0; 29: SpO2, 87.898; 30: HR, 101.765; 30: RR, 20.889; 30: SpO2, 90.632; 30: 1min HRV, 4.830; 30: SBP, 123.0; 30: DBP, 62.0; 30: MAP, 82.333; 31: HR, 101.333; 31: RR, 19.233; 31: SpO2, 92.1; 31: 1min HRV, 4.776; 32: HR, 100.138; 32: RR, 17.362; 32: SpO2, 91.483; 32: 1min HRV, 4.689; 32: 5min HRV, 6.331; 33: HR, 99.0; 33: RR, 17.983; 33: SpO2, 92.593; 33: 1min HRV, 3.153; 34: HR, 98.475; 34: RR, 23.085; 34: SpO2, 91.780; 34: 1min HRV, 7.334; 35: HR, 98.310; 35: RR, 19.121; 35: SpO2, 91.259; 35: 1min HRV, 6.017; 35: ACETAMINOPHEN, 325 MG PO TABS; 36: HR:, 97.169; 36: RR, 21.034; 36: SpO2, 91.119; 36: 1min HRV, 2.545; 37: HR, 96.707; 37: RR, 19.052; 37: SpO2, 90.759; 37: 1min HRV, 9.207; 37: 5min HRV, 7.719; 38: HR, 95.881; 38: RR, 21.695; 38: SpO2, 91.661; 38: 1min HRV, 13.105; 39: HR, 97.339; 39: RR, 26.017; 39: SpO2, 90.305; 39: 1min HRV, 6.039; 40: HR, 97.776; 40: RR, 20.672; 40: SpO2, 91.034; 40: 1min HRV, 4.908; 41: HR, 96.390; 41: RR, 18.407; 41: SpO2, 91.661; 41: 1min HRV, 9.422; 42: HR, 96.828; 42: RR, 20.569; 42: SpO2, 91.190; 42: 1min HRV, 8.440; 42: 5min HRV, 9.844; 43: HR, 96.466; 43: RR, 19.569; 43: SpO2, 90.586; 43: 1min HRV, 3.590; 44: HR, 96.339; 44: RR, 23.763; 44: SpO2, 91.542; 44: 1min HRV, 5.054; 45: HR, 95.831; 45: RR, 28.254; 45: SpO2, 90.932; 45: 1min HRV, 2.598; 46: HR, 95.525; 46: RR, 26.932; 46: SpO2, 90.136; 46: 1min HRV, 5.323; 47: HR, 95.483; 47: RR, 22.931; 47: SpO2, 90.621; 47: 1min HRV, 5.140; 47: 5min HRV, 5.528; 48: HR, 95.339; 48: RR, 27.0; 48: SpO2, 90.153; 48: 1min HRV, 4.641; 49: HR, 94.879; 49: RR, 24.948; 49: SpO2, 89.810; 49: 1min HRV, 4.375; 50: HR, 94.780; 50: RR, 22.0; 50: SpO2, 90.627; 50: 1min HRV, 2.481; 51: HR, 95.203; 51: RR, 27.576; 51: SpO2, 90.068; 51: 1min HRV, 2.493; 52: HR, 95.431; 52: RR, 23.103; 52: SpO2, 89.914; 52: 1min HRV, 4.808; 52: 5min HRV, 4.417; 53: HR, 94.864; 53: RR, 23.237; 53: SpO2, 90.610; 53: 1min HRV, 6.341; 54: HR, 95.655; 54: RR, 26.397; 54: SpO2, 91.241; 54: 1min HRV, 4.805; 55: HR, 96.431; 55: RR, 20.586; 55: SpO2, 91.345; 55: 1min HRV, 3.885; 56: POC PH (V) ISTAT, 7.40; 56: POC BASE EXCESS ISTAT, 9 mmol/L; 56: POC O2 SATURATION ISTAT VENOUS, 69 %; 56: POC PO2 (V) ISTAT, 37 mmHg; 56: POC HCO3 (V) ISTAT, 33.7 mmol/L; 56: POC LACTATE ISTAT, 1.52 mmol/L; 56: POC PCO2 (V) ISTAT, 53.9 mmHg; 56: POC TCO2 (V) ISTAT, 35 mmol/L; 56: HR, 95.881; 56: RR, 16.627; 56: SpO2, 91.695; 56: 1min HRV, 4.064; 57: HR, 95.966; 57: RR, 17.305; 57: SpO2, 92.153; 57: 1min HRV, 6.730; 57: 5min HRV, 6.051; 58: HR, 94.763; 58: RR, 16.831; 58: SpO2, 92.356; 58: 1min HRV, 16.739; 58: SBP, 134.0; 58: DBP, 72.0; 58: MAP, 92.667; 59: HR, 96.897; 59: RR, 19.690; 59: SpO2, 93.0; 59: 1min HRV, 4.855; 60: HR, 95.915; 60: RR, 19.458; 60: SpO2, 92.915; 60: 1min HRV, 8.370; 61: HR, 101.542; 61: RR, 22.881; 61: SpO2, 93.729; 61: 1min HRV, 16.173; 62: HR, 106.879; 62: RR, 23.190; 62: SpO2, 91.534; 62: Perf, 2.954; 62: 1min HRV, 17.762; 62: 5min HRV, 30.337; 72: WAM DIFTYP, AUTO; 72: EOSINOPHIL % (AUTO DIFF), 0.5 %; 72: MONOCYTE % (AUTO DIFF), 4.3 %; 72: HEMATOCRIT (HCT), 45.1 %; 72: NEUTROPHIL % (AUTO DIFF), 84.7 %; 72: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.06 K/uL; 72: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.7 pg; 72: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 72: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.6 %; 72: PLATELET COUNT (PLT), 283 K/uL; 72: MEAN CORPUSCULAR VOLUME (MCV), 93.6 fL; 72: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.9 g/dL; 72: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 72: HEMOGLOBIN (HGB), 15.3 g/dL; 72: RED CELL DISTRIBUTION WIDTH (RDW), 12.8 %; 72: NRBC PERCENT (HEMATOLOGY), 0.0 %; 72: MONOCYTE ABSOLUTE (AUTO DIFF), 0.45 K/uL; 72: LYMPHOCYTE % (AUTO DIFF), 9.5 %; 72: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 72: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.99 K/uL; 72: WHITE BLOOD CELLS (WBC), 10.4 K/uL; 72: RED BLOOD CELLS (RBC), 4.82 MIL/uL; 72: NEUTROPHIL ABSOLUTE (AUTO DIFF), 8.84 K/uL; 72: BASOPHIL % (AUTO DIFF), 0.4 %; 86: DEXAMETHASONE SODIUM PHOSPHATE, 4 MG/ML INJ SOLN; 87: HR:, 93.0; 87: RR, 26.0; 87: SpO2, 92.0; 87: SBP, 114.0; 87: DBP, 49.0; 87: MAP, 70.667; 88: INR, 1.0; 88: PROTHROMBIN TIME, 12.5 seconds; 89: PART. THROMBOPLASTIN TIME, 27.9 seconds; 110: TROPONIN I, <.017 ng/mL; 113: CREATININE, 0.80 mg/dL; 113: SODIUM, 137 mmol/L; 113: BLOOD UREA NITROGEN (BUN), 14 mg/dL; 113: EGFR FOR AFRICAN AMERICAN, 134 mL/min/1.73 m2; 113: BILIRUBIN TOTAL, 0.5 mg/dL; 113: EGFR REFIT WITHOUT RACE (2021), 116 mL/min/1.73 m2; 113: POTASSIUM, 5.0 mmol/L; 113: PROTEIN TOTAL, 7.5 g/dL; 113: CO2, 25 mmol/L; 113: GLUCOSE, 127 mg/dL; 113: CHLORIDE, 99 mmol/L; 113: ANION GAP, 13 mmol/L; 113: ALBUMIN, 4.2 g/dL; 113: CORRECTED CALCIUM, 9.3 mg/dL; 113: ALT (SGPT), 74 U/L; 113: CALCIUM, 9.5 mg/dL; 113: AST (SGOT), 47 U/L; 113: ALKALINE PHOSPHATASE, 66 U/L; 113: GLOBULIN, 3.3 g/dL; 0: Age, 34; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 38.8; 0: Triage HR, 100.0; 0: Triage RR, 22.0; 0: Triage SBP, 107.0; 0: Triage DBP, 55.0; 0: Triage acuity, 2-Emergent; 0: CC, CHEST PAIN",
            "answer": false,
            "llm_answer": "Yes",
            "llm_explanation": "The patient exhibits several indicators common in sepsis, including tachycardia (consistently high heart rate), hypotension (indicated by lower diastolic blood pressures at several times), tachypnea (elevated respiratory rate), and abnormal temperature (suggesting fever). There are also variations in heart rate variability and decreased SpO2 levels, which can be signs of systemic infection or respiratory compromise. The administration of dexamethasone, typically used for inflammation, further suggests a potential concern for sepsis, alongside certain lab results showing elevated neutrophil percentages. Collectively, these factors suggest a high risk of developing sepsis within 12 hours.",
            "claims": [
                "The patient exhibits several indicators common in sepsis.",
                "One indicator of sepsis is tachycardia, which is a consistently high heart rate.",
                "Another indicator of sepsis is hypotension, which is indicated by lower diastolic blood pressures at several times.",
                "A third indicator of sepsis is tachypnea, which is characterized by an elevated respiratory rate.",
                "The patient also shows abnormal temperature, suggesting fever.",
                "There are variations in heart rate variability.",
                "Decreased SpO2 levels can be signs of systemic infection or respiratory compromise.",
                "The administration of dexamethasone suggests a potential concern for sepsis.",
                "Dexamethasone is typically used for inflammation.",
                "Certain lab results show elevated neutrophil percentages.",
                "Collectively, these factors suggest a high risk of developing sepsis within 12 hours."
            ],
            "relevant_claims": [
                "One indicator of sepsis is tachycardia, which is a consistently high heart rate.",
                "Another indicator of sepsis is hypotension, which is indicated by lower diastolic blood pressures at several times.",
                "A third indicator of sepsis is tachypnea, which is characterized by an elevated respiratory rate.",
                "The patient also shows abnormal temperature, suggesting fever.",
                "Decreased SpO2 levels can be signs of systemic infection or respiratory compromise.",
                "The administration of dexamethasone suggests a potential concern for sepsis.",
                "Certain lab results show elevated neutrophil percentages."
            ],
            "alignment_scores": [
                0.8,
                0.7,
                0.7,
                0.6,
                0.6,
                0.3,
                0.7
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "High qSOFA Score (\u22652)",
                "SIRS Positivity (\u22652 Criteria)",
                "SOFA Score Increase (\u22652 points)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "SIRS Positivity (\u22652 Criteria)"
            ],
            "alignment_reasonings": [
                "Tachycardia, defined as a heart rate >90 bpm, is one of the criteria for SIRS, which is used to identify systemic inflammation consistent with early sepsis. The claim specifically mentions a consistently high heart rate, aligning clearly with the SIRS criterion, although it can also relate to other conditions. Therefore, the alignment is strong but not exclusively definitive for sepsis prediction.",
                "The claim discusses hypotension, which is directly related to the category of sepsis-associated hypotension. However, the claim specifically references lower diastolic blood pressure, whereas the category typically uses systolic blood pressure (SBP) and mean arterial pressure (MAP) metrics. This partial overlap in the concept of hypotension gives it a moderate alignment rating.",
                "Tachypnea (elevated respiratory rate) is a component of both SIRS and qSOFA criteria. However, as an \"indicator of sepsis,\" it strongly aligns with the qSOFA's role in assessing high-risk sepsis, specifically respiratory rate being a qSOFA component (\u226522/min). While a single indicator doesn\u2019t fully establish the criteria, the claim's focus on respiratory status aligns more strongly with qSOFA than SIRS.",
                "The mention of an \"abnormal temperature\" suggests a fever, which aligns with the temperature criterion of SIRS (>38\u00b0C). Although the specific temperature is not provided, the claim's nature implies a connection to systemic inflammation, aligning it moderately with the SIRS category.",
                "The claim about decreased SpO2 levels indirectly relates to the SOFA score, which includes PaO\u2082/FiO\u2082 as an indicator of impaired oxygenation. While SpO2 is not directly part of the SOFA criteria, it is conceptually related to the assessment of organ dysfunction due to respiratory compromise. The alignment is indirect but meaningful, reflecting partial overlap with the evaluation of sepsis risk.",
                "The administration of dexamethasone, a steroid, is not directly tied to the sepsis indicators like antibiotic administration or blood cultures reflecting active suspicion of infection. However, it implies a level of clinical concern that could be aligned with the increased care in response to inflammation or infection. The alignment is indirect and thus receives a low but non-zero rating since the treatment can reflect a broader strategy in managing potential complications associated with sepsis risk.",
                "Elevated neutrophil percentages suggest an inflammatory or infectious process, which could contribute to systemic inflammation monitored by SIRS criteria. Although neutrophil percentage is not explicitly listed under SIRS, it is a component of the total white blood cell count, an explicit SIRS criterion. Therefore, the alignment is reasonably strong but not absolute, reflecting partial relevance to SIRS positivity."
            ],
            "final_alignment_score": 0.6285714285714287
        },
        {
            "input": "4: HR, 98.0; 4: RR, 20.0; 4: SpO2, 98.0; 4: SBP, 156.0; 4: DBP, 91.0; 4: MAP, 112.667; 4: Pain, 9.0; 4: Temp, 97.3; 17: Pain, 9.0; 47: SpO2, 99.815; 47: Perf, 5.65; 48: SpO2, 99.698; 48: Perf, 4.866; 49: SpO2, 99.654; 49: Perf, 6.326; 50: SpO2, 98.283; 50: Perf, 6.188; 51: SpO2, 98.692; 51: Perf, 4.329; 52: SpO2, 99.887; 52: Perf, 5.396; 53: SpO2, 98.698; 53: Perf, 6.652; 54: SpO2, 97.788; 54: Perf, 6.915; 55: SpO2, 98.321; 55: Perf, 5.774; 56: SpO2, 98.769; 56: Perf, 5.436; 57: SpO2, 99.796; 57: Perf, 3.147; 58: SpO2, 99.981; 58: Perf, 5.669; 59: SpO2, 98.852; 59: Perf, 6.074; 60: SpO2, 98.962; 60: Perf, 5.853; 61: SpO2, 98.327; 61: Perf, 6.366; 62: SpO2, 97.887; 62: Perf, 4.309; 63: WAM DIFTYP, AUTO; 63: WHITE BLOOD CELLS (WBC), 9.2 K/uL; 63: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.0 %; 63: PLATELET COUNT (PLT), 111 K/uL; 63: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.11 K/uL; 63: RED BLOOD CELLS (RBC), 3.36 MIL/uL; 63: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.8 pg; 63: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.8 g/dL; 63: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.09 K/uL; 63: MONOCYTE ABSOLUTE (AUTO DIFF), 0.60 K/uL; 63: MONOCYTE % (AUTO DIFF), 6.5 %; 63: LYMPHOCYTE % (AUTO DIFF), 23.5 %; 63: NEUTROPHIL % (AUTO DIFF), 67.4 %; 63: MEAN CORPUSCULAR VOLUME (MCV), 90.8 fL; 63: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 63: HEMATOCRIT (HCT), 30.5 %; 63: NEUTROPHIL ABSOLUTE (AUTO DIFF), 6.21 K/uL; 63: BASOPHIL % (AUTO DIFF), 0.4 %; 63: EOSINOPHIL % (AUTO DIFF), 1.2 %; 63: HEMOGLOBIN (HGB), 10.0 g/dL; 63: NRBC PERCENT (HEMATOLOGY), 0.0 %; 63: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.17 K/uL; 63: RED CELL DISTRIBUTION WIDTH (RDW), 14.5 %; 63: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 63: SpO2, 98.472; 63: Perf, 5.038; 64: SpO2, 97.75; 64: Perf, 5.482; 65: SpO2, 98.811; 65: Perf, 4.566; 66: SpO2, 100.0; 66: Perf, 4.300; 67: SpO2, 99.679; 67: Perf, 4.146; 68: SpO2, 98.453; 68: Perf, 3.965; 69: SpO2, 97.692; 69: Perf, 3.954; 70: SpO2, 98.604; 70: Perf, 4.070; 71: SpO2, 98.963; 71: Perf, 3.789; 72: SpO2, 99.208; 72: Perf, 3.189; 73: SpO2, 99.226; 73: Perf, 3.142; 74: SpO2, 98.731; 74: Perf, 4.288; 75: SpO2, 99.830; 75: Perf, 4.364; 76: SpO2, 99.212; 76: Perf, 3.890; 77: SpO2, 99.358; 77: Perf, 2.905; 78: SpO2, 99.192; 78: Perf, 3.487; 79: SpO2, 100.0; 79: Perf, 2.814; 80: SpO2, 99.302; 80: Perf, 2.529; 81: SpO2, 99.827; 81: Perf, 2.478; 82: SpO2, 99.679; 82: Perf, 2.804; 83: SpO2, 99.358; 83: Perf, 3.397; 84: SpO2, 99.660; 84: Perf, 2.971; 85: SpO2, 99.722; 85: Perf, 3.593; 86: SpO2, 98.462; 86: Perf, 2.956; 87: SpO2, 99.094; 87: Perf, 2.975; 88: SpO2, 98.731; 88: Perf, 4.379; 89: SpO2, 99.226; 89: Perf, 7.745; 90: SpO2, 98.717; 90: Perf, 7.697; 91: SpO2, 98.885; 91: Perf, 5.139; 92: ANION GAP, 8 mmol/L; 92: PROTEIN TOTAL, 6.5 g/dL; 92: CREATININE, 1.69 mg/dL; 92: ALKALINE PHOSPHATASE, 204 U/L; 92: BLOOD UREA NITROGEN (BUN), 19 mg/dL; 92: GLUCOSE, 194 mg/dL; 92: AST (SGOT), 103 U/L; 92: BILIRUBIN TOTAL, 1.9 mg/dL; 92: POTASSIUM, 4.2 mmol/L; 92: CHLORIDE, 107 mmol/L; 92: GLOBULIN, 3.7 g/dL; 92: CALCIUM, 8.2 mg/dL; 92: EGFR REFIT WITHOUT RACE (2021), 41 mL/min/1.73 m2; 92: CORRECTED CALCIUM, 9.2 mg/dL; 92: SODIUM, 137 mmol/L; 92: ALT (SGPT), 35 U/L; 92: CO2, 22 mmol/L; 92: LIPASE, 7 U/L; 92: ALBUMIN, 2.8 g/dL; 92: SpO2, 99.585; 92: Perf, 5.095; 93: SpO2, 100.0; 93: Perf, 4.939; 93: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 94: SpO, 2: 100.0; 94: Perf, 6.090; 95: SpO2, 99.547; 95: Perf, 7.254; 96: SpO2, 99.698; 96: Perf, 3.639; 96: HYDROMORPHONE, 1 MG/ML INJ SYRG; 97: SpO, 2: 100.0; 97: Perf, 2.333; 98: SpO2, 100.0; 98: Perf, 1.970; 99: SpO2, 100.0; 99: Perf, 1.992; 100: SpO2, 100.0; 100: Perf, 2.358; 101: SpO2, 100.0; 101: Perf, 2.456; 102: SpO2, 100.0; 102: Perf, 2.726; 103: SpO2, 100.0; 103: Perf, 2.592; 104: SpO2, 100.0; 104: Perf, 2.425; 105: SpO2, 100.0; 105: Perf, 2.096; 106: SpO2, 100.0; 106: Perf, 2.291; 107: SpO2, 99.679; 107: Perf, 2.310; 108: POC PH (V) ISTAT, 7.54; 108: POC PCO2 (V) ISTAT, 23.5 mmHg; 108: POC O2 SATURATION ISTAT VENOUS, 77 %; 108: POC PO2 (V) ISTAT, 35 mmHg; 108: POC BASE EXCESS ISTAT, -2 mmol/L; 108: POC LACTATE ISTAT, 1.68 mmol/L; 108: POC TCO2 (V) ISTAT, 21 mmol/L; 108: POC HCO3 (V) ISTAT, 20.3 mmol/L; 108: SpO2, 99.792; 108: Perf, 2.784; 109: SpO2, 100.0; 109: Perf, 2.668; 110: POC, HCG, ISTAT QUALITATIVE: Negative; 110: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 110: SpO2, 99.788; 110: Perf, 2.271; 110: LR IV BOLUS -, 500 ML; 111: SpO, 2: 100.0; 111: Perf, 2.174; 112: SpO2, 100.0; 112: Perf, 2.461; 113: SpO2, 99.925; 113: Perf, 2.120; 114: SpO2, 98.736; 114: Perf, 2.366; 114: SBP, 125.0; 114: DBP, 72.0; 114: MAP, 89.667; 115: SpO2, 94.868; 115: Perf, 2.387; 116: SpO2, 99.302; 116: Perf, 2.58; 117: HR, 94.0; 117: RR, 18.0; 117: SpO2, 99.642; 117: Perf, 2.295; 117: SBP, 125.0; 117: DBP, 72.0; 117: MAP, 89.667; 117: Pain, 9.0; 118: SpO2, 97.231; 118: Perf, 2.053; 119: SpO2, 90.167; 119: Perf, 2.086; 0: Age, 31; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.3; 0: Triage HR, 98.0; 0: Triage RR, 20.0; 0: Triage SBP, 156.0; 0: Triage DBP, 91.0; 0: Triage acuity, 2-Emergent; 0: CC, ABDOMINAL PAIN",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The patient's vital signs, including heart rate, respiratory rate, blood pressure, and temperature, remain relatively stable and within normal ranges throughout the recorded period. Although the patient experiences high pain levels and some abnormalities in lab values (e.g., low hemoglobin and albumin), there is no significant drop in blood pressure or alteration in mental status, common indicators of sepsis. Overall, there are no clear signs of systemic infection or shock to suggest a high risk of sepsis within the next 12 hours.",
            "claims": [
                "The patient's vital signs remain relatively stable and within normal ranges throughout the recorded period.",
                "The vital signs include heart rate, respiratory rate, blood pressure, and temperature.",
                "The patient experiences high pain levels.",
                "The patient has some abnormalities in lab values, such as low hemoglobin and albumin.",
                "There is no significant drop in blood pressure.",
                "There is no alteration in mental status.",
                "A significant drop in blood pressure and alteration in mental status are common indicators of sepsis.",
                "Overall, there are no clear signs of systemic infection.",
                "There are no signs of shock to suggest a high risk of sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The patient has some abnormalities in lab values, such as low hemoglobin and albumin."
            ],
            "alignment_scores": [
                0.3
            ],
            "alignment_category": [
                "SOFA Score Increase (\u22652 points)"
            ],
            "alignment_reasonings": [
                "The claim references abnormalities in lab values like low hemoglobin and albumin. Although not directly included in the SOFA criteria, they can be related to underlying issues like liver dysfunction or bleeding, generally associated with organ dysfunction. The alignment is indirect and weak, as these specific lab values are not SOFA components."
            ],
            "final_alignment_score": 0.3
        },
        {
            "input": "8: HR, 120.0; 8: RR, 25.0; 8: SpO2, 86.0; 8: SBP, 105.0; 8: DBP, 77.0; 8: MAP, 86.333; 8: LPM O2, 2.0; 8: Pain, 0.0; 8: Temp, 98.8; 17: HR, 108.0; 17: SpO2, 91.538; 17: 1min HRV, 7.040; 18: HR, 112.138; 18: SpO2, 92.966; 18: Perf, 0.71; 18: 1min HRV, 6.005; 19: HR, 110.915; 19: RR, 24.2; 19: SpO2, 94.932; 19: Perf, 0.629; 19: 1min HRV, 24.315; 20: HR, 111.190; 20: RR, 17.7; 20: SpO2, 96.203; 20: Perf, 0.600; 20: 1min HRV, 4.859; 21: SpO2, 96.224; 21: Perf, 0.638; 21: 5min HRV, 16.412; 22: SpO2, 95.661; 22: Perf, 0.788; 23: HR, 110.6; 23: RR, 28.25; 23: SpO2, 96.310; 23: Perf, 0.871; 23: 1min HRV, 3.451; 24: HR, 110.644; 24: RR, 25.492; 24: SpO2, 95.441; 24: Perf, 0.802; 24: 1min HRV, 8.795; 25: POC PH (V) ISTAT, 7.33; 25: POC PCO2 (V) ISTAT, 34.3 mmHg; 25: POC HCO3 (V) ISTAT, 17.9 mmol/L; 25: POC O2 SATURATION ISTAT VENOUS, 63 %; 25: POC LACTATE ISTAT, 1.94 mmol/L; 25: POC PO2 (V) ISTAT, 35 mmHg; 25: POC TCO2 (V) ISTAT, 19 mmol/L; 25: POC BASE EXCESS ISTAT, -8 mmol/L; 25: HR, 110.576; 25: RR, 28.034; 25: SpO2, 92.746; 25: Perf, 0.727; 25: 1min HRV, 4.456; 26: HR, 109.914; 26: RR, 26.052; 26: SpO2, 92.931; 26: Perf, 0.758; 26: 1min HRV, 4.512; 26: 5min HRV, 6.624; 27: HR, 110.644; 27: RR, 27.237; 27: SpO2, 93.0; 27: Perf, 0.727; 27: 1min HRV, 6.069; 28: HR, 110.793; 28: RR, 24.707; 28: SpO2, 92.052; 28: Perf, 0.718; 28: 1min HRV, 5.125; 29: HR, 110.508; 29: RR, 24.441; 29: SpO2, 91.678; 29: Perf, 0.881; 29: 1min HRV, 24.560; 30: HR, 109.712; 30: RR, 27.068; 30: SpO2, 90.322; 30: Perf, 1.013; 30: 1min HRV, 7.817; 31: HR, 108.431; 31: RR, 26.759; 31: SpO2, 92.638; 31: Perf, 1.119; 31: 1min HRV, 6.071; 31: 5min HRV, 13.418; 31: LPM O2, 3.0; 32: HR, 106.271; 32: RR, 25.339; 32: SpO2, 94.542; 32: Perf, 1.045; 32: 1min HRV, 6.875; 32: SBP, 106.0; 32: DBP, 73.0; 32: MAP, 84.0; 33: HR, 107.586; 33: RR, 25.397; 33: SpO2, 95.0; 33: Perf, 1.158; 33: 1min HRV, 7.604; 35: POC, HCG, ISTAT QUALITATIVE: Negative; 35: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 36: 5min HRV, 7.778; 46: WAM DIFTYP, AUTO; 46: LYMPHOCYTE % (AUTO DIFF), 18.4 %; 46: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.6 g/dL; 46: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 46: PLATELET COUNT (PLT), 209 K/uL; 46: MEAN CORPUSCULAR VOLUME (MCV), 78.8 fL; 46: RED BLOOD CELLS (RBC), 3.86 MIL/uL; 46: RED CELL DISTRIBUTION WIDTH (RDW), 18.5 %; 46: MONOCYTE % (AUTO DIFF), 11.2 %; 46: NRBC ABSOLUTE (HEMATOLOGY), 0.02 K/uL; 46: NEUTROPHIL ABSOLUTE (AUTO DIFF), 9.77 K/uL; 46: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.5 %; 46: HEMATOCRIT (HCT), 30.4 %; 46: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 25.6 pg; 46: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.63 K/uL; 46: MONOCYTE ABSOLUTE (AUTO DIFF), 1.60 K/uL; 46: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.22 K/uL; 46: WHITE BLOOD CELLS (WBC), 14.3 K/uL; 46: BASOPHIL % (AUTO DIFF), 0.3 %; 46: HEMOGLOBIN (HGB), 9.9 g/dL; 46: NEUTROPHIL % (AUTO DIFF), 68.5 %; 46: EOSINOPHIL % (AUTO DIFF), 0.1 %; 46: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 46: NRBC PERCENT (HEMATOLOGY), 0.1 %; 74: CEFEPIME, 2 GRAM/20 ML IV PUSH; 80: SARS-COV-, 2 RNA: Not Detected; 80: VANCOMYCIN-WATER INJECT (PEG), 1 GRAM/200 ML IV PGBK; 83: ALT (SGPT):, 33 U/L; 83: ALKALINE PHOSPHATASE, 300 U/L; 83: AST (SGOT), 27 U/L; 83: BLOOD UREA NITROGEN (BUN), 35 mg/dL; 83: PROTEIN TOTAL, 4.8 g/dL; 83: CALCIUM, 10.9 mg/dL; 83: CORRECTED CALCIUM, 12.3 mg/dL; 83: CREATININE, 1.40 mg/dL; 83: GLOBULIN, 2.5 g/dL; 83: ALBUMIN, 2.3 g/dL; 83: BILIRUBIN TOTAL, 1.2 mg/dL; 83: GLUCOSE, 117 mg/dL; 83: SODIUM, 125 mmol/L; 83: CHLORIDE, 98 mmol/L; 83: EGFR FOR AFRICAN AMERICAN, 56 mL/min/1.73 m2; 83: ANION GAP, 9 mmol/L; 83: POTASSIUM, 4.3 mmol/L; 83: EGFR REFIT WITHOUT RACE (2021), 48 mL/min/1.73 m2; 83: CO2, 18 mmol/L; 92: TROPONIN I, <.017 ng/mL; 99: GLUCOSE, URINE (UA): Negative; 99: NITRITE, URINE (UA): Negative; 99: SPECIFIC GRAVITY, URINE (UA): 1.009; 99: KETONE, URINE (UA): Negative; 99: PH, URINE (UA): 6.0; 117: BNP NT-PRO, 363 pg/mL; 0: Age, 35; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 37.1; 0: Triage HR, 120.0; 0: Triage RR, 25.0; 0: Triage SBP, 105.0; 0: Triage DBP, 77.0; 0: Triage acuity, 2-Emergent; 0: CC, BREATHING PROBLEM",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient presents with several indicators of high sepsis risk, including tachycardia (high heart rate), tachypnea (increased respiratory rate), and low oxygen saturation consistently throughout the time series. Additionally, the lab results show elevated white blood cell count, which can indicate infection, and metabolic acidosis (low bicarbonate levels and low venous pH). The administration of antibiotics such as Cefepime indicates clinical suspicion of a bacterial infection. These factors suggest a high risk of developing sepsis within 12 hours.",
            "claims": [
                "The patient presents with several indicators of high sepsis risk.",
                "The patient has tachycardia (high heart rate).",
                "The patient has tachypnea (increased respiratory rate).",
                "The patient has low oxygen saturation consistently throughout the time series.",
                "The lab results show an elevated white blood cell count.",
                "An elevated white blood cell count can indicate infection.",
                "The lab results show metabolic acidosis.",
                "Metabolic acidosis is characterized by low bicarbonate levels and low venous pH.",
                "The administration of antibiotics such as Cefepime indicates clinical suspicion of a bacterial infection.",
                "These factors suggest a high risk of developing sepsis within 12 hours."
            ],
            "relevant_claims": [
                "The patient presents with several indicators of high sepsis risk.",
                "The patient has tachycardia (high heart rate).",
                "The patient has tachypnea (increased respiratory rate).",
                "The patient has low oxygen saturation consistently throughout the time series.",
                "An elevated white blood cell count can indicate infection.",
                "The lab results show metabolic acidosis.",
                "The administration of antibiotics such as Cefepime indicates clinical suspicion of a bacterial infection.",
                "These factors suggest a high risk of developing sepsis within 12 hours."
            ],
            "alignment_scores": [
                0.3,
                0.7,
                0.8,
                0.7,
                0.9,
                0.7,
                0.8,
                0.3
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SOFA Score Increase (\u22652 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "The claim refers vaguely to \"several indicators of high sepsis risk\" without specifying any criteria or measurements. The NEWS score incorporates multiple vitals that contribute to assessing sepsis risk. Although the claim doesn't specify the related markers, the idea of \"several indicators\" conceptually aligns with the aggregation of various signs in the NEWS calculation. However, the lack of detail in the claim reduces alignment specificity, thus resulting in a lower alignment rating.",
                "Tachycardia, defined as a heart rate >90 bpm, is explicitly mentioned as one of the criteria for SIRS positivity. It aligns well with this category as it is a key indicator of systemic inflammation and early sepsis risk, though it independently does not fully meet the SIRS '\u22652 criteria' threshold. Thus, the alignment is strong but not perfect.",
                "Tachypnea, or an increased respiratory rate, is directly associated with the SIRS criteria (specifically, a respiratory rate > 20/min). This suggests systemic inflammation, consistent with early sepsis. Although the claim does not provide specific respiratory rate values, tachypnea aligns well with this category, warranting a high alignment rating. The direct link, however, could be stronger if exact values were provided.",
                "Low oxygen saturation indicates potential issues with oxygenation, which could correspond to the respiratory component of the SOFA score. Although it doesn't directly measure PaO\u2082/FiO\u2082, it suggests possible impaired lung function, fitting the SOFA criteria context. The alignment is indirect but significant, thus the rating is moderate.",
                "The claim mentions an elevated white blood cell count, which is explicitly listed as one of the SIRS criteria to identify systemic inflammation consistent with early sepsis. The alignment is strong, but the claim does not provide specific WBC values to meet the precise SIRS threshold (WBC\u202f>\u202f12,000/\u00b5L or\u202f<\u202f4,000/\u00b5L), hence slightly less than perfect alignment.",
                "Metabolic acidosis can be associated with elevated lactate levels due to tissue hypoperfusion, which is often seen in sepsis. While not explicitly stating the serum lactate level, the concept of metabolic acidosis closely aligns with the risk factor of elevated serum lactate used in sepsis prediction. The alignment is indirect but relevant, hence the moderate rating.",
                "The claim directly mentions the administration of antibiotics, which is a key clinical action strongly associated with this category. Administering antibiotics like Cefepime suggests a high suspicion of bacterial infection, a situation where rapid response is crucial. However, the timing (within 2 hours) isn't specified, preventing a perfect alignment.",
                "The claim is very general and does not specify any specific factors or clinical measurements. An elevated NEWS score is a general predictor of clinical deterioration, which could include sepsis. Given that the claim implies a prediction of sepsis within a specific timeframe (12 hours), it loosely aligns with the purpose of using an elevated NEWS score to predict deterioration, though the alignment is weak without specific details."
            ],
            "final_alignment_score": 0.65
        },
        {
            "input": "5: HR, 136.0; 5: RR, 16.0; 5: SpO2, 98.0; 5: SBP, 122.0; 5: DBP, 79.0; 5: MAP, 93.333; 5: Temp, 100.8; 14: SpO2, 96.089; 15: HR, 129.462; 15: RR, 20.722; 15: SpO2, 97.431; 15: 1min HRV, 7.348; 16: HR, 127.492; 16: RR, 21.695; 16: SpO2, 97.356; 16: 1min HRV, 3.740; 17: HR, 129.172; 17: RR, 20.086; 17: SpO2, 97.517; 17: 1min HRV, 4.378; 18: HR, 128.814; 18: RR, 21.169; 18: SpO2, 97.864; 18: 1min HRV, 3.746; 18: 5min HRV, 5.221; 19: HR, 126.881; 19: RR, 26.492; 19: SpO2, 97.576; 19: 1min HRV, 9.624; 20: POC PH (V) ISTAT, 7.44; 20: POC LACTATE ISTAT, 1.52 mmol/L; 20: POC TCO2 (V) ISTAT, 26 mmol/L; 20: POC BASE EXCESS ISTAT, 1 mmol/L; 20: POC O2 SATURATION ISTAT VENOUS, 78 %; 20: POC HCO3 (V) ISTAT, 25.2 mmol/L; 20: POC PO2 (V) ISTAT, 41 mmHg; 20: POC PCO2 (V) ISTAT, 37.1 mmHg; 20: HR, 125.397; 20: RR, 25.517; 20: SpO2, 97.310; 20: 1min HRV, 6.978; 21: HR, 127.136; 21: RR, 26.424; 21: SpO2, 97.559; 21: 1min HRV, 4.623; 22: HR, 127.121; 22: RR, 24.828; 22: SpO2, 97.328; 22: 1min HRV, 16.265; 23: HR, 128.102; 23: RR, 21.220; 23: SpO2, 97.864; 23: 1min HRV, 17.616; 23: 5min HRV, 12.635; 24: HR, 126.051; 24: RR, 24.424; 24: SpO2, 97.729; 24: 1min HRV, 5.951; 25: HR, 126.776; 25: RR, 24.155; 25: SpO2, 97.362; 25: 1min HRV, 4.675; 26: HR, 127.0; 26: RR, 23.508; 26: SpO2, 97.966; 26: 1min HRV, 4.440; 26: SBP, 116.0; 26: DBP, 77.0; 26: MAP, 90.0; 27: HR, 125.879; 27: RR, 27.259; 27: SpO2, 97.466; 27: 1min HRV, 5.543; 28: HR, 126.508; 28: RR, 25.475; 28: SpO2, 97.712; 28: 1min HRV, 7.168; 28: 5min HRV, 6.036; 28: SBP, 124.0; 28: DBP, 74.0; 28: MAP, 90.667; 28: Temp, 101.1; 29: HR, 124.603; 29: RR, 24.052; 29: SpO2, 98.0; 29: 1min HRV, 8.227; 29: SBP, 124.0; 29: DBP, 74.0; 29: MAP, 90.667; 30: HR, 126.407; 30: RR, 21.610; 30: SpO2, 97.949; 30: 1min HRV, 5.456; 31: HR, 126.0; 31: RR, 27.0; 31: SpO2, 97.322; 31: 1min HRV, 4.318; 32: HR, 124.552; 32: RR, 27.586; 32: SpO2, 97.552; 32: 1min HRV, 18.025; 33: HR, 125.746; 33: RR, 27.695; 33: SpO2, 97.610; 33: 1min HRV, 4.128; 33: 5min HRV, 9.856; 34: HR, 125.310; 34: RR, 27.845; 34: SpO2, 97.621; 34: 1min HRV, 4.438; 35: HR, 124.068; 35: RR, 25.729; 35: SpO2, 97.576; 35: 1min HRV, 5.781; 36: HR, 124.966; 36: RR, 25.814; 36: SpO2, 97.864; 36: 1min HRV, 6.834; 37: HR, 124.621; 37: RR, 23.603; 37: SpO2, 97.983; 37: 1min HRV, 6.626; 38: HR, 128.559; 38: RR, 27.322; 38: SpO2, 97.542; 38: 1min HRV, 11.386; 38: 5min HRV, 10.032; 38: ACETAMINOPHEN, 500 MG PO TABS; 39: HR:, 125.466; 39: RR, 23.931; 39: SpO2, 98.586; 39: 1min HRV, 13.072; 40: HR, 125.305; 40: RR, 18.831; 40: SpO2, 98.068; 40: Perf, 1.216; 40: 1min HRV, 22.549; 41: HR, 123.034; 41: RR, 23.966; 41: SpO2, 97.966; 41: Perf, 1.656; 41: 1min HRV, 10.291; 42: HR, 127.224; 42: RR, 23.828; 42: SpO2, 97.862; 42: Perf, 1.72; 42: 1min HRV, 8.718; 43: HR, 124.763; 43: RR, 24.034; 43: SpO2, 97.475; 43: Perf, 1.72; 43: 1min HRV, 5.967; 43: 5min HRV, 13.759; 44: HR, 123.293; 44: RR, 24.672; 44: SpO2, 97.121; 44: Perf, 1.72; 44: 1min HRV, 6.401; 44: SBP, 130.0; 44: DBP, 76.0; 44: MAP, 94.0; 45: HR, 123.475; 45: RR, 26.712; 45: SpO2, 97.237; 45: Perf, 1.72; 45: 1min HRV, 4.158; 46: HR, 123.492; 46: RR, 27.729; 46: SpO2, 97.305; 46: Perf, 1.72; 46: 1min HRV, 4.571; 47: HR, 125.310; 47: RR, 25.017; 47: SpO2, 97.5; 47: Perf, 1.72; 47: 1min HRV, 8.107; 48: HR, 122.814; 48: RR, 24.271; 48: SpO2, 97.831; 48: Perf, 1.72; 48: 1min HRV, 4.364; 48: 5min HRV, 6.794; 49: HR, 123.655; 49: RR, 24.121; 49: SpO2, 97.862; 49: Perf, 1.72; 49: 1min HRV, 4.398; 53: 5min HRV, 4.398; 57: ANTIBODY SCREEN 3, NEG; 57: ABO/RH (AUTOMATION), A Positive; 61: LR IV BOLUS -, 1000 ML; 62: INR:, 1.0; 62: PROTHROMBIN TIME, 13.3 seconds; 63: PART. THROMBOPLASTIN TIME, 36.0 seconds; 71: GLOBULIN, 2.3 g/dL; 71: CALCIUM, 9.5 mg/dL; 71: EGFR FOR AFRICAN AMERICAN, 111 mL/min/1.73 m2; 71: ALT (SGPT), 58 U/L; 71: BILIRUBIN TOTAL, 1.3 mg/dL; 71: CO2, 24 mmol/L; 71: ALKALINE PHOSPHATASE, 89 U/L; 71: AST (SGOT), 35 U/L; 71: BLOOD UREA NITROGEN (BUN), 14 mg/dL; 71: PROTEIN TOTAL, 6.5 g/dL; 71: ALBUMIN, 4.2 g/dL; 71: GLUCOSE, 120 mg/dL; 71: CHLORIDE, 102 mmol/L; 71: POTASSIUM, 4.0 mmol/L; 71: ANION GAP, 11 mmol/L; 71: CREATININE, 0.79 mg/dL; 71: EGFR REFIT WITHOUT RACE (2021), 96 mL/min/1.73 m2; 71: SODIUM, 137 mmol/L; 71: CORRECTED CALCIUM, 9.3 mg/dL; 95: SARS-COV-2 RNA, Not Detected; 116: CEFEPIME, 2 GRAM/20 ML IV PUSH; 118: HR:, 111.0; 118: RR, 20.0; 118: SpO2, 98.0; 118: SBP, 116.0; 118: DBP, 71.0; 118: MAP, 86.0; 118: Temp, 99.5; 0: Age, 62; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 38.2; 0: Triage HR, 136.0; 0: Triage RR, 16.0; 0: Triage SBP, 122.0; 0: Triage DBP, 79.0; 0: Triage acuity, 2-Emergent; 0: CC, CHILLS",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient presents with multiple sepsis risk indicators: elevated heart rate (136 BPM initially), fever (temperatures above 38\u00b0C), and a high respiration rate (above 20 breaths per minute during several time points). The presence of chills and administration of antibiotics and IV fluid suggest clinical concern for sepsis. The decision by the healthcare team to administer antibiotics (Cefepime) indicates a suspicion of a bacterial infection, further supporting the high-risk assessment for sepsis within the next 12 hours.",
            "claims": [
                "The patient presents with multiple sepsis risk indicators.",
                "The patient has an elevated heart rate of 136 BPM initially.",
                "The patient has a fever with temperatures above 38\u00b0C.",
                "The patient has a high respiration rate above 20 breaths per minute during several time points.",
                "The presence of chills suggests clinical concern for sepsis.",
                "The administration of antibiotics indicates clinical concern for sepsis.",
                "The administration of IV fluid suggests clinical concern for sepsis.",
                "The healthcare team decided to administer antibiotics (Cefepime).",
                "The administration of Cefepime indicates a suspicion of a bacterial infection.",
                "The suspicion of a bacterial infection supports the high-risk assessment for sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The patient presents with multiple sepsis risk indicators.",
                "The patient has an elevated heart rate of 136 BPM initially.",
                "The patient has a fever with temperatures above 38\u00b0C.",
                "The patient has a high respiration rate above 20 breaths per minute during several time points.",
                "The presence of chills suggests clinical concern for sepsis.",
                "The administration of antibiotics indicates clinical concern for sepsis.",
                "The administration of IV fluid suggests clinical concern for sepsis.",
                "The healthcare team decided to administer antibiotics (Cefepime).",
                "The administration of Cefepime indicates a suspicion of a bacterial infection.",
                "The suspicion of a bacterial infection supports the high-risk assessment for sepsis within the next 12 hours."
            ],
            "alignment_scores": [
                0.5,
                0.5,
                0.8,
                0.9,
                0.4,
                0.9,
                0.6,
                1.0,
                0.9,
                0.5
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "Early Antibiotic/Culture Orders (within 2 hours)"
            ],
            "alignment_reasonings": [
                "The claim mentions \"multiple sepsis risk indicators,\" which suggests a general observation of multiple concerning symptoms, similar to the NEWS score approach, where multiple vital signs are monitored and aggregated to assess risk. The alignment is moderate since the claim lacks specific identifiers that belong to a particular category, providing a more generalized indication rather than specific criteria required by other more defined categories.",
                "The elevated heart rate (tachycardia) indicated in the claim exceeds the SIRS criteria threshold of >90 bpm, directly relating to one of the SIRS criteria used to identify systemic inflammation consistent with early sepsis. However, since the claim only mentions one criterion (heart rate) and not two or more required for full SIRS positivity, the alignment is moderate.",
                "Fever with a temperature above 38\u00b0C is one of the criteria explicitly listed under the Systemic Inflammatory Response Syndrome (SIRS) category, which indicates systemic inflammation consistent with early sepsis. While a fever by itself meets one of the SIRS criteria (temperature > 38\u00b0C), alignment would be perfect if there were additional SIRS criteria present. Therefore, the alignment is strong but not complete, hence a score of 0.8.",
                "A respiration rate above 20 breaths per minute matches one of the specific SIRS criteria for identifying systemic inflammation consistent with early sepsis. Although the claim only provides one criterion, the high respiration rate is precisely listed under SIRS criteria, indicating a strong alignment but not complete since it requires at least two criteria.",
                "The presence of chills indicates a potential infection and a concern for sepsis, which may prompt further investigation, such as blood cultures or antibiotics. However, this claim lacks explicit reference to any concrete diagnostic or treatment actions, aligning indirectly with the category of early suspicion for sepsis.",
                "The claim involves the administration of antibiotics, which directly aligns with the category concerning early antibiotic orders within the context of suspected sepsis. Although the timing relative to the sepsis identification metric (within 2 hours) isn\u2019t explicitly mentioned, the administration alone indicates a strong alignment with clinician suspicion of serious infection, thus justifying a high alignment rating.",
                "The administration of IV fluids often indicates concern for hypotension or dehydration, which in the context of sepsis commonly aligns with efforts to treat or prevent sepsis-associated hypotension. While the claim does not specify blood pressure measurements that would perfectly align with this category, the IV fluid administration suggests an indirect concern for potential hemodynamic instability associated with sepsis. The alignment isn't direct due to the lack of specific blood pressure readings, but it is a meaningful consideration in the context of sepsis management.",
                "The claim directly references the administration of antibiotics, which is a concrete clinical action indicating a suspicion of serious infection. This aligns perfectly with the Early Antibiotic/Culture Orders category, suggesting a high sepsis risk.",
                "The administration of Cefepime, a broad-spectrum antibiotic, strongly indicates clinician suspicion of a serious bacterial infection, aligning well with the category that involves early antibiotic administration. The near-perfect alignment reflects the proactive treatment step typical in confirmed or highly suspected sepsis cases.",
                "The claim mentions suspicion of a bacterial infection, which aligns conceptually with the category that involves early intervention steps based on suspected infection. However, the claim does not specify actions such as administering antibiotics or conducting cultures within 2 hours. Thus, the alignment with the category is present but not strongly defined by specific clinical actions, warranting a moderate rating."
            ],
            "final_alignment_score": 0.7000000000000001
        },
        {
            "input": "3: HR, 113.0; 3: RR, 16.0; 3: SpO2, 99.0; 3: SBP, 100.0; 3: DBP, 53.0; 3: MAP, 68.667; 3: Pain, 9.0; 3: Temp, 97.7; 63: HR, 108.259; 63: RR, 23.222; 63: 1min HRV, 2.271; 64: HR, 107.390; 64: RR, 18.0; 64: SpO2, 98.5; 64: 1min HRV, 20.909; 65: HR, 104.797; 65: RR, 18.288; 65: SpO2, 99.0; 65: Perf, 0.282; 65: 1min HRV, 3.347; 66: HR, 104.569; 66: RR, 20.379; 66: SpO2, 99.589; 66: Perf, 0.233; 66: 1min HRV, 3.413; 66: 5min HRV, 13.865; 66: SBP, 99.0; 66: DBP, 60.0; 66: MAP, 73.0; 67: HR, 105.220; 67: RR, 20.559; 67: SpO2, 99.305; 67: Perf, 0.468; 67: 1min HRV, 3.043; 68: HR, 104.862; 68: RR, 17.431; 68: SpO2, 99.138; 68: Perf, 0.607; 68: 1min HRV, 19.816; 69: HR, 103.508; 69: RR, 17.339; 69: SpO2, 98.746; 69: Perf, 0.731; 69: 1min HRV, 5.278; 70: HR, 103.397; 70: RR, 18.759; 70: SpO2, 98.276; 70: Perf, 0.855; 70: 1min HRV, 4.453; 71: HR, 105.220; 71: RR, 16.814; 71: SpO2, 97.672; 71: Perf, 0.354; 71: 1min HRV, 3.284; 71: 5min HRV, 10.753; 72: HR, 106.254; 72: RR, 19.525; 72: SpO2, 98.0; 72: Perf, 0.328; 72: 1min HRV, 3.043; 73: HR, 105.086; 73: RR, 17.379; 73: SpO2, 97.966; 73: Perf, 0.460; 73: 1min HRV, 4.894; 74: HR, 105.169; 74: RR, 19.407; 74: SpO2, 98.475; 74: Perf, 0.698; 74: 1min HRV, 5.951; 75: HR, 103.897; 75: RR, 20.086; 75: SpO2, 98.431; 75: Perf, 0.831; 75: 1min HRV, 2.929; 76: HR, 101.593; 76: RR, 22.356; 76: SpO2, 98.115; 76: Perf, 0.738; 76: 1min HRV, 5.040; 76: 5min HRV, 10.054; 76: SBP, 99.0; 76: DBP, 60.0; 76: MAP, 73.0; 77: HR, 101.475; 77: RR, 23.559; 77: SpO2, 98.891; 77: Perf, 0.798; 77: 1min HRV, 7.057; 78: HR, 102.517; 78: RR, 18.845; 78: SpO2, 99.25; 78: Perf, 0.83; 78: 1min HRV, 6.585; 79: HR, 102.220; 79: RR, 18.034; 79: 1min HRV, 15.981; 80: HR, 101.448; 80: RR, 17.914; 80: 1min HRV, 3.591; 81: HR, 101.763; 81: RR, 19.525; 81: 1min HRV, 4.064; 81: 5min HRV, 9.065; 82: HR, 102.237; 82: RR, 19.847; 82: 1min HRV, 4.790; 82: SBP, 93.0; 82: DBP, 60.0; 82: MAP, 71.0; 83: HR, 103.759; 83: RR, 21.017; 83: 1min HRV, 2.918; 84: HR, 103.458; 84: RR, 22.153; 84: 1min HRV, 25.080; 85: HR, 102.741; 85: RR, 17.431; 85: 1min HRV, 3.035; 86: HR, 102.763; 86: RR, 20.508; 86: SpO2, 97.707; 86: 1min HRV, 16.972; 86: 5min HRV, 14.220; 87: HR, 102.932; 87: RR, 16.169; 87: SpO2, 96.898; 87: Perf, 0.732; 87: 1min HRV, 2.928; 88: HR, 102.310; 88: RR, 15.914; 88: SpO2, 97.379; 88: Perf, 0.589; 88: 1min HRV, 2.836; 89: HR, 101.136; 89: RR, 20.339; 89: SpO2, 96.407; 89: Perf, 0.467; 89: 1min HRV, 28.272; 90: HR, 102.690; 90: RR, 18.552; 90: SpO2, 97.052; 90: Perf, 0.338; 90: 1min HRV, 2.962; 91: HR, 102.186; 91: RR, 20.288; 91: SpO2, 97.789; 91: Perf, 0.322; 91: 1min HRV, 2.993; 91: 5min HRV, 13.305; 92: HR, 101.017; 92: RR, 19.271; 92: SpO2, 97.741; 92: Perf, 0.298; 92: 1min HRV, 3.328; 93: HR, 100.914; 93: RR, 20.259; 93: SpO2, 98.328; 93: Perf, 0.307; 93: 1min HRV, 4.303; 94: HR, 100.254; 94: RR, 19.305; 94: SpO2, 98.542; 94: Perf, 0.392; 94: 1min HRV, 16.879; 95: BLOOD UREA NITROGEN (BUN), 44 mg/dL; 95: EGFR REFIT WITHOUT RACE (2021), 22 mL/min/1.73 m2; 95: AST (SGOT), 66 U/L; 95: SODIUM, 130 mmol/L; 95: ANION GAP, 18 mmol/L; 95: CO2, 24 mmol/L; 95: ALKALINE PHOSPHATASE, 67 U/L; 95: ALT (SGPT), 19 U/L; 95: CREATININE, 2.50 mg/dL; 95: CHLORIDE, 88 mmol/L; 95: GLOBULIN, 5.0 g/dL; 95: PROTEIN TOTAL, 8.7 g/dL; 95: POTASSIUM, 5.6 mmol/L; 95: CALCIUM, 9.9 mg/dL; 95: CORRECTED CALCIUM, 10.1 mg/dL; 95: BILIRUBIN TOTAL, 0.5 mg/dL; 95: ALBUMIN, 3.7 g/dL; 95: GLUCOSE, 158 mg/dL; 95: HR, 100.638; 95: RR, 20.466; 95: SpO2, 99.0; 95: Perf, 0.416; 95: 1min HRV, 8.345; 96: SARS-COV-2 RNA, Not Detected; 96: HR, 100.288; 96: RR, 17.864; 96: SpO2, 99.169; 96: Perf, 0.434; 96: 1min HRV, 7.287; 96: 5min HRV, 9.559; 96: Pain, 10.0; 97: HR, 97.322; 97: RR, 15.288; 97: SpO2, 99.339; 97: Perf, 0.489; 97: 1min HRV, 6.903; 98: HR, 95.603; 98: RR, 12.103; 98: SpO2, 98.121; 98: Perf, 0.430; 98: 1min HRV, 5.772; 99: HR, 97.0; 99: RR, 14.576; 99: SpO2, 97.356; 99: Perf, 0.417; 99: 1min HRV, 27.925; 100: HR, 95.448; 100: RR, 18.810; 100: SpO2, 98.241; 100: Perf, 0.445; 100: 1min HRV, 7.272; 101: HR, 96.712; 101: RR, 21.085; 101: SpO2, 98.0; 101: Perf, 0.409; 101: 1min HRV, 5.961; 101: 5min HRV, 14.265; 102: HR, 96.845; 102: RR, 18.397; 102: SpO2, 98.948; 102: Perf, 0.392; 102: 1min HRV, 5.895; 103: HR, 95.492; 103: RR, 19.153; 103: SpO2, 98.814; 103: Perf, 0.334; 103: 1min HRV, 5.351; 104: HR, 95.305; 104: RR, 19.644; 104: SpO2, 98.780; 104: Perf, 0.324; 104: 1min HRV, 8.790; 105: HR, 94.190; 105: RR, 18.190; 105: SpO2, 99.475; 105: Perf, 0.292; 105: 1min HRV, 3.851; 106: HR, 95.220; 106: RR, 18.983; 106: SpO2, 99.282; 106: Perf, 0.21; 106: 1min HRV, 7.364; 106: 5min HRV, 8.084; 107: HR, 92.397; 107: RR, 20.379; 107: SpO2, 99.394; 107: Perf, 0.216; 107: 1min HRV, 8.601; 108: HR, 92.254; 108: RR, 16.695; 108: SpO2, 98.947; 108: Perf, 0.201; 108: 1min HRV, 8.056; 108: MORPHINE, 4 MG/ML IV SYRG; 109: HR:, 92.678; 109: RR, 18.356; 109: SpO2, 98.814; 109: Perf, 0.276; 109: 1min HRV, 9.551; 110: HR, 93.259; 110: RR, 19.069; 110: SpO2, 97.509; 110: Perf, 0.314; 110: 1min HRV, 5.623; 111: HR, 93.763; 111: RR, 19.864; 111: SpO2, 98.807; 111: Perf, 0.306; 111: 1min HRV, 5.628; 111: 5min HRV, 8.911; 111: LR IV BOLUS -, 1000 ML; 112: HR:, 95.345; 112: RR, 19.483; 112: SpO2, 98.879; 112: Perf, 0.294; 112: 1min HRV, 6.629; 112: SBP, 79.0; 112: DBP, 59.0; 112: MAP, 65.667; 113: HR, 95.373; 113: RR, 18.051; 113: SpO2, 99.356; 113: Perf, 0.352; 113: 1min HRV, 6.753; 114: HR, 93.881; 114: RR, 19.763; 114: SpO2, 99.407; 114: Perf, 0.336; 114: 1min HRV, 7.098; 115: HR, 93.741; 115: RR, 18.879; 115: SpO2, 98.912; 115: Perf, 0.289; 115: 1min HRV, 7.738; 116: HR, 94.119; 116: RR, 17.847; 116: SpO2, 99.0; 116: Perf, 0.26; 116: 1min HRV, 8.469; 116: 5min HRV, 9.063; 117: HR, 91.983; 117: RR, 20.207; 117: SpO2, 99.316; 117: Perf, 0.245; 117: 1min HRV, 6.011; 118: HR, 92.186; 118: RR, 18.119; 118: SpO2, 100.0; 118: Perf, 0.156; 118: 1min HRV, 7.891; 119: HR, 94.458; 119: RR, 18.220; 119: SpO2, 100.0; 119: Perf, 0.13; 119: 1min HRV, 23.407; 119: SBP, 84.0; 119: DBP, 53.0; 119: MAP, 63.333; 0: Age, 59; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.5; 0: Triage HR, 113.0; 0: Triage RR, 16.0; 0: Triage SBP, 100.0; 0: Triage DBP, 53.0; 0: Triage acuity, 3-Urgent; 0: CC, WOUND CHECK",
            "answer": true,
            "llm_answer": "No",
            "llm_explanation": "The initial presentation shows some signs that could be concerning, such as elevated heart rate and low diastolic blood pressure, which are monitored over time. However, the patient\u2019s heart rate stabilizes, the respiratory rate remains within a reasonable range, and the oxygen saturation is consistently high. No persistent hypotension or elevated lactate levels are visible in the data provided, which are typically strong indicators of sepsis risk. Additionally, the patient received morphine and a liter of IV fluids, which may influence some parameters like heart rate and blood pressure. Considering these observations, the data doesn't strongly indicate a high risk of developing sepsis within the next 12 hours.",
            "claims": [
                "The initial presentation shows some concerning signs.",
                "The concerning signs include elevated heart rate and low diastolic blood pressure.",
                "Heart rate is monitored over time.",
                "The patient's heart rate stabilizes.",
                "The respiratory rate remains within a reasonable range.",
                "The oxygen saturation is consistently high.",
                "No persistent hypotension is visible in the data provided.",
                "No elevated lactate levels are visible in the data provided.",
                "Persistent hypotension and elevated lactate levels are typically strong indicators of sepsis risk.",
                "The patient received morphine.",
                "The patient received a liter of IV fluids.",
                "Morphine and IV fluids may influence parameters like heart rate and blood pressure.",
                "The data does not strongly indicate a high risk of developing sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The concerning signs include elevated heart rate and low diastolic blood pressure.",
                "No persistent hypotension is visible in the data provided.",
                "No elevated lactate levels are visible in the data provided."
            ],
            "alignment_scores": [
                0.8,
                0.8,
                0.7
            ],
            "alignment_category": [
                "Elevated Shock Index (\u22651.0)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Elevated Serum Lactate (\u22652 mmol/L)"
            ],
            "alignment_reasonings": [
                "The claim specifically mentions \"elevated heart rate\" and \"low diastolic blood pressure,\" which together suggest potential haemodynamic instability characteristic of an elevated shock index (heart rate \u00f7 systolic BP). While the claim doesn't explicitly calculate the shock index, the presence of these factors indicates a likely elevation. The alignment is strong because both elements directly contribute to determining a shock index, but the claim does not specifically mention the index itself, leading to a slightly less than perfect score.",
                "The claim directly references the absence of persistent hypotension, which is a key factor within the \"Sepsis-Associated Hypotension\" category. The absence suggests a low risk of sepsis progression towards shock, aligning well with the category's focus, but since it's an absence of criteria rather than presence, the alignment is not perfect.",
                "The claim specifically mentions the absence of elevated lactate levels, which is directly related to the category of elevated serum lactate as a marker for sepsis risk. While the claim aligns with the category, the absence of elevated lactate levels does not confirm sepsis risk, hence the alignment rating is moderate."
            ],
            "final_alignment_score": 0.7666666666666666
        },
        {
            "input": "14: HR, 142.0; 14: RR, 20.0; 14: SpO2, 94.0; 14: SBP, 105.0; 14: DBP, 72.0; 14: MAP, 83.0; 14: Pain, 0.0; 14: Temp, 97.9; 36: POC PH (V) ISTAT, 7.30; 36: POC LACTATE ISTAT, 1.08 mmol/L; 36: POC TCO2 (V) ISTAT, 27 mmol/L; 36: POC HCO3 (V) ISTAT, 25.2 mmol/L; 36: POC PCO2 (V) ISTAT, 51.6 mmHg; 36: POC PO2 (V) ISTAT, 29 mmHg; 36: POC BASE EXCESS ISTAT, -1 mmol/L; 36: POC O2 SATURATION ISTAT VENOUS, 48 %; 37: HR, 126.719; 37: RR, 25.732; 37: 1min HRV, 13.425; 37: SBP, 121.0; 37: DBP, 73.0; 37: MAP, 89.0; 37: LR IV BOLUS -, 1000 ML; 38: HR:, 126.638; 38: RR, 22.397; 38: SpO2, 96.0; 38: 1min HRV, 14.436; 38: SBP, 121.0; 38: DBP, 73.0; 38: MAP, 89.0; 39: HR, 129.441; 39: RR, 16.407; 39: 1min HRV, 10.516; 40: HR, 126.203; 40: RR, 19.780; 40: 1min HRV, 21.605; 40: 5min HRV, 16.186; 41: HR, 124.534; 41: RR, 19.672; 41: 1min HRV, 15.972; 42: HR, 124.169; 42: RR, 23.763; 42: 1min HRV, 13.252; 42: Pain, 6.0; 43: HR, 121.569; 43: RR, 16.466; 43: 1min HRV, 23.672; 44: HR, 122.220; 44: RR, 19.169; 44: 1min HRV, 26.307; 45: HR, 120.678; 45: RR, 19.627; 45: SpO2, 96.0; 45: 1min HRV, 16.388; 45: 5min HRV, 20.748; 45: SBP, 114.0; 45: DBP, 88.0; 45: MAP, 96.667; 46: HR, 117.397; 46: RR, 17.362; 46: 1min HRV, 21.886; 46: SBP, 114.0; 46: DBP, nan; 46: MAP, nan; 47: HR, 115.661; 47: RR, 17.085; 47: 1min HRV, 45.698; 48: HR, 120.776; 48: RR, 20.293; 48: 1min HRV, 21.509; 49: HR, 119.339; 49: RR, 20.898; 49: 1min HRV, 19.138; 50: HR, 117.356; 50: RR, 19.220; 50: 1min HRV, 21.795; 50: 5min HRV, 28.716; 51: HR, 116.655; 51: RR, 17.638; 51: 1min HRV, 40.855; 52: HR, 116.390; 52: RR, 19.119; 52: 1min HRV, 20.976; 53: HR, 114.414; 53: RR, 21.828; 53: 1min HRV, 22.699; 54: HR, 111.559; 54: RR, 20.797; 54: 1min HRV, 23.915; 55: HR, 112.424; 55: RR, 20.881; 55: 1min HRV, 37.342; 55: 5min HRV, 31.574; 56: HR, 113.276; 56: RR, 17.328; 56: 1min HRV, 19.370; 57: HR, 110.576; 57: RR, 20.203; 57: 1min HRV, 38.104; 58: HR, 105.931; 58: RR, 22.845; 58: 1min HRV, 14.892; 59: HR, 107.576; 59: RR, 23.864; 59: 1min HRV, 16.178; 60: HR, 109.724; 60: RR, 23.914; 60: 1min HRV, 33.069; 60: 5min HRV, 29.141; 61: HR, 109.492; 61: RR, 21.271; 61: 1min HRV, 36.478; 62: HR, 107.949; 62: RR, 23.068; 62: 1min HRV, 28.136; 63: HR, 109.397; 63: RR, 25.552; 63: 1min HRV, 31.885; 64: HR, 105.881; 64: RR, 21.712; 64: 1min HRV, 45.909; 65: HR, 105.052; 65: RR, 20.966; 65: 1min HRV, 35.182; 65: 5min HRV, 37.445; 66: HR, 107.271; 66: RR, 23.085; 66: 1min HRV, 36.498; 67: HR, 103.695; 67: RR, 20.864; 67: 1min HRV, 40.807; 68: POC HGB (CALC) ISTAT, 17.7 g/dL; 68: POC HCT ISTAT, 52 %; 68: POC POTASSIUM ISTAT, 7.0 mmol/L; 68: POC SODIUM ISTAT, 128 mmol/L; 68: POC GLUCOSE ISTAT, 97 mg/dL; 68: HR, 102.897; 68: RR, 21.103; 68: 1min HRV, 42.232; 69: WAM DIFTYP, AUTO; 69: MEAN CORPUSCULAR VOLUME (MCV), 85.0 fL; 69: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 69: RED CELL DISTRIBUTION WIDTH (RDW), 14.6 %; 69: HEMATOCRIT (HCT), 54.4 %; 69: BASOPHIL % (AUTO DIFF), 0.6 %; 69: LYMPHOCYTE % (AUTO DIFF), 12.2 %; 69: NEUTROPHIL ABSOLUTE (AUTO DIFF), 13.58 K/uL; 69: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.1 pg; 69: WHITE BLOOD CELLS (WBC), 17.6 K/uL; 69: RED BLOOD CELLS (RBC), 6.40 MIL/uL; 69: NRBC PERCENT (HEMATOLOGY), 0.0 %; 69: HEMOGLOBIN (HGB), 18.6 g/dL; 69: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 69: EOSINOPHIL % (AUTO DIFF), 1.6 %; 69: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.09 K/uL; 69: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.2 g/dL; 69: MONOCYTE ABSOLUTE (AUTO DIFF), 1.42 K/uL; 69: MONOCYTE % (AUTO DIFF), 8.0 %; 69: PLATELET COUNT (PLT), 520 K/uL; 69: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.16 K/uL; 69: NEUTROPHIL % (AUTO DIFF), 77.1 %; 69: BASOPHIL ABSOLUTE (AUTO DIFF), 0.11 K/uL; 69: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.28 K/uL; 69: HR, 106.203; 69: RR, 22.695; 69: 1min HRV, 24.347; 70: 5min HRV, 38.258; 78: CALCIUM GLUC IN NACL ISO-OSM, 1 GRAM/50 ML IV SOLN; 82: HIGH SENSITIVITY TROPONIN: <, 4 ng/L; 94: INFLUENZA A, Not Detected; 94: RSV, Not Detected; 94: SARS-COV-2 RNA, Not Detected; 94: INFLUENZA B, Not Detected; 98: RR, 23.0; 98: SpO2, 97.0; 98: LPM O2, 15.0; 98: ALBUTEROL CONTINUOUS NEBULIZER SOLUTION, 15 MG/HR (RT MIXTURE); 116: POC GLUCOSE BY METER:, 88 mg/dL; 119: DEXTROSE, 20 % IN WATER (D20W) IVPB BOLUS; 0: Age:, 18; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 142.0; 0: Triage RR, 20.0; 0: Triage SBP, 105.0; 0: Triage DBP, 72.0; 0: Triage acuity, 2-Emergent; 0: CC, RAPID HEART RATE",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient exhibits several indicators of potential sepsis risk, such as persistently elevated heart rate (tachycardia), elevated respiratory rate (tachypnea), and abnormalities in blood results like high potassium and low sodium levels. The presence of high white blood cell count and neutrophilia, increased lactate levels, and elevated heart rate variability further suggest systemic stress. Together, these factors indicate a potentially high risk of the patient developing sepsis within the next 12 hours.",
            "claims": [
                "The patient exhibits several indicators of potential sepsis risk.",
                "The patient has a persistently elevated heart rate (tachycardia).",
                "The patient has an elevated respiratory rate (tachypnea).",
                "The patient has abnormalities in blood results, including high potassium levels.",
                "The patient has abnormalities in blood results, including low sodium levels.",
                "The presence of a high white blood cell count suggests systemic stress.",
                "The presence of neutrophilia suggests systemic stress.",
                "Increased lactate levels suggest systemic stress.",
                "Elevated heart rate variability suggests systemic stress.",
                "Together, these factors indicate a potentially high risk of the patient developing sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The patient exhibits several indicators of potential sepsis risk.",
                "The patient has a persistently elevated heart rate (tachycardia).",
                "The patient has an elevated respiratory rate (tachypnea).",
                "The patient has abnormalities in blood results, including high potassium levels.",
                "The presence of a high white blood cell count suggests systemic stress.",
                "The presence of neutrophilia suggests systemic stress.",
                "Increased lactate levels suggest systemic stress.",
                "Elevated heart rate variability suggests systemic stress.",
                "Together, these factors indicate a potentially high risk of the patient developing sepsis within the next 12 hours."
            ],
            "alignment_scores": [
                0.3,
                0.8,
                0.7,
                0.3,
                0.9,
                0.7,
                0.8,
                0.3,
                0.3
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SOFA Score Increase (\u22652 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "The claim suggests the presence of several indicators of potential sepsis risk, which aligns conceptually with the idea of deranged vitals contributing to the NEWS score. However, without specific indicators listed, the alignment is weak and indirect, as any combination of sepsis-related symptoms could potentially fit this description.",
                "Tachycardia, or an elevated heart rate (>90 bpm), is one of the criteria for SIRS. This makes the claim directly relevant to the SIRS category, which identifies systemic inflammation consistent with early sepsis. The alignment is strong, as the presence of one SIRS criterion (though not fulfilling the requirement of \u22652) is an indicator of sepsis progression likelihood.",
                "An elevated respiratory rate (tachypnea) is directly listed as one of the SIRS criteria\u2014specifically, a respiratory rate >20/min. While this alone doesn't confirm SIRS Positivity as it requires \u22652 criteria, it directly aligns with one of its components. Thus, the claim strongly relates to the SIRS category but isn\u2019t sufficient on its own, resulting in less than a perfect alignment score.",
                "High potassium levels can indicate renal impairment, which is related to SOFA criteria such as elevated creatinine levels. While high potassium is not a direct SOFA component, it can suggest potential renal dysfunction, indicating a weak but relevant connection to this category.",
                "An elevated white blood cell count is explicitly part of the SIRS criteria, which are used to identify systemic inflammation consistent with early sepsis. While the claim mentions \"systemic stress,\" which is somewhat broader, the specific mention of a high WBC aligns closely with the SIRS criteria, making the alignment very strong but not perfect.",
                "Neutrophilia, an increase in neutrophil count, often indicates systemic inflammation, which aligns with the concept of SIRS criteria aimed at identifying early signs of systemic stress due to infection. Neutrophilia itself is not a specific SIRS criterion but is related to the WBC abnormalities described in the SIRS criteria (WBC\u202f>\u202f12,000/\u00b5L). The alignment is partial but relevant to the detection of systemic inflammation.",
                "The claim refers to increased lactate levels, which aligns with the Elevated Serum Lactate category. Elevated lactate is specifically mentioned as indicating tissue hypoperfusion and high sepsis mortality risk. However, the claim speaks generally about systemic stress without specifying the extent of lactate elevation (\u22652 mmol/L), so the alignment is high but not perfect.",
                "Heart rate variability isn't directly part of the SIRS criteria, but an elevated heart rate can be indicative of systemic stress or inflammation, which are related to sepsis. The alignment is weak because SIRS explicitly requires a heart rate of >90 bpm, while heart rate variability is a more general measure of autonomic function and stress rather than meeting the specified SIRS criteria directly.",
                "The claim suggests a composite assessment reflecting potential sepsis risk soon, but lacks specific details. The Elevated NEWS Score is the most holistic category, using deranged vitals to predict deterioration. Although the claim is not explicit, the concept aligns with a NEWS assessment. However, due to the lack of explicit clinical parameters, the alignment is weak."
            ],
            "final_alignment_score": 0.5666666666666668
        },
        {
            "input": "8: HR, 70.0; 8: RR, 18.0; 8: SpO2, 100.0; 8: SBP, 159.0; 8: DBP, 83.0; 8: MAP, 108.333; 12: Pain, 9.0; 33: SpO2, 100.0; 34: HR, 82.0; 34: RR, 20.0; 34: SpO2, 100.0; 34: Perf, 1.700; 34: SBP, 138.0; 34: DBP, 81.0; 34: MAP, 100.0; 34: Temp, 97.9; 35: SpO2, 100.0; 35: Perf, 2.154; 36: SpO2, 100.0; 36: Perf, 2.221; 37: SpO2, 100.0; 37: Perf, 1.998; 38: SpO2, 100.0; 38: Perf, 1.810; 39: SpO2, 100.0; 39: Perf, 1.716; 40: SpO2, 99.915; 40: Perf, 1.645; 41: SpO2, 99.627; 41: Perf, 1.527; 42: SpO2, 99.897; 42: Perf, 1.582; 43: SpO2, 99.424; 43: Perf, 1.827; 44: HR, 80.0; 44: RR, 22.0; 44: SpO2, 99.328; 44: Perf, 1.891; 44: SBP, 159.0; 44: DBP, 92.0; 44: MAP, 114.333; 44: Pain, 9.0; 45: SpO2, 99.492; 45: Perf, 1.696; 45: SBP, 159.0; 45: DBP, 92.0; 45: MAP, 114.333; 46: SpO2, 99.898; 46: Perf, 1.302; 47: SpO2, 99.895; 47: Perf, 1.316; 48: SpO2, 100.0; 48: Perf, 1.239; 49: SpO2, 100.0; 49: Perf, 1.162; 50: SpO2, 99.932; 50: Perf, 1.170; 51: SpO2, 100.0; 51: Perf, 1.271; 52: SpO2, 100.0; 52: Perf, 1.272; 53: SpO2, 99.898; 53: Perf, 1.299; 54: POC, HCG, ISTAT QUALITATIVE: Negative; 54: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 54: SpO2, 99.914; 54: Perf, 1.518; 55: SpO2, 99.881; 55: Perf, 1.807; 56: SpO2, 99.776; 56: Perf, 1.771; 57: SpO2, 100.0; 57: Perf, 1.647; 58: SpO2, 100.0; 58: Perf, 1.594; 59: SpO2, 99.879; 59: Perf, 1.747; 60: SpO2, 99.814; 60: Perf, 1.711; 61: SpO2, 99.879; 61: Perf, 1.805; 62: SpO2, 99.831; 62: Perf, 2.869; 63: SpO2, 99.881; 63: Perf, 2.230; 64: SpO2, 100.0; 64: Perf, 1.868; 65: SpO2, 100.0; 65: Perf, 1.737; 66: SpO2, 100.0; 66: Perf, 1.750; 67: SpO2, 100.0; 67: Perf, 2.172; 68: SpO2, 99.475; 68: Perf, 3.406; 69: SpO2, 99.776; 69: Perf, 2.376; 70: SpO2, 99.593; 70: Perf, 1.955; 71: SpO2, 100.0; 71: Perf, 3.23; 72: SpO2, 99.288; 72: Perf, 7.179; 73: SpO2, 99.525; 73: Perf, 5.067; 74: SpO2, 98.741; 74: Perf, 1.804; 75: SpO2, 98.797; 75: Perf, 1.396; 76: SpO2, 99.0; 76: Perf, 1.391; 77: SpO2, 98.586; 77: Perf, 1.382; 78: SpO2, 98.458; 78: Perf, 1.414; 78: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 78: ACETAMINOPHEN 1,000 MG/100 ML (10 MG/ML) IV SOLN; 79: WAM DIFTYP, AUTO; 79: RED CELL DISTRIBUTION WIDTH (RDW), 18.6 %; 79: LYMPHOCYTE % (AUTO DIFF), 8.2 %; 79: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 79: PLATELET COUNT (PLT), 238 K/uL; 79: MONOCYTE ABSOLUTE (AUTO DIFF), 0.91 K/uL; 79: BASOPHIL % (AUTO DIFF), 0.8 %; 79: HEMOGLOBIN (HGB), 13.2 g/dL; 79: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 24.9 pg; 79: BASOPHIL ABSOLUTE (AUTO DIFF), 0.13 K/uL; 79: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.08 K/uL; 79: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 29.9 g/dL; 79: EOSINOPHIL % (AUTO DIFF), 0.1 %; 79: NRBC PERCENT (HEMATOLOGY), 0.0 %; 79: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.38 K/uL; 79: MEAN CORPUSCULAR VOLUME (MCV), 83.1 fL; 79: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 79: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 79: WHITE BLOOD CELLS (WBC), 16.9 K/uL; 79: MONOCYTE % (AUTO DIFF), 5.4 %; 79: HEMATOCRIT (HCT), 44.1 %; 79: RED BLOOD CELLS (RBC), 5.31 MIL/uL; 79: NEUTROPHIL ABSOLUTE (AUTO DIFF), 14.42 K/uL; 79: NEUTROPHIL % (AUTO DIFF), 85.0 %; 79: SpO2, 99.897; 79: Perf, 1.471; 79: KETOROLAC, 30 MG/ML (1 ML) INJ SOLN; 79: LR IV BOLUS -, 1000 ML; 80: SpO2, 99.864; 80: Perf, 1.835; 81: SpO2, 98.345; 81: Perf, 1.771; 82: SpO2, 98.356; 82: Perf, 1.736; 83: SpO2, 99.621; 83: Perf, 1.849; 84: SpO2, 99.475; 84: Perf, 1.761; 85: SpO2, 100.0; 85: Perf, 1.923; 86: SpO2, 99.707; 86: Perf, 1.697; 87: SpO2, 99.0; 87: Perf, 1.564; 88: SpO2, 99.0; 88: Perf, 1.585; 89: SpO2, 98.831; 89: Perf, 1.430; 90: INFLUENZA A, Not Detected; 90: SARS-COV-2 RNA, Not Detected; 90: RSV, Not Detected; 90: INFLUENZA B, Not Detected; 90: SpO2, 99.322; 90: Perf, 1.201; 91: SpO2, 99.845; 91: Perf, 1.121; 92: SpO2, 98.729; 92: Perf, 1.032; 93: SpO2, 98.276; 93: Perf, 1.166; 94: SpO2, 98.966; 94: Perf, 1.158; 95: SpO2, 98.712; 95: Perf, 1.161; 96: SpO2, 97.772; 96: Perf, 1.171; 97: SpO2, 99.068; 97: Perf, 1.172; 98: SpO2, 98.879; 98: Perf, 1.252; 99: SpO2, 98.695; 99: Perf, 1.220; 100: SpO2, 98.407; 100: Perf, 1.230; 101: SpO2, 99.0; 101: Perf, 1.339; 102: SpO2, 99.0; 102: Perf, 1.359; 103: SpO2, 99.0; 103: Perf, 1.370; 104: SpO2, 99.0; 104: Perf, 1.355; 105: SpO2, 99.0; 105: Perf, 1.396; 106: SpO2, 99.0; 106: Perf, 1.319; 107: SpO2, 99.0; 107: Perf, 1.301; 108: SpO2, 98.948; 108: Perf, 1.274; 109: SpO2, 99.0; 109: Perf, 1.318; 110: SpO2, 99.0; 110: Perf, 1.316; 111: SpO2, 99.0; 111: Perf, 1.387; 112: LIPASE, 22 U/L; 112: SpO2, 99.0; 112: Perf, 1.382; 113: SpO2, 99.0; 113: Perf, 1.321; 114: SpO2, 99.0; 114: Perf, 1.407; 115: SpO2, 99.0; 115: Perf, 1.360; 116: SpO2, 99.103; 116: Perf, 1.299; 117: SpO2, 99.576; 117: Perf, 1.475; 118: HR, 83.786; 118: SpO2, 99.517; 118: Perf, 1.436; 118: 1min HRV, 62.269; 119: HR, 83.746; 119: RR, 22.0; 119: SpO2, 99.610; 119: Perf, 1.606; 119: 1min HRV, 55.335; 119: 5min HRV, 60.184; 0: Age, 44; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 70.0; 0: Triage RR, 18.0; 0: Triage SBP, 159.0; 0: Triage DBP, 83.0; 0: Triage acuity, 2-Emergent; 0: CC, ABDOMINAL PAIN",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The patient's vital signs, including heart rate (HR), blood pressure (SBP/DBP), respiratory rate (RR), and temperature, remain relatively stable and within normal ranges over the 2-hour observation period. The patient maintains high oxygen saturation (SpO2) levels consistently, indicating adequate oxygenation. Although the patient reports high pain levels, there is no significant deviation in vital signs or other laboratory values suggesting systemic infection or organ dysfunction necessary to predict a high risk of sepsis within the next 12 hours.",
            "claims": [
                "The patient's vital signs remain relatively stable over the 2-hour observation period.",
                "The patient's vital signs include heart rate (HR), blood pressure (SBP/DBP), respiratory rate (RR), and temperature.",
                "The patient's vital signs are within normal ranges.",
                "The patient maintains high oxygen saturation (SpO2) levels consistently.",
                "High oxygen saturation (SpO2) levels indicate adequate oxygenation.",
                "The patient reports high pain levels.",
                "There is no significant deviation in vital signs suggesting systemic infection.",
                "There is no significant deviation in other laboratory values suggesting systemic infection.",
                "There is no significant deviation in vital signs suggesting organ dysfunction.",
                "There is no significant deviation in laboratory values suggesting organ dysfunction.",
                "The patient's condition does not indicate a high risk of sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The patient's vital signs remain relatively stable over the 2-hour observation period.",
                "There is no significant deviation in laboratory values suggesting organ dysfunction.",
                "The patient's condition does not indicate a high risk of sepsis within the next 12 hours."
            ],
            "alignment_scores": [
                0.3,
                0.2,
                0.0
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "SOFA Score Increase (\u22652 points)",
                "None"
            ],
            "alignment_reasonings": [
                "The claim mentions that the patient's vital signs remain relatively stable over a 2-hour period. While this indirectly could suggest a stable or low NEWS score, which would indicate low risk for clinical deterioration compatible with sepsis, the claim is not strongly aligned with any specific category indicating sepsis risk. The NEWS score is designed to detect physiological instability, and since the claim indicates stability, there is indirect relevance primarily because it negates any criteria that might contribute to an elevated NEWS score. Therefore, the alignment is weak but present due to the indirect suggestion of low risk based on stable vitals.",
                "The claim mentions that there is no significant deviation in laboratory values, which indirectly refers to a stable SOFA score\u2014as SOFA scores are dependent on various lab values to indicate organ dysfunction. A lack of deviation suggests there is no increase in SOFA score, implying no heightened sepsis risk related to organ dysfunction. The alignment is very weak, as organ stability does not preclude other sepsis indicators outside of SOFA criteria.",
                "The claim suggests that there is no high risk of sepsis for the patient within the specified timeframe. It doesn't align with any specific expert category that predicts high sepsis risk. The absence of factors that indicate high risk doesn't correspond to a diagnosis or classification under the provided sepsis categories, leading to a rating of 0.0 for category alignment."
            ],
            "final_alignment_score": 0.16666666666666666
        },
        {
            "input": "3: HR, 112.0; 3: RR, 18.0; 3: SpO2, 100.0; 3: SBP, 120.0; 3: DBP, 90.0; 3: MAP, 100.0; 3: Pain, 8.0; 3: Temp, 99.1; 8: Pain, 8.0; 38: POC PH (V) ISTAT, 7.38; 38: POC O2 SATURATION ISTAT VENOUS, 46 %; 38: POC PCO2 (V) ISTAT, 51.6 mmHg; 38: POC BASE EXCESS ISTAT, 5 mmol/L; 38: POC LACTATE ISTAT, 0.87 mmol/L; 38: POC TCO2 (V) ISTAT, 32 mmol/L; 38: POC HCO3 (V) ISTAT, 30.3 mmol/L; 38: POC PO2 (V) ISTAT, 26 mmHg; 53: WAM DIFTYP, AUTO; 53: RED BLOOD CELLS (RBC), 4.87 MIL/uL; 53: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 53: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 53: NRBC PERCENT (HEMATOLOGY), 0.0 %; 53: MEAN CORPUSCULAR VOLUME (MCV), 87.1 fL; 53: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.2 %; 53: HEMOGLOBIN (HGB), 14.6 g/dL; 53: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 53: RED CELL DISTRIBUTION WIDTH (RDW), 11.9 %; 53: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.4 g/dL; 53: WHITE BLOOD CELLS (WBC), 8.6 K/uL; 53: MONOCYTE ABSOLUTE (AUTO DIFF), 0.94 K/uL; 53: NEUTROPHIL % (AUTO DIFF), 70.5 %; 53: PLATELET COUNT (PLT), 235 K/uL; 53: BASOPHIL % (AUTO DIFF), 0.2 %; 53: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 53: MONOCYTE % (AUTO DIFF), 10.9 %; 53: HEMATOCRIT (HCT), 42.4 %; 53: EOSINOPHIL % (AUTO DIFF), 0.5 %; 53: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.52 K/uL; 53: LYMPHOCYTE % (AUTO DIFF), 17.7 %; 53: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.0 pg; 53: NEUTROPHIL ABSOLUTE (AUTO DIFF), 6.06 K/uL; 81: ALKALINE PHOSPHATASE, 52 U/L; 81: CORRECTED CALCIUM, 9.3 mg/dL; 81: CALCIUM, 9.5 mg/dL; 81: CREATININE, 1.22 mg/dL; 81: POTASSIUM, 3.5 mmol/L; 81: GLUCOSE, 91 mg/dL; 81: ALT (SGPT), 15 U/L; 81: EGFR REFIT WITHOUT RACE (2021), 78 mL/min/1.73 m2; 81: GLOBULIN, 2.8 g/dL; 81: ANION GAP, 13 mmol/L; 81: BILIRUBIN TOTAL, 0.5 mg/dL; 81: BLOOD UREA NITROGEN (BUN), 12 mg/dL; 81: AST (SGOT), 17 U/L; 81: CO2, 28 mmol/L; 81: ALBUMIN, 4.3 g/dL; 81: CHLORIDE, 98 mmol/L; 81: SODIUM, 139 mmol/L; 81: PROTEIN TOTAL, 7.1 g/dL; 90: SpO2, 97.667; 91: SpO2, 97.766; 92: SpO2, 98.676; 93: HR, 117.189; 93: RR, 17.417; 93: SpO2, 98.339; 93: 1min HRV, 35.892; 94: HR, 118.897; 94: RR, 19.397; 94: SpO2, 99.052; 94: Perf, 0.651; 94: 1min HRV, 36.582; 94: SBP, 110.0; 94: DBP, 70.0; 94: MAP, 83.333; 95: HR, 112.356; 95: RR, 14.763; 95: SpO2, 98.949; 95: Perf, 0.622; 95: 1min HRV, 23.354; 95: SBP, 110.0; 95: DBP, 70.0; 95: MAP, 83.333; 95: Temp, 100.3; 96: HR, 117.103; 96: RR, 16.034; 96: SpO2, 97.828; 96: Perf, 0.617; 96: 1min HRV, 12.359; 96: 5min HRV, 30.311; 97: SARS-COV-2 RNA, Not Detected; 97: HR, 114.542; 97: RR, 19.729; 97: SpO2, 96.661; 97: Perf, 0.561; 97: 1min HRV, 10.839; 98: HR, 115.746; 98: RR, 16.831; 98: SpO2, 97.271; 98: Perf, 0.554; 98: 1min HRV, 70.725; 99: HR, 112.448; 99: RR, 14.552; 99: SpO2, 99.638; 99: Perf, 0.597; 99: 1min HRV, 15.210; 99: SBP, 111.0; 99: DBP, 73.0; 99: MAP, 85.667; 99: Pain, 9.0; 100: HR, 115.424; 100: RR, 14.949; 100: SpO2, 97.814; 100: Perf, 0.601; 100: 1min HRV, 7.647; 101: HR, 115.259; 101: RR, 17.172; 101: SpO2, 97.328; 101: Perf, 0.575; 101: 1min HRV, 18.362; 101: 5min HRV, 33.974; 102: HR, 113.593; 102: RR, 14.017; 102: SpO2, 97.797; 102: Perf, 0.537; 102: 1min HRV, 29.787; 102: SBP, 111.0; 102: DBP, 73.0; 102: MAP, 85.667; 103: HR, 116.407; 103: RR, 19.034; 103: SpO2, 99.0; 103: Perf, 0.519; 103: 1min HRV, 21.083; 103: HYDROMORPHONE, 1 MG/ML INJ SYRG; 104: HR:, 116.672; 104: RR, 18.190; 104: SpO2, 98.207; 104: Perf, 0.492; 104: 1min HRV, 17.796; 105: HR, 114.729; 105: RR, 15.881; 105: SpO2, 98.119; 105: Perf, 0.471; 105: 1min HRV, 30.473; 105: LR IV BOLUS -, 1000 ML; 106: HR:, 116.379; 106: RR, 17.379; 106: SpO2, 97.638; 106: Perf, 0.471; 106: 1min HRV, 16.924; 106: 5min HRV, 24.392; 106: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 107: HR:, 115.593; 107: RR, 21.797; 107: SpO2, 97.881; 107: Perf, 0.519; 107: 1min HRV, 13.793; 108: HR, 116.288; 108: RR, 20.780; 108: SpO2, 97.746; 108: Perf, 0.519; 108: 1min HRV, 14.276; 109: HR, 114.776; 109: RR, 11.345; 109: SpO2, 98.931; 109: Perf, 0.505; 109: 1min HRV, 13.103; 110: HR, 115.254; 110: RR, 16.0; 110: SpO2, 97.424; 110: Perf, 0.498; 110: 1min HRV, 21.313; 111: HR, 116.034; 111: RR, 17.034; 111: SpO2, 97.310; 111: Perf, 0.484; 111: 1min HRV, 19.157; 111: 5min HRV, 16.964; 112: HR, 112.034; 112: RR, 18.373; 112: SpO2, 96.559; 112: Perf, 0.524; 112: 1min HRV, 14.941; 113: HR, 113.983; 113: RR, 18.586; 113: SpO2, 97.466; 113: Perf, 0.536; 113: 1min HRV, 11.433; 114: HR, 112.271; 114: RR, 20.407; 114: SpO2, 96.780; 114: Perf, 0.540; 114: 1min HRV, 15.690; 115: HR, 112.051; 115: RR, 15.034; 115: SpO2, 95.356; 115: Perf, 0.529; 115: 1min HRV, 20.846; 116: HR, 111.948; 116: RR, 16.379; 116: SpO2, 95.914; 116: Perf, 0.514; 116: 1min HRV, 13.143; 116: 5min HRV, 15.961; 117: HR, 112.644; 117: RR, 14.203; 117: SpO2, 97.339; 117: Perf, 0.507; 117: 1min HRV, 16.865; 118: HR, 113.810; 118: RR, 16.741; 118: SpO2, 95.983; 118: Perf, 0.52; 118: 1min HRV, 11.521; 119: HR, 114.186; 119: RR, 17.254; 119: SpO2, 96.119; 119: Perf, 0.52; 119: 1min HRV, 13.682; 0: Age, 38; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.3; 0: Triage HR, 112.0; 0: Triage RR, 18.0; 0: Triage SBP, 120.0; 0: Triage DBP, 90.0; 0: Triage acuity, 3-Urgent; 0: CC, WOUND CHECK",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "Throughout the time series, the patient's vital signs like heart rate, blood pressure, and respiratory rate are stable and within acceptable ranges, with slight tachycardia noted. The lactate levels are within normal limits, reducing the likelihood of tissue hypoperfusion, a key indicator of sepsis. Furthermore, there are no significant abnormalities in the patient's laboratory results or evidence of organ dysfunction. Therefore, the patient demonstrates low risk for developing sepsis within 12 hours.",
            "claims": [
                "The patient's vital signs are stable and within acceptable ranges.",
                "The patient's heart rate shows slight tachycardia.",
                "The lactate levels are within normal limits.",
                "Normal lactate levels reduce the likelihood of tissue hypoperfusion.",
                "Tissue hypoperfusion is a key indicator of sepsis.",
                "There are no significant abnormalities in the patient's laboratory results.",
                "There is no evidence of organ dysfunction in the patient.",
                "The patient demonstrates low risk for developing sepsis within 12 hours."
            ],
            "relevant_claims": [
                "The patient's heart rate shows slight tachycardia."
            ],
            "alignment_scores": [
                0.7
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)"
            ],
            "alignment_reasonings": [
                "Tachycardia, defined as a heart rate over 90 bpm, is explicitly mentioned as one of the criteria for SIRS, which helps identify systemic inflammation indicative of early sepsis. Although \"slight tachycardia\" indicates the heart rate may be just above 90 bpm, it still directly corresponds to one of the SIRS criteria, establishing a strong alignment with this category. However, as it suggests just a slight increase, it doesn't strongly indicate sepsis risk on its own, so the alignment rating is less than perfect."
            ],
            "final_alignment_score": 0.7
        },
        {
            "input": "11: HR, 128.0; 11: RR, 22.0; 11: SpO2, 100.0; 11: SBP, 135.0; 11: DBP, 95.0; 11: MAP, 108.333; 11: LPM O2, 4.0; 11: Temp, 99.2; 20: Pain, 2.0; 46: HR, 122.0; 46: RR, 23.0; 46: SpO2, 100.0; 46: SBP, 150.0; 46: DBP, 110.0; 46: MAP, 123.333; 52: HR, 122.939; 52: RR, 23.25; 52: SpO2, 100.0; 52: 1min HRV, 5.704; 53: HR, 122.845; 53: RR, 21.517; 53: SpO2, 99.914; 53: Perf, 2.808; 53: 1min HRV, 5.565; 53: SBP, 150.0; 53: DBP, 110.0; 53: MAP, 123.333; 54: HR, 123.831; 54: RR, 24.644; 54: SpO2, 99.661; 54: Perf, 2.638; 54: 1min HRV, 10.795; 55: HR, 121.0; 55: RR, 25.508; 55: SpO2, 99.915; 55: Perf, 2.988; 55: 1min HRV, 10.056; 56: HR, 122.84; 56: RR, 26.149; 56: SpO2, 99.948; 56: Perf, 3.283; 56: 1min HRV, 8.571; 56: 5min HRV, 8.940; 57: HR, 122.576; 57: RR, 19.769; 57: SpO2, 99.864; 57: Perf, 3.919; 57: 1min HRV, 7.105; 58: HR, 122.879; 58: RR, 22.517; 58: SpO2, 99.879; 58: Perf, 4.124; 58: 1min HRV, 8.843; 59: HR, 123.034; 59: RR, 25.678; 59: SpO2, 100.0; 59: Perf, 3.976; 59: 1min HRV, 4.672; 60: HR, 122.508; 60: RR, 24.169; 60: SpO2, 100.0; 60: Perf, 3.974; 60: 1min HRV, 7.319; 61: HR, 120.776; 61: RR, 25.017; 61: SpO2, 100.0; 61: Perf, 3.710; 61: 1min HRV, 9.472; 61: 5min HRV, 8.257; 62: HR, 122.085; 62: RR, 21.136; 62: SpO2, 99.729; 62: Perf, 3.300; 62: 1min HRV, 5.797; 63: HR, 121.190; 63: RR, 22.569; 63: SpO2, 100.0; 63: Perf, 3.961; 63: 1min HRV, 6.137; 64: HR, 121.492; 64: RR, 23.712; 64: SpO2, 99.864; 64: Perf, 3.505; 64: 1min HRV, 7.056; 65: HR, 121.475; 65: RR, 21.966; 65: SpO2, 100.0; 65: Perf, 3.676; 65: 1min HRV, 5.555; 66: HR, 124.069; 66: RR, 25.638; 66: SpO2, 100.0; 66: Perf, 3.285; 66: 1min HRV, 6.096; 66: 5min HRV, 7.719; 67: HR, 122.441; 67: RR, 20.119; 67: SpO2, 99.932; 67: Perf, 3.020; 67: 1min HRV, 10.566; 68: POC PH (V) ISTAT, 7.27; 68: POC LACTATE ISTAT, <.30 mmol/L; 68: POC PO2 (V) ISTAT, 52 mmHg; 68: POC O2 SATURATION ISTAT VENOUS, 79 %; 68: POC BASE EXCESS ISTAT, 16 mmol/L; 68: POC TCO2 (V) ISTAT, 46 mmol/L; 68: POC PCO2 (V) ISTAT, 93.1 mmHg; 68: POC HCO3 (V) ISTAT, 43.1 mmol/L; 68: HR, 122.759; 68: RR, 22.862; 68: SpO2, 100.0; 68: Perf, 3.085; 68: 1min HRV, 6.594; 69: HR, 122.220; 69: RR, 24.593; 69: SpO2, 99.763; 69: Perf, 3.244; 69: 1min HRV, 11.331; 70: HR, 120.983; 70: RR, 23.356; 70: SpO2, 99.847; 70: Perf, 2.363; 70: 1min HRV, 7.587; 71: HR, 121.017; 71: RR, 22.431; 71: SpO2, 100.0; 71: Perf, 2.784; 71: 1min HRV, 9.820; 71: 5min HRV, 9.871; 72: HR, 120.864; 72: RR, 21.915; 72: SpO2, 99.915; 72: Perf, 3.830; 72: 1min HRV, 16.374; 73: HR, 120.103; 73: RR, 24.759; 73: SpO2, 100.0; 73: Perf, 3.610; 73: 1min HRV, 10.152; 74: HR, 118.492; 74: RR, 18.559; 74: SpO2, 99.492; 74: Perf, 3.811; 74: 1min HRV, 18.415; 75: HR, 101.776; 75: RR, 24.276; 75: SpO2, 98.810; 75: Perf, 3.638; 75: 1min HRV, 60.252; 76: HR, 112.729; 76: RR, 25.119; 76: SpO2, 97.441; 76: Perf, 4.093; 76: 1min HRV, 62.110; 76: 5min HRV, 53.036; 77: HR, 129.0; 77: RR, 21.203; 77: SpO2, 96.847; 77: Perf, 3.652; 77: 1min HRV, 4.517; 78: HR, 127.362; 78: RR, 21.466; 78: SpO2, 97.672; 78: Perf, 2.806; 78: 1min HRV, 9.283; 79: HR, 125.898; 79: RR, 30.441; 79: SpO2, 99.186; 79: Perf, 3.482; 79: 1min HRV, 7.209; 80: HR, 125.207; 80: RR, 27.448; 80: SpO2, 99.552; 80: Perf, 4.992; 80: 1min HRV, 7.198; 81: HR, 124.119; 81: RR, 25.729; 81: SpO2, 99.661; 81: Perf, 4.143; 81: 1min HRV, 4.572; 81: 5min HRV, 9.969; 82: HR, 122.712; 82: RR, 22.220; 82: SpO2, 99.814; 82: Perf, 4.987; 82: 1min HRV, 8.090; 83: HR, 121.931; 83: RR, 21.862; 83: SpO2, 99.621; 83: Perf, 2.813; 83: 1min HRV, 10.376; 86: 5min HRV, 9.461; 89: WAM DIFTYP, AUTO; 89: HEMATOCRIT (HCT), 40.8 %; 89: PLATELET COUNT (PLT), 327 K/uL; 89: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 27.0 pg; 89: HEMOGLOBIN (HGB), 12.1 g/dL; 89: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 29.7 g/dL; 89: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.04 K/uL; 89: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 89: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.84 K/uL; 89: MEAN CORPUSCULAR VOLUME (MCV), 91.1 fL; 89: LYMPHOCYTE % (AUTO DIFF), 6.7 %; 89: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 89: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.29 K/uL; 89: MONOCYTE % (AUTO DIFF), 8.5 %; 89: MONOCYTE ABSOLUTE (AUTO DIFF), 1.06 K/uL; 89: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 89: RED CELL DISTRIBUTION WIDTH (RDW), 12.4 %; 89: EOSINOPHIL % (AUTO DIFF), 2.3 %; 89: NRBC PERCENT (HEMATOLOGY), 0.0 %; 89: NEUTROPHIL % (AUTO DIFF), 81.9 %; 89: WHITE BLOOD CELLS (WBC), 12.5 K/uL; 89: RED BLOOD CELLS (RBC), 4.48 MIL/uL; 89: BASOPHIL % (AUTO DIFF), 0.3 %; 89: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.20 K/uL; 95: NS IV BOLUS -, 1000 ML; 97: INR:, 1.0; 97: PROTHROMBIN TIME, 13.2 seconds; 97: PART. THROMBOPLASTIN TIME, 29.0 seconds; 100: POC, BHCG, ISTAT QUANTITATIVE: 5.0 IU/L; 106: HR, 113.0; 106: RR, 17.0; 106: SpO2, 98.0; 106: SBP, 159.0; 106: DBP, 103.0; 106: MAP, 121.667; 106: LPM O2, 4.0; 110: CO2, 37 mmol/L; 110: CREATININE, 0.59 mg/dL; 110: BLOOD UREA NITROGEN (BUN), 25 mg/dL; 110: ANION GAP, 7 mmol/L; 110: EGFR FOR AFRICAN AMERICAN, 137 mL/min/1.73 m2; 110: GLUCOSE, 247 mg/dL; 110: CHLORIDE, 94 mmol/L; 110: CORRECTED CALCIUM, 9.9 mg/dL; 110: GLOBULIN, 3.4 g/dL; 110: AST (SGOT), 22 U/L; 110: ALKALINE PHOSPHATASE, 122 U/L; 110: SODIUM, 138 mmol/L; 110: PROTEIN TOTAL, 7.3 g/dL; 110: BILIRUBIN TOTAL, <.2 mg/dL; 110: EGFR REFIT WITHOUT RACE (2021), 119 mL/min/1.73 m2; 110: POTASSIUM, 4.4 mmol/L; 110: CALCIUM, 9.8 mg/dL; 110: ALBUMIN, 3.9 g/dL; 110: ALT (SGPT), 25 U/L; 111: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 0: Age:, 37; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.3; 0: Triage HR, 128.0; 0: Triage RR, 22.0; 0: Triage SBP, 135.0; 0: Triage DBP, 95.0; 0: Triage acuity, 2-Emergent; 0: CC, COUGH",
            "answer": true,
            "llm_answer": "No",
            "llm_explanation": "The patient shows elevated heart rate (HR) and respiratory rate (RR), which may suggest increased stress or mild infection. However, the absence of typical sepsis indicators such as hypotension, fever, or significantly elevated lactate levels (lactate is reported as <0.30 mmol/L, which is very low) suggests the risk of sepsis is low. Additionally, the patient's blood work and vital signs do not show concerning patterns typical of sepsis, such as abnormal white blood cell counts, decreased oxygen saturation, or organ dysfunction. Overall, the data does not strongly indicate a high risk of developing sepsis within the next 12 hours.",
            "claims": [
                "The patient shows elevated heart rate (HR).",
                "The patient shows elevated respiratory rate (RR).",
                "Elevated heart rate (HR) may suggest increased stress or mild infection.",
                "Elevated respiratory rate (RR) may suggest increased stress or mild infection.",
                "The absence of typical sepsis indicators suggests the risk of sepsis is low.",
                "Typical sepsis indicators include hypotension, fever, and significantly elevated lactate levels.",
                "The lactate level is reported as <0.30 mmol/L.",
                "A lactate level of <0.30 mmol/L is very low.",
                "The patient's blood work does not show concerning patterns typical of sepsis.",
                "The patient's vital signs do not show concerning patterns typical of sepsis.",
                "Concerning patterns typical of sepsis include abnormal white blood cell counts, decreased oxygen saturation, and organ dysfunction.",
                "Overall, the data does not strongly indicate a high risk of developing sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The patient shows elevated heart rate (HR).",
                "Elevated heart rate (HR) may suggest increased stress or mild infection.",
                "The lactate level is reported as <0.30 mmol/L.",
                "The patient's vital signs do not show concerning patterns typical of sepsis.",
                "Concerning patterns typical of sepsis include abnormal white blood cell counts, decreased oxygen saturation, and organ dysfunction."
            ],
            "alignment_scores": [
                0.8,
                0.3,
                0.0,
                0.3,
                0.7
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "Elevated NEWS Score (\u22655 points)",
                "SOFA Score Increase (\u22652 points)"
            ],
            "alignment_reasonings": [
                "Elevated heart rate is explicitly listed as one of the criteria under SIRS (heart rate > 90 bpm). The claim directly aligns with one component of the SIRS criteria, indicating systemic inflammation that is consistent with early sepsis. However, SIRS positivity requires the presence of two or more criteria, so the alignment is strong but not complete without additional criteria.",
                "An elevated heart rate (>90 bpm) is one of the criteria for SIRS, indicating systemic inflammation consistent with early sepsis. However, the claim's context suggests mild infection or increased stress, which weakens the direct link to SIRS as it may not meet the threshold. The connection to sepsis prediction is indirect and not specified to the extent required by SIRS, hence a moderate to low alignment rating.",
                "The claim states a lactate level of <0.30 mmol/L, which is far below the threshold of \u22652 mmol/L that indicates elevated sepsis risk according to this category. There is no alignment with the criterion of elevated serum lactate being a risk factor for sepsis.",
                "The claim references the patient's vital signs, which are integral to the calculation of the National Early Warning Score (NEWS) used to predict clinical deterioration as seen in sepsis. However, the claim states there are no concerning patterns, suggesting a low NEWS score, contrasting with the category criteria. Therefore, the alignment is weak, as it only indirectly relates to evaluating vital signs without meeting the thresholds for concern.",
                "The claim encompasses elements relating to organ dysfunction, such as decreased oxygen saturation and abnormal white blood cell counts. While abnormal WBC counts could also hint at SIRS criteria, the inclusion of \"organ dysfunction\" strongly implies a connection to the SOFA score, which tracks such dysfunctions. The alignment is strong but not complete since not all specific SOFA criteria components are explicitly addressed."
            ],
            "final_alignment_score": 0.42000000000000004
        },
        {
            "input": "12: HR, 105.0; 12: RR, 28.0; 12: SpO2, 95.0; 12: SBP, 140.0; 12: DBP, 63.0; 12: MAP, 88.667; 12: Temp, 99.7; 74: HR, 95.688; 74: SpO2, 93.758; 74: 1min HRV, 8.974; 74: SBP, 144.0; 74: DBP, 63.0; 74: MAP, 90.0; 75: HR, 98.203; 75: SpO2, 94.966; 75: 1min HRV, 12.323; 75: 5min HRV, 14.276; 76: HR, 96.569; 76: SpO2, 94.776; 76: Perf, 6.578; 76: 1min HRV, 12.903; 77: SARS-COV-2 RNA, Not Detected; 77: HR, 99.102; 77: SpO2, 94.339; 77: Perf, 4.638; 77: 1min HRV, 15.613; 78: HR, 96.879; 78: SpO2, 94.431; 78: Perf, 4.077; 78: 1min HRV, 7.583; 79: HR, 97.881; 79: SpO2, 94.153; 79: Perf, 4.416; 79: 1min HRV, 18.735; 80: HR, 100.508; 80: SpO2, 94.322; 80: Perf, 4.084; 80: 1min HRV, 15.058; 80: 5min HRV, 16.596; 81: HR, 97.052; 81: SpO2, 94.138; 81: Perf, 3.874; 81: 1min HRV, 9.255; 82: HR, 98.153; 82: SpO2, 94.0; 82: Perf, 4.344; 82: 1min HRV, 8.571; 83: HR, 95.810; 83: SpO2, 93.724; 83: Perf, 4.399; 83: 1min HRV, 9.797; 84: HR, 95.508; 84: SpO2, 92.881; 84: Perf, 4.271; 84: 1min HRV, 15.169; 85: HR, 95.610; 85: SpO2, 93.0; 85: Perf, 4.012; 85: 1min HRV, 7.541; 85: 5min HRV, 12.341; 86: POC PH (V) ISTAT, 7.51; 86: POC LACTATE ISTAT, 1.04 mmol/L; 86: POC BASE EXCESS ISTAT, 7 mmol/L; 86: POC PO2 (V) ISTAT, 45 mmHg; 86: POC O2 SATURATION ISTAT VENOUS, 85 %; 86: POC HCO3 (V) ISTAT, 29.9 mmol/L; 86: POC PCO2 (V) ISTAT, 37.9 mmHg; 86: POC TCO2 (V) ISTAT, 31 mmol/L; 86: HR, 95.086; 86: SpO2, 93.397; 86: Perf, 4.21; 86: 1min HRV, 3.706; 87: HR, 95.525; 87: SpO2, 93.254; 87: Perf, 4.314; 87: 1min HRV, 10.295; 88: HR, 95.793; 88: SpO2, 94.0; 88: Perf, 4.491; 88: 1min HRV, 10.727; 89: HR, 94.186; 89: SpO2, 93.661; 89: Perf, 4.244; 89: 1min HRV, 6.677; 90: HR, 93.763; 90: SpO2, 93.542; 90: Perf, 4.679; 90: 1min HRV, 10.949; 90: 5min HRV, 9.909; 91: HR, 94.793; 91: SpO2, 93.207; 91: Perf, 4.523; 91: 1min HRV, 11.560; 92: HR, 92.186; 92: SpO2, 92.729; 92: Perf, 4.081; 92: 1min HRV, 10.722; 93: HR, 93.310; 93: SpO2, 93.259; 93: Perf, 4.575; 93: 1min HRV, 11.295; 93: LIDOCAINE, 5 % TP PTMD; 94: HR:, 94.041; 94: SpO2, 93.407; 94: Perf, 5.464; 94: 1min HRV, 18.225; 95: HR, 93.862; 95: SpO2, 94.276; 95: Perf, 4.087; 95: 1min HRV, 23.162; 95: 5min HRV, 16.508; 96: HR, 95.847; 96: SpO2, 93.898; 96: Perf, 3.660; 96: 1min HRV, 19.795; 97: HR, 95.288; 97: SpO2, 94.085; 97: Perf, 3.631; 97: 1min HRV, 26.480; 98: WAM DIFTYP, AUTO; 98: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.54 K/uL; 98: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.08 K/uL; 98: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 98: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.7 %; 98: PLATELET COUNT (PLT), 363 K/uL; 98: MONOCYTE ABSOLUTE (AUTO DIFF), 1.35 K/uL; 98: RED CELL DISTRIBUTION WIDTH (RDW), 13.0 %; 98: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 98: BASOPHIL % (AUTO DIFF), 0.3 %; 98: WHITE BLOOD CELLS (WBC), 11.6 K/uL; 98: RED BLOOD CELLS (RBC), 4.05 MIL/uL; 98: EOSINOPHIL % (AUTO DIFF), 0.3 %; 98: LYMPHOCYTE % (AUTO DIFF), 4.7 %; 98: HEMOGLOBIN (HGB), 13.1 g/dL; 98: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 32.3 pg; 98: MONOCYTE % (AUTO DIFF), 11.7 %; 98: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.7 g/dL; 98: NEUTROPHIL ABSOLUTE (AUTO DIFF), 9.52 K/uL; 98: NRBC PERCENT (HEMATOLOGY), 0.0 %; 98: MEAN CORPUSCULAR VOLUME (MCV), 96.0 fL; 98: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 98: NEUTROPHIL % (AUTO DIFF), 82.3 %; 98: HEMATOCRIT (HCT), 38.9 %; 98: HR, 93.810; 98: SpO2, 94.017; 98: Perf, 4.691; 98: 1min HRV, 23.968; 99: HR, 96.339; 99: SpO2, 94.203; 99: Perf, 5.558; 99: 1min HRV, 18.059; 100: HR, 94.052; 100: SpO2, 93.862; 100: Perf, 4.896; 100: 1min HRV, 20.223; 100: 5min HRV, 22.715; 101: HR, 92.797; 101: SpO2, 94.136; 101: Perf, 4.679; 101: 1min HRV, 18.505; 102: HR, 94.102; 102: SpO2, 93.356; 102: Perf, 4.308; 102: 1min HRV, 24.808; 103: HR, 90.397; 103: SpO2, 93.552; 103: Perf, 3.735; 103: 1min HRV, 21.601; 104: HR, 91.458; 104: SpO2, 94.0; 104: Perf, 3.391; 104: 1min HRV, 19.831; 105: HR, 90.362; 105: SpO2, 93.690; 105: Perf, 3.608; 105: 1min HRV, 19.193; 105: 5min HRV, 22.761; 106: HR, 88.695; 106: SpO2, 93.322; 106: Perf, 3.818; 106: 1min HRV, 30.647; 107: HR, 87.864; 107: SpO2, 93.102; 107: Perf, 6.080; 107: 1min HRV, 21.781; 108: HR, 91.793; 108: SpO2, 93.379; 108: Perf, 4.790; 108: 1min HRV, 20.482; 109: HR, 90.068; 109: SpO2, 93.627; 109: Perf, 5.224; 109: 1min HRV, 9.640; 110: HR, 90.690; 110: SpO2, 92.448; 110: Perf, 5.879; 110: 1min HRV, 10.436; 110: 5min HRV, 22.487; 111: HR, 91.017; 111: SpO2, 92.424; 111: Perf, 5.972; 111: 1min HRV, 13.902; 112: HR, 90.203; 112: SpO2, 93.0; 112: Perf, 6.482; 112: 1min HRV, 8.039; 113: HR, 90.483; 113: SpO2, 92.810; 113: Perf, 6.112; 113: 1min HRV, 9.718; 114: HR, 90.051; 114: SpO2, 92.864; 114: Perf, 5.358; 114: 1min HRV, 8.979; 115: HR, 90.879; 115: SpO2, 92.845; 115: Perf, 5.083; 115: 1min HRV, 16.757; 115: 5min HRV, 12.244; 116: HR, 88.525; 116: SpO2, 93.932; 116: Perf, 4.567; 116: 1min HRV, 22.357; 117: HR, 89.746; 117: SpO2, 93.814; 117: Perf, 4.894; 117: 1min HRV, 12.992; 118: HR, 91.879; 118: SpO2, 93.362; 118: Perf, 5.772; 118: 1min HRV, 13.784; 119: HR, 88.525; 119: SpO2, 93.661; 119: Perf, 4.697; 119: 1min HRV, 14.209; 0: Age, 81; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.6; 0: Triage HR, 105.0; 0: Triage RR, 28.0; 0: Triage SBP, 140.0; 0: Triage DBP, 63.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The patient's vital signs, such as heart rate and respiratory rate, are elevated but not critically so, and there's no significant drop in blood pressure or significant rise in lactate levels to suggest acute sepsis. The SpO2 readings remain above 92%, indicating adequate oxygenation. The patient's HRV values show variability, which can be considered a sign of adaptability rather than stress in this context. While the white blood cell count is slightly elevated, it is not uncommon for elderly patients with fever. Overall, these factors suggest the patient is not at high risk of developing sepsis within the next 12 hours.",
            "claims": [
                "The patient's vital signs are elevated.",
                "The patient's heart rate is elevated but not critically so.",
                "The patient's respiratory rate is elevated but not critically so.",
                "There is no significant drop in blood pressure.",
                "There is no significant rise in lactate levels.",
                "The absence of significant blood pressure drop or lactate rise does not suggest acute sepsis.",
                "The SpO2 readings remain above 92%.",
                "SpO2 readings above 92% indicate adequate oxygenation.",
                "The patient's HRV values show variability.",
                "HRV variability can be considered a sign of adaptability rather than stress in this context.",
                "The white blood cell count is slightly elevated.",
                "It is not uncommon for elderly patients with fever to have a slightly elevated white blood cell count.",
                "Overall, these factors suggest the patient is not at high risk of developing sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The patient's vital signs are elevated.",
                "There is no significant drop in blood pressure.",
                "There is no significant rise in lactate levels."
            ],
            "alignment_scores": [
                0.3,
                0.3,
                0.7
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Elevated Serum Lactate (\u22652 mmol/L)"
            ],
            "alignment_reasonings": [
                "The claim about elevated vital signs vaguely points toward physiological deterioration, which is broadly assessed via the National Early Warning Score (NEWS). However, the claim doesn't provide specifics or confirm that the NEWS threshold is met, hence the low alignment rating.",
                "The claim relates to blood pressure stability, which is associated with the category of sepsis-associated hypotension. However, the claim indicates that there's no significant drop in blood pressure, contrasting with the hypotension definition in the category. Thus, there is a low but relevant alignment as it confirms the absence of a key risk factor.",
                "The claim specifically refers to lactate levels, which are directly evaluated in this category. The lack of a significant rise suggests a lower risk of tissue hypoperfusion and sepsis. The alignment is relatively strong because it directly addresses the criterion, albeit pointing towards the absence of elevated risk due to unchanged lactate levels."
            ],
            "final_alignment_score": 0.4333333333333333
        },
        {
            "input": "2: SpO2, 95.604; 2: SBP, 73.0; 2: DBP, nan; 2: MAP, nan; 3: SpO2, 97.633; 3: Perf, 0.510; 4: SpO2, 98.0; 4: Perf, 0.485; 4: SBP, 71.0; 4: DBP, 48.0; 4: MAP, 55.667; 5: HR, 115.0; 5: RR, 19.0; 5: SpO2, 96.729; 5: Perf, 0.322; 5: SBP, 79.0; 5: DBP, 48.0; 5: MAP, 58.333; 5: Pain, 3.0; 5: Temp, 98.0; 6: SpO2, 95.264; 6: Perf, 0.711; 7: SpO2, 96.038; 7: Perf, 0.838; 8: SpO2, 97.849; 8: Perf, 0.911; 9: SpO2, 99.0; 9: Perf, 1.024; 10: SpO2, 98.212; 10: Perf, 0.978; 10: SBP, 73.0; 10: DBP, 43.0; 10: MAP, 53.0; 11: SpO2, 98.642; 11: Perf, 0.448; 12: SpO2, 98.712; 12: Perf, 0.979; 13: SpO2, 99.245; 13: Perf, 1.204; 14: SpO2, 99.212; 14: Perf, 1.499; 15: SpO2, 99.887; 15: Perf, 1.369; 16: SpO2, 99.478; 16: Perf, 1.329; 17: SpO2, 94.333; 17: Perf, 1.36; 19: SpO2, 93.769; 19: Perf, 0.170; 20: SpO2, 93.0; 20: Perf, 0.23; 20: SBP, 63.0; 20: DBP, 45.0; 20: MAP, 51.0; 21: SpO2, 94.0; 21: Perf, 0.286; 22: SpO2, 98.423; 22: Perf, 0.689; 23: SpO2, 98.0; 23: Perf, 0.410; 24: SpO2, 98.875; 24: Perf, 0.394; 24: LR IV BOLUS -, 500 ML; 25: SpO, 2: 96.395; 25: Perf, 0.432; 26: SpO2, 98.288; 26: Perf, 1.126; 27: SpO2, 95.981; 27: Perf, 1.025; 28: SpO2, 98.415; 28: Perf, 1.452; 28: SBP, 71.0; 28: DBP, 32.0; 28: MAP, 45.0; 29: SpO2, 99.192; 29: Perf, 0.813; 30: SpO2, 99.509; 30: Perf, 0.659; 31: POC PH (V) ISTAT, 7.63; 31: POC O2 SATURATION ISTAT VENOUS, 92 %; 31: POC TCO2 (V) ISTAT, 34 mmol/L; 31: POC BASE EXCESS ISTAT, 12 mmol/L; 31: POC PCO2 (V) ISTAT, 32.1 mmHg; 31: POC PO2 (V) ISTAT, 51 mmHg; 31: POC LACTATE ISTAT, 1.99 mmol/L; 31: POC HCO3 (V) ISTAT, 33.5 mmol/L; 31: SpO2, 99.385; 31: Perf, 0.763; 32: SpO2, 96.385; 32: Perf, 0.773; 33: SpO2, 96.094; 33: Perf, 0.739; 34: SpO2, 97.231; 34: Perf, 0.936; 35: SpO2, 99.094; 35: Perf, 1.320; 35: SBP, 76.0; 35: DBP, 54.0; 35: MAP, 61.333; 36: SpO2, 98.596; 36: Perf, 0.990; 37: SpO2, 98.094; 37: Perf, 0.757; 38: SpO2, 96.283; 38: Perf, 0.687; 39: SpO2, 95.712; 39: Perf, 0.747; 40: SpO2, 97.755; 40: Perf, 1.372; 41: SpO2, 97.923; 41: Perf, 1.720; 42: SpO2, 95.585; 42: Perf, 1.869; 43: SpO2, 94.72; 43: Perf, 1.339; 44: SpO2, 95.667; 44: Perf, 0.698; 45: SpO2, 96.019; 45: Perf, 0.370; 46: WAM DIFTYP, AUTO; 46: RED CELL DISTRIBUTION WIDTH (RDW), 16.2 %; 46: HEMATOCRIT (HCT), 30.5 %; 46: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 46: MONOCYTE ABSOLUTE (AUTO DIFF), 0.63 K/uL; 46: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 46: PLATELET COUNT (PLT), 250 K/uL; 46: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 32.1 pg; 46: NEUTROPHIL % (AUTO DIFF), 75.4 %; 46: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.8 g/dL; 46: HEMOGLOBIN (HGB), 10.0 g/dL; 46: MEAN CORPUSCULAR VOLUME (MCV), 97.8 fL; 46: LYMPHOCYTE % (AUTO DIFF), 12.8 %; 46: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 46: NRBC PERCENT (HEMATOLOGY), 0.0 %; 46: NEUTROPHIL ABSOLUTE (AUTO DIFF), 4.82 K/uL; 46: RED BLOOD CELLS (RBC), 3.12 MIL/uL; 46: WHITE BLOOD CELLS (WBC), 6.4 K/uL; 46: BASOPHIL % (AUTO DIFF), 0.5 %; 46: EOSINOPHIL % (AUTO DIFF), 0.6 %; 46: MONOCYTE % (AUTO DIFF), 9.9 %; 46: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.8 %; 46: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.82 K/uL; 46: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 46: SpO2, 98.75; 46: Perf, 1.011; 47: SpO2, 99.585; 47: Perf, 0.703; 48: SpO2, 98.830; 48: Perf, 0.596; 49: SpO2, 98.462; 49: Perf, 0.741; 50: SpO2, 97.868; 50: Perf, 0.314; 51: SpO2, 99.0; 51: Perf, 0.335; 52: SpO2, 99.82; 52: Perf, 0.290; 53: SpO2, 98.733; 53: Perf, 0.208; 54: SpO2, 99.442; 54: Perf, 0.407; 55: SpO2, 98.698; 55: Perf, 0.510; 56: SpO2, 97.885; 56: Perf, 0.373; 57: SpO2, 97.717; 57: Perf, 0.412; 58: SpO2, 99.5; 58: Perf, 0.699; 59: SpO2, 99.019; 59: Perf, 0.417; 60: SpO2, 99.226; 60: Perf, 0.292; 61: SpO2, 99.154; 61: Perf, 0.311; 62: SpO2, 99.434; 62: Perf, 0.488; 63: SpO2, 100.0; 63: Perf, 0.649; 63: SBP, 103.0; 63: DBP, 54.0; 63: MAP, 70.333; 67: ALT (SGPT), 20 U/L; 67: PROTEIN TOTAL, 7.8 g/dL; 67: BILIRUBIN TOTAL, 0.5 mg/dL; 67: ALKALINE PHOSPHATASE, 81 U/L; 67: SODIUM, 131 mmol/L; 67: CALCIUM, 8.9 mg/dL; 67: ANION GAP, 14 mmol/L; 67: ALBUMIN, 4.1 g/dL; 67: POTASSIUM, 4.5 mmol/L; 67: CO2, 28 mmol/L; 67: EGFR REFIT WITHOUT RACE (2021), 14 mL/min/1.73 m2; 67: AST (SGOT), 54 U/L; 67: BLOOD UREA NITROGEN (BUN), 18 mg/dL; 67: GLUCOSE, 118 mg/dL; 67: GLOBULIN, 3.7 g/dL; 67: CHLORIDE, 89 mmol/L; 67: CREATININE, 3.37 mg/dL; 67: CORRECTED CALCIUM, 8.8 mg/dL; 69: HR, 89.0; 69: SpO2, 99.0; 69: SBP, 87.0; 69: DBP, 58.0; 69: MAP, 67.667; 87: HR, 82.0; 87: RR, 18.0; 87: SpO2, 99.0; 87: SBP, 85.0; 87: DBP, 69.0; 87: MAP, 74.333; 95: INR, 1.1; 95: PROTHROMBIN TIME, 15.0 seconds; 96: PART. THROMBOPLASTIN TIME, 28.3 seconds; 114: SARS-COV-2 RNA, Not Detected; 114: INFLUENZA B, Not Detected; 114: RSV, Not Detected; 114: INFLUENZA A, Not Detected; 0: Age, 67; 0: Gender, F; 0: Race, Native Hawaiian or Other Pacific Islander; 0: Means of arrival, EMS; 0: Triage Temp, 36.7; 0: Triage HR, 115.0; 0: Triage RR, 19.0; 0: Triage SBP, 101.0; 0: Triage DBP, 57.0; 0: Triage acuity, 3-Urgent; 0: CC, GENERAL WEAKNESS",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient exhibits several warning signs of high sepsis risk, such as hypotension (SBP readings consistently below 90 mmHg), tachycardia (HR of 115 bpm initially), altered lactate level (1.99 mmol/L), and impaired renal function (eGFR of 14 mL/min/1.73 m\u00b2 and creatinine of 3.37 mg/dL). These factors, along with the acuity level and general weakness as chief complaint, indicate a high risk of sepsis.",
            "claims": [
                "The patient exhibits several warning signs of high sepsis risk.",
                "The patient has hypotension with systolic blood pressure (SBP) readings consistently below 90 mmHg.",
                "The patient has tachycardia with a heart rate (HR) of 115 bpm initially.",
                "The patient has an altered lactate level of 1.99 mmol/L.",
                "The patient has impaired renal function with an estimated glomerular filtration rate (eGFR) of 14 mL/min/1.73 m\u00b2.",
                "The patient's creatinine level is 3.37 mg/dL.",
                "The patient's acuity level indicates a high risk of sepsis.",
                "The patient's general weakness is a chief complaint.",
                "These factors indicate a high risk of sepsis."
            ],
            "relevant_claims": [
                "The patient has hypotension with systolic blood pressure (SBP) readings consistently below 90 mmHg.",
                "The patient has tachycardia with a heart rate (HR) of 115 bpm initially.",
                "The patient has an altered lactate level of 1.99 mmol/L.",
                "The patient has impaired renal function with an estimated glomerular filtration rate (eGFR) of 14 mL/min/1.73 m\u00b2.",
                "The patient's creatinine level is 3.37 mg/dL.",
                "The patient's acuity level indicates a high risk of sepsis.",
                "The patient's general weakness is a chief complaint.",
                "These factors indicate a high risk of sepsis."
            ],
            "alignment_scores": [
                1.0,
                0.8,
                0.9,
                0.7,
                1.0,
                0.5,
                0.2,
                0.4
            ],
            "alignment_category": [
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "AElevated NEWS Score (\u22655 points)",
                "SOFA Score Increase (\u22652 points)",
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "The claim directly mentions hypotension with systolic blood pressure consistently below 90 mmHg, which precisely aligns with the category definition of sepsis-associated hypotension (SBP <90 mmHg). This condition indicates progression toward septic shock, making the alignment perfect and strong.",
                "Tachycardia, defined as a heart rate >90 bpm, is explicitly one of the criteria for SIRS. The claim directly mentions a heart rate of 115 bpm, which clearly exceeds the threshold for tachycardia in the SIRS criteria, indicating a strong alignment with this category. However, since only one SIRS criterion is mentioned and the full SIRS positivity requires \u22652 criteria, it is not a perfect alignment.",
                "The claim involves a lactate level very close to the threshold (2 mmol/L) for this category, which is indicative of elevated sepsis mortality risk. Although the level doesn't quite meet the criteria, it is very close and conceptually relevant, suggesting possible tissue hypoperfusion. Thus, the alignment is high but not perfect.",
                "Impaired renal function, as evidenced by the low eGFR, suggests kidney dysfunction, which is closely related to criteria in the SOFA score, such as elevated creatinine levels. While the claim does not directly mention SOFA or provide creatinine levels, renal impairment is a critical factor in SOFA assessments for sepsis risk. The alignment is strong but not direct because specific SOFA criteria weren't mentioned.",
                "An increase in creatinine >2 mg/dL is explicitly mentioned as a component of the SOFA score, indicating new organ dysfunction and a high risk of sepsis. Since the claim directly references an elevated creatinine level, which aligns perfectly with the SOFA component, the alignment is perfect.",
                "The term \"acuity level\" suggests a need for heightened clinical awareness and monitoring, similar to what an elevated NEWS score indicates for the risk of clinical deterioration, including sepsis. However, without specific reference to vital sign derangements or a precise NEWS score, the alignment remains moderate rather than explicit.",
                "General weakness can be indicative of organ dysfunction or systemic illness, which are concepts related to the SOFA score that assesses new organ dysfunction. However, the claim is nonspecific and lacks direct reference to any SOFA metrics, such as altered mental status or specific organ failure indicators. As such, the alignment is weak and indirect.",
                "The claim is vague and does not specify any particular factor or measurement. However, \"factors indicate a high risk of sepsis\" can relate conceptually to an elevated NEWS score, which integrates multiple deranged vitals predicting deterioration and sepsis. The alignment is indirect because the claim lacks specific information that ties it directly to any expert category."
            ],
            "final_alignment_score": 0.6875
        },
        {
            "input": "2: SpO2, 92.286; 3: HR, 108.0; 3: RR, 18.0; 3: SpO2, 94.712; 3: SBP, 104.0; 3: DBP, 58.0; 3: MAP, 73.333; 3: Pain, 10.0; 3: Temp, 98.4; 4: SpO2, 94.424; 4: 1min HRV, 3.128; 5: HR, 105.679; 5: RR, 22.017; 5: SpO2, 95.345; 5: 1min HRV, 12.321; 5: 5min HRV, 12.071; 5: SBP, 104.0; 5: DBP, 58.0; 5: MAP, 73.333; 6: HR, 100.898; 6: RR, 14.288; 6: SpO2, 94.881; 6: 1min HRV, 13.117; 7: HR, 99.603; 7: RR, 16.103; 7: SpO2, 94.172; 7: 1min HRV, 11.406; 8: HR, 98.797; 8: RR, 15.797; 8: SpO2, 93.305; 8: Perf, 3.430; 8: 1min HRV, 10.144; 9: HR, 97.695; 9: RR, 22.237; 9: SpO2, 93.932; 9: Perf, 3.684; 9: 1min HRV, 4.646; 10: HR, 97.810; 10: RR, 27.793; 10: SpO2, 94.672; 10: Perf, 4.924; 10: 1min HRV, 6.557; 10: 5min HRV, 11.750; 11: HR, 98.678; 11: RR, 18.847; 11: SpO2, 96.0; 11: Perf, 4.99; 11: 1min HRV, 6.099; 12: HR, 101.091; 12: RR, 18.091; 12: SpO2, 95.455; 12: Perf, 4.99; 12: 1min HRV, 1.898; 14: HR, 101.0; 14: RR, 27.0; 14: SpO2, 95.0; 14: Perf, 4.99; 15: HR, 103.562; 15: RR, 26.562; 15: SpO2, 93.55; 15: Perf, 4.75; 15: 1min HRV, 2.806; 15: 5min HRV, 11.961; 16: HR, 102.559; 16: RR, 21.864; 16: SpO2, 93.712; 16: Perf, 3.154; 16: 1min HRV, 9.604; 16: SBP, 92.0; 16: DBP, 53.0; 16: MAP, 66.0; 17: HR, 101.559; 17: RR, 21.627; 17: SpO2, 94.424; 17: Perf, 1.920; 17: 1min HRV, 14.599; 18: HR, 96.690; 18: RR, 29.897; 18: SpO2, 94.741; 18: Perf, 2.758; 18: 1min HRV, 11.359; 19: HR, 93.864; 19: RR, 25.746; 19: SpO2, 94.542; 19: Perf, 3.453; 19: 1min HRV, 14.594; 20: HR, 96.052; 20: RR, 28.724; 20: SpO2, 95.0; 20: Perf, 3.637; 20: 1min HRV, 4.509; 20: 5min HRV, 23.489; 21: HR, 97.441; 21: RR, 32.508; 21: SpO2, 94.271; 21: Perf, 3.552; 21: 1min HRV, 4.268; 22: HR, 97.814; 22: RR, 31.441; 22: SpO2, 93.136; 22: Perf, 3.410; 22: 1min HRV, 4.070; 23: HR, 96.862; 23: RR, 30.345; 23: SpO2, 92.362; 23: Perf, 3.15; 23: 1min HRV, 6.574; 24: HR, 97.898; 24: RR, 29.271; 24: SpO2, 94.362; 24: Perf, 3.041; 24: 1min HRV, 6.397; 25: HR, 96.931; 25: RR, 33.103; 25: SpO2, 94.034; 25: 1min HRV, 2.760; 25: 5min HRV, 5.875; 26: HR, 98.356; 26: RR, 32.441; 26: SpO2, 93.780; 26: 1min HRV, 3.452; 27: HR, 99.542; 27: RR, 33.661; 27: SpO2, 94.0; 27: 1min HRV, 2.319; 28: HR, 100.103; 28: RR, 33.569; 28: SpO2, 93.810; 28: 1min HRV, 1.990; 29: HR, 100.729; 29: RR, 33.407; 29: SpO2, 94.0; 29: 1min HRV, 2.201; 30: HR, 100.879; 30: RR, 32.776; 30: SpO2, 93.931; 30: 1min HRV, 4.129; 30: 5min HRV, 5.757; 31: HR, 100.186; 31: RR, 32.424; 31: SpO2, 92.273; 31: 1min HRV, 9.024; 31: SBP, 99.0; 31: DBP, 47.0; 31: MAP, 64.333; 32: HR, 101.525; 32: RR, 33.542; 32: SpO2, 93.932; 32: 1min HRV, 2.930; 33: HR, 102.655; 33: RR, 32.517; 33: SpO2, 93.914; 33: 1min HRV, 2.312; 34: HR, 101.373; 34: RR, 28.576; 34: SpO2, 93.390; 34: 1min HRV, 9.428; 35: HR, 101.241; 35: RR, 22.172; 35: SpO2, 93.621; 35: Perf, 3.324; 35: 1min HRV, 8.231; 35: 5min HRV, 8.377; 36: HR, 102.712; 36: RR, 20.797; 36: SpO2, 94.254; 36: Perf, 3.239; 36: 1min HRV, 6.205; 37: HR, 101.576; 37: RR, 32.373; 37: SpO2, 93.322; 37: Perf, 2.84; 37: 1min HRV, 4.236; 38: HR, 102.293; 38: RR, 26.017; 38: SpO2, 93.638; 38: Perf, 2.84; 38: 1min HRV, 3.312; 39: HR, 101.237; 39: RR, 20.508; 39: SpO2, 94.149; 39: Perf, 2.84; 39: 1min HRV, 9.369; 40: HR, 100.190; 40: RR, 20.034; 40: SpO2, 93.845; 40: 1min HRV, 9.251; 40: 5min HRV, 9.019; 41: HR, 98.085; 41: RR, 22.288; 41: SpO2, 95.475; 41: 1min HRV, 11.561; 42: HR, 98.559; 42: RR, 28.881; 42: SpO2, 95.034; 42: 1min HRV, 3.942; 43: HR, 98.621; 43: RR, 28.138; 43: SpO2, 94.966; 43: 1min HRV, 5.115; 44: HR, 98.322; 44: RR, 32.017; 44: SpO2, 94.136; 44: 1min HRV, 8.521; 45: HR, 98.879; 45: RR, 33.534; 45: SpO2, 92.586; 45: Perf, 2.88; 45: 1min HRV, 4.662; 45: 5min HRV, 7.515; 46: HR, 98.966; 46: RR, 31.475; 46: SpO2, 92.0; 46: Perf, 3.082; 46: 1min HRV, 8.390; 46: SBP, 89.0; 46: DBP, 44.0; 46: MAP, 59.0; 47: HR, 101.818; 47: RR, 21.762; 47: SpO2, 92.535; 47: Perf, 2.787; 47: 1min HRV, 4.126; 47: SBP, 94.0; 47: DBP, 56.0; 47: MAP, 68.667; 50: HR, 102.0; 50: RR, 19.0; 50: SpO2, 94.0; 50: 5min HRV, 10.895; 50: SBP, 94.0; 50: DBP, 56.0; 50: MAP, 68.667; 77: SpO2, 95.176; 78: SpO2, 95.932; 78: Perf, 3.047; 79: SpO2, 95.397; 79: Perf, 2.886; 80: SpO2, 95.576; 80: Perf, 2.753; 81: SpO2, 95.153; 81: Perf, 2.917; 82: SpO2, 94.759; 82: Perf, 3.042; 83: SpO2, 95.0; 83: Perf, 2.844; 84: SpO2, 95.0; 84: Perf, 2.474; 85: SpO2, 95.0; 85: Perf, 2.152; 86: SpO2, 95.138; 86: Perf, 2.112; 87: SpO2, 95.492; 87: Perf, 2.163; 88: SpO2, 95.763; 88: Perf, 2.362; 89: SpO2, 95.586; 89: Perf, 2.067; 90: SpO2, 95.763; 90: Perf, 1.954; 91: SpO2, 95.644; 91: Perf, 1.944; 92: SpO2, 95.603; 92: Perf, 1.77; 93: SpO2, 94.932; 93: Perf, 1.731; 94: SpO2, 95.207; 94: Perf, 1.576; 95: SpO2, 95.0; 95: Perf, 1.505; 96: SpO2, 95.390; 96: Perf, 1.500; 97: SpO2, 95.759; 97: Perf, 1.497; 98: SpO2, 95.379; 98: Perf, 1.476; 99: SpO2, 95.780; 99: Perf, 1.509; 100: SpO2, 95.492; 100: Perf, 1.502; 101: SpO2, 95.593; 101: Perf, 1.464; 102: SpO2, 94.931; 102: Perf, 1.498; 103: SpO2, 95.576; 103: Perf, 1.543; 104: SpO2, 95.845; 104: Perf, 1.474; 105: SpO2, 95.644; 105: Perf, 1.305; 106: SpO2, 96.151; 106: Perf, 0.808; 107: SpO2, 97.207; 107: Perf, 0.534; 108: SpO2, 97.271; 108: Perf, 0.505; 109: SpO2, 95.793; 109: Perf, 0.665; 110: SpO2, 93.414; 110: Perf, 0.695; 111: SpO2, 96.983; 111: Perf, 0.61; 112: SpO2, 97.169; 112: Perf, 0.61; 113: SpO2, 97.525; 113: Perf, 0.61; 114: SpO2, 97.345; 114: Perf, 0.61; 115: SpO2, 96.644; 115: Perf, 0.61; 116: SpO2, 96.034; 116: Perf, 0.61; 117: SpO2, 95.932; 117: Perf, 0.61; 118: SpO2, 95.576; 118: Perf, 0.61; 118: SBP, 93.0; 118: DBP, nan; 118: MAP, nan; 119: SpO2, 96.172; 119: Perf, 0.612; 0: Age, 46; 0: Gender, M; 0: Race, White; 0: Means of arrival, EMS; 0: Triage Temp, 36.9; 0: Triage HR, 108.0; 0: Triage RR, 18.0; 0: Triage SBP, 104.0; 0: Triage DBP, 58.0; 0: Triage acuity, 3-Urgent; 0: CC, KNEE PAIN",
            "answer": true,
            "llm_answer": "No",
            "llm_explanation": "The patient's vital signs show fluctuations, but none strongly suggest a high sepsis risk. The heart rate is elevated but remains relatively stable. The respiratory rate tends to increase, potentially indicating stress or discomfort but not necessarily sepsis. While SpO2 is slightly low at times, it remains generally stable. Although there is some variability in blood pressure and heart rate variability, there is no clear indication of a significant risk of rapid deterioration typical of sepsis. Therefore, based on the provided time series, the patient is not at high risk of developing sepsis within 12 hours.",
            "claims": [
                "The patient's vital signs show fluctuations.",
                "None of the fluctuations in vital signs strongly suggest a high sepsis risk.",
                "The heart rate is elevated.",
                "The heart rate remains relatively stable.",
                "The respiratory rate tends to increase.",
                "An increasing respiratory rate may indicate stress or discomfort.",
                "An increasing respiratory rate does not necessarily indicate sepsis.",
                "SpO2 is slightly low at times.",
                "SpO2 remains generally stable.",
                "There is variability in blood pressure.",
                "There is variability in heart rate.",
                "There is no clear indication of a significant risk of rapid deterioration typical of sepsis.",
                "The patient is not at high risk of developing sepsis within 12 hours."
            ],
            "relevant_claims": [
                "None of the fluctuations in vital signs strongly suggest a high sepsis risk.",
                "The heart rate is elevated."
            ],
            "alignment_scores": [
                0.3,
                0.7
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "SIRS Positivity (\u22652 Criteria)"
            ],
            "alignment_reasonings": [
                "The claim references fluctuations in vital signs, which are typically assessed using scoring systems like the NEWS to predict deterioration related to sepsis. However, it indicates that none of these fluctuations suggest a high risk, so the alignment is weak because it implies absence of criteria that would be defined under a high NEWS score, but there is still an indirect connection to monitoring vital signs for sepsis risk assessment.",
                "The claim mentions an elevated heart rate, which is one of the criteria for SIRS (>90 bpm). While the claim does not specify the exact heart rate or other SIRS criteria, this elevated heart rate aligns with systemic inflammatory response indications used in early sepsis detection. Hence, the alignment is relatively strong but not complete without additional criteria."
            ],
            "final_alignment_score": 0.5
        },
        {
            "input": "5: SBP, 156.0; 5: DBP, 80.0; 5: MAP, 105.333; 6: SpO2, 97.265; 7: SpO2, 96.695; 7: Perf, 0.607; 8: HR, 76.163; 8: RR, 21.787; 8: SpO2, 97.0; 8: Perf, 0.360; 8: 1min HRV, 18.003; 9: HR, 75.259; 9: RR, 20.603; 9: SpO2, 96.897; 9: Perf, 0.341; 9: 1min HRV, 20.634; 10: HR, 73.373; 10: RR, 18.593; 10: SpO2, 96.525; 10: Perf, 0.417; 10: 1min HRV, 9.648; 11: HR, 73.397; 11: RR, 18.828; 11: SpO2, 97.0; 11: Perf, 1.269; 11: 1min HRV, 13.256; 12: HR, 73.542; 12: RR, 18.068; 12: SpO2, 97.0; 12: Perf, 1.663; 12: 1min HRV, 9.717; 12: 5min HRV, 18.442; 12: SBP, 131.0; 12: DBP, 61.0; 12: MAP, 84.333; 13: HR, 74.542; 13: RR, 18.576; 13: SpO2, 96.508; 13: Perf, 1.742; 13: 1min HRV, 13.443; 13: SBP, 131.0; 13: DBP, 61.0; 13: MAP, 84.333; 14: HR, 74.414; 14: RR, 18.241; 14: SpO2, 96.655; 14: Perf, 1.770; 14: 1min HRV, 12.028; 15: HR, 76.310; 15: RR, 19.621; 15: SpO2, 96.466; 15: Perf, 1.963; 15: 1min HRV, 25.404; 16: HR, 80.407; 16: RR, 16.797; 16: SpO2, 96.763; 16: Perf, 1.335; 16: 1min HRV, 12.899; 17: HR, 79.448; 17: RR, 21.034; 17: SpO2, 96.983; 17: Perf, 1.158; 17: 1min HRV, 21.785; 17: 5min HRV, 30.540; 18: HR, 77.05; 18: RR, 22.217; 18: SpO2, 97.283; 18: Perf, 1.249; 18: 1min HRV, 13.935; 19: HR, 81.018; 19: RR, 18.386; 19: SpO2, 97.386; 19: Perf, 1.181; 19: 1min HRV, 20.072; 20: HR, 79.898; 20: RR, 22.593; 20: SpO2, 97.390; 20: Perf, 1.124; 20: 1min HRV, 20.390; 21: HR, 81.655; 21: RR, 23.069; 21: SpO2, 97.517; 21: Perf, 1.018; 21: 1min HRV, 15.768; 22: HR, 81.136; 22: RR, 22.102; 22: SpO2, 97.390; 22: Perf, 1.014; 22: 1min HRV, 27.226; 22: 5min HRV, 25.597; 23: HR, 81.217; 23: RR, 23.167; 23: SpO2, 97.05; 23: Perf, 1.053; 23: 1min HRV, 23.937; 23: Pain, 10.0; 24: HR, 81.018; 24: RR, 21.123; 24: SpO2, 96.877; 24: Perf, 1.125; 24: 1min HRV, 38.289; 25: HR, 83.017; 25: RR, 21.8; 25: SpO2, 97.233; 25: Perf, 1.119; 25: 1min HRV, 20.266; 26: HR, 81.404; 26: RR, 19.947; 26: SpO2, 96.912; 26: Perf, 1.140; 26: 1min HRV, 21.604; 27: HR, 80.864; 27: RR, 23.169; 27: SpO2, 97.203; 27: Perf, 1.119; 27: 1min HRV, 14.880; 27: 5min HRV, 25.481; 27: SBP, 154.0; 27: DBP, 79.0; 27: MAP, 104.0; 28: HR, 81.3; 28: RR, 21.967; 28: SpO2, 97.1; 28: Perf, 1.037; 28: 1min HRV, 17.820; 28: SBP, 154.0; 28: DBP, 79.0; 28: MAP, 104.0; 29: HR, 82.175; 29: RR, 24.035; 29: SpO2, 97.228; 29: Perf, 0.969; 29: 1min HRV, 21.252; 30: HR, 80.458; 30: RR, 22.508; 30: SpO2, 97.237; 30: Perf, 1.003; 30: 1min HRV, 19.101; 31: HR, 78.441; 31: RR, 19.797; 31: SpO2, 97.508; 31: Perf, 1.016; 31: 1min HRV, 22.356; 32: HR, 83.845; 32: RR, 16.293; 32: SpO2, 96.276; 32: Perf, 0.984; 32: 1min HRV, 16.489; 32: 5min HRV, 24.109; 33: HR, 79.475; 33: RR, 22.864; 33: SpO2, 96.915; 33: Perf, 0.929; 33: 1min HRV, 18.395; 34: HR, 79.814; 34: RR, 22.051; 34: SpO2, 97.254; 34: Perf, 0.933; 34: 1min HRV, 27.613; 35: HR, 76.172; 35: RR, 21.293; 35: SpO2, 96.914; 35: Perf, 1.011; 35: 1min HRV, 34.719; 36: HR, 78.847; 36: RR, 20.881; 36: SpO2, 96.932; 36: Perf, 1.105; 36: 1min HRV, 25.498; 37: HR, 79.638; 37: RR, 22.5; 37: SpO2, 97.448; 37: Perf, 0.987; 37: 1min HRV, 10.071; 37: 5min HRV, 27.434; 38: HR, 80.0; 38: RR, 21.220; 38: SpO2, 97.441; 38: Perf, 1.018; 38: 1min HRV, 14.389; 39: HR, 79.138; 39: RR, 23.638; 39: SpO2, 97.586; 39: Perf, 1.066; 39: 1min HRV, 13.513; 40: HR, 80.763; 40: RR, 21.729; 40: SpO2, 97.593; 40: Perf, 1.016; 40: 1min HRV, 11.630; 41: HR, 80.932; 41: RR, 22.169; 41: SpO2, 97.915; 41: Perf, 1.100; 41: 1min HRV, 13.254; 42: HR, 82.051; 42: RR, 20.322; 42: SpO2, 97.373; 42: Perf, 1.055; 42: 1min HRV, 29.948; 42: 5min HRV, 20.107; 43: HR, 79.724; 43: RR, 21.259; 43: SpO2, 97.276; 43: Perf, 1.029; 43: 1min HRV, 30.056; 43: SBP, 181.0; 43: DBP, 167.0; 43: MAP, 171.667; 44: HR, 80.712; 44: RR, 21.814; 44: SpO2, 97.593; 44: Perf, 0.926; 44: 1min HRV, 15.547; 45: HR, 80.661; 45: RR, 22.203; 45: SpO2, 97.407; 45: Perf, 1.028; 45: 1min HRV, 13.599; 47: 5min HRV, 21.117; 57: HR, 74.0; 57: RR, 18.0; 57: SpO2, 97.0; 57: SBP, 136.0; 57: DBP, 76.0; 57: MAP, 96.0; 81: WAM DIFTYP, AUTO; 81: RED BLOOD CELLS (RBC), 2.72 MIL/uL; 81: MONOCYTE ABSOLUTE (AUTO DIFF), 0.43 K/uL; 81: NRBC PERCENT (HEMATOLOGY), 0.0 %; 81: BASOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 81: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.6 g/dL; 81: BASOPHIL % (AUTO DIFF), 0.3 %; 81: MONOCYTE % (AUTO DIFF), 12.4 %; 81: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 81: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 81: NEUTROPHIL ABSOLUTE (AUTO DIFF), 2.32 K/uL; 81: HEMOGLOBIN (HGB), 8.4 g/dL; 81: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.9 pg; 81: NEUTROPHIL % (AUTO DIFF), 66.8 %; 81: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.68 K/uL; 81: LYMPHOCYTE % (AUTO DIFF), 19.6 %; 81: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.6 %; 81: RED CELL DISTRIBUTION WIDTH (RDW), 16.4 %; 81: MEAN CORPUSCULAR VOLUME (MCV), 94.9 fL; 81: PLATELET COUNT (PLT), 176 K/uL; 81: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 81: HEMATOCRIT (HCT), 25.8 %; 81: EOSINOPHIL % (AUTO DIFF), 0.3 %; 81: WHITE BLOOD CELLS (WBC), 3.5 K/uL; 111: HIGH SENSITIVITY TROPONIN, 14 ng/L; 0: Age, 90; 0: Gender, M; 0: Race, White; 0: Means of arrival, EMS; 0: Triage Temp, 36.7; 0: Triage HR, 74.0; 0: Triage RR, 18.0; 0: Triage SBP, 131.0; 0: Triage DBP, 61.0; 0: Triage acuity, 3-Urgent; 0: CC, RIB PAIN",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The patient's vital signs are relatively stable with no marked fever, hypothermia, hypotension, tachycardia, or tachypnea that would denote a high risk for sepsis. Although the blood tests show anemia (low hemoglobin and hematocrit) and leukopenia (low white blood cell count), which can indicate a risk for infection, there's no clear indication of a systemic inflammatory response. Despite being 90 years old, the patient's heart rate, blood pressure, temperature, and respiration rate are within ranges that do not suggest imminent sepsis, thus the classification is \"No\".",
            "claims": [
                "The patient's vital signs are relatively stable.",
                "There is no marked fever.",
                "There is no marked hypothermia.",
                "There is no marked hypotension.",
                "There is no marked tachycardia.",
                "There is no marked tachypnea.",
                "The absence of these conditions does not denote a high risk for sepsis.",
                "The blood tests show anemia.",
                "Anemia is indicated by low hemoglobin and hematocrit.",
                "The blood tests show leukopenia.",
                "Leukopenia is indicated by a low white blood cell count.",
                "Anemia and leukopenia can indicate a risk for infection.",
                "There is no clear indication of a systemic inflammatory response.",
                "The patient is 90 years old.",
                "The patient's heart rate is within a range that does not suggest imminent sepsis.",
                "The patient's blood pressure is within a range that does not suggest imminent sepsis.",
                "The patient's temperature is within a range that does not suggest imminent sepsis.",
                "The patient's respiration rate is within a range that does not suggest imminent sepsis.",
                "Thus, the classification is \"No\"."
            ],
            "relevant_claims": [
                "There is no marked fever.",
                "There is no marked hypothermia.",
                "There is no marked hypotension.",
                "Anemia is indicated by low hemoglobin and hematocrit.",
                "Leukopenia is indicated by a low white blood cell count.",
                "There is no clear indication of a systemic inflammatory response.",
                "The patient's temperature is within a range that does not suggest imminent sepsis."
            ],
            "alignment_scores": [
                0.3,
                0.2,
                0.2,
                0.3,
                1.0,
                1.0,
                0.2
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "SOFA Score Increase (\u22652 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)"
            ],
            "alignment_reasonings": [
                "The absence of marked fever relates to the temperature criteria in the SIRS Positivity category, which considers temperature >38\u2009\u00b0C as a component. The claim reflects information pertinent to assessing SIRS but directly indicates the lack of one criterion. Since it's relevant but negates the criteria rather than confirming it, the alignment is weak.",
                "The mention of hypothermia (or lack thereof) relates to the SIRS criteria, which consider temperature deviations as a factor. However, the claim notes the absence of hypothermia rather than its presence, or any presence of hyperthermia, thus only slightly touching on the criteria for SIRS positivity. The alignment is weak because there's no actual presence of abnormal temperature.",
                "The claim indicates the absence of hypotension, which relates to the Sepsis-Associated Hypotension category. However, the presence of hypotension is a direct indicator and the claim is discussing its absence, so the alignment is weak.",
                "Anemia, indicated by low hemoglobin and hematocrit, can be related to broader issues of organ dysfunction or blood abnormalities, which may contribute indirectly to changes in certain SOFA components, such as platelet count or other hematologic parameters. However, anemia is not a direct SOFA score metric, resulting in a low alignment with the category that evaluates more specific organ dysfunctions directly related to sepsis risk.",
                "Leukopenia, characterized by a low white blood cell count (<4,000/\u00b5L), is explicitly one of the criteria under SIRS. This directly indicates systemic inflammation consistent with early sepsis, achieving perfect alignment with the category.",
                "The claim directly addresses the absence of a systemic inflammatory response, which is essentially the opposite of meeting the SIRS criteria (presence of \u22652 criteria indicating systemic inflammation). The mention of \"no clear indication\" implies a lack of positive SIRS criteria, aligning fully with what the category is designed to capture. This strong relevance and direct reference lead to a perfect alignment rating.",
                "The claim references the patient's temperature, which relates to one of the SIRS criteria for identifying systemic inflammation. However, it specifically mentions that the temperature does not suggest imminent sepsis, indicating the SIRS criterion for temperature is not met. Although there is a conceptual tie to the category, there is minimal alignment because the criterion is not satisfied."
            ],
            "final_alignment_score": 0.4571428571428572
        },
        {
            "input": "10: HR, 96.0; 10: RR, 26.0; 10: SpO2, 98.0; 10: SBP, 133.0; 10: DBP, 76.0; 10: MAP, 95.0; 10: Temp, 99.1; 27: SpO2, 97.156; 27: SBP, 131.0; 27: DBP, nan; 27: MAP, nan; 28: SpO2, 97.357; 29: SpO2, 98.341; 30: SpO2, 97.492; 31: SpO2, 95.793; 31: SBP, 119.0; 31: DBP, 58.0; 31: MAP, 78.333; 32: SpO2, 95.237; 33: SpO2, 97.308; 34: SpO2, 97.517; 35: SpO2, 97.932; 36: SpO2, 97.569; 37: SpO2, 97.655; 38: SpO2, 97.367; 39: SpO2, 97.263; 40: SpO2, 97.914; 41: SpO2, 97.644; 42: SpO2, 97.724; 43: SpO2, 96.5; 44: SpO2, 99.0; 44: Perf, 3.644; 45: SpO2, 97.983; 45: Perf, 3.672; 46: HR, 69.0; 46: RR, 30.0; 46: SpO2, 96.958; 46: Perf, 3.73; 46: SBP, 130.0; 46: DBP, 116.0; 46: MAP, 120.667; 46: Temp, 98.3; 47: HR, 62.0; 47: SpO2, 95.103; 47: SBP, 130.0; 47: DBP, 116.0; 47: MAP, 120.667; 48: SpO2, 99.375; 49: SpO2, 97.864; 50: SpO2, 95.862; 51: SpO2, 95.644; 52: SpO2, 95.949; 53: SpO2, 96.712; 54: SpO2, 97.052; 55: SpO2, 97.102; 56: SpO2, 96.810; 57: SpO2, 96.276; 57: Perf, 3.434; 58: SpO2, 96.780; 58: Perf, 3.367; 59: SpO2, 96.276; 59: Perf, 3.348; 60: SpO2, 96.831; 60: Perf, 3.294; 61: SpO2, 96.879; 61: Perf, 3.28; 62: HR, 106.809; 62: RR, 19.659; 62: SpO2, 97.203; 62: Perf, 3.316; 62: 1min HRV, 66.908; 63: HR, 107.776; 63: RR, 20.328; 63: SpO2, 97.034; 63: Perf, 3.291; 63: 1min HRV, 64.980; 64: HR, 107.103; 64: RR, 23.525; 64: SpO2, 97.729; 64: Perf, 3.29; 64: 1min HRV, 61.610; 65: HR, 108.610; 65: RR, 14.053; 65: SpO2, 97.847; 65: Perf, 3.232; 65: 1min HRV, 71.515; 65: 5min HRV, 66.948; 66: HR, 107.789; 66: SpO2, 97.333; 66: Perf, 3.108; 66: 1min HRV, 64.832; 67: HR, 109.559; 67: SpO2, 97.305; 67: Perf, 3.065; 67: 1min HRV, 66.942; 68: HR, 111.069; 68: SpO2, 96.810; 68: Perf, 3.06; 68: 1min HRV, 67.297; 69: HR, 105.695; 69: SpO2, 96.085; 69: Perf, 3.204; 69: 1min HRV, 65.368; 70: WAM DIFTYP, AUTO; 70: MEAN CORPUSCULAR VOLUME (MCV), 91.1 fL; 70: HEMOGLOBIN (HGB), 16.0 g/dL; 70: HEMATOCRIT (HCT), 48.3 %; 70: RED BLOOD CELLS (RBC), 5.30 MIL/uL; 70: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.2 pg; 70: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 70: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.6 %; 70: MONOCYTE % (AUTO DIFF), 7.3 %; 70: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 70: WHITE BLOOD CELLS (WBC), 6.5 K/uL; 70: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.1 g/dL; 70: MONOCYTE ABSOLUTE (AUTO DIFF), 0.47 K/uL; 70: LYMPHOCYTE % (AUTO DIFF), 9.7 %; 70: NEUTROPHIL % (AUTO DIFF), 81.6 %; 70: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.63 K/uL; 70: RED CELL DISTRIBUTION WIDTH (RDW), 12.9 %; 70: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.04 K/uL; 70: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 70: NEUTROPHIL ABSOLUTE (AUTO DIFF), 5.29 K/uL; 70: NRBC PERCENT (HEMATOLOGY), 0.0 %; 70: BASOPHIL % (AUTO DIFF), 0.5 %; 70: PLATELET COUNT (PLT), 203 K/uL; 70: EOSINOPHIL % (AUTO DIFF), 0.3 %; 70: HR, 107.627; 70: SpO2, 96.424; 70: Perf, 3.251; 70: 1min HRV, 60.198; 70: 5min HRV, 65.907; 71: HR, 104.517; 71: SpO2, 97.621; 71: Perf, 3.208; 71: 1min HRV, 76.915; 72: HR, 107.390; 72: SpO2, 97.119; 72: Perf, 3.320; 72: 1min HRV, 64.587; 73: HR, 105.534; 73: SpO2, 96.966; 73: Perf, 3.356; 73: 1min HRV, 65.170; 74: GLUCOSE, URINE (UA): Negative; 74: KETONE, URINE (UA): Negative; 74: PH, URINE (UA): 5.0; 74: LEUKOCYTE ESTERASE, URINE (UA): Negative; 74: NITRITE, URINE (UA): Negative; 74: SPECIFIC GRAVITY, URINE (UA): 1.027; 74: HR, 106.881; 74: SpO2, 96.153; 74: Perf, 3.34; 74: 1min HRV, 67.444; 75: HR, 109.949; 75: SpO2, 96.542; 75: Perf, 3.34; 75: 1min HRV, 64.928; 75: 5min HRV, 68.501; 76: HR, 106.569; 76: SpO2, 97.0; 76: Perf, 3.365; 76: 1min HRV, 66.408; 77: HR, 108.746; 77: SpO2, 97.203; 77: Perf, 3.376; 77: 1min HRV, 59.347; 78: HR, 111.0; 78: SpO2, 97.466; 78: Perf, 3.38; 78: 1min HRV, 72.866; 79: HR, 108.351; 79: RR, 29.957; 79: SpO2, 97.458; 79: Perf, 3.38; 79: 1min HRV, 69.164; 80: HR, 113.881; 80: RR, 28.872; 80: SpO2, 95.746; 80: Perf, 3.38; 80: 1min HRV, 56.213; 80: 5min HRV, 66.186; 81: HR, 111.0; 81: RR, 21.552; 81: SpO2, 97.931; 81: Perf, 3.390; 81: 1min HRV, 54.996; 82: HR, 109.322; 82: RR, 19.471; 82: SpO2, 97.864; 82: Perf, 3.436; 82: 1min HRV, 58.811; 83: HR, 110.707; 83: RR, 22.382; 83: SpO2, 97.810; 83: Perf, 3.44; 83: 1min HRV, 50.588; 84: HR, 110.203; 84: RR, 31.25; 84: SpO2, 97.085; 84: Perf, 3.44; 84: 1min HRV, 57.078; 85: HR, 104.948; 85: RR, 21.397; 85: SpO2, 97.0; 85: Perf, 3.421; 85: 1min HRV, 63.378; 85: 5min HRV, 57.972; 86: HR, 105.455; 86: RR, 19.75; 86: SpO2, 97.103; 86: Perf, 3.377; 86: 1min HRV, 62.959; 87: HR, 104.224; 87: RR, 21.069; 87: SpO2, 97.0; 87: Perf, 3.37; 87: 1min HRV, 65.987; 88: HR, 107.471; 88: RR, 25.810; 88: SpO2, 97.845; 88: Perf, 3.351; 88: 1min HRV, 59.549; 89: HR, 107.932; 89: RR, 13.639; 89: SpO2, 97.593; 89: Perf, 3.289; 89: 1min HRV, 63.945; 90: HR, 109.508; 90: RR, 16.552; 90: SpO2, 96.831; 90: Perf, 3.182; 90: 1min HRV, 64.924; 90: 5min HRV, 64.664; 91: HR, 107.0; 91: SpO2, 96.0; 91: Perf, 2.889; 93: INR, 1.2; 93: PROTHROMBIN TIME, 15.0 seconds; 94: PART. THROMBOPLASTIN TIME, 36.6 seconds; 102: BNP NT-PRO, 2531 pg/mL; 102: CEFTRIAXONE, 1 GRAM/10 ML IV PUSH (VIAL ONLY); 109: TROPONIN I: ., 030 ng/mL; 0: Age, 48; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.3; 0: Triage HR, 96.0; 0: Triage RR, 26.0; 0: Triage SBP, 133.0; 0: Triage DBP, 76.0; 0: Triage acuity, 3-Urgent; 0: CC, URINARY PAIN,FEVER",
            "answer": false,
            "llm_answer": "Yes",
            "llm_explanation": "The patient presents with symptoms indicative of a possible infection, such as fever and urinary pain. The respiratory rate and heart rate are elevated, suggesting a physiological response to infection, and there's a significant BNP NT-Pro value of 2531 pg/mL, which may indicate cardiac stress associated with sepsis. Additionally, the administration of ceftriaxone, an antibiotic, suggests that a serious bacterial infection is suspected. These factors collectively imply a high risk of sepsis, potentially within the next 12 hours.",
            "claims": [
                "The patient presents with symptoms indicative of a possible infection.",
                "The symptoms include fever and urinary pain.",
                "The respiratory rate is elevated.",
                "The heart rate is elevated.",
                "Elevated respiratory and heart rates suggest a physiological response to infection.",
                "The BNP NT-Pro value is 2531 pg/mL.",
                "A BNP NT-Pro value of 2531 pg/mL may indicate cardiac stress associated with sepsis.",
                "The administration of ceftriaxone suggests that a serious bacterial infection is suspected.",
                "These factors collectively imply a high risk of sepsis.",
                "There is a potential high risk of sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The patient presents with symptoms indicative of a possible infection.",
                "The symptoms include fever and urinary pain.",
                "The respiratory rate is elevated.",
                "The heart rate is elevated.",
                "Elevated respiratory and heart rates suggest a physiological response to infection.",
                "The BNP NT-Pro value is 2531 pg/mL.",
                "A BNP NT-Pro value of 2531 pg/mL may indicate cardiac stress associated with sepsis.",
                "The administration of ceftriaxone suggests that a serious bacterial infection is suspected."
            ],
            "alignment_scores": [
                0.5,
                0.3,
                0.7,
                0.7,
                0.8,
                0.2,
                0.3,
                1.0
            ],
            "alignment_category": [
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "High qSOFA Score (\u22652)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated Shock Index (\u22651.0)",
                "SOFA Score Increase (\u22652 points)",
                "Early Antibiotic/Culture Orders (within 2 hours)"
            ],
            "alignment_reasonings": [
                "The claim suggests a suspicion of infection, which aligns with the reasoning behind ordering early antibiotics or cultures. However, it lacks specific details about immediate clinical actions such as antibiotic administration or culture testing, which would strengthen the alignment with this category.",
                "The claim mentions symptoms such as fever and urinary pain, which suggest a potential infection, possibly a urinary tract infection (UTI). While these symptoms might raise clinician suspicion of a serious infection and could prompt further investigation (like ordering cultures or antibiotics), there is no direct indication of concrete clinical actions (such as antibiotic administration or cultures being drawn) in the claim. Thus, the alignment is indirect and somewhat speculative.",
                "An elevated respiratory rate is one of the components of the qSOFA score, which flags risk of sepsis-related organ dysfunction when score is \u22652. However, the claim doesn\u2019t provide enough detail to determine the full qSOFA score, thus the alignment rating isn't 1.0. Nonetheless, there is a meaningful connection.",
                "The claim mentions an elevated heart rate, which is one of the criteria for SIRS (>90 bpm). While the claim does not specify the exact heart rate or other SIRS criteria, this elevated heart rate aligns with systemic inflammatory response indications used in early sepsis detection. Hence, the alignment is relatively strong but not complete without additional criteria.",
                "The claim references elevated respiratory and heart rates, both of which are included in the SIRS criteria (heart rate\u202f>\u202f90\u202fbpm and respiratory\u202frate\u202f>\u202f20\u202f/min). While the claim suggests a physiological response to infection, it doesn\u2019t specify exact values, preventing a perfect alignment. However, the association with systemic inflammation and sepsis risk is strong.",
                "The claim about an elevated BNP NT-Pro value is not directly linked to any of the expert sepsis categories provided. BNP is more commonly associated with heart failure and fluid overload. Although it could indirectly suggest hemodynamic instability, which is conceptually related to shock (akin to Elevated Shock Index), BNP is not a criterion for sepsis risk in this context. Therefore, the alignment is weak and indirect.",
                "BNP NT-Pro is a biomarker indicating cardiac stress, which doesn't directly align with any of the sepsis prediction categories provided. However, it hints at potential organ dysfunction due to cardiac issues, conceptually linking to the SOFA Score, which considers organ function. The alignment is weak and indirect, thus a low rating.",
                "The claim specifically references the administration of ceftriaxone, which is a broad-spectrum antibiotic. This directly signifies a clinician's suspicion of a serious bacterial infection, which aligns perfectly with the category of early antibiotic orders that signify a high sepsis risk."
            ],
            "final_alignment_score": 0.5625
        },
        {
            "input": "12: HR, 71.0; 12: RR, 14.0; 12: SpO2, 95.0; 12: SBP, 101.0; 12: DBP, 53.0; 12: MAP, 69.0; 12: Temp, 95.5; 15: Pain, 0.0; 21: POC GLUCOSE BY METER, 110 mg/dL; 23: Temp, 98.4; 68: HR, 71.048; 68: RR, 21.216; 68: 1min HRV, 118.647; 68: 5min HRV, 118.647; 69: HR, 68.203; 69: RR, 22.881; 69: SpO2, 94.054; 69: Perf, 8.043; 69: 1min HRV, 25.429; 70: HR, 69.0; 70: RR, 20.069; 70: SpO2, 95.190; 70: Perf, 7.138; 70: 1min HRV, 23.513; 71: HR, 68.661; 71: RR, 21.051; 71: SpO2, 94.983; 71: Perf, 6.486; 71: 1min HRV, 22.759; 72: HR, 66.881; 72: RR, 20.169; 72: SpO2, 94.729; 72: Perf, 6.701; 72: 1min HRV, 13.082; 73: HR, 66.293; 73: RR, 20.914; 73: SpO2, 93.914; 73: Perf, 6.633; 73: 1min HRV, 10.359; 73: 5min HRV, 24.827; 74: HR, 67.627; 74: RR, 20.729; 74: SpO2, 94.017; 74: Perf, 6.500; 74: 1min HRV, 14.015; 75: HR, 68.741; 75: RR, 20.983; 75: SpO2, 94.776; 75: Perf, 6.494; 75: 1min HRV, 23.017; 76: HR, 68.051; 76: RR, 18.847; 76: SpO2, 93.915; 76: Perf, 6.348; 76: 1min HRV, 24.286; 77: HR, 66.864; 77: RR, 20.542; 77: SpO2, 94.458; 77: Perf, 6.000; 77: 1min HRV, 17.775; 78: HR, 67.270; 78: RR, 20.324; 78: SpO2, 93.625; 78: Perf, 5.996; 78: 1min HRV, 22.862; 78: 5min HRV, 21.776; 93: HR, 67.0; 93: RR, 21.0; 93: SpO2, 96.0; 93: Pain, 0.0; 94: HR, 66.0; 94: RR, 15.412; 94: SpO2, 95.077; 94: 1min HRV, 9.971; 95: HR, 66.724; 95: RR, 19.362; 95: SpO2, 95.534; 95: Perf, 5.150; 95: 1min HRV, 20.369; 96: HR, 67.949; 96: RR, 18.458; 96: SpO2, 95.305; 96: Perf, 5.37; 96: 1min HRV, 19.084; 97: INFLUENZA A, Not Detected; 97: INFLUENZA B, Not Detected; 97: SARS-COV-2 RNA, Not Detected; 97: RSV, Not Detected; 97: HR, 66.534; 97: RR, 18.845; 97: SpO2, 94.328; 97: Perf, 5.031; 97: 1min HRV, 18.682; 98: HR, 67.153; 98: RR, 19.746; 98: SpO2, 94.153; 98: Perf, 4.881; 98: 1min HRV, 13.253; 98: 5min HRV, 18.928; 99: HR, 66.932; 99: RR, 18.373; 99: SpO2, 94.627; 99: Perf, 4.283; 99: 1min HRV, 22.392; 100: HR, 65.966; 100: RR, 18.293; 100: SpO2, 94.328; 100: Perf, 4.909; 100: 1min HRV, 11.049; 101: HR, 66.356; 101: RR, 17.458; 101: SpO2, 94.661; 101: Perf, 4.382; 101: 1min HRV, 21.931; 102: HR, 68.517; 102: RR, 19.534; 102: SpO2, 96.828; 102: Perf, 4.202; 102: 1min HRV, 41.638; 103: HR, 66.881; 103: RR, 19.356; 103: SpO2, 94.627; 103: Perf, 3.830; 103: 1min HRV, 27.780; 103: 5min HRV, 28.206; 104: HR, 66.881; 104: RR, 18.220; 104: SpO2, 93.169; 104: Perf, 3.421; 104: 1min HRV, 24.512; 105: HR, 67.310; 105: RR, 19.190; 105: SpO2, 94.345; 105: Perf, 2.697; 105: 1min HRV, 26.227; 106: HR, 66.102; 106: RR, 19.136; 106: SpO2, 94.373; 106: Perf, 2.676; 106: 1min HRV, 26.542; 107: HR, 65.897; 107: RR, 19.172; 107: SpO2, 94.431; 107: Perf, 2.753; 107: 1min HRV, 27.196; 108: HR, 66.034; 108: RR, 18.949; 108: SpO2, 94.220; 108: Perf, 2.97; 108: 1min HRV, 28.092; 108: 5min HRV, 27.770; 109: POC HCT ISTAT, 30 %; 109: POC GLUCOSE ISTAT, 119 mg/dL; 109: POC HGB (CALC) ISTAT, 10.2 g/dL; 109: POC SODIUM ISTAT, 133 mmol/L; 109: POC POTASSIUM ISTAT, 3.3 mmol/L; 109: HR, 65.356; 109: RR, 17.559; 109: SpO2, 94.322; 109: Perf, 2.850; 109: 1min HRV, 27.110; 110: POC PH (V) ISTAT, 7.48; 110: POC BASE EXCESS ISTAT, 9 mmol/L; 110: POC PCO2 (V) ISTAT, 44.2 mmHg; 110: POC TCO2 (V) ISTAT, 34 mmol/L; 110: POC O2 SATURATION ISTAT VENOUS, 85 %; 110: POC PO2 (V) ISTAT, 47 mmHg; 110: POC LACTATE ISTAT, 0.50 mmol/L; 110: POC HCO3 (V) ISTAT, 33.0 mmol/L; 110: HR, 67.259; 110: RR, 20.552; 110: SpO2, 94.793; 110: Perf, 2.956; 110: 1min HRV, 30.449; 111: HR, 68.034; 111: RR, 19.203; 111: SpO2, 95.0; 111: Perf, 3.131; 111: 1min HRV, 23.808; 112: HR, 67.879; 112: RR, 19.293; 112: SpO2, 94.052; 112: Perf, 3.301; 112: 1min HRV, 28.090; 113: HR, 68.339; 113: RR, 20.508; 113: SpO2, 94.542; 113: Perf, 3.465; 113: 1min HRV, 20.705; 113: 5min HRV, 29.870; 114: HR, 68.542; 114: RR, 20.186; 114: SpO2, 94.458; 114: Perf, 3.305; 114: 1min HRV, 25.128; 115: HR, 66.586; 115: RR, 20.552; 115: SpO2, 93.776; 115: Perf, 4.752; 115: 1min HRV, 23.213; 116: HR, 66.525; 116: RR, 18.508; 116: SpO2, 95.983; 116: Perf, 3.87; 116: 1min HRV, 24.671; 117: HR, 67.793; 117: RR, 19.276; 117: SpO2, 94.345; 117: Perf, 4.154; 117: 1min HRV, 28.839; 118: HR, 67.475; 118: RR, 18.322; 118: SpO2, 94.203; 118: Perf, 4.330; 118: 1min HRV, 31.003; 118: 5min HRV, 28.383; 119: ABO/RH (AUTOMATION), O Positive; 119: HR, 67.932; 119: RR, 20.203; 119: SpO2, 93.966; 119: Perf, 4.078; 119: 1min HRV, 32.047; 0: Age, 69; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 35.3; 0: Triage HR, 71.0; 0: Triage RR, 14.0; 0: Triage SBP, 101.0; 0: Triage DBP, 53.0; 0: Triage acuity, 3-Urgent; 0: CC, FALL",
            "answer": true,
            "llm_answer": "No",
            "llm_explanation": "The patient's vital signs, like heart rate, respiratory rate, and blood pressure, remain relatively stable throughout the observation period, with marginal fluctuations that are within normal limits. The patient shows a normal lactate level (0.50 mmol/L), often used to assess sepsis risk, and a lack of other significant indicators of systemic infection. While the initial low temperature and low blood pressure might be concerns, no continuous or increasing trend suggests acute deterioration. Hence, based on this data, the patient is not at high risk of developing sepsis within 12 hours.",
            "claims": [
                "The patient's vital signs remain relatively stable throughout the observation period.",
                "The patient's vital signs include heart rate, respiratory rate, and blood pressure.",
                "There are marginal fluctuations in the vital signs that are within normal limits.",
                "The patient shows a normal lactate level of 0.50 mmol/L.",
                "Lactate levels are often used to assess sepsis risk.",
                "There is a lack of other significant indicators of systemic infection in the patient.",
                "The patient's initial low temperature may be a concern.",
                "The patient's initial low blood pressure may be a concern.",
                "There is no continuous or increasing trend that suggests acute deterioration.",
                "Based on this data, the patient is not at high risk of developing sepsis within 12 hours."
            ],
            "relevant_claims": [
                "There is a lack of other significant indicators of systemic infection in the patient.",
                "The patient's initial low temperature may be a concern.",
                "The patient's initial low blood pressure may be a concern.",
                "There is no continuous or increasing trend that suggests acute deterioration."
            ],
            "alignment_scores": [
                0.3,
                0.3,
                0.7,
                0.3
            ],
            "alignment_category": [
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "SIRS Positivity (\u22652 Criteria)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "The claim suggests the absence of significant indicators of systemic infection, implying an indirect relation to clinician suspicion of infection, possibly influencing their decision regarding early antibiotic or culture orders. However, the claim lacks direct reference to or evidence of specific clinical actions that would confirm high suspicion of infection, leading to a low alignment rating.",
                "The claim mentions an \"initial low temperature,\" which could relate to one of the SIRS criteria\u2014temperature\u202f<\u202f36\u202f\u00b0C. However, the claim is vague about the exact temperature and whether it meets the specific threshold for SIRS. Therefore, this category is only weakly aligned with the claim.",
                "The claim mentions \"initial low blood pressure,\" which is a direct indication of hypotension. Although it does not specify the exact measurements or thresholds (such as SBP <90 mmHg or MAP <70 mmHg), it is strongly suggestive of potential sepsis-associated hypotension, hence indicating a progression towards septic shock. The alignment is strong but not perfect, as explicit thresholds or comparisons to baselines are not detailed in the claim.",
                "The claim implies stability, with no signs of acute deterioration. The NEWS score, which predicts imminent clinical deterioration, is conceptually relevant as the absence of an increasing trend suggests a lower NEWS score. There is some indirect alignment due to the absence of warning signs, but the claim does not offer specific NEWS criteria or values. Thus, it only partially aligns with the category related to monitoring for clinical deterioration."
            ],
            "final_alignment_score": 0.39999999999999997
        },
        {
            "input": "8: HR, 122.0; 8: 1min HRV, 6.485; 9: HR, 119.949; 9: 1min HRV, 5.774; 10: HR, 119.431; 10: RR, 25.0; 10: SpO2, 99.0; 10: 1min HRV, 7.438; 10: SBP, 157.0; 10: DBP, 111.0; 10: MAP, 126.333; 10: Pain, 10.0; 10: Temp, 97.7; 11: HR, 125.864; 11: 1min HRV, 5.985; 12: HR, 128.552; 12: 1min HRV, 12.354; 12: 5min HRV, 15.326; 13: HR, 132.763; 13: 1min HRV, 5.476; 14: HR, 128.237; 14: 1min HRV, 5.782; 15: HR, 127.052; 15: 1min HRV, 6.009; 16: HR, 129.576; 16: 1min HRV, 3.205; 17: HR, 131.397; 17: SpO2, 81.0; 17: 1min HRV, 3.718; 17: 5min HRV, 8.351; 18: HR, 134.780; 18: SpO2, 81.6; 18: 1min HRV, 3.966; 19: HR, 134.322; 19: 1min HRV, 3.130; 20: HR, 134.966; 20: 1min HRV, 2.578; 21: HR, 136.186; 21: 1min HRV, 3.903; 22: HR, 135.621; 22: 1min HRV, 2.507; 22: 5min HRV, 3.855; 23: HR, 135.915; 23: 1min HRV, 3.906; 24: HR, 138.593; 24: 1min HRV, 12.697; 25: HR, 137.172; 25: 1min HRV, 2.892; 26: HR, 137.729; 26: 1min HRV, 5.677; 27: HR, 141.534; 27: 1min HRV, 10.735; 27: 5min HRV, 9.730; 28: HR, 140.305; 28: 1min HRV, 3.041; 29: HR, 136.603; 29: 1min HRV, 7.352; 30: HR, 136.898; 30: SpO2, 72.030; 30: 1min HRV, 3.811; 31: HR, 141.288; 31: SpO2, 71.5; 31: 1min HRV, 10.722; 32: HR, 141.086; 32: 1min HRV, 6.121; 32: 5min HRV, 10.326; 33: HR, 140.068; 33: 1min HRV, 3.493; 34: HR, 140.362; 34: 1min HRV, 3.298; 35: HR, 145.552; 35: SpO2, 84.059; 35: 1min HRV, 11.218; 36: HR, 143.617; 36: 1min HRV, 12.918; 37: HR, 147.948; 37: 1min HRV, 17.235; 37: 5min HRV, 13.856; 38: HR, 145.186; 38: SpO2, 80.0; 38: 1min HRV, 11.901; 39: HR, 143.362; 39: SpO2, 80.611; 39: 1min HRV, 5.209; 40: HR, 141.119; 40: 1min HRV, 4.706; 41: HR, 143.576; 41: 1min HRV, 15.462; 42: HR, 143.431; 42: 1min HRV, 5.235; 42: 5min HRV, 10.431; 43: HR, 143.085; 43: 1min HRV, 16.664; 44: HR, 142.431; 44: 1min HRV, 3.801; 44: HYDROMORPHONE, 1 MG/ML INJ SYRG; 45: HR:, 141.322; 45: 1min HRV, 3.006; 46: HR, 140.729; 46: 1min HRV, 6.007; 47: HR, 144.759; 47: 1min HRV, 5.140; 47: 5min HRV, 9.141; 48: HR, 140.534; 48: 1min HRV, 12.333; 49: HR, 137.186; 49: 1min HRV, 2.207; 50: HR, 137.153; 50: 1min HRV, 3.967; 51: HR, 135.915; 51: 1min HRV, 3.492; 52: HR, 137.448; 52: 1min HRV, 5.259; 52: 5min HRV, 7.911; 53: HR, 140.576; 53: 1min HRV, 7.635; 54: HR, 140.586; 54: 1min HRV, 3.035; 55: HR, 139.763; 55: 1min HRV, 2.794; 56: HR, 136.746; 56: 1min HRV, 4.514; 57: HR, 136.224; 57: 1min HRV, 5.090; 57: 5min HRV, 7.816; 58: HR, 135.525; 58: 1min HRV, 2.689; 59: HR, 136.483; 59: 1min HRV, 3.506; 60: HR, 136.569; 60: 1min HRV, 2.851; 61: HR, 136.915; 61: 1min HRV, 15.564; 62: HR, 136.068; 62: 1min HRV, 2.720; 62: 5min HRV, 7.596; 63: HR, 135.356; 63: 1min HRV, 3.134; 64: HR, 136.552; 64: 1min HRV, 4.518; 65: HR, 139.661; 65: 1min HRV, 7.439; 66: HR, 133.0; 66: 1min HRV, 19.097; 67: HR, 132.492; 67: 1min HRV, 3.197; 67: 5min HRV, 12.820; 68: HR, 133.186; 68: 1min HRV, 4.656; 69: HR, 134.966; 69: 1min HRV, 3.943; 70: HR, 134.712; 70: 1min HRV, 2.937; 71: HR, 134.983; 71: 1min HRV, 3.785; 72: HR, 133.879; 72: 1min HRV, 2.891; 72: 5min HRV, 4.401; 73: HR, 133.85; 73: 1min HRV, 3.464; 74: HR, 135.828; 74: 1min HRV, 5.596; 75: HR, 139.271; 75: 1min HRV, 5.174; 76: HR, 142.5; 76: 1min HRV, 0.740; 77: SARS-COV-2 RNA, Not Detected; 77: 5min HRV, 9.243; 79: HR, 143.0; 79: 1min HRV, 1.797; 80: HR, 140.949; 80: 1min HRV, 16.120; 81: HR, 136.966; 81: 1min HRV, 3.455; 82: HR, 135.542; 82: 1min HRV, 2.452; 82: 5min HRV, 12.124; 83: HR, 134.797; 83: 1min HRV, 2.825; 84: HR, 135.483; 84: 1min HRV, 2.503; 84: LR IV BOLUS -, 1000 ML; 85: HR:, 135.068; 85: 1min HRV, 3.966; 86: HR, 135.310; 86: 1min HRV, 4.188; 87: HR, 135.288; 87: 1min HRV, 3.515; 87: 5min HRV, 3.577; 88: HR, 136.417; 88: 1min HRV, 2.231; 92: 5min HRV, 2.231; 93: SpO2, 94.778; 97: Pain, 8.0; 110: SpO2, 92.444; 0: Age, 40; 0: Gender, F; 0: Race, Black or African American; 0: Means of arrival, EMS; 0: Triage Temp, 36.5; 0: Triage HR, 120.0; 0: Triage RR, 25.0; 0: Triage SBP, 157.0; 0: Triage DBP, 111.0; 0: Triage acuity, 2-Emergent; 0: CC, ABDOMINAL PAIN,FLANK PAIN",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient shows signs of potential sepsis risk, including persistent tachycardia (high heart rate), indicating possible physiological stress. The SpO2 levels are often below the normal range, which could be suggestive of respiratory issues or poor oxygenation, both associated with sepsis. Frequent changes in HRV and persistent high acuity conditions further contribute to categorizing the patient as at high risk for sepsis development within the next 12 hours.",
            "claims": [
                "The patient shows signs of potential sepsis risk.",
                "The patient has persistent tachycardia.",
                "Persistent tachycardia indicates possible physiological stress.",
                "The SpO2 levels are often below the normal range.",
                "SpO2 levels below the normal range could suggest respiratory issues.",
                "SpO2 levels below the normal range could suggest poor oxygenation.",
                "Both respiratory issues and poor oxygenation are associated with sepsis.",
                "Frequent changes in heart rate variability (HRV) contribute to the risk assessment.",
                "Persistent high acuity conditions contribute to the risk assessment.",
                "The patient is categorized as at high risk for sepsis development within the next 12 hours."
            ],
            "relevant_claims": [
                "The patient shows signs of potential sepsis risk.",
                "The patient has persistent tachycardia.",
                "Persistent tachycardia indicates possible physiological stress.",
                "The SpO2 levels are often below the normal range.",
                "SpO2 levels below the normal range could suggest respiratory issues.",
                "SpO2 levels below the normal range could suggest poor oxygenation.",
                "Both respiratory issues and poor oxygenation are associated with sepsis.",
                "Frequent changes in heart rate variability (HRV) contribute to the risk assessment.",
                "Persistent high acuity conditions contribute to the risk assessment."
            ],
            "alignment_scores": [
                0.3,
                0.8,
                0.6,
                0.7,
                0.5,
                0.6,
                0.7,
                0.3,
                0.6
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "Elevated Shock Index (\u22651.0)",
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "The claim is vague and does not provide specific information that directly aligns with any single category. However, the term \"potential sepsis risk\" suggests that there might be some clinical observations that warrant concern, which could be akin to the process of determining a NEWS score for assessing deteriorating patient condition. The alignment is weak due to the lack of specific indicators or criteria from the provided categories.",
                "Persistent tachycardia (heart rate\u202f>\u202f90\u202fbpm) is one of the specific criteria for SIRS. Tachycardia alone does not meet the requirement for SIRS positivity, which requires two or more criteria, but it is directly relevant to this category as it suggests systemic inflammation or a response to infection, which are consistent with early sepsis. The alignment is strong but not complete as it partially fulfills the criteria.",
                "Tachycardia, defined as a heart rate >90 bpm, is a criterion under SIRS criteria, which are used to indicate systemic inflammation and possible early sepsis. The claim directly mentions persistent tachycardia, which partially aligns with the SIRS category, although it does not account for the other criteria needed to fully satisfy the SIRS condition. The relationship is clear but partial, thereby resulting in an intermediate alignment rating.",
                "While SpO2 levels are not directly part of the SOFA score, they relate to respiratory function and oxygenation, which are conceptually connected to the PaO\u2082/FiO\u2082 ratio used in the SOFA score. Low SpO2 can signify issues with oxygenation and potential organ dysfunction, aligning it somewhat strongly with the SOFA category, though the alignment is not perfect.",
                "The SpO2 level, or oxygen saturation, being below the normal range can indicate issues with respiratory function or hypoxia. While SpO2 is not a direct component of the SOFA score, it relates to PaO\u2082, which is considered in the PaO\u2082/FiO\u2082 ratio for SOFA scoring. This connection to impaired oxygenation and possible organ dysfunction provides a moderate alignment with the SOFA score category.",
                "The claim refers to SpO2 levels being below normal, which suggests poor oxygenation. Although SpO2 is not directly a part of the SOFA score, it conceptually relates to impaired oxygenation, a component of the score (PaO\u2082/FiO\u2082). The alignment is indirect but meaningful in terms of assessing sepsis risk through potential organ dysfunction.",
                "The claim mentions respiratory issues and poor oxygenation, which conceptually relate to the SOFA criteria involving respiratory function, particularly the measure of PaO\u2082/FiO\u2082. While the specific components of SOFA are not explicitly cited, poor oxygenation is indicative of potential organ dysfunction assessed by the SOFA score. The alignment is moderately strong due to the clear connection to respiratory dysfunction.",
                "Heart rate variability (HRV) changes are not directly listed in any sepsis prediction category, but they relate conceptually to haemodynamic instability and autonomic nervous system responses, which are relevant to the Elevated Shock Index category. The alignment is indirect, as HRV changes can imply instability, but without specific heart rate or blood pressure data, the connection is weak.",
                "The claim mentions \"persistent high acuity conditions,\" which suggests ongoing concerns about the patient's vitals and overall stability. This aligns conceptually with the NEWS score, which is designed to quantify a patient\u2019s acuity based on vital signs and clinical indicators. However, the claim does not specify NEWS directly or provide specific scores or parameters that are deranged, so the alignment, while relevant, is indirect and not definitive."
            ],
            "final_alignment_score": 0.5666666666666667
        },
        {
            "input": "9: HR, 95.0; 9: RR, 18.0; 9: SpO2, 77.0; 9: SBP, 112.0; 9: DBP, 84.0; 9: MAP, 93.333; 9: LPM O2, nan; 9: Temp, 98.1; 14: SpO2, 96.0; 14: LPM O2, 4.0; 45: HR, 82.0; 45: SpO2, 96.0; 45: SBP, 122.0; 45: DBP, 80.0; 45: MAP, 94.0; 45: LPM O2, 4.0; 49: SpO2, 96.0; 50: SpO2, 95.109; 50: Perf, 1.92; 51: SpO2, 94.774; 51: Perf, 1.96; 75: SpO2, 97.0; 76: SpO2, 96.566; 77: SpO2, 96.358; 78: SpO2, 96.808; 79: SpO2, 97.245; 80: SpO2, 97.135; 81: SpO2, 97.093; 82: SpO2, 97.321; 82: Perf, 0.838; 83: SpO2, 98.115; 83: Perf, 1.027; 84: SpO2, 98.811; 84: Perf, 1.008; 85: HR, 83.152; 85: RR, 23.25; 85: SpO2, 98.962; 85: Perf, 0.881; 85: 1min HRV, 92.396; 85: 5min HRV, 92.396; 86: HR, 83.981; 86: RR, 22.811; 86: SpO2, 99.415; 86: Perf, 0.951; 86: 1min HRV, 91.875; 87: HR, 83.189; 87: RR, 18.151; 87: SpO2, 98.906; 87: Perf, 0.996; 87: 1min HRV, 99.886; 88: HR, 84.346; 88: RR, 20.596; 88: SpO2, 98.904; 88: Perf, 0.978; 88: 1min HRV, 98.378; 89: HR, 87.698; 89: RR, 23.340; 89: SpO2, 98.684; 89: Perf, 0.97; 89: 1min HRV, 103.759; 90: HR, 86.269; 90: RR, 19.558; 90: SpO2, 98.0; 90: Perf, 0.974; 90: 1min HRV, 87.281; 90: 5min HRV, 97.058; 91: HR, 86.170; 91: RR, 24.434; 91: SpO2, 97.830; 91: Perf, 0.982; 91: 1min HRV, 114.745; 92: HR, 86.547; 92: RR, 20.755; 92: SpO2, 98.377; 92: Perf, 0.993; 92: 1min HRV, 96.649; 93: HR, 87.887; 93: RR, 25.377; 93: SpO2, 98.509; 93: Perf, 1.400; 93: 1min HRV, 128.835; 94: HR, 88.094; 94: RR, 23.755; 94: SpO2, 98.377; 94: Perf, 1.707; 94: 1min HRV, 115.796; 95: HR, 85.423; 95: RR, 20.481; 95: SpO2, 98.0; 95: Perf, 1.755; 95: 1min HRV, 87.944; 95: 5min HRV, 109.781; 96: HR, 84.811; 96: RR, 19.170; 96: SpO2, 98.308; 96: Perf, 1.494; 96: 1min HRV, 107.870; 97: HR, 83.887; 97: RR, 18.962; 97: SpO2, 98.0; 97: Perf, 1.488; 97: 1min HRV, 96.765; 98: HR, 83.654; 98: RR, 19.212; 98: SpO2, 98.269; 98: Perf, 1.531; 98: 1min HRV, 106.380; 99: HR, 83.415; 99: RR, 16.887; 99: SpO2, 98.576; 99: Perf, 1.367; 99: 1min HRV, 102.632; 100: HR, 83.846; 100: RR, 17.75; 100: SpO2, 97.923; 100: Perf, 1.313; 100: 1min HRV, 83.002; 100: 5min HRV, 99.817; 101: WAM DIFTYP, AUTO; 101: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 101: NEUTROPHIL ABSOLUTE (AUTO DIFF), 4.80 K/uL; 101: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.4 g/dL; 101: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 101: MONOCYTE ABSOLUTE (AUTO DIFF), 0.69 K/uL; 101: WHITE BLOOD CELLS (WBC), 7.0 K/uL; 101: MONOCYTE % (AUTO DIFF), 9.9 %; 101: LYMPHOCYTE % (AUTO DIFF), 15.4 %; 101: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 101: NRBC PERCENT (HEMATOLOGY), 0.0 %; 101: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.35 K/uL; 101: EOSINOPHIL % (AUTO DIFF), 5.0 %; 101: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.07 K/uL; 101: MEAN CORPUSCULAR VOLUME (MCV), 114.1 fL; 101: NEUTROPHIL % (AUTO DIFF), 69.2 %; 101: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 35.9 pg; 101: RED BLOOD CELLS (RBC), 2.90 MIL/uL; 101: HEMOGLOBIN (HGB), 10.4 g/dL; 101: HEMATOCRIT (HCT), 33.1 %; 101: PLATELET COUNT (PLT), 197 K/uL; 101: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.1 %; 101: RED CELL DISTRIBUTION WIDTH (RDW), 14.4 %; 101: BASOPHIL % (AUTO DIFF), 0.4 %; 101: HR, 84.057; 101: RR, 19.132; 101: SpO2, 98.453; 101: Perf, 1.311; 101: 1min HRV, 120.978; 102: HR, 83.396; 102: RR, 17.943; 102: SpO2, 97.566; 102: Perf, 1.299; 102: 1min HRV, 100.458; 103: HR, 84.192; 103: RR, 21.981; 103: SpO2, 98.0; 103: Perf, 1.255; 103: 1min HRV, 117.417; 104: HR, 83.981; 104: RR, 19.226; 104: SpO2, 97.906; 104: Perf, 1.149; 104: 1min HRV, 95.129; 105: HR, 82.942; 105: RR, 17.558; 105: SpO2, 98.327; 105: Perf, 1.450; 105: 1min HRV, 86.174; 105: 5min HRV, 103.831; 105: LPM O2, 4.0; 106: HR, 83.509; 106: RR, 19.019; 106: SpO2, 97.566; 106: Perf, 1.604; 106: 1min HRV, 98.076; 107: HR, 83.472; 107: RR, 20.075; 107: SpO2, 98.019; 107: Perf, 1.633; 107: 1min HRV, 81.495; 108: HR, 82.925; 108: RR, 20.679; 108: SpO2, 98.245; 108: Perf, 0.948; 108: 1min HRV, 121.444; 109: HR, 83.075; 109: RR, 21.132; 109: SpO2, 98.434; 109: Perf, 0.889; 109: 1min HRV, 102.718; 110: HR, 81.923; 110: RR, 22.231; 110: SpO2, 97.962; 110: Perf, 1.283; 110: 1min HRV, 85.795; 110: 5min HRV, 99.079; 111: HR, 82.642; 111: RR, 20.585; 111: SpO2, 98.830; 111: Perf, 1.488; 111: 1min HRV, 84.665; 112: HR, 84.712; 112: RR, 20.635; 112: SpO2, 98.769; 112: Perf, 1.543; 112: 1min HRV, 110.879; 113: HR, 82.283; 113: RR, 25.396; 113: SpO2, 98.434; 113: Perf, 1.144; 113: 1min HRV, 86.141; 114: HR, 83.222; 114: RR, 20.778; 114: SpO2, 98.611; 114: Perf, 0.899; 114: 1min HRV, 84.949; 115: HR, 82.423; 115: RR, 21.827; 115: SpO2, 98.365; 115: Perf, 0.94; 115: 1min HRV, 89.629; 115: 5min HRV, 91.965; 116: HR, 82.755; 116: RR, 20.811; 116: SpO2, 98.755; 116: Perf, 1.107; 116: 1min HRV, 102.620; 117: HR, 83.712; 117: RR, 18.865; 117: SpO2, 98.308; 117: Perf, 1.218; 117: 1min HRV, 88.153; 118: HR, 83.094; 118: RR, 20.962; 118: SpO2, 97.792; 118: Perf, 1.218; 118: 1min HRV, 102.102; 119: HR, 85.111; 119: RR, 22.0; 119: SpO2, 98.0; 119: Perf, 1.23; 119: 1min HRV, 109.427; 0: Age, 66; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 95.0; 0: Triage RR, 18.0; 0: Triage SBP, 112.0; 0: Triage DBP, 84.0; 0: Triage acuity, 2-Emergent; 0: CC, BREATHING PROBLEM",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The time series data does not indicate a high risk of sepsis within the next 12 hours. Although the SpO2 is initially low at 77.0%, it quickly improves, and subsequent readings show stable SpO2 levels around 98%, suggesting adequate oxygenation. The heart rate and blood pressure are mostly stable within normal ranges, and there's no significant increase in the respiratory rate or other vital signs that would suggest a deteriorating condition typically associated with sepsis. Additionally, the lab results, such as white blood cell count and other cell differentials, do not suggest an active infection or inflammatory process typical of sepsis.",
            "claims": [
                "The time series data does not indicate a high risk of sepsis within the next 12 hours.",
                "The SpO2 is initially low at 77.0%.",
                "The SpO2 quickly improves after the initial reading.",
                "Subsequent SpO2 readings show stable levels around 98%.",
                "Stable SpO2 levels suggest adequate oxygenation.",
                "The heart rate is mostly stable within normal ranges.",
                "The blood pressure is mostly stable within normal ranges.",
                "There is no significant increase in the respiratory rate.",
                "There are no other vital signs that suggest a deteriorating condition typically associated with sepsis.",
                "The lab results, such as white blood cell count, do not suggest an active infection.",
                "The lab results do not suggest an inflammatory process typical of sepsis."
            ],
            "relevant_claims": [
                "The time series data does not indicate a high risk of sepsis within the next 12 hours.",
                "The SpO2 is initially low at 77.0%.",
                "The SpO2 quickly improves after the initial reading.",
                "The lab results, such as white blood cell count, do not suggest an active infection.",
                "The lab results do not suggest an inflammatory process typical of sepsis."
            ],
            "alignment_scores": [
                0.3,
                0.7,
                0.3,
                0.3,
                0.7
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)"
            ],
            "alignment_reasonings": [
                "The claim suggests that the time series data does not indicate high sepsis risk, which could imply that an aggregate score like NEWS wasn't elevated (\u22655), as it predicts imminent deterioration. However, it is indirect and suggests absence rather than presence of risk factors, so the alignment is weak.",
                "The claim regarding low SpO2 (77.0%) is not directly measured by SOFA, but it suggests significant hypoxia, which conceptually relates to impaired oxygenation (similar to PaO\u2082/FiO\u2082 used in SOFA). While not a direct match, it indicates a risk of organ dysfunction and could suggest a potential increase in the SOFA score. The alignment is indirect but relevant to the category.",
                "The claim discusses improvement in SpO2, suggesting a positive change in oxygenation. This does not directly address the SOFA criteria for organ dysfunction or sepsis risk but touches on the concept of impaired oxygenation, which is relevant to the SOFA score's PaO\u2082/FiO\u2082 component. The alignment is weak since the focus is on improvement, whereas the SOFA score looks for worsening indicators.",
                "The claim indirectly relates to the SIRS criteria, particularly focusing on the white blood cell count, which is a specific part of the SIRS criteria for identifying systemic inflammation and potential sepsis. However, the statement indicates the absence of signs suggesting active infection or inflammation, which weakly aligns with the category since no specific SIRS criteria are met. Therefore, the alignment is minimal.",
                "The claim focuses on the absence of an inflammatory process, which directly pertains to SIRS criteria since these criteria are used to detect systemic inflammation indicative of sepsis. Thus, there is a strong but indirect alignment with the claim addressing the lack of expected indications for SIRS positivity."
            ],
            "final_alignment_score": 0.45999999999999996
        },
        {
            "input": "10: HR, 124.0; 10: RR, 18.0; 10: SBP, 123.0; 10: DBP, 85.0; 10: MAP, 97.667; 10: Temp, 99.3; 34: SpO2, 98.474; 35: SpO2, 99.169; 35: Perf, 2.224; 36: SpO2, 98.948; 36: Perf, 2.137; 37: SpO2, 99.119; 37: Perf, 2.362; 38: SpO2, 98.603; 38: Perf, 1.824; 39: SpO2, 97.678; 39: Perf, 1.582; 40: SpO2, 98.458; 40: Perf, 1.283; 41: SpO2, 98.534; 41: Perf, 1.659; 42: SpO2, 98.746; 42: Perf, 1.824; 43: SpO2, 98.379; 43: Perf, 1.852; 44: SpO2, 98.441; 44: Perf, 1.785; 45: SpO2, 98.220; 45: Perf, 1.027; 46: SpO2, 98.690; 46: Perf, 1.103; 47: SpO2, 99.678; 47: Perf, 1.772; 48: SpO2, 99.810; 48: Perf, 2.277; 49: SpO2, 99.780; 49: Perf, 2.665; 50: SpO2, 98.661; 50: Perf, 2.874; 51: SpO2, 98.810; 51: Perf, 2.65; 52: SpO2, 99.0; 52: Perf, 1.746; 53: SpO2, 98.414; 53: Perf, 1.777; 54: SpO2, 98.237; 54: Perf, 1.994; 55: SpO2, 97.678; 55: Perf, 2.447; 56: SpO2, 99.017; 56: Perf, 2.373; 57: SpO2, 98.203; 57: Perf, 2.956; 58: SpO2, 98.914; 58: Perf, 3.224; 59: SpO2, 99.186; 59: Perf, 2.435; 60: SpO2, 98.271; 60: Perf, 1.618; 61: SpO2, 97.224; 61: Perf, 1.683; 62: SpO2, 96.339; 62: Perf, 0.938; 63: SpO2, 96.724; 63: Perf, 0.922; 64: SpO2, 97.153; 64: Perf, 0.700; 65: SpO2, 97.0; 65: Perf, 0.776; 66: SpO2, 97.186; 66: Perf, 1.047; 67: SpO2, 97.237; 67: Perf, 1.001; 68: SpO2, 96.845; 68: Perf, 0.894; 69: SpO2, 97.085; 69: Perf, 0.953; 70: POC, HCG, ISTAT QUALITATIVE: Negative; 70: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 70: SpO2, 99.138; 70: Perf, 1.017; 71: SpO2, 97.661; 71: Perf, 1.419; 72: POC PH (V) ISTAT, 7.40; 72: POC PCO2 (V) ISTAT, 40.6 mmHg; 72: POC PO2 (V) ISTAT, 36 mmHg; 72: POC O2 SATURATION ISTAT VENOUS, 69 %; 72: POC HCO3 (V) ISTAT, 25.0 mmol/L; 72: POC LACTATE ISTAT, 0.93 mmol/L; 72: POC BASE EXCESS ISTAT, 0 mmol/L; 72: POC TCO2 (V) ISTAT, 26 mmol/L; 72: SpO2, 98.0; 72: Perf, 1.794; 73: SpO2, 98.0; 73: Perf, 1.956; 74: SpO2, 98.0; 74: Perf, 2.021; 74: LR IV BOLUS -, 1000 ML; 75: SpO, 2: 97.293; 75: Perf, 1.599; 76: SpO2, 97.492; 76: Perf, 2.369; 77: SpO2, 97.424; 77: Perf, 2.6; 78: SpO2, 99.207; 78: Perf, 2.413; 79: SpO2, 98.678; 79: Perf, 2.122; 80: SpO2, 98.879; 80: Perf, 1.586; 81: SpO2, 98.898; 81: Perf, 1.792; 82: SpO2, 98.237; 82: Perf, 1.856; 83: SpO2, 98.897; 83: Perf, 1.813; 84: SpO2, 98.814; 84: Perf, 1.436; 85: SpO2, 99.138; 85: Perf, 1.005; 86: SpO2, 98.356; 86: Perf, 1.135; 87: SpO2, 98.034; 87: Perf, 1.147; 88: SpO2, 99.0; 88: Perf, 1.075; 89: SpO2, 98.712; 89: Perf, 1.979; 90: SpO2, 98.966; 90: Perf, 1.538; 91: SpO2, 97.746; 91: Perf, 0.917; 92: SpO2, 97.559; 92: Perf, 0.788; 93: SpO2, 98.293; 93: Perf, 0.755; 94: SpO2, 98.339; 94: Perf, 0.913; 95: SpO2, 98.121; 95: Perf, 1.300; 96: SpO2, 97.695; 96: Perf, 1.225; 97: SpO2, 97.569; 97: Perf, 1.103; 98: SpO2, 98.237; 98: Perf, 0.971; 99: SpO2, 98.254; 99: Perf, 1.076; 100: SpO2, 99.052; 100: Perf, 0.774; 101: SpO2, 99.610; 101: Perf, 0.882; 102: SpO2, 98.707; 102: Perf, 0.931; 103: SpO2, 99.542; 103: Perf, 0.719; 104: SpO2, 99.931; 104: Perf, 1.281; 105: SpO2, 100.0; 105: Perf, 1.238; 106: SpO2, 99.610; 106: Perf, 1.108; 107: SpO2, 99.086; 107: Perf, 0.759; 108: SpO2, 97.636; 108: Perf, 0.521; 109: SpO2, 98.611; 110: SpO2, 98.966; 110: Perf, 0.720; 111: SpO2, 99.593; 111: Perf, 0.645; 112: SpO2, 99.707; 112: Perf, 0.756; 113: SpO2, 98.966; 113: Perf, 0.805; 114: SpO2, 98.690; 114: Perf, 0.62; 115: RBC MORPHOLOGY (SLIDE REVIEW), Abnormal; 115: PROTEIN TOTAL, 7.6 g/dL; 115: ANION GAP, 11 mmol/L; 115: ALT (SGPT), 12 U/L; 115: BLOOD UREA NITROGEN (BUN), 9 mg/dL; 115: GLUCOSE, 132 mg/dL; 115: AST (SGOT), 16 U/L; 115: EGFR REFIT WITHOUT RACE (2021), 44 mL/min/1.73 m2; 115: GLOBULIN, 4.0 g/dL; 115: CHLORIDE, 105 mmol/L; 115: CORRECTED CALCIUM, 8.4 mg/dL; 115: SODIUM, 142 mmol/L; 115: ALKALINE PHOSPHATASE, 82 U/L; 115: POTASSIUM, 3.5 mmol/L; 115: CO2, 26 mmol/L; 115: CALCIUM, 8.1 mg/dL; 115: BILIRUBIN TOTAL, 0.2 mg/dL; 115: EGFR FOR AFRICAN AMERICAN, 51 mL/min/1.73 m2; 115: ALBUMIN, 3.6 g/dL; 115: CREATININE, 1.52 mg/dL; 115: RED CELL DISTRIBUTION WIDTH (RDW), 18.8 %; 115: HEMATOCRIT (HCT), 24.7 %; 115: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 17.9 pg; 115: WHITE BLOOD CELLS (WBC), 8.5 K/uL; 115: HEMOGLOBIN (HGB), 6.4 g/dL; 115: PLATELET COUNT (PLT), 369 K/uL; 115: MEAN CORPUSCULAR VOLUME (MCV), 69.0 fL; 115: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 25.9 g/dL; 115: RED BLOOD CELLS (RBC), 3.58 MIL/uL; 115: NEUTROPHILS BANDS % (MANUAL DIFF), 0.0 %; 115: LYMPHOCYTES % (MANUAL DIFF), 10.4 %; 115: EOSINOPHILS ABSOLUTE (MANUAL DIFF), 0.14 K/uL; 115: MONOCYTES ABSOLUTE (MANUAL DIFF), 0.30 K/uL; 115: EOSINOPHILS % (MANUAL DIFF), 1.7 %; 115: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 7.19 K/uL; 115: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 0.89 K/uL; 115: MONOCYTES % (MANUAL DIFF), 3.5 %; 115: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 84.4 %; 115: SpO2, 98.576; 115: Perf, 0.578; 116: SpO2, 98.136; 116: Perf, 0.589; 117: SpO2, 98.414; 117: Perf, 0.684; 118: SpO2, 98.508; 118: Perf, 1.111; 119: SpO2, 98.593; 119: Perf, 1.259; 0: Age, 33; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 37.4; 0: Triage HR, 124.0; 0: Triage RR, 18.0; 0: Triage SBP, 123.0; 0: Triage DBP, 85.0; 0: Triage acuity, 3-Urgent; 0: CC, FEVER,EMESIS,DIARRHEA",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The patient presents with a high heart rate and fever, symptoms that might suggest an infection risk. However, the patient maintains a stable respiratory rate, blood pressure, and oxygen saturation throughout the monitoring period. Laboratory values, such as lactate, are within normal ranges, decreasing the likelihood of sepsis. Despite severe anemia, other clinical signs do not point towards imminent sepsis risk, so the label is \"No\" for high risk of developing sepsis within the next 12 hours.",
            "claims": [
                "The patient presents with a high heart rate.",
                "The patient presents with a fever.",
                "A high heart rate and fever might suggest an infection risk.",
                "The patient maintains a stable respiratory rate throughout the monitoring period.",
                "The patient maintains a stable blood pressure throughout the monitoring period.",
                "The patient maintains stable oxygen saturation throughout the monitoring period.",
                "Laboratory values, such as lactate, are within normal ranges.",
                "Laboratory values being within normal ranges decreases the likelihood of sepsis.",
                "The patient has severe anemia.",
                "Other clinical signs do not point towards imminent sepsis risk.",
                "The label for the patient is \"No\" for high risk of developing sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The patient presents with a high heart rate.",
                "A high heart rate and fever might suggest an infection risk."
            ],
            "alignment_scores": [
                0.7,
                0.9
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)"
            ],
            "alignment_reasonings": [
                "The claim refers to a high heart rate, which is one of the criteria under the SIRS category (heart rate >90 bpm). This criterion is directly linked to identifying systemic inflammation related to early sepsis, suggesting a strong alignment. However, without the presence of at least one other SIRS criterion, the alignment is not complete, thus the rating is not maximal.",
                "The claim describes a high heart rate and fever, both of which are explicitly part of the SIRS criteria used to identify systemic inflammation and early sepsis. The strong connection of both symptoms to the SIRS positivity makes the alignment very high, just shy of perfect because it stops short of explicitly confirming both criteria are met or clinical significance outside a potential risk."
            ],
            "final_alignment_score": 0.8
        },
        {
            "input": "13: HR, 128.0; 13: RR, 18.0; 13: SpO2, 99.0; 13: SBP, 120.0; 13: DBP, 51.0; 13: MAP, 74.0; 13: Temp, 99.5; 59: HR, 117.362; 59: RR, 23.914; 59: Perf, 0.43; 59: 1min HRV, 6.545; 60: HR, 117.915; 60: RR, 23.441; 60: SpO2, 100.0; 60: 1min HRV, 7.644; 61: HR, 119.576; 61: RR, 23.373; 61: SpO2, 99.610; 61: Perf, 0.551; 61: 1min HRV, 6.043; 61: 5min HRV, 7.955; 62: HR, 120.086; 62: RR, 23.328; 62: SpO2, 99.310; 62: Perf, 0.769; 62: 1min HRV, 4.305; 63: HR, 121.153; 63: RR, 25.085; 63: SpO2, 99.153; 63: Perf, 0.875; 63: 1min HRV, 4.458; 64: HR, 121.810; 64: RR, 24.466; 64: SpO2, 98.931; 64: Perf, 0.934; 64: 1min HRV, 3.305; 65: HR, 122.034; 65: RR, 22.525; 65: SpO2, 99.305; 65: Perf, 0.970; 65: 1min HRV, 7.228; 66: HR, 122.542; 66: RR, 25.068; 66: SpO2, 99.407; 66: Perf, 1.144; 66: 1min HRV, 9.828; 66: 5min HRV, 7.036; 67: HR, 121.397; 67: RR, 23.034; 67: SpO2, 99.621; 67: Perf, 1.108; 67: 1min HRV, 15.414; 68: HR, 121.966; 68: RR, 22.949; 68: SpO2, 99.780; 68: Perf, 0.948; 68: 1min HRV, 4.909; 69: HR, 121.517; 69: RR, 22.776; 69: SpO2, 99.017; 69: Perf, 1.183; 69: 1min HRV, 13.828; 70: HR, 122.475; 70: RR, 25.169; 70: SpO2, 99.203; 70: Perf, 1.144; 70: 1min HRV, 3.591; 71: HR, 123.259; 71: RR, 24.966; 71: SpO2, 99.810; 71: Perf, 1.064; 71: 1min HRV, 4.648; 71: 5min HRV, 10.297; 72: HR, 122.034; 72: RR, 23.254; 72: SpO2, 99.508; 72: Perf, 0.958; 72: 1min HRV, 10.127; 72: SBP, 102.0; 72: DBP, 58.0; 72: MAP, 72.667; 73: HR, 121.237; 73: RR, 24.169; 73: SpO2, 99.525; 73: Perf, 1.137; 73: 1min HRV, 4.810; 74: HR, 122.638; 74: RR, 24.983; 74: SpO2, 99.828; 74: Perf, 1.003; 74: 1min HRV, 3.128; 75: HR, 122.458; 75: RR, 24.254; 75: SpO2, 99.644; 75: Perf, 0.895; 75: 1min HRV, 8.975; 76: HR, 121.638; 76: RR, 25.379; 76: SpO2, 99.690; 76: Perf, 0.811; 76: 1min HRV, 12.485; 76: 5min HRV, 8.911; 77: HR, 122.915; 77: RR, 25.085; 77: SpO2, 99.729; 77: Perf, 0.893; 77: 1min HRV, 3.437; 78: HR, 123.034; 78: RR, 24.644; 78: SpO2, 99.915; 78: Perf, 0.860; 78: 1min HRV, 3.121; 79: HR, 122.190; 79: RR, 20.793; 79: SpO2, 99.759; 79: Perf, 0.882; 79: 1min HRV, 8.052; 80: HR, 119.610; 80: RR, 19.559; 80: SpO2, 99.322; 80: Perf, 0.682; 80: 1min HRV, 15.067; 81: HR, 119.586; 81: RR, 17.759; 81: SpO2, 98.586; 81: Perf, 0.478; 81: 1min HRV, 21.346; 81: 5min HRV, 14.003; 82: HR, 121.678; 82: RR, 23.390; 82: SpO2, 98.2; 82: Perf, 0.48; 82: 1min HRV, 7.006; 83: HR, 120.729; 83: RR, 22.237; 83: SpO2, 99.677; 83: Perf, 0.48; 83: 1min HRV, 10.215; 84: HR, 122.069; 84: RR, 25.603; 84: SpO2, 99.845; 84: Perf, 0.596; 84: 1min HRV, 2.628; 85: HR, 123.051; 85: RR, 24.407; 85: SpO2, 99.949; 85: Perf, 0.599; 85: 1min HRV, 4.199; 86: HR, 123.224; 86: RR, 24.138; 86: SpO2, 100.0; 86: Perf, 0.641; 86: 1min HRV, 6.186; 86: 5min HRV, 7.510; 87: HR, 120.254; 87: RR, 31.0; 87: SpO2, 99.939; 87: Perf, 0.620; 87: 1min HRV, 11.018; 87: SBP, 106.0; 87: DBP, 63.0; 87: MAP, 77.333; 88: HR, 118.186; 88: RR, 23.068; 88: SpO2, 99.949; 88: Perf, 0.555; 88: 1min HRV, 17.155; 89: HR, 119.828; 89: RR, 23.569; 89: SpO2, 99.789; 89: Perf, 0.579; 89: 1min HRV, 11.270; 90: HR, 118.927; 90: RR, 22.322; 90: SpO2, 99.641; 90: Perf, 0.542; 90: 1min HRV, 4.142; 91: HR, 122.190; 91: RR, 26.397; 91: Perf, 0.54; 91: 1min HRV, 5.678; 91: 5min HRV, 13.005; 92: HR, 122.339; 92: RR, 26.288; 92: 1min HRV, 12.070; 93: HR, 119.102; 93: RR, 23.966; 93: SpO2, 100.0; 93: Perf, 0.37; 93: 1min HRV, 17.897; 94: HR, 117.983; 94: RR, 25.293; 94: SpO2, 99.948; 94: Perf, 0.498; 94: 1min HRV, 11.574; 95: HR, 117.847; 95: RR, 23.915; 95: SpO2, 100.0; 95: Perf, 0.695; 95: 1min HRV, 13.356; 96: HR, 118.776; 96: RR, 22.707; 96: SpO2, 99.966; 96: Perf, 0.776; 96: 1min HRV, 3.920; 96: 5min HRV, 13.245; 97: HR, 118.102; 97: RR, 24.627; 97: SpO2, 99.102; 97: Perf, 0.695; 97: 1min HRV, 5.616; 98: HR, 120.102; 98: RR, 23.339; 98: SpO2, 98.661; 98: Perf, 0.927; 98: 1min HRV, 2.730; 99: HR, 121.190; 99: RR, 24.052; 99: SpO2, 99.759; 99: Perf, 0.931; 99: 1min HRV, 8.752; 100: HR, 121.864; 100: RR, 24.424; 100: SpO2, 100.0; 100: Perf, 1.029; 100: 1min HRV, 2.311; 101: HR, 122.828; 101: RR, 24.672; 101: SpO2, 99.655; 101: Perf, 1.052; 101: 1min HRV, 3.685; 101: 5min HRV, 8.392; 101: SBP, 105.0; 101: DBP, 61.0; 101: MAP, 75.667; 102: HR, 121.576; 102: RR, 24.915; 102: SpO2, 99.407; 102: Perf, 1.066; 102: 1min HRV, 3.417; 102: SBP, 105.0; 102: DBP, 61.0; 102: MAP, 75.667; 103: HR, 123.224; 103: RR, 24.828; 103: SpO2, 98.897; 103: Perf, 1.087; 103: 1min HRV, 2.370; 104: HR, 123.661; 104: RR, 26.085; 104: SpO2, 98.915; 104: Perf, 1.184; 104: 1min HRV, 3.678; 105: HR, 124.390; 105: RR, 25.390; 105: SpO2, 98.983; 105: Perf, 1.227; 105: 1min HRV, 2.959; 106: HR, 124.707; 106: RR, 23.983; 106: SpO2, 98.914; 106: Perf, 1.160; 106: 1min HRV, 6.864; 106: 5min HRV, 6.006; 107: SARS-COV-2 RNA, Not Detected; 107: HR, 124.390; 107: RR, 27.017; 107: SpO2, 99.034; 107: Perf, 1.212; 107: 1min HRV, 3.047; 108: HR, 124.897; 108: RR, 28.0; 108: SpO2, 99.103; 108: Perf, 1.169; 108: 1min HRV, 12.130; 109: HR, 124.339; 109: RR, 24.322; 109: SpO2, 99.288; 109: Perf, 0.893; 109: 1min HRV, 10.818; 110: HR, 124.271; 110: RR, 26.475; 110: SpO2, 98.949; 110: Perf, 0.796; 110: 1min HRV, 11.932; 111: HR, 123.069; 111: RR, 24.259; 111: SpO2, 99.845; 111: Perf, 0.678; 111: 1min HRV, 11.822; 111: 5min HRV, 10.934; 112: HR, 120.864; 112: RR, 28.068; 112: SpO2, 99.442; 112: Perf, 0.482; 112: 1min HRV, 24.982; 113: HR, 123.190; 113: RR, 27.034; 113: SpO2, 97.909; 113: Perf, 0.26; 113: 1min HRV, 8.670; 114: HR, 122.153; 114: RR, 26.780; 114: Perf, 0.26; 114: 1min HRV, 6.498; 115: HR, 123.627; 115: RR, 27.017; 115: SpO2, 98.0; 115: Perf, 0.224; 115: 1min HRV, 11.989; 116: HR, 123.948; 116: RR, 28.414; 116: 1min HRV, 4.802; 116: 5min HRV, 14.052; 117: HR, 122.932; 117: RR, 27.763; 117: 1min HRV, 4.905; 117: SBP, 110.0; 117: DBP, 58.0; 117: MAP, 75.333; 118: HR, 123.897; 118: RR, 25.638; 118: SpO2, 95.0; 118: 1min HRV, 3.633; 119: HR, 121.847; 119: RR, 32.153; 119: 1min HRV, 16.656; 0: Age, 44; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.5; 0: Triage HR, 128.0; 0: Triage RR, 18.0; 0: Triage SBP, 120.0; 0: Triage DBP, 51.0; 0: Triage acuity, 2-Emergent; 0: CC, WOUND CHECK",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient presents with sustained tachycardia (HR > 120 bpm) and elevated respiratory rates (RR > 20) throughout the time series, indicating cardiovascular and respiratory distress. Additionally, the low diastolic blood pressure and reduced perfusion values (Perf < 1) suggest poor circulation. The SpO2 occasionally drops below standard levels, further suggesting compromised oxygenation. As these are critical signs and symptoms associated with sepsis, the patient is at a high risk of developing sepsis within 12 hours.",
            "claims": [
                "The patient presents with sustained tachycardia.",
                "Sustained tachycardia is defined as a heart rate greater than 120 beats per minute.",
                "The patient has elevated respiratory rates throughout the time series.",
                "Elevated respiratory rates are defined as a respiratory rate greater than 20 breaths per minute.",
                "Sustained tachycardia and elevated respiratory rates indicate cardiovascular and respiratory distress.",
                "The patient has low diastolic blood pressure.",
                "Low diastolic blood pressure suggests poor circulation.",
                "The patient has reduced perfusion values.",
                "Reduced perfusion values are defined as perfusion values less than 1.",
                "Reduced perfusion indicates poor circulation.",
                "The patient's SpO2 occasionally drops below standard levels.",
                "A drop in SpO2 below standard levels suggests compromised oxygenation.",
                "These signs and symptoms are critical indicators associated with sepsis.",
                "The patient is at a high risk of developing sepsis within 12 hours."
            ],
            "relevant_claims": [
                "The patient presents with sustained tachycardia.",
                "Sustained tachycardia is defined as a heart rate greater than 120 beats per minute.",
                "The patient has elevated respiratory rates throughout the time series.",
                "Elevated respiratory rates are defined as a respiratory rate greater than 20 breaths per minute.",
                "Sustained tachycardia and elevated respiratory rates indicate cardiovascular and respiratory distress.",
                "The patient has low diastolic blood pressure.",
                "Low diastolic blood pressure suggests poor circulation.",
                "The patient has reduced perfusion values.",
                "Reduced perfusion indicates poor circulation.",
                "The patient's SpO2 occasionally drops below standard levels.",
                "A drop in SpO2 below standard levels suggests compromised oxygenation.",
                "These signs and symptoms are critical indicators associated with sepsis.",
                "The patient is at a high risk of developing sepsis within 12 hours."
            ],
            "alignment_scores": [
                0.7,
                0.8,
                0.7,
                0.8,
                0.7,
                0.7,
                0.5,
                0.7,
                0.6,
                0.5,
                0.6,
                0.3,
                0.3
            ],
            "alignment_category": [
                "Elevated Shock Index (\u22651.0)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "High qSOFA Score (\u22652)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Elevated Shock Index (\u22651.0)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "Tachycardia (elevated heart rate) contributes to an elevated Shock Index (heart rate \u00f7 systolic BP), indicating haemodynamic instability, which is a risk indicator for severe sepsis. While the claim mentions tachycardia, it doesn't specify systolic BP, so the alignment is significant but not complete.",
                "The claim mentions sustained tachycardia with a heart rate greater than 120 bpm, which is above the SIRS criterion of >90 bpm and is relevant for identifying systemic inflammation consistent with early sepsis. However, since only one SIRS criterion is mentioned (and not \u22652), the alignment is strong but not perfect.",
                "An elevated respiratory rate is one of the criteria used to identify SIRS, a state of systemic inflammation that is consistent with early sepsis. The claim does not specify if other SIRS criteria are met, but the alignment is strong with this category because one of the criteria (respiratory rate > 20/min) is directly referenced. Therefore, while a complete SIRS diagnosis requires at least two criteria, the presence of an elevated respiratory rate suggests partial alignment with this category.",
                "The claim mentions an elevated respiratory rate, which is directly related to one of the SIRS criteria (respiratory rate\u202f>\u202f20\u202f/min). While the claim doesn't explicitly state that the patient's respiratory rate exceeds this threshold, it directly references the criterion. Thus, there is a strong, but not perfect, alignment because the actual patient measurement is not provided to confirm the SIRS positivity.",
                "The claim references \"sustained tachycardia and elevated respiratory rates,\" which align well with qSOFA criteria, involving respiratory rate\u202f\u2265\u202f22/min and systolic\u202fBP\u202f\u2264\u202f100\u202fmmHg (the latter not directly mentioned) or altered mentation. While the claim doesn't mention systolic BP or altered mentation to meet the qSOFA score explicitly, it points to cardiovascular and respiratory distress typically associated with organ dysfunction\u2014concepts relevant to qSOFA assessment. Thus, the alignment is strong but not complete, as not all elements of the qSOFA criteria are covered.",
                "While the claim specifies low diastolic blood pressure rather than systolic or mean arterial pressure, hypotension in general aligns with the sepsis-associated hypotension category. Diastolic blood pressure isn't explicitly mentioned, but it indirectly relates to overall blood pressure stability. The alignment is moderate because specific values aren't provided to confirm the exact thresholds stated in the category.",
                "The claim refers to low diastolic blood pressure suggesting poor circulation, which could imply haemodynamic instability. Although the claim does not explicitly mention the shock index or its components (heart rate and systolic blood pressure), poor circulation is related conceptually to an increased shock index indicating haemodynamic instability. The alignment is indirect, thus a moderate alignment rating is given.",
                "Reduced perfusion often indicates tissue hypoperfusion, which is closely associated with elevated serum lactate levels. Although the claim does not explicitly mention serum lactate, the concept of hypoperfusion aligns significantly with this category, suggesting an elevated risk of sepsis. The alignment is strong but indirect, as the specific laboratory value is not provided.",
                "Reduced perfusion suggests poor tissue oxygenation and potential hypoperfusion, which aligns conceptually with elevated serum lactate\u2014a marker of tissue hypoperfusion. While the claim does not explicitly mention serum lactate levels, the link between compromised circulation and potential lactate elevation justifies a moderate alignment rating.",
                "The claim about occasional drops in SpO2 is suggestive of potential respiratory issues, which relate conceptually to impaired oxygenation as assessed by the PaO\u2082/FiO\u2082 ratio in the SOFA score. This connection is indirect, given SpO2 is not part of the direct SOFA criteria, but hypoxemia indicates concern for organ dysfunction.",
                "A drop in SpO2 suggests compromised oxygenation, which indirectly pertains to the SOFA score, specifically the PaO\u2082/FiO\u2082 component. Although SpO2 is not a direct measure in SOFA calculations, decreased oxygen saturation can indicate impaired respiratory function similar to decreased PaO\u2082/FiO\u2082 ratios. Hence, the relationship is indirect but meaningful.",
                "The claim refers to \"critical indicators associated with sepsis,\" which suggests a heightened awareness and suspicion of infection. However, it lacks specific actions or measurements related to the other expert categories. The closest alignment is with early intervention measures such as starting antibiotics or obtaining cultures, but without more concrete details, the alignment is weak.",
                "The claim broadly states a high risk of developing sepsis but provides no specific clinical criteria or actions to categorize accurately. An elevated NEWS score often forecasts clinical deterioration associated with sepsis risk. However, without explicit evaluation data or quantified score details, the claim weakly aligns with this category."
            ],
            "final_alignment_score": 0.6076923076923075
        },
        {
            "input": "3: HR, 83.0; 3: RR, 22.0; 3: SpO2, 97.0; 3: SBP, 132.0; 3: DBP, 70.0; 3: MAP, 90.667; 3: Temp, 101.8; 26: ACETAMINOPHEN, 500 MG PO TABS; 58: SpO, 2: 95.778; 58: SBP, 138.0; 58: DBP, 104.0; 58: MAP, 115.333; 59: SpO2, 96.0; 60: SpO2, 96.135; 61: HR, 78.4; 61: RR, 37.636; 61: SpO2, 96.966; 61: Perf, 2.613; 61: 1min HRV, 54.137; 61: 5min HRV, 54.137; 62: HR, 80.552; 62: RR, 22.569; 62: SpO2, 96.759; 62: Perf, 2.475; 62: 1min HRV, 31.869; 63: HR, 84.203; 63: RR, 22.576; 63: SpO2, 96.288; 63: Perf, 2.57; 63: 1min HRV, 24.486; 64: HR, 86.881; 64: RR, 16.373; 64: SpO2, 95.407; 64: Perf, 2.217; 64: 1min HRV, 12.052; 65: HR, 83.121; 65: RR, 15.793; 65: SpO2, 95.552; 65: Perf, 1.664; 65: 1min HRV, 63.931; 66: HR, 81.746; 66: RR, 19.051; 66: SpO2, 96.559; 66: Perf, 2.129; 66: 1min HRV, 99.476; 66: 5min HRV, 58.807; 67: HR, 81.707; 67: RR, 25.707; 67: SpO2, 96.638; 67: Perf, 2.599; 67: 1min HRV, 47.917; 68: HR, 84.153; 68: RR, 21.271; 68: Perf, 2.62; 68: 1min HRV, 47.688; 69: HR, 83.983; 69: RR, 21.390; 69: SpO2, 95.0; 69: 1min HRV, 44.754; 70: HR, 80.034; 70: RR, 20.845; 70: SpO2, 95.0; 70: Perf, 1.500; 70: 1min HRV, 105.585; 71: HR, 78.288; 71: RR, 18.814; 71: SpO2, 94.475; 71: Perf, 1.42; 71: 1min HRV, 14.070; 71: 5min HRV, 63.502; 72: HR, 82.414; 72: RR, 22.397; 72: SpO2, 95.345; 72: Perf, 1.442; 72: 1min HRV, 15.649; 73: HR, 80.0; 73: RR, 22.983; 73: SpO2, 95.397; 73: Perf, 1.507; 73: 1min HRV, 74.428; 74: HR, 80.237; 74: RR, 22.458; 74: SpO2, 96.898; 74: Perf, 1.717; 74: 1min HRV, 58.426; 75: HR, 80.322; 75: RR, 20.932; 75: SpO2, 97.085; 75: Perf, 1.729; 75: 1min HRV, 50.628; 76: HR, 81.763; 76: RR, 23.610; 76: SpO2, 96.213; 76: Perf, 1.724; 76: 1min HRV, 64.968; 76: 5min HRV, 58.062; 77: HR, 84.811; 77: RR, 20.515; 77: SpO2, 95.467; 77: 1min HRV, 16.010; 78: SpO2, 94.261; 78: 1min HRV, 1.0; 79: SpO2, 92.0; 79: 1min HRV, 187.650; 80: HR, 75.95; 80: SpO2, 94.136; 80: 1min HRV, 104.821; 81: HR, 75.271; 81: SpO2, 98.936; 81: Perf, 2.756; 81: 1min HRV, 26.686; 81: 5min HRV, 78.357; 82: HR, 74.276; 82: SpO2, 98.707; 82: Perf, 2.544; 82: 1min HRV, 16.525; 83: HR, 71.458; 83: SpO2, 98.847; 83: Perf, 2.519; 83: 1min HRV, 28.946; 84: HR, 69.414; 84: SpO2, 99.5; 84: Perf, 2.354; 84: 1min HRV, 23.730; 85: HR, 68.025; 85: SpO2, 98.322; 85: Perf, 2.74; 85: 1min HRV, 14.451; 86: SpO2, 98.678; 86: Perf, 2.871; 86: 1min HRV, 12.582; 86: 5min HRV, 34.479; 87: SpO2, 97.793; 87: Perf, 2.800; 88: SpO2, 97.75; 88: Perf, 2.76; 89: HR, 78.973; 89: SpO2, 97.0; 89: 1min HRV, 28.399; 90: HR, 74.571; 90: SpO2, 97.591; 90: 1min HRV, 59.356; 91: HR, 74.508; 91: SpO2, 93.556; 91: 1min HRV, 30.373; 91: 5min HRV, 46.173; 92: HR, 74.293; 92: 1min HRV, 33.253; 93: HR, 74.881; 93: SpO2, 97.2; 93: 1min HRV, 77.865; 94: HR, 79.25; 94: RR, 19.0; 94: SpO2, 97.237; 94: 1min HRV, 26.789; 95: HR, 82.949; 95: RR, 24.492; 95: 1min HRV, 51.157; 96: HR, 78.288; 96: RR, 18.915; 96: SpO2, 96.062; 96: 1min HRV, 72.650; 96: 5min HRV, 65.329; 97: HR, 76.759; 97: RR, 19.587; 97: SpO2, 98.155; 97: 1min HRV, 66.829; 98: HR, 75.814; 98: RR, 21.102; 98: SpO2, 98.305; 98: Perf, 1.928; 98: 1min HRV, 37.754; 99: HR, 82.397; 99: RR, 21.052; 99: SpO2, 99.0; 99: Perf, 2.0; 99: 1min HRV, 63.652; 99: SBP, 143.0; 99: DBP, 115.0; 99: MAP, 124.333; 99: NS IV BOLUS -, 1000 ML; 100: HR:, 86.508; 100: RR, 15.407; 100: 1min HRV, 139.471; 101: HR, 87.254; 101: RR, 17.712; 101: SpO2, 100.0; 101: Perf, 3.762; 101: 1min HRV, 96.572; 101: 5min HRV, 100.532; 102: HR, 81.672; 102: RR, 20.103; 102: SpO2, 100.0; 102: Perf, 4.789; 102: 1min HRV, 123.858; 103: HR, 81.186; 103: RR, 23.678; 103: SpO2, 99.542; 103: Perf, 3.881; 103: 1min HRV, 52.570; 104: HR, 79.5; 104: RR, 19.879; 104: SpO2, 97.5; 104: Perf, 1.252; 104: 1min HRV, 53.142; 105: HR, 78.542; 105: RR, 20.729; 105: SpO2, 97.525; 105: Perf, 1.479; 105: 1min HRV, 22.765; 106: SARS-COV-2 RNA, Detected; 106: INFLUENZA A, Not Detected; 106: RSV, Not Detected; 106: INFLUENZA A, Not Detected; 106: INFLUENZA B, Not Detected; 106: SARS-COV-2 RNA, Detected; 106: INFLUENZA B, Not Detected; 106: RSV, Not Detected; 106: HR, 79.830; 106: RR, 13.413; 106: SpO2, 98.328; 106: Perf, 2.225; 106: 1min HRV, 44.293; 106: 5min HRV, 71.117; 107: HR, 75.844; 107: RR, 21.462; 107: SpO2, 98.525; 107: Perf, 2.288; 107: 1min HRV, 83.852; 108: HR, 74.729; 108: RR, 19.932; 108: SpO2, 98.932; 108: Perf, 3.335; 108: 1min HRV, 28.074; 109: HR, 77.534; 109: RR, 25.509; 109: SpO2, 99.138; 109: Perf, 5.675; 109: 1min HRV, 62.654; 110: HR, 75.316; 110: SpO2, 98.438; 110: Perf, 5.76; 110: 1min HRV, 170.130; 111: HR, 72.448; 111: Perf, 5.76; 111: 1min HRV, 100.507; 111: 5min HRV, 94.140; 112: HR, 68.186; 112: SpO2, 96.0; 112: Perf, 5.714; 112: 1min HRV, 25.196; 113: HR, 71.562; 113: SpO2, 94.286; 113: Perf, 5.58; 113: 1min HRV, 132.946; 114: HR, 71.25; 114: Perf, 5.58; 114: 1min HRV, 148.337; 115: HR, 73.971; 115: 1min HRV, 142.429; 116: SpO2, 100.0; 116: 5min HRV, 102.586; 117: SpO2, 22.583; 118: SpO2, 100.0; 119: SpO2, 98.558; 0: Age, 66; 0: Gender, F; 0: Race, Black or African American; 0: Means of arrival, Self; 0: Triage Temp, 38.8; 0: Triage HR, 83.0; 0: Triage RR, 22.0; 0: Triage SBP, 132.0; 0: Triage DBP, 70.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER,COUGH,SHORTNESS OF BREATH",
            "answer": false,
            "llm_answer": "Yes",
            "llm_explanation": "The patient presents with key symptoms such as fever, cough, and shortness of breath along with a high triage temperature (38.8\u00b0C). Elevated respiratory rates, fluctuations in heart rate variability, and a detected SARS-CoV-2 RNA suggest potential infection and immune response. While SpO2 levels remain mostly stable, the constellation of symptoms and signs combined with potential COVID-19 suggest the patient is at high risk of developing sepsis within the next 12 hours.",
            "claims": [
                "The patient presents with key symptoms such as fever, cough, and shortness of breath.",
                "The patient has a high triage temperature of 38.8\u00b0C.",
                "The patient has elevated respiratory rates.",
                "The patient shows fluctuations in heart rate variability.",
                "SARS-CoV-2 RNA has been detected in the patient.",
                "The detections suggest potential infection and immune response.",
                "SpO2 levels remain mostly stable for the patient.",
                "The constellation of symptoms and signs suggests the patient is at high risk of developing sepsis.",
                "The patient is at high risk of developing sepsis within the next 12 hours.",
                "Potential COVID-19 is associated with the patient's condition."
            ],
            "relevant_claims": [
                "The patient presents with key symptoms such as fever, cough, and shortness of breath.",
                "The patient has a high triage temperature of 38.8\u00b0C.",
                "The patient has elevated respiratory rates.",
                "SARS-CoV-2 RNA has been detected in the patient.",
                "The detections suggest potential infection and immune response.",
                "The constellation of symptoms and signs suggests the patient is at high risk of developing sepsis.",
                "Potential COVID-19 is associated with the patient's condition."
            ],
            "alignment_scores": [
                0.8,
                0.8,
                0.7,
                0.3,
                0.7,
                0.4,
                0.3
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "High qSOFA Score (\u22652)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "SIRS Positivity (\u22652 Criteria)",
                "High qSOFA Score (\u22652)",
                "Early Antibiotic/Culture Orders (within 2 hours)"
            ],
            "alignment_reasonings": [
                "The claim mentions fever, which is a direct criterion of SIRS, and shortness of breath, which suggests possible respiratory distress. While cough isn't a direct SIRS criterion, this combination strongly indicates systemic inflammation. The primary symptoms align well with SIRS, although the exact criteria like specific temperature or respiratory rate values aren't detailed, justifying a rating slightly below full alignment.",
                "The claim directly refers to a high temperature of 38.8\u00b0C, which exceeds the SIRS criterion of >38\u00b0C for systemic inflammation. While the temperature aligns directly with one SIRS criterion, full SIRS positivity requires at least two criteria. However, the high temperature is a strong indicator of potential sepsis, aligning closely with this category.",
                "An elevated respiratory rate is a specific component of the qSOFA score, which includes a respiratory rate of \u226522/min as one of its criteria. Though the claim does not directly state the respiratory rate or confirm if it meets the qSOFA threshold, the fact that it is described as \"elevated\" suggests a notable risk related to sepsis. Therefore, it aligns well with the High qSOFA Score category, but since the exact threshold is not confirmed, the alignment is not perfect.",
                "The detection of SARS-CoV-2 RNA indicates the presence of a viral infection, which can be a precursor to sepsis, particularly in severe cases. However, the claim doesn't specifically pertain to the administration of antibiotics or the immediate drawing of cultures, which are central to the \"Early Antibiotic/Culture Orders\" category. The alignment is indirect, as the presence of a known infection could lead to these clinical actions but isn't a direct mention within the category context.",
                "The claim refers to potential infection and immune response, which aligns conceptually with systemic inflammation identified by SIRS criteria. While it's not a direct match to specific SIRS measures, the underlying theme of infection and immune activity is consistent with the rationale for using SIRS to detect early sepsis. The alignment is indirect but fairly strong.",
                "The claim about a \"constellation of symptoms and signs\" being indicative of high sepsis risk is a vague but somewhat descriptive echo of a high qSOFA score, which flags risk based on the presence of certain signs and symptoms. However, the claim does not refer to specific parameters detailed in the qSOFA criteria, making the alignment indirect and moderately weak.",
                "The mention of potential COVID-19 suggests a suspicion of serious infection. However, there is no direct reference to antibiotic administration or culture orders being issued. The claim is somewhat relevant because COVID-19 can prompt urgent clinical attention similar to sepsis management, but the alignment is relatively weak without explicit actions being taken, such as antibiotic or culture orders."
            ],
            "final_alignment_score": 0.5714285714285714
        },
        {
            "input": "2: HR, 135.0; 2: RR, 18.0; 2: SpO2, 100.0; 2: SBP, 148.0; 2: DBP, 93.0; 2: MAP, 111.333; 2: Temp, 97.5; 12: Pain, 0.0; 51: HR, 128.0; 51: 1min HRV, 19.943; 52: HR, 128.946; 52: RR, 22.490; 52: SpO2, 99.0; 52: 1min HRV, 4.637; 52: 5min HRV, 5.984; 52: SBP, 168.0; 52: DBP, 90.0; 52: MAP, 116.0; 53: HR, 128.136; 53: RR, 22.153; 53: SpO2, 98.746; 53: Perf, 0.575; 53: 1min HRV, 7.372; 54: HR, 127.397; 54: RR, 21.259; 54: SpO2, 98.810; 54: Perf, 0.537; 54: 1min HRV, 7.201; 55: HR, 128.407; 55: RR, 26.441; 55: SpO2, 98.153; 55: Perf, 0.493; 55: 1min HRV, 7.224; 56: HR, 126.897; 56: RR, 22.017; 56: SpO2, 98.793; 56: Perf, 0.455; 56: 1min HRV, 3.731; 57: HR, 126.379; 57: RR, 19.310; 57: SpO2, 98.552; 57: Perf, 0.399; 57: 1min HRV, 4.321; 57: 5min HRV, 6.676; 58: HR, 127.407; 58: RR, 19.593; 58: SpO2, 98.712; 58: Perf, 0.374; 58: 1min HRV, 3.207; 59: HR, 127.5; 59: RR, 19.966; 59: SpO2, 99.0; 59: Perf, 0.362; 59: 1min HRV, 3.383; 59: SBP, 168.0; 59: DBP, 93.0; 59: MAP, 118.0; 60: HR, 128.0; 60: RR, 23.085; 60: SpO2, 98.966; 60: Perf, 0.370; 60: 1min HRV, 4.359; 61: HR, 126.190; 61: RR, 22.966; 61: SpO2, 98.966; 61: Perf, 0.390; 61: 1min HRV, 5.101; 62: HR, 126.475; 62: RR, 26.017; 62: SpO2, 99.0; 62: Perf, 0.407; 62: 1min HRV, 3.753; 62: 5min HRV, 4.820; 63: HR, 125.746; 63: RR, 24.881; 63: SpO2, 98.898; 63: Perf, 0.429; 63: 1min HRV, 6.197; 64: HR, 125.828; 64: RR, 19.931; 64: SpO2, 99.0; 64: Perf, 0.400; 64: 1min HRV, 5.279; 64: LR IV BOLUS -, 1000 ML; 65: HR:, 125.915; 65: RR, 20.831; 65: SpO2, 99.0; 65: Perf, 0.416; 65: 1min HRV, 4.462; 66: HR, 126.569; 66: RR, 21.259; 66: SpO2, 99.0; 66: Perf, 0.439; 66: 1min HRV, 4.439; 67: HR, 126.155; 67: RR, 17.017; 67: SpO2, 99.0; 67: Perf, 0.456; 67: 1min HRV, 7.104; 67: 5min HRV, 5.712; 68: HR, 125.102; 68: RR, 16.831; 68: SpO2, 99.0; 68: Perf, 0.495; 68: 1min HRV, 7.596; 69: HR, 127.259; 69: RR, 23.638; 69: SpO2, 99.0; 69: Perf, 0.476; 69: 1min HRV, 5.688; 69: FAMOTIDINE (PF), 20 MG/2 ML IV SOLN; 70: HR:, 125.949; 70: RR, 22.576; 70: SpO2, 99.0; 70: Perf, 0.472; 70: 1min HRV, 4.833; 70: SBP, 168.0; 70: DBP, 93.0; 70: MAP, 118.0; 71: HR, 124.931; 71: RR, 20.845; 71: SpO2, 99.0; 71: Perf, 0.459; 71: 1min HRV, 6.740; 72: HR, 125.729; 72: RR, 18.881; 72: SpO2, 99.0; 72: Perf, 0.45; 72: 1min HRV, 4.659; 72: 5min HRV, 6.808; 72: SBP, 160.0; 72: DBP, 93.0; 72: MAP, 115.333; 73: INFLUENZA A, Not Detected; 73: INFLUENZA B, Not Detected; 73: RSV, Not Detected; 73: SARS-COV-2 RNA, Not Detected; 73: HR, 125.322; 73: RR, 16.864; 73: SpO2, 99.0; 73: Perf, 0.458; 73: 1min HRV, 6.378; 73: SBP, 160.0; 73: DBP, 93.0; 73: MAP, 115.333; 74: HR, 124.397; 74: RR, 18.431; 74: SpO2, 99.172; 74: Perf, 0.450; 74: 1min HRV, 8.981; 75: HR, 124.203; 75: RR, 17.186; 75: SpO2, 99.305; 75: Perf, 0.461; 75: 1min HRV, 7.082; 76: HR, 126.224; 76: RR, 18.759; 76: SpO2, 98.879; 76: Perf, 0.458; 76: 1min HRV, 7.494; 77: HR, 123.228; 77: RR, 18.439; 77: SpO2, 99.386; 77: Perf, 0.438; 77: 1min HRV, 5.823; 77: 5min HRV, 7.821; 78: HR, 124.55; 78: RR, 18.867; 78: SpO2, 99.133; 78: Perf, 0.445; 78: 1min HRV, 7.017; 79: HR, 122.614; 79: RR, 17.561; 79: SpO2, 99.0; 79: Perf, 0.436; 79: 1min HRV, 8.683; 80: HR, 125.017; 80: RR, 19.133; 80: SpO2, 99.05; 80: Perf, 0.435; 80: 1min HRV, 15.972; 81: HR, 125.690; 81: RR, 19.207; 81: SpO2, 99.310; 81: Perf, 0.393; 81: 1min HRV, 11.273; 82: HR, 124.475; 82: RR, 18.017; 82: SpO2, 99.576; 82: Perf, 0.411; 82: 1min HRV, 9.940; 82: 5min HRV, 11.653; 83: HR, 124.458; 83: RR, 20.898; 83: SpO2, 99.390; 83: Perf, 0.430; 83: 1min HRV, 6.755; 84: HR, 124.053; 84: RR, 20.544; 84: SpO2, 99.0; 84: Perf, 0.41; 84: 1min HRV, 12.448; 85: HR, 123.85; 85: RR, 21.683; 85: SpO2, 99.317; 85: Perf, 0.401; 85: 1min HRV, 9.913; 86: HR, 126.456; 86: RR, 22.053; 86: SpO2, 99.123; 86: Perf, 0.385; 86: 1min HRV, 7.107; 87: HR, 117.224; 87: RR, 25.190; 87: SpO2, 98.397; 87: Perf, 0.39; 87: 1min HRV, 72.391; 87: 5min HRV, 33.854; 88: HR, 132.881; 88: RR, 22.322; 88: SpO2, 99.3; 88: Perf, 0.401; 88: 1min HRV, 64.352; 89: WAM DIFTYP, AUTO; 89: EOSINOPHIL % (AUTO DIFF), 0.1 %; 89: HEMATOCRIT (HCT), 49.6 %; 89: BASOPHIL % (AUTO DIFF), 0.7 %; 89: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.24 K/uL; 89: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 89: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.5 g/dL; 89: RED CELL DISTRIBUTION WIDTH (RDW), 13.2 %; 89: NEUTROPHIL % (AUTO DIFF), 81.2 %; 89: NEUTROPHIL ABSOLUTE (AUTO DIFF), 14.28 K/uL; 89: RED BLOOD CELLS (RBC), 4.73 MIL/uL; 89: NRBC PERCENT (HEMATOLOGY), 0.0 %; 89: HEMOGLOBIN (HGB), 15.6 g/dL; 89: BASOPHIL ABSOLUTE (AUTO DIFF), 0.12 K/uL; 89: MONOCYTE % (AUTO DIFF), 7.8 %; 89: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.55 K/uL; 89: MONOCYTE ABSOLUTE (AUTO DIFF), 1.38 K/uL; 89: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.4 %; 89: MEAN CORPUSCULAR VOLUME (MCV), 104.9 fL; 89: LYMPHOCYTE % (AUTO DIFF), 8.8 %; 89: WHITE BLOOD CELLS (WBC), 17.6 K/uL; 89: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 33.0 pg; 89: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 89: PLATELET COUNT (PLT), 291 K/uL; 89: HR, 137.879; 89: RR, 22.241; 89: SpO2, 99.224; 89: Perf, 0.513; 89: 1min HRV, 13.514; 90: HR, 133.712; 90: RR, 24.831; 90: SpO2, 99.0; 90: Perf, 0.515; 90: 1min HRV, 17.901; 91: HR, 129.291; 91: RR, 27.667; 91: SpO2, 99.0; 91: Perf, 0.474; 91: 1min HRV, 9.513; 92: 5min HRV, 36.740; 107: LORAZEPAM, 2 MG/ML INJ SOLN; 0: Age:, 58; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.4; 0: Triage HR, 135.0; 0: Triage RR, 18.0; 0: Triage SBP, 148.0; 0: Triage DBP, 93.0; 0: Triage acuity, 3-Urgent; 0: CC, SHORTNESS OF BREATH",
            "answer": true,
            "llm_answer": "No",
            "llm_explanation": "The patient has elevated heart rate (HR) and white blood cell count (WBC), which may indicate stress or infection, but other vital signs such as blood pressure (BP), respiratory rate (RR), and oxygen saturation (SpO2) remain stable. Additionally, there are no significant trends suggesting septic shock or organ dysfunction. Given the absence of clear indicators of severe physiological deterioration, the immediate risk of sepsis within 12 hours appears low.",
            "claims": [
                "The patient has an elevated heart rate (HR).",
                "The patient has an elevated white blood cell count (WBC).",
                "An elevated heart rate (HR) may indicate stress or infection.",
                "An elevated white blood cell count (WBC) may indicate stress or infection.",
                "Other vital signs such as blood pressure (BP) remain stable.",
                "Other vital signs such as respiratory rate (RR) remain stable.",
                "Other vital signs such as oxygen saturation (SpO2) remain stable.",
                "There are no significant trends suggesting septic shock.",
                "There are no significant trends suggesting organ dysfunction.",
                "The absence of clear indicators of severe physiological deterioration is noted.",
                "The immediate risk of sepsis within 12 hours appears low."
            ],
            "relevant_claims": [
                "The patient has an elevated heart rate (HR).",
                "An elevated heart rate (HR) may indicate stress or infection.",
                "There are no significant trends suggesting septic shock.",
                "There are no significant trends suggesting organ dysfunction."
            ],
            "alignment_scores": [
                0.3,
                0.7,
                0.3,
                0.2
            ],
            "alignment_category": [
                "Elevated Shock Index (\u22651.0)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated Shock Index (\u22651.0)",
                "SOFA Score Increase (\u22652 points)"
            ],
            "alignment_reasonings": [
                "The claim highlights an elevated heart rate, which is a component of the Shock Index calculation (heart rate \u00f7 systolic BP). While the claim does not provide information about blood pressure to assess the full Shock Index, an elevated heart rate suggests concern for hemodynamic instability and potential sepsis. This makes the alignment indirect and partial.",
                "An elevated heart rate is specifically mentioned in the SIRS criteria (HR > 90 bpm) as an indicator of systemic inflammation, which can be associated with early sepsis. The claim suggests the possibility of infection or stress, aligning well with the purpose of the SIRS criteria to identify conditions consistent with early sepsis, although it does not confirm the presence of other criteria needed for a full SIRS score.",
                "The claim discusses the absence of trends suggesting septic shock. While this doesn't directly mention the shock index, the implication relates to hemodynamic stability, which the shock index aims to assess. The alignment is indirect and low because the claim is about the absence of risk, rather than the presence of indicators specified by the categories.",
                "The claim refers to the absence of organ dysfunction, which is indirectly related to the SOFA score that tracks organ dysfunction. However, the focus of the claim on the absence of dysfunction offers only minimal relevance to sepsis prediction through SOFA scores. The alignment is weak because the claim describes what is not present, rather than a risk factor or criterion that actively indicates sepsis."
            ],
            "final_alignment_score": 0.375
        },
        {
            "input": "6: HR, 107.0; 6: RR, 22.0; 6: SpO2, 98.0; 6: SBP, 150.0; 6: DBP, 92.0; 6: MAP, 111.333; 6: Temp, 98.1; 8: Pain, 6.0; 35: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 39: NS IV BOLUS -, 1000 ML; 40: SBP, 146.0; 40: DBP, 103.0; 40: MAP, 117.333; 43: SBP, 145.0; 43: DBP, 100.0; 43: MAP, 115.0; 44: SpO2, 99.0; 45: SpO2, 98.471; 46: SpO2, 98.593; 46: Perf, 5.352; 47: SpO2, 98.780; 47: Perf, 5.709; 48: SpO2, 98.632; 48: Perf, 5.135; 49: WAM DIFTYP, AUTO; 49: WHITE BLOOD CELLS (WBC), 13.3 K/uL; 49: NRBC PERCENT (HEMATOLOGY), 0.0 %; 49: PLATELET COUNT (PLT), 394 K/uL; 49: HEMOGLOBIN (HGB), 14.0 g/dL; 49: BASOPHIL % (AUTO DIFF), 0.2 %; 49: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.06 K/uL; 49: HEMATOCRIT (HCT), 44.5 %; 49: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.22 K/uL; 49: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 49: LYMPHOCYTE % (AUTO DIFF), 14.6 %; 49: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 49: RED CELL DISTRIBUTION WIDTH (RDW), 17.6 %; 49: MONOCYTE % (AUTO DIFF), 9.4 %; 49: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.5 g/dL; 49: MONOCYTE ABSOLUTE (AUTO DIFF), 1.25 K/uL; 49: NEUTROPHIL % (AUTO DIFF), 73.6 %; 49: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 20.9 pg; 49: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 49: MEAN CORPUSCULAR VOLUME (MCV), 66.4 fL; 49: RED BLOOD CELLS (RBC), 6.70 MIL/uL; 49: NEUTROPHIL ABSOLUTE (AUTO DIFF), 9.80 K/uL; 49: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.94 K/uL; 49: EOSINOPHIL % (AUTO DIFF), 1.7 %; 49: SpO2, 98.814; 49: Perf, 5.578; 50: SpO2, 98.621; 50: Perf, 2.859; 51: SpO2, 98.0; 51: Perf, 3.014; 52: SpO2, 98.864; 52: Perf, 2.384; 53: SpO2, 98.259; 53: Perf, 4.219; 54: SpO2, 98.407; 54: Perf, 4.476; 55: SpO2, 99.017; 55: Perf, 3.234; 56: SpO2, 99.153; 56: Perf, 3.459; 57: SpO2, 99.169; 57: Perf, 4.327; 58: SpO2, 98.554; 58: Perf, 3.131; 58: SBP, 146.0; 58: DBP, 90.0; 58: MAP, 108.667; 59: SpO2, 98.948; 59: Perf, 3.605; 60: SpO2, 98.544; 60: Perf, 4.458; 61: SpO2, 98.508; 61: Perf, 4.895; 62: SpO2, 98.483; 62: Perf, 4.893; 63: SpO2, 98.810; 63: Perf, 3.064; 64: SpO2, 98.831; 64: Perf, 4.203; 65: SpO2, 98.759; 65: Perf, 5.463; 66: SpO2, 99.0; 66: Perf, 6.117; 67: INR, 1.0; 67: PROTHROMBIN TIME, 13.2 seconds; 67: PART. THROMBOPLASTIN TIME, 29.8 seconds; 67: SpO2, 98.458; 67: Perf, 7.107; 68: SARS-COV-2 RNA, Not Detected; 68: INFLUENZA B, Not Detected; 68: INFLUENZA A, Not Detected; 68: SpO2, 98.655; 68: Perf, 4.515; 69: SpO2, 99.102; 69: Perf, 5.877; 70: SpO2, 99.088; 70: Perf, 5.058; 71: SpO2, 98.661; 71: Perf, 5.588; 72: SpO2, 98.897; 72: Perf, 5.861; 73: SpO2, 99.324; 73: Perf, 6.02; 74: SpO2, 98.672; 74: Perf, 5.988; 75: SpO2, 98.322; 75: Perf, 5.623; 76: SpO2, 98.305; 76: Perf, 4.111; 77: SpO2, 98.155; 77: Perf, 2.146; 78: SpO2, 97.983; 78: Perf, 2.190; 79: SpO2, 98.203; 79: Perf, 2.648; 80: EGFR FOR AFRICAN AMERICAN, 156 mL/min/1.73 m2; 80: ALBUMIN, 4.7 g/dL; 80: BLOOD UREA NITROGEN (BUN), 10 mg/dL; 80: CALCIUM, 9.8 mg/dL; 80: EGFR REFIT WITHOUT RACE (2021), 135 mL/min/1.73 m2; 80: AST (SGOT), 37 U/L; 80: ALKALINE PHOSPHATASE, 50 U/L; 80: ANION GAP, 13 mmol/L; 80: SODIUM, 138 mmol/L; 80: LIPASE, 33 U/L; 80: ALT (SGPT), 76 U/L; 80: GLOBULIN, 3.2 g/dL; 80: GLUCOSE, 140 mg/dL; 80: CREATININE, 0.61 mg/dL; 80: CHLORIDE, 101 mmol/L; 80: CORRECTED CALCIUM, 9.2 mg/dL; 80: POTASSIUM, 3.8 mmol/L; 80: CO2, 24 mmol/L; 80: BILIRUBIN TOTAL, 0.6 mg/dL; 80: PROTEIN TOTAL, 7.9 g/dL; 80: SpO2, 98.397; 80: Perf, 1.753; 81: SpO2, 98.5; 81: Perf, 1.938; 82: SpO2, 97.862; 82: Perf, 4.743; 83: SpO2, 98.356; 83: Perf, 3.823; 84: SpO2, 99.0; 84: Perf, 4.239; 85: SpO2, 98.879; 85: Perf, 3.032; 86: SpO2, 99.086; 86: Perf, 2.513; 87: SpO2, 99.458; 87: Perf, 2.665; 88: SpO2, 99.746; 88: Perf, 1.855; 89: SpO2, 99.525; 89: Perf, 2.494; 90: SpO2, 98.966; 90: Perf, 3.134; 91: SpO2, 98.763; 91: Perf, 2.510; 92: SpO2, 99.246; 92: Perf, 1.828; 93: SpO2, 99.534; 93: Perf, 1.934; 94: SpO2, 99.1; 94: Perf, 1.72; 95: SpO2, 97.860; 95: Perf, 1.700; 96: SpO2, 99.322; 96: Perf, 1.862; 97: POC GLUCOSE BY METER, 143 mg/dL; 97: SpO2, 99.379; 97: Perf, 2.176; 98: SpO2, 98.948; 98: Perf, 1.813; 99: SpO2, 99.695; 99: Perf, 2.000; 100: POC PH (V) ISTAT, 7.41; 100: POC HCO3 (V) ISTAT, 26.2 mmol/L; 100: POC BASE EXCESS ISTAT, 2 mmol/L; 100: POC PO2 (V) ISTAT, 28 mmHg; 100: POC LACTATE ISTAT, 1.44 mmol/L; 100: POC O2 SATURATION ISTAT VENOUS, 53 %; 100: POC PCO2 (V) ISTAT, 41.5 mmHg; 100: POC TCO2 (V) ISTAT, 27 mmol/L; 100: SpO2, 99.407; 100: Perf, 2.821; 101: SpO2, 99.186; 101: Perf, 2.667; 102: SpO2, 98.860; 102: Perf, 2.243; 103: SpO2, 98.729; 103: Perf, 3.206; 104: SpO2, 98.345; 104: Perf, 3.29; 105: SpO2, 98.695; 105: Perf, 3.340; 106: SpO2, 98.203; 106: Perf, 3.875; 107: SpO2, 98.368; 107: Perf, 4.513; 108: SpO2, 98.678; 108: Perf, 4.579; 109: SpO2, 98.103; 109: Perf, 4.212; 110: SpO2, 98.707; 110: Perf, 2.987; 111: SpO2, 99.153; 111: Perf, 2.532; 112: SpO2, 98.5; 112: Perf, 2.301; 113: SpO2, 98.0; 113: Perf, 1.517; 114: SpO2, 98.0; 114: Perf, 1.459; 115: SpO2, 98.475; 115: Perf, 1.668; 116: SpO2, 98.729; 116: Perf, 2.262; 117: SpO2, 98.431; 117: Perf, 2.479; 118: SpO2, 98.797; 118: Perf, 2.42; 119: SpO2, 98.621; 119: Perf, 2.42; 0: Age, 31; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 107.0; 0: Triage RR, 22.0; 0: Triage SBP, 150.0; 0: Triage DBP, 92.0; 0: Triage acuity, 2-Emergent; 0: CC, BLOOD IN VOMIT",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "Despite the elevated heart rate and slightly elevated respiratory rate initially, the patient's vital signs appear relatively stable throughout the time series. The majority of SpO2 readings remain high, indicative of adequate oxygen saturation, and other laboratory parameters, such as white blood cell count and lactate levels, do not suggest sepsis risk. Consequently, given the lack of significant indicators of deterioration or systemic infection within 12 hours, the patient is not considered at high risk for sepsis.",
            "claims": [
                "The patient's heart rate is elevated initially.",
                "The patient's respiratory rate is slightly elevated initially.",
                "The patient's vital signs appear relatively stable throughout the time series.",
                "The majority of SpO2 readings remain high.",
                "High SpO2 readings indicate adequate oxygen saturation.",
                "Other laboratory parameters do not suggest sepsis risk.",
                "The white blood cell count does not indicate sepsis risk.",
                "The lactate levels do not indicate sepsis risk.",
                "There is a lack of significant indicators of deterioration within 12 hours.",
                "There is a lack of significant indicators of systemic infection within 12 hours.",
                "The patient is not considered at high risk for sepsis."
            ],
            "relevant_claims": [
                "The patient's heart rate is elevated initially.",
                "The white blood cell count does not indicate sepsis risk.",
                "The lactate levels do not indicate sepsis risk."
            ],
            "alignment_scores": [
                0.3,
                0.5,
                0.7
            ],
            "alignment_category": [
                "Elevated Shock Index (\u22651.0)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated Serum Lactate (\u22652 mmol/L)"
            ],
            "alignment_reasonings": [
                "The claim about an elevated heart rate suggests potential hemodynamic instability, which is relevant to the \"Elevated Shock Index\" category. However, the claim lacks information about the patient's blood pressure, which is necessary to fully assess the shock index. Thus, while the elevated heart rate aligns with the concept of the Shock Index, the alignment is weak because the necessary information to compute the index is missing.",
                "The claim refers to white blood cell count, which is part of the SIRS criteria for identifying systemic inflammation associated with early sepsis. However, the statement emphasizes the absence of an elevated WBC count (a SIRS criterion), indicating a lower risk rather than confirming sepsis. Thus, the alignment is moderate as it addresses a component of the category but suggests a negative finding.",
                "The claim refers directly to lactate levels, which is specifically addressed in the Elevated Serum Lactate category. Although the claim states the levels do not indicate sepsis risk, it still aligns with this category because it concerns lactate as a sepsis indicator. The alignment is strong but not complete (lower than 1.0) because the claim negates the presence of elevated lactate levels associated with increased sepsis risk."
            ],
            "final_alignment_score": 0.5
        },
        {
            "input": "3: HR, 95.0; 3: RR, 18.0; 3: SpO2, 98.0; 3: SBP, 144.0; 3: DBP, 71.0; 3: MAP, 95.333; 3: Temp, 99.7; 5: Pain, 0.0; 28: SpO2, 98.576; 28: SBP, 123.0; 28: DBP, 80.0; 28: MAP, 94.333; 29: SpO2, 98.763; 29: Perf, 8.052; 30: SpO2, 98.534; 30: Perf, 7.895; 31: SpO2, 99.0; 31: Perf, 6.956; 32: SpO2, 99.0; 32: Perf, 6.084; 33: SpO2, 98.897; 33: Perf, 6.188; 33: SBP, 123.0; 33: DBP, 78.0; 33: MAP, 93.0; 34: SpO2, 99.0; 34: Perf, 5.995; 35: SpO2, 99.103; 35: Perf, 4.756; 36: SpO2, 99.017; 36: Perf, 4.286; 37: SpO2, 99.034; 37: Perf, 4.279; 38: SpO2, 98.864; 38: Perf, 4.909; 39: SpO2, 99.136; 39: Perf, 3.534; 40: SpO2, 98.776; 40: Perf, 3.986; 41: SpO2, 98.712; 41: Perf, 7.136; 42: SpO2, 99.0; 42: Perf, 8.326; 43: SpO2, 98.741; 43: Perf, 7.809; 44: SpO2, 98.695; 44: Perf, 8.455; 45: SpO2, 98.983; 45: Perf, 7.046; 46: SpO2, 98.593; 46: Perf, 7.803; 47: SpO2, 98.586; 47: Perf, 7.997; 48: SpO2, 98.729; 48: Perf, 8.226; 49: SpO2, 99.220; 49: Perf, 6.527; 50: SpO2, 98.966; 50: Perf, 5.83; 51: SpO2, 99.0; 51: Perf, 6.004; 52: SpO2, 99.0; 52: Perf, 4.165; 53: SpO2, 99.0; 53: Perf, 2.851; 54: SpO2, 98.966; 54: Perf, 3.823; 55: POC PH (V) ISTAT, 7.41; 55: POC BASE EXCESS ISTAT, 0 mmol/L; 55: POC TCO2 (V) ISTAT, 26 mmol/L; 55: POC PCO2 (V) ISTAT, 39.4 mmHg; 55: POC O2 SATURATION ISTAT VENOUS, 96 %; 55: POC PO2 (V) ISTAT, 79 mmHg; 55: POC LACTATE ISTAT, 0.68 mmol/L; 55: POC HCO3 (V) ISTAT, 24.9 mmol/L; 55: SpO2, 98.828; 55: Perf, 5.279; 56: SpO2, 99.034; 56: Perf, 6.270; 57: SpO2, 99.288; 57: Perf, 5.352; 58: SpO2, 99.0; 58: Perf, 6.585; 59: SpO2, 98.915; 59: Perf, 6.762; 60: INFLUENZA B, Not Detected; 60: RSV, Not Detected; 60: INFLUENZA A, Not Detected; 60: SARS-COV-2 RNA, Not Detected; 60: SpO2, 99.0; 60: Perf, 7.976; 61: SpO2, 98.898; 61: Perf, 7.899; 62: HR, 88.0; 62: SpO2, 98.898; 62: Perf, 6.503; 62: SBP, 118.0; 62: DBP, 76.0; 62: MAP, 90.0; 63: SpO2, 99.193; 63: Perf, 4.902; 63: SBP, 118.0; 63: DBP, 76.0; 63: MAP, 90.0; 64: SpO2, 99.0; 64: Perf, 5.622; 65: WAM DIFTYP, AUTO; 65: MONOCYTE ABSOLUTE (AUTO DIFF), 0.80 K/uL; 65: MEAN CORPUSCULAR VOLUME (MCV), 101.6 fL; 65: PLATELET COUNT (PLT), 264 K/uL; 65: MONOCYTE % (AUTO DIFF), 8.8 %; 65: WHITE BLOOD CELLS (WBC), 9.1 K/uL; 65: RED BLOOD CELLS (RBC), 3.12 MIL/uL; 65: NRBC ABSOLUTE (HEMATOLOGY), 0.02 K/uL; 65: BASOPHIL % (AUTO DIFF), 0.3 %; 65: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.48 K/uL; 65: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.12 K/uL; 65: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.4 g/dL; 65: LYMPHOCYTE % (AUTO DIFF), 16.4 %; 65: NEUTROPHIL ABSOLUTE (AUTO DIFF), 6.54 K/uL; 65: RED CELL DISTRIBUTION WIDTH (RDW), 11.9 %; 65: HEMATOCRIT (HCT), 31.7 %; 65: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 34.0 pg; 65: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 65: EOSINOPHIL % (AUTO DIFF), 0.9 %; 65: HEMOGLOBIN (HGB), 10.6 g/dL; 65: NRBC PERCENT (HEMATOLOGY), 0.2 %; 65: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.3 %; 65: NEUTROPHIL % (AUTO DIFF), 72.3 %; 65: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 65: SpO2, 99.0; 65: Perf, 6.659; 66: SpO2, 99.0; 66: Perf, 6.964; 67: SpO2, 98.695; 67: Perf, 6.546; 68: SpO2, 99.052; 68: Perf, 5.081; 69: SpO2, 99.034; 69: Perf, 5.156; 70: SpO2, 98.690; 70: Perf, 3.570; 71: SpO2, 98.034; 71: Perf, 1.72; 72: SpO2, 97.638; 72: Perf, 1.801; 73: SpO2, 98.424; 73: Perf, 2.185; 74: SpO2, 98.966; 74: Perf, 3.629; 75: SpO2, 98.810; 75: Perf, 3.656; 76: SpO2, 98.186; 76: Perf, 3.903; 77: SpO2, 99.052; 77: Perf, 6.108; 78: SpO2, 99.068; 78: Perf, 6.196; 79: SpO2, 98.424; 79: Perf, 6.029; 80: SpO2, 98.190; 80: Perf, 5.042; 81: SpO2, 98.35; 81: Perf, 5.184; 82: SpO2, 98.845; 82: Perf, 6.514; 83: SpO2, 98.797; 83: Perf, 6.342; 84: SpO2, 96.0; 84: Perf, 6.15; 89: ANION GAP, 12 mmol/L; 89: CORRECTED CALCIUM, 9.0 mg/dL; 89: GLUCOSE, 105 mg/dL; 89: POTASSIUM, 4.0 mmol/L; 89: BLOOD UREA NITROGEN (BUN), 13 mg/dL; 89: GLOBULIN, 2.9 g/dL; 89: ALKALINE PHOSPHATASE, 145 U/L; 89: ALBUMIN, 4.0 g/dL; 89: PROTEIN TOTAL, 6.9 g/dL; 89: SODIUM, 139 mmol/L; 89: AST (SGOT), 30 U/L; 89: ALT (SGPT), 55 U/L; 89: CALCIUM, 9.0 mg/dL; 89: CREATININE, 0.60 mg/dL; 89: BILIRUBIN TOTAL, 0.2 mg/dL; 89: EGFR REFIT WITHOUT RACE (2021), 123 mL/min/1.73 m2; 89: CHLORIDE, 105 mmol/L; 89: CO2, 22 mmol/L; 100: SpO2, 98.448; 100: SBP, 113.0; 100: DBP, 78.0; 100: MAP, 89.667; 101: SpO2, 98.254; 101: Perf, 5.693; 102: SpO2, 98.690; 102: Perf, 5.617; 103: SpO2, 98.780; 103: Perf, 4.489; 104: SpO2, 98.776; 104: Perf, 4.781; 105: SpO2, 98.915; 105: Perf, 5.713; 106: SpO2, 98.898; 106: Perf, 6.084; 107: SpO2, 98.931; 107: Perf, 6.246; 108: SpO2, 98.621; 108: Perf, 5.710; 109: SpO2, 99.0; 109: Perf, 5.128; 110: SpO2, 98.797; 110: Perf, 4.415; 111: SpO2, 98.254; 111: Perf, 5.385; 112: SpO2, 98.345; 112: Perf, 5.914; 113: SpO2, 98.356; 113: Perf, 6.226; 114: SpO2, 98.0; 114: Perf, 6.491; 115: SpO2, 98.0; 115: Perf, 7.201; 116: SpO2, 98.0; 116: Perf, 7.171; 117: SpO2, 98.241; 117: Perf, 7.102; 118: SpO2, 99.169; 118: Perf, 6.303; 119: SpO2, 98.828; 119: Perf, 6.511; 0: Age, 30; 0: Gender, F; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 37.6; 0: Triage HR, 95.0; 0: Triage RR, 18.0; 0: Triage SBP, 144.0; 0: Triage DBP, 71.0; 0: Triage acuity, 3-Urgent; 0: CC, FEVER",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The patient's vital signs, including blood pressure, heart rate, respiration rate, and oxygen saturation, remain within normal limits or show only minor deviations. The laboratory values, such as lactate, are also within normal range, suggesting no signs of significant metabolic stress. Additionally, infectious disease tests for common respiratory pathogens, including influenza and SARS-CoV-2, returned negative. Overall, the data does not indicate a high risk of sepsis within the next 12 hours.",
            "claims": [
                "The patient's vital signs are within normal limits.",
                "The patient's heart rate remains within normal limits.",
                "The patient's respiration rate remains within normal limits.",
                "The patient's oxygen saturation remains within normal limits.",
                "The patient's blood pressure remains within normal limits.",
                "The patient's vital signs show only minor deviations.",
                "The laboratory values, such as lactate, are within normal range.",
                "The normal lactate levels suggest no signs of significant metabolic stress.",
                "Infectious disease tests for common respiratory pathogens returned negative.",
                "The tests for influenza returned negative.",
                "The tests for SARS-CoV-2 returned negative.",
                "Overall, the data does not indicate a high risk of sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The normal lactate levels suggest no signs of significant metabolic stress.",
                "Infectious disease tests for common respiratory pathogens returned negative."
            ],
            "alignment_scores": [
                0.9,
                0.3
            ],
            "alignment_category": [
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "Early Antibiotic/Culture Orders (within 2 hours)"
            ],
            "alignment_reasonings": [
                "The claim references normal lactate levels, which directly relates to the serum lactate category since elevated lactate levels are a significant sepsis risk factor indicating tissue hypoperfusion. The claim suggests no risk based on this criterion, showing a strong alignment with the category focused specifically on lactate as a metabolic stress indicator, but the absence of elevation is noted rather than its presence, leading to a slight deduction in alignment rating.",
                "The claim mentions infectious disease tests, which suggests some level of suspicion for infection, aligning it tangentially with the concept of early diagnostic efforts related to sepsis. However, since the claim specifically states that tests returned negative and does not mention early antibiotic administration or cultures drawn as a proactive measure, the alignment with this category is weak."
            ],
            "final_alignment_score": 0.6
        },
        {
            "input": "1: SpO2, 98.630; 1: Perf, 3.019; 1: SBP, 152.0; 1: DBP, 96.0; 1: MAP, 114.667; 2: HR, 143.083; 2: RR, 16.192; 2: SpO2, 98.810; 2: Perf, 3.446; 2: 1min HRV, 2.178; 3: HR, 141.678; 3: RR, 24.271; 3: SpO2, 98.322; 3: Perf, 3.714; 3: 1min HRV, 2.554; 3: 5min HRV, 3.429; 4: HR, 140.724; 4: RR, 27.379; 4: SpO2, 96.655; 4: Perf, 3.744; 4: 1min HRV, 2.447; 5: HR, 138.881; 5: RR, 36.847; 5: SpO2, 94.780; 5: Perf, 3.694; 5: 1min HRV, 5.014; 6: HR, 136.017; 6: RR, 37.0; 6: SpO2, 94.576; 6: Perf, 4.768; 6: 1min HRV, 2.594; 7: HR, 136.638; 7: RR, 27.707; 7: SpO2, 94.828; 7: Perf, 4.575; 7: 1min HRV, 3.223; 8: HR, 136.288; 8: RR, 35.712; 8: SpO2, 94.831; 8: Perf, 5.021; 8: 1min HRV, 2.220; 8: 5min HRV, 6.473; 9: HR, 137.220; 9: RR, 35.932; 9: SpO2, 93.847; 9: Perf, 4.974; 9: 1min HRV, 3.275; 10: HR, 135.517; 10: RR, 37.828; 10: SpO2, 94.224; 10: Perf, 4.255; 10: 1min HRV, 2.338; 10: SBP, 148.0; 10: DBP, 88.0; 10: MAP, 108.0; 10: Pain, 2.0; 10: Temp, 98.2; 11: HR, 136.237; 11: RR, 35.797; 11: SpO2, 93.644; 11: Perf, 4.098; 11: 1min HRV, 1.728; 11: SBP, 148.0; 11: DBP, 88.0; 11: MAP, 108.0; 12: HR, 136.362; 12: RR, 34.328; 12: SpO2, 93.138; 12: Perf, 3.829; 12: 1min HRV, 1.689; 13: HR, 136.814; 13: RR, 33.814; 13: SpO2, 93.068; 13: Perf, 3.642; 13: 1min HRV, 2.513; 13: 5min HRV, 3.005; 14: HR, 133.508; 14: RR, 35.390; 14: SpO2, 94.0; 14: Perf, 3.389; 14: 1min HRV, 5.601; 14: SBP, 145.0; 14: DBP, 85.0; 14: MAP, 105.0; 15: HR, 135.707; 15: RR, 29.966; 15: SpO2, 93.259; 15: Perf, 3.463; 15: 1min HRV, 1.602; 16: HR, 135.831; 16: RR, 35.068; 16: SpO2, 92.644; 16: Perf, 3.218; 16: 1min HRV, 2.306; 17: HR, 137.483; 17: RR, 28.017; 17: SpO2, 92.483; 17: Perf, 2.914; 17: 1min HRV, 2.149; 18: HR, 139.525; 18: RR, 33.695; 18: SpO2, 93.831; 18: Perf, 3.005; 18: 1min HRV, 4.277; 18: 5min HRV, 7.611; 19: HR, 140.5; 19: RR, 30.155; 19: SpO2, 94.276; 19: Perf, 3.315; 19: 1min HRV, 2.195; 20: HR, 142.136; 20: RR, 26.153; 20: SpO2, 93.983; 20: Perf, 3.305; 20: 1min HRV, 4.383; 21: HR, 138.356; 21: RR, 39.475; 21: SpO2, 93.780; 21: Perf, 3.03; 21: 1min HRV, 3.559; 22: HR, 137.534; 22: RR, 24.172; 22: SpO2, 94.103; 22: Perf, 3.151; 22: 1min HRV, 4.053; 23: HR, 138.203; 23: RR, 26.0; 23: SpO2, 94.407; 23: Perf, 3.031; 23: 1min HRV, 3.148; 23: 5min HRV, 6.289; 23: SBP, 160.0; 23: DBP, 84.0; 23: MAP, 109.333; 24: HR, 138.379; 24: RR, 27.431; 24: SpO2, 95.414; 24: Perf, 2.772; 24: 1min HRV, 2.778; 24: SBP, 160.0; 24: DBP, 84.0; 24: MAP, 109.333; 25: HR, 138.424; 25: RR, 30.458; 25: SpO2, 94.610; 25: Perf, 2.843; 25: 1min HRV, 4.149; 26: HR, 137.729; 26: RR, 30.288; 26: SpO2, 94.593; 26: Perf, 2.971; 26: 1min HRV, 3.643; 27: HR, 136.034; 27: RR, 34.276; 27: SpO2, 94.431; 27: Perf, 3.723; 27: 1min HRV, 4.158; 28: HR, 135.525; 28: RR, 36.847; 28: SpO2, 94.322; 28: Perf, 3.027; 28: 1min HRV, 3.855; 28: 5min HRV, 5.509; 29: HR, 133.897; 29: RR, 37.845; 29: SpO2, 94.862; 29: Perf, 2.952; 29: 1min HRV, 2.374; 30: HR, 134.424; 30: RR, 36.119; 30: SpO2, 94.492; 30: Perf, 2.938; 30: 1min HRV, 2.384; 31: HR, 133.915; 31: RR, 35.661; 31: SpO2, 94.119; 31: Perf, 2.657; 31: 1min HRV, 3.336; 32: HR, 132.431; 32: RR, 29.241; 32: SpO2, 94.845; 32: Perf, 2.761; 32: 1min HRV, 29.569; 33: HR, 140.0; 33: RR, 40.0; 33: SpO2, 94.0; 33: 5min HRV, 14.178; 33: SBP, 140.0; 33: DBP, 93.0; 33: MAP, 108.667; 42: NORMOSOL-R IV BOLUS -, 500 ML; 43: POC CREATININE,ISTAT: .6 mg/dL; 43: POC EGFR REFIT WITHOUT RACE (2021), 102 mL/min/1.73 m2; 43: POC EGFR FOR AFRICAN AMERICAN, 118 mL/min/1.73 m2; 43: HR, 130.0; 43: RR, 34.0; 43: SpO2, 95.0; 43: SBP, 139.0; 43: DBP, 81.0; 43: MAP, 100.333; 53: HR, 131.0; 53: RR, 37.0; 53: SpO2, 96.0; 53: SBP, 154.0; 53: DBP, 85.0; 53: MAP, 108.0; 56: AZITHROMYCIN, 500 MG IN D5W 250 ML IVPB; 61: CEFEPIME, 2 GRAM/20 ML IV PUSH; 63: HR, 130.0; 63: RR, 38.0; 63: SpO2, 96.0; 63: SBP, 122.0; 63: DBP, 109.0; 63: MAP, 113.333; 73: HR, 134.0; 73: RR, 25.0; 73: SpO2, 95.0; 83: HR, 132.0; 83: RR, 23.0; 83: SpO2, 96.0; 83: SBP, 145.0; 83: DBP, 76.0; 83: MAP, 99.0; 93: HR, 129.0; 93: RR, 35.0; 93: SpO2, 96.0; 93: SBP, 138.0; 93: DBP, 82.0; 93: MAP, 100.667; 103: HR, 127.0; 103: RR, 36.0; 103: SpO2, 95.0; 103: SBP, 118.0; 103: DBP, 92.0; 103: MAP, 100.667; 112: ALBUMIN, 3.7 g/dL; 112: GLUCOSE, 197 mg/dL; 112: ALKALINE PHOSPHATASE, 450 U/L; 112: BLOOD UREA NITROGEN (BUN), 11 mg/dL; 112: POTASSIUM, 3.7 mmol/L; 112: GLOBULIN, 3.1 g/dL; 112: EGFR REFIT WITHOUT RACE (2021), 100 mL/min/1.73 m2; 112: CREATININE, 0.65 mg/dL; 112: CHLORIDE, 101 mmol/L; 112: LIPASE, 24 U/L; 112: AST (SGOT), 83 U/L; 112: PROTEIN TOTAL, 6.8 g/dL; 112: ANION GAP, 12 mmol/L; 112: SODIUM, 135 mmol/L; 112: MAGNESIUM, 1.9 mg/dL; 112: CALCIUM, 8.7 mg/dL; 112: BILIRUBIN TOTAL, 0.6 mg/dL; 112: CORRECTED CALCIUM, 8.9 mg/dL; 112: CO2, 22 mmol/L; 112: ALT (SGPT), 29 U/L; 112: EGFR FOR AFRICAN AMERICAN, 115 mL/min/1.73 m2; 112: TSH, 1.65 uIU/mL; 113: HR, 123.0; 113: RR, 29.0; 113: SpO2, 95.0; 113: SBP, 121.0; 113: DBP, 67.0; 113: MAP, 85.0; 114: TROPONIN I, <.017 ng/mL; 0: Age, 56; 0: Gender, F; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 36.8; 0: Triage HR, 136.0; 0: Triage RR, 36.0; 0: Triage SBP, 148.0; 0: Triage DBP, 88.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient presents with several indicators of a high risk for sepsis, including consistently elevated heart rate (HR > 130), respiratory rate (RR > 30), and decreased SpO2 levels (some measurements around 94%). Despite interventions with IV fluids and antibiotics (Azithromycin and Cefepime), vital signs remain concerning. The persistent tachycardia and tachypnea, along with shortness of breath and emergent triage classification, suggest the patient may develop sepsis within 12 hours.",
            "claims": [
                "The patient presents with several indicators of a high risk for sepsis.",
                "The patient has a consistently elevated heart rate (HR > 130).",
                "The patient's respiratory rate (RR) is greater than 30.",
                "The patient has decreased SpO2 levels, with some measurements around 94%.",
                "Interventions with IV fluids have been administered.",
                "Interventions with antibiotics (Azithromycin and Cefepime) have been administered.",
                "Despite interventions, vital signs remain concerning.",
                "The patient is experiencing persistent tachycardia.",
                "The patient is experiencing persistent tachypnea.",
                "The patient is experiencing shortness of breath.",
                "The patient has been classified as emergent during triage.",
                "The indicators suggest the patient may develop sepsis within 12 hours."
            ],
            "relevant_claims": [
                "The patient presents with several indicators of a high risk for sepsis.",
                "The patient has a consistently elevated heart rate (HR > 130).",
                "The patient's respiratory rate (RR) is greater than 30.",
                "The patient has decreased SpO2 levels, with some measurements around 94%.",
                "Interventions with IV fluids have been administered.",
                "Interventions with antibiotics (Azithromycin and Cefepime) have been administered.",
                "Despite interventions, vital signs remain concerning.",
                "The patient is experiencing persistent tachycardia.",
                "The patient is experiencing persistent tachypnea.",
                "The patient is experiencing shortness of breath.",
                "The indicators suggest the patient may develop sepsis within 12 hours."
            ],
            "alignment_scores": [
                0.3,
                0.8,
                0.8,
                0.5,
                0.7,
                1.0,
                0.7,
                0.7,
                0.8,
                0.7,
                0.3
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "High qSOFA Score (\u22652)",
                "SOFA Score Increase (\u22652 points)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "Elevated NEWS Score (\u22655 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "High qSOFA Score (\u22652)",
                "High qSOFA Score (\u22652)",
                "AElevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "The claim suggests that the patient has several indicators of high sepsis risk, which is broadly consistent with a high NEWS score indicating clinical deterioration compatible with sepsis. However, since it does not specify any particular indicators, the alignment is quite general and not strongly tied to one specific category. Therefore, the claim aligns more with a general assessment of risk, potentially covered by the comprehensive nature of the NEWS score. However, due to the lack of specificity, the alignment is rated as low.",
                "The claim focuses on a consistently elevated heart rate of HR > 130, which exceeds the threshold for one of the SIRS criteria (heart rate > 90 bpm). This indicates systemic inflammation consistent with early sepsis. Since only one SIRS criterion is mentioned, and two are needed for full SIRS positivity, the alignment is strong but not perfect.",
                "An elevated respiratory rate (\u226522/min) is one of the criteria for a high qSOFA score, which flags a high risk of sepsis-related organ dysfunction and mortality. While the claim directly provides a respiratory rate significantly higher than the qSOFA threshold, it alone does not confirm a high qSOFA score since other factors (systolic BP or altered mentation) are also considered in qSOFA. Therefore, while there is a strong alignment based on the information given, the full qSOFA criteria aren't met with the claim alone, leading to an alignment rating of 0.8.",
                "Decreased SpO2 levels indicate possible hypoxemia, which is conceptually related to impaired oxygenation and can suggest organ dysfunction. Although SpO2 is not a direct measurement for SOFA scoring, this aligns with the potential for respiratory issues impacting the PaO\u2082/FiO\u2082 ratio\u2014a component of the SOFA score. The connection is indirect but relevant, resulting in a moderate alignment rating.",
                "Administration of IV fluids is commonly used to treat hypotension and to maintain hemodynamic stability, especially in sepsis-related scenarios. This association closely aligns with the \"Sepsis-Associated Hypotension\" category, as hypotension often prompts fluid resuscitation. While the claim does not provide specific blood pressure readings, the intervention is a typical response to hypotension, indicating a reasonable alignment with this category.",
                "The claim directly mentions that antibiotics (Azithromycin and Cefepime) have been administered. This aligns perfectly with the category of \"Early Antibiotic/Culture Orders,\" which includes the administration of broad-spectrum antibiotics as a key indicator of clinician suspicion of serious infection, emphasizing the risk of sepsis.",
                "The claim of \"concerning vital signs\" suggests that the patient's condition is not stabilizing despite interventions, which may be captured by a high NEWS score indicating clinical deterioration. This fits with the spirit of the Elevated NEWS Score category, but the claim lacks specifics on the exact vital sign changes or the corresponding NEWS score, hence the partial alignment rating.",
                "Tachycardia (heart rate >90 bpm) is one of the criteria listed under SIRS, which identifies systemic inflammation consistent with early sepsis. Though the claim does not specify the degree or exact heart rate, \"persistent\" implies that the heart rate is consistently elevated, making the alignment with the SIRS criterion a strong one, albeit not absolute without additional information.",
                "Tachypnea, or rapid breathing, is directly linked to a criterion of the qSOFA score, specifically a respiratory rate of \u226522/min. Although the claim does not specify the respiratory rate, \"persistent tachypnea\" strongly implies a rate that might contribute to a high qSOFA score. The alignment is strong, but lacking exact numerical information prevents a perfect score.",
                "Shortness of breath can be indicative of an increased respiratory rate, which is part of the criteria for a high qSOFA score (specifically, a respiratory rate\u202f\u2265\u202f22\u202f/min). While the claim does not provide a specific respiratory rate to meet the qSOFA threshold, shortness of breath suggests possible alignment with one of the qSOFA criteria. The alignment is not direct or confirmed, so the rating is moderate.",
                "The claim broadly suggests impending clinical deterioration, which aligns somewhat with what an elevated NEWS score indicates\u2014imminent clinical decline compatible with sepsis. However, the claim lacks specific reference to any data or criteria directly used in NEWS, making the alignment weak."
            ],
            "final_alignment_score": 0.6636363636363636
        },
        {
            "input": "7: HR, 91.596; 7: RR, 24.462; 7: SpO2, 96.562; 7: Perf, 0.259; 7: 1min HRV, 72.990; 8: POC PH (V) ISTAT, 7.25; 8: POC GLUCOSE ISTAT, 100 mg/dL; 8: POC SODIUM ISTAT, 141 mmol/L; 8: POC HGB (CALC) ISTAT, 11.6 g/dL; 8: POC POTASSIUM ISTAT, 4.1 mmol/L; 8: POC HCT ISTAT, 34 %; 8: POC HCO3 (V) ISTAT, 30.1 mmol/L; 8: POC BASE EXCESS ISTAT, 3 mmol/L; 8: POC TCO2 (V) ISTAT, 32 mmol/L; 8: POC LACTATE ISTAT, 0.83 mmol/L; 8: POC O2 SATURATION ISTAT VENOUS, 21 %; 8: POC PO2 (V) ISTAT, 19 mmHg; 8: POC PCO2 (V) ISTAT, 68.9 mmHg; 8: HR, 92.434; 8: RR, 24.623; 8: SpO2, 96.519; 8: Perf, 0.241; 8: 1min HRV, 51.204; 8: 5min HRV, 63.099; 9: HR, 93.135; 9: RR, 19.731; 9: SpO2, 95.95; 9: Perf, 0.217; 9: 1min HRV, 56.604; 10: HR, 91.208; 10: RR, 21.585; 10: SpO2, 96.679; 10: Perf, 0.21; 10: 1min HRV, 41.598; 11: HR, 92.302; 11: RR, 21.321; 11: Perf, 0.21; 11: 1min HRV, 56.135; 12: HR, 92.481; 12: RR, 20.827; 12: SpO2, 97.778; 12: Perf, 0.21; 12: 1min HRV, 33.525; 13: HR, 97.585; 13: RR, 25.849; 13: SpO2, 96.811; 13: Perf, 0.21; 13: 1min HRV, 41.248; 13: 5min HRV, 50.267; 14: HR, 105.887; 14: RR, 21.642; 14: SpO2, 95.947; 14: 1min HRV, 52.404; 15: HR, 104.755; 15: RR, 16.019; 15: SpO2, 97.0; 15: 1min HRV, 15.021; 16: HR, 99.509; 16: RR, 22.623; 16: SpO2, 97.868; 16: Perf, 0.806; 16: 1min HRV, 6.890; 17: HR, 99.327; 17: RR, 19.538; 17: SpO2, 98.462; 17: Perf, 1.002; 17: 1min HRV, 45.299; 18: HR, 98.204; 18: RR, 25.833; 18: SpO2, 98.5; 18: Perf, 0.96; 18: 1min HRV, 7.606; 18: 5min HRV, 37.717; 19: HR, 98.538; 19: RR, 26.731; 19: SpO2, 98.0; 19: Perf, 0.96; 19: 1min HRV, 21.760; 19: SBP, 171.0; 19: DBP, 137.0; 19: MAP, 148.333; 20: HR, 97.667; 20: RR, 20.407; 20: SpO2, 97.824; 20: Perf, 0.96; 20: 1min HRV, 38.205; 21: HR, 97.887; 21: RR, 21.245; 21: SpO2, 98.302; 21: Perf, 0.96; 21: 1min HRV, 38.711; 22: HR, 96.212; 22: RR, 21.673; 22: SpO2, 99.0; 22: Perf, 0.96; 22: 1min HRV, 15.498; 23: HR, 95.679; 23: RR, 23.340; 23: SpO2, 98.041; 23: Perf, 0.959; 23: 1min HRV, 12.652; 23: 5min HRV, 29.080; 23: SBP, 171.0; 23: DBP, 137.0; 23: MAP, 148.333; 23: LPM O2, 2.0; 23: Pain, 1.0; 23: Temp, 101.3; 24: HR, 95.058; 24: RR, 23.654; 24: SpO2, 97.385; 24: Perf, 0.820; 24: 1min HRV, 17.024; 25: HR, 94.755; 25: RR, 22.038; 25: SpO2, 96.925; 25: Perf, 0.358; 25: 1min HRV, 13.002; 26: HR, 93.923; 26: RR, 20.442; 26: SpO2, 96.981; 26: Perf, 0.331; 26: 1min HRV, 17.608; 27: HR, 93.5; 27: RR, 22.519; 27: SpO2, 96.704; 27: Perf, 0.344; 27: 1min HRV, 10.366; 27: SBP, 125.0; 27: DBP, 33.0; 27: MAP, 63.667; 27: LPM O2, 2.0; 28: HR, 93.887; 28: RR, 23.151; 28: SpO2, 96.302; 28: Perf, 0.353; 28: 1min HRV, 4.850; 28: 5min HRV, 13.955; 29: HR, 94.5; 29: RR, 25.077; 29: SpO2, 96.077; 29: Perf, 0.371; 29: 1min HRV, 42.092; 30: HR, 92.208; 30: RR, 29.113; 30: SpO2, 95.660; 30: Perf, 0.388; 30: 1min HRV, 19.633; 31: HR, 93.0; 31: RR, 22.519; 31: SpO2, 94.808; 31: Perf, 0.391; 31: 1min HRV, 28.109; 32: HR, 92.593; 32: RR, 20.204; 32: SpO2, 95.185; 32: Perf, 0.455; 32: 1min HRV, 18.466; 33: 5min HRV, 29.373; 38: ABO/RH, B Positive; 39: ANTIBODY SCREEN 3, NEG; 44: PH.SER/PLAS, 7.22; 44: CALCIUM IONIZED, 1.14 mmol/L; 45: WAM DIFTYP, AUTO; 45: RED CELL DISTRIBUTION WIDTH (RDW), 15.3 %; 45: WHITE BLOOD CELLS (WBC), 11.9 K/uL; 45: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.3 g/dL; 45: NRBC PERCENT (HEMATOLOGY), 0.0 %; 45: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.07 K/uL; 45: HEMOGLOBIN (HGB), 10.0 g/dL; 45: LYMPHOCYTE % (AUTO DIFF), 8.1 %; 45: BASOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 45: MEAN CORPUSCULAR VOLUME (MCV), 110.3 fL; 45: HEMATOCRIT (HCT), 32.0 %; 45: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.96 K/uL; 45: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 45: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 45: PLATELET COUNT (PLT), 185 K/uL; 45: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 34.5 pg; 45: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.08 K/uL; 45: EOSINOPHIL % (AUTO DIFF), 0.4 %; 45: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.7 %; 45: NEUTROPHIL % (AUTO DIFF), 84.7 %; 45: MONOCYTE % (AUTO DIFF), 6.0 %; 45: RED BLOOD CELLS (RBC), 2.90 MIL/uL; 45: BASOPHIL % (AUTO DIFF), 0.1 %; 45: MONOCYTE ABSOLUTE (AUTO DIFF), 0.71 K/uL; 46: ACETAMINOPHEN, 1 000 MG/100 ML (10 MG/ML) IV SOLN; 58: CEFTRIAXONE, 1 GRAM/10 ML IV PUSH (VIAL ONLY); 63: HR, 91.0; 63: SpO2, 100.0; 63: SBP, 109.0; 63: DBP, 44.0; 63: MAP, 65.667; 63: LPM O2, 2.0; 63: VANCOMYCIN-WATER INJECT (PEG), 2 GRAM/400 ML IV PGBK; 69: INR:, 1.1; 69: THROMBIN TIME, 20.9 seconds; 69: PART. THROMBOPLASTIN TIME, 40.8 seconds; 69: FIBRINOGEN, 654 mg/dL; 69: D-DIMER, 1.40 ug/mL FEU; 69: PROTHROMBIN TIME, 13.4 seconds; 70: SARS-COV-2 RNA, Detected; 70: INFLUENZA B, Not Detected; 70: INFLUENZA A, Not Detected; 70: SARS-COV-2 RNA, Detected; 70: INFLUENZA B, Not Detected; 70: INFLUENZA A, Not Detected; 71: BLOOD TYPE VERIFICATION-MANUAL, B Positive; 75: MAGNESIUM, 2.1 mg/dL; 75: PHOSPHORUS, 2.6 mg/dL; 75: BNP NT-PRO, 2986 pg/mL; 88: TROPONIN I, 0.020 ng/mL; 116: KETONE, URINE (UA): Negative; 116: NITRITE, URINE (UA): Negative; 116: SPECIFIC GRAVITY, URINE (UA): 1.020; 116: PH, URINE (UA): 5.0; 116: GLUCOSE, URINE (UA): Negative; 116: LEUKOCYTE ESTERASE, URINE (UA): Negative; 0: Age, 81; 0: Gender, F; 0: Race, Native Hawaiian or Other Pacific Islander; 0: Means of arrival, EMS; 0: Triage Temp, 38.5; 0: Triage HR, 94.0; 0: Triage RR, 23.0; 0: Triage SBP, 171.0; 0: Triage DBP, 137.0; 0: Triage acuity, 2-Emergent; 0: CC, ALTERED MENTAL STATUS",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient demonstrates several indicators of sepsis risk. The elevated triage temperature (38.5\u00b0C), increased respiratory rate, and altered mental status suggest potential infection and systemic inflammation. Additionally, a venous pH of 7.25 indicates acidosis, and the D-dimer level of 1.40 ug/mL might reflect increased clotting activity. Furthermore, the patient has tested positive for SARS-CoV-2, adding to the complexity of their condition. The administration of antibiotics like Ceftriaxone and Vancomycin further suggests clinical concern for infection, leading to a high risk of sepsis within 12 hours.",
            "claims": [
                "The patient demonstrates several indicators of sepsis risk.",
                "The elevated triage temperature is 38.5\u00b0C.",
                "An elevated triage temperature suggests potential infection and systemic inflammation.",
                "The patient has an increased respiratory rate.",
                "An increased respiratory rate indicates potential infection and systemic inflammation.",
                "The patient has an altered mental status.",
                "An altered mental status suggests potential infection and systemic inflammation.",
                "The venous pH of the patient is 7.25.",
                "A venous pH of 7.25 indicates acidosis.",
                "The D-dimer level of the patient is 1.40 ug/mL.",
                "An elevated D-dimer level might reflect increased clotting activity.",
                "The patient has tested positive for SARS-CoV-2.",
                "Testing positive for SARS-CoV-2 adds complexity to the patient's condition.",
                "The administration of antibiotics like Ceftriaxone and Vancomycin is occurring.",
                "The administration of antibiotics suggests clinical concern for infection.",
                "The clinical concern for infection leads to a high risk of sepsis within 12 hours."
            ],
            "relevant_claims": [
                "The patient demonstrates several indicators of sepsis risk.",
                "The elevated triage temperature is 38.5\u00b0C.",
                "An elevated triage temperature suggests potential infection and systemic inflammation.",
                "The patient has an increased respiratory rate.",
                "An increased respiratory rate indicates potential infection and systemic inflammation.",
                "The patient has an altered mental status.",
                "An altered mental status suggests potential infection and systemic inflammation.",
                "The venous pH of the patient is 7.25.",
                "A venous pH of 7.25 indicates acidosis.",
                "The D-dimer level of the patient is 1.40 ug/mL.",
                "An elevated D-dimer level might reflect increased clotting activity.",
                "The patient has tested positive for SARS-CoV-2.",
                "Testing positive for SARS-CoV-2 adds complexity to the patient's condition.",
                "The administration of antibiotics like Ceftriaxone and Vancomycin is occurring.",
                "The administration of antibiotics suggests clinical concern for infection.",
                "The clinical concern for infection leads to a high risk of sepsis within 12 hours."
            ],
            "alignment_scores": [
                0.3,
                1.0,
                0.8,
                0.7,
                0.7,
                0.8,
                0.7,
                0.3,
                0.3,
                0.2,
                0.4,
                0.3,
                0.3,
                1.0,
                0.8,
                0.6
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "High qSOFA Score (\u22652)",
                "High qSOFA Score (\u22652)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "SOFA Score Increase (\u22652 points)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "Early Antibiotic/Culture Orders (within 2 hours)"
            ],
            "alignment_reasonings": [
                "The claim broadly mentions \"several indicators of sepsis risk\" without specificity. This could loosely correspond to a range of abnormal vital signs or other factors, like those aggregated in a scoring system such as NEWS, which assesses clinical deterioration. However, the claim's vagueness results in a very weak alignment as it doesn\u2019t specify the detailed criteria present in the NEWS Score.",
                "The claim directly references the elevated temperature of 38.5\u00b0C, which exceeds the SIRS criteria threshold of >38\u00b0C. This criterion is used to identify systemic inflammation consistent with early sepsis, showing perfect alignment with the SIRS category.",
                "The claim pertains to an elevated temperature, which is one of the criteria for SIRS (Systemic Inflammatory Response Syndrome). An elevated temperature is a direct indicator of systemic inflammation, highly aligned with this category, though additional SIRS criteria would further strengthen the alignment.",
                "An increased respiratory rate is directly relevant to one of the SIRS criteria (respiratory rate > 20/min). Although the exact value isn't specified, the claim strongly hints at meeting or exceeding this threshold, suggesting systemic inflammation consistent with early sepsis. However, without additional SIRS criteria, the alignment isn't complete, hence a 0.7 rating.",
                "An increased respiratory rate is explicitly listed under SIRS criteria, which is used to identify systemic inflammation consistent with early sepsis. The claim suggests a link to infection and systemic inflammation but doesn't specify the threshold rate or how many other criteria are met, making it quite relevant but not fully aligned.",
                "Altered mentation is directly listed as one of the criteria for a high qSOFA score, which identifies a patient at high risk of sepsis\u2011related organ dysfunction and mortality. The presence of altered mental status is a strong indicator associated with this category, reflecting a significant but not exhaustive overlap with the criteria needed for a qSOFA score of \u22652.",
                "The claim regarding altered mental status aligns with the criteria of a high qSOFA score, which considers altered mentation as a key component. While altered mental status also implies systemic inflammation, it directly informs the qSOFA score, which assesses the risk of sepsis-related complications. The alignment is substantial as altered mentation is an explicit criterion for qSOFA, although the claim doesn't discuss the other qSOFA criteria.",
                "While venous pH itself is not directly listed in any category, a low pH (acidosis) can suggest metabolic disturbances often linked with elevated serum lactate levels due to tissue hypoperfusion and can indirectly indicate a high risk of sepsis. Since the pH aligns conceptually with conditions that raise lactate, the alignment is weak but present.",
                "A venous pH of 7.25 indicating acidosis is related to conditions that often coincide with elevated lactate levels, as both reflect potential metabolic derangement and tissue hypoperfusion. The connection is indirect because the claim itself does not mention lactate, but metabolic acidosis can be associated with lactate elevation, which is a strong predictor of sepsis risk. Hence, the alignment is minimal but relevant.",
                "D-dimer is not explicitly related to any of the sepsis prediction categories listed, as it is primarily used to assess the presence of thrombotic events like deep vein thrombosis or pulmonary embolism rather than sepsis. However, elevated D-dimer levels could correlate with systemic inflammation and potential organ dysfunction, which loosely ties to categories involving markers of clinical deterioration or tissue perfusion. Among these, Elevated Serum Lactate is related as it indicates tissue hypoperfusion, although the link is very indirect. Therefore, the alignment rating is minimal.",
                "An elevated D-dimer is not a specific criterion in the SOFA score but indicates a potential derangement in coagulation, which could be indirectly related to sepsis and organ dysfunction. The connection to a specific SOFA criterion like an increase in the SOFA score due to coagulation parameters is indirect, resulting in a lower alignment rating.",
                "Testing positive for SARS-CoV-2 indicates a viral infection, associated with a potential risk of sepsis, but does not directly align with any specific sepsis prediction category. It may prompt close monitoring and potential early interventions like cultures if bacterial superinfection is suspected, offering a weak connection to early antibiotic/culture orders associated with sepsis risk assessment.",
                "While SARS-CoV-2 positivity can indicate an active infection, which might increase sepsis risk, the claim does not directly mention concrete actions like administering antibiotics or ordering cultures, which would strongly suggest sepsis risk management. The alignment is weakly indirect because SARS-CoV-2 could elevate suspicion of infection, but without specific actions, the connection to the category is minimal.",
                "The claim explicitly mentions the administration of antibiotics, which directly aligns with the category relating to early antibiotic or culture orders. This action reflects a suspicion of serious infection and is a key component in assessing sepsis risk, leading to a perfect alignment rating.",
                "The claim regarding the administration of antibiotics indicates a strong suspicion of a serious infection, which aligns with the category focused on early antibiotic orders. However, the claim doesn't mention the timing (within 2 hours), which slightly weakens the alignment, preventing a perfect score.",
                "The claim indicates a clinical concern for infection, which aligns conceptually with the category involving early antibiotic or culture orders that signify suspicion of a serious infection. Although there is no explicit mention of the actions (antibiotic administration or cultures), the expressed high risk of sepsis due to infection concern suggests these measures might be considered, providing a moderate alignment."
            ],
            "final_alignment_score": 0.575
        },
        {
            "input": "3: HR, 114.0; 3: RR, 18.0; 3: SpO2, 100.0; 3: SBP, 150.0; 3: DBP, 95.0; 3: MAP, 113.333; 3: Temp, 98.4; 74: RR, 42.2; 74: SpO2, 99.878; 74: Perf, 0.56; 74: SBP, 149.0; 74: DBP, 103.0; 74: MAP, 118.333; 75: HR, 100.725; 75: RR, 21.948; 75: SpO2, 100.0; 75: Perf, 0.532; 75: 1min HRV, 10.091; 76: HR, 99.814; 76: RR, 18.746; 76: SpO2, 100.0; 76: Perf, 0.793; 76: 1min HRV, 14.214; 77: HR, 99.552; 77: RR, 20.517; 77: SpO2, 100.0; 77: Perf, 0.815; 77: 1min HRV, 11.457; 78: HR, 100.847; 78: RR, 18.288; 78: SpO2, 100.0; 78: Perf, 0.925; 78: 1min HRV, 4.612; 79: HR, 98.254; 79: RR, 17.763; 79: SpO2, 100.0; 79: Perf, 1.615; 79: 1min HRV, 3.239; 79: 5min HRV, 11.448; 80: HR, 96.466; 80: RR, 17.534; 80: SpO2, 100.0; 80: Perf, 1.863; 80: 1min HRV, 4.446; 80: SBP, 146.0; 80: DBP, 104.0; 80: MAP, 118.0; 81: HR, 95.373; 81: RR, 18.085; 81: SpO2, 100.0; 81: Perf, 1.857; 81: 1min HRV, 5.160; 82: HR, 95.897; 82: RR, 17.828; 82: SpO2, 100.0; 82: Perf, 2.077; 82: 1min HRV, 2.885; 83: HR, 95.237; 83: RR, 17.305; 83: SpO2, 100.0; 83: Perf, 2.075; 83: 1min HRV, 2.467; 84: HR, 95.407; 84: RR, 16.441; 84: SpO2, 100.0; 84: Perf, 2.015; 84: 1min HRV, 14.413; 84: 5min HRV, 7.621; 85: HR, 95.966; 85: RR, 18.534; 85: SpO2, 100.0; 85: Perf, 1.242; 85: 1min HRV, 6.758; 86: HR, 94.441; 86: RR, 17.661; 86: SpO2, 100.0; 86: Perf, 1.800; 86: 1min HRV, 7.076; 87: HR, 94.638; 87: RR, 18.810; 87: SpO2, 100.0; 87: Perf, 1.988; 87: 1min HRV, 6.194; 88: HR, 94.864; 88: RR, 18.305; 88: SpO2, 100.0; 88: Perf, 1.841; 88: 1min HRV, 6.704; 89: HR, 95.729; 89: RR, 18.712; 89: SpO2, 100.0; 89: Perf, 1.769; 89: 1min HRV, 11.545; 89: 5min HRV, 8.848; 90: HR, 97.345; 90: RR, 20.569; 90: SpO2, 100.0; 90: Perf, 1.424; 90: 1min HRV, 14.899; 91: HR, 97.220; 91: RR, 18.932; 91: SpO2, 100.0; 91: Perf, 1.581; 91: 1min HRV, 23.578; 92: HR, 95.431; 92: RR, 17.138; 92: SpO2, 100.0; 92: Perf, 1.650; 92: 1min HRV, 5.315; 93: HR, 94.322; 93: RR, 17.017; 93: SpO2, 100.0; 93: Perf, 1.803; 93: 1min HRV, 21.750; 94: HR, 94.864; 94: RR, 15.186; 94: SpO2, 100.0; 94: Perf, 1.650; 94: 1min HRV, 4.707; 94: 5min HRV, 17.740; 95: HR, 94.948; 95: RR, 15.845; 95: SpO2, 99.932; 95: Perf, 1.643; 95: 1min HRV, 7.039; 95: SBP, 153.0; 95: DBP, 101.0; 95: MAP, 118.333; 96: HR, 96.915; 96: RR, 19.593; 96: SpO2, 100.0; 96: Perf, 1.13; 96: 1min HRV, 6.773; 97: HR, 97.172; 97: RR, 20.759; 97: SpO2, 100.0; 97: Perf, 1.264; 97: 1min HRV, 5.834; 98: HR, 97.559; 98: RR, 17.458; 98: SpO2, 100.0; 98: Perf, 1.547; 98: 1min HRV, 3.804; 99: HR, 97.119; 99: RR, 19.627; 99: SpO2, 100.0; 99: Perf, 1.605; 99: 1min HRV, 4.123; 99: 5min HRV, 7.908; 100: HR, 96.310; 100: RR, 19.621; 100: SpO2, 100.0; 100: Perf, 1.606; 100: 1min HRV, 6.912; 101: HR, 96.492; 101: RR, 18.508; 101: SpO2, 100.0; 101: Perf, 1.390; 101: 1min HRV, 18.678; 102: HR, 95.1; 102: RR, 17.190; 102: SpO2, 100.0; 102: Perf, 1.610; 102: 1min HRV, 14.997; 103: HR, 96.356; 103: RR, 18.424; 103: SpO2, 100.0; 103: Perf, 1.005; 103: 1min HRV, 30.601; 104: HR, 100.322; 104: RR, 17.831; 104: SpO2, 99.186; 104: Perf, 0.591; 104: 1min HRV, 48.953; 104: 5min HRV, 32.817; 105: HR, 99.5; 105: RR, 21.069; 105: SpO2, 99.121; 105: Perf, 0.519; 105: 1min HRV, 17.292; 106: HR, 97.661; 106: RR, 18.966; 106: SpO2, 99.542; 106: Perf, 0.567; 106: 1min HRV, 11.182; 107: HR, 99.810; 107: RR, 19.362; 107: SpO2, 99.310; 107: Perf, 0.503; 107: 1min HRV, 8.945; 108: HR, 97.017; 108: RR, 23.593; 108: SpO2, 99.186; 108: Perf, 0.460; 108: 1min HRV, 11.619; 109: HR, 97.483; 109: RR, 20.138; 109: SpO2, 100.0; 109: Perf, 0.639; 109: 1min HRV, 13.210; 109: 5min HRV, 13.786; 110: HR, 95.559; 110: RR, 17.644; 110: SpO2, 100.0; 110: Perf, 0.806; 110: 1min HRV, 5.844; 111: HR, 93.966; 111: RR, 16.576; 111: SpO2, 100.0; 111: Perf, 0.747; 111: 1min HRV, 9.589; 112: HR, 96.672; 112: RR, 21.828; 112: SpO2, 100.0; 112: Perf, 0.716; 112: 1min HRV, 6.406; 113: HR, 96.712; 113: RR, 18.034; 113: SpO2, 100.0; 113: Perf, 0.719; 113: 1min HRV, 31.059; 114: HR, 94.207; 114: RR, 18.534; 114: SpO2, 100.0; 114: Perf, 0.779; 114: 1min HRV, 7.562; 114: 5min HRV, 17.005; 115: POC PH (V) ISTAT, 7.42; 115: POC HCO3 (V) ISTAT, 30.2 mmol/L; 115: POC PO2 (V) ISTAT, 48 mmHg; 115: POC O2 SATURATION ISTAT VENOUS, 83 %; 115: POC TCO2 (V) ISTAT, 32 mmol/L; 115: POC PCO2 (V) ISTAT, 46.3 mmHg; 115: POC LACTATE ISTAT, 2.32 mmol/L; 115: POC BASE EXCESS ISTAT, 6 mmol/L; 115: HR, 97.220; 115: RR, 18.339; 115: SpO2, 100.0; 115: Perf, 0.886; 115: 1min HRV, 8.098; 116: HR, 96.237; 116: RR, 18.847; 116: SpO2, 100.0; 116: Perf, 0.819; 116: 1min HRV, 6.137; 117: HR, 95.034; 117: RR, 17.190; 117: SpO2, 100.0; 117: Perf, 1.051; 117: 1min HRV, 16.127; 118: HR, 95.475; 118: RR, 15.831; 118: SpO2, 100.0; 118: Perf, 1.116; 118: 1min HRV, 8.013; 119: HR, 92.862; 119: RR, 18.155; 119: SpO2, 100.0; 119: Perf, 0.879; 119: 1min HRV, 9.869; 119: 5min HRV, 14.104; 0: Age, 71; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.9; 0: Triage HR, 114.0; 0: Triage RR, 18.0; 0: Triage SBP, 150.0; 0: Triage DBP, 95.0; 0: Triage acuity, 3-Urgent; 0: CC, DEHYDRATION,CHEST PAIN",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The patient data shows stable vital signs, with HR, blood pressure, and SpO2 remaining within normal ranges throughout the monitoring period. The heart rate variability (HRV) is generally in an acceptable range without significant fluctuations that would indicate stress on the body. Additionally, key laboratory values, such as POC lactate, are not elevated to levels typically associated with high sepsis risk. Overall, the patient's condition appears stable, suggesting a low risk of developing sepsis within the next 12 hours.",
            "claims": [
                "The patient data shows stable vital signs.",
                "The heart rate remains within normal ranges.",
                "The blood pressure remains within normal ranges.",
                "The SpO2 remains within normal ranges throughout the monitoring period.",
                "The heart rate variability (HRV) is generally in an acceptable range.",
                "There are no significant fluctuations in HRV that would indicate stress on the body.",
                "Key laboratory values, such as POC lactate, are not elevated.",
                "Elevated POC lactate levels are typically associated with high sepsis risk.",
                "The patient's condition appears stable.",
                "The stability of the patient's condition suggests a low risk of developing sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "Key laboratory values, such as POC lactate, are not elevated.",
                "Elevated POC lactate levels are typically associated with high sepsis risk."
            ],
            "alignment_scores": [
                0.7,
                0.9
            ],
            "alignment_category": [
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "Elevated Serum Lactate (\u22652 mmol/L)"
            ],
            "alignment_reasonings": [
                "The claim directly addresses serum lactate levels, which are critical for sepsis risk assessment. Since it specifies that POC lactate is not elevated, it suggests a reduced risk of sepsis, contrasting with the category where elevated lactate signals high risk. The alignment is strong due to the direct reference to lactate, although it reports the absence of elevation.",
                "The claim directly references elevated point-of-care (POC) lactate levels, which closely aligns with the category of Elevated Serum Lactate (\u22652 mmol/L). This category specifically concerns the measurement of serum lactate as an indicator of tissue hypoperfusion and elevated sepsis risk. However, the exact numerical value of the lactate level is not specified in the claim, slightly reducing the alignment certainty compared to fully meeting the criterion of being \u22652 mmol/L."
            ],
            "final_alignment_score": 0.8
        },
        {
            "input": "2: HR, 100.0; 2: RR, 18.0; 2: SpO2, 99.0; 2: SBP, 92.0; 2: DBP, 49.0; 2: MAP, 63.333; 2: Pain, 10.0; 2: Temp, 97.5; 21: SpO2, 96.0; 22: HR, 109.821; 22: RR, 16.308; 22: SpO2, 95.831; 22: Perf, 0.709; 22: 1min HRV, 55.738; 22: SBP, 113.0; 22: DBP, 64.0; 22: MAP, 80.333; 23: HR, 109.412; 23: RR, 21.983; 23: SpO2, 95.897; 23: Perf, 1.001; 23: 1min HRV, 2.469; 24: HR, 109.655; 24: RR, 15.407; 24: SpO2, 97.678; 24: Perf, 0.791; 24: 1min HRV, 47.215; 25: HR, 105.810; 25: RR, 12.259; 25: SpO2, 98.0; 25: Perf, 0.890; 25: 1min HRV, 62.161; 25: 5min HRV, 51.744; 26: HR, 105.322; 26: RR, 14.644; 26: SpO2, 96.034; 26: Perf, 1.468; 26: 1min HRV, 66.515; 26: SBP, 111.0; 26: DBP, 64.0; 26: MAP, 79.667; 27: HR, 103.915; 27: RR, 13.644; 27: SpO2, 96.254; 27: Perf, 1.285; 27: 1min HRV, 50.293; 28: HR, 103.603; 28: RR, 18.483; 28: SpO2, 96.414; 28: Perf, 1.205; 28: 1min HRV, 56.883; 29: HR, 104.356; 29: RR, 16.508; 29: SpO2, 96.712; 29: Perf, 0.952; 29: 1min HRV, 74.698; 30: HR, 105.678; 30: RR, 17.475; 30: SpO2, 96.831; 30: Perf, 0.944; 30: 1min HRV, 41.682; 30: 5min HRV, 59.934; 31: HR, 105.345; 31: RR, 18.379; 31: SpO2, 97.276; 31: Perf, 0.855; 31: 1min HRV, 71.599; 32: HR, 104.492; 32: RR, 16.729; 32: SpO2, 96.898; 32: Perf, 1.194; 32: 1min HRV, 62.066; 33: HR, 105.069; 33: RR, 16.621; 33: SpO2, 96.397; 33: Perf, 1.545; 33: 1min HRV, 80.449; 34: HR, 104.746; 34: RR, 18.983; 34: SpO2, 95.983; 34: Perf, 1.803; 34: 1min HRV, 73.898; 35: HR, 105.576; 35: RR, 16.322; 35: SpO2, 95.729; 35: Perf, 1.834; 35: 1min HRV, 61.796; 35: 5min HRV, 70.356; 36: HR, 104.983; 36: RR, 15.448; 36: SpO2, 96.069; 36: Perf, 1.99; 36: 1min HRV, 83.070; 37: HR, 104.034; 37: RR, 16.475; 37: SpO2, 95.610; 37: Perf, 2.194; 37: 1min HRV, 102.005; 38: HR, 104.966; 38: RR, 15.845; 38: SpO2, 95.759; 38: Perf, 2.007; 38: 1min HRV, 69.008; 39: HR, 103.780; 39: RR, 14.119; 39: SpO2, 95.254; 39: Perf, 2.145; 39: 1min HRV, 83.238; 40: HR, 103.881; 40: RR, 19.559; 40: SpO2, 94.847; 40: Perf, 2.348; 40: 1min HRV, 76.667; 40: 5min HRV, 83.563; 40: SBP, 111.0; 40: DBP, 64.0; 40: MAP, 79.667; 41: HR, 102.759; 41: RR, 14.621; 41: SpO2, 95.552; 41: Perf, 2.174; 41: 1min HRV, 86.573; 41: SBP, 111.0; 41: DBP, 64.0; 41: MAP, 79.667; 42: HR, 102.576; 42: RR, 17.508; 42: SpO2, 95.102; 42: Perf, 2.320; 42: 1min HRV, 82.545; 43: HR, 102.966; 43: RR, 14.897; 43: SpO2, 94.948; 43: Perf, 2.434; 43: 1min HRV, 91.755; 44: HR, 103.017; 44: RR, 16.254; 44: SpO2, 94.712; 44: Perf, 2.529; 44: 1min HRV, 70.841; 45: HR, 103.898; 45: RR, 15.186; 45: SpO2, 95.305; 45: Perf, 2.507; 45: 1min HRV, 75.420; 45: 5min HRV, 82.383; 46: HR, 103.431; 46: RR, 17.828; 46: SpO2, 96.103; 46: Perf, 2.182; 46: 1min HRV, 83.408; 47: HR, 102.203; 47: RR, 19.492; 47: SpO2, 94.017; 47: Perf, 1.954; 47: 1min HRV, 77.013; 48: HR, 104.759; 48: RR, 18.517; 48: SpO2, 95.448; 48: Perf, 1.667; 48: 1min HRV, 72.746; 49: HR, 104.153; 49: RR, 17.983; 49: SpO2, 95.0; 49: Perf, 1.693; 49: 1min HRV, 76.780; 50: HR, 103.017; 50: RR, 17.397; 50: SpO2, 94.759; 50: Perf, 2.124; 50: 1min HRV, 79.480; 50: 5min HRV, 78.245; 51: HR, 104.136; 51: RR, 19.288; 51: SpO2, 95.254; 51: Perf, 2.163; 51: 1min HRV, 92.776; 52: HR, 103.847; 52: RR, 18.390; 52: SpO2, 97.542; 52: Perf, 1.824; 52: 1min HRV, 83.089; 53: HR, 103.034; 53: RR, 18.431; 53: SpO2, 97.328; 53: Perf, 1.928; 53: 1min HRV, 76.756; 54: HR, 102.508; 54: RR, 14.390; 54: SpO2, 96.424; 54: Perf, 2.107; 54: 1min HRV, 85.108; 55: HR, 104.121; 55: RR, 12.517; 55: SpO2, 95.310; 55: Perf, 2.358; 55: 1min HRV, 81.613; 55: 5min HRV, 83.963; 56: HR, 103.407; 56: RR, 18.271; 56: SpO2, 96.0; 56: Perf, 1.747; 56: 1min HRV, 82.473; 56: SBP, 117.0; 56: DBP, 67.0; 56: MAP, 83.667; 57: HR, 103.085; 57: RR, 16.525; 57: SpO2, 95.0; 57: Perf, 1.738; 57: 1min HRV, 90.579; 58: HR, 103.983; 58: RR, 15.431; 58: SpO2, 95.017; 58: Perf, 1.492; 58: 1min HRV, 82.048; 59: HR, 103.169; 59: RR, 14.203; 59: SpO2, 96.0; 59: Perf, 1.310; 59: 1min HRV, 69.464; 60: HR, 103.052; 60: RR, 19.690; 60: SpO2, 95.879; 60: Perf, 1.244; 60: 1min HRV, 78.540; 60: 5min HRV, 81.043; 61: HR, 104.271; 61: RR, 15.153; 61: SpO2, 97.153; 61: Perf, 1.157; 61: 1min HRV, 82.632; 65: 5min HRV, 82.632; 86: SARS-COV-2 RNA, Not Detected; 95: WAM DIFTYP, AUTO; 95: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.40 K/uL; 95: NRBC ABSOLUTE (HEMATOLOGY), 0.04 K/uL; 95: RED CELL DISTRIBUTION WIDTH (RDW), 19.4 %; 95: NEUTROPHIL % (AUTO DIFF), 91.0 %; 95: HEMATOCRIT (HCT), 30.8 %; 95: NEUTROPHIL ABSOLUTE (AUTO DIFF), 21.21 K/uL; 95: EOSINOPHIL % (AUTO DIFF), 0.1 %; 95: WHITE BLOOD CELLS (WBC), 23.3 K/uL; 95: NRBC PERCENT (HEMATOLOGY), 0.2 %; 95: LYMPHOCYTE % (AUTO DIFF), 3.3 %; 95: PLATELET COUNT (PLT), 666 K/uL; 95: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 95: MEAN CORPUSCULAR VOLUME (MCV), 60.0 fL; 95: RED BLOOD CELLS (RBC), 5.13 MIL/uL; 95: BASOPHIL % (AUTO DIFF), 0.1 %; 95: HEMOGLOBIN (HGB), 9.2 g/dL; 95: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.7 %; 95: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 29.9 g/dL; 95: MONOCYTE % (AUTO DIFF), 3.8 %; 95: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 95: MONOCYTE ABSOLUTE (AUTO DIFF), 0.88 K/uL; 95: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.78 K/uL; 95: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 17.9 pg; 97: INR, 1.5; 97: PROTHROMBIN TIME, 17.6 seconds; 97: PART. THROMBOPLASTIN TIME, 34.5 seconds; 100: HR, 98.0; 100: RR, 17.0; 100: SpO2, 98.0; 100: SBP, 115.0; 100: DBP, 76.0; 100: MAP, 89.0; 0: Age, 74; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.4; 0: Triage HR, 100.0; 0: Triage RR, 18.0; 0: Triage SBP, 92.0; 0: Triage DBP, 49.0; 0: Triage acuity, 2-Emergent; 0: CC, FALL,ALTERED MENTAL STATUS,BACK PAIN",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient's initial low blood pressure, high heart rate, and emergent triage acuity indicate potential hemodynamic instability. The sustained elevated heart rates and fluctuating heart rate variability suggest ongoing stress on the cardiovascular system. Laboratory results show significantly elevated white blood cells and neutrophils, indicating a possible infection or inflammatory process. Additionally, the patient\u2019s low hemoglobin and high red cell distribution width could suggest underlying health issues. These factors collectively indicate a high risk of sepsis within the next 12 hours.",
            "claims": [
                "The patient's initial blood pressure is low.",
                "The patient's initial heart rate is high.",
                "The patient's emergent triage acuity indicates potential hemodynamic instability.",
                "Sustained elevated heart rates suggest ongoing stress on the cardiovascular system.",
                "Fluctuating heart rate variability suggests ongoing stress on the cardiovascular system.",
                "Laboratory results show significantly elevated white blood cells.",
                "Laboratory results show significantly elevated neutrophils.",
                "Significantly elevated white blood cells indicate a possible infection or inflammatory process.",
                "Significantly elevated neutrophils indicate a possible infection or inflammatory process.",
                "The patient has low hemoglobin levels.",
                "The patient has high red cell distribution width.",
                "Low hemoglobin and high red cell distribution width could suggest underlying health issues.",
                "These factors collectively indicate a high risk of sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The patient's initial blood pressure is low.",
                "The patient's initial heart rate is high.",
                "The patient's emergent triage acuity indicates potential hemodynamic instability.",
                "Sustained elevated heart rates suggest ongoing stress on the cardiovascular system.",
                "Fluctuating heart rate variability suggests ongoing stress on the cardiovascular system.",
                "Laboratory results show significantly elevated white blood cells.",
                "Laboratory results show significantly elevated neutrophils.",
                "Significantly elevated white blood cells indicate a possible infection or inflammatory process.",
                "Significantly elevated neutrophils indicate a possible infection or inflammatory process.",
                "The patient has low hemoglobin levels.",
                "The patient has high red cell distribution width.",
                "Low hemoglobin and high red cell distribution width could suggest underlying health issues.",
                "These factors collectively indicate a high risk of sepsis within the next 12 hours."
            ],
            "alignment_scores": [
                0.7,
                0.3,
                0.7,
                0.7,
                0.5,
                1.0,
                0.8,
                1.0,
                0.8,
                0.2,
                0.2,
                0.3,
                0.4
            ],
            "alignment_category": [
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Elevated Shock Index (\u22651.0)",
                "Elevated Shock Index (\u22651.0)",
                "Elevated Shock Index (\u22651.0)",
                "Elevated Shock Index (\u22651.0)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "The claim states that the patient's initial blood pressure is low, which aligns with the Sepsis-Associated Hypotension category. However, it does not provide specific measurements to clearly fit the criteria for sepsis-associated hypotension (such as SBP <90 mmHg or MAP <70 mmHg). Consequently, while the concept is directly relevant, the lack of specific details about the blood pressure readings results in a less than perfect alignment.",
                "A high heart rate can contribute to an elevated shock index, which indicates hemodynamic instability associated with severe sepsis. However, the claim solely mentions a high heart rate without additional context (such as systolic BP) to directly assess the shock index, leading to only a partial alignment with this category.",
                "The claim references \"hemodynamic instability,\" which is a cornerstone of the Elevated Shock Index category, where a shock index \u22651.0 indicates such instability. However, the claim doesn't provide a specific shock index value to confirm the alignment fully. Therefore, while the claim's context aligns with hemodynamic instability, the lack of numerical or direct reference results in a moderate but not perfect alignment.",
                "The claim mentions \"sustained elevated heart rates,\" which is directly linked to the shock index that considers heart rate in relation to systolic blood pressure. While the claim does not mention blood pressure levels, an elevated heart rate is a significant component of determining the shock index, which denotes hemodynamic instability and increased risk of severe sepsis. Hence, the alignment is strong but not complete without blood pressure data.",
                "Fluctuating heart rate variability indicates cardiovascular stress, which could be related to haemodynamic instability, a component of the Elevated Shock Index category. Although heart rate variability isn't explicitly mentioned in the shock index criteria, the underlying concept of cardiovascular stress aligns moderately with the risk of severe sepsis as indicated by an elevated shock index. Thus, the category alignment is indirect but relevant.",
                "The claim of significantly elevated white blood cells aligns directly with one of the SIRS criteria (WBC\u202f>\u202f12\u202f000/\u00b5L or\u202f<\u202f4\u202f000/\u00b5L) used to identify systemic inflammation consistent with early sepsis. This makes the alignment perfect since the elevated WBC directly matches a SIRS criterion.",
                "Elevated neutrophils typically indicate a response to infection, which aligns with the SIRS criteria for systemic inflammation. However, the SIRS criteria explicitly mention elevated WBC counts, rather than neutrophil counts specifically. Given the close relationship but not exact match, the alignment is strong but not perfect.",
                "The claim directly mentions significantly elevated white blood cells (WBC), which is explicitly listed among the SIRS criteria. The presence of elevated WBCs is a strong indicator of systemic inflammation consistent with early sepsis, perfectly aligning with this category.",
                "Elevated neutrophils are indicative of an inflammatory or infectious process and align directly with the systemic inflammatory response commonly seen in early sepsis. While the claim does not explicitly state the other SIRS criteria, it strongly suggests an inflammatory state that would be assessed in this category. The alignment is high but not perfect because it doesn\u2019t confirm the presence of two or more SIRS criteria.",
                "Low hemoglobin levels are not directly associated with any specific sepsis category. However, anemia can be indicative of potential underlying issues and might contribute to organ dysfunction or poor oxygen delivery, conceptually linking it to the SOFA category. The alignment is very weak since hemoglobin levels themselves are not specific criteria for SOFA or other sepsis prediction metrics provided.",
                "High red cell distribution width (RDW) is not directly a part of the SOFA scoring system for new organ dysfunction in sepsis, but it can be associated with systemic inflammation and overall poor prognosis in critical illness. The alignment is tangential and not directly applicable, but there is a minimal conceptual link to organ dysfunction and sepsis risk, warranting a low rating.",
                "Low hemoglobin and high red cell distribution width indicate potential underlying health issues, which may indirectly relate to organ dysfunction. While these factors are not directly part of the SOFA criteria, they could be associated with broader signs of organ dysfunction or systemic issues, such as anemia or altered blood parameters, which are relevant in a sepsis context. The alignment is weak, as the relationship is indirect and not explicitly mentioned in the SOFA criteria.",
                "The claim mentions a high risk of sepsis within the next 12 hours, which can generally align with the concept of an elevated NEWS score indicating imminent clinical deterioration related to sepsis. However, the claim lacks specifics about deranged vitals or clinical actions that would better anchor it to a particular category, thus achieving only a moderate alignment."
            ],
            "final_alignment_score": 0.5846153846153845
        },
        {
            "input": "6: Pain, 5.0; 11: HR, 102.0; 11: RR, 18.0; 11: SpO2, 99.0; 11: SBP, 100.0; 11: DBP, 65.0; 11: MAP, 76.667; 11: Pain, 5.0; 11: Temp, 98.2; 30: HR, 111.25; 30: RR, 14.657; 30: SpO2, 100.0; 30: 1min HRV, 81.817; 31: HR, 102.414; 31: RR, 16.914; 31: SpO2, 100.0; 31: Perf, 0.753; 31: 1min HRV, 98.629; 31: SBP, 110.0; 31: DBP, 75.0; 31: MAP, 86.667; 32: HR, 103.237; 32: RR, 17.898; 32: SpO2, 100.0; 32: Perf, 1.658; 32: 1min HRV, 78.261; 33: HR, 97.517; 33: RR, 15.517; 33: SpO2, 100.0; 33: Perf, 1.683; 33: 1min HRV, 150.061; 33: 5min HRV, 109.610; 34: HR, 80.729; 34: RR, 18.966; 34: SpO2, 99.926; 34: Perf, 2.32; 34: 1min HRV, 122.922; 34: SBP, 91.0; 34: DBP, 52.0; 34: MAP, 65.0; 35: HR, 89.085; 35: RR, 16.661; 35: SpO2, 100.0; 35: Perf, 2.199; 35: 1min HRV, 78.485; 36: HR, 92.931; 36: RR, 17.672; 36: SpO2, 100.0; 36: Perf, 2.005; 36: 1min HRV, 93.865; 37: HR, 85.085; 37: RR, 19.864; 37: SpO2, 100.0; 37: Perf, 2.101; 37: 1min HRV, 84.424; 38: HR, 91.086; 38: RR, 20.397; 38: SpO2, 100.0; 38: Perf, 1.374; 38: 1min HRV, 77.182; 38: 5min HRV, 98.481; 39: HR, 89.237; 39: RR, 17.610; 39: SpO2, 100.0; 39: Perf, 2.134; 39: 1min HRV, 48.857; 40: HR, 96.373; 40: RR, 19.288; 40: SpO2, 100.0; 40: Perf, 2.359; 40: 1min HRV, 75.919; 41: HR, 99.724; 41: RR, 14.759; 41: SpO2, 100.0; 41: Perf, 1.386; 41: 1min HRV, 88.768; 42: HR, 95.814; 42: RR, 16.593; 42: SpO2, 100.0; 42: Perf, 1.323; 42: 1min HRV, 64.111; 43: HR, 103.603; 43: RR, 14.776; 43: SpO2, 100.0; 43: Perf, 1.383; 43: 1min HRV, 67.070; 43: 5min HRV, 76.235; 44: HR, 102.017; 44: RR, 13.475; 44: SpO2, 100.0; 44: Perf, 1.581; 44: 1min HRV, 90.454; 45: HR, 90.586; 45: RR, 18.483; 45: SpO2, 100.0; 45: Perf, 2.140; 45: 1min HRV, 117.585; 46: HR, 86.678; 46: RR, 14.729; 46: SpO2, 100.0; 46: Perf, 1.606; 46: 1min HRV, 109.479; 47: HR, 88.390; 47: RR, 15.915; 47: SpO2, 99.898; 47: Perf, 1.572; 47: 1min HRV, 82.073; 48: HR, 92.207; 48: RR, 19.259; 48: SpO2, 100.0; 48: Perf, 1.086; 48: 1min HRV, 70.404; 48: 5min HRV, 102.281; 49: HR, 89.458; 49: RR, 14.542; 49: SpO2, 100.0; 49: Perf, 0.949; 49: 1min HRV, 91.342; 49: SBP, 120.0; 49: DBP, 91.0; 49: MAP, 100.667; 50: HR, 89.345; 50: RR, 21.069; 50: SpO2, 100.0; 50: Perf, 1.104; 50: 1min HRV, 58.674; 51: HR, 93.746; 51: RR, 17.288; 51: SpO2, 100.0; 51: Perf, 1.145; 51: 1min HRV, 52.221; 52: HR, 94.814; 52: RR, 13.254; 52: SpO2, 100.0; 52: Perf, 0.876; 52: 1min HRV, 103.907; 53: HR, 90.397; 53: RR, 16.0; 53: SpO2, 100.0; 53: Perf, 0.88; 53: 1min HRV, 81.909; 53: 5min HRV, 81.277; 54: HR, 86.441; 54: RR, 16.119; 54: SpO2, 100.0; 54: Perf, 0.841; 54: 1min HRV, 85.111; 55: HR, 92.845; 55: RR, 16.897; 55: SpO2, 100.0; 55: Perf, 1.127; 55: 1min HRV, 66.007; 56: HR, 96.271; 56: RR, 17.542; 56: SpO2, 100.0; 56: Perf, 1.338; 56: 1min HRV, 73.784; 57: HR, 100.729; 57: RR, 18.814; 57: SpO2, 100.0; 57: Perf, 1.393; 57: 1min HRV, 88.383; 58: HR, 88.517; 58: RR, 17.069; 58: SpO2, 100.0; 58: Perf, 1.814; 58: 1min HRV, 76.327; 58: 5min HRV, 85.133; 59: HR, 81.674; 59: RR, 17.568; 59: SpO2, 100.0; 59: Perf, 1.497; 59: 1min HRV, 79.274; 63: 5min HRV, 79.274; 72: NS IV BOLUS -, 1000 ML; 73: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 88: WAM DIFTYP, AUTO; 88: MONOCYTE ABSOLUTE (AUTO DIFF), 0.45 K/uL; 88: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 88: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.71 K/uL; 88: RED BLOOD CELLS (RBC), 4.81 MIL/uL; 88: BASOPHIL % (AUTO DIFF), 0.7 %; 88: LYMPHOCYTE % (AUTO DIFF), 24.8 %; 88: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 88: NEUTROPHIL % (AUTO DIFF), 67.0 %; 88: EOSINOPHIL % (AUTO DIFF), 0.3 %; 88: RED CELL DISTRIBUTION WIDTH (RDW), 16.5 %; 88: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.1 g/dL; 88: NEUTROPHIL ABSOLUTE (AUTO DIFF), 4.61 K/uL; 88: HEMATOCRIT (HCT), 36.7 %; 88: BASOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 88: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 23.7 pg; 88: PLATELET COUNT (PLT), 346 K/uL; 88: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 88: HEMOGLOBIN (HGB), 11.4 g/dL; 88: MEAN CORPUSCULAR VOLUME (MCV), 76.3 fL; 88: MONOCYTE % (AUTO DIFF), 6.5 %; 88: NRBC PERCENT (HEMATOLOGY), 0.0 %; 88: WHITE BLOOD CELLS (WBC), 6.9 K/uL; 88: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.7 %; 107: SARS-COV-2 RNA, Not Detected; 107: RSV, Not Detected; 107: INFLUENZA A, Not Detected; 107: INFLUENZA B, Not Detected; 118: GLUCOSE, URINE (UA): Negative; 118: SPECIFIC GRAVITY, URINE (UA): 1.024; 118: PH, URINE (UA): 5.0; 118: NITRITE, URINE (UA): Negative; 118: PROTEIN, URINE (UA): Negative; 118: PROTEIN TOTAL, 8.2 g/dL; 118: SODIUM, 133 mmol/L; 118: ALT (SGPT), 13 U/L; 118: CO2, 13 mmol/L; 118: CHLORIDE, 98 mmol/L; 118: GLUCOSE, 64 mg/dL; 118: EGFR REFIT WITHOUT RACE (2021), 132 mL/min/1.73 m2; 118: BILIRUBIN TOTAL, 0.7 mg/dL; 118: ALBUMIN, 5.5 g/dL; 118: CREATININE, 0.61 mg/dL; 118: ALKALINE PHOSPHATASE, 58 U/L; 118: GLOBULIN, 2.7 g/dL; 118: CALCIUM, 9.9 mg/dL; 118: EGFR FOR AFRICAN AMERICAN, 152 mL/min/1.73 m2; 118: BLOOD UREA NITROGEN (BUN), 8 mg/dL; 118: CORRECTED CALCIUM, 8.7 mg/dL; 118: ANION GAP, 22 mmol/L; 118: POTASSIUM, 3.7 mmol/L; 118: AST (SGOT), 22 U/L; 0: Age, 20; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.8; 0: Triage HR, 102.0; 0: Triage RR, 18.0; 0: Triage SBP, 100.0; 0: Triage DBP, 65.0; 0: Triage acuity, 3-Urgent; 0: CC, EMESIS",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "Despite initial elevated heart rate (HR) and low blood pressure (BP) which could suggest sepsis, the overall vitals stabilize including HR and BP readings after initial assessment. There is no significant drop in blood pressure, and the oxygen saturation remains at 100%. Additionally, laboratory values do not indicate infection or major organ dysfunction typical of sepsis risk. Hence, the patient is not at high risk of developing sepsis within the next 12 hours.",
            "claims": [
                "The initial heart rate (HR) is elevated.",
                "The initial blood pressure (BP) is low.",
                "Elevated HR and low BP could suggest sepsis.",
                "The overall vitals stabilize after the initial assessment.",
                "The HR readings stabilize after the initial assessment.",
                "The BP readings stabilize after the initial assessment.",
                "There is no significant drop in blood pressure.",
                "The oxygen saturation remains at 100%.",
                "Laboratory values do not indicate infection.",
                "Laboratory values do not indicate major organ dysfunction.",
                "Major organ dysfunction is typical of sepsis risk.",
                "The patient is not at high risk of developing sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The initial heart rate (HR) is elevated.",
                "The initial blood pressure (BP) is low.",
                "Elevated HR and low BP could suggest sepsis.",
                "Laboratory values do not indicate infection."
            ],
            "alignment_scores": [
                0.4,
                0.8,
                0.8,
                0.3
            ],
            "alignment_category": [
                "Elevated Shock Index (\u22651.0)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Elevated Shock Index (\u22651.0)",
                "Early Antibiotic/Culture Orders (within 2 hours)"
            ],
            "alignment_reasonings": [
                "The claim mentions an elevated heart rate, which is a component of the Shock Index (heart rate \u00f7 systolic BP). While an elevated HR hints at possible haemodynamic instability, the claim doesn't provide information about blood pressure, needed to fully assess the Shock Index. Consequently, there's some but not full alignment with this category.",
                "The claim about low blood pressure aligns with the category of sepsis-associated hypotension, as hypotension is a critical indicator of progression towards septic shock. Although the claim does not provide specific blood pressure values to directly match the criteria, \"low\" blood pressure reasonably suggests a situation that could fall under this category of concern for sepsis. Thus, the alignment is high but not perfect due to lack of exact measurements.",
                "The claim mentions elevated heart rate (HR) and low blood pressure (BP), which aligns with the concept of the shock index (HR divided by systolic BP). An elevated shock index suggests hemodynamic instability that can indicate severe sepsis. Although the claim doesn\u2019t provide exact values, both elevated HR and low BP point toward a likely elevated shock index, giving this category a strong, though not perfect, alignment.",
                "The claim suggests that there is no laboratory indication of infection, implying that no immediate clinician action (like ordering antibiotics or cultures) is warranted. This loosely pertains to the lack of suspicion or confirmation of infection, thus indirectly aligning with the category focused on early interventions based on suspected infection. However, the alignment is weak since the absence of infection indications does not strongly connect with proactive clinical actions outlined in the category."
            ],
            "final_alignment_score": 0.575
        },
        {
            "input": "14: HR, 156.0; 14: RR, 22.0; 14: SpO2, 93.0; 14: SBP, 184.0; 14: DBP, 168.0; 14: MAP, 173.333; 14: Temp, 97.3; 35: HR, 73.452; 35: RR, 33.366; 35: 1min HRV, 88.112; 36: HR, 70.379; 36: RR, 41.362; 36: 1min HRV, 83.043; 37: HR, 70.136; 37: RR, 39.831; 37: 1min HRV, 83.907; 38: HR, 71.271; 38: RR, 37.661; 38: 1min HRV, 104.463; 39: HR, 69.610; 39: RR, 38.0; 39: 1min HRV, 87.117; 39: 5min HRV, 90.988; 40: HR, 70.379; 40: RR, 38.190; 40: 1min HRV, 113.496; 41: HR, 70.678; 41: RR, 40.169; 41: 1min HRV, 117.322; 42: HR, 69.776; 42: RR, 37.0; 42: 1min HRV, 115.847; 43: HR, 68.390; 43: RR, 40.169; 43: 1min HRV, 110.946; 44: HR, 70.373; 44: RR, 41.017; 44: 1min HRV, 121.203; 44: 5min HRV, 116.373; 45: HR, 64.345; 45: RR, 38.948; 45: 1min HRV, 6.663; 46: HR, 62.780; 46: RR, 39.864; 46: 1min HRV, 92.436; 47: HR, 73.276; 47: RR, 24.948; 47: 1min HRV, 154.990; 48: HR, 69.915; 48: RR, 25.254; 48: 1min HRV, 110.643; 49: HR, 75.483; 49: RR, 23.448; 49: 1min HRV, 131.734; 49: 5min HRV, 125.448; 50: HR, 77.559; 50: RR, 23.831; 50: 1min HRV, 147.393; 51: HR, 76.407; 51: RR, 30.068; 51: 1min HRV, 107.678; 51: Temp, 100.6; 52: HR, 74.534; 52: RR, 38.569; 52: 1min HRV, 124.051; 53: HR, 71.661; 53: RR, 33.695; 53: 1min HRV, 122.241; 54: HR, 71.759; 54: RR, 36.5; 54: 1min HRV, 130.296; 54: 5min HRV, 130.490; 55: HR, 71.729; 55: RR, 36.305; 55: 1min HRV, 135.077; 56: HR, 68.153; 56: RR, 37.983; 56: 1min HRV, 125.658; 57: HR, 63.828; 57: RR, 36.776; 57: 1min HRV, 103.130; 58: HR, 65.407; 58: RR, 37.729; 58: 1min HRV, 103.953; 59: HR, 66.466; 59: RR, 38.414; 59: 1min HRV, 135.229; 59: 5min HRV, 127.500; 60: HR, 70.102; 60: RR, 31.085; 60: 1min HRV, 142.860; 61: HR, 68.017; 61: RR, 31.305; 61: 1min HRV, 147.320; 62: HR, 69.914; 62: RR, 31.121; 62: 1min HRV, 141.935; 63: HR, 67.271; 63: RR, 36.932; 63: 1min HRV, 139.864; 64: HR, 68.155; 64: RR, 38.310; 64: 1min HRV, 163.649; 64: 5min HRV, 147.753; 65: HR, 69.441; 65: RR, 34.898; 65: 1min HRV, 157.793; 66: HR, 69.780; 66: RR, 37.508; 66: SpO2, 97.0; 66: 1min HRV, 148.174; 67: HR, 66.0; 67: RR, 38.224; 67: 1min HRV, 146.767; 68: HR, 66.203; 68: RR, 36.678; 68: 1min HRV, 137.768; 69: HR, 64.672; 69: RR, 40.121; 69: 1min HRV, 136.136; 69: 5min HRV, 149.031; 70: HR, 63.220; 70: RR, 38.797; 70: 1min HRV, 133.571; 71: HR, 70.814; 71: RR, 38.542; 71: 1min HRV, 157.983; 72: HR, 65.414; 72: RR, 38.466; 72: 1min HRV, 144.074; 73: HR, 64.254; 73: RR, 34.102; 73: 1min HRV, 140.864; 74: HR, 68.517; 74: RR, 29.448; 74: 1min HRV, 137.646; 74: 5min HRV, 148.502; 75: HR, 68.627; 75: RR, 29.271; 75: 1min HRV, 140.437; 76: HR, 69.322; 76: RR, 30.797; 76: 1min HRV, 153.600; 77: HR, 69.052; 77: RR, 34.431; 77: 1min HRV, 154.615; 78: HR, 67.407; 78: RR, 35.729; 78: 1min HRV, 139.424; 79: HR, 69.086; 79: RR, 26.397; 79: 1min HRV, 140.216; 79: 5min HRV, 146.596; 80: HR, 64.390; 80: RR, 38.661; 80: 1min HRV, 146.641; 81: SARS-COV-2 RNA, Not Detected; 81: HR, 66.190; 81: RR, 35.707; 81: 1min HRV, 129.707; 82: HR, 65.186; 82: RR, 38.034; 82: 1min HRV, 128.806; 83: HR, 68.983; 83: RR, 34.644; 83: 1min HRV, 144.160; 84: HR, 70.931; 84: RR, 37.103; 84: 1min HRV, 154.379; 84: 5min HRV, 144.235; 85: HR, 68.661; 85: RR, 35.610; 85: 1min HRV, 154.297; 86: HR, 69.931; 86: RR, 37.397; 86: 1min HRV, 151.109; 87: HR, 70.390; 87: RR, 39.305; 87: 1min HRV, 156.446; 88: HR, 69.475; 88: RR, 36.949; 88: 1min HRV, 151.355; 89: HR, 67.793; 89: RR, 34.845; 89: 1min HRV, 149.483; 89: 5min HRV, 153.149; 90: HR, 65.017; 90: RR, 33.831; 90: SpO2, 96.0; 90: 1min HRV, 131.283; 91: HR, 67.5; 91: RR, 30.017; 91: 1min HRV, 139.116; 92: HR, 70.949; 92: RR, 38.763; 92: SpO2, 97.0; 92: 1min HRV, 174.120; 93: HR, 76.407; 93: RR, 32.576; 93: SpO2, 97.0; 93: 1min HRV, 141.376; 94: HR, 73.017; 94: RR, 34.138; 94: 1min HRV, 135.197; 94: 5min HRV, 152.108; 95: HR, 71.915; 95: RR, 36.458; 95: 1min HRV, 138.877; 96: HR, 71.190; 96: RR, 39.517; 96: 1min HRV, 156.430; 97: HR, 66.492; 97: RR, 34.322; 97: 1min HRV, 132.356; 98: HR, 69.119; 98: RR, 30.983; 98: 1min HRV, 147.886; 99: HR, 69.190; 99: RR, 34.5; 99: 1min HRV, 144.492; 99: 5min HRV, 145.686; 100: HR, 71.492; 100: RR, 38.237; 100: 1min HRV, 150.561; 101: HR, 71.293; 101: RR, 37.793; 101: 1min HRV, 138.640; 102: HR, 68.424; 102: RR, 38.237; 102: 1min HRV, 133.726; 103: HR, 67.881; 103: RR, 38.288; 103: 1min HRV, 135.745; 104: HR, 69.310; 104: RR, 39.690; 104: 1min HRV, 134.999; 104: 5min HRV, 139.607; 105: HR, 69.356; 105: RR, 40.051; 105: SpO2, 96.0; 105: 1min HRV, 160.859; 106: HR, 74.793; 106: RR, 39.690; 106: 1min HRV, 165.740; 107: HR, 66.797; 107: RR, 34.356; 107: SpO2, 94.5; 107: 1min HRV, 141.305; 108: HR, 65.424; 108: RR, 35.186; 108: SpO2, 94.0; 108: 1min HRV, 133.033; 109: HR, 67.914; 109: RR, 38.517; 109: SpO2, 94.889; 109: 1min HRV, 148.623; 109: 5min HRV, 153.681; 110: HR, 69.254; 110: RR, 36.085; 110: 1min HRV, 146.020; 111: HR, 69.397; 111: RR, 35.603; 111: SpO2, 100.0; 111: 1min HRV, 152.806; 111: SBP, 102.0; 111: DBP, 52.0; 111: MAP, 68.667; 112: HR, 68.237; 112: RR, 27.881; 112: 1min HRV, 181.621; 113: HR, 71.5; 113: RR, 30.466; 113: 1min HRV, 139.520; 114: HR, 66.407; 114: RR, 38.373; 114: SpO2, 93.2; 114: 1min HRV, 139.131; 114: 5min HRV, 152.803; 115: HR, 69.661; 115: RR, 34.288; 115: 1min HRV, 139.376; 115: SBP, 106.0; 115: DBP, 63.0; 115: MAP, 77.333; 116: HR, 69.448; 116: RR, 35.690; 116: 1min HRV, 141.771; 117: HR, 66.407; 117: RR, 37.017; 117: 1min HRV, 123.354; 118: HR, 67.810; 118: RR, 34.707; 118: 1min HRV, 144.249; 119: HR, 66.746; 119: RR, 34.610; 119: 1min HRV, 138.079; 119: 5min HRV, 138.635; 0: Age, 88; 0: Gender, F; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.3; 0: Triage HR, 156.0; 0: Triage RR, 22.0; 0: Triage SBP, 184.0; 0: Triage DBP, 168.0; 0: Triage acuity, 3-Urgent; 0: CC, REFERRAL",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "Initially, the patient's high blood pressure, elevated heart rate, and urgent triage acuity suggest concern. The respiratory rate remains elevated, and while some vital signs stabilize, episodes of high respiratory rates and changes in heart rate variability indicate instability. The temperature spike, particularly to 100.6 degrees, along with fluctuations in SpO2 and vital signs, suggest a likelihood of sepsis, indicating a high risk of sepsis within 12 hours.",
            "claims": [
                "The patient's blood pressure is high.",
                "The patient's heart rate is elevated.",
                "The patient's urgent triage acuity suggests concern.",
                "The respiratory rate remains elevated.",
                "Some vital signs are stabilizing.",
                "There are episodes of high respiratory rates.",
                "There are changes in heart rate variability.",
                "The changes in heart rate variability indicate instability.",
                "The patient's temperature spiked to 100.6 degrees.",
                "Fluctuations in SpO2 levels are observed.",
                "Fluctuations in vital signs are observed.",
                "The combination of these findings suggests a likelihood of sepsis.",
                "The patient is at high risk of developing sepsis within 12 hours."
            ],
            "relevant_claims": [
                "The patient's blood pressure is high.",
                "The patient's heart rate is elevated.",
                "The patient's urgent triage acuity suggests concern.",
                "The respiratory rate remains elevated.",
                "There are episodes of high respiratory rates.",
                "The changes in heart rate variability indicate instability.",
                "Fluctuations in vital signs are observed.",
                "The combination of these findings suggests a likelihood of sepsis.",
                "The patient is at high risk of developing sepsis within 12 hours."
            ],
            "alignment_scores": [
                0.2,
                0.7,
                0.5,
                0.7,
                0.9,
                0.3,
                0.6,
                0.2,
                0.3
            ],
            "alignment_category": [
                "Elevated Shock Index (\u22651.0)",
                "SIRS Positivity (\u22652 Criteria)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "High qSOFA Score (\u22652)",
                "High qSOFA Score (\u22652)",
                "Elevated Shock Index (\u22651.0)",
                "Elevated NEWS Score (\u22655 points)",
                "SOFA Score Increase (\u22652 points)",
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "The claim mentions high blood pressure, which negatively correlates with some sepsis-related categories like shock index or sepsis-associated hypotension. High blood pressure is not directly related to any expert sepsis category (which focus more on low blood pressures or changes in shock index related to hemodynamic instability). The potential link is very weak, as elevated blood pressure doesn't align well with any specific sepsis prediction criteria listed.",
                "An elevated heart rate is explicitly listed under SIRS criteria (heart rate >90 bpm), which indicates systemic inflammation consistent with early sepsis. However, since the claim does not provide the exact heart rate or confirm that it's over the specified threshold, the alignment is not absolute, resulting in a rating of 0.7.",
                "The claim describes an urgent triage acuity, suggesting heightened concern for the patient's condition, likely due to suspected infection. This aligns conceptually with clinical suspicion that might lead to prioritizing early interventions like antibiotics or cultures. However, the claim does not mention any specific actions or scoring, making the alignment moderate rather than strong.",
                "Elevated respiratory rate is one component of the qSOFA criteria, which assesses the risk of sepsis-related complications. While the claim doesn't specify if the respiratory rate is \u226522/min, it suggests concern for sepsis risk through possible altered respiratory metrics. There is strong, but not complete, alignment given the lack of specific values.",
                "High respiratory rates are directly mentioned as part of the qSOFA criteria (respiratory rate\u202f\u2265\u202f22\u202f/min). This aligns strongly with the High qSOFA Score category, as increased respiratory rate is a key component. While the claim does not specify if the rate is \u226522/min to determine if it meets that specific threshold, episodes suggest it could be frequent or significant, justifying a high alignment rating.",
                "The claim mentions instability related to changes in heart rate variability. While heart rate variability isn't the same as the shock index, both involve the heart rate and suggest potential hemodynamic instability. Since the claim does not explicitly mention heart rate or systolic blood pressure values required to calculate a shock index, the alignment is indirect and moderate, thus warranting a rating of 0.3.",
                "The claim references fluctuations in vital signs, which closely relates to the NEWS score category. The NEWS score is calculated based on various vital signs, and fluctuations could suggest derangements that contribute to a high NEWS score. However, the claim lacks specific detail such as the exact NEWS score or which vital signs changed, so while related, the alignment is not exact or very strong.",
                "The claim mentions a general likelihood of sepsis based on a combination of unspecified findings. This aligns most closely with the SOFA Score, which considers multiple parameters to confirm organ dysfunction indicating sepsis. However, since no specific SOFA criteria or clinical details are mentioned, the claim's alignment with this category is weak. The broad, non-specific nature of the claim results in a low alignment rating.",
                "The claim is a general statement about a patient being at high risk of developing sepsis in the near future. Among the categories, an Elevated NEWS Score is often used to predict imminent clinical deterioration, which aligns somewhat with the idea of a high short-term risk of sepsis. However, the claim lacks specific detail about what factors are contributing to the risk, so the alignment is low but still relevant to the prediction aspect. Other categories might also relate but require specific criteria to be mentioned, which this claim does not provide."
            ],
            "final_alignment_score": 0.4888888888888888
        },
        {
            "input": "3: HR, 94.929; 3: RR, 16.486; 3: SpO2, 91.0; 3: 1min HRV, 17.711; 3: SBP, 127.0; 3: DBP, 80.0; 3: MAP, 95.667; 4: HR, 91.220; 4: RR, 13.746; 4: SpO2, 94.0; 4: Perf, 4.33; 4: 1min HRV, 26.173; 5: HR, 91.034; 5: RR, 18.759; 5: SpO2, 94.034; 5: Perf, 4.506; 5: 1min HRV, 21.867; 6: HR, 88.085; 6: RR, 14.915; 6: SpO2, 92.595; 6: Perf, 5.485; 6: 1min HRV, 38.426; 7: HR, 88.508; 7: RR, 14.797; 7: 1min HRV, 22.214; 7: 5min HRV, 30.947; 8: HR, 89.069; 8: RR, 11.793; 8: SpO2, 95.04; 8: Perf, 4.972; 8: 1min HRV, 31.508; 8: SBP, 127.0; 8: DBP, 80.0; 8: MAP, 95.667; 8: Temp, 98.0; 9: HR, 86.559; 9: RR, 12.068; 9: SpO2, 97.034; 9: Perf, 4.628; 9: 1min HRV, 31.643; 10: HR, 90.517; 10: RR, 14.103; 10: SpO2, 96.569; 10: Perf, 5.033; 10: 1min HRV, 24.404; 11: HR, 92.695; 11: RR, 15.254; 11: SpO2, 95.071; 11: Perf, 5.347; 11: 1min HRV, 36.291; 12: HR, 91.864; 12: RR, 19.831; 12: 1min HRV, 17.732; 12: 5min HRV, 32.707; 13: HR, 94.052; 13: RR, 18.914; 13: SpO2, 96.467; 13: 1min HRV, 18.839; 14: HR, 91.898; 14: RR, 18.466; 14: SpO2, 97.702; 14: Perf, 5.816; 14: 1min HRV, 23.276; 17: 5min HRV, 22.371; 18: HR, 94.154; 18: RR, 16.143; 18: 1min HRV, 14.662; 19: HR, 88.831; 19: RR, 17.034; 19: SpO2, 93.017; 19: 1min HRV, 51.436; 20: HR, 87.069; 20: RR, 16.707; 20: SpO2, 96.517; 20: Perf, 3.891; 20: 1min HRV, 57.287; 21: HR, 79.034; 21: RR, 9.797; 21: SpO2, 91.068; 21: Perf, 2.904; 21: 1min HRV, 32.628; 22: HR, 79.695; 22: RR, 10.220; 22: SpO2, 89.102; 22: Perf, 2.107; 22: 1min HRV, 26.250; 22: 5min HRV, 58.567; 23: HR, 89.776; 23: RR, 17.552; 23: SpO2, 90.448; 23: Perf, 1.569; 23: 1min HRV, 48.867; 24: HR, 79.339; 24: RR, 13.254; 24: SpO2, 94.305; 24: Perf, 1.277; 24: 1min HRV, 37.752; 25: HR, 75.086; 25: RR, 13.276; 25: SpO2, 92.983; 25: Perf, 2.273; 25: 1min HRV, 35.708; 26: HR, 76.898; 26: RR, 12.559; 26: SpO2, 94.508; 26: Perf, 1.732; 26: 1min HRV, 24.237; 27: HR, 86.466; 27: RR, 15.586; 27: SpO2, 93.023; 27: Perf, 1.560; 27: 1min HRV, 60.706; 27: 5min HRV, 70.179; 28: HR, 78.559; 28: RR, 14.712; 28: SpO2, 95.731; 28: 1min HRV, 65.069; 29: HR, 74.864; 29: RR, 12.017; 29: SpO2, 96.694; 29: 1min HRV, 63.373; 30: HR, 85.155; 30: RR, 19.828; 30: SpO2, 95.583; 30: Perf, 3.318; 30: 1min HRV, 77.497; 31: HR, 81.644; 31: RR, 16.542; 31: 1min HRV, 53.816; 32: HR, 74.017; 32: RR, 11.052; 32: 1min HRV, 61.141; 32: 5min HRV, 82.942; 33: HR, 70.915; 33: RR, 10.898; 33: 1min HRV, 53.525; 34: HR, 77.203; 34: RR, 15.169; 34: 1min HRV, 48.164; 35: HR, 80.948; 35: RR, 14.741; 35: 1min HRV, 84.492; 36: HR, 91.356; 36: RR, 20.424; 36: 1min HRV, 40.012; 37: HR, 81.414; 37: RR, 18.052; 37: 1min HRV, 66.938; 37: 5min HRV, 83.929; 38: HR, 73.746; 38: RR, 15.017; 38: 1min HRV, 101.429; 39: HR, 79.847; 39: RR, 21.763; 39: 1min HRV, 101.943; 40: HR, 67.293; 40: RR, 13.345; 40: 1min HRV, 18.546; 41: HR, 81.881; 41: RR, 18.898; 41: 1min HRV, 82.296; 42: HR, 73.534; 42: RR, 14.086; 42: 1min HRV, 50.919; 42: 5min HRV, 96.880; 43: HR, 80.373; 43: RR, 15.712; 43: 1min HRV, 70.035; 44: HR, 74.305; 44: RR, 18.237; 44: 1min HRV, 67.631; 45: HR, 74.086; 45: RR, 16.052; 45: 1min HRV, 63.685; 46: HR, 68.661; 46: RR, 12.220; 46: 1min HRV, 32.208; 47: HR, 86.845; 47: RR, 20.483; 47: 1min HRV, 23.165; 47: 5min HRV, 90.445; 48: HR, 79.220; 48: RR, 18.458; 48: 1min HRV, 65.133; 49: HR, 83.983; 49: RR, 14.576; 49: 1min HRV, 96.461; 50: HR, 78.138; 50: RR, 15.862; 50: 1min HRV, 79.422; 51: HR, 78.339; 51: RR, 14.186; 51: 1min HRV, 89.940; 52: HR, 82.379; 52: RR, 18.690; 52: 1min HRV, 78.629; 52: 5min HRV, 89.913; 53: HR, 69.576; 53: RR, 14.576; 53: 1min HRV, 55.195; 54: HR, 66.966; 54: RR, 10.475; 54: 1min HRV, 20.401; 55: HR, 67.672; 55: RR, 10.103; 55: 1min HRV, 24.726; 56: HR, 72.085; 56: RR, 12.0; 56: 1min HRV, 65.450; 57: HR, 73.828; 57: RR, 16.621; 57: 1min HRV, 47.900; 57: 5min HRV, 57.603; 58: HR, 71.949; 58: RR, 17.576; 58: 1min HRV, 34.180; 59: HR, 85.586; 59: RR, 20.810; 59: 1min HRV, 51.570; 60: HR, 76.424; 60: RR, 17.525; 60: 1min HRV, 47.778; 61: HR, 69.085; 61: RR, 18.220; 61: 1min HRV, 67.097; 62: HR, 69.897; 62: RR, 10.724; 62: 1min HRV, 53.313; 62: 5min HRV, 80.218; 63: HR, 76.271; 63: RR, 13.119; 63: 1min HRV, 28.041; 64: HR, 70.690; 64: RR, 10.5; 64: 1min HRV, 66.011; 65: HR, 92.085; 65: RR, 15.932; 65: 1min HRV, 55.711; 66: HR, 88.881; 66: RR, 22.271; 66: 1min HRV, 22.920; 67: HR, 92.552; 67: RR, 23.207; 67: 1min HRV, 64.729; 67: 5min HRV, 92.926; 68: HR, 88.881; 68: RR, 14.610; 68: 1min HRV, 79.447; 69: HR, 101.0; 69: RR, 27.0; 72: 5min HRV, 79.447; 0: Age, 33; 0: Gender, M; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 36.7; 0: Triage HR, 83.0; 0: Triage RR, 16.0; 0: Triage SBP, 127.0; 0: Triage DBP, 80.0; 0: Triage acuity, 2-Emergent; 0: CC, ACUTE NEUROLOGICAL PROBLEM",
            "answer": true,
            "llm_answer": "No",
            "llm_explanation": "The patient's vital signs such as heart rate, respiratory rate, body temperature, and blood pressure remain relatively stable and within normal ranges throughout the time series. Although there are some fluctuations in heart rate variability (HRV) and occasional dips in SpO2, there is no consistent pattern or indication of significant deterioration such as sustained tachycardia, hypotension, or increased respiratory rate that would suggest a high risk of developing sepsis within the next 12 hours.",
            "claims": [
                "The patient's vital signs remain relatively stable throughout the time series.",
                "The patient's vital signs are within normal ranges.",
                "There are fluctuations in heart rate variability (HRV).",
                "There are occasional dips in SpO2.",
                "There is no consistent pattern indicating significant deterioration.",
                "There is no indication of sustained tachycardia.",
                "There is no indication of hypotension.",
                "There is no indication of increased respiratory rate.",
                "The absence of significant deterioration suggests a low risk of developing sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "There is no consistent pattern indicating significant deterioration.",
                "There is no indication of sustained tachycardia."
            ],
            "alignment_scores": [
                0.3,
                0.4
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "Elevated Shock Index (\u22651.0)"
            ],
            "alignment_reasonings": [
                "The claim indicates the absence of significant deterioration, which indirectly suggests that a NEWS score might not be elevated. While an elevated NEWS score often predicts clinical deterioration, the lack of significant patterns hints at potentially normal vital signs. Therefore, the alignment is weak as the claim is more about the absence of the NEWS scoring indications.",
                "The claim refers to the absence of sustained tachycardia, which is part of the calculation of the shock index (heart rate \u00f7 systolic BP). While the presence of sustained tachycardia could contribute to an elevated shock index, the claim's focus on its absence suggests that the shock index might not be elevated. This relates to shock index, yet in a more indirect manner, hence the moderate alignment rating."
            ],
            "final_alignment_score": 0.35
        },
        {
            "input": "5: HR, 148.0; 6: HR, 147.308; 6: RR, 33.12; 6: SpO2, 99.0; 6: 1min HRV, 1.682; 6: SBP, 129.0; 6: DBP, 87.0; 6: MAP, 101.0; 6: LPM O2, 6.0; 6: Pain, 0.0; 6: Temp, 98.2; 7: HR, 147.224; 7: RR, 33.569; 7: 1min HRV, 1.191; 8: HR, 146.763; 8: RR, 30.068; 8: 1min HRV, 2.764; 8: 5min HRV, 2.393; 9: HR, 145.961; 9: RR, 29.65; 9: 1min HRV, 1.375; 9: SBP, 127.0; 9: DBP, 80.0; 9: MAP, 95.667; 10: HR, 146.276; 10: RR, 31.103; 10: 1min HRV, 0.989; 11: HR, 145.441; 11: RR, 28.847; 11: 1min HRV, 2.797; 12: HR, 145.466; 12: RR, 27.776; 12: 1min HRV, 1.743; 13: HR, 145.424; 13: RR, 29.831; 13: 1min HRV, 1.490; 13: 5min HRV, 2.104; 14: HR, 145.610; 14: RR, 29.831; 14: SpO2, 100.0; 14: Perf, 0.57; 14: 1min HRV, 1.934; 15: HR, 147.259; 15: RR, 34.121; 15: SpO2, 100.0; 15: 1min HRV, 3.816; 16: HR, 147.864; 16: RR, 26.898; 16: 1min HRV, 3.060; 17: HR, 147.052; 17: RR, 31.310; 17: SpO2, 99.636; 17: 1min HRV, 4.018; 18: HR, 150.305; 18: RR, 24.373; 18: SpO2, 98.0; 18: 1min HRV, 2.201; 18: 5min HRV, 5.055; 19: HR, 151.169; 19: RR, 33.508; 19: SpO2, 99.062; 19: 1min HRV, 3.213; 20: HR, 147.517; 20: RR, 30.552; 20: SpO2, 99.176; 20: Perf, 0.37; 20: 1min HRV, 2.140; 21: HR, 148.102; 21: RR, 31.305; 21: SpO2, 99.133; 21: Perf, 0.389; 21: 1min HRV, 4.108; 22: HR, 148.052; 22: RR, 33.414; 22: SpO2, 99.0; 22: 1min HRV, 2.972; 23: HR, 146.593; 23: RR, 30.915; 23: SpO2, 99.0; 23: 1min HRV, 1.722; 23: 5min HRV, 5.107; 23: SBP, 128.0; 23: DBP, 83.0; 23: MAP, 98.0; 23: LPM O2, 6.0; 24: HR, 145.881; 24: RR, 31.136; 24: SpO2, 99.592; 24: 1min HRV, 1.097; 24: SBP, 128.0; 24: DBP, 83.0; 24: MAP, 98.0; 25: HR, 146.241; 25: RR, 28.759; 25: SpO2, 98.438; 25: Perf, 0.793; 25: 1min HRV, 1.190; 26: HR, 145.881; 26: RR, 28.119; 26: SpO2, 99.932; 26: Perf, 0.795; 26: 1min HRV, 0.960; 27: HR, 145.138; 27: RR, 28.672; 27: SpO2, 99.017; 27: Perf, 0.723; 27: 1min HRV, 1.042; 28: HR, 145.153; 28: RR, 28.593; 28: SpO2, 99.173; 28: Perf, 0.73; 28: 1min HRV, 1.207; 28: 5min HRV, 1.542; 29: HR, 145.525; 29: RR, 27.407; 29: Perf, 0.73; 29: 1min HRV, 1.633; 30: HR, 145.517; 30: RR, 27.552; 30: 1min HRV, 1.037; 31: HR, 145.915; 31: RR, 29.610; 31: SpO2, 97.195; 31: 1min HRV, 1.695; 32: HR, 147.879; 32: RR, 39.362; 32: SpO2, 97.889; 32: Perf, 0.77; 32: 1min HRV, 3.703; 33: HR, 146.678; 33: RR, 33.051; 33: 1min HRV, 2.117; 33: 5min HRV, 3.198; 66: WAM DIFTYP, AUTO; 66: HEMATOCRIT (HCT), 27.6 %; 66: EOSINOPHIL % (AUTO DIFF), 0.5 %; 66: MONOCYTE ABSOLUTE (AUTO DIFF), 0.60 K/uL; 66: RED BLOOD CELLS (RBC), 2.95 MIL/uL; 66: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 66: MEAN CORPUSCULAR VOLUME (MCV), 93.6 fL; 66: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 66: PLATELET COUNT (PLT), 172 K/uL; 66: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 66: NEUTROPHIL ABSOLUTE (AUTO DIFF), 4.83 K/uL; 66: LYMPHOCYTE % (AUTO DIFF), 10.6 %; 66: WHITE BLOOD CELLS (WBC), 6.2 K/uL; 66: RED CELL DISTRIBUTION WIDTH (RDW), 19.5 %; 66: HEMOGLOBIN (HGB), 8.3 g/dL; 66: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 66: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 66: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.1 pg; 66: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 30.1 g/dL; 66: NEUTROPHIL % (AUTO DIFF), 78.4 %; 66: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.65 K/uL; 66: BASOPHIL % (AUTO DIFF), 0.3 %; 66: NRBC PERCENT (HEMATOLOGY), 0.0 %; 66: MONOCYTE % (AUTO DIFF), 9.7 %; 99: CHLORIDE, 93 mmol/L; 99: ALKALINE PHOSPHATASE, 232 U/L; 99: EGFR REFIT WITHOUT RACE (2021), 155 mL/min/1.73 m2; 99: BLOOD UREA NITROGEN (BUN), 3 mg/dL; 99: POTASSIUM, 4.1 mmol/L; 99: CO2, 37 mmol/L; 99: SODIUM, 135 mmol/L; 99: AST (SGOT), 60 U/L; 99: EGFR FOR AFRICAN AMERICAN, 178 mL/min/1.73 m2; 99: GLOBULIN, 3.4 g/dL; 99: PROTEIN TOTAL, 5.9 g/dL; 99: CORRECTED CALCIUM, 9.9 mg/dL; 99: ANION GAP, 5 mmol/L; 99: BILIRUBIN TOTAL, 0.2 mg/dL; 99: ALBUMIN, 2.5 g/dL; 99: CREATININE, 0.25 mg/dL; 99: ALT (SGPT), 16 U/L; 99: CALCIUM, 8.7 mg/dL; 99: GLUCOSE, 104 mg/dL; 99: BNP NT-PRO, 415 pg/mL; 100: LR IV BOLUS -, 500 ML; 0: Age:, 38; 0: Gender, F; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 36.8; 0: Triage HR, 147.0; 0: Triage RR, 29.0; 0: Triage SBP, 129.0; 0: Triage DBP, 87.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient presents with several concerning indicators suggestive of a high risk for sepsis. Upon ED admission, they exhibit tachycardia (HR consistently around 145-150 BPM), tachypnea (RR > 30), and low 1-minute heart rate variability, all of which can be indicative of systemic stress or inflammation. Additionally, the patient shows anemia (Hgb 8.3 g/dL and Hct 27.6%), low albumin (2.5 g/dL), and high NT-proBNP (415 pg/mL), which may point to potential underlying issues affecting physiological stability. Despite normal white blood cell values and the administration of IV fluids, these combined factors suggest the patient is at high risk of developing sepsis within 12 hours.",
            "claims": [
                "The patient presents with several concerning indicators suggestive of a high risk for sepsis.",
                "Upon ED admission, the patient exhibits tachycardia.",
                "The patient's heart rate is consistently around 145-150 BPM.",
                "The patient exhibits tachypnea.",
                "The patient's respiratory rate is greater than 30.",
                "The patient has low 1-minute heart rate variability.",
                "Low heart rate variability can be indicative of systemic stress or inflammation.",
                "The patient shows signs of anemia.",
                "The patient's hemoglobin level is 8.3 g/dL.",
                "The patient's hematocrit level is 27.6%.",
                "The patient has low albumin levels.",
                "The patient's albumin level is 2.5 g/dL.",
                "The patient has high NT-proBNP levels.",
                "The patient's NT-proBNP level is 415 pg/mL.",
                "High NT-proBNP levels may point to potential underlying issues affecting physiological stability.",
                "The patient has normal white blood cell values.",
                "The patient has received intravenous (IV) fluids.",
                "The combined factors suggest the patient is at high risk of developing sepsis within 12 hours."
            ],
            "relevant_claims": [
                "The patient presents with several concerning indicators suggestive of a high risk for sepsis.",
                "Upon ED admission, the patient exhibits tachycardia.",
                "The patient's heart rate is consistently around 145-150 BPM.",
                "The patient exhibits tachypnea.",
                "The patient's respiratory rate is greater than 30.",
                "The patient has low 1-minute heart rate variability.",
                "Low heart rate variability can be indicative of systemic stress or inflammation.",
                "The patient shows signs of anemia.",
                "The patient's hemoglobin level is 8.3 g/dL.",
                "The patient's hematocrit level is 27.6%.",
                "The patient's albumin level is 2.5 g/dL.",
                "The patient has high NT-proBNP levels.",
                "The patient's NT-proBNP level is 415 pg/mL.",
                "High NT-proBNP levels may point to potential underlying issues affecting physiological stability.",
                "The patient has received intravenous (IV) fluids.",
                "The combined factors suggest the patient is at high risk of developing sepsis within 12 hours."
            ],
            "alignment_scores": [
                0.3,
                0.8,
                0.8,
                0.6,
                0.9,
                0.2,
                0.3,
                0.3,
                0.3,
                0.3,
                0.3,
                0.3,
                0.2,
                0.3,
                0.3,
                0.2
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "High qSOFA Score (\u22652)",
                "High qSOFA Score (\u22652)",
                "Elevated Shock Index (\u22651.0)",
                "SIRS Positivity (\u22652 Criteria)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "Elevated Shock Index (\u22651.0)",
                "Elevated Shock Index (\u22651.0)",
                "Elevated Shock Index (\u22651.0)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "The claim refers to \"several concerning indicators suggestive of a high risk for sepsis\" without detailing any specific indicators. The NEWS score encompasses various vital sign abnormalities and is used to identify patients at risk of clinical deterioration, which aligns broadly with the idea of \"concerning indicators.\" However, because the claim lacks specificity about which indicators are present, the alignment is weak.",
                "Tachycardia, defined as a heart rate >90 bpm, is one of the criteria explicitly listed under SIRS. This strongly suggests systemic inflammation and could indicate early sepsis. However, SIRS requires the presence of at least two criteria, and the claim mentions only one. Thus, while the alignment with the category is strong due to the direct connection, it is not complete, reflecting a high but not perfect rating.",
                "A heart rate over 90 BPM is one of the established criteria for SIRS, which helps identify systemic inflammation indicative of early sepsis. The claim describes a heart rate significantly higher than the SIRS criterion, strongly suggesting the presence of systemic inflammation, though it doesn't specify if other SIRS criteria are met. The alignment is strong due to this elevated heart rate.",
                "Tachypnea (increased respiratory rate) is directly referenced as a component of both the SIRS criteria and qSOFA score. However, the qSOFA assessment includes a specific respiratory rate threshold (\u226522/min), and while the claim indicates the presence of tachypnea, it does not specify if this threshold is met. As such, alignment is meaningful but not definitive, hence the partial rating.",
                "A respiratory rate of \u226522 per minute is a component of the qSOFA score, which assesses the risk of sepsis-related organ dysfunction and mortality. Although the claim specifies a higher respiratory rate (>30), which reinforces this observation, the alignment is strong but not absolute since qSOFA considers multiple criteria and requires meeting at least two for full alignment.",
                "Low heart rate variability does not directly correspond with any specific category, including Elevated Shock Index. However, it can suggest autonomic dysfunction or stress levels often linked to cardiovascular instability, which indicates a weak connection to the concept of hemodynamic instability hinted in the Elevated Shock Index category. The alignment is indirect and minimal, hence the low rating.",
                "Low heart rate variability is not expressly part of any given criteria but can be indicative of systemic stress or inflammation, similar to conditions assessed by SIRS. The alignment reflects a possible connection with systemic response to inflammation, but it does not correspond directly to the specific SIRS criteria.",
                "Anemia itself is not directly a part of the SOFA criteria; however, it may relate to underlying conditions affecting oxygen transport, which indirectly ties to SOFA score elements like organ dysfunction. This connection is weak in terms of direct criteria alignment, hence the low rating.",
                "Hemoglobin levels are not explicitly part of the SOFA score criteria. However, a low hemoglobin level can be indicative of broader issues affecting organ function, such as decreased oxygen delivery, which conceptually aligns with the SOFA score's purpose of assessing organ dysfunction. The alignment is weak because hemoglobin isn't directly used in calculating SOFA, but it can inform clinical evaluation of a patient's condition.",
                "Hematocrit levels are not directly outlined in the expert sepsis categories or the SOFA score components. However, a low hematocrit might imply potential issues with blood oxygen transport, indirectly hinting at possible complications like organ dysfunctions relevant to SOFA. The alignment is weak due to its indirect and peripheral connection.",
                "While the claim about low albumin levels does not directly match any SOFA score component, low albumin can be an indirect indicator of liver dysfunction or inflammation, which are relevant in systemic organ assessment. Though not specifically mentioned in SOFA criteria, it suggests possible organ dysfunction and a slight indirect relevance to this category.",
                "High NT-proBNP levels are generally associated with cardiac stress or heart failure. While not directly related to the shock index, there is an indirect connection through hemodynamic instability, as both high NT-proBNP and an elevated shock index can indicate cardiac-related issues. However, the alignment is weak because NT-proBNP is not a component of the shock index itself or any specific sepsis criteria listed here.",
                "The claim references NT-proBNP levels, typically associated with cardiac function rather than any specific sepsis metric. While NT-proBNP is not part of the shock index calculation, elevated levels might imply cardiac stress and indirectly suggest potential hemodynamic instability, often seen in sepsis contexts. Hence, there is a minimal alignment with elevated shock index due to this indirect implication.",
                "High NT-proBNP levels are generally associated with heart failure and can indicate cardiac issues that impact physiological stability. While this doesn\u2019t directly align with shock index criteria, heart failure may lead to hemodynamic instability, which is conceptually related to the shock index measurement. However, the alignment is indirect and weak because NT-proBNP is not directly related to heart rate or blood pressure parameters used in calculating the shock index.",
                "The administration of IV fluids can potentially be associated with treating sepsis-related hypotension to stabilize blood pressure, but the claim does not specify actual hypotension or other vital signs. Thus, while there's a conceivable indirect connection, it remains speculative without additional details confirming hypotension.",
                "The claim references a general assessment of high sepsis risk but lacks specific details aligning with any particular category. The category \"Elevated NEWS Score\" often involves considering a combination of vital sign abnormalities to predict clinical deterioration, which could align with a general evaluation of high sepsis risk. However, without specific details on vital signs or scoring, the alignment is very weak."
            ],
            "final_alignment_score": 0.4
        },
        {
            "input": "3: HR, 99.0; 3: RR, 22.0; 3: SpO2, 100.0; 3: SBP, 105.0; 3: DBP, 69.0; 3: MAP, 81.0; 3: Temp, 97.9; 22: SpO2, 93.583; 22: SBP, 117.0; 22: DBP, 84.0; 22: MAP, 95.0; 23: HR, 97.0; 23: SpO2, 99.780; 23: Perf, 2.001; 23: SBP, 117.0; 23: DBP, 84.0; 23: MAP, 95.0; 24: SpO2, 99.932; 24: Perf, 2.445; 25: SpO2, 99.661; 25: Perf, 2.122; 26: SpO2, 99.38; 26: Perf, 1.821; 27: SpO2, 97.827; 27: Perf, 1.817; 28: SpO2, 98.931; 28: Perf, 1.873; 29: SpO2, 99.366; 29: Perf, 1.780; 30: SpO2, 98.368; 30: Perf, 1.356; 31: SpO2, 98.845; 31: Perf, 0.549; 32: SpO2, 98.492; 32: Perf, 0.372; 33: SpO2, 99.379; 33: Perf, 0.356; 34: SpO2, 100.0; 34: Perf, 0.402; 35: SpO2, 99.069; 35: Perf, 0.376; 36: SpO2, 99.661; 36: Perf, 0.32; 37: SpO2, 99.828; 37: Perf, 0.361; 38: SpO2, 99.822; 38: Perf, 0.566; 39: SpO2, 99.897; 39: Perf, 0.906; 40: SpO2, 100.0; 40: Perf, 0.948; 41: SpO2, 99.6; 41: Perf, 0.961; 42: SpO2, 99.931; 42: Perf, 0.961; 43: SpO2, 99.881; 43: Perf, 1.230; 44: SpO2, 99.897; 44: Perf, 1.309; 45: SpO2, 99.627; 45: Perf, 1.438; 46: SpO2, 99.610; 46: Perf, 1.369; 47: SpO2, 99.879; 47: Perf, 1.217; 48: SpO2, 100.0; 48: Perf, 1.026; 49: SpO2, 99.289; 49: Perf, 1.059; 50: SpO2, 99.431; 50: Perf, 1.124; 51: SpO2, 99.051; 51: Perf, 1.196; 52: SpO2, 99.508; 52: Perf, 1.242; 53: SpO2, 99.741; 53: Perf, 1.119; 54: POC GLUCOSE BY METER, 362 mg/dL; 54: SpO2, 99.898; 54: Perf, 0.730; 54: Pain, 10.0; 55: SpO2, 99.897; 55: Perf, 0.728; 56: SpO2, 100.0; 56: Perf, 0.930; 57: SpO2, 99.909; 57: Perf, 1.122; 58: SpO2, 99.926; 58: Perf, 1.155; 59: SpO2, 99.017; 59: Perf, 1.204; 60: SpO2, 98.397; 60: Perf, 1.234; 61: SpO2, 99.254; 61: Perf, 1.24; 62: SpO2, 99.746; 62: Perf, 1.293; 63: SpO2, 100.0; 63: Perf, 1.296; 63: ACETAMINOPHEN, 325 MG PO TABS; 64: SpO, 2: 98.974; 64: Perf, 1.24; 65: SpO2, 100.0; 65: Perf, 0.973; 66: SpO2, 98.385; 66: Perf, 0.579; 67: SpO2, 99.3; 67: Perf, 0.605; 68: SpO2, 100.0; 68: Perf, 0.708; 69: SpO2, 100.0; 69: Perf, 0.72; 70: SpO2, 99.345; 70: Perf, 0.714; 71: SpO2, 97.136; 71: Perf, 0.901; 72: SpO2, 99.610; 72: Perf, 1.007; 73: WAM DIFTYP, AUTO; 73: NEUTROPHIL % (AUTO DIFF), 74.7 %; 73: RED BLOOD CELLS (RBC), 4.08 MIL/uL; 73: PLATELET COUNT (PLT), 330 K/uL; 73: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 73: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 73: MONOCYTE ABSOLUTE (AUTO DIFF), 0.69 K/uL; 73: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 73: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.64 K/uL; 73: MEAN CORPUSCULAR VOLUME (MCV), 82.8 fL; 73: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.4 g/dL; 73: WHITE BLOOD CELLS (WBC), 9.7 K/uL; 73: LYMPHOCYTE % (AUTO DIFF), 17.0 %; 73: BASOPHIL % (AUTO DIFF), 0.3 %; 73: NRBC PERCENT (HEMATOLOGY), 0.0 %; 73: HEMOGLOBIN (HGB), 11.3 g/dL; 73: HEMATOCRIT (HCT), 33.8 %; 73: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 73: NEUTROPHIL ABSOLUTE (AUTO DIFF), 7.21 K/uL; 73: RED CELL DISTRIBUTION WIDTH (RDW), 13.1 %; 73: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.04 K/uL; 73: MONOCYTE % (AUTO DIFF), 7.2 %; 73: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 27.7 pg; 73: EOSINOPHIL % (AUTO DIFF), 0.4 %; 73: SpO2, 96.224; 73: Perf, 0.768; 74: SpO2, 95.458; 74: Perf, 0.792; 75: SpO2, 98.293; 75: Perf, 0.817; 76: SpO2, 98.136; 76: Perf, 0.884; 77: SpO2, 99.517; 77: Perf, 0.841; 78: SpO2, 98.644; 78: Perf, 0.785; 79: SpO2, 97.102; 79: Perf, 0.917; 80: RSV, Not Detected; 80: INFLUENZA A, Not Detected; 80: RSV, Not Detected; 80: INFLUENZA B, Not Detected; 80: INFLUENZA B, Not Detected; 80: SARS-COV-2 RNA, Detected; 80: SARS-COV-2 RNA, Detected; 80: INFLUENZA A, Not Detected; 80: SpO2, 99.483; 80: Perf, 0.866; 81: SpO2, 96.712; 81: Perf, 0.947; 82: SpO2, 98.776; 82: Perf, 0.976; 83: SpO2, 99.017; 83: Perf, 0.907; 84: SpO2, 97.814; 84: Perf, 0.839; 85: SpO2, 99.155; 85: Perf, 1.053; 86: SpO2, 99.627; 86: Perf, 1.14; 87: SpO2, 99.517; 87: Perf, 1.522; 88: SpO2, 99.966; 88: Perf, 1.546; 89: SpO2, 99.627; 89: Perf, 1.1; 90: SpO2, 99.603; 90: Perf, 1.061; 91: C-REACTIVE PROTEIN (CRP), 0.2 mg/dL; 91: SpO2, 98.695; 91: Perf, 0.867; 92: SpO2, 98.672; 92: Perf, 0.728; 93: SpO2, 98.610; 93: Perf, 0.464; 94: SpO2, 98.390; 94: Perf, 0.468; 95: SpO2, 98.638; 95: Perf, 0.427; 96: SpO2, 98.508; 96: Perf, 0.42; 97: SpO2, 98.121; 97: Perf, 0.421; 98: SpO2, 98.305; 98: Perf, 0.429; 99: SpO2, 98.237; 99: Perf, 0.415; 100: SpO2, 99.241; 100: Perf, 0.502; 101: SpO2, 99.949; 101: Perf, 1.445; 102: SpO2, 99.566; 102: Perf, 1.361; 103: SpO2, 100.0; 103: Perf, 1.270; 104: SpO2, 100.0; 104: Perf, 1.095; 113: TSH, 1.50 uIU/mL; 113: DROPERIDOL, 2.5 MG/ML INJ SOLN; 116: SpO, 2: 97.286; 117: SpO2, 96.672; 117: Perf, 1.520; 118: SpO2, 99.041; 118: Perf, 1.304; 119: SpO2, 95.509; 119: Perf, 1.17; 0: Age, 29; 0: Gender, F; 0: Race, Native Hawaiian or Other Pacific Islander; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 99.0; 0: Triage RR, 22.0; 0: Triage SBP, 105.0; 0: Triage DBP, 69.0; 0: Triage acuity, 3-Urgent; 0: CC, ELBOW PAIN,KNEE PAIN",
            "answer": true,
            "llm_answer": "No",
            "llm_explanation": "The patient's initial vital signs and lab results do not indicate a high risk of sepsis. Heart rate, respiratory rate, and SpO2 levels are within normal ranges overall, although there are moments of mild tachycardia and elevated respiratory rate, which can be common with pain or anxiety in the ED setting. There are no extreme abnormalities in white blood cell count, and the significantly elevated glucose level may be stress-related rather than an indicator of sepsis. While a SARS-COV-2 positive status warrants monitoring, the available data does not suggest an imminent risk of sepsis within the next 12 hours.",
            "claims": [
                "The patient's initial vital signs do not indicate a high risk of sepsis.",
                "Heart rate is within normal ranges overall.",
                "Respiratory rate is within normal ranges overall.",
                "SpO2 levels are within normal ranges overall.",
                "There are moments of mild tachycardia.",
                "There are moments of elevated respiratory rate.",
                "Mild tachycardia can be common with pain in the ED setting.",
                "Mild tachycardia can be common with anxiety in the ED setting.",
                "There are no extreme abnormalities in white blood cell count.",
                "The significantly elevated glucose level may be stress-related.",
                "The significantly elevated glucose level may not be an indicator of sepsis.",
                "A SARS-COV-2 positive status warrants monitoring.",
                "The available data does not suggest an imminent risk of sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The patient's initial vital signs do not indicate a high risk of sepsis.",
                "There are moments of mild tachycardia.",
                "Mild tachycardia can be common with pain in the ED setting.",
                "There are no extreme abnormalities in white blood cell count.",
                "The significantly elevated glucose level may be stress-related.",
                "A SARS-COV-2 positive status warrants monitoring.",
                "The available data does not suggest an imminent risk of sepsis within the next 12 hours."
            ],
            "alignment_scores": [
                0.6,
                0.6,
                0.3,
                0.3,
                0.2,
                0.3,
                0.3
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "Early Antibiotic/Culture Orders (within 2 hours)"
            ],
            "alignment_reasonings": [
                "The claim references the initial vital signs not indicating a high risk of sepsis, which indirectly pertains to a low National Early Warning Score (NEWS), as deranged vital signs resulting in a NEWS of\u202f\u2265\u202f5 predict clinical deterioration compatible with sepsis. The alignment is indirect because it assumes the absence of deranged vitals corresponding to a low NEWS score, thus suggesting less risk of imminent sepsis.",
                "Tachycardia, which is a heart rate >90 bpm, is one of the criteria used to identify SIRS. The term \"mild\" suggests this may be close to the threshold, but the presence of tachycardia itself is relevant to the SIRS criteria. The alignment is moderate because it involves one of the SIRS components directly but does not confirm the presence of two or more criteria as required for SIRS positivity.",
                "Tachycardia (heart rate >90 bpm) is one of the SIRS criteria used to identify systemic inflammation consistent with early sepsis. However, the claim suggests mild tachycardia might be due to pain rather than a systemic inflammatory response. Therefore, while there is some relevance, the alignment is weak as the context suggests an alternative explanation for the tachycardia.",
                "The lack of extreme abnormalities in white blood cell count directly relates to the SIRS criteria, which include WBC count thresholds. However, the claim indicates that these criteria are not met, making the alignment weak but relevant\u2014as a normal WBC count opposes one of the potential indicators for SIRS positivity.",
                "Hyperglycemia can be associated with stress responses, including those during sepsis, and while it doesn't directly align with any specific category here, it is an indirect marker that can occasionally parallel mechanisms like tissue hypoperfusion associated with sepsis (contextually similar to elevated lactate). However, the link between glucose and sepsis is not directly captured in the list, making the alignment weak and indirect.",
                "A SARS-COV-2 positive status indicates a potential infectious process, which heightens the possibility of developing sepsis. This claim suggests the need for monitoring but doesn't imply immediate clinical action such as antibiotic administration or blood culture orders, which are the actions associated with the \"Early Antibiotic/Culture Orders\" category. Although relevant due to the infectious nature, the alignment is indirect and weak.",
                "The claim suggests that there is no imminent risk of sepsis, which might imply that no urgent clinical action, like ordering antibiotics or cultures, is necessary at this time. However, due to lack of specific indicators referenced in the claim, the alignment with any category is weak. The mention of \"imminent risk\" could slightly hint towards absence of actions like early antibiotic or culture orders, but due to its broad and non-specific nature, it aligns weakly with the category."
            ],
            "final_alignment_score": 0.3714285714285714
        },
        {
            "input": "3: SpO2, 98.0; 5: SpO2, 98.333; 6: HR, 93.0; 6: RR, 28.0; 6: SpO2, 95.75; 6: 1min HRV, 31.387; 6: SBP, 134.0; 6: DBP, 95.0; 6: MAP, 108.0; 6: Pain, 0.0; 6: Temp, 99.0; 7: HR, 84.458; 7: RR, 21.627; 7: SpO2, 98.0; 7: 1min HRV, 104.688; 8: HR, 94.293; 8: RR, 23.052; 8: SpO2, 96.0; 8: 1min HRV, 94.542; 9: HR, 93.038; 9: RR, 24.254; 9: SpO2, 98.083; 9: 1min HRV, 92.495; 10: HR, 90.259; 10: RR, 23.293; 10: SpO2, 97.0; 10: 1min HRV, 112.587; 10: 5min HRV, 101.228; 11: HR, 81.390; 11: RR, 22.051; 11: SpO2, 99.0; 11: 1min HRV, 72.280; 12: HR, 82.881; 12: RR, 22.407; 12: 1min HRV, 129.498; 13: HR, 88.017; 13: RR, 20.914; 13: SpO2, 97.0; 13: 1min HRV, 95.278; 14: HR, 78.102; 14: RR, 19.322; 14: SpO2, 96.667; 14: 1min HRV, 109.998; 15: HR, 82.964; 15: RR, 31.448; 15: SpO2, 96.0; 15: 1min HRV, 31.449; 15: 5min HRV, 113.038; 16: HR, 94.931; 16: RR, 24.847; 16: SpO2, 99.489; 16: 1min HRV, 69.945; 17: HR, 94.678; 17: RR, 25.644; 17: SpO2, 96.759; 17: 1min HRV, 40.994; 18: HR, 85.517; 18: RR, 24.517; 18: SpO2, 96.24; 18: 1min HRV, 93.672; 19: HR, 90.220; 19: RR, 21.763; 19: SpO2, 97.030; 19: 1min HRV, 79.258; 20: HR, 92.0; 20: RR, 19.586; 20: SpO2, 98.0; 20: 1min HRV, 87.822; 20: 5min HRV, 92.999; 21: HR, 82.475; 21: RR, 25.186; 21: SpO2, 95.4; 21: 1min HRV, 109.828; 21: SBP, 123.0; 21: DBP, 94.0; 21: MAP, 103.667; 22: HR, 85.414; 22: RR, 22.0; 22: SpO2, 94.0; 22: 1min HRV, 83.980; 23: HR, 81.847; 23: 1min HRV, 124.486; 24: HR, 94.831; 24: SpO2, 92.737; 24: 1min HRV, 63.324; 25: HR, 87.224; 25: 1min HRV, 86.715; 25: 5min HRV, 103.995; 26: HR, 79.339; 26: SpO2, 94.0; 26: 1min HRV, 94.155; 27: HR, 92.207; 27: 1min HRV, 83.240; 28: HR, 79.220; 28: 1min HRV, 81.363; 29: HR, 86.525; 29: SpO2, 96.0; 29: 1min HRV, 86.182; 30: HR, 92.190; 30: RR, 24.4; 30: SpO2, 84.0; 30: 1min HRV, 80.311; 30: 5min HRV, 98.806; 31: HR, 101.153; 31: RR, 24.610; 31: 1min HRV, 55.800; 32: WAM DIFTYP, AUTO; 32: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 32: RED CELL DISTRIBUTION WIDTH (RDW), 18.7 %; 32: BASOPHIL % (AUTO DIFF), 0.9 %; 32: RED BLOOD CELLS (RBC), 3.85 MIL/uL; 32: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 26.2 pg; 32: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 32: NRBC PERCENT (HEMATOLOGY), 0.0 %; 32: NEUTROPHIL ABSOLUTE (AUTO DIFF), 2.49 K/uL; 32: WHITE BLOOD CELLS (WBC), 4.4 K/uL; 32: EOSINOPHIL % (AUTO DIFF), 1.8 %; 32: LYMPHOCYTE % (AUTO DIFF), 32.9 %; 32: NEUTROPHIL % (AUTO DIFF), 56.8 %; 32: MEAN CORPUSCULAR VOLUME (MCV), 86.8 fL; 32: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 32: HEMATOCRIT (HCT), 33.4 %; 32: PLATELET COUNT (PLT), 481 K/uL; 32: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 30.2 g/dL; 32: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 32: MONOCYTE ABSOLUTE (AUTO DIFF), 0.31 K/uL; 32: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 32: MONOCYTE % (AUTO DIFF), 7.1 %; 32: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.44 K/uL; 32: HEMOGLOBIN (HGB), 10.1 g/dL; 32: HR, 101.455; 32: RR, 25.707; 32: SpO2, 76.0; 32: 1min HRV, 41.524; 33: HR, 94.418; 33: RR, 21.186; 33: SpO2, 85.639; 33: 1min HRV, 75.895; 34: HR, 79.864; 34: RR, 22.492; 34: SpO2, 83.6; 34: 1min HRV, 131.719; 35: HR, 81.966; 35: RR, 27.207; 35: 1min HRV, 94.631; 35: 5min HRV, 112.726; 35: SBP, 126.0; 35: DBP, 99.0; 35: MAP, 108.0; 36: HR, 77.385; 36: RR, 24.644; 36: 1min HRV, 64.092; 36: SBP, 126.0; 36: DBP, 99.0; 36: MAP, 108.0; 37: HR, 81.414; 37: RR, 18.862; 37: 1min HRV, 106.216; 38: HR, 84.932; 38: RR, 19.390; 38: 1min HRV, 120.461; 39: HR, 94.833; 39: RR, 22.524; 39: SpO2, 71.714; 39: 1min HRV, 104.928; 40: HR, 102.116; 40: RR, 28.2; 40: SpO2, 81.0; 40: 1min HRV, 76.230; 40: 5min HRV, 116.478; 41: HR, 100.567; 41: RR, 30.424; 41: SpO2, 84.0; 41: 1min HRV, 146.366; 42: HR, 96.966; 42: RR, 24.475; 42: SpO2, 92.895; 42: 1min HRV, 198.539; 43: HR, 95.579; 43: RR, 29.667; 43: 1min HRV, 31.594; 44: HR, 99.754; 44: RR, 25.74; 44: 1min HRV, 57.814; 45: HR, 96.348; 45: RR, 28.833; 45: 1min HRV, 11.723; 45: 5min HRV, 84.891; 46: HR, 91.780; 46: 1min HRV, 56.944; 47: HR, 88.333; 47: 1min HRV, 38.182; 48: HR, 88.205; 48: 1min HRV, 140.676; 49: HR, 89.158; 49: 1min HRV, 118.585; 50: HR, 98.868; 50: 1min HRV, 41.762; 50: 5min HRV, 81.611; 60: SpO2, 71.0; 61: Pain, 0.0; 62: HIGH SENSITIVITY TROPONIN, 24 ng/L; 63: BLOOD UREA NITROGEN (BUN), 22 mg/dL; 63: CHLORIDE, 106 mmol/L; 63: ALBUMIN, 3.1 g/dL; 63: GLOBULIN, 4.1 g/dL; 63: CREATININE, 0.80 mg/dL; 63: ANION GAP, 9 mmol/L; 63: CORRECTED CALCIUM, 9.2 mg/dL; 63: POTASSIUM, 3.6 mmol/L; 63: GLUCOSE, 103 mg/dL; 63: ALKALINE PHOSPHATASE, 168 U/L; 63: PROTEIN TOTAL, 7.2 g/dL; 63: ALT (SGPT), 100 U/L; 63: AST (SGOT), 40 U/L; 63: SODIUM, 139 mmol/L; 63: EGFR REFIT WITHOUT RACE (2021), 110 mL/min/1.73 m2; 63: CALCIUM, 8.5 mg/dL; 63: BILIRUBIN TOTAL, 0.8 mg/dL; 63: CO2, 24 mmol/L; 63: BNP NT-PRO, 17298 pg/mL; 73: SpO2, 86.714; 82: HR, 88.833; 82: 1min HRV, 108.601; 83: HR, 79.333; 83: 1min HRV, 112.306; 84: HR, 74.733; 84: 1min HRV, 114.475; 85: 5min HRV, 121.752; 0: Age, 47; 0: Gender, M; 0: Race, White; 0: Means of arrival, EMS; 0: Triage Temp, 37.2; 0: Triage HR, 105.0; 0: Triage RR, 19.0; 0: Triage SBP, 134.0; 0: Triage DBP, 95.0; 0: Triage acuity, 3-Urgent; 0: CC, CHEST PAIN",
            "answer": false,
            "llm_answer": "Yes",
            "llm_explanation": "The time series indicates multiple concerning trends, including consistently elevated heart rates (above 90 BPM frequently), fluctuations in respiratory rate, and SpO2 levels dropping to as low as 71%, which are indicative of potential respiratory distress or hypoxemia. Most notably, the BNP NT-PRO is exceptionally high at 17,298 pg/mL, which is a strong marker of cardiac stress and could indicate heart failure or other critical conditions. These clinical indicators, combined with the patient's presentation to the ED with chest pain, suggest a high risk of sepsis, justifying a \"Yes\" label for being at high risk of developing sepsis within 12 hours.",
            "claims": [
                "The time series indicates multiple concerning trends.",
                "The heart rates are frequently elevated above 90 BPM.",
                "There are fluctuations in the respiratory rate.",
                "The SpO2 levels have dropped to as low as 71%.",
                "A SpO2 level of 71% is indicative of potential respiratory distress or hypoxemia.",
                "The BNP NT-PRO level is exceptionally high at 17,298 pg/mL.",
                "A BNP NT-PRO level of 17,298 pg/mL is a strong marker of cardiac stress.",
                "The high BNP NT-PRO level could indicate heart failure or other critical conditions.",
                "The patient's presentation to the ED includes chest pain.",
                "These clinical indicators suggest a high risk of sepsis.",
                "The \"Yes\" label for being at high risk of developing sepsis within 12 hours is justified."
            ],
            "relevant_claims": [
                "The heart rates are frequently elevated above 90 BPM.",
                "There are fluctuations in the respiratory rate.",
                "The SpO2 levels have dropped to as low as 71%.",
                "A SpO2 level of 71% is indicative of potential respiratory distress or hypoxemia.",
                "The BNP NT-PRO level is exceptionally high at 17,298 pg/mL.",
                "A BNP NT-PRO level of 17,298 pg/mL is a strong marker of cardiac stress.",
                "The high BNP NT-PRO level could indicate heart failure or other critical conditions.",
                "The patient's presentation to the ED includes chest pain.",
                "These clinical indicators suggest a high risk of sepsis."
            ],
            "alignment_scores": [
                0.8,
                0.2,
                0.7,
                0.7,
                0.2,
                0.2,
                0.3,
                0.2,
                0.3
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)",
                "High qSOFA Score (\u22652)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "Elevated Shock Index (\u22651.0)",
                "Elevated Shock Index (\u22651.0)",
                "Elevated Shock Index (\u22651.0)",
                "Elevated Shock Index (\u22651.0)",
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "The claim directly references an elevated heart rate above 90 BPM, which is one of the criteria for SIRS positivity. This aligns well with the SIRS category since it specifies heart rate as a component. However, SIRS positivity involves meeting two or more criteria, and the claim only mentions one, so the alignment is strong but not perfect.",
                "While changes in respiratory rate could conceptually relate to the High qSOFA Score due to its criterion of respiratory rate \u226522/min, the claim only mentions fluctuations without specifying whether they reach the threshold. The alignment is weak due to the lack of specificity towards the category criterion.",
                "A drop in SpO2 levels to 71% strongly indicates severe hypoxia, which is related to impaired oxygenation\u2014a key factor in assessing respiratory dysfunction in the SOFA score. While SpO2 isn't a direct measurement within the SOFA criteria (like PaO\u2082/FiO\u2082), it is conceptually aligned with significant respiratory compromise, strongly suggesting organ dysfunction. The alignment is strong but not perfect as it's an indirect measure.",
                "An SpO2 level of 71% strongly suggests significant hypoxemia, which relates to impaired oxygenation and potential organ dysfunction. Although SpO2 is not explicitly a measure in the SOFA scoring system, it relates to the concept of declining PaO\u2082/FiO\u2082 ratios, which are included. Therefore, while indirect, the association with SOFA score increase and risk of sepsis-related organ dysfunction is meaningful.",
                "While BNP NT-PRO is not directly mentioned in the expert sepsis categories, exceptionally high levels of this marker are associated with heart failure and cardiovascular stress, potentially impacting hemodynamic stability. The claim suggests possible shock or heart failure, which could relate conceptually to the Elevated Shock Index category. However, the alignment is indirect since BNP NT-PRO is not specifically related to heart rate or blood pressure calculations. The rating reflects this tenuous connection.",
                "This claim refers to a biomarker (BNP NT-PRO level) that indicates cardiac stress, which is associated with heart failure or cardiac issues, rather than being an explicit indicator used in sepsis prediction. Elevated shock index, which involves heart rate and blood pressure factors, could indirectly relate to cardiac stress but there is no direct alignment. The alignment is minimal as BNP is not part of the shock index criteria but suggests possible hemodynamic instability related to cardiac function.",
                "The claim concerns BNP NT-PRO, usually associated with heart failure and can indicate hemodynamic instability when elevated. While it isn't a direct component of the shock index (heart rate \u00f7 systolic BP), both suggest potential cardiovascular compromise. Given this indirect connection, the alignment is weak but relevant.",
                "Chest pain is not directly associated with any specific sepsis prediction category. However, it can be indicative of cardiovascular instability, which links conceptually, though weakly, to shock or haemodynamic concerns as described by the Elevated Shock Index category. Nevertheless, the connection is indirect and speculative, leading to a low alignment rating.",
                "The claim refers to clinical indicators suggesting a high risk of sepsis, which broadly aligns with several potential categories. However, an \"Elevated NEWS Score\" is a common tool used to identify clinical deterioration compatible with sepsis. The claim is non-specific and general, creating a weak alignment with NEWS, which encompasses various vital signs and clinical indicators, but lacks the concreteness needed for a higher rating."
            ],
            "final_alignment_score": 0.39999999999999997
        },
        {
            "input": "5: HR, 113.0; 5: RR, 18.0; 5: SpO2, 96.0; 5: SBP, 125.0; 5: DBP, 73.0; 5: MAP, 90.333; 5: Temp, 97.9; 37: HR, 110.0; 37: RR, 21.0; 37: SpO2, 97.0; 37: SBP, 127.0; 37: DBP, 72.0; 37: MAP, 90.333; 38: SpO2, 96.5; 39: SpO2, 96.9; 39: 1min HRV, 0.0; 40: HR, 110.833; 40: RR, 21.52; 40: SpO2, 97.695; 40: Perf, 1.694; 40: 1min HRV, 12.659; 41: HR, 110.759; 41: RR, 16.879; 41: SpO2, 97.810; 41: Perf, 2.023; 41: 1min HRV, 6.433; 42: HR, 109.864; 42: RR, 19.441; 42: SpO2, 98.305; 42: Perf, 1.888; 42: 1min HRV, 6.731; 43: HR, 111.224; 43: RR, 22.052; 43: SpO2, 98.466; 43: Perf, 1.622; 43: 1min HRV, 11.941; 43: 5min HRV, 10.269; 44: HR, 110.695; 44: RR, 21.695; 44: SpO2, 99.644; 44: Perf, 0.866; 44: 1min HRV, 5.987; 45: HR, 109.847; 45: RR, 22.831; 45: SpO2, 99.017; 45: Perf, 0.763; 45: 1min HRV, 3.764; 46: HR, 109.810; 46: RR, 22.034; 46: SpO2, 99.0; 46: Perf, 0.810; 46: 1min HRV, 6.749; 46: SBP, 121.0; 46: DBP, 79.0; 46: MAP, 93.0; 47: HR, 110.220; 47: RR, 20.356; 47: SpO2, 99.169; 47: Perf, 0.666; 47: 1min HRV, 6.619; 48: HR, 108.931; 48: RR, 22.259; 48: SpO2, 99.793; 48: Perf, 0.478; 48: 1min HRV, 6.830; 48: 5min HRV, 6.697; 49: HR, 109.254; 49: RR, 20.305; 49: SpO2, 100.0; 49: Perf, 0.428; 49: 1min HRV, 2.846; 50: HR, 109.793; 50: RR, 19.017; 50: SpO2, 100.0; 50: Perf, 0.474; 50: 1min HRV, 2.873; 51: HR, 109.780; 51: RR, 19.390; 51: SpO2, 100.0; 51: Perf, 0.514; 51: 1min HRV, 12.912; 52: HR, 109.559; 52: RR, 20.712; 52: SpO2, 100.0; 52: Perf, 0.488; 52: 1min HRV, 3.660; 53: HR, 110.793; 53: RR, 18.552; 53: SpO2, 99.552; 53: Perf, 0.612; 53: 1min HRV, 36.775; 53: 5min HRV, 17.866; 54: HR, 109.525; 54: RR, 18.915; 54: SpO2, 99.4; 54: Perf, 0.701; 54: 1min HRV, 6.136; 55: HR, 109.707; 55: RR, 20.276; 55: SpO2, 99.483; 55: Perf, 0.681; 55: 1min HRV, 8.137; 56: HR, 110.407; 56: RR, 19.593; 56: SpO2, 99.0; 56: Perf, 0.909; 56: 1min HRV, 3.681; 57: HR, 110.881; 57: RR, 21.932; 57: SpO2, 99.0; 57: Perf, 0.878; 57: 1min HRV, 4.624; 58: HR, 111.069; 58: RR, 21.224; 58: SpO2, 99.0; 58: Perf, 0.896; 58: 1min HRV, 3.577; 58: 5min HRV, 6.241; 59: HR, 111.220; 59: RR, 19.932; 59: SpO2, 99.288; 59: Perf, 0.800; 59: 1min HRV, 3.403; 60: HR, 111.190; 60: RR, 19.862; 60: SpO2, 99.241; 60: Perf, 0.764; 60: 1min HRV, 4.661; 61: HR, 110.983; 61: RR, 20.542; 61: SpO2, 99.271; 61: Perf, 0.727; 61: 1min HRV, 2.780; 61: SBP, 116.0; 61: DBP, 74.0; 61: MAP, 88.0; 62: HR, 110.695; 62: RR, 18.847; 62: SpO2, 99.305; 62: Perf, 0.716; 62: 1min HRV, 4.893; 63: HR, 109.862; 63: RR, 19.569; 63: SpO2, 99.534; 63: Perf, 0.562; 63: 1min HRV, 4.713; 63: 5min HRV, 4.639; 64: HR, 111.356; 64: RR, 19.847; 64: SpO2, 99.763; 64: Perf, 0.669; 64: 1min HRV, 4.143; 65: POC, BHCG, ISTAT QUANTITATIVE: 14.7 IU/L; 65: HR, 110.741; 65: RR, 18.259; 65: SpO2, 99.655; 65: Perf, 0.701; 65: 1min HRV, 4.586; 66: HR, 109.949; 66: RR, 19.051; 66: SpO2, 99.305; 66: Perf, 0.851; 66: 1min HRV, 4.560; 67: POC PH (V) ISTAT, 7.41; 67: POC BASE EXCESS ISTAT, 7 mmol/L; 67: POC LACTATE ISTAT, 0.59 mmol/L; 67: POC O2 SATURATION ISTAT VENOUS, 69 %; 67: POC HCO3 (V) ISTAT, 31.9 mmol/L; 67: POC TCO2 (V) ISTAT, 33 mmol/L; 67: POC PCO2 (V) ISTAT, 50.1 mmHg; 67: POC PO2 (V) ISTAT, 36 mmHg; 67: HR, 109.508; 67: RR, 18.390; 67: SpO2, 99.305; 67: Perf, 0.799; 67: 1min HRV, 5.604; 68: HR, 110.586; 68: RR, 18.241; 68: SpO2, 99.966; 68: Perf, 0.647; 68: 1min HRV, 5.464; 68: 5min HRV, 5.615; 69: HR, 110.576; 69: RR, 18.847; 69: SpO2, 99.822; 69: Perf, 0.63; 69: 1min HRV, 3.598; 69: SBP, 116.0; 69: DBP, 74.0; 69: MAP, 88.0; 70: HR, 110.207; 70: RR, 19.724; 70: SpO2, 99.879; 70: Perf, 0.533; 70: 1min HRV, 8.213; 71: HR, 112.5; 71: RR, 22.538; 71: SpO2, 99.0; 71: Perf, 0.54; 71: 1min HRV, 8.868; 73: 5min HRV, 7.325; 76: HR, 108.0; 76: RR, 20.0; 76: SpO2, 100.0; 99: ABO/RH (AUTOMATION), AB Positive; 99: ANTIBODY SCREEN 3, NEG; 109: WAM DIFTYP, AUTO; 109: WHITE BLOOD CELLS (WBC), 23.3 K/uL; 109: LYMPHOCYTE % (AUTO DIFF), 3.9 %; 109: RED CELL DISTRIBUTION WIDTH (RDW), 24.1 %; 109: HEMOGLOBIN (HGB), 8.4 g/dL; 109: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.90 K/uL; 109: EOSINOPHIL % (AUTO DIFF), 1.4 %; 109: PLATELET COUNT (PLT), 415 K/uL; 109: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 109: NRBC PERCENT (HEMATOLOGY), 0.0 %; 109: BASOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 109: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 25.8 pg; 109: MEAN CORPUSCULAR VOLUME (MCV), 82.8 fL; 109: HEMATOCRIT (HCT), 26.9 %; 109: BASOPHIL % (AUTO DIFF), 0.3 %; 109: NEUTROPHIL % (AUTO DIFF), 79.9 %; 109: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.62 K/uL; 109: MONOCYTE % (AUTO DIFF), 11.8 %; 109: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.33 K/uL; 109: MONOCYTE ABSOLUTE (AUTO DIFF), 2.75 K/uL; 109: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.2 g/dL; 109: RED BLOOD CELLS (RBC), 3.25 MIL/uL; 109: NEUTROPHIL ABSOLUTE (AUTO DIFF), 18.61 K/uL; 109: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 2.7 %; 0: Age, 33; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 113.0; 0: Triage RR, 18.0; 0: Triage SBP, 125.0; 0: Triage DBP, 73.0; 0: Triage acuity, 2-Emergent; 0: CC, BLOOD IN VOMIT",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The patient's data shows elevated heart rate and respiratory rate, which can be signs of potential sepsis. However, these are not sufficient alone for a high sepsis risk prediction. The patient's lactate level (0.59 mmol/L) is very low, which suggests low likelihood of sepsis, as high lactate levels often indicate sepsis. Additionally, other parameters such as blood pressure, oxygen saturation, and past medical history (hemoglobin is low indicating anemia but not directly sepsis) do not support a high risk of developing sepsis within 12 hours.",
            "claims": [
                "The patient's data shows an elevated heart rate.",
                "An elevated heart rate can be a sign of potential sepsis.",
                "The patient's data shows an elevated respiratory rate.",
                "An elevated respiratory rate can be a sign of potential sepsis.",
                "Elevated heart rate and respiratory rate alone are not sufficient for a high sepsis risk prediction.",
                "The patient's lactate level is 0.59 mmol/L.",
                "A lactate level of 0.59 mmol/L is very low.",
                "A very low lactate level suggests a low likelihood of sepsis.",
                "High lactate levels often indicate sepsis.",
                "Other parameters such as blood pressure do not support a high risk of developing sepsis within 12 hours.",
                "Oxygen saturation levels do not support a high risk of developing sepsis within 12 hours.",
                "The patient's past medical history indicates low hemoglobin levels, which signifies anemia.",
                "Anemia does not directly indicate sepsis.",
                "Low hemoglobin levels do not support a high risk of developing sepsis within 12 hours."
            ],
            "relevant_claims": [
                "An elevated heart rate can be a sign of potential sepsis.",
                "The patient's data shows an elevated respiratory rate.",
                "An elevated respiratory rate can be a sign of potential sepsis.",
                "Elevated heart rate and respiratory rate alone are not sufficient for a high sepsis risk prediction.",
                "Anemia does not directly indicate sepsis."
            ],
            "alignment_scores": [
                0.7,
                0.7,
                0.7,
                0.7,
                0.2
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)",
                "High qSOFA Score (\u22652)",
                "High qSOFA Score (\u22652)",
                "SIRS Positivity (\u22652 Criteria)",
                "SOFA Score Increase (\u22652 points)"
            ],
            "alignment_reasonings": [
                "An elevated heart rate (>90 bpm) is explicitly stated as one of the criteria for SIRS, which is used to identify systemic inflammation consistent with early sepsis. Although the claim does not provide specific heart rate values to confirm meeting the threshold, the mention of elevated heart rate aligns with the concept of SIRS criteria and thus directly relates to potential sepsis. This warrants a strong but not perfect alignment rating.",
                "An elevated respiratory rate is a component of the qSOFA score, which helps identify patients at high risk of sepsis-related deterioration. While the exact respiratory rate isn't provided, the claim implies potential alignment with the qSOFA criteria of a respiratory rate \u226522/min. However, since not all components of the qSOFA score are discussed, the alignment is strong but not perfect.",
                "The claim about an elevated respiratory rate aligns with the High qSOFA Score category, as a respiratory rate\u202f\u2265\u202f22\u202f/min is part of the qSOFA criteria that flags potential sepsis-related risk. However, since the claim does not specify the respiratory rate as being \u2265\u202f22\u202f/min, it does not fulfill the criteria entirely, hence a moderate alignment rating.",
                "The claim discusses elevated heart rate and respiratory rate, both of which are components of the SIRS criteria. While the claim suggests that these alone are not sufficient for a high sepsis risk prediction, they directly relate to the category's criteria for identifying systemic inflammation as indicative of early sepsis. However, because the claim implies that these indicators alone are insufficient for high risk, the alignment is not perfect, hence the rating of 0.7.",
                "Anemia itself is not a direct indicator of sepsis or any particular category here. However, anemia can be related to decreased hemoglobin, which may indirectly link to tissue hypoperfusion and organ dysfunction concepts. The alignment is tenuous and indirect, reflected in a low alignment rating."
            ],
            "final_alignment_score": 0.6
        },
        {
            "input": "4: HR, 65.0; 4: RR, 16.0; 4: SpO2, 99.0; 4: SBP, 108.0; 4: DBP, 54.0; 4: MAP, 72.0; 4: Pain, 0.0; 4: Temp, 101.1; 15: SpO2, 97.0; 16: SpO2, 96.797; 16: Perf, 3.364; 17: SpO2, 96.5; 17: Perf, 4.262; 18: SpO2, 97.424; 18: Perf, 4.689; 18: SBP, 107.0; 18: DBP, 60.0; 18: MAP, 75.667; 19: SpO2, 96.169; 19: Perf, 6.684; 20: SpO2, 95.845; 20: Perf, 6.728; 21: SpO2, 95.847; 21: Perf, 5.936; 22: SpO2, 95.897; 22: Perf, 6.207; 23: SpO2, 96.0; 23: Perf, 5.800; 24: SpO2, 95.763; 24: Perf, 5.422; 25: SpO2, 95.879; 25: Perf, 4.448; 26: SpO2, 96.881; 26: Perf, 3.318; 27: SpO2, 96.897; 27: Perf, 3.804; 28: SpO2, 96.373; 28: Perf, 4.445; 29: SpO2, 96.153; 29: Perf, 4.615; 30: SpO2, 96.362; 30: Perf, 4.2; 31: SpO2, 96.119; 31: Perf, 4.233; 32: SpO2, 96.155; 32: Perf, 2.824; 33: SpO2, 96.797; 33: Perf, 2.251; 34: SpO2, 96.864; 34: Perf, 2.579; 35: SpO2, 96.879; 35: Perf, 2.442; 36: SpO2, 96.661; 36: Perf, 3.264; 37: SpO2, 96.207; 37: Perf, 3.824; 38: SpO2, 95.831; 38: Perf, 4.185; 39: SpO2, 97.068; 39: Perf, 4.148; 40: SpO2, 96.707; 40: Perf, 4.992; 41: HR, 66.0; 41: SpO2, 96.322; 41: Perf, 2.957; 41: SBP, 105.0; 41: DBP, 60.0; 41: MAP, 75.0; 42: SpO2, 96.793; 42: Perf, 2.268; 42: SBP, 105.0; 42: DBP, 60.0; 42: MAP, 75.0; 43: SpO2, 95.983; 43: Perf, 2.158; 44: SpO2, 96.276; 44: Perf, 1.960; 45: SpO2, 95.864; 45: Perf, 2.225; 46: SpO2, 96.085; 46: Perf, 2.727; 47: SpO2, 96.052; 47: Perf, 2.607; 48: SpO2, 95.712; 48: Perf, 2.585; 49: SpO2, 96.552; 49: Perf, 2.895; 50: SpO2, 97.0; 50: Perf, 3.872; 51: POC PH (V) ISTAT, 7.43; 51: POC LACTATE ISTAT, 1.50 mmol/L; 51: POC TCO2 (V) ISTAT, 28 mmol/L; 51: POC BASE EXCESS ISTAT, 2 mmol/L; 51: POC PO2 (V) ISTAT, 33 mmHg; 51: POC HCO3 (V) ISTAT, 26.7 mmol/L; 51: POC PCO2 (V) ISTAT, 40.1 mmHg; 51: POC O2 SATURATION ISTAT VENOUS, 65 %; 51: SpO2, 96.119; 51: Perf, 4.245; 52: SpO2, 95.379; 52: Perf, 4.339; 53: SpO2, 95.203; 53: Perf, 4.983; 54: SpO2, 95.414; 54: Perf, 4.544; 55: SpO2, 95.339; 55: Perf, 3.686; 56: SpO2, 95.492; 56: Perf, 2.525; 57: SpO2, 95.690; 57: Perf, 2.330; 58: SpO2, 96.322; 58: Perf, 2.288; 59: SpO2, 96.879; 59: Perf, 2.320; 60: SpO2, 96.576; 60: Perf, 2.423; 61: SpO2, 96.271; 61: Perf, 2.796; 62: SpO2, 96.603; 62: Perf, 2.776; 63: SpO2, 96.322; 63: Perf, 2.685; 64: SpO2, 96.569; 64: Perf, 2.665; 65: HR, 68.0; 65: RR, 18.0; 65: SpO2, 97.034; 65: Perf, 2.549; 65: Pain, 0.0; 65: Temp, 98.8; 66: SpO2, 96.153; 66: Perf, 3.064; 67: SpO2, 96.0; 67: Perf, 3.010; 68: SpO2, 96.0; 68: Perf, 3.140; 69: SpO2, 95.862; 69: Perf, 2.665; 70: SpO2, 96.017; 70: Perf, 2.534; 71: SpO2, 96.373; 71: Perf, 2.460; 72: SpO2, 95.724; 72: Perf, 2.733; 73: SpO2, 96.5; 73: Perf, 2.844; 74: SpO2, 97.475; 74: Perf, 2.574; 75: SpO2, 97.339; 75: Perf, 3.392; 76: SpO2, 96.776; 76: Perf, 3.584; 77: SpO2, 96.017; 77: Perf, 3.487; 78: SpO2, 96.102; 78: Perf, 3.156; 79: SpO2, 96.897; 79: Perf, 2.657; 80: SpO2, 97.356; 80: Perf, 1.940; 81: SpO2, 96.931; 81: Perf, 2.155; 82: SpO2, 97.254; 82: Perf, 3.481; 83: SpO2, 97.0; 83: Perf, 3.891; 84: SpO2, 96.948; 84: Perf, 4.301; 85: SpO2, 96.746; 85: Perf, 4.189; 86: SpO2, 96.879; 86: Perf, 4.32; 87: SpO2, 97.0; 87: Perf, 3.467; 88: SpO2, 97.0; 88: Perf, 3.842; 89: SpO2, 96.586; 89: Perf, 4.186; 90: SpO2, 97.288; 90: Perf, 2.210; 91: SpO2, 97.414; 91: Perf, 2.020; 92: SpO2, 97.627; 92: Perf, 2.045; 93: SpO2, 97.586; 93: Perf, 2.665; 94: SpO2, 97.102; 94: Perf, 2.485; 95: SpO2, 97.169; 95: Perf, 2.391; 96: SpO2, 97.741; 96: Perf, 1.804; 97: SpO2, 98.458; 97: Perf, 1.764; 98: INR, 1.3; 98: PROTHROMBIN TIME, 16.2 seconds; 98: SpO2, 97.724; 98: Perf, 1.940; 99: PART. THROMBOPLASTIN TIME, 40.6 seconds; 99: SpO2, 97.475; 99: Perf, 2.127; 100: SpO2, 97.220; 100: Perf, 2.529; 101: SpO2, 97.466; 101: Perf, 2.502; 102: SpO2, 98.0; 102: Perf, 2.511; 102: SBP, 102.0; 102: DBP, 60.0; 102: MAP, 74.0; 103: SpO2, 98.259; 103: Perf, 2.868; 104: SpO2, 97.237; 104: Perf, 3.350; 105: SpO2, 97.339; 105: Perf, 2.797; 106: SpO2, 97.138; 106: Perf, 2.413; 107: SpO2, 97.339; 107: Perf, 1.779; 108: SpO2, 97.172; 108: Perf, 2.104; 109: SpO2, 96.949; 109: Perf, 2.225; 110: SpO2, 97.169; 110: Perf, 1.982; 111: SpO2, 96.845; 111: Perf, 2.225; 112: ALKALINE PHOSPHATASE, 83 U/L; 112: GLUCOSE, 98 mg/dL; 112: POTASSIUM, 3.9 mmol/L; 112: BLOOD UREA NITROGEN (BUN), 14 mg/dL; 112: CHLORIDE, 103 mmol/L; 112: CALCIUM, 9.1 mg/dL; 112: EGFR FOR AFRICAN AMERICAN, 102 mL/min/1.73 m2; 112: ALBUMIN, 3.9 g/dL; 112: ALT (SGPT), 30 U/L; 112: EGFR REFIT WITHOUT RACE (2021), 88 mL/min/1.73 m2; 112: CORRECTED CALCIUM, 9.2 mg/dL; 112: GLOBULIN, 2.9 g/dL; 112: BILIRUBIN TOTAL, 0.8 mg/dL; 112: CO2, 25 mmol/L; 112: ANION GAP, 10 mmol/L; 112: PROTEIN TOTAL, 6.8 g/dL; 112: SODIUM, 138 mmol/L; 112: CREATININE, 0.97 mg/dL; 112: AST (SGOT), 37 U/L; 112: SpO2, 97.271; 112: Perf, 2.201; 113: SpO2, 97.069; 113: Perf, 2.263; 114: SpO2, 97.441; 114: Perf, 2.106; 115: SpO2, 97.153; 115: Perf, 2.087; 116: SpO2, 97.638; 116: Perf, 1.803; 117: SpO2, 97.712; 117: Perf, 2.006; 118: SpO2, 97.621; 118: Perf, 3.632; 119: SpO2, 96.831; 119: Perf, 2.841; 0: Age, 52; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 38.4; 0: Triage HR, 65.0; 0: Triage RR, 16.0; 0: Triage SBP, 108.0; 0: Triage DBP, 54.0; 0: Triage acuity, 3-Urgent; 0: CC, FEVER",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "Examination of the time series data shows relatively stable vital signs, with no significant abnormalities in heart rate, respiratory rate, blood pressure, oxygen saturation, or temperature that would indicate a high risk of developing sepsis. The patient's lactate levels are within normal range, suggesting adequate tissue perfusion. Additionally, no signs of organ dysfunction are suggestive of impending sepsis, leading to a conclusion of low sepsis risk within the next 12 hours.",
            "claims": [
                "Examination of the time series data shows relatively stable vital signs.",
                "There are no significant abnormalities in heart rate.",
                "There are no significant abnormalities in respiratory rate.",
                "There are no significant abnormalities in blood pressure.",
                "There are no significant abnormalities in oxygen saturation.",
                "There are no significant abnormalities in temperature.",
                "The normal vital signs indicate a low risk of developing sepsis.",
                "The patient's lactate levels are within normal range.",
                "Normal lactate levels suggest adequate tissue perfusion.",
                "There are no signs of organ dysfunction.",
                "The absence of organ dysfunction suggests a low risk of impending sepsis.",
                "The overall conclusion is a low sepsis risk within the next 12 hours."
            ],
            "relevant_claims": [
                "The normal vital signs indicate a low risk of developing sepsis."
            ],
            "alignment_scores": [
                0.8
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "The assertion about normal vital signs closely aligns with the NEWS score, which is derived from assessing deranged vital signs. Although the claim does not explicitly state the NEWS score, it implies a low value (under 5 points) due to normal vitals, indicating a lower sepsis risk. This indirect connection warrants a high alignment rating."
            ],
            "final_alignment_score": 0.8
        },
        {
            "input": "2: HR, 84.0; 2: RR, 24.0; 2: SpO2, 100.0; 2: SBP, 143.0; 2: DBP, 55.0; 2: MAP, 84.333; 2: Temp, 97.2; 80: HR, 94.548; 80: RR, 31.238; 80: 1min HRV, 56.958; 80: SBP, 148.0; 80: DBP, 61.0; 80: MAP, 90.0; 81: HR, 90.729; 81: RR, 33.898; 81: SpO2, 97.882; 81: 1min HRV, 103.265; 82: HR, 90.517; 82: RR, 30.293; 82: SpO2, 97.259; 82: Perf, 0.19; 82: 1min HRV, 62.996; 82: 5min HRV, 79.552; 82: SBP, 145.0; 82: DBP, 74.0; 82: MAP, 97.667; 83: HR, 89.898; 83: RR, 24.949; 83: SpO2, 98.316; 83: Perf, 0.153; 83: 1min HRV, 117.529; 83: SBP, 145.0; 83: DBP, 74.0; 83: MAP, 97.667; 84: HR, 90.914; 84: RR, 27.017; 84: SpO2, 98.941; 84: Perf, 0.186; 84: 1min HRV, 40.962; 85: HR, 90.729; 85: RR, 24.831; 85: SpO2, 98.957; 85: Perf, 0.170; 85: 1min HRV, 93.212; 86: HR, 92.017; 86: RR, 35.576; 86: SpO2, 99.842; 86: Perf, 0.17; 86: 1min HRV, 106.341; 87: HR, 90.569; 87: RR, 31.672; 87: SpO2, 98.661; 87: Perf, 0.17; 87: 1min HRV, 77.268; 87: 5min HRV, 90.692; 88: HR, 90.712; 88: RR, 29.339; 88: SpO2, 97.970; 88: Perf, 0.166; 88: 1min HRV, 39.251; 89: HR, 88.483; 89: RR, 30.345; 89: SpO2, 98.3; 89: Perf, 0.160; 89: 1min HRV, 59.194; 90: HR, 87.559; 90: RR, 32.051; 90: SpO2, 98.788; 90: Perf, 0.152; 90: 1min HRV, 83.922; 91: HR, 87.052; 91: RR, 28.690; 91: SpO2, 98.783; 91: Perf, 0.181; 91: 1min HRV, 16.064; 92: HR, 87.356; 92: RR, 25.373; 92: SpO2, 98.952; 92: Perf, 0.177; 92: 1min HRV, 32.678; 92: 5min HRV, 52.812; 93: HR, 88.407; 93: RR, 26.610; 93: SpO2, 98.837; 93: Perf, 0.163; 93: 1min HRV, 63.430; 94: HR, 87.483; 94: RR, 30.086; 94: SpO2, 99.463; 94: Perf, 0.168; 94: 1min HRV, 49.410; 95: HR, 87.153; 95: RR, 30.525; 95: SpO2, 98.5; 95: Perf, 0.163; 95: 1min HRV, 68.312; 96: HR, 88.203; 96: RR, 28.644; 96: SpO2, 98.310; 96: Perf, 0.16; 96: 1min HRV, 62.534; 97: HR, 89.052; 97: RR, 31.224; 97: SpO2, 99.0; 97: Perf, 0.16; 97: 1min HRV, 45.705; 97: 5min HRV, 58.445; 98: HR, 92.508; 98: RR, 31.339; 98: SpO2, 98.955; 98: Perf, 0.154; 98: 1min HRV, 58.106; 99: HR, 90.155; 99: RR, 30.672; 99: SpO2, 99.111; 99: Perf, 0.181; 99: 1min HRV, 72.588; 100: HR, 89.034; 100: RR, 29.610; 100: SpO2, 99.0; 100: Perf, 0.181; 100: 1min HRV, 74.885; 101: HR, 88.649; 101: RR, 27.345; 101: Perf, 0.18; 101: 1min HRV, 82.167; 102: HR, 86.345; 102: RR, 27.931; 102: 1min HRV, 85.908; 102: 5min HRV, 76.514; 103: HR, 84.678; 103: RR, 27.695; 103: SpO2, 98.889; 103: 1min HRV, 99.837; 104: HR, 86.576; 104: RR, 28.983; 104: SpO2, 95.444; 104: 1min HRV, 63.969; 105: HR, 84.949; 105: RR, 28.441; 105: SpO2, 98.944; 105: Perf, 0.18; 105: 1min HRV, 91.749; 106: HR, 84.508; 106: RR, 28.051; 106: SpO2, 98.429; 106: Perf, 0.18; 106: 1min HRV, 95.686; 107: HR, 84.759; 107: RR, 27.293; 107: SpO2, 97.095; 107: Perf, 0.171; 107: 1min HRV, 90.017; 107: 5min HRV, 89.852; 108: HR, 86.627; 108: RR, 28.305; 108: SpO2, 99.1; 108: Perf, 0.17; 108: 1min HRV, 9.485; 109: HR, 87.224; 109: RR, 27.241; 109: SpO2, 98.0; 109: Perf, 0.17; 109: 1min HRV, 47.279; 110: HR, 88.847; 110: RR, 26.644; 110: SpO2, 96.938; 110: Perf, 0.177; 110: 1min HRV, 95.307; 111: HR, 85.593; 111: RR, 28.102; 111: SpO2, 97.339; 111: Perf, 0.196; 111: 1min HRV, 28.518; 112: HR, 85.931; 112: RR, 27.5; 112: SpO2, 98.245; 112: Perf, 0.21; 112: 1min HRV, 34.042; 112: 5min HRV, 52.342; 113: HR, 84.814; 113: RR, 27.508; 113: SpO2, 98.389; 113: Perf, 0.208; 113: 1min HRV, 53.801; 114: HR, 87.328; 114: RR, 25.897; 114: SpO2, 99.2; 114: Perf, 0.17; 114: 1min HRV, 13.145; 115: HR, 86.102; 115: RR, 26.559; 115: SpO2, 98.188; 115: Perf, 0.18; 115: 1min HRV, 11.984; 116: HR, 86.569; 116: RR, 29.0; 116: SpO2, 97.333; 116: Perf, 0.19; 116: 1min HRV, 7.712; 117: HR, 86.085; 117: RR, 27.458; 117: SpO2, 98.857; 117: Perf, 0.174; 117: 1min HRV, 48.261; 117: 5min HRV, 33.786; 118: HR, 85.559; 118: RR, 27.322; 118: SpO2, 98.462; 118: Perf, 0.17; 118: 1min HRV, 13.360; 119: HR, 86.897; 119: RR, 28.741; 119: SpO2, 99.0; 119: Perf, 0.17; 119: 1min HRV, 48.790; 0: Age, 85; 0: Gender, F; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.2; 0: Triage HR, 84.0; 0: Triage RR, 24.0; 0: Triage SBP, 143.0; 0: Triage DBP, 55.0; 0: Triage acuity, 3-Urgent; 0: CC, ABDOMINAL PAIN",
            "answer": true,
            "llm_answer": "No",
            "llm_explanation": "The patient's vital signs demonstrate consistent blood pressure and heart rate, normal oxygen saturation, and a steadily high respiratory rate. Despite the elevated respiratory rate, other indicators such as temperature, MAP, and HRV variations remain within a stable range. While these signs warrant monitoring, they do not collectively indicate a high risk of sepsis within the next 12 hours, supporting the \"No\" label for high-risk prediction.",
            "claims": [
                "The patient's vital signs demonstrate consistent blood pressure and heart rate.",
                "The patient has normal oxygen saturation.",
                "The patient has a steadily high respiratory rate.",
                "Despite the elevated respiratory rate, other indicators such as temperature, MAP, and HRV variations remain within a stable range.",
                "The signs warrant monitoring.",
                "The signs do not collectively indicate a high risk of sepsis within the next 12 hours.",
                "The evaluation supports the \"No\" label for high-risk prediction."
            ],
            "relevant_claims": [
                "The signs do not collectively indicate a high risk of sepsis within the next 12 hours."
            ],
            "alignment_scores": [
                0.3
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)"
            ],
            "alignment_reasonings": [
                "The claim suggests an overall low risk of sepsis, indicating that the criteria for identifying early sepsis, such as SIRS or other related categories, are not collectively met. Since SIRS criteria are often a basis for early recognition of sepsis, the lack of collective indicators is slightly aligned with low SIRS positivity, but not specific to any single category. Hence, a low alignment rating is warranted."
            ],
            "final_alignment_score": 0.3
        },
        {
            "input": "2: HR, 100.0; 2: RR, 18.0; 2: SpO2, 100.0; 2: SBP, 129.0; 2: DBP, 90.0; 2: MAP, 103.0; 2: Temp, 97.5; 32: POC, HCG, ISTAT QUALITATIVE: Negative; 32: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 42: SpO2, 100.0; 42: SBP, 121.0; 42: DBP, 84.0; 42: MAP, 96.333; 43: SpO2, 100.0; 43: Perf, 1.407; 44: SpO2, 100.0; 44: Perf, 1.549; 45: SpO2, 99.949; 45: Perf, 1.471; 45: SBP, 139.0; 45: DBP, 90.0; 45: MAP, 106.333; 46: SpO2, 100.0; 46: Perf, 1.485; 47: SpO2, 100.0; 47: Perf, 1.395; 48: SpO2, 100.0; 48: Perf, 1.493; 49: SpO2, 100.0; 49: Perf, 1.580; 50: SpO2, 100.0; 50: Perf, 1.320; 51: SpO2, 100.0; 51: Perf, 1.367; 52: SpO2, 100.0; 52: Perf, 1.446; 53: SpO2, 100.0; 53: Perf, 1.679; 54: SpO2, 100.0; 54: Perf, 1.779; 55: SpO2, 100.0; 55: Perf, 1.764; 56: SpO2, 99.845; 56: Perf, 1.48; 57: SpO2, 100.0; 57: Perf, 1.282; 58: SpO2, 100.0; 58: Perf, 1.390; 59: SpO2, 100.0; 59: Perf, 1.111; 60: SpO2, 100.0; 60: Perf, 1.357; 60: SBP, 148.0; 60: DBP, 91.0; 60: MAP, 110.0; 61: SpO2, 99.759; 61: Perf, 1.514; 62: SpO2, 99.915; 62: Perf, 1.576; 63: SpO2, 99.898; 63: Perf, 1.522; 64: SpO2, 99.914; 64: Perf, 1.142; 65: SpO2, 99.763; 65: Perf, 1.102; 66: WAM DIFTYP, AUTO; 66: BASOPHIL % (AUTO DIFF), 0.5 %; 66: MONOCYTE ABSOLUTE (AUTO DIFF), 0.38 K/uL; 66: HEMATOCRIT (HCT), 32.5 %; 66: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 66: RED CELL DISTRIBUTION WIDTH (RDW), 14.7 %; 66: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.5 pg; 66: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.37 K/uL; 66: NEUTROPHIL ABSOLUTE (AUTO DIFF), 6.03 K/uL; 66: MONOCYTE % (AUTO DIFF), 4.6 %; 66: RED BLOOD CELLS (RBC), 3.38 MIL/uL; 66: EOSINOPHIL % (AUTO DIFF), 4.7 %; 66: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 66: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.39 K/uL; 66: MEAN CORPUSCULAR VOLUME (MCV), 96.2 fL; 66: WHITE BLOOD CELLS (WBC), 8.3 K/uL; 66: LYMPHOCYTE % (AUTO DIFF), 16.6 %; 66: PLATELET COUNT (PLT), 349 K/uL; 66: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 66: NRBC PERCENT (HEMATOLOGY), 0.0 %; 66: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.6 %; 66: HEMOGLOBIN (HGB), 10.3 g/dL; 66: NEUTROPHIL % (AUTO DIFF), 73.0 %; 66: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.7 g/dL; 66: SpO2, 100.0; 66: Perf, 1.377; 67: SpO2, 99.898; 67: Perf, 1.314; 68: SpO2, 99.864; 68: Perf, 1.382; 69: SpO2, 99.293; 69: Perf, 1.647; 70: SpO2, 99.864; 70: Perf, 1.749; 71: SpO2, 99.897; 71: Perf, 1.719; 72: SpO2, 100.0; 72: Perf, 1.875; 73: SpO2, 100.0; 73: Perf, 2.066; 74: SpO2, 99.828; 74: Perf, 1.824; 75: SpO2, 100.0; 75: Perf, 1.525; 75: SBP, 145.0; 75: DBP, 94.0; 75: MAP, 111.0; 76: SpO2, 100.0; 76: Perf, 1.591; 77: SpO2, 98.949; 77: Perf, 1.554; 78: SpO2, 99.793; 78: Perf, 1.474; 79: SpO2, 100.0; 79: Perf, 1.346; 80: SpO2, 100.0; 80: Perf, 1.755; 81: SpO2, 99.914; 81: Perf, 1.211; 82: SARS-COV-2 RNA, Not Detected; 82: SpO2, 100.0; 82: Perf, 1.267; 83: SpO2, 99.879; 83: Perf, 1.263; 84: SpO2, 99.983; 84: Perf, 1.283; 85: SpO2, 100.0; 85: Perf, 1.625; 86: SpO2, 99.914; 86: Perf, 1.966; 87: SpO2, 100.0; 87: Perf, 1.905; 88: SpO2, 100.0; 88: Perf, 1.642; 89: SpO2, 100.0; 89: Perf, 1.408; 90: SpO2, 100.0; 90: Perf, 1.682; 90: SBP, 156.0; 90: DBP, 109.0; 90: MAP, 124.667; 91: SpO2, 100.0; 91: Perf, 1.419; 92: SpO2, 99.932; 92: Perf, 1.327; 93: SpO2, 99.828; 93: Perf, 1.536; 94: SpO2, 100.0; 94: Perf, 1.546; 95: SpO2, 99.525; 95: Perf, 1.69; 96: SpO2, 99.293; 96: Perf, 1.753; 97: SpO2, 100.0; 97: Perf, 1.554; 98: SpO2, 100.0; 98: Perf, 1.802; 99: SpO2, 100.0; 99: Perf, 1.849; 100: SpO2, 99.390; 100: Perf, 1.844; 101: SpO2, 99.897; 101: Perf, 1.603; 102: SpO2, 100.0; 102: Perf, 1.579; 103: SpO2, 99.897; 103: Perf, 1.589; 104: SpO2, 100.0; 104: Perf, 1.547; 105: SpO2, 100.0; 105: Perf, 1.587; 105: SBP, 168.0; 105: DBP, 155.0; 105: MAP, 159.333; 106: SpO2, 100.0; 106: Perf, 1.513; 107: SpO2, 100.0; 107: Perf, 1.597; 107: SBP, 149.0; 107: DBP, 98.0; 107: MAP, 115.0; 108: SpO2, 100.0; 108: Perf, 1.563; 109: SpO2, 100.0; 109: Perf, 1.600; 110: SpO2, 99.845; 110: Perf, 1.718; 111: SpO2, 100.0; 111: Perf, 1.665; 112: SpO2, 100.0; 112: Perf, 1.813; 113: SpO2, 99.931; 113: Perf, 1.657; 114: SpO2, 100.0; 114: Perf, 1.736; 115: SpO2, 99.793; 115: Perf, 1.530; 116: ALKALINE PHOSPHATASE, 72 U/L; 116: CORRECTED CALCIUM, 8.5 mg/dL; 116: BILIRUBIN TOTAL, 0.2 mg/dL; 116: EGFR REFIT WITHOUT RACE (2021), 63 mL/min/1.73 m2; 116: ALT (SGPT), 6 U/L; 116: PROTEIN TOTAL, 7.0 g/dL; 116: CO2, 18 mmol/L; 116: CHLORIDE, 102 mmol/L; 116: SODIUM, 136 mmol/L; 116: GLOBULIN, 3.1 g/dL; 116: AST (SGOT), 12 U/L; 116: GLUCOSE, 237 mg/dL; 116: ALBUMIN, 3.9 g/dL; 116: POTASSIUM, 4.3 mmol/L; 116: CALCIUM, 8.4 mg/dL; 116: BLOOD UREA NITROGEN (BUN), 15 mg/dL; 116: LIPASE, 16 U/L; 116: ANION GAP, 16 mmol/L; 116: EGFR FOR AFRICAN AMERICAN, 73 mL/min/1.73 m2; 116: CREATININE, 1.05 mg/dL; 116: SpO2, 100.0; 116: Perf, 2.034; 117: SpO2, 100.0; 117: Perf, 1.921; 118: SpO2, 99.897; 118: Perf, 1.865; 119: SpO2, 99.932; 119: Perf, 1.826; 0: Age, 47; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.4; 0: Triage HR, 100.0; 0: Triage RR, 18.0; 0: Triage SBP, 129.0; 0: Triage DBP, 90.0; 0: Triage acuity, 3-Urgent; 0: CC, ABDOMINAL PAIN",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The patient's vital signs, such as heart rate, blood pressure, and respiratory rate, remain within normal ranges and show no significant alarming trends over time. The perfusion and oxygen saturation (SpO2) levels are consistently high, indicating adequate oxygen delivery. Lab results do not reveal critical abnormalities that would suggest a significant risk for sepsis. The patient is stable, and there are no clinical indicators of imminent deterioration pointing towards sepsis.",
            "claims": [
                "The patient's vital signs remain within normal ranges.",
                "The patient's heart rate is within normal ranges.",
                "The patient's blood pressure is within normal ranges.",
                "The patient's respiratory rate is within normal ranges.",
                "There are no significant alarming trends in the patient's vital signs over time.",
                "The perfusion levels are consistently high.",
                "The oxygen saturation (SpO2) levels are consistently high.",
                "Consistently high perfusion and oxygen saturation levels indicate adequate oxygen delivery.",
                "Lab results do not reveal critical abnormalities.",
                "There are no lab results suggesting a significant risk for sepsis.",
                "The patient is stable.",
                "There are no clinical indicators of imminent deterioration pointing towards sepsis."
            ],
            "relevant_claims": [
                "Consistently high perfusion and oxygen saturation levels indicate adequate oxygen delivery."
            ],
            "alignment_scores": [
                0.3
            ],
            "alignment_category": [
                "SOFA Score Increase (\u22652 points)"
            ],
            "alignment_reasonings": [
                "The claim about high perfusion and oxygen saturation suggests adequate oxygen delivery, which indirectly relates to one component of the SOFA score involving organ function and oxygenation (PaO\u2082/FiO\u2082). However, it does not directly indicate a new organ dysfunction or an increase in SOFA score, leading to a low alignment rating."
            ],
            "final_alignment_score": 0.3
        },
        {
            "input": "5: HR, 108.0; 5: RR, 18.0; 5: SpO2, 95.0; 5: SBP, 150.0; 5: DBP, 70.0; 5: MAP, 96.667; 5: Temp, 100.6; 47: POC PH (V) ISTAT, 7.41; 47: POC PO2 (V) ISTAT, 14 mmHg; 47: POC HCO3 (V) ISTAT, 28.3 mmol/L; 47: POC O2 SATURATION ISTAT VENOUS, 18 %; 47: POC LACTATE ISTAT, 0.82 mmol/L; 47: POC TCO2 (V) ISTAT, 30 mmol/L; 47: POC PCO2 (V) ISTAT, 44.7 mmHg; 47: POC BASE EXCESS ISTAT, 4 mmol/L; 69: SpO2, 95.082; 69: Perf, 6.772; 70: SpO2, 95.159; 70: Perf, 7.448; 70: SBP, 126.0; 70: DBP, 55.0; 70: MAP, 78.667; 72: HR, 92.64; 72: RR, 27.7; 72: 1min HRV, 57.204; 73: HR, 92.593; 73: RR, 24.898; 73: 1min HRV, 53.127; 74: HR, 93.281; 74: RR, 22.719; 74: SpO2, 96.0; 74: 1min HRV, 43.048; 74: 5min HRV, 50.360; 74: SBP, 126.0; 74: DBP, 55.0; 74: MAP, 78.667; 74: Pain, 0.0; 74: Temp, 100.0; 75: WAM DIFTYP, AUTO; 75: LYMPHOCYTE % (AUTO DIFF), 8.1 %; 75: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 26.2 pg; 75: RED BLOOD CELLS (RBC), 4.61 MIL/uL; 75: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.32 K/uL; 75: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.08 K/uL; 75: MEAN CORPUSCULAR VOLUME (MCV), 85.2 fL; 75: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 75: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 75: MONOCYTE % (AUTO DIFF), 6.6 %; 75: HEMOGLOBIN (HGB), 12.1 g/dL; 75: BASOPHIL % (AUTO DIFF), 0.3 %; 75: RED CELL DISTRIBUTION WIDTH (RDW), 14.9 %; 75: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 30.8 g/dL; 75: NEUTROPHIL ABSOLUTE (AUTO DIFF), 13.50 K/uL; 75: HEMATOCRIT (HCT), 39.3 %; 75: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.24 K/uL; 75: MONOCYTE ABSOLUTE (AUTO DIFF), 1.08 K/uL; 75: NRBC PERCENT (HEMATOLOGY), 0.0 %; 75: WHITE BLOOD CELLS (WBC), 16.3 K/uL; 75: PLATELET COUNT (PLT), 277 K/uL; 75: EOSINOPHIL % (AUTO DIFF), 1.5 %; 75: BASOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 75: NEUTROPHIL % (AUTO DIFF), 83.0 %; 75: HR, 93.356; 75: RR, 27.746; 75: 1min HRV, 40.677; 76: HR, 91.914; 76: RR, 27.259; 76: 1min HRV, 8.585; 77: HR, 92.525; 77: RR, 27.780; 77: 1min HRV, 6.611; 78: HR, 92.661; 78: RR, 29.102; 78: 1min HRV, 7.071; 79: HR, 92.579; 79: RR, 27.789; 79: 1min HRV, 9.463; 79: 5min HRV, 19.702; 80: HR, 91.949; 80: RR, 27.085; 80: 1min HRV, 5.027; 81: HR, 91.138; 81: RR, 26.931; 81: 1min HRV, 4.219; 82: HR, 91.373; 82: RR, 27.576; 82: 1min HRV, 6.705; 83: HR, 92.158; 83: RR, 25.351; 83: 1min HRV, 9.338; 84: HR, 90.492; 84: RR, 25.271; 84: SpO2, 97.0; 84: 1min HRV, 9.232; 84: 5min HRV, 8.128; 84: SBP, 118.0; 84: DBP, 55.0; 84: MAP, 76.0; 85: HR, 90.085; 85: RR, 26.864; 85: 1min HRV, 59.939; 85: SBP, 118.0; 85: DBP, 55.0; 85: MAP, 76.0; 86: HR, 91.509; 86: RR, 27.386; 86: 1min HRV, 5.108; 87: HR, 90.017; 87: RR, 27.034; 87: 1min HRV, 10.785; 88: HR, 91.276; 88: RR, 27.017; 88: 1min HRV, 6.485; 89: HR, 90.034; 89: RR, 27.254; 89: 1min HRV, 41.373; 89: 5min HRV, 33.336; 90: HR, 90.949; 90: RR, 27.254; 90: 1min HRV, 7.295; 91: HR, 91.684; 91: RR, 28.228; 91: 1min HRV, 38.357; 92: HR, 90.593; 92: RR, 27.661; 92: 1min HRV, 14.779; 92: CEFEPIME, 2 GRAM/20 ML IV PUSH; 93: HR:, 91.034; 93: RR, 28.259; 93: 1min HRV, 5.225; 94: HR, 91.203; 94: RR, 27.831; 94: 1min HRV, 33.017; 94: 5min HRV, 24.101; 95: HR, 90.175; 95: RR, 28.053; 95: 1min HRV, 4.054; 96: HR, 90.085; 96: RR, 28.119; 96: 1min HRV, 9.153; 97: HR, 89.254; 97: RR, 28.356; 97: 1min HRV, 40.998; 98: HR, 91.983; 98: RR, 19.879; 98: 1min HRV, 13.356; 99: HR, 92.328; 99: RR, 25.224; 99: 1min HRV, 19.558; 99: 5min HRV, 23.573; 100: HR, 95.119; 100: RR, 19.356; 100: 1min HRV, 38.958; 100: SBP, 118.0; 100: DBP, 55.0; 100: MAP, 76.0; 100: LR IV BOLUS -, 1000 ML; 101: HR:, 92.828; 101: RR, 24.724; 101: 1min HRV, 7.677; 102: CO2, 27 mmol/L; 102: AST (SGOT), 20 U/L; 102: ALT (SGPT), 21 U/L; 102: CORRECTED CALCIUM, 9.8 mg/dL; 102: EGFR REFIT WITHOUT RACE (2021), 57 mL/min/1.73 m2; 102: CREATININE, 1.37 mg/dL; 102: SODIUM, 138 mmol/L; 102: BLOOD UREA NITROGEN (BUN), 20 mg/dL; 102: ANION GAP, 9 mmol/L; 102: GLUCOSE, 143 mg/dL; 102: GLOBULIN, 3.3 g/dL; 102: BILIRUBIN TOTAL, 0.2 mg/dL; 102: CALCIUM, 9.8 mg/dL; 102: ALBUMIN, 4.0 g/dL; 102: PROTEIN TOTAL, 7.3 g/dL; 102: ALKALINE PHOSPHATASE, 96 U/L; 102: POTASSIUM, 4.0 mmol/L; 102: CHLORIDE, 102 mmol/L; 102: HR, 92.780; 102: RR, 22.237; 102: 1min HRV, 7.634; 103: HR, 93.121; 103: RR, 23.086; 103: 1min HRV, 57.319; 104: HR, 91.729; 104: RR, 24.271; 104: 1min HRV, 9.637; 104: 5min HRV, 32.482; 105: HR, 92.414; 105: RR, 22.241; 105: 1min HRV, 3.310; 106: HR, 92.847; 106: RR, 23.424; 106: 1min HRV, 15.807; 107: HR, 92.845; 107: RR, 25.362; 107: 1min HRV, 9.563; 108: HR, 91.259; 108: RR, 25.034; 108: 1min HRV, 7.513; 109: INR, 1.2; 109: PART. THROMBOPLASTIN TIME, 30.9 seconds; 109: PROTHROMBIN TIME, 15.8 seconds; 109: HR, 90.627; 109: RR, 25.949; 109: 1min HRV, 7.505; 109: 5min HRV, 11.746; 110: HR, 94.879; 110: RR, 24.690; 110: 1min HRV, 19.871; 111: HR, 93.345; 111: RR, 28.793; 111: 1min HRV, 45.103; 112: HR, 91.661; 112: RR, 25.695; 112: 1min HRV, 6.633; 113: HR, 90.293; 113: RR, 25.155; 113: 1min HRV, 45.384; 114: HR, 89.881; 114: RR, 26.780; 114: 1min HRV, 42.987; 114: 5min HRV, 38.858; 115: HR, 89.789; 115: RR, 26.123; 115: 1min HRV, 8.617; 116: HR, 88.0; 116: RR, 28.0; 119: SARS-COV-2 RNA, Not Detected; 119: 5min HRV, 8.617; 0: Age, 65; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 38.1; 0: Triage HR, 108.0; 0: Triage RR, 18.0; 0: Triage SBP, 150.0; 0: Triage DBP, 70.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "In evaluating the patient's sepsis risk, we consider several indicators such as elevated heart rate, respiratory rate, temperature, and laboratory findings. While the patient does have fever and mildly elevated heart and respiratory rates, there is no indication of increased lactate levels or significant immune response (e.g., the white blood cell count is elevated but not severely). Moreover, the other lab results do not strongly suggest organ dysfunction or critical shifts that are typical in sepsis. The absence of more substantial biomarkers for sepsis suggests a lower risk within the next 12 hours.",
            "claims": [
                "Several indicators are considered in evaluating the patient's sepsis risk.",
                "Elevated heart rate is one of the indicators for assessing sepsis risk.",
                "Elevated respiratory rate is one of the indicators for assessing sepsis risk.",
                "Elevated temperature is one of the indicators for assessing sepsis risk.",
                "Laboratory findings are one of the indicators for assessing sepsis risk.",
                "The patient has a fever.",
                "The patient has a mildly elevated heart rate.",
                "The patient has a mildly elevated respiratory rate.",
                "There is no indication of increased lactate levels in the patient.",
                "The patient's white blood cell count is elevated but not severely.",
                "The other lab results do not strongly suggest organ dysfunction.",
                "The lab results do not indicate significant shifts typical in sepsis.",
                "The absence of substantial biomarkers for sepsis suggests a lower risk within the next 12 hours."
            ],
            "relevant_claims": [
                "Elevated respiratory rate is one of the indicators for assessing sepsis risk.",
                "Elevated temperature is one of the indicators for assessing sepsis risk.",
                "The patient has a fever.",
                "The patient has a mildly elevated heart rate.",
                "The patient's white blood cell count is elevated but not severely.",
                "The other lab results do not strongly suggest organ dysfunction.",
                "The lab results do not indicate significant shifts typical in sepsis."
            ],
            "alignment_scores": [
                0.7,
                0.8,
                0.8,
                0.3,
                0.8,
                0.3,
                0.4
            ],
            "alignment_category": [
                "High qSOFA Score (\u22652)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)"
            ],
            "alignment_reasonings": [
                "An elevated respiratory rate (\u226522/min) is one of the indicators included in the qSOFA score, which is used to assess the risk of sepsis-related organ dysfunction and mortality. This claim directly references an element of the qSOFA criteria, making it moderately aligned. However, since additional components of the qSOFA score are necessary for a full assessment, the alignment is not complete (i.e., the claim does not specify the respiratory rate value, nor does it confirm the presence of other qSOFA criteria).",
                "An elevated temperature is directly mentioned as a criterion in the SIRS criteria for identifying systemic inflammation consistent with early sepsis. The claim highlights its role in assessing sepsis risk, aligning well with SIRS criteria, though it does not specify whether the temperature exceeds the threshold, resulting in a slightly less than perfect alignment.",
                "A fever is directly related to the SIRS criteria, where a temperature >38 \u00b0C (100.4 \u00b0F) is one of the thresholds indicating systemic inflammation. The claim aligns well with this category since a fever often signals such inflammation, but without the specific temperature data, it does not fully confirm meeting the criterion. However, the concept of fever strongly suggests a potential alignment with early sepsis identification, warranting a high alignment rating.",
                "A mildly elevated heart rate suggests the beginning of a systemic inflammatory response, which is part of the SIRS criteria. However, without specifying a heart rate over 90 bpm (the SIRS criterion threshold), the alignment is weak and only partially relevant to SIRS positivity.",
                "An elevated white blood cell count is part of the SIRS criteria, which are used to assess systemic inflammation indicative of early sepsis. Although the claim states that the elevation is not severe, the presence of an elevated WBC directly ties it to the SIRS category, hence the high alignment rating, albeit slightly reduced due to the lack of severity.",
                "The claim indicates that other lab results do not strongly suggest organ dysfunction. While this indirectly relates to the SOFA score, which measures organ dysfunction, the lack of strong suggestion does not meet the criteria for a SOFA score increase. Therefore, the alignment is weak, but relevant due to the conceptual connection to organ dysfunction assessment.",
                "A lack of significant shifts in lab results suggests no increase in SOFA components, which indicates no new organ dysfunction. This makes the claim somewhat relevant to the SOFA category but in a negative sense, as it's more about the absence of sepsis indicators rather than presence. The alignment is indirect and weak."
            ],
            "final_alignment_score": 0.5857142857142856
        },
        {
            "input": "8: HR, 119.0; 8: RR, 18.0; 8: SpO2, 95.0; 8: SBP, 169.0; 8: DBP, 103.0; 8: MAP, 125.0; 8: Pain, 6.0; 8: Temp, 95.0; 33: POC PH (V) ISTAT, 7.45; 33: POC O2 SATURATION ISTAT VENOUS, 55 %; 33: POC LACTATE ISTAT, 1.54 mmol/L; 33: POC HCO3 (V) ISTAT, 29.1 mmol/L; 33: POC PO2 (V) ISTAT, 28 mmHg; 33: POC BASE EXCESS ISTAT, 5 mmol/L; 33: POC TCO2 (V) ISTAT, 30 mmol/L; 33: POC PCO2 (V) ISTAT, 42.3 mmHg; 44: HR, 88.590; 44: RR, 18.406; 44: SpO2, 99.0; 44: 1min HRV, 20.500; 44: 5min HRV, 20.500; 45: HR, 92.305; 45: RR, 15.068; 45: SpO2, 98.797; 45: Perf, 0.735; 45: 1min HRV, 15.914; 46: HR, 94.085; 46: RR, 17.729; 46: SpO2, 98.542; 46: Perf, 0.682; 46: 1min HRV, 20.121; 47: HR, 94.931; 47: RR, 12.603; 47: SpO2, 97.980; 47: Perf, 0.69; 47: 1min HRV, 17.878; 48: HR, 88.931; 48: RR, 11.190; 48: SpO2, 98.604; 48: Perf, 0.69; 48: 1min HRV, 25.098; 49: HR, 90.576; 49: RR, 14.102; 49: SpO2, 98.881; 49: Perf, 0.691; 49: 1min HRV, 22.655; 49: 5min HRV, 26.130; 50: HR, 88.254; 50: RR, 13.356; 50: SpO2, 99.797; 50: Perf, 0.768; 50: 1min HRV, 20.065; 51: HR, 85.797; 51: RR, 12.881; 51: SpO2, 99.847; 51: Perf, 0.780; 51: 1min HRV, 25.433; 51: NORMOSOL-R IV BOLUS -, 1000 ML; 52: HR:, 87.828; 52: RR, 14.483; 52: SpO2, 99.0; 52: Perf, 0.801; 52: 1min HRV, 17.872; 53: HR, 87.492; 53: RR, 13.441; 53: SpO2, 98.424; 53: Perf, 0.752; 53: 1min HRV, 14.349; 54: HR, 87.259; 54: RR, 12.741; 54: SpO2, 98.552; 54: Perf, 0.726; 54: 1min HRV, 21.211; 54: 5min HRV, 21.158; 54: SBP, 194.0; 54: DBP, 112.0; 54: MAP, 139.333; 55: HR, 87.797; 55: RR, 16.271; 55: SpO2, 98.909; 55: Perf, 0.696; 55: 1min HRV, 20.357; 55: SBP, 194.0; 55: DBP, 112.0; 55: MAP, 139.333; 56: HR, 88.542; 56: RR, 11.136; 56: SpO2, 99.164; 56: Perf, 0.578; 56: 1min HRV, 21.854; 56: SBP, 191.0; 56: DBP, 107.0; 56: MAP, 135.0; 56: Temp, 99.0; 57: HR, 85.724; 57: RR, 12.897; 57: SpO2, 98.638; 57: Perf, 0.604; 57: 1min HRV, 23.184; 57: SBP, 191.0; 57: DBP, 107.0; 57: MAP, 135.0; 58: HR, 86.508; 58: RR, 14.508; 58: SpO2, 99.409; 58: Perf, 0.57; 58: 1min HRV, 24.025; 59: HR, 85.845; 59: RR, 17.259; 59: SpO2, 99.310; 59: Perf, 0.546; 59: 1min HRV, 35.505; 59: 5min HRV, 27.028; 60: HR, 93.741; 60: RR, 23.621; 60: SpO2, 98.707; 60: Perf, 0.559; 60: 1min HRV, 31.804; 61: HR, 96.627; 61: RR, 13.831; 61: SpO2, 98.458; 61: Perf, 0.563; 61: 1min HRV, 16.269; 62: HR, 97.305; 62: RR, 14.695; 62: SpO2, 97.0; 62: Perf, 0.586; 62: 1min HRV, 13.340; 63: INR, 1.0; 63: PROTHROMBIN TIME, 12.6 seconds; 63: PART. THROMBOPLASTIN TIME, 27.5 seconds; 63: HR, 97.220; 63: RR, 14.390; 63: SpO2, 97.305; 63: Perf, 0.606; 63: 1min HRV, 40.075; 64: HR, 93.259; 64: RR, 13.259; 64: SpO2, 98.586; 64: Perf, 0.716; 64: 1min HRV, 16.946; 64: 5min HRV, 29.308; 64: SBP, 178.0; 64: DBP, 99.0; 64: MAP, 125.333; 65: HR, 89.305; 65: RR, 12.458; 65: SpO2, 99.153; 65: Perf, 0.709; 65: 1min HRV, 14.345; 65: SBP, 178.0; 65: DBP, 99.0; 65: MAP, 125.333; 66: HR, 89.914; 66: RR, 15.5; 66: SpO2, 99.069; 66: Perf, 0.746; 66: 1min HRV, 11.732; 67: HR, 89.983; 67: RR, 15.492; 67: SpO2, 98.881; 67: Perf, 0.7; 67: 1min HRV, 12.711; 68: HR, 90.356; 68: RR, 18.373; 68: SpO2, 98.610; 68: Perf, 0.700; 68: 1min HRV, 21.647; 69: HR, 88.190; 69: RR, 14.379; 69: SpO2, 98.828; 69: Perf, 0.804; 69: 1min HRV, 16.146; 69: 5min HRV, 16.123; 70: HR, 88.695; 70: RR, 13.322; 70: SpO2, 98.576; 70: Perf, 0.778; 70: 1min HRV, 12.567; 71: HR, 89.517; 71: RR, 14.190; 71: SpO2, 97.586; 71: Perf, 0.757; 71: 1min HRV, 18.283; 72: HR, 90.831; 72: RR, 13.034; 72: SpO2, 97.712; 72: Perf, 0.781; 72: 1min HRV, 30.201; 73: HR, 89.441; 73: RR, 13.441; 73: SpO2, 97.763; 73: Perf, 0.792; 73: 1min HRV, 17.698; 74: HR, 90.052; 74: RR, 15.517; 74: SpO2, 97.552; 74: Perf, 0.767; 74: 1min HRV, 18.816; 74: 5min HRV, 21.222; 75: AST (SGOT), 38 U/L; 75: EGFR FOR AFRICAN AMERICAN, 88 mL/min/1.73 m2; 75: CHLORIDE, 101 mmol/L; 75: EGFR REFIT WITHOUT RACE (2021), 76 mL/min/1.73 m2; 75: CORRECTED CALCIUM, 9.4 mg/dL; 75: ALBUMIN, 4.4 g/dL; 75: CO2, 27 mmol/L; 75: ANION GAP, 13 mmol/L; 75: GLOBULIN, 2.5 g/dL; 75: CALCIUM, 9.7 mg/dL; 75: POTASSIUM, 3.7 mmol/L; 75: BILIRUBIN TOTAL, 0.6 mg/dL; 75: CREATININE, 0.85 mg/dL; 75: ALT (SGPT), 75 U/L; 75: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 75: ALKALINE PHOSPHATASE, 136 U/L; 75: PROTEIN TOTAL, 6.9 g/dL; 75: GLUCOSE, 134 mg/dL; 75: SODIUM, 141 mmol/L; 75: MAGNESIUM, 2.2 mg/dL; 75: C-REACTIVE PROTEIN (CRP), 12.9 mg/dL; 75: HR, 92.576; 75: RR, 15.492; 75: SpO2, 97.458; 75: Perf, 0.738; 75: 1min HRV, 15.039; 75: LABETALOL, 5 MG/ML IV SOLN; 76: HR:, 91.172; 76: RR, 14.914; 76: SpO2, 98.086; 76: Perf, 0.761; 76: 1min HRV, 22.991; 77: HR, 92.593; 77: RR, 12.966; 77: SpO2, 97.847; 77: Perf, 0.732; 77: 1min HRV, 12.759; 78: HR, 90.322; 78: RR, 11.407; 78: SpO2, 97.763; 78: Perf, 0.629; 78: 1min HRV, 29.457; 79: HR, 81.672; 79: RR, 11.603; 79: SpO2, 96.724; 79: Perf, 0.630; 79: 1min HRV, 12.557; 79: 5min HRV, 39.153; 80: SBP, 160.0; 80: DBP, 140.0; 80: MAP, 146.667; 98: PROCALCITONIN, 3.91 ng/mL; 100: ESR (AUTOMATED), 112 mm/hr; 110: TROPONIN I, 0.028 ng/mL; 0: Age, 57; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, nan; 0: Triage HR, 119.0; 0: Triage RR, 18.0; 0: Triage SBP, 169.0; 0: Triage DBP, 103.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER",
            "answer": false,
            "llm_answer": "Yes",
            "llm_explanation": "The patient's records show elevated heart rate (Triage HR: 119) and elevated procalcitonin (3.91 ng/mL), which are both indicative of infection and inflammation. The elevated CRP (12.9 mg/dL) and ESR (112 mm/hr) reinforce the likelihood of a significant inflammatory response, commonly seen in sepsis. The high blood pressure and high base excess could indicate compensation for metabolic disturbances seen in sepsis. Collectively, these factors suggest the patient is at high risk of developing sepsis within 12 hours.",
            "claims": [
                "The patient's records show an elevated heart rate.",
                "The triage heart rate is 119.",
                "An elevated heart rate is indicative of infection and inflammation.",
                "The patient has an elevated procalcitonin level of 3.91 ng/mL.",
                "An elevated procalcitonin level is indicative of infection and inflammation.",
                "The patient has an elevated CRP level of 12.9 mg/dL.",
                "An elevated CRP level reinforces the likelihood of a significant inflammatory response.",
                "The patient has an elevated ESR level of 112 mm/hr.",
                "An elevated ESR level reinforces the likelihood of a significant inflammatory response.",
                "A significant inflammatory response is commonly seen in sepsis.",
                "The patient has high blood pressure.",
                "High blood pressure could indicate compensation for metabolic disturbances seen in sepsis.",
                "The patient has a high base excess.",
                "A high base excess could indicate compensation for metabolic disturbances seen in sepsis.",
                "Collectively, these factors suggest the patient is at high risk of developing sepsis within 12 hours."
            ],
            "relevant_claims": [
                "The patient's records show an elevated heart rate.",
                "The triage heart rate is 119.",
                "An elevated heart rate is indicative of infection and inflammation.",
                "The patient has an elevated procalcitonin level of 3.91 ng/mL.",
                "An elevated procalcitonin level is indicative of infection and inflammation.",
                "The patient has an elevated CRP level of 12.9 mg/dL.",
                "An elevated CRP level reinforces the likelihood of a significant inflammatory response.",
                "The patient has an elevated ESR level of 112 mm/hr.",
                "An elevated ESR level reinforces the likelihood of a significant inflammatory response.",
                "The patient has high blood pressure.",
                "High blood pressure could indicate compensation for metabolic disturbances seen in sepsis.",
                "A high base excess could indicate compensation for metabolic disturbances seen in sepsis.",
                "Collectively, these factors suggest the patient is at high risk of developing sepsis within 12 hours."
            ],
            "alignment_scores": [
                0.7,
                0.7,
                0.7,
                0.3,
                0.5,
                0.3,
                0.6,
                0.3,
                0.3,
                0.2,
                0.3,
                0.6,
                0.3
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "High qSOFA Score (\u22652)",
                "Elevated Shock Index (\u22651.0)",
                "SOFA Score Increase (\u22652 points)",
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "An elevated heart rate is one of the SIRS criteria (heart rate > 90 bpm) used to identify systemic inflammation consistent with early sepsis. However, to fully meet SIRS criteria, at least two conditions should be present. Given the information provided, we can partially align the claim with SIRS positivity.",
                "The claim mentions a heart rate of 119 bpm, which exceeds the SIRS criterion of heart rate > 90 bpm. While this heart rate clearly meets SIRS criterion, SIRS requires at least two criteria to be fully met. The alignment is high due to the heart rate's direct connection to one of the SIRS criteria, but not perfect as no other criteria are mentioned.",
                "An elevated heart rate (greater than 90 bpm) is listed as one of the criteria for SIRS, which helps identify systemic inflammation consistent with early sepsis. However, while this claim aligns with one of the SIRS criteria, it does not specify a complete set of criteria, hence the alignment is strong but not perfect.",
                "While the claim mentions an elevated procalcitonin level, which is often used as a biomarker for bacterial infection and can suggest sepsis, it is not directly listed in the provided categories. The closest related category is elevated serum lactate, as both procalcitonin and lactate are markers used to assess the risk of sepsis. However, since procalcitonin is not explicitly mentioned in any sepsis category provided, the alignment is indirect and relatively weak.",
                "An elevated procalcitonin level is associated with bacterial infections and inflammation, which aligns with the clinical suspicion of sepsis or a serious infection. While it signals an increased risk for infection and possible sepsis, the claim does not explicitly mention the administration of antibiotics or performance of blood cultures. Therefore, the alignment is partially relevant, reflecting moderate applicability to the category.",
                "An elevated CRP level is indicative of inflammation, which can be associated with a systemic inflammatory response. While CRP is not explicitly one of the SIRS criteria, its indication of inflammation hints at possible early sepsis. However, since it is not directly listed in the criteria, the alignment with SIRS Positivity is indirect and hence rated as 0.3.",
                "Elevated CRP (C-reactive protein) is a marker of inflammation, which conceptually aligns with SIRS, a category that identifies systemic inflammation in early sepsis. Although CRP itself is not listed as one of the specific criteria for SIRS, it supports the presence of an inflammatory process similar to what SIRS criteria aim to detect. Thus, there is a moderate alignment with the category.",
                "Although an elevated erythrocyte sedimentation rate (ESR) is indicative of inflammation, it is not directly mentioned in the criteria for SIRS, which focuses more on specific vital signs and white blood cell counts. Therefore, the alignment with SIRS Positivity is indirect and marginal.",
                "An elevated erythrocyte sedimentation rate (ESR) is a general indicator of inflammation, similar to some aspects of SIRS, which focuses on systemic inflammation. However, ESR is not directly part of the SIRS criteria, which include specific vital signs and blood cell counts. Therefore, the alignment is indirect and limited, warranting a moderate alignment rating.",
                "High blood pressure is not explicitly part of the criteria for any of the specified expert categories, including the qSOFA score, which considers low blood pressure (systolic\u202fBP\u202f\u2264\u202f100\u202fmmHg) rather than high blood pressure. The mention of blood pressure relates somewhat weakly to qSOFA due to the involvement of blood pressure in its criteria, but the alignment is minimal. Other categories focus on low blood pressure or specific indices related to blood pressure, not high blood pressure.",
                "The claim suggests that high blood pressure might be a compensatory mechanism in response to metabolic disturbances associated with sepsis. While high blood pressure isn't a direct indicator in any sepsis category, it indirectly relates to hemodynamic changes that could influence the shock index. The shock index evaluates the balance between heart rate and blood pressure, and although the claim doesn't discuss an elevated heart rate or low systolic BP, the concept of hemodynamic compensation connects weakly to this category. There is limited direct alignment, hence the low rating.",
                "A high base excess is not directly mentioned in the SOFA score criteria, but it could relate to metabolic disturbances and organ dysfunction, which are relevant to SOFA score considerations. SOFA includes components like oxygenation, coagulation, liver function, cardiovascular function, central nervous system, and renal function, where metabolic disturbances could manifest. Though the link is indirect, it conceptually aligns with the SOFA framework as a marker of organ dysfunction often seen in sepsis.",
                "The claim's emphasis on a collective high risk for developing sepsis is generally aligned with the concept of an Elevated NEWS Score, which aggregates various vital sign derangements into a summary score reflecting imminent deterioration risk synonymous with sepsis prediction. However, the claim does not specify any components or scores that precisely match the NEWS criteria, making the alignment indirect and weak."
            ],
            "final_alignment_score": 0.44615384615384607
        },
        {
            "input": "2: SpO2, 98.912; 3: HR, 127.55; 3: RR, 25.833; 3: SpO2, 99.0; 3: 1min HRV, 9.900; 3: 5min HRV, 9.900; 3: SBP, 112.0; 3: DBP, 60.0; 3: MAP, 77.333; 4: HR, 123.810; 4: RR, 14.64; 4: SpO2, 93.6; 4: 1min HRV, 8.630; 5: HR, 123.759; 5: RR, 20.083; 5: SpO2, 100.0; 5: Perf, 0.17; 5: 1min HRV, 9.799; 6: HR, 121.237; 6: RR, 20.864; 6: SpO2, 100.0; 6: Perf, 0.173; 6: 1min HRV, 8.424; 7: HR, 122.534; 7: RR, 18.897; 7: SpO2, 99.806; 7: Perf, 0.180; 7: 1min HRV, 10.581; 8: HR, 122.237; 8: RR, 21.153; 8: SpO2, 100.0; 8: Perf, 0.165; 8: 1min HRV, 11.457; 8: 5min HRV, 10.763; 8: SBP, 112.0; 8: DBP, 60.0; 8: MAP, 77.333; 8: Pain, 0.0; 8: Temp, 99.1; 9: HR, 121.466; 9: RR, 22.138; 9: SpO2, 99.711; 9: Perf, 0.17; 9: 1min HRV, 12.729; 10: HR, 120.085; 10: RR, 18.373; 10: SpO2, 99.826; 10: Perf, 0.17; 10: 1min HRV, 8.977; 11: HR, 121.356; 11: RR, 20.847; 11: SpO2, 99.96; 11: Perf, 0.159; 11: 1min HRV, 6.412; 13: 5min HRV, 10.151; 20: POC PH (V) ISTAT, 7.35; 20: POC TCO2 (V) ISTAT, 32 mmol/L; 20: POC O2 SATURATION ISTAT VENOUS, 28 %; 20: POC PCO2 (V) ISTAT, 54.3 mmHg; 20: POC HCO3 (V) ISTAT, 30.1 mmol/L; 20: POC LACTATE ISTAT, 0.86 mmol/L; 20: POC BASE EXCESS ISTAT, 5 mmol/L; 20: POC PO2 (V) ISTAT, 20 mmHg; 27: ABO/RH (AUTOMATION), AB Positive; 27: ANTIBODY SCREEN 3, NEG; 29: HR, 117.0; 29: RR, 20.0; 29: SpO2, 100.0; 29: SBP, 104.0; 29: DBP, 67.0; 29: MAP, 79.333; 40: WAM DIFTYP, AUTO; 40: PLATELET COUNT (PLT), 300 K/uL; 40: HEMATOCRIT (HCT), 29.4 %; 40: HEMOGLOBIN (HGB), 9.7 g/dL; 40: MONOCYTE ABSOLUTE (AUTO DIFF), 1.06 K/uL; 40: MEAN CORPUSCULAR VOLUME (MCV), 85.2 fL; 40: NEUTROPHIL ABSOLUTE (AUTO DIFF), 12.92 K/uL; 40: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.06 K/uL; 40: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 40: RED BLOOD CELLS (RBC), 3.45 MIL/uL; 40: EOSINOPHIL % (AUTO DIFF), 0.0 %; 40: BASOPHIL % (AUTO DIFF), 0.1 %; 40: NEUTROPHIL % (AUTO DIFF), 87.3 %; 40: MONOCYTE % (AUTO DIFF), 7.2 %; 40: NRBC PERCENT (HEMATOLOGY), 0.0 %; 40: WHITE BLOOD CELLS (WBC), 14.8 K/uL; 40: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.74 K/uL; 40: BASOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 40: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 40: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.0 g/dL; 40: RED CELL DISTRIBUTION WIDTH (RDW), 17.3 %; 40: LYMPHOCYTE % (AUTO DIFF), 5.0 %; 40: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.1 pg; 40: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 43: HR, 114.0; 43: RR, 27.0; 43: SpO2, 100.0; 43: SBP, 107.0; 43: DBP, 62.0; 43: MAP, 77.0; 50: INR, 1.1; 50: PROTHROMBIN TIME, 14.4 seconds; 51: PART. THROMBOPLASTIN TIME, 33.5 seconds; 56: ETOMIDATE, 2 MG/ML IV SOLN; 58: SUCCINYLCHOLINE CHLORIDE, 20 MG/ML INJ SOLN; 60: ALT (SGPT), 47 U/L; 60: ANION GAP, 8 mmol/L; 60: ALBUMIN, 3.4 g/dL; 60: EGFR FOR AFRICAN AMERICAN, 150 mL/min/1.73 m2; 60: CALCIUM, 8.6 mg/dL; 60: CREATININE, 0.42 mg/dL; 60: GLUCOSE, 120 mg/dL; 60: CORRECTED CALCIUM, 9.1 mg/dL; 60: GLOBULIN, 3.2 g/dL; 60: BILIRUBIN TOTAL, 0.3 mg/dL; 60: EGFR REFIT WITHOUT RACE (2021), 130 mL/min/1.73 m2; 60: SODIUM, 130 mmol/L; 60: PROTEIN TOTAL, 6.6 g/dL; 60: ALKALINE PHOSPHATASE, 95 U/L; 60: BLOOD UREA NITROGEN (BUN), 10 mg/dL; 60: AST (SGOT), 33 U/L; 60: CHLORIDE, 95 mmol/L; 60: CO2, 27 mmol/L; 60: POTASSIUM, 4.6 mmol/L; 63: HR, 59.0; 63: RR, 18.0; 63: SBP, 117.0; 63: DBP, 100.0; 63: MAP, 105.667; 68: HR, 59.0; 68: RR, 20.0; 68: SBP, 100.0; 68: DBP, 49.0; 68: MAP, 66.0; 69: HR, 59.0; 69: RR, 23.0; 69: SBP, 72.0; 69: DBP, 45.0; 69: MAP, 54.0; 69: PHENYLEPHRINE HCL IN, 0.9% NACL 0.5 MG/5 ML (100 MCG/ML) IV SYRG; 70: RR:, 24.0; 70: SBP, 87.0; 70: DBP, 54.0; 70: MAP, 65.0; 71: PHENYLEPHRINE HCL IN, 0.9% NACL 0.5 MG/5 ML (100 MCG/ML) IV SYRG; 72: TRANEXAMIC ACID, 100 MG/ML NEBULIZED INHALATION; 73: RR, 18.0; 73: SBP, 89.0; 73: DBP, 63.0; 73: MAP, 71.667; 74: HR, 140.0; 74: RR, 21.0; 74: SBP, 139.0; 74: DBP, 86.0; 74: MAP, 103.667; 74: NOREPINEPHRINE BITARTRATE-NACL, 4 MG/250 ML (16 MCG/ML) IV SOLN; 76: CALCIUM GLUCONATE IN, 0.9% NACL 1 GRAM/50 ML IV SOLN; 78: HR, 138.0; 78: RR, 16.0; 78: SpO2, 100.0; 78: SBP, 167.0; 78: DBP, 91.0; 78: MAP, 116.333; 82: HR, 138.0; 82: RR, 24.0; 82: SpO2, 100.0; 82: SBP, 118.0; 82: DBP, 89.0; 82: MAP, 98.667; 83: HR, 133.0; 83: RR, 14.0; 83: SpO2, 100.0; 83: SBP, 140.0; 83: DBP, 76.0; 83: MAP, 97.333; 85: PROPOFOL, 10 MG/ML IV INFUSION; 87: FENTANYL CITRATE (PF), 50 MCG/ML INJ SOLN (WRAPPER RECORD); 88: HR, 125.0; 88: RR, 13.0; 88: SpO2, 100.0; 88: SBP, 105.0; 88: DBP, 47.0; 88: MAP, 66.333; 93: HR, 119.0; 93: RR, 20.0; 93: SpO2, 99.0; 93: SBP, 133.0; 93: DBP, 50.0; 93: MAP, 77.667; 98: HR, 109.0; 98: RR, 21.0; 98: SpO2, 99.0; 98: FENTANYL CITRATE (PF), 50 MCG/ML INJ SOLN (WRAPPER RECORD); 102: POC PH (A), ISTAT: 7.21; 102: POC BASE EXCESS ISTAT, -11 mmol/L; 102: POC LACTATE ISTAT, 7.13 mmol/L; 102: POC HCO3 (A) ISTAT, 16.6 mmol/L; 102: POC O2 SATURATION ISTAT, 98 %; 102: POC PO2 (A) ISTAT, 122 mmHg; 102: POC TCO2 (A) ISTAT, 18 mmol/L; 102: POC PCO2 (A) ISTAT, 41.2 mmHg; 108: HR, 105.0; 108: RR, 20.0; 108: SpO2, 98.0; 113: HR, 89.0; 113: RR, 21.0; 113: SpO2, 100.0; 118: HR, 103.0; 118: RR, 20.0; 118: SpO2, 100.0; 118: Pain, 0.0; 118: Pain, 1.0; 0: Age, 37; 0: Gender, F; 0: Race, Asian; 0: Means of arrival, EMS; 0: Triage Temp, 37.3; 0: Triage HR, 118.0; 0: Triage RR, 22.0; 0: Triage SBP, 112.0; 0: Triage DBP, 60.0; 0: Triage acuity, 2-Emergent; 0: CC, BLOOD IN VOMIT",
            "answer": false,
            "llm_answer": "Yes",
            "llm_explanation": "The patient's vital signs indicate instability, notably the high heart rate, fluctuating and often low blood pressure, and elevated respiratory rate, all of which can be indicative of sepsis. Additionally, the lactate level is quite high at 7.13 mmol/L, which can also point to possible sepsis. The administration of norepinephrine suggests attempts to stabilize blood pressure, further supporting the concern for acute clinical deterioration consistent with sepsis. Overall, these factors indicate a high risk of developing sepsis within a short timeframe.",
            "claims": [
                "The patient's vital signs indicate instability.",
                "The heart rate is high.",
                "The blood pressure is fluctuating and often low.",
                "The respiratory rate is elevated.",
                "High heart rate, fluctuating low blood pressure, and elevated respiratory rate can be indicative of sepsis.",
                "The lactate level is quite high at 7.13 mmol/L.",
                "A lactate level of 7.13 mmol/L can point to possible sepsis.",
                "The administration of norepinephrine suggests attempts to stabilize blood pressure.",
                "The attempts to stabilize blood pressure support the concern for acute clinical deterioration.",
                "Acute clinical deterioration is consistent with sepsis.",
                "These factors indicate a high risk of developing sepsis within a short timeframe."
            ],
            "relevant_claims": [
                "The patient's vital signs indicate instability.",
                "The heart rate is high.",
                "The blood pressure is fluctuating and often low.",
                "The respiratory rate is elevated.",
                "High heart rate, fluctuating low blood pressure, and elevated respiratory rate can be indicative of sepsis.",
                "The lactate level is quite high at 7.13 mmol/L.",
                "A lactate level of 7.13 mmol/L can point to possible sepsis.",
                "The administration of norepinephrine suggests attempts to stabilize blood pressure.",
                "The attempts to stabilize blood pressure support the concern for acute clinical deterioration.",
                "Acute clinical deterioration is consistent with sepsis.",
                "These factors indicate a high risk of developing sepsis within a short timeframe."
            ],
            "alignment_scores": [
                0.5,
                0.7,
                0.8,
                0.7,
                0.8,
                1.0,
                1.0,
                0.9,
                0.7,
                0.7,
                0.3
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "High qSOFA Score (\u22652)",
                "High qSOFA Score (\u22652)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Elevated NEWS Score (\u22655 points)",
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "The claim of \"vital signs indicating instability\" most closely aligns with the Elevated NEWS Score category, which is derived from deranged vital signs predicting potential deterioration. However, without specific vital signs or a quantifiable score provided in the claim, the alignment is not strong. The general idea of instability suggests a possible rise in the NEWS score, but the lack of explicit details results in a moderate alignment rating.",
                "The claim mentions a high heart rate, which is explicitly part of the SIRS criteria (heart rate > 90 bpm). Although the claim lacks specific numbers, it aligns well by directly involving one of the SIRS criteria related to systemic inflammation and early sepsis detection. The lack of precise heart rate data limits the alignment rating to a degree.",
                "The claim about fluctuating and often low blood pressure suggests potential hypotension, which is a key component of the Sepsis-Associated Hypotension category. While it does not provide specific numeric values (e.g., exact mmHg), it aligns conceptually with the concerns of hypotension signaling progression toward septic shock. However, due to the lack of specific blood pressure values, the alignment rating is slightly reduced.",
                "An elevated respiratory rate is one of the components of the qSOFA score, which flags risk of sepsis-related organ dysfunction when score is \u22652. However, the claim doesn\u2019t provide enough detail to determine the full qSOFA score, thus the alignment rating isn't 1.0. Nonetheless, there is a meaningful connection.",
                "The claim mentions high heart rate, fluctuating low blood pressure, and elevated respiratory rate. These symptoms strongly align with the criteria for a high qSOFA score, which includes elevated respiratory rate and low blood pressure as key factors. While heart rate is not directly part of the qSOFA score, the combination of other factors suggests a significant alignment with this category, though not perfect. Thus, a rating of 0.8 reflects the strong relevance of these observations to the high qSOFA criteria.",
                "The claim explicitly states that the lactate level is \"quite high at 7.13 mmol/L,\" which significantly exceeds the threshold of \u22652 mmol/L defined in the Elevated Serum Lactate category. This elevated lactate level strongly signals tissue hypoperfusion and elevates the risk of sepsis mortality, aligning perfectly with the category's criteria.",
                "The claim specifically mentions a lactate level of 7.13 mmol/L, which is well above the threshold of 2 mmol/L identified in the Elevated Serum Lactate category. This strongly indicates tissue hypoperfusion and a high risk of sepsis, resulting in perfect alignment with the category.",
                "The use of norepinephrine is often indicative of an attempt to counteract hypotension, typically seen in septic shock or severe sepsis. The administration closely aligns with efforts to correct sepsis-associated hypotension, as outlined in the category. While the claim does not provide explicit blood pressure measurements, norepinephrine is a vasopressor used to stabilize blood pressure in the context of sepsis, suggesting strong alignment with hypotensive criteria.",
                "The claim mentions attempts to stabilize blood pressure, indicating a concern for acute clinical deterioration, which aligns with the category of sepsis-associated hypotension. This category specifically concerns low blood pressure as an indicator of sepsis progression, potentially leading to shock. The claim indirectly references these concerns through the necessity of intervention to stabilize blood pressure, indicating possible hypotension but does not provide explicit blood pressure measurements, leading to a moderate but not perfect alignment.",
                "The claim mentions \"acute clinical deterioration,\" which aligns with the concept of an elevated National Early Warning Score (NEWS). NEWS is designed to predict clinical deterioration, including that related to sepsis, by assessing deranged vital signs. Although the claim does not specify a NEWS score, the notion of deterioration due to sepsis suggests a possible elevation in NEWS. The alignment is based on the general concept rather than specific data, hence the partial rating.",
                "The claim lacks specific details or measurements to directly relate to any particular expert category. However, it implies a situation of imminent clinical deterioration, which aligns most broadly with the concept of an elevated NEWS score that predicts acute clinical decline. The alignment rating is low due to the absence of precise information or metrics that are directly tied to any specific category."
            ],
            "final_alignment_score": 0.7363636363636364
        },
        {
            "input": "1: HR, 79.882; 1: RR, 18.0; 1: SpO2, 92.348; 1: Perf, 2.965; 1: 1min HRV, 16.865; 2: HR, 79.475; 2: RR, 17.102; 2: SpO2, 92.459; 2: Perf, 3.261; 2: 1min HRV, 12.250; 2: 5min HRV, 13.874; 2: SBP, 91.0; 2: DBP, 56.0; 2: MAP, 67.667; 3: HR, 79.603; 3: RR, 17.552; 3: SpO2, 92.167; 3: Perf, 4.201; 3: 1min HRV, 9.150; 3: SBP, 89.0; 3: DBP, 54.0; 3: MAP, 65.667; 4: HR, 80.017; 4: RR, 19.814; 4: SpO2, 91.797; 4: Perf, 4.437; 4: 1min HRV, 7.918; 5: HR, 79.483; 5: RR, 17.897; 5: SpO2, 92.466; 5: Perf, 4.719; 5: 1min HRV, 19.889; 6: HR, 77.898; 6: RR, 17.203; 6: SpO2, 93.034; 6: Perf, 4.849; 6: 1min HRV, 8.734; 7: HR, 77.305; 7: RR, 17.915; 7: SpO2, 94.172; 7: Perf, 4.749; 7: 1min HRV, 29.252; 7: 5min HRV, 20.200; 7: SBP, 82.0; 7: DBP, 58.0; 7: MAP, 66.0; 8: HR, 77.603; 8: RR, 19.879; 8: SpO2, 94.845; 8: Perf, 4.85; 8: 1min HRV, 15.192; 9: HR, 77.932; 9: RR, 18.898; 9: SpO2, 95.729; 9: Perf, 5.131; 9: 1min HRV, 12.593; 10: HR, 77.845; 10: RR, 16.397; 10: SpO2, 96.293; 10: Perf, 4.86; 10: 1min HRV, 16.278; 10: SBP, 82.0; 10: DBP, 56.0; 10: MAP, 64.667; 11: HR, 77.458; 11: RR, 19.085; 11: SpO2, 96.492; 11: Perf, 5.061; 11: 1min HRV, 23.636; 12: HR, 77.441; 12: RR, 19.458; 12: SpO2, 96.0; 12: Perf, 4.676; 12: 1min HRV, 26.166; 12: 5min HRV, 19.846; 13: HR, 77.086; 13: RR, 19.672; 13: SpO2, 96.517; 13: Perf, 4.590; 13: 1min HRV, 27.453; 14: HR, 78.068; 14: RR, 20.780; 14: SpO2, 97.119; 14: Perf, 4.273; 14: 1min HRV, 29.638; 15: HR, 78.259; 15: RR, 18.069; 15: SpO2, 96.017; 15: Perf, 4.582; 15: 1min HRV, 26.424; 16: HR, 77.0; 16: RR, 21.712; 16: SpO2, 95.831; 16: Perf, 4.953; 16: 1min HRV, 21.531; 17: HR, 74.655; 17: RR, 19.983; 17: SpO2, 96.0; 17: Perf, 5.045; 17: 1min HRV, 32.942; 17: 5min HRV, 30.473; 18: HR, 76.627; 18: RR, 18.644; 18: SpO2, 96.881; 18: Perf, 4.553; 18: 1min HRV, 42.603; 18: SBP, 86.0; 18: DBP, 56.0; 18: MAP, 66.0; 19: HR, 76.746; 19: RR, 20.695; 19: SpO2, 96.085; 19: Perf, 4.913; 19: 1min HRV, 22.919; 20: HR, 75.914; 20: RR, 19.672; 20: SpO2, 96.810; 20: Perf, 4.996; 20: 1min HRV, 15.346; 21: HR, 75.695; 21: RR, 21.186; 21: SpO2, 96.068; 21: Perf, 4.31; 21: 1min HRV, 18.165; 22: HR, 75.0; 22: RR, 19.897; 22: SpO2, 96.0; 22: Perf, 5.584; 22: 1min HRV, 15.242; 22: 5min HRV, 26.758; 23: SpO2, 95.627; 23: Perf, 6.732; 24: SpO2, 95.847; 24: Perf, 6.377; 25: SpO2, 95.103; 25: Perf, 5.538; 26: SpO2, 95.271; 26: Perf, 4.859; 27: SpO2, 94.431; 27: Perf, 3.054; 28: SpO2, 97.0; 28: Perf, 3.627; 29: SpO2, 95.644; 29: Perf, 3.088; 30: SpO2, 96.862; 30: Perf, 2.077; 31: SpO2, 96.068; 31: Perf, 2.325; 32: SpO2, 97.759; 32: Perf, 1.248; 33: SpO2, 97.068; 33: Perf, 0.830; 33: SBP, 110.0; 33: DBP, 71.0; 33: MAP, 84.0; 34: SpO2, 97.949; 34: Perf, 0.764; 34: NORMOSOL-R IV BOLUS -, 1000 ML; 35: HR:, 75.0; 35: RR, 20.0; 35: SpO2, 96.828; 35: Perf, 0.739; 35: SBP, 110.0; 35: DBP, 71.0; 35: MAP, 84.0; 36: POC PH (V) ISTAT, 7.42; 36: POC PCO2 (V) ISTAT, 35.1 mmHg; 36: POC PO2 (V) ISTAT, 37 mmHg; 36: POC HCO3 (V) ISTAT, 22.7 mmol/L; 36: POC O2 SATURATION ISTAT VENOUS, 73 %; 36: POC LACTATE ISTAT, 1.78 mmol/L; 36: POC TCO2 (V) ISTAT, 24 mmol/L; 36: POC BASE EXCESS ISTAT, -2 mmol/L; 36: HR, 73.935; 36: RR, 26.932; 36: SpO2, 95.593; 36: Perf, 1.088; 36: 1min HRV, 15.067; 37: HR, 76.224; 37: RR, 22.655; 37: SpO2, 97.5; 37: Perf, 1.012; 37: 1min HRV, 13.381; 37: 5min HRV, 18.055; 38: HR, 78.051; 38: RR, 28.356; 38: SpO2, 97.932; 38: Perf, 0.629; 38: 1min HRV, 16.546; 39: HR, 80.0; 39: RR, 25.254; 39: SpO2, 98.390; 39: Perf, 0.600; 39: 1min HRV, 21.224; 40: HR, 81.121; 40: RR, 23.741; 40: SpO2, 98.810; 40: Perf, 0.593; 40: 1min HRV, 13.943; 41: HR, 83.542; 41: RR, 26.373; 41: SpO2, 98.0; 41: Perf, 0.600; 41: 1min HRV, 19.886; 42: HR, 83.897; 42: RR, 29.414; 42: SpO2, 98.086; 42: Perf, 0.639; 42: 1min HRV, 17.444; 42: 5min HRV, 26.739; 43: HR, 84.475; 43: RR, 28.780; 43: SpO2, 98.661; 43: Perf, 0.669; 43: 1min HRV, 13.889; 44: HR, 85.712; 44: RR, 26.424; 44: SpO2, 98.644; 44: Perf, 0.677; 44: 1min HRV, 17.314; 47: 5min HRV, 16.253; 62: INR, 1.3; 62: PROTHROMBIN TIME, 15.6 seconds; 63: PART. THROMBOPLASTIN TIME, 35.1 seconds; 71: PIPERACILLIN-TAZOBACTAM-DEXTRS, 4.5 GRAM/100 ML IV PGBK; 74: LIPASE:, 3 U/L; 77: EGFR REFIT WITHOUT RACE (2021), 71 mL/min/1.73 m2; 77: ALT (SGPT), 20 U/L; 77: PROTEIN TOTAL, 5.4 g/dL; 77: CREATININE, 1.01 mg/dL; 77: POTASSIUM, 4.2 mmol/L; 77: GLOBULIN, 2.7 g/dL; 77: AST (SGOT), 62 U/L; 77: ALKALINE PHOSPHATASE, 362 U/L; 77: GLUCOSE, 194 mg/dL; 77: BILIRUBIN TOTAL, 2.1 mg/dL; 77: EGFR FOR AFRICAN AMERICAN, 82 mL/min/1.73 m2; 77: CORRECTED CALCIUM, 8.5 mg/dL; 77: ANION GAP, 11 mmol/L; 77: ALBUMIN, 2.7 g/dL; 77: SODIUM, 133 mmol/L; 77: CALCIUM, 7.5 mg/dL; 77: BLOOD UREA NITROGEN (BUN), 23 mg/dL; 77: CO2, 23 mmol/L; 77: CHLORIDE, 99 mmol/L; 118: HEMOGLOBIN (HGB), 11.1 g/dL; 118: WHITE BLOOD CELLS (WBC), 2.9 K/uL; 118: PLATELET COUNT (PLT), 47 K/uL; 118: HEMATOCRIT (HCT), 33.3 %; 118: RED CELL DISTRIBUTION WIDTH (RDW), 15.4 %; 118: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.3 g/dL; 118: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 32.4 pg; 118: RED BLOOD CELLS (RBC), 3.43 MIL/uL; 118: MEAN CORPUSCULAR VOLUME (MCV), 97.1 fL; 118: LYMPHOCYTES % (MANUAL DIFF), 6.0 %; 118: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 78.0 %; 118: MONOCYTES % (MANUAL DIFF), 0.0 %; 118: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 2.75 K/uL; 118: NEUTROPHILS BANDS % (MANUAL DIFF), 16.0 %; 118: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 0.18 K/uL; 0: Age, 80; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, EMS; 0: Triage Temp, 38.2; 0: Triage HR, 77.0; 0: Triage RR, 16.0; 0: Triage SBP, 92.0; 0: Triage DBP, 53.0; 0: Triage acuity, 3-Urgent; 0: CC, GENERAL WEAKNESS",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient is an 80-year-old male with a persistently low blood pressure and MAP, indicative of potential circulatory instability. Initial high temperature and low SpO2 suggest possible infection or respiratory issues. The high respiratory rate, low platelet count, elevated neutrophil bands, and low WBC count are concerning for sepsis. Additionally, the administration of Piperacillin-Tazobactam suggests the medical team suspected or treated for sepsis, supporting a high sepsis risk prediction.",
            "claims": [
                "The patient is an 80-year-old male.",
                "The patient has a persistently low blood pressure.",
                "The patient has a persistently low mean arterial pressure (MAP).",
                "Persistently low blood pressure and MAP are indicative of potential circulatory instability.",
                "The patient has an initial high temperature.",
                "The patient has a low SpO2.",
                "A high temperature and low SpO2 suggest possible infection or respiratory issues.",
                "The patient has a high respiratory rate.",
                "The patient has a low platelet count.",
                "The patient has elevated neutrophil bands.",
                "The patient has a low white blood cell (WBC) count.",
                "A high respiratory rate, low platelet count, elevated neutrophil bands, and low WBC count are concerning for sepsis.",
                "The administration of Piperacillin-Tazobactam suggests the medical team suspected sepsis.",
                "The administration of Piperacillin-Tazobactam indicates treatment for sepsis.",
                "The treatment with Piperacillin-Tazobactam supports a high sepsis risk prediction."
            ],
            "relevant_claims": [
                "The patient is an 80-year-old male.",
                "The patient has a persistently low blood pressure.",
                "The patient has a persistently low mean arterial pressure (MAP).",
                "Persistently low blood pressure and MAP are indicative of potential circulatory instability.",
                "The patient has an initial high temperature.",
                "The patient has a low SpO2.",
                "A high temperature and low SpO2 suggest possible infection or respiratory issues.",
                "The patient has a high respiratory rate.",
                "The patient has a low platelet count.",
                "The patient has elevated neutrophil bands.",
                "The patient has a low white blood cell (WBC) count.",
                "A high respiratory rate, low platelet count, elevated neutrophil bands, and low WBC count are concerning for sepsis.",
                "The administration of Piperacillin-Tazobactam suggests the medical team suspected sepsis.",
                "The administration of Piperacillin-Tazobactam indicates treatment for sepsis.",
                "The treatment with Piperacillin-Tazobactam supports a high sepsis risk prediction."
            ],
            "alignment_scores": [
                1.0,
                0.8,
                0.8,
                0.9,
                0.7,
                0.6,
                0.7,
                0.7,
                0.9,
                0.7,
                0.9,
                0.7,
                0.9,
                0.9,
                0.9
            ],
            "alignment_category": [
                "Elderly Susceptibility (Age \u226565 years)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "SIRS Positivity (\u22652 Criteria)",
                "SOFA Score Increase (\u22652 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SOFA Score Increase (\u22652 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "Early Antibiotic/Culture Orders (within 2 hours)"
            ],
            "alignment_reasonings": [
                "The claim explicitly mentions the patient's age as 80, which clearly falls within the defined age category (\u226565 years) that indicates increased susceptibility to sepsis progression and risks. Thus, the alignment with this category is perfect.",
                "The claim of \"persistently low blood pressure\" closely relates to sepsis-associated hypotension, which is a specific criterion indicating progression toward septic shock. However, the claim doesn't specify whether the blood pressure is below the thresholds defined (e.g., SBP <90 mmHg), so while the alignment is strong due to conceptual overlap, it isn't perfectly matched because the exact parameters aren't confirmed.",
                "The claim mentions a persistently low mean arterial pressure (MAP), which is directly relevant to the Sepsis-Associated Hypotension category. However, the lack of specific numeric thresholds (e.g., MAP <70 mmHg) slightly reduces the alignment strength from perfect. The persistent low MAP strongly suggests progression toward septic shock, aligning well with this category.",
                "The claim mentions \"persistently low blood pressure and MAP,\" which directly corresponds to the category that indicates sepsis-associated hypotension (defined as SBP <90 mmHg, MAP <70 mmHg, or a significant drop from baseline). This condition highlights circulatory instability, aligning strongly with the category mentioned. The alignment rating is set to 0.9 because the claim does not provide specific numeric values or additional context that provides complete certainty regarding the sepsis criteria.",
                "A high temperature is directly related to the SIRS criteria, which include a temperature >38\u00b0C (100.4\u00b0F). Although the claim does not specify whether the temperature exceeds the SIRS threshold, it aligns well with the concept of systemic inflammation indicative of early sepsis. Therefore, the alignment is strong, though not complete without specific values, warranting a rating of 0.7.",
                "Low SpO2 indicates hypoxia, which conceptually relates to impaired oxygenation\u2014a factor indirectly associated with the SOFA score (specifically the PaO\u2082/FiO\u2082 ratio used to assess respiratory function). Although SpO2 is not a direct SOFA measure, it reflects potential deterioration in respiratory status, meriting a moderate alignment rating.",
                "The claim mentions \"a high temperature,\" which directly relates to one of the SIRS criteria (temperature >38\u00b0C). Low SpO2 is not a part of the SIRS criteria but can be associated with respiratory distress, which aligns with possible infection or respiratory issues pertinent to early sepsis identification. Although low SpO2 is not directly a SIRS measure, the overall claim touches on signs consistent with systemic inflammation and hypoxia, suggesting a meaningful but not perfect alignment with SIRS criteria.",
                "The claim of a high respiratory rate relates directly to one of the SIRS criteria (respiratory rate >20/min). This criterion is used to identify systemic inflammation and is consistent with early sepsis, indicating a strong but somewhat indirect alignment as only one SIRS criterion is mentioned.",
                "The claim cites a low platelet count, which is one of the components of the SOFA score (specifically, platelets < 100 \u00d7 10\u2079/L). This aligns strongly with the SOFA criteria used to assess the risk of sepsis through new organ dysfunction, though the claim does not specify the exact platelet count to fully confirm a SOFA score increase. Hence, the alignment is nearly perfect but not absolute.",
                "Elevated neutrophil bands suggest an inflammatory or infectious process likely related to systemic inflammation. Although neutrophil bands themselves aren't explicitly mentioned in the SIRS criteria, they often accompany changes in white blood cell counts, which are a direct SIRS criterion. This indirect yet relevant link results in a moderate alignment.",
                "A low white blood cell (WBC) count is explicitly one of the criteria under SIRS (WBC\u202f<\u202f4\u202f000/\u00b5L) used to identify systemic inflammation associated with early signs of sepsis. The claim directly mentions a low WBC count, which aligns strongly with SIRS criteria, justifying a high alignment rating.",
                "The claim mentions \"high respiratory rate\" and \"low WBC count,\" both of which are explicitly included in the SIRS criteria, indicating systemic inflammation consistent with early sepsis. The elevated neutrophil bands are suggestive of infection but are not directly part of the SIRS criteria, and the low platelet count is relevant to SOFA score assessment rather than SIRS. Therefore, the SIRS category is most aligned due to the inclusion of specific criteria, though not perfectly given other factors also implying sepsis, warranting a moderate alignment rating.",
                "The claim mentions the administration of Piperacillin-Tazobactam, which is a broad-spectrum antibiotic. This closely aligns with the category since administering antibiotics within a short period typically reflects suspicion of a serious infection like sepsis. The strong implication of sepsis risk is highly relevant but lacks the explicit timing detail to be a perfect match, resulting in a slightly less than perfect alignment.",
                "The administration of Piperacillin-Tazobactam, a broad-spectrum antibiotic, strongly suggests suspicion and treatment of a severe infection, likely sepsis. While the claim does not specify that this occurs within 2 hours, the act of administering such antibiotics aligns closely with the category that signifies clinician suspicion of serious infection. Hence, the alignment is very strong, given that early antibiotic administration is a key aspect of this category.",
                "The claim involves the administration of Piperacillin-Tazobactam, a broad-spectrum antibiotic, which is closely linked to early clinician intervention for suspected serious infection. The claim strongly suggests clinician suspicion of sepsis risk, aligning closely with this category. The alignment rating is high, as administering broad-spectrum antibiotics is a key indicator noted in the category description, though the exact timing of administration relative to sepsis suspicion isn't provided, slightly reducing the rating from a perfect score."
            ],
            "final_alignment_score": 0.8066666666666666
        },
        {
            "input": "24: HR, 67.0; 24: RR, 21.0; 24: SpO2, 100.0; 24: SBP, 150.0; 24: DBP, 75.0; 24: MAP, 100.0; 24: Pain, 4.0; 24: Temp, 98.1; 72: SpO2, 96.85; 73: HR, 73.429; 73: SpO2, 97.448; 73: 1min HRV, 39.770; 74: HR, 76.576; 74: RR, 24.111; 74: SpO2, 97.847; 74: 1min HRV, 79.227; 74: 5min HRV, 75.764; 75: HR, 73.879; 75: RR, 24.069; 75: SpO2, 99.052; 75: 1min HRV, 64.406; 76: HR, 72.508; 76: RR, 22.203; 76: SpO2, 100.0; 76: 1min HRV, 40.756; 77: HR, 73.593; 77: RR, 22.881; 77: SpO2, 100.0; 77: 1min HRV, 84.321; 78: HR, 71.828; 78: RR, 26.414; 78: 1min HRV, 66.034; 79: HR, 71.915; 79: RR, 24.475; 79: SpO2, 99.0; 79: 1min HRV, 68.889; 79: 5min HRV, 66.426; 80: HR, 73.241; 80: RR, 26.810; 80: 1min HRV, 49.479; 81: HR, 72.729; 81: RR, 27.203; 81: 1min HRV, 70.379; 82: HR, 70.390; 82: RR, 27.136; 82: SpO2, 88.647; 82: 1min HRV, 80.163; 83: HR, 72.052; 83: RR, 27.034; 83: SpO2, 100.0; 83: 1min HRV, 56.723; 84: HR, 72.051; 84: RR, 24.610; 84: SpO2, 100.0; 84: 1min HRV, 74.728; 84: 5min HRV, 68.300; 85: HR, 71.586; 85: RR, 24.569; 85: SpO2, 99.909; 85: 1min HRV, 38.538; 86: HR, 70.627; 86: RR, 23.847; 86: SpO2, 100.0; 86: 1min HRV, 67.076; 87: POC PH (V) ISTAT, 7.30; 87: POC PCO2 (V) ISTAT, 51.4 mmHg; 87: POC O2 SATURATION ISTAT VENOUS, 30 %; 87: POC PO2 (V) ISTAT, 21 mmHg; 87: POC BASE EXCESS ISTAT, -1 mmol/L; 87: POC LACTATE ISTAT, 1.03 mmol/L; 87: POC TCO2 (V) ISTAT, 27 mmol/L; 87: POC HCO3 (V) ISTAT, 25.2 mmol/L; 87: HR, 70.966; 87: RR, 24.017; 87: SpO2, 100.0; 87: 1min HRV, 47.630; 88: HR, 70.305; 88: RR, 24.085; 88: SpO2, 100.0; 88: 1min HRV, 27.826; 89: HR, 70.034; 89: RR, 21.017; 89: SpO2, 100.0; 89: 1min HRV, 54.584; 89: 5min HRV, 49.265; 90: HR, 72.414; 90: RR, 21.862; 90: SpO2, 100.0; 90: 1min HRV, 61.558; 91: HR, 71.169; 91: RR, 22.051; 91: 1min HRV, 60.250; 92: HR, 71.121; 92: RR, 29.707; 92: SpO2, 99.957; 92: 1min HRV, 82.983; 93: HR, 71.661; 93: RR, 28.237; 93: SpO2, 99.569; 93: 1min HRV, 52.021; 94: HR, 72.932; 94: RR, 27.034; 94: SpO2, 99.322; 94: 1min HRV, 61.645; 94: 5min HRV, 65.404; 95: HR, 70.897; 95: RR, 23.328; 95: SpO2, 97.931; 95: 1min HRV, 83.476; 96: HR, 70.915; 96: RR, 22.610; 96: SpO2, 96.0; 96: 1min HRV, 129.629; 97: HR, 73.069; 97: RR, 22.310; 97: 1min HRV, 81.351; 98: HR, 70.983; 98: RR, 26.610; 98: SpO2, 96.923; 98: 1min HRV, 77.855; 99: HR, 72.441; 99: RR, 24.322; 99: SpO2, 97.844; 99: 1min HRV, 65.983; 99: 5min HRV, 85.807; 100: HR, 72.948; 100: RR, 31.707; 100: 1min HRV, 60.048; 101: HR, 70.661; 101: RR, 28.932; 101: SpO2, 96.357; 101: 1min HRV, 75.586; 102: HR, 71.569; 102: RR, 29.517; 102: SpO2, 98.471; 102: 1min HRV, 50.917; 103: HR, 71.983; 103: RR, 29.288; 103: SpO2, 98.017; 103: 1min HRV, 37.331; 104: HR, 72.390; 104: RR, 24.695; 104: SpO2, 96.373; 104: 1min HRV, 57.989; 104: 5min HRV, 58.190; 105: HR, 72.534; 105: RR, 29.086; 105: SpO2, 97.172; 105: 1min HRV, 42.429; 106: HR, 72.576; 106: RR, 29.508; 106: SpO2, 97.254; 106: 1min HRV, 54.927; 107: HR, 73.741; 107: RR, 26.862; 107: SpO2, 97.0; 107: 1min HRV, 34.070; 108: WAM DIFTYP, AUTO; 108: HEMATOCRIT (HCT), 32.9 %; 108: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 108: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 27.0 pg; 108: NRBC PERCENT (HEMATOLOGY), 0.0 %; 108: RED CELL DISTRIBUTION WIDTH (RDW), 14.5 %; 108: MONOCYTE % (AUTO DIFF), 7.9 %; 108: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.50 K/uL; 108: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.11 K/uL; 108: NEUTROPHIL ABSOLUTE (AUTO DIFF), 3.91 K/uL; 108: LYMPHOCYTE % (AUTO DIFF), 35.1 %; 108: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 108: WHITE BLOOD CELLS (WBC), 7.1 K/uL; 108: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 108: MONOCYTE ABSOLUTE (AUTO DIFF), 0.56 K/uL; 108: EOSINOPHIL % (AUTO DIFF), 1.5 %; 108: RED BLOOD CELLS (RBC), 4.08 MIL/uL; 108: BASOPHIL % (AUTO DIFF), 0.4 %; 108: NEUTROPHIL % (AUTO DIFF), 54.8 %; 108: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 108: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.4 g/dL; 108: HEMOGLOBIN (HGB), 11.0 g/dL; 108: PLATELET COUNT (PLT), 181 K/uL; 108: MEAN CORPUSCULAR VOLUME (MCV), 80.6 fL; 108: HR, 73.237; 108: RR, 24.119; 108: SpO2, 96.424; 108: 1min HRV, 72.738; 109: HR, 73.610; 109: RR, 23.203; 109: SpO2, 96.0; 109: 1min HRV, 54.247; 109: 5min HRV, 53.550; 110: HR, 75.207; 110: RR, 22.914; 110: SpO2, 96.0; 110: 1min HRV, 47.829; 111: HR, 80.424; 111: RR, 25.814; 111: 1min HRV, 65.162; 112: HR, 81.845; 112: RR, 25.655; 112: SpO2, 96.0; 112: 1min HRV, 56.303; 113: HR, 79.576; 113: RR, 24.695; 113: SpO2, 96.405; 113: 1min HRV, 69.113; 114: HR, 79.864; 114: RR, 23.610; 114: SpO2, 97.0; 114: 1min HRV, 58.916; 114: 5min HRV, 62.870; 114: SBP, 162.0; 114: DBP, 89.0; 114: MAP, 113.333; 114: LPM O2, 2.0; 114: Pain, 4.0; 115: HR, 75.241; 115: RR, 26.397; 115: SpO2, 97.0; 115: 1min HRV, 74.272; 115: SBP, 162.0; 115: DBP, 89.0; 115: MAP, 113.333; 116: HR, 76.746; 116: RR, 30.831; 116: SpO2, 96.932; 116: 1min HRV, 60.360; 117: HR, 76.017; 117: RR, 29.034; 117: SpO2, 97.771; 117: 1min HRV, 54.618; 118: HR, 75.661; 118: RR, 28.203; 118: SpO2, 97.812; 118: 1min HRV, 64.985; 119: HR, 75.379; 119: RR, 25.707; 119: SpO2, 97.86; 119: 1min HRV, 44.094; 119: 5min HRV, 60.569; 0: Age, 90; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 67.0; 0: Triage RR, 21.0; 0: Triage SBP, 150.0; 0: Triage DBP, 75.0; 0: Triage acuity, 2-Emergent; 0: CC, MULTIPLE COMPLAINTS",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The patient's vital signs and laboratory results do not indicate a high risk of sepsis. Although there are occasional increases in respiratory rate, they are not consistently high, and the oxygen saturation remains stable, indicating effective oxygenation. The heart rate, blood pressure, and temperature are within normal ranges. The POC lactate level is normal (1.03 mmol/L), and the White Blood Cell count is not elevated, which are important indicators for assessing sepsis risk. Thus, the overall data suggests a low risk of developing sepsis within the next 12 hours.",
            "claims": [
                "The patient's vital signs do not indicate a high risk of sepsis.",
                "There are occasional increases in the patient's respiratory rate.",
                "The increases in respiratory rate are not consistently high.",
                "The oxygen saturation remains stable.",
                "Stable oxygen saturation indicates effective oxygenation.",
                "The heart rate is within normal ranges.",
                "The blood pressure is within normal ranges.",
                "The temperature is within normal ranges.",
                "The POC lactate level is normal at 1.03 mmol/L.",
                "The White Blood Cell count is not elevated.",
                "Normal POC lactate levels and a non-elevated White Blood Cell count are important indicators for assessing sepsis risk.",
                "Overall data suggests a low risk of developing sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The POC lactate level is normal at 1.03 mmol/L.",
                "The White Blood Cell count is not elevated."
            ],
            "alignment_scores": [
                0.1,
                0.2
            ],
            "alignment_category": [
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "SIRS Positivity (\u22652 Criteria)"
            ],
            "alignment_reasonings": [
                "Although the claim references lactate levels, the value provided (1.03 mmol/L) is well below the threshold for elevated serum lactate as defined in the expert category (\u22652 mmol/L). Therefore, it has minimal alignment with the category, as it does not indicate a high risk of tissue hypoperfusion or sepsis.",
                "The claim states that the White Blood Cell (WBC) count is not elevated. Since an elevated WBC is one of the criteria for SIRS, the absence of this criteria suggests a potential reduced risk of sepsis. While this relates to the concept of SIRS, it doesn't meet the criteria for SIRS positivity, making the alignment weak."
            ],
            "final_alignment_score": 0.15000000000000002
        },
        {
            "input": "4: HR, 106.0; 4: RR, 16.0; 4: SpO2, 98.0; 4: SBP, 131.0; 4: DBP, 64.0; 4: MAP, 86.333; 4: Pain, 5.0; 4: Temp, 99.7; 21: POC PH (V) ISTAT, 7.51; 21: POC HCO3 (V) ISTAT, 23.9 mmol/L; 21: POC BASE EXCESS ISTAT, 1 mmol/L; 21: POC PCO2 (V) ISTAT, 30.3 mmHg; 21: POC LACTATE ISTAT, 1.29 mmol/L; 21: POC O2 SATURATION ISTAT VENOUS, 55 %; 21: POC PO2 (V) ISTAT, 26 mmHg; 21: POC TCO2 (V) ISTAT, 25 mmol/L; 45: WAM DIFTYP, AUTO; 45: MONOCYTE % (AUTO DIFF), 1.4 %; 45: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 45: BASOPHIL % (AUTO DIFF), 0.2 %; 45: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 45: MONOCYTE ABSOLUTE (AUTO DIFF), 0.09 K/uL; 45: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.7 pg; 45: HEMATOCRIT (HCT), 42.6 %; 45: RED CELL DISTRIBUTION WIDTH (RDW), 12.9 %; 45: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 45: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 45: NRBC PERCENT (HEMATOLOGY), 0.0 %; 45: RED BLOOD CELLS (RBC), 4.98 MIL/uL; 45: WHITE BLOOD CELLS (WBC), 6.6 K/uL; 45: NEUTROPHIL ABSOLUTE (AUTO DIFF), 5.91 K/uL; 45: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.52 K/uL; 45: BASOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 45: EOSINOPHIL % (AUTO DIFF), 0.2 %; 45: NEUTROPHIL % (AUTO DIFF), 90.0 %; 45: HEMOGLOBIN (HGB), 14.3 g/dL; 45: LYMPHOCYTE % (AUTO DIFF), 7.9 %; 45: MEAN CORPUSCULAR VOLUME (MCV), 85.5 fL; 45: PLATELET COUNT (PLT), 137 K/uL; 45: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.6 g/dL; 49: SpO2, 96.216; 50: HR, 97.929; 50: RR, 21.923; 50: SpO2, 97.105; 50: Perf, 2.812; 50: 1min HRV, 29.329; 50: SBP, 116.0; 50: DBP, 63.0; 50: MAP, 80.667; 51: HR, 96.559; 51: RR, 33.831; 51: SpO2, 97.361; 51: Perf, 2.605; 51: 1min HRV, 34.380; 52: HR, 96.328; 52: RR, 30.379; 52: SpO2, 97.172; 52: Perf, 3.327; 52: 1min HRV, 24.923; 52: 5min HRV, 30.085; 53: HR, 96.034; 53: RR, 25.712; 53: SpO2, 97.627; 53: Perf, 3.753; 53: 1min HRV, 25.405; 54: HR, 95.763; 54: RR, 37.576; 54: SpO2, 96.458; 54: Perf, 3.767; 54: 1min HRV, 28.660; 55: HR, 95.948; 55: RR, 28.862; 55: SpO2, 96.862; 55: Perf, 3.849; 55: 1min HRV, 23.770; 56: HR, 95.759; 56: RR, 34.759; 56: SpO2, 96.776; 56: Perf, 3.85; 56: 1min HRV, 25.753; 57: HR, 97.542; 57: RR, 29.661; 57: SpO2, 96.407; 57: Perf, 3.858; 57: 1min HRV, 28.382; 57: 5min HRV, 26.741; 58: HR, 96.424; 58: RR, 28.407; 58: SpO2, 96.051; 58: Perf, 3.928; 58: 1min HRV, 26.958; 59: HR, 98.508; 59: RR, 28.729; 59: SpO2, 96.322; 59: Perf, 4.044; 59: 1min HRV, 27.299; 59: NS IV BOLUS -, 1000 ML; 60: HR:, 97.828; 60: RR, 26.603; 60: SpO2, 96.483; 60: Perf, 3.747; 60: 1min HRV, 30.139; 61: HR, 96.102; 61: RR, 33.576; 61: SpO2, 95.220; 61: Perf, 3.977; 61: 1min HRV, 21.766; 62: HR, 95.276; 62: RR, 34.759; 62: SpO2, 95.103; 62: Perf, 4.003; 62: 1min HRV, 13.770; 62: 5min HRV, 26.118; 63: PART. THROMBOPLASTIN TIME, 28.5 seconds; 63: HR, 95.186; 63: RR, 32.966; 63: SpO2, 95.458; 63: Perf, 3.943; 63: 1min HRV, 18.218; 64: HR, 96.898; 64: RR, 28.034; 64: SpO2, 96.017; 64: Perf, 3.907; 64: 1min HRV, 26.648; 65: HR, 95.466; 65: RR, 26.655; 65: SpO2, 96.534; 65: Perf, 3.322; 65: 1min HRV, 19.805; 66: HR, 94.085; 66: RR, 35.492; 66: SpO2, 98.0; 66: Perf, 3.414; 66: 1min HRV, 27.787; 67: HR, 96.259; 67: RR, 24.069; 67: SpO2, 97.586; 67: Perf, 3.469; 67: 1min HRV, 20.987; 67: 5min HRV, 24.017; 68: HR, 101.203; 68: RR, 24.712; 68: SpO2, 98.627; 68: Perf, 3.187; 68: 1min HRV, 42.194; 69: HR, 102.483; 69: RR, 25.672; 69: SpO2, 98.466; 69: Perf, 2.435; 69: 1min HRV, 24.507; 70: HR, 98.305; 70: RR, 35.390; 70: SpO2, 97.797; 70: Perf, 3.664; 70: 1min HRV, 24.606; 71: HR, 97.966; 71: RR, 34.407; 71: SpO2, 97.0; 71: Perf, 4.119; 71: 1min HRV, 25.309; 72: HR, 97.552; 72: RR, 34.431; 72: SpO2, 96.897; 72: Perf, 4.384; 72: 1min HRV, 22.467; 72: 5min HRV, 30.756; 73: HR, 97.474; 73: RR, 32.919; 73: SpO2, 97.322; 73: Perf, 4.642; 73: 1min HRV, 24.391; 74: SpO2, 97.0; 74: Perf, 4.79; 75: BNP NT-PRO, 454 pg/mL; 75: HR, 98.0; 75: RR, 30.0; 75: SpO2, 97.0; 75: LPM O2, 2.0; 76: INR, 1.3; 76: PROTHROMBIN TIME, 15.8 seconds; 77: 5min HRV, 24.391; 82: HR, 95.0; 82: RR, 31.0; 82: SpO2, 96.0; 82: SBP, 104.0; 82: DBP, 58.0; 82: MAP, 73.333; 82: LPM O2, 2.0; 82: Pain, 0.0; 90: CREATININE, 1.38 mg/dL; 90: EGFR REFIT WITHOUT RACE (2021), 58 mL/min/1.73 m2; 90: EGFR FOR AFRICAN AMERICAN, 67 mL/min/1.73 m2; 90: ANION GAP, 15 mmol/L; 90: AST (SGOT), 42 U/L; 90: CO2, 23 mmol/L; 90: GLUCOSE, 131 mg/dL; 90: CORRECTED CALCIUM, 8.4 mg/dL; 90: ALT (SGPT), 17 U/L; 90: SODIUM, 138 mmol/L; 90: GLOBULIN, 2.9 g/dL; 90: BILIRUBIN TOTAL, 0.9 mg/dL; 90: POTASSIUM, 3.6 mmol/L; 90: BLOOD UREA NITROGEN (BUN), 21 mg/dL; 90: ALBUMIN, 4.1 g/dL; 90: CALCIUM, 8.5 mg/dL; 90: CHLORIDE, 100 mmol/L; 90: PROTEIN TOTAL, 7.0 g/dL; 90: ALKALINE PHOSPHATASE, 72 U/L; 93: IOPAMIDOL, 76 % IV SOLN (RADIOLOGY) 500 ML; 109: SpO, 2: 97.0; 110: SpO2, 97.0; 110: Perf, 3.739; 111: SpO2, 97.0; 111: Perf, 3.808; 112: SpO2, 97.0; 112: Perf, 3.783; 113: SpO2, 97.0; 113: Perf, 3.796; 114: SpO2, 96.862; 114: Perf, 3.921; 115: PH, URINE (UA): 5.0; 115: KETONE, URINE (UA): Negative; 115: NITRITE, URINE (UA): Positive; 115: GLUCOSE, URINE (UA): Negative; 115: SPECIFIC GRAVITY, URINE (UA): 1.011; 115: SpO2, 96.593; 115: Perf, 6.781; 116: HR, 97.333; 116: RR, 34.308; 116: SpO2, 97.310; 116: Perf, 7.19; 116: 1min HRV, 16.514; 117: HR, 97.136; 117: RR, 32.847; 117: SpO2, 97.339; 117: Perf, 7.19; 117: 1min HRV, 11.804; 117: 5min HRV, 13.074; 118: HR, 96.881; 118: RR, 33.305; 118: SpO2, 97.0; 118: Perf, 7.1; 118: 1min HRV, 12.584; 119: HR, 96.310; 119: RR, 32.103; 119: SpO2, 96.759; 119: Perf, 6.88; 119: 1min HRV, 3.420; 0: Age, 56; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.6; 0: Triage HR, 106.0; 0: Triage RR, 16.0; 0: Triage SBP, 131.0; 0: Triage DBP, 64.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER,BREATHING PROBLEM",
            "answer": true,
            "llm_answer": "No",
            "llm_explanation": "The patient exhibits elevated heart rate and respiratory rate, which are concerning, but other indicators like temperature, blood pressure, and lab results such as lactate levels do not strongly suggest sepsis. The lactate level is within normal range, and there are no critical abnormalities in the metabolic panel. Although there are some symptoms and vital signs that require monitoring, the available clinical data does not indicate an imminent risk of sepsis within the next 12 hours.",
            "claims": [
                "The patient exhibits an elevated heart rate.",
                "The patient exhibits an elevated respiratory rate.",
                "An elevated heart rate is concerning.",
                "An elevated respiratory rate is concerning.",
                "Other indicators such as temperature, blood pressure, and lab results do not strongly suggest sepsis.",
                "The lactate level is within normal range.",
                "There are no critical abnormalities in the metabolic panel.",
                "Some symptoms and vital signs require monitoring.",
                "The available clinical data does not indicate an imminent risk of sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The patient exhibits an elevated heart rate.",
                "An elevated heart rate is concerning.",
                "An elevated respiratory rate is concerning.",
                "The available clinical data does not indicate an imminent risk of sepsis within the next 12 hours."
            ],
            "alignment_scores": [
                0.7,
                0.8,
                0.7,
                0.2
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "High qSOFA Score (\u22652)",
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "An elevated heart rate is one of the explicit criteria listed under SIRS, making it relevant to this category. However, the claim does not mention the presence of any other SIRS criteria, so the alignment is not complete. Thus, while relevant, it is not a perfect match, leading to a rating of 0.7.",
                "An elevated heart rate is explicitly listed as one of the criteria in the SIRS (Systemic Inflammatory Response Syndrome) category. While this indicates a systemic inflammatory response associated with early sepsis, the claim does not provide enough information to confirm the presence of other SIRS criteria required for positivity. However, the alignment is strong due to the explicit mention of heart rate in the SIRS criteria.",
                "An elevated respiratory rate is directly mentioned as a part of the qSOFA criteria (respiratory rate \u226522/min is one of the components). However, the claim does not specify the exact rate or state that it meets or exceeds the threshold for qSOFA. Therefore, while it potentially aligns with the concern for sepsis risk and organ dysfunction, the alignment is not perfect due to the lack of specific detail required to fully satisfy the qSOFA criterion.",
                "The claim states that there is no imminent risk of sepsis, which suggests that clinical metrics do not indicate deterioration. The NEWS score evaluates the risk of deterioration from vital signs; low NEWS would align with no imminent risk. However, the claim doesn't provide specific NEWS data, so alignment is weak."
            ],
            "final_alignment_score": 0.6000000000000001
        },
        {
            "input": "6: HR, 113.0; 6: RR, 18.0; 6: SpO2, 100.0; 6: SBP, 129.0; 6: DBP, 99.0; 6: MAP, 109.0; 6: Pain, 8.0; 6: Temp, 97.5; 14: SpO2, 98.0; 14: Perf, 3.832; 15: SpO2, 98.0; 15: Perf, 2.722; 16: SpO2, 97.828; 16: Perf, 2.920; 17: SpO2, 98.797; 17: Perf, 4.697; 18: SpO2, 97.949; 18: Perf, 5.500; 19: SpO2, 97.776; 19: Perf, 4.514; 20: SpO2, 98.186; 20: Perf, 3.809; 21: SpO2, 98.0; 21: Perf, 5.181; 22: POC, HCG, ISTAT QUALITATIVE: Negative; 22: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 22: SpO2, 97.237; 22: Perf, 5.756; 23: POC PH (V) ISTAT, 7.44; 23: POC O2 SATURATION ISTAT VENOUS, 76 %; 23: POC BASE EXCESS ISTAT, 0 mmol/L; 23: POC LACTATE ISTAT, 1.46 mmol/L; 23: POC PO2 (V) ISTAT, 39 mmHg; 23: POC PCO2 (V) ISTAT, 36.1 mmHg; 23: POC HCO3 (V) ISTAT, 24.6 mmol/L; 23: POC TCO2 (V) ISTAT, 26 mmol/L; 23: SpO2, 98.051; 23: Perf, 3.662; 24: SpO2, 97.190; 24: Perf, 4.291; 25: SpO2, 97.559; 25: Perf, 2.529; 26: SpO2, 97.534; 26: Perf, 2.696; 27: SpO2, 98.780; 27: Perf, 3.376; 28: SpO2, 98.85; 28: Perf, 4.125; 38: HR, 96.0; 38: SpO2, 99.0; 38: SBP, 130.0; 38: DBP, 89.0; 38: MAP, 102.667; 38: Pain, 8.0; 40: SpO2, 98.781; 40: HYDROMORPHONE, 1 MG/ML INJ SYRG; 40: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 41: SpO2, 98.552; 41: Perf, 1.926; 42: SpO2, 97.983; 42: Perf, 1.936; 43: SpO2, 97.793; 43: Perf, 1.598; 44: SpO2, 98.186; 44: Perf, 1.330; 45: SpO2, 97.627; 45: Perf, 4.355; 46: SpO2, 95.948; 46: Perf, 6.526; 47: SpO2, 95.814; 47: Perf, 7.211; 48: SpO2, 94.897; 48: Perf, 7.489; 49: SpO2, 94.949; 49: Perf, 7.38; 50: SpO2, 95.288; 50: Perf, 6.922; 51: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.4 pg; 51: RED CELL DISTRIBUTION WIDTH (RDW), 15.7 %; 51: PLATELET COUNT (PLT), 237 K/uL; 51: RED BLOOD CELLS (RBC), 4.69 MIL/uL; 51: WHITE BLOOD CELLS (WBC), 14.3 K/uL; 51: HEMOGLOBIN (HGB), 13.8 g/dL; 51: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.8 g/dL; 51: HEMATOCRIT (HCT), 40.8 %; 51: MEAN CORPUSCULAR VOLUME (MCV), 87.0 fL; 51: SpO2, 95.534; 51: Perf, 6.612; 52: SpO2, 95.136; 52: Perf, 6.263; 53: SpO2, 95.724; 53: Perf, 5.561; 54: SpO2, 96.712; 54: Perf, 4.76; 55: SpO2, 97.237; 55: Perf, 5.833; 56: SpO2, 96.362; 56: Perf, 4.918; 57: SpO2, 95.847; 57: Perf, 3.894; 58: SpO2, 97.052; 58: Perf, 3.035; 59: SpO2, 97.932; 59: Perf, 1.960; 60: SpO2, 97.508; 60: Perf, 1.363; 61: SpO2, 98.621; 61: Perf, 0.817; 62: SpO2, 98.441; 62: Perf, 0.831; 63: SpO2, 97.811; 63: Perf, 0.81; 64: SpO2, 97.457; 64: Perf, 0.933; 65: SpO2, 98.0; 65: Perf, 1.696; 66: SpO2, 97.017; 66: Perf, 2.477; 67: SpO2, 97.0; 67: Perf, 2.975; 68: SpO2, 96.293; 68: Perf, 3.856; 69: SpO2, 97.017; 69: Perf, 2.624; 70: BILIRUBIN TOTAL, 0.8 mg/dL; 70: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 70: EGFR FOR AFRICAN AMERICAN, 83 mL/min/1.73 m2; 70: CALCIUM, 8.7 mg/dL; 70: EGFR REFIT WITHOUT RACE (2021), 72 mL/min/1.73 m2; 70: ALT (SGPT), 35 U/L; 70: CHLORIDE, 104 mmol/L; 70: PROTEIN TOTAL, 6.4 g/dL; 70: GLOBULIN, 3.0 g/dL; 70: SODIUM, 137 mmol/L; 70: CO2, 23 mmol/L; 70: ANION GAP, 10 mmol/L; 70: POTASSIUM, 4.2 mmol/L; 70: CORRECTED CALCIUM, 9.2 mg/dL; 70: GLUCOSE, 197 mg/dL; 70: CREATININE, 1.04 mg/dL; 70: AST (SGOT), 58 U/L; 70: ALBUMIN, 3.4 g/dL; 70: ALKALINE PHOSPHATASE, 152 U/L; 70: SpO2, 96.458; 70: Perf, 3.956; 71: SpO2, 95.983; 71: Perf, 3.871; 72: SpO2, 97.136; 72: Perf, 2.959; 73: SpO2, 97.552; 73: Perf, 1.859; 74: SpO2, 96.831; 74: Perf, 1.531; 75: SpO2, 96.672; 75: Perf, 2.519; 76: SpO2, 96.034; 76: Perf, 4.384; 77: SpO2, 96.068; 77: Perf, 5.572; 78: SpO2, 96.259; 78: Perf, 5.864; 79: SpO2, 96.339; 79: Perf, 4.983; 80: SpO2, 95.948; 80: Perf, 4.156; 81: SpO2, 96.0; 81: Perf, 6.151; 82: SpO2, 95.322; 82: Perf, 6.860; 83: SpO2, 95.569; 83: Perf, 6.102; 84: SpO2, 97.542; 84: Perf, 2.928; 85: SpO2, 97.603; 85: Perf, 2.236; 86: SpO2, 97.407; 86: Perf, 1.993; 87: SpO2, 97.763; 87: Perf, 2.127; 88: SpO2, 98.517; 88: Perf, 1.963; 89: SpO2, 98.163; 89: Perf, 2.272; 90: SpO2, 97.983; 90: Perf, 1.775; 91: SpO2, 98.712; 91: Perf, 1.189; 92: SpO2, 98.136; 92: Perf, 1.692; 93: SpO2, 98.0; 93: Perf, 1.553; 94: SpO2, 97.695; 94: Perf, 1.424; 95: SpO2, 97.828; 95: Perf, 1.935; 96: SpO2, 97.864; 96: Perf, 2.417; 97: SpO2, 97.424; 97: Perf, 3.952; 98: SpO2, 97.948; 98: Perf, 2.007; 98: Pain, 8.0; 98: HYDROMORPHONE, 1 MG/ML INJ SYRG; 99: SpO, 2: 97.407; 99: Perf, 1.745; 100: SpO2, 97.207; 100: Perf, 2.058; 101: SpO2, 98.475; 101: Perf, 1.515; 102: SpO2, 96.559; 102: Perf, 4.064; 103: SpO2, 95.672; 103: Perf, 6.009; 104: SpO2, 95.797; 104: Perf, 6.499; 105: LIPASE, 3 U/L; 105: SpO2, 96.690; 105: Perf, 6.050; 106: SpO2, 96.085; 106: Perf, 4.536; 107: HR, 100.0; 107: RR, 16.0; 107: SpO2, 96.103; 107: Perf, 3.992; 107: SBP, 122.0; 107: DBP, 83.0; 107: MAP, 96.0; 107: Pain, 7.0; 107: LR IV BOLUS -, 1000 ML; 108: SpO, 2: 95.830; 108: Perf, 4.809; 109: SpO2, 96.593; 109: Perf, 2.287; 110: SpO2, 96.862; 110: Perf, 3.286; 111: SpO2, 96.814; 111: Perf, 5.008; 112: SpO2, 96.155; 112: Perf, 6.273; 113: SpO2, 96.0; 113: Perf, 7.343; 114: SpO2, 96.0; 114: Perf, 8.217; 115: SpO2, 96.0; 115: Perf, 8.392; 116: SpO2, 96.0; 116: Perf, 8.23; 117: SpO2, 96.0; 117: Perf, 7.856; 118: SpO2, 96.186; 118: Perf, 7.616; 119: SpO2, 96.254; 119: Perf, 5.937; 0: Age, 30; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.4; 0: Triage HR, 113.0; 0: Triage RR, 18.0; 0: Triage SBP, 129.0; 0: Triage DBP, 99.0; 0: Triage acuity, 2-Emergent; 0: CC, ABDOMINAL PAIN",
            "answer": true,
            "llm_answer": "No",
            "llm_explanation": "The patient exhibits a number of stable vital signs and lab values that are not indicative of sepsis risk. Although there are instances of elevated heart rate and WBC count, there is also a lack of significant abnormalities in vital signs like blood pressure, respiratory rate, or temperature that typically accompany sepsis. Furthermore, lactate levels and venous blood gases are within normal ranges, and SpO2 levels remain consistently adequate, suggesting that the patient is not at high risk for developing sepsis within the next 12 hours.",
            "claims": [
                "The patient exhibits a number of stable vital signs and lab values.",
                "The stable vital signs and lab values are not indicative of sepsis risk.",
                "There are instances of elevated heart rate.",
                "There are instances of elevated WBC count.",
                "There is a lack of significant abnormalities in blood pressure.",
                "There is a lack of significant abnormalities in respiratory rate.",
                "There is a lack of significant abnormalities in temperature.",
                "These abnormalities typically accompany sepsis.",
                "Lactate levels are within normal ranges.",
                "Venous blood gases are within normal ranges.",
                "SpO2 levels remain consistently adequate.",
                "The findings suggest that the patient is not at high risk for developing sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The stable vital signs and lab values are not indicative of sepsis risk.",
                "There are instances of elevated heart rate."
            ],
            "alignment_scores": [
                0.7,
                0.8
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "SIRS Positivity (\u22652 Criteria)"
            ],
            "alignment_reasonings": [
                "The claim suggests that the patient's vital signs and lab values are stable, implying they do not meet criteria for deterioration as predicted by tools like the NEWS score. While it doesn\u2019t directly quantify a low NEWS score, the indirect negation of sepsis risk through stability aligns it with the concept of not reaching a concerning NEWS threshold, indicative of low sepsis risk. Hence, the alignment is moderate due to this indirect conclusion.",
                "Elevated heart rate is one of the SIRS criteria used to identify systemic inflammation, which is consistent with early sepsis. While the claim does not specify the heart rate is above 90 bpm, it strongly suggests this criterion is met or near being met for SIRS positivity, thus closely aligning with the category."
            ],
            "final_alignment_score": 0.75
        },
        {
            "input": "6: Pain, 3.0; 11: HR, 110.0; 11: RR, 16.0; 11: SpO2, 98.0; 11: SBP, 101.0; 11: DBP, 71.0; 11: MAP, 81.0; 11: Temp, 100.6; 72: HR, 92.222; 72: RR, 21.875; 72: 1min HRV, 43.704; 73: HR, 89.305; 73: RR, 17.288; 73: SpO2, 98.8; 73: 1min HRV, 29.523; 73: 5min HRV, 33.011; 74: HR, 90.915; 74: RR, 18.271; 74: SpO2, 99.339; 74: 1min HRV, 25.600; 75: HR, 91.966; 75: RR, 12.310; 75: SpO2, 99.067; 75: 1min HRV, 33.168; 76: HR, 92.542; 76: RR, 11.017; 76: SpO2, 98.478; 76: 1min HRV, 25.871; 77: HR, 90.724; 77: RR, 11.052; 77: 1min HRV, 46.247; 78: HR, 91.0; 78: RR, 13.983; 78: 1min HRV, 41.994; 78: 5min HRV, 36.581; 79: HR, 89.271; 79: RR, 21.220; 79: SpO2, 98.630; 79: 1min HRV, 38.635; 80: HR, 90.362; 80: RR, 17.621; 80: SpO2, 98.793; 80: 1min HRV, 25.565; 81: HR, 89.724; 81: RR, 16.879; 81: SpO2, 99.707; 81: Perf, 1.096; 81: 1min HRV, 23.929; 82: HR, 91.424; 82: RR, 17.610; 82: SpO2, 98.949; 82: Perf, 1.005; 82: 1min HRV, 24.082; 83: HR, 88.458; 83: RR, 18.373; 83: SpO2, 98.864; 83: Perf, 0.826; 83: 1min HRV, 38.059; 83: 5min HRV, 31.944; 83: ACETAMINOPHEN, 500 MG PO TABS; 83: OXYCODONE, 5 MG PO TABS; 83: KETOROLAC, 15 MG/ML INJ SOLN; 84: HR:, 90.254; 84: RR, 16.983; 84: SpO2, 99.051; 84: Perf, 0.804; 84: 1min HRV, 30.058; 85: HR, 90.534; 85: RR, 12.517; 85: SpO2, 98.579; 85: Perf, 0.836; 85: 1min HRV, 27.375; 86: HR, 96.610; 86: RR, 15.678; 86: SpO2, 98.797; 86: Perf, 0.833; 86: 1min HRV, 31.678; 87: HR, 91.914; 87: RR, 20.276; 87: SpO2, 99.5; 87: Perf, 0.746; 87: 1min HRV, 29.713; 88: HR, 91.593; 88: RR, 20.780; 88: SpO2, 99.339; 88: Perf, 0.707; 88: 1min HRV, 20.362; 88: 5min HRV, 31.524; 89: HR, 88.186; 89: RR, 24.390; 89: SpO2, 99.847; 89: Perf, 0.611; 89: 1min HRV, 28.514; 90: HR, 86.017; 90: RR, 24.776; 90: SpO2, 99.0; 90: Perf, 0.495; 90: 1min HRV, 31.844; 91: HR, 86.780; 91: RR, 23.254; 91: SpO2, 99.339; 91: Perf, 0.51; 91: 1min HRV, 45.691; 92: HR, 89.655; 92: RR, 23.328; 92: SpO2, 98.966; 92: Perf, 0.562; 92: 1min HRV, 34.010; 93: HR, 90.207; 93: RR, 21.879; 93: SpO2, 99.862; 93: Perf, 0.567; 93: 1min HRV, 20.106; 93: 5min HRV, 35.050; 93: Pain, 2.0; 94: POC PH (V) ISTAT, 7.42; 94: POC BASE EXCESS ISTAT, 3 mmol/L; 94: POC PO2 (V) ISTAT, 21 mmHg; 94: POC TCO2 (V) ISTAT, 29 mmol/L; 94: POC PCO2 (V) ISTAT, 42.8 mmHg; 94: POC O2 SATURATION ISTAT VENOUS, 35 %; 94: POC LACTATE ISTAT, 0.65 mmol/L; 94: POC HCO3 (V) ISTAT, 27.7 mmol/L; 94: HR, 90.55; 94: RR, 17.9; 94: SpO2, 98.942; 94: Perf, 0.58; 94: 1min HRV, 31.606; 95: HR, 88.534; 95: RR, 22.086; 95: SpO2, 99.622; 95: Perf, 0.550; 95: 1min HRV, 26.931; 96: HR, 91.017; 96: RR, 22.576; 96: SpO2, 98.847; 96: Perf, 0.441; 96: 1min HRV, 25.494; 96: NORMOSOL-R IV BOLUS -, 2000 ML; 97: HR:, 85.966; 97: RR, 27.155; 97: SpO2, 99.810; 97: Perf, 0.425; 97: 1min HRV, 25.770; 98: HR, 86.593; 98: RR, 22.780; 98: SpO2, 99.559; 98: Perf, 0.628; 98: 1min HRV, 36.433; 98: 5min HRV, 32.757; 99: HR, 84.576; 99: RR, 19.424; 99: SpO2, 99.763; 99: Perf, 1.418; 99: 1min HRV, 43.134; 100: HR, 88.603; 100: RR, 20.328; 100: SpO2, 99.517; 100: Perf, 0.829; 100: 1min HRV, 28.072; 101: HR, 88.305; 101: RR, 22.542; 101: SpO2, 99.288; 101: Perf, 0.703; 101: 1min HRV, 62.987; 102: HR, 87.517; 102: RR, 19.776; 102: SpO2, 99.259; 102: Perf, 0.7; 102: 1min HRV, 30.948; 103: HR, 90.356; 103: RR, 20.305; 103: SpO2, 99.288; 103: Perf, 0.7; 103: 1min HRV, 20.254; 103: 5min HRV, 41.813; 104: HR, 89.086; 104: RR, 18.121; 104: SpO2, 99.362; 104: Perf, 0.7; 104: 1min HRV, 24.861; 105: HR, 90.034; 105: RR, 20.847; 105: SpO2, 99.305; 105: Perf, 0.7; 105: 1min HRV, 22.729; 106: HR, 91.475; 106: RR, 18.712; 106: SpO2, 99.542; 106: Perf, 0.7; 106: 1min HRV, 11.326; 107: HR, 90.534; 107: RR, 21.293; 107: SpO2, 99.45; 107: Perf, 0.7; 107: 1min HRV, 20.989; 108: HR, 91.729; 108: RR, 18.898; 108: SpO2, 99.390; 108: 1min HRV, 17.928; 108: 5min HRV, 21.353; 109: HR, 90.345; 109: RR, 19.448; 109: SpO2, 99.034; 109: 1min HRV, 23.798; 110: HR, 90.932; 110: RR, 20.780; 110: SpO2, 99.492; 110: 1min HRV, 14.083; 111: HR, 90.237; 111: RR, 21.593; 111: SpO2, 98.932; 111: 1min HRV, 14.092; 112: HR, 93.510; 112: RR, 25.067; 112: SpO2, 99.034; 112: 1min HRV, 24.214; 113: HR, 93.155; 113: RR, 25.04; 113: SpO2, 98.797; 113: Perf, 3.01; 113: 1min HRV, 17.315; 113: 5min HRV, 21.145; 114: HR, 89.483; 114: RR, 25.684; 114: SpO2, 99.362; 114: Perf, 3.138; 114: 1min HRV, 30.205; 115: HR, 94.583; 115: RR, 22.361; 115: SpO2, 98.712; 115: Perf, 2.212; 115: 1min HRV, 17.856; 116: HR, 89.814; 116: RR, 19.729; 116: SpO2, 98.864; 116: Perf, 2.262; 116: 1min HRV, 43.068; 117: HR, 86.914; 117: RR, 15.966; 117: SpO2, 99.069; 117: Perf, 2.278; 117: 1min HRV, 71.766; 118: HR, 82.414; 118: RR, 12.276; 118: SpO2, 98.690; 118: Perf, 2.049; 118: 1min HRV, 73.083; 118: 5min HRV, 61.493; 119: HR, 86.949; 119: RR, 17.169; 119: SpO2, 98.915; 119: Perf, 1.853; 119: 1min HRV, 53.403; 0: Age, 25; 0: Gender, M; 0: Race, White; 0: Means of arrival, Other/Unknown; 0: Triage Temp, 38.1; 0: Triage HR, 110.0; 0: Triage RR, 16.0; 0: Triage SBP, 101.0; 0: Triage DBP, 71.0; 0: Triage acuity, 3-Urgent; 0: CC, FEVER",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "While the patient shows signs of fever and elevated heart rate initially, which could be indicative of an infection, the subsequent vitals are relatively stable, with HRV oscillating but not consistently low, and SpO2 levels consistently above 98%, suggesting no immediate respiratory distress or critical perfusion issues. Additionally, there is no significant fluctuation in blood pressure or other common signs of acute deterioration typically associated with high sepsis risk. Thus, the patient appears not to be at high risk for developing sepsis within the next 12 hours.",
            "claims": [
                "The patient shows signs of fever and elevated heart rate initially.",
                "Signs of fever and elevated heart rate could be indicative of an infection.",
                "The subsequent vitals are relatively stable.",
                "Heart rate variability (HRV) is oscillating but not consistently low.",
                "SpO2 levels are consistently above 98%.",
                "Consistently high SpO2 levels suggest no immediate respiratory distress.",
                "There are no critical perfusion issues.",
                "There is no significant fluctuation in blood pressure.",
                "There are no other common signs of acute deterioration typically associated with high sepsis risk.",
                "The patient appears not to be at high risk for developing sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The patient shows signs of fever and elevated heart rate initially.",
                "Signs of fever and elevated heart rate could be indicative of an infection.",
                "Consistently high SpO2 levels suggest no immediate respiratory distress.",
                "There are no other common signs of acute deterioration typically associated with high sepsis risk."
            ],
            "alignment_scores": [
                0.9,
                0.8,
                0.3,
                0.3
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SOFA Score Increase (\u22652 points)",
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "The claim indicates signs of fever and an elevated heart rate, both of which are criteria used in the identification process for SIRS. However, the exact temperature is not provided to confirm if it surpasses the SIRS threshold of >38\u00b0C, nor is the exact heart rate provided to ensure it exceeds 90 bpm, which slightly limits the certainty. Nevertheless, the alignment is very strong because both signs are typically components of the SIRS criteria.",
                "The claim mentions fever and elevated heart rate, both of which are SIRS criteria (temperature\u202f>\u202f38\u202f\u00b0C and heart\u202frate\u202f>\u202f90\u202fbpm). Since the claim addresses two elements indicating systemic inflammation, there is a strong alignment with the SIRS Positivity category. However, the specific values are not provided, preventing a perfect alignment score.",
                "Although SpO2 levels are not a direct component of the SOFA score, they are related to respiratory function and tissue oxygenation. High SpO2 levels suggest adequate oxygenation, contrasting with the respiratory impairment that would contribute to a SOFA score increase. The alignment is marginal because it only indirectly comments on the absence of respiratory distress rather than indicating organ dysfunction or high sepsis risk.",
                "The claim mentions an absence of common signs of acute deterioration, which are often assessed using the National Early Warning Score (NEWS). While the claim suggests stability rather than specific NEWS points, the implication of monitoring for deterioration indirectly relates to the NEWS category. However, the lack of specific reference to the score system or explicit vital sign data results in a low alignment rating."
            ],
            "final_alignment_score": 0.575
        },
        {
            "input": "4: HR, 82.0; 4: RR, 16.0; 4: SpO2, 100.0; 4: SBP, 146.0; 4: DBP, 98.0; 4: MAP, 114.0; 4: Pain, 7.0; 4: Temp, 98.1; 7: Pain, 7.0; 33: WAM DIFTYP, AUTO; 33: NEUTROPHIL % (AUTO DIFF), 62.5 %; 33: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.31 K/uL; 33: NRBC PERCENT (HEMATOLOGY), 0.0 %; 33: MONOCYTE % (AUTO DIFF), 7.0 %; 33: PLATELET COUNT (PLT), 367 K/uL; 33: HEMATOCRIT (HCT), 38.3 %; 33: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.6 pg; 33: BASOPHIL % (AUTO DIFF), 0.3 %; 33: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 33: HEMOGLOBIN (HGB), 13.4 g/dL; 33: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 33: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 33: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.07 K/uL; 33: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 3.79 K/uL; 33: NEUTROPHIL ABSOLUTE (AUTO DIFF), 8.63 K/uL; 33: MONOCYTE ABSOLUTE (AUTO DIFF), 0.96 K/uL; 33: EOSINOPHIL % (AUTO DIFF), 2.2 %; 33: MEAN CORPUSCULAR VOLUME (MCV), 90.3 fL; 33: RED CELL DISTRIBUTION WIDTH (RDW), 11.2 %; 33: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 35.0 g/dL; 33: LYMPHOCYTE % (AUTO DIFF), 27.5 %; 33: WHITE BLOOD CELLS (WBC), 13.8 K/uL; 33: RED BLOOD CELLS (RBC), 4.24 MIL/uL; 38: HR, 80.0; 38: SpO2, 99.0; 38: SBP, 162.0; 38: DBP, 101.0; 38: MAP, 121.333; 39: HR, 83.0; 39: SpO2, 98.407; 39: Perf, 2.286; 39: SBP, 159.0; 39: DBP, 107.0; 39: MAP, 124.333; 40: SpO2, 98.793; 40: Perf, 1.983; 41: SpO2, 99.017; 41: Perf, 1.678; 42: SpO2, 98.831; 42: Perf, 1.288; 43: SpO2, 99.103; 43: Perf, 1.572; 44: SpO2, 98.773; 44: Perf, 2.47; 44: SBP, 142.0; 44: DBP, 97.0; 44: MAP, 112.0; 45: SpO2, 99.310; 45: Perf, 2.105; 46: SpO2, 98.525; 46: Perf, 2.503; 47: PH, URINE (UA): 6.0; 47: KETONE, URINE (UA): Negative; 47: SPECIFIC GRAVITY, URINE (UA): 1.010; 47: PROTEIN, URINE (UA): Negative; 47: LEUKOCYTE ESTERASE, URINE (UA): Negative; 47: NITRITE, URINE (UA): Negative; 47: GLUCOSE, URINE (UA): Negative; 47: SpO2, 98.169; 47: Perf, 2.853; 48: HR, 79.0; 48: RR, 18.0; 48: SpO2, 98.138; 48: Perf, 2.775; 48: SBP, 142.0; 48: DBP, 97.0; 48: MAP, 112.0; 49: SpO2, 98.695; 49: Perf, 3.093; 50: SpO2, 98.621; 50: Perf, 3.136; 51: SpO2, 97.881; 51: Perf, 3.083; 52: SpO2, 98.222; 52: Perf, 2.428; 60: SODIUM, 137 mmol/L; 60: BLOOD UREA NITROGEN (BUN), 9 mg/dL; 60: ALT (SGPT), 95 U/L; 60: BILIRUBIN TOTAL, 0.4 mg/dL; 60: ALBUMIN, 4.5 g/dL; 60: PROTEIN TOTAL, 8.5 g/dL; 60: CALCIUM, 9.7 mg/dL; 60: CHLORIDE, 101 mmol/L; 60: CORRECTED CALCIUM, 9.3 mg/dL; 60: GLOBULIN, 4.0 g/dL; 60: GLUCOSE, 167 mg/dL; 60: CREATININE, 0.44 mg/dL; 60: ALKALINE PHOSPHATASE, 96 U/L; 60: AST (SGOT), 58 U/L; 60: POTASSIUM, 3.7 mmol/L; 60: ANION GAP, 12 mmol/L; 60: CO2, 24 mmol/L; 60: EGFR REFIT WITHOUT RACE (2021), 132 mL/min/1.73 m2; 66: SpO2, 98.273; 66: SBP, 138.0; 66: DBP, 91.0; 66: MAP, 106.667; 67: SpO2, 98.119; 67: Perf, 1.559; 68: HR, 79.0; 68: SpO2, 98.776; 68: Perf, 2.141; 68: SBP, 138.0; 68: DBP, 91.0; 68: MAP, 106.667; 69: SpO2, 98.102; 69: Perf, 2.627; 70: SpO2, 97.431; 70: Perf, 2.77; 71: SpO2, 97.424; 71: Perf, 2.602; 72: SpO2, 98.138; 72: Perf, 1.685; 73: SpO2, 98.203; 73: Perf, 1.359; 74: SpO2, 98.542; 74: Perf, 1.387; 75: SpO2, 97.017; 75: Perf, 1.193; 76: SpO2, 99.658; 76: Perf, 1.508; 77: SpO2, 99.052; 77: Perf, 4.531; 78: SpO2, 99.458; 78: Perf, 3.426; 79: SpO2, 98.797; 79: Perf, 3.575; 80: SpO2, 98.276; 80: Perf, 2.550; 81: SpO2, 97.102; 81: Perf, 2.810; 82: SpO2, 95.966; 82: Perf, 2.693; 83: SpO2, 98.203; 83: Perf, 1.976; 84: SpO2, 97.356; 84: Perf, 2.381; 85: SpO2, 97.362; 85: Perf, 2.297; 86: SpO2, 95.390; 86: Perf, 2.546; 87: SpO2, 95.190; 87: Perf, 2.503; 88: SpO2, 95.932; 88: Perf, 2.038; 89: SpO2, 95.593; 89: Perf, 1.964; 90: SpO2, 98.121; 90: Perf, 1.987; 91: SpO2, 98.593; 91: Perf, 1.973; 92: SpO2, 99.121; 92: Perf, 2.620; 93: SpO2, 97.0; 93: Perf, 3.478; 94: SpO2, 93.322; 94: Perf, 3.164; 95: SpO2, 98.707; 95: Perf, 1.441; 96: SpO2, 97.729; 96: Perf, 1.631; 97: SpO2, 99.0; 97: Perf, 1.952; 98: SpO2, 99.102; 98: Perf, 2.415; 99: SpO2, 98.695; 99: Perf, 2.855; 100: SpO2, 98.5; 100: Perf, 3.036; 101: SpO2, 98.237; 101: Perf, 2.378; 102: SpO2, 98.241; 102: Perf, 2.211; 103: SpO2, 98.797; 103: Perf, 3.313; 104: SpO2, 98.845; 104: Perf, 2.617; 105: SpO2, 98.559; 105: Perf, 2.219; 106: SpO2, 98.492; 106: Perf, 1.441; 107: SpO2, 98.483; 107: Perf, 1.413; 108: SpO2, 98.356; 108: Perf, 1.123; 109: HIGH SENSITIVITY TROPONIN, <4 ng/L; 109: SpO2, 97.897; 109: Perf, 1.762; 110: SpO2, 97.966; 110: Perf, 2.066; 111: SpO2, 98.339; 111: Perf, 4.271; 112: SpO2, 98.724; 112: Perf, 4.038; 113: SpO2, 98.678; 113: Perf, 3.599; 114: SpO2, 98.879; 114: Perf, 5.345; 115: SpO2, 99.169; 115: Perf, 4.547; 116: SpO2, 98.627; 116: Perf, 4.874; 117: INFLUENZA B, Not Detected; 117: RSV, Not Detected; 117: SARS-COV-2 RNA, Not Detected; 117: INFLUENZA A, Not Detected; 117: SpO2, 98.397; 117: Perf, 2.488; 118: HR, 74.0; 118: RR, 16.0; 118: SpO2, 99.339; 118: Perf, 2.690; 118: SBP, 138.0; 118: DBP, 90.0; 118: MAP, 106.0; 119: SpO2, 98.897; 119: Perf, 4.056; 0: Age, 33; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 82.0; 0: Triage RR, 16.0; 0: Triage SBP, 146.0; 0: Triage DBP, 98.0; 0: Triage acuity, 3-Urgent; 0: CC, HEADACHE",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The EHR data does not show significant signs of sepsis risk within the next 12 hours. The patient maintains stable vitals, with normal blood pressure and heart rate trends. There are no abnormal laboratory values that raise immediate concern for infection or sepsis, such as markedly elevated white blood cell counts or organ dysfunction indicators. Although the patient reports a high pain level, their other metrics remain within acceptable ranges, indicating low risk for sepsis.",
            "claims": [
                "The EHR data does not show significant signs of sepsis risk within the next 12 hours.",
                "The patient maintains stable vitals.",
                "The patient has normal blood pressure trends.",
                "The patient has normal heart rate trends.",
                "There are no abnormal laboratory values that raise immediate concern for infection or sepsis.",
                "There are no markedly elevated white blood cell counts.",
                "There are no indicators of organ dysfunction.",
                "The patient reports a high pain level.",
                "The patient's other metrics remain within acceptable ranges.",
                "The patient's condition indicates low risk for sepsis."
            ],
            "relevant_claims": [
                "The EHR data does not show significant signs of sepsis risk within the next 12 hours.",
                "There are no abnormal laboratory values that raise immediate concern for infection or sepsis.",
                "There are no markedly elevated white blood cell counts.",
                "The patient reports a high pain level."
            ],
            "alignment_scores": [
                0.0,
                0.2,
                0.3,
                0.2
            ],
            "alignment_category": [
                "None of the Expert Sepsis Categories",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "SIRS Positivity (\u22652 Criteria)",
                "Early Antibiotic/Culture Orders (within 2 hours)"
            ],
            "alignment_reasonings": [
                "The claim suggests an absence of significant sepsis risk indicators, implying that none of the expert sepsis categories are applicable. Since no specific risk factor or metric aligns with the categories provided, the alignment rating is 0.0, indicating no connection to any outlined categories.",
                "The claim emphasizes a lack of concerning lab values, which contrasts with triggers for clinical action like ordering antibiotics or cultures due to strong infection suspicion. The alignment is weak and indirect since it suggests no immediate infection concern, lightly touching on the broader idea of infection assessment.",
                "The claim relates to a lack of elevated white blood cell counts, which is part of the SIRS criteria. The absence of this criterion suggests low risk of systemic inflammation consistent with early sepsis. However, the alignment is weak because it references the absence of a criterion rather than the presence of factors indicating risk.",
                "The claim about high pain level doesn't directly correspond to any of the sepsis prediction categories, such as vital signs or laboratory markers. However, a report of high pain could potentially prompt further investigation for infection, possibly leading to early antibiotics/culture orders as part of clinician suspicion. The alignment is quite weak, given the indirect connection."
            ],
            "final_alignment_score": 0.175
        },
        {
            "input": "6: SpO2, 100.0; 6: 1min HRV, 0.0; 6: 5min HRV, 0.0; 7: HR, 89.619; 7: RR, 22.685; 7: SpO2, 99.944; 7: 1min HRV, 11.931; 7: SBP, 121.0; 7: DBP, 79.0; 7: MAP, 93.0; 7: Pain, 0.0; 7: Temp, 99.2; 8: HR, 85.983; 8: RR, 17.322; 8: SpO2, 98.407; 8: Perf, 1.51; 8: 1min HRV, 15.479; 9: HR, 85.186; 9: RR, 17.966; 9: SpO2, 99.610; 9: Perf, 1.854; 9: 1min HRV, 12.859; 10: HR, 82.138; 10: RR, 21.569; 10: SpO2, 99.983; 10: Perf, 3.417; 10: 1min HRV, 8.644; 10: SBP, 121.0; 10: DBP, 79.0; 10: MAP, 93.0; 11: HR, 80.610; 11: RR, 20.407; 11: SpO2, 98.983; 11: Perf, 3.693; 11: 1min HRV, 9.208; 11: 5min HRV, 28.237; 12: HR, 80.879; 12: RR, 20.310; 12: SpO2, 99.724; 12: Perf, 3.354; 12: 1min HRV, 7.965; 12: SBP, 126.0; 12: DBP, 74.0; 12: MAP, 91.333; 13: HR, 80.627; 13: RR, 19.339; 13: SpO2, 99.407; 13: Perf, 4.203; 13: 1min HRV, 21.634; 14: HR, 83.407; 14: RR, 19.881; 14: SpO2, 100.0; 14: Perf, 3.270; 14: 1min HRV, 14.516; 15: HR, 83.828; 15: RR, 20.741; 15: SpO2, 100.0; 15: Perf, 2.916; 15: 1min HRV, 13.868; 16: HR, 82.780; 16: RR, 20.559; 16: SpO2, 100.0; 16: Perf, 3.216; 16: 1min HRV, 14.416; 16: 5min HRV, 18.190; 17: HR, 83.379; 17: RR, 19.776; 17: SpO2, 99.914; 17: Perf, 3.048; 17: 1min HRV, 12.498; 18: HR, 83.593; 18: RR, 18.475; 18: SpO2, 99.780; 18: Perf, 3.221; 18: 1min HRV, 9.845; 19: HR, 83.483; 19: RR, 18.414; 19: SpO2, 100.0; 19: Perf, 3.773; 19: 1min HRV, 15.395; 20: HR, 82.102; 20: RR, 17.627; 20: SpO2, 100.0; 20: Perf, 4.452; 20: 1min HRV, 12.347; 21: HR, 80.983; 21: RR, 21.644; 21: SpO2, 100.0; 21: Perf, 4.297; 21: 1min HRV, 8.791; 21: 5min HRV, 14.222; 22: HR, 81.534; 22: RR, 22.586; 22: SpO2, 100.0; 22: Perf, 4.374; 22: 1min HRV, 10.385; 23: HR, 81.695; 23: RR, 21.814; 23: SpO2, 100.0; 23: Perf, 4.000; 23: 1min HRV, 8.485; 24: HR, 84.0; 24: RR, 18.103; 24: SpO2, 99.828; 24: Perf, 3.904; 24: 1min HRV, 17.086; 25: HR, 80.932; 25: RR, 21.949; 25: SpO2, 99.898; 25: Perf, 2.998; 25: 1min HRV, 14.699; 26: HR, 79.661; 26: RR, 23.542; 26: SpO2, 100.0; 26: Perf, 3.536; 26: 1min HRV, 11.626; 26: 5min HRV, 18.159; 27: HR, 80.069; 27: RR, 19.241; 27: SpO2, 100.0; 27: Perf, 3.759; 27: 1min HRV, 11.552; 28: HR, 81.407; 28: RR, 21.831; 28: SpO2, 100.0; 28: Perf, 4.380; 28: 1min HRV, 42.345; 29: HR, 80.741; 29: RR, 23.379; 29: SpO2, 99.281; 29: Perf, 4.449; 29: 1min HRV, 15.668; 30: HR, 86.542; 30: RR, 24.441; 30: SpO2, 98.974; 30: Perf, 4.22; 30: 1min HRV, 10.281; 31: HR, 80.729; 31: RR, 22.153; 31: SpO2, 99.068; 31: Perf, 4.201; 31: 1min HRV, 41.651; 31: 5min HRV, 37.735; 32: HR, 77.362; 32: RR, 20.603; 32: SpO2, 98.741; 32: Perf, 4.049; 32: 1min HRV, 74.029; 33: HR, 78.610; 33: RR, 22.712; 33: SpO2, 99.0; 33: Perf, 3.340; 33: 1min HRV, 21.139; 34: HR, 79.241; 34: RR, 20.379; 34: SpO2, 99.793; 34: Perf, 2.175; 34: 1min HRV, 30.534; 35: HR, 77.492; 35: RR, 22.356; 35: SpO2, 100.0; 35: Perf, 1.999; 35: 1min HRV, 34.039; 36: HR, 78.0; 36: RR, 15.576; 36: SpO2, 100.0; 36: Perf, 2.634; 36: 1min HRV, 21.351; 36: 5min HRV, 41.722; 37: HR, 78.241; 37: RR, 23.914; 37: SpO2, 100.0; 37: Perf, 2.585; 37: 1min HRV, 27.046; 38: HR, 78.254; 38: RR, 23.542; 38: SpO2, 100.0; 38: Perf, 2.801; 38: 1min HRV, 22.826; 38: NS IV BOLUS -, 1000 ML; 39: HR:, 80.776; 39: RR, 20.483; 39: SpO2, 100.0; 39: Perf, 2.416; 39: 1min HRV, 23.835; 39: ACETAMINOPHEN, 500 MG PO TABS; 40: HR:, 82.458; 40: RR, 18.847; 40: SpO2, 100.0; 40: Perf, 1.982; 40: 1min HRV, 21.585; 41: HR, 83.915; 41: RR, 22.644; 41: SpO2, 99.203; 41: Perf, 1.928; 41: 1min HRV, 31.481; 41: 5min HRV, 34.632; 42: HR, 80.259; 42: RR, 25.103; 42: SpO2, 99.586; 42: Perf, 1.913; 42: 1min HRV, 22.326; 42: SBP, 127.0; 42: DBP, 98.0; 42: MAP, 107.667; 43: HR, 77.593; 43: RR, 25.203; 43: SpO2, 100.0; 43: Perf, 3.700; 43: 1min HRV, 23.540; 44: HR, 77.241; 44: RR, 23.707; 44: SpO2, 100.0; 44: Perf, 4.000; 44: 1min HRV, 17.694; 45: HR, 78.949; 45: RR, 19.847; 45: SpO2, 99.746; 45: Perf, 3.578; 45: 1min HRV, 71.802; 46: 5min HRV, 40.598; 54: WAM DIFTYP, AUTO; 54: MONOCYTE % (AUTO DIFF), 17.1 %; 54: NEUTROPHIL ABSOLUTE (AUTO DIFF), 1.40 K/uL; 54: PLATELET COUNT (PLT), 251 K/uL; 54: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.20 K/uL; 54: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.2 %; 54: HEMATOCRIT (HCT), 30.9 %; 54: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.04 K/uL; 54: MONOCYTE ABSOLUTE (AUTO DIFF), 0.56 K/uL; 54: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 54: LYMPHOCYTE % (AUTO DIFF), 36.6 %; 54: BASOPHIL % (AUTO DIFF), 1.8 %; 54: EOSINOPHIL % (AUTO DIFF), 0.6 %; 54: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 35.3 g/dL; 54: WHITE BLOOD CELLS (WBC), 3.3 K/uL; 54: MEAN CORPUSCULAR VOLUME (MCV), 86.3 fL; 54: RED BLOOD CELLS (RBC), 3.58 MIL/uL; 54: NEUTROPHIL % (AUTO DIFF), 42.7 %; 54: RED CELL DISTRIBUTION WIDTH (RDW), 16.8 %; 54: NRBC PERCENT (HEMATOLOGY), 0.0 %; 54: HEMOGLOBIN (HGB), 10.9 g/dL; 54: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 54: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.4 pg; 54: BASOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 95: HR, 89.0; 95: RR, 20.0; 95: SpO2, 99.0; 95: SBP, 135.0; 95: DBP, 73.0; 95: MAP, 93.667; 95: GABAPENTIN, 600 MG PO TABS; 111: TROPONIN I: <., 017 ng/mL; 0: Age, 71; 0: Gender, M; 0: Race, Black or African American; 0: Means of arrival, EMS; 0: Triage Temp, 37.3; 0: Triage HR, 81.0; 0: Triage RR, 18.0; 0: Triage SBP, 121.0; 0: Triage DBP, 79.0; 0: Triage acuity, 3-Urgent; 0: CC, RAPID HEART RATE",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The patient's vital signs remain relatively stable throughout the time series, with heart rate, blood pressure, respiratory rate, and oxygen saturation levels within reasonable ranges for most entries. Although some metrics, like the variation in heart rate variability (HRV) and slightly elevated white blood cell count, might suggest possible concern, they do not consistently indicate a progression towards sepsis within 12 hours. Moreover, no critical thresholds for potential sepsis indicators, such as significant hypotension or respiratory distress, are consistently breached across the dataset.",
            "claims": [
                "The patient's vital signs remain relatively stable throughout the time series.",
                "Heart rate, blood pressure, respiratory rate, and oxygen saturation levels are within reasonable ranges for most entries.",
                "Some metrics, like the variation in heart rate variability (HRV) and slightly elevated white blood cell count, might suggest possible concern.",
                "The variation in heart rate variability (HRV) does not consistently indicate a progression towards sepsis within 12 hours.",
                "The slightly elevated white blood cell count does not consistently indicate a progression towards sepsis within 12 hours.",
                "No critical thresholds for potential sepsis indicators are consistently breached across the dataset.",
                "Significant hypotension is not consistently breached across the dataset.",
                "Respiratory distress is not consistently breached across the dataset."
            ],
            "relevant_claims": [
                "The variation in heart rate variability (HRV) does not consistently indicate a progression towards sepsis within 12 hours.",
                "The slightly elevated white blood cell count does not consistently indicate a progression towards sepsis within 12 hours.",
                "No critical thresholds for potential sepsis indicators are consistently breached across the dataset."
            ],
            "alignment_scores": [
                0.2,
                0.3,
                0.2
            ],
            "alignment_category": [
                "High qSOFA Score (\u22652)",
                "SIRS Positivity (\u22652 Criteria)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)"
            ],
            "alignment_reasonings": [
                "Heart rate variability (HRV) is not a direct factor in any sepsis prediction category listed. However, HRV is often indirectly related to cardiovascular stability and changes in autonomic regulation, which might conceptually relate to the physiological assessment in qSOFA, where heart rate is indirectly considered through systolic BP and respiratory criteria. Due to HRV's indirect and non-categorical relevance, the alignment is minimal.",
                "While an elevated white blood cell count is one of the SIRS criteria used to identify systemic inflammation consistent with early sepsis, the claim states that the elevation is slight and does not indicate progression towards sepsis within 12 hours. This suggests that the elevation does not meet the threshold for a strong alignment with SIRS Positivity. The alignment is weak because the claim does not reinforce a significant risk of sepsis progression.",
                "The claim mentions that no critical thresholds for potential sepsis indicators are consistently breached. This implies that metrics such as blood pressure, which are typically associated with sepsis when they fall below specific thresholds, are not consistently abnormal in this case. While the claim doesn't directly reference hypotension or sepsis-associated blood pressure changes, hypotension is a critical threshold commonly considered in sepsis assessment. The alignment is low because the statement refers generically to multiple indicators rather than specifically to blood pressure or hypotension."
            ],
            "final_alignment_score": 0.2333333333333333
        },
        {
            "input": "2: HR, 117.0; 2: RR, 18.0; 2: SpO2, 97.0; 2: SBP, 127.0; 2: DBP, 74.0; 2: MAP, 91.667; 2: Temp, 101.0; 11: Pain, 4.0; 25: RR, 18.0; 28: POC PH (V) ISTAT, 7.45; 28: POC BASE EXCESS ISTAT, 6 mmol/L; 28: POC PO2 (V) ISTAT, 20 mmHg; 28: POC O2 SATURATION ISTAT VENOUS, 33 %; 28: POC LACTATE ISTAT, 1.05 mmol/L; 28: POC HCO3 (V) ISTAT, 30.4 mmol/L; 28: POC PCO2 (V) ISTAT, 44.3 mmHg; 28: POC TCO2 (V) ISTAT, 32 mmol/L; 30: ACETAMINOPHEN, 500 MG PO TABS; 55: INR:, 1.0; 55: PROTHROMBIN TIME, 14.0 seconds; 56: PART. THROMBOPLASTIN TIME, 30.6 seconds; 61: SARS-COV-2 RNA, Not Detected; 72: HR, 109.543; 72: RR, 14.92; 72: 1min HRV, 10.910; 72: SBP, 125.0; 72: DBP, 77.0; 72: MAP, 93.0; 73: HR, 108.661; 73: RR, 20.322; 73: SpO2, 98.0; 73: 1min HRV, 9.919; 73: 5min HRV, 10.791; 73: SBP, 125.0; 73: DBP, 77.0; 73: MAP, 93.0; 73: Pain, 6.0; 73: Temp, 97.2; 74: HR, 109.780; 74: RR, 15.373; 74: 1min HRV, 9.975; 75: HR, 107.241; 75: RR, 18.914; 75: 1min HRV, 13.266; 76: HR, 105.356; 76: RR, 21.169; 76: 1min HRV, 8.440; 77: CREATININE, 0.89 mg/dL; 77: PROTEIN TOTAL, 8.4 g/dL; 77: BLOOD UREA NITROGEN (BUN), 11 mg/dL; 77: AST (SGOT), 46 U/L; 77: CO2, 27 mmol/L; 77: ALT (SGPT), 31 U/L; 77: BILIRUBIN TOTAL, 0.8 mg/dL; 77: ANION GAP, 11 mmol/L; 77: CHLORIDE, 95 mmol/L; 77: POTASSIUM, 4.2 mmol/L; 77: EGFR REFIT WITHOUT RACE (2021), 102 mL/min/1.73 m2; 77: GLUCOSE, 112 mg/dL; 77: CALCIUM, 8.8 mg/dL; 77: GLOBULIN, 4.1 g/dL; 77: CORRECTED CALCIUM, 8.6 mg/dL; 77: SODIUM, 133 mmol/L; 77: ALBUMIN, 4.3 g/dL; 77: ALKALINE PHOSPHATASE, 73 U/L; 77: LIPASE, 27 U/L; 77: HR, 107.517; 77: RR, 19.690; 77: 1min HRV, 13.170; 78: HR, 104.915; 78: RR, 19.475; 78: 1min HRV, 7.905; 78: 5min HRV, 13.380; 79: HR, 106.678; 79: RR, 23.237; 79: 1min HRV, 10.356; 80: HR, 106.966; 80: RR, 19.397; 80: 1min HRV, 10.673; 81: HR, 107.102; 81: RR, 21.559; 81: 1min HRV, 22.506; 82: HR, 105.466; 82: RR, 19.345; 82: 1min HRV, 10.033; 83: HR, 105.288; 83: RR, 18.017; 83: 1min HRV, 16.411; 83: 5min HRV, 15.158; 84: HR, 104.847; 84: RR, 18.441; 84: 1min HRV, 15.242; 85: HR, 105.603; 85: RR, 12.879; 85: 1min HRV, 14.937; 86: HR, 103.780; 86: RR, 20.780; 86: 1min HRV, 11.609; 87: HR, 105.857; 87: RR, 17.079; 87: 1min HRV, 23.708; 88: HR, 106.169; 88: RR, 18.333; 88: 1min HRV, 11.407; 88: 5min HRV, 16.147; 89: HR, 104.897; 89: RR, 20.810; 89: 1min HRV, 18.039; 90: HR, 104.621; 90: RR, 15.621; 90: 1min HRV, 10.529; 91: HR, 105.695; 91: RR, 19.712; 91: 1min HRV, 22.887; 92: HR, 106.069; 92: RR, 21.328; 92: 1min HRV, 19.021; 93: HR, 104.0; 93: RR, 17.542; 93: 1min HRV, 7.265; 93: 5min HRV, 17.503; 94: HR, 102.845; 94: RR, 21.983; 94: 1min HRV, 10.541; 95: HR, 102.102; 95: RR, 21.593; 95: 1min HRV, 11.068; 96: HR, 104.576; 96: RR, 23.237; 96: 1min HRV, 11.313; 97: HR, 104.759; 97: RR, 21.138; 97: 1min HRV, 19.620; 98: HR, 102.559; 98: RR, 21.288; 98: 1min HRV, 11.768; 98: 5min HRV, 14.812; 99: HR, 103.246; 99: RR, 22.807; 99: 1min HRV, 22.341; 100: HEMATOCRIT (HCT), 43.7 %; 100: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.0 pg; 100: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.1 g/dL; 100: RED CELL DISTRIBUTION WIDTH (RDW), 10.9 %; 100: WHITE BLOOD CELLS (WBC), 7.0 K/uL; 100: RED BLOOD CELLS (RBC), 4.80 MIL/uL; 100: MEAN CORPUSCULAR VOLUME (MCV), 91.0 fL; 100: PLATELET COUNT (PLT), 199 K/uL; 100: HEMOGLOBIN (HGB), 14.9 g/dL; 100: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 35.7 %; 100: LYMPHOCYTES VARIANT ABSOLUTE (MANUAL DIFF), 0.06 K/uL; 100: EOSINOPHILS % (MANUAL DIFF), 0.9 %; 100: NEUTROPHILS BANDS % (MANUAL DIFF), 36.4 %; 100: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 5.08 K/uL; 100: MONOCYTES ABSOLUTE (MANUAL DIFF), 0.73 K/uL; 100: BASOPHILS % (MANUAL DIFF), 0.9 %; 100: MONOCYTES % (MANUAL DIFF), 10.4 %; 100: LYMPHOCYTES VARIANT % (MANUAL DIFF), 0.9 %; 100: LYMPHOCYTES % (MANUAL DIFF), 14.8 %; 100: EOSINOPHILS ABSOLUTE (MANUAL DIFF), 0.06 K/uL; 100: BASOPHILS ABSOLUTE (MANUAL DIFF), 0.06 K/uL; 100: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 1.04 K/uL; 100: HR, 103.576; 100: RR, 20.627; 100: 1min HRV, 14.543; 101: HR, 102.746; 101: RR, 25.254; 101: 1min HRV, 13.129; 102: HR, 108.08; 102: RR, 20.714; 102: 1min HRV, 31.538; 103: HR, 105.153; 103: RR, 10.763; 103: 1min HRV, 17.801; 103: 5min HRV, 22.944; 104: HR, 101.862; 104: RR, 16.569; 104: 1min HRV, 9.539; 104: SBP, 122.0; 104: DBP, 83.0; 104: MAP, 96.0; 105: HR, 102.441; 105: RR, 18.356; 105: 1min HRV, 22.460; 106: HR, 100.254; 106: RR, 22.322; 106: 1min HRV, 10.142; 107: HR, 104.276; 107: RR, 26.655; 107: 1min HRV, 19.422; 108: HR, 99.552; 108: RR, 17.017; 108: 1min HRV, 14.436; 108: 5min HRV, 19.297; 109: HR, 100.879; 109: RR, 17.431; 109: 1min HRV, 18.475; 110: HR, 100.983; 110: RR, 15.661; 110: 1min HRV, 17.022; 111: HR, 102.424; 111: RR, 16.0; 111: 1min HRV, 21.414; 111: LR IV BOLUS -, 1000 ML; 112: HR:, 101.5; 112: RR, 19.879; 112: 1min HRV, 23.754; 113: HR, 99.153; 113: RR, 18.525; 113: 1min HRV, 11.421; 113: 5min HRV, 19.897; 114: HR, 99.812; 114: RR, 16.667; 114: 1min HRV, 11.782; 118: 5min HRV, 11.782; 0: Age, 53; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 38.3; 0: Triage HR, 117.0; 0: Triage RR, 18.0; 0: Triage SBP, 127.0; 0: Triage DBP, 74.0; 0: Triage acuity, 2-Emergent; 0: CC, ABDOMINAL PAIN",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The patient presents with an elevated heart rate (tachycardia) and a mildly elevated temperature (fever). However, there is no significant deterioration in blood pressure, respiratory rate, or oxygen saturation, and the lab values for lactate and white blood cell count are within normal ranges, which are critical indicators of sepsis risk. Additionally, the patient's HRV remains moderately variable, suggesting normal autonomic regulation. Given these factors, the patient is currently not at high risk of developing sepsis within the next 12 hours.",
            "claims": [
                "The patient presents with an elevated heart rate (tachycardia).",
                "The patient has a mildly elevated temperature (fever).",
                "There is no significant deterioration in blood pressure.",
                "There is no significant deterioration in respiratory rate.",
                "There is no significant deterioration in oxygen saturation.",
                "The lab values for lactate are within normal ranges.",
                "The lab values for white blood cell count are within normal ranges.",
                "Lactate and white blood cell count are critical indicators of sepsis risk.",
                "The patient's heart rate variability (HRV) remains moderately variable.",
                "Moderately variable HRV suggests normal autonomic regulation.",
                "Given these factors, the patient is currently not at high risk of developing sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The patient presents with an elevated heart rate (tachycardia).",
                "The patient has a mildly elevated temperature (fever).",
                "There is no significant deterioration in blood pressure."
            ],
            "alignment_scores": [
                0.8,
                0.3,
                0.2
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated Shock Index (\u22651.0)"
            ],
            "alignment_reasonings": [
                "Tachycardia, defined as an elevated heart rate (heart rate\u202f>\u202f90\u202fbpm), is explicitly listed as one of the criteria for SIRS. This suggests systemic inflammation consistent with early sepsis. While the claim only references a single SIRS criterion, it is directly relevant to the detection of early sepsis risk, hence the strong alignment.",
                "A mildly elevated temperature indicates the possibility of a febrile response, which is a consideration in the SIRS criteria (temperature >38\u00b0C). However, without knowing the exact temperature, it's uncertain whether it meets the threshold required to contribute directly to a SIRS-positive status. Thus, the alignment is weak and indirect.",
                "The claim pertains to blood pressure. While it indicates no significant deterioration, which could infer stability and not aligning directly with hypotension, it indirectly touches on the concept of hemodynamic stability considered in the Elevated Shock Index category. However, since the claim specifies there is no deterioration, the association with the shock index, which indicates instability, is weak. Therefore, the alignment rating is low."
            ],
            "final_alignment_score": 0.43333333333333335
        },
        {
            "input": "4: HR, 107.811; 4: RR, 20.453; 4: SpO2, 97.875; 4: 1min HRV, 98.468; 5: HR, 103.660; 5: RR, 17.604; 5: SpO2, 95.154; 5: 1min HRV, 130.891; 5: 5min HRV, 117.559; 5: SBP, 109.0; 5: DBP, 67.0; 5: MAP, 81.0; 5: Temp, 97.7; 6: HR, 103.808; 6: RR, 18.712; 6: SpO2, 94.0; 6: 1min HRV, 119.633; 7: HR, 101.774; 7: RR, 22.0; 7: SpO2, 94.0; 7: 1min HRV, 106.343; 8: HR, 102.558; 8: RR, 17.635; 8: SpO2, 98.775; 8: 1min HRV, 142.784; 9: HR, 106.604; 9: RR, 20.283; 9: SpO2, 98.818; 9: 1min HRV, 114.243; 10: HR, 110.170; 10: RR, 19.623; 10: SpO2, 97.115; 10: 1min HRV, 130.733; 10: 5min HRV, 125.114; 11: HR, 105.981; 11: RR, 21.327; 11: SpO2, 97.545; 11: 1min HRV, 110.793; 12: HR, 97.075; 12: RR, 18.962; 12: SpO2, 99.139; 12: 1min HRV, 154.971; 13: HR, 105.923; 13: RR, 19.308; 13: SpO2, 98.674; 13: 1min HRV, 121.821; 14: HR, 102.08; 14: RR, 23.057; 14: SpO2, 99.053; 14: Perf, 0.24; 14: 1min HRV, 127.983; 15: HR, 107.358; 15: RR, 19.962; 15: SpO2, 99.729; 15: Perf, 0.255; 15: 1min HRV, 142.063; 15: 5min HRV, 135.303; 16: HR, 105.404; 16: RR, 19.48; 16: SpO2, 99.654; 16: Perf, 0.268; 16: 1min HRV, 131.069; 16: SBP, 108.0; 16: DBP, 72.0; 16: MAP, 84.0; 17: HR, 102.113; 17: RR, 21.333; 17: SpO2, 99.5; 17: Perf, 0.287; 17: 1min HRV, 118.922; 18: HR, 107.404; 18: RR, 22.25; 18: SpO2, 99.25; 18: Perf, 0.292; 18: 1min HRV, 136.870; 19: HR, 105.396; 19: RR, 19.660; 19: SpO2, 99.020; 19: Perf, 0.297; 19: 1min HRV, 112.584; 20: HR, 104.755; 20: RR, 18.279; 20: SpO2, 99.06; 20: Perf, 0.268; 20: 1min HRV, 145.764; 20: 5min HRV, 130.300; 21: HR, 105.942; 21: RR, 22.827; 21: SpO2, 99.913; 21: Perf, 0.25; 21: 1min HRV, 160.123; 22: HR, 107.887; 22: RR, 24.566; 22: SpO2, 99.0; 22: Perf, 0.25; 22: 1min HRV, 97.245; 23: HR, 107.404; 23: RR, 18.673; 23: Perf, 0.25; 23: 1min HRV, 100.277; 24: HR, 107.16; 24: RR, 22.472; 24: Perf, 0.25; 24: 1min HRV, 50.432; 25: HR, 109.396; 25: RR, 19.453; 25: SpO2, 98.679; 25: 1min HRV, 151.744; 25: 5min HRV, 130.502; 26: HR, 98.442; 26: RR, 18.8; 26: SpO2, 98.312; 26: 1min HRV, 145.506; 27: HR, 104.396; 27: RR, 18.717; 27: SpO2, 96.943; 27: Perf, 0.498; 27: 1min HRV, 123.708; 28: HR, 104.385; 28: RR, 23.7; 28: SpO2, 98.282; 28: Perf, 0.492; 28: 1min HRV, 128.235; 29: HR, 104.660; 29: RR, 17.019; 29: SpO2, 98.0; 29: Perf, 0.49; 29: 1min HRV, 135.629; 30: HR, 107.936; 30: RR, 26.5; 30: SpO2, 97.933; 30: Perf, 0.481; 30: 1min HRV, 148.137; 30: 5min HRV, 137.295; 31: HR, 102.453; 31: RR, 19.388; 31: SpO2, 97.849; 31: Perf, 0.506; 31: 1min HRV, 146.413; 31: SBP, 107.0; 31: DBP, 76.0; 31: MAP, 86.333; 32: HR, 106.038; 32: RR, 19.491; 32: SpO2, 97.226; 32: Perf, 0.482; 32: 1min HRV, 113.776; 33: HR, 101.851; 33: RR, 21.538; 33: SpO2, 99.419; 33: Perf, 0.433; 33: 1min HRV, 146.124; 34: HR, 107.151; 34: RR, 17.962; 34: SpO2, 98.293; 34: Perf, 0.418; 34: 1min HRV, 115.549; 35: HR, 106.904; 35: RR, 18.519; 35: SpO2, 98.0; 35: Perf, 0.41; 35: 1min HRV, 112.346; 35: 5min HRV, 126.538; 36: HR, 100.914; 36: RR, 22.019; 36: Perf, 0.41; 36: 1min HRV, 61.116; 37: HR, 108.041; 37: RR, 15.395; 37: Perf, 0.41; 37: 1min HRV, 132.412; 38: HR, 105.7; 38: RR, 21.02; 38: SpO2, 98.682; 38: Perf, 0.412; 38: 1min HRV, 134.087; 39: HR, 103.717; 39: RR, 19.906; 39: SpO2, 97.769; 39: Perf, 0.465; 39: 1min HRV, 134.831; 40: HR, 98.962; 40: RR, 19.744; 40: SpO2, 98.636; 40: Perf, 0.478; 40: 1min HRV, 183.842; 40: 5min HRV, 150.445; 41: WAM DIFTYP, AUTO; 41: LYMPHOCYTE % (AUTO DIFF), 7.7 %; 41: NRBC PERCENT (HEMATOLOGY), 0.0 %; 41: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.4 pg; 41: BASOPHIL % (AUTO DIFF), 0.1 %; 41: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 41: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 41: PLATELET COUNT (PLT), 195 K/uL; 41: HEMOGLOBIN (HGB), 11.5 g/dL; 41: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 41: WHITE BLOOD CELLS (WBC), 16.4 K/uL; 41: NEUTROPHIL % (AUTO DIFF), 87.1 %; 41: NEUTROPHIL ABSOLUTE (AUTO DIFF), 14.27 K/uL; 41: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.07 K/uL; 41: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 30.6 g/dL; 41: HEMATOCRIT (HCT), 37.6 %; 41: MEAN CORPUSCULAR VOLUME (MCV), 92.8 fL; 41: RED BLOOD CELLS (RBC), 4.05 MIL/uL; 41: RED CELL DISTRIBUTION WIDTH (RDW), 16.4 %; 41: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.26 K/uL; 41: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 41: MONOCYTE ABSOLUTE (AUTO DIFF), 0.76 K/uL; 41: EOSINOPHIL % (AUTO DIFF), 0.1 %; 41: MONOCYTE % (AUTO DIFF), 4.6 %; 41: HR, 103.824; 41: RR, 19.275; 41: SpO2, 96.981; 41: Perf, 0.493; 41: 1min HRV, 149.126; 45: 5min HRV, 149.126; 68: ALT (SGPT), 63 U/L; 68: BLOOD UREA NITROGEN (BUN), 31 mg/dL; 68: CO2, 21 mmol/L; 68: PROTEIN TOTAL, 6.4 g/dL; 68: CHLORIDE, 106 mmol/L; 68: ALKALINE PHOSPHATASE, 107 U/L; 68: ANION GAP, 12 mmol/L; 68: EGFR FOR AFRICAN AMERICAN, 62 mL/min/1.73 m2; 68: AST (SGOT), 82 U/L; 68: BILIRUBIN TOTAL, 0.4 mg/dL; 68: SODIUM, 139 mmol/L; 68: GLUCOSE, 239 mg/dL; 68: POTASSIUM, 4.3 mmol/L; 68: CORRECTED CALCIUM, 10.5 mg/dL; 68: EGFR REFIT WITHOUT RACE (2021), 54 mL/min/1.73 m2; 68: CREATININE, 0.88 mg/dL; 68: GLOBULIN, 3.2 g/dL; 68: CALCIUM, 9.9 mg/dL; 68: ALBUMIN, 3.2 g/dL; 89: SARS-COV-2 RNA, Not Detected; 91: LIPASE, 25 U/L; 91: BNP NT-PRO, 28823 pg/mL; 107: TROPONIN I, 0.665 ng/mL; 107: TROPONIN I, 0.665 ng/mL; 0: Age, 90; 0: Gender, F; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 36.5; 0: Triage HR, 91.0; 0: Triage RR, 13.0; 0: Triage SBP, 109.0; 0: Triage DBP, 67.0; 0: Triage acuity, 2-Emergent; 0: CC, FATIGUE,IRREGULAR HEART BEAT,ARM SWELLING",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient is elderly, with a triage acuity of '2-Emergent', suggesting high acuity or potential severity of their condition. The heart rate is consistently high, with episodes of tachycardia, as evidenced by HR values frequently over 100 bpm. Laboratory results reveal a significantly elevated BNP NT-PRO level, which is associated with heart failure and can indicate severe systemic stress, often seen in sepsis. Additionally, the white blood cell count is elevated (16.4 K/uL), which can indicate an infection, and the respiratory rate varies widely, further signaling potential respiratory distress. These factors collectively point toward a high risk of the patient developing sepsis within 12 hours.",
            "claims": [
                "The patient is elderly.",
                "The triage acuity of the patient is '2-Emergent'.",
                "A triage acuity of '2-Emergent' suggests high acuity or potential severity of the patient's condition.",
                "The heart rate of the patient is consistently high.",
                "The patient has episodes of tachycardia.",
                "The heart rate values of the patient frequently exceed 100 bpm.",
                "Laboratory results reveal a significantly elevated BNP NT-PRO level.",
                "An elevated BNP NT-PRO level is associated with heart failure.",
                "An elevated BNP NT-PRO level can indicate severe systemic stress.",
                "Severe systemic stress is often seen in sepsis.",
                "The white blood cell count of the patient is elevated at 16.4 K/uL.",
                "An elevated white blood cell count can indicate an infection.",
                "The respiratory rate of the patient varies widely.",
                "A varying respiratory rate may signal potential respiratory distress.",
                "These factors collectively point toward a high risk of the patient developing sepsis within 12 hours."
            ],
            "relevant_claims": [
                "A triage acuity of '2-Emergent' suggests high acuity or potential severity of the patient's condition.",
                "The heart rate of the patient is consistently high.",
                "The patient has episodes of tachycardia.",
                "The heart rate values of the patient frequently exceed 100 bpm.",
                "Laboratory results reveal a significantly elevated BNP NT-PRO level.",
                "An elevated BNP NT-PRO level is associated with heart failure.",
                "An elevated BNP NT-PRO level can indicate severe systemic stress.",
                "The white blood cell count of the patient is elevated at 16.4 K/uL.",
                "An elevated white blood cell count can indicate an infection.",
                "A varying respiratory rate may signal potential respiratory distress."
            ],
            "alignment_scores": [
                0.3,
                0.7,
                0.7,
                0.8,
                0.0,
                0.3,
                0.3,
                1.0,
                1.0,
                0.5
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "None of the listed categories specifically align with elevated BNP NT-PRO levels.",
                "Elevated Shock Index (\u22651.0)",
                "SOFA Score Increase (\u22652 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "High qSOFA Score (\u22652)"
            ],
            "alignment_reasonings": [
                "The claim refers to a '2-Emergent' triage acuity, indicating a high level of urgency and potential severity, aligning conceptually with the notion of clinical deterioration risk captured by a high NEWS score. However, without specific vital signs data or equivalent criteria, the alignment with the NEWS score\u2014predicated on specific physiological measurements\u2014is indirect and thus weak.",
                "An elevated heart rate (>90 bpm) is one of the criteria for SIRS positivity, which indicates systemic inflammation consistent with early sepsis. The claim highlights consistent elevation, suggesting the criterion is met, though it does not specify the exact value. Thus, there is strong alignment, though the lack of specific numerical data prevents a perfect score.",
                "Tachycardia, defined as a heart rate\u202f>\u202f90 bpm, is one of the criteria for SIRS, which identifies systemic inflammation consistent with early sepsis. The claim aligns with one of the specific SIRS criteria, contributing significantly to the identification of a patient at risk for sepsis. The presence of tachycardia alone does not meet the full SIRS positivity threshold (\u22652 criteria), but it is a relevant and strong indication, hence a high alignment rating.",
                "The claim directly mentions elevated heart rates which exceed one of the SIRS criteria thresholds (heart rate > 90 bpm). This indicates systemic inflammation, which is relevant to early sepsis detection. Although only one SIRS criterion is mentioned, the claim is strongly aligned with the systemic inflammation category, hence the high alignment rating.",
                "Elevated BNP NT-PRO levels are typically associated with cardiac stress or heart failure rather than directly with sepsis. None of the expert sepsis categories explicitly mention or relate to BNP NT-PRO levels, resulting in no alignment with the specified categories. Therefore, no meaningful connection can be made to sepsis prediction in this context.",
                "An elevated BNP NT-PRO level is primarily an indicator of heart failure and is not directly listed under any specific sepsis categories. However, heart failure can contribute to haemodynamic instability, relating conceptually to the Elevated Shock Index category. Despite this indirect link, it's more associated with cardiac issues than sepsis risk itself, so the alignment is weak at best.",
                "Elevated BNP NT-PRO levels suggest cardiac stress and possible systemic issues but are not directly part of the SOFA score criteria. However, since they can reflect systemic stress potentially leading to organ dysfunction, there's a weak conceptual connection to the SOFA score, which measures organ dysfunction. The alignment is indirect and minimal.",
                "The claim specifies an elevated white blood cell count (WBC > 12,000/\u00b5L), which directly meets one of the SIRS criteria for identifying systemic inflammation associated with early sepsis. This direct mention of a SIRS criterion results in full alignment.",
                "The claim about elevated white blood cell count directly corresponds to one of the SIRS criteria used to identify systemic inflammation and early signs of sepsis. The SIRS criteria include elevated WBC as a key indicator, making the alignment strong and direct.",
                "The claim refers to a varying respiratory rate, which can indicate potential respiratory issues. The High qSOFA Score category considers respiratory rate as one of its criteria (specifically, a respiratory rate\u202f\u2265\u202f22\u202f/min). Although the claim does not specify whether the rate meets or exceeds 22/min, the reference to potential respiratory distress suggests a connection to the respiratory component of the qSOFA criteria. Hence, the alignment is moderate, reflecting a conceptual link without specific values."
            ],
            "final_alignment_score": 0.5599999999999999
        },
        {
            "input": "3: HR, 99.0; 3: RR, 20.0; 3: SpO2, 100.0; 3: SBP, 140.0; 3: DBP, 85.0; 3: MAP, 103.333; 3: Pain, nan; 3: Temp, 98.0; 4: SpO2, 100.0; 5: HR, 96.625; 5: RR, 26.391; 5: SpO2, 100.0; 5: 1min HRV, 65.045; 6: HR, 93.655; 6: RR, 13.828; 6: SpO2, 81.8; 6: 1min HRV, 14.901; 6: SBP, 140.0; 6: DBP, 85.0; 6: MAP, 103.333; 7: HR, 95.102; 7: RR, 16.983; 7: SpO2, 100.0; 7: 1min HRV, 27.905; 8: HR, 92.271; 8: RR, 19.763; 8: SpO2, 100.0; 8: Perf, 3.422; 8: 1min HRV, 26.209; 8: 5min HRV, 33.677; 9: HR, 87.948; 9: RR, 14.483; 9: SpO2, 100.0; 9: Perf, 3.304; 9: 1min HRV, 14.298; 10: HR, 88.508; 10: RR, 14.475; 10: SpO2, 100.0; 10: Perf, 3.767; 10: 1min HRV, 24.175; 11: HR, 87.966; 11: RR, 17.793; 11: SpO2, 100.0; 11: Perf, 2.893; 11: 1min HRV, 14.373; 12: HR, 90.017; 12: RR, 16.220; 12: SpO2, 100.0; 12: Perf, 1.955; 12: 1min HRV, 14.858; 13: HR, 88.322; 13: RR, 13.339; 13: SpO2, 100.0; 13: Perf, 1.784; 13: 1min HRV, 16.979; 13: 5min HRV, 18.750; 14: HR, 85.466; 14: RR, 13.983; 14: SpO2, 100.0; 14: Perf, 1.337; 14: 1min HRV, 41.162; 15: HR, 85.915; 15: RR, 8.089; 15: SpO2, 100.0; 15: Perf, 1.305; 15: 1min HRV, 47.027; 16: HR, 87.034; 16: RR, 14.241; 16: SpO2, 99.034; 16: Perf, 1.554; 16: 1min HRV, 13.824; 17: HR, 86.881; 17: RR, 19.322; 17: SpO2, 99.780; 17: Perf, 1.531; 17: 1min HRV, 16.674; 18: HR, 88.424; 18: RR, 22.508; 18: SpO2, 100.0; 18: Perf, 1.917; 18: 1min HRV, 18.220; 18: 5min HRV, 32.184; 19: HR, 86.328; 19: RR, 17.862; 19: SpO2, 99.879; 19: Perf, 2.174; 19: 1min HRV, 30.876; 19: SBP, 132.0; 19: DBP, 94.0; 19: MAP, 106.667; 20: HR, 84.864; 20: RR, 17.627; 20: SpO2, 100.0; 20: Perf, 2.211; 20: 1min HRV, 12.137; 21: HR, 84.966; 21: RR, 18.914; 21: SpO2, 99.879; 21: Perf, 2.119; 21: 1min HRV, 16.061; 22: HR, 87.203; 22: RR, 17.814; 22: SpO2, 100.0; 22: Perf, 1.934; 22: 1min HRV, 19.905; 23: HR, 91.586; 23: RR, 16.621; 23: SpO2, 100.0; 23: Perf, 1.638; 23: 1min HRV, 33.288; 23: 5min HRV, 29.349; 24: HR, 85.695; 24: RR, 20.085; 24: SpO2, 100.0; 24: Perf, 2.043; 24: 1min HRV, 43.239; 25: HR, 89.186; 25: RR, 16.644; 25: SpO2, 100.0; 25: Perf, 1.875; 25: 1min HRV, 20.964; 26: HR, 91.586; 26: RR, 17.0; 26: SpO2, 100.0; 26: Perf, 1.781; 26: 1min HRV, 12.019; 27: HR, 95.576; 27: RR, 16.966; 27: SpO2, 100.0; 27: Perf, 1.809; 27: 1min HRV, 24.570; 28: HR, 95.207; 28: RR, 20.759; 28: SpO2, 99.914; 28: Perf, 2.004; 28: 1min HRV, 12.423; 28: 5min HRV, 36.506; 29: HR, 93.038; 29: RR, 21.583; 29: SpO2, 99.966; 29: Perf, 2.114; 29: 1min HRV, 17.322; 30: SpO2, 99.763; 30: Perf, 2.112; 31: SpO2, 100.0; 31: Perf, 1.998; 32: SpO2, 100.0; 32: Perf, 2.940; 33: SpO2, 100.0; 33: Perf, 4.336; 33: 5min HRV, 17.322; 34: SpO2, 100.0; 34: Perf, 3.641; 34: SBP, 141.0; 34: DBP, 128.0; 34: MAP, 132.333; 35: SpO2, 100.0; 35: Perf, 3.437; 36: SpO2, 100.0; 36: Perf, 2.395; 37: SpO2, 100.0; 37: Perf, 1.783; 38: SpO2, 100.0; 38: Perf, 1.336; 39: WAM DIFTYP, AUTO; 39: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.2 pg; 39: PLATELET COUNT (PLT), 212 K/uL; 39: NEUTROPHIL ABSOLUTE (AUTO DIFF), 3.26 K/uL; 39: BASOPHIL % (AUTO DIFF), 0.9 %; 39: HEMOGLOBIN (HGB), 13.0 g/dL; 39: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.7 g/dL; 39: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 39: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 39: MONOCYTE ABSOLUTE (AUTO DIFF), 0.72 K/uL; 39: RED BLOOD CELLS (RBC), 4.17 MIL/uL; 39: LYMPHOCYTE % (AUTO DIFF), 32.2 %; 39: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.2 %; 39: NEUTROPHIL % (AUTO DIFF), 51.2 %; 39: MEAN CORPUSCULAR VOLUME (MCV), 89.9 fL; 39: BASOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 39: WHITE BLOOD CELLS (WBC), 6.4 K/uL; 39: RED CELL DISTRIBUTION WIDTH (RDW), 13.3 %; 39: MONOCYTE % (AUTO DIFF), 11.3 %; 39: NRBC PERCENT (HEMATOLOGY), 0.0 %; 39: EOSINOPHIL % (AUTO DIFF), 4.2 %; 39: HEMATOCRIT (HCT), 37.5 %; 39: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.05 K/uL; 39: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.27 K/uL; 39: SpO2, 99.864; 39: Perf, 1.502; 40: SpO2, 100.0; 40: Perf, 1.656; 41: SpO2, 100.0; 41: Perf, 1.606; 42: SpO2, 100.0; 42: Perf, 1.024; 43: SpO2, 100.0; 43: Perf, 0.829; 44: SpO2, 100.0; 44: Perf, 0.882; 45: SpO2, 100.0; 45: Perf, 0.867; 46: SpO2, 100.0; 46: Perf, 0.679; 47: SpO2, 100.0; 47: Perf, 0.640; 48: SpO2, 100.0; 48: Perf, 0.650; 49: SpO2, 99.943; 49: Perf, 0.674; 49: SBP, 142.0; 49: DBP, 95.0; 49: MAP, 110.667; 56: BLOOD TYPE VERIFICATION-AUTOMATION, O Positive; 56: ANTIBODY SCREEN 3, NEG; 56: ABO/RH (AUTOMATION), O Positive; 60: PART. THROMBOPLASTIN TIME, 30.7 seconds; 61: INR, 1.2; 61: PROTHROMBIN TIME, 14.5 seconds; 83: HR, 84.0; 83: SpO2, 100.0; 83: SBP, 141.0; 83: DBP, 95.0; 83: MAP, 110.333; 83: Pain, 8.0; 91: MORPHINE, 4 MG/ML IV SYRG; 96: LR IV BOLUS -, 1000 ML; 97: CEFAZOLIN IV PUSH (, 1 GRAM VIAL + NS VIAL); 108: HR:, 85.0; 108: RR, 16.0; 108: SpO2, 100.0; 108: SBP, 170.0; 108: DBP, 98.0; 108: MAP, 122.0; 108: Pain, 0.0; 108: Pain, 0.0; 0: Age, 60; 0: Gender, M; 0: Race, Black or African American; 0: Means of arrival, EMS; 0: Triage Temp, 36.7; 0: Triage HR, 99.0; 0: Triage RR, 20.0; 0: Triage SBP, 140.0; 0: Triage DBP, 85.0; 0: Triage acuity, 2-Emergent; 0: CC, LEG INJURY",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "While the patient\u2019s initial high heart rate and respiratory rate might initially raise suspicion, these values stabilize over time, and the overall vital signs, including blood pressure, oxygen saturation levels, and heart rate, remain largely within normal ranges throughout the observation period. Additionally, there are no significant changes in white blood cell counts, hemoglobin, or blood pressure indicative of an inflammatory response typical of sepsis. Importantly, there is no persistent or sudden deterioration in the patient's condition that would signal a high risk of sepsis within the next 12 hours.",
            "claims": [
                "The patient\u2019s initial heart rate is high.",
                "The patient\u2019s initial respiratory rate is high.",
                "The high heart rate and respiratory rate might initially raise suspicion.",
                "The patient\u2019s heart rate and respiratory rate stabilize over time.",
                "The overall vital signs remain largely within normal ranges throughout the observation period.",
                "These vital signs include blood pressure, oxygen saturation levels, and heart rate.",
                "There are no significant changes in white blood cell counts.",
                "There are no significant changes in hemoglobin levels.",
                "There are no significant changes in blood pressure indicative of an inflammatory response typical of sepsis.",
                "There is no persistent deterioration in the patient's condition.",
                "There is no sudden deterioration in the patient's condition.",
                "The lack of deterioration signals a low risk of sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The patient\u2019s initial heart rate is high.",
                "The high heart rate and respiratory rate might initially raise suspicion.",
                "There are no significant changes in blood pressure indicative of an inflammatory response typical of sepsis."
            ],
            "alignment_scores": [
                0.5,
                0.7,
                0.7
            ],
            "alignment_category": [
                "Elevated Shock Index (\u22651.0)",
                "SIRS Positivity (\u22652 Criteria)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)"
            ],
            "alignment_reasonings": [
                "An elevated heart rate can contribute to an increased shock index, given it is one part of the calculation (heart rate \u00f7 systolic BP). However, the claim doesn't provide additional details like the systolic blood pressure to directly ascertain the shock index. Thus, while high heart rate may suggest hemodynamic instability, it cannot alone confirm an elevated shock index, resulting in a moderate alignment.",
                "The claim mentions both an elevated heart rate and an elevated respiratory rate, which are two specific criteria within the SIRS criteria used to assess systemic inflammation typical of early sepsis. Although the exact values are not provided, the simultaneous reference to both parameters strongly suggests SIRS positivity. The alignment is significant but slightly reduced since the exact numbers are unspecified.",
                "The claim references \"no significant changes in blood pressure,\" which pertains to the absence of sepsis-associated hypotension\u2014a condition defined by specific blood pressure changes indicating progression toward septic shock. Although the claim is about the absence of such changes, it still aligns with this category because identifying absence is part of assessing sepsis risk. However, since the claim notes an absence rather than a presence of signs, it reduces direct alignment slightly."
            ],
            "final_alignment_score": 0.6333333333333333
        },
        {
            "input": "4: HR, 94.0; 4: RR, 18.0; 4: SpO2, 97.0; 4: SBP, 149.0; 4: DBP, 80.0; 4: MAP, 103.0; 4: Temp, 98.1; 5: Pain, 10.0; 35: SBP, 156.0; 35: DBP, 95.0; 35: MAP, 115.333; 36: SpO2, 96.429; 37: SpO2, 97.121; 37: Perf, 7.669; 38: SpO2, 97.576; 38: Perf, 8.638; 39: SpO2, 97.0; 39: Perf, 9.328; 40: SpO2, 97.0; 40: Perf, 9.307; 41: SpO2, 97.0; 41: Perf, 8.818; 42: SpO2, 97.0; 42: Perf, 8.903; 43: SpO2, 97.153; 43: Perf, 8.949; 44: SpO2, 96.810; 44: Perf, 8.050; 44: SBP, 148.0; 44: DBP, 87.0; 44: MAP, 107.333; 45: SpO2, 97.220; 45: Perf, 6.380; 46: SpO2, 97.898; 46: Perf, 4.710; 47: SpO2, 97.759; 47: Perf, 5.927; 48: SpO2, 97.186; 48: Perf, 5.645; 49: SpO2, 97.672; 49: Perf, 6.817; 50: SpO2, 98.237; 50: Perf, 7.622; 51: SpO2, 98.051; 51: Perf, 6.411; 52: SpO2, 97.534; 52: Perf, 6.707; 53: SpO2, 97.305; 53: Perf, 6.303; 54: SpO2, 97.776; 54: Perf, 5.712; 55: SpO2, 97.305; 55: Perf, 6.576; 56: SpO2, 97.237; 56: Perf, 7.164; 57: SpO2, 97.724; 57: Perf, 6.803; 58: SpO2, 98.407; 58: Perf, 6.343; 59: SpO2, 97.913; 59: Perf, 7.230; 60: SpO2, 97.667; 60: Perf, 6.017; 61: SpO2, 98.0; 61: Perf, 6.329; 62: SpO2, 98.0; 62: Perf, 5.887; 63: SpO2, 98.169; 63: Perf, 4.860; 64: SpO2, 98.0; 64: Perf, 4.885; 65: SpO2, 98.390; 65: Perf, 4.871; 66: SARS-COV-2 RNA, Not Detected; 66: SpO2, 97.914; 66: Perf, 3.335; 67: SpO2, 97.729; 67: Perf, 4.893; 68: SpO2, 97.847; 68: Perf, 4.188; 69: SpO2, 98.155; 69: Perf, 3.854; 70: SpO2, 97.661; 70: Perf, 4.066; 71: SpO2, 98.0; 71: Perf, 3.812; 72: SpO2, 98.0; 72: Perf, 3.116; 73: SpO2, 97.814; 73: Perf, 3.468; 74: SpO2, 97.310; 74: Perf, 4.189; 75: SpO2, 97.881; 75: Perf, 4.555; 76: SpO2, 97.810; 76: Perf, 4.746; 77: SpO2, 97.576; 77: Perf, 4.867; 78: SpO2, 97.763; 78: Perf, 5.017; 79: SpO2, 98.0; 79: Perf, 3.619; 80: WAM DIFTYP, AUTO; 80: RED BLOOD CELLS (RBC), 3.98 MIL/uL; 80: HEMATOCRIT (HCT), 37.6 %; 80: PLATELET COUNT (PLT), 330 K/uL; 80: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.93 K/uL; 80: NRBC PERCENT (HEMATOLOGY), 0.0 %; 80: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 80: MONOCYTE % (AUTO DIFF), 7.6 %; 80: NEUTROPHIL % (AUTO DIFF), 75.6 %; 80: EOSINOPHIL % (AUTO DIFF), 1.7 %; 80: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.2 g/dL; 80: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.2 %; 80: NEUTROPHIL ABSOLUTE (AUTO DIFF), 4.91 K/uL; 80: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.11 K/uL; 80: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.4 pg; 80: BASOPHIL % (AUTO DIFF), 0.6 %; 80: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 80: MEAN CORPUSCULAR VOLUME (MCV), 94.5 fL; 80: HEMOGLOBIN (HGB), 12.5 g/dL; 80: LYMPHOCYTE % (AUTO DIFF), 14.3 %; 80: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 80: MONOCYTE ABSOLUTE (AUTO DIFF), 0.49 K/uL; 80: WHITE BLOOD CELLS (WBC), 6.5 K/uL; 80: RED CELL DISTRIBUTION WIDTH (RDW), 13.1 %; 80: SpO2, 98.0; 80: Perf, 5.174; 81: SpO2, 98.0; 81: Perf, 5.211; 82: SpO2, 98.0; 82: Perf, 5.194; 83: SpO2, 98.0; 83: Perf, 5.017; 84: SpO2, 97.983; 84: Perf, 5.164; 85: SpO2, 97.373; 85: Perf, 5.423; 86: SpO2, 97.448; 86: Perf, 5.285; 87: SpO2, 98.203; 87: Perf, 4.216; 88: SpO2, 98.0; 88: Perf, 4.705; 89: SpO2, 98.0; 89: Perf, 4.904; 90: INR, 1.0; 90: PROTHROMBIN TIME, 13.6 seconds; 90: SpO2, 97.797; 90: Perf, 4.908; 91: PART. THROMBOPLASTIN TIME, 34.5 seconds; 91: SpO2, 97.966; 91: Perf, 5.132; 92: SpO2, 97.759; 92: Perf, 4.758; 93: SpO2, 97.0; 93: Perf, 4.934; 94: SpO2, 97.220; 94: Perf, 4.892; 95: SpO2, 97.305; 95: Perf, 5.384; 96: SpO2, 97.241; 96: Perf, 4.886; 97: SpO2, 97.492; 97: Perf, 4.839; 98: SpO2, 97.310; 98: Perf, 4.930; 99: SpO2, 97.102; 99: Perf, 4.921; 100: SpO2, 97.254; 100: Perf, 4.941; 101: SpO2, 98.0; 101: Perf, 4.536; 102: HR, 64.0; 102: SpO2, 97.373; 102: Perf, 4.608; 102: SBP, 180.0; 102: DBP, 75.0; 102: MAP, 110.0; 103: SpO2, 97.931; 103: Perf, 4.404; 104: CHLORIDE, 100 mmol/L; 104: AST (SGOT), 18 U/L; 104: PROTEIN TOTAL, 6.9 g/dL; 104: ALBUMIN, 4.2 g/dL; 104: SODIUM, 137 mmol/L; 104: GLOBULIN, 2.7 g/dL; 104: CALCIUM, 9.0 mg/dL; 104: ALT (SGPT), 10 U/L; 104: EGFR REFIT WITHOUT RACE (2021), 83 mL/min/1.73 m2; 104: BLOOD UREA NITROGEN (BUN), 10 mg/dL; 104: GLUCOSE, 118 mg/dL; 104: BILIRUBIN TOTAL, 0.3 mg/dL; 104: CREATININE, 0.66 mg/dL; 104: CORRECTED CALCIUM, 8.8 mg/dL; 104: ALKALINE PHOSPHATASE, 68 U/L; 104: ANION GAP, 10 mmol/L; 104: POTASSIUM, 4.3 mmol/L; 104: CO2, 27 mmol/L; 104: SpO2, 97.214; 104: Perf, 4.583; 104: SBP, 180.0; 104: DBP, 75.0; 104: MAP, 110.0; 105: SpO2, 97.138; 105: Perf, 3.575; 106: SpO2, 98.0; 106: Perf, 4.002; 107: SpO2, 97.407; 107: Perf, 4.150; 108: SpO2, 97.948; 108: Perf, 4.002; 109: SpO2, 97.373; 109: Perf, 4.398; 110: SpO2, 97.458; 110: Perf, 4.330; 111: SpO2, 97.707; 111: Perf, 4.44; 112: SpO2, 97.475; 112: Perf, 4.413; 113: SpO2, 97.121; 113: Perf, 4.282; 114: SpO2, 97.102; 114: Perf, 4.464; 115: SpO2, 97.136; 115: Perf, 4.567; 116: SpO2, 97.586; 116: Perf, 4.080; 117: SpO2, 98.441; 117: Perf, 3.871; 118: SpO2, 98.207; 118: Perf, 4.447; 119: SpO2, 97.932; 119: Perf, 4.550; 0: Age, 90; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 94.0; 0: Triage RR, 18.0; 0: Triage SBP, 149.0; 0: Triage DBP, 80.0; 0: Triage acuity, 3-Urgent; 0: CC, HEMORRHOIDS",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "The patient's vital signs are relatively stable, with a SpO2 consistently around 97-98% and a MAP within normal limits. Additionally, the laboratory results do not indicate any abnormalities suggestive of infection or organ dysfunction. The absence of symptoms like fever or altered mental state, which could be indicative of sepsis, and the largely normal laboratory results support a low risk of developing sepsis within the next 12 hours.",
            "claims": [
                "The patient's vital signs are relatively stable.",
                "The SpO2 is consistently around 97-98%.",
                "The MAP is within normal limits.",
                "The laboratory results do not indicate any abnormalities.",
                "The laboratory results do not suggest an infection.",
                "The laboratory results do not indicate organ dysfunction.",
                "The patient does not have symptoms like fever.",
                "The patient does not have an altered mental state.",
                "The absence of fever and altered mental state could indicate a low risk of sepsis.",
                "The largely normal laboratory results support a low risk of developing sepsis.",
                "The overall assessment supports a low risk of sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The laboratory results do not suggest an infection.",
                "The laboratory results do not indicate organ dysfunction.",
                "The patient does not have symptoms like fever.",
                "The largely normal laboratory results support a low risk of developing sepsis."
            ],
            "alignment_scores": [
                0.2,
                0.3,
                0.3,
                0.2
            ],
            "alignment_category": [
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "SOFA Score Increase (\u22652 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "Early Antibiotic/Culture Orders (within 2 hours)"
            ],
            "alignment_reasonings": [
                "The claim indirectly concerns the suspicion of infection but asserts a lack of laboratory evidence for infection. This contrasts with the category that involves proactive steps (like ordering antibiotics or cultures) due to suspected infection. While related to infection assessment, the claim conflicts with the category\u2019s action-oriented criteria, resulting in low alignment.",
                "The claim mentions the absence of organ dysfunction, which indirectly relates to no increase in SOFA score (a measure of organ dysfunction). There is some conceptual connection since a lack of organ dysfunction means the SOFA score wouldn't increase, but the relationship is indirect and not indicative of current or increased sepsis risk.",
                "The absence of a fever (temperature >38\u00b0C) directly relates to one of the SIRS criteria for identifying systemic inflammation suggestive of early sepsis. However, the claim highlights a lack of symptom rather than its presence, which weakly aligns with the category's emphasis, hence the low rating.",
                "The claim references \"largely normal laboratory results,\" which suggests that there is no immediate clinical concern requiring urgent action (such as ordering antibiotics or cultures). This aligns somewhat with the decision against early intervention, but it's a weak alignment because it doesn't indicate explicit clinical actions or criteria used to deem the case low risk. The context of assessing risk based on lab results partially fits with overall assessments made when considering early intervention, but it is not a direct match to any specific category."
            ],
            "final_alignment_score": 0.25
        },
        {
            "input": "16: Pain, 0.0; 18: HR, 117.0; 18: RR, 16.0; 18: SpO2, 100.0; 18: SBP, 103.0; 18: DBP, 74.0; 18: MAP, 83.667; 18: LPM O2, 2.0; 18: Temp, 97.7; 67: POC PH (V) ISTAT, 7.33; 67: POC PCO2 (V) ISTAT, 61.8 mmHg; 67: POC HCO3 (V) ISTAT, 32.6 mmol/L; 67: POC BASE EXCESS ISTAT, 7 mmol/L; 67: POC O2 SATURATION ISTAT VENOUS, 20 %; 67: POC TCO2 (V) ISTAT, 34 mmol/L; 67: POC PO2 (V) ISTAT, 17 mmHg; 67: POC LACTATE ISTAT, 2.77 mmol/L; 71: SpO2, 100.0; 71: Perf, 0.388; 72: HR, 114.091; 72: RR, 27.833; 72: SpO2, 100.0; 72: Perf, 0.453; 72: 1min HRV, 5.252; 72: SBP, 116.0; 72: DBP, 90.0; 72: MAP, 98.667; 72: LPM O2, 2.0; 73: HR, 113.862; 73: RR, 27.0; 73: SpO2, 99.943; 73: Perf, 0.43; 73: 1min HRV, 4.683; 74: HR, 114.983; 74: RR, 26.542; 74: SpO2, 100.0; 74: Perf, 0.382; 74: 1min HRV, 6.631; 75: HR, 115.356; 75: RR, 25.407; 75: SpO2, 100.0; 75: Perf, 0.301; 75: 1min HRV, 2.988; 76: HR, 115.224; 76: RR, 25.172; 76: SpO2, 100.0; 76: Perf, 0.226; 76: 1min HRV, 3.239; 76: 5min HRV, 5.415; 76: SBP, nan; 76: DBP, nan; 76: MAP, nan; 77: HR, 115.627; 77: RR, 25.254; 77: SpO2, 100.0; 77: Perf, 0.193; 77: 1min HRV, 8.700; 78: HR, 115.305; 78: RR, 27.966; 78: SpO2, 100.0; 78: Perf, 0.199; 78: 1min HRV, 5.428; 79: HR, 121.586; 79: RR, 29.397; 79: SpO2, 100.0; 79: 1min HRV, 6.808; 80: HR, 126.0; 80: RR, 33.339; 80: SpO2, 100.0; 80: Perf, 0.239; 80: 1min HRV, 11.828; 81: HR, 121.310; 81: RR, 27.914; 81: SpO2, 100.0; 81: Perf, 0.251; 81: 1min HRV, 11.118; 81: 5min HRV, 19.998; 82: HR, 117.305; 82: RR, 28.763; 82: SpO2, 100.0; 82: Perf, 0.367; 82: 1min HRV, 9.659; 83: HR, 117.017; 83: RR, 26.627; 83: SpO2, 99.915; 83: Perf, 0.396; 83: 1min HRV, 5.729; 84: HR, 116.534; 84: RR, 25.293; 84: SpO2, 99.674; 84: Perf, 0.363; 84: 1min HRV, 6.921; 85: HR, 116.833; 85: RR, 29.647; 85: SpO2, 99.085; 85: 1min HRV, 9.961; 86: HR, 116.741; 86: RR, 27.552; 86: SpO2, 100.0; 86: Perf, 0.321; 86: 1min HRV, 4.353; 86: 5min HRV, 7.542; 87: HR, 114.610; 87: RR, 23.576; 87: SpO2, 100.0; 87: Perf, 0.332; 87: 1min HRV, 7.569; 88: HR, 114.831; 88: RR, 25.373; 88: SpO2, 100.0; 88: Perf, 0.202; 88: 1min HRV, 13.931; 89: HR, 117.069; 89: RR, 30.741; 89: SpO2, 100.0; 89: Perf, 0.278; 89: 1min HRV, 16.662; 90: WAM DIFTYP, AUTO; 90: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.13 K/uL; 90: LYMPHOCYTE % (AUTO DIFF), 19.4 %; 90: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 90: MONOCYTE ABSOLUTE (AUTO DIFF), 1.26 K/uL; 90: EOSINOPHIL % (AUTO DIFF), 1.2 %; 90: RED CELL DISTRIBUTION WIDTH (RDW), 18.2 %; 90: NEUTROPHIL ABSOLUTE (AUTO DIFF), 11.82 K/uL; 90: NEUTROPHIL % (AUTO DIFF), 70.8 %; 90: MONOCYTE % (AUTO DIFF), 7.6 %; 90: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.5 g/dL; 90: NRBC PERCENT (HEMATOLOGY), 0.0 %; 90: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.20 K/uL; 90: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 26.6 pg; 90: HEMATOCRIT (HCT), 44.7 %; 90: PLATELET COUNT (PLT), 472 K/uL; 90: MEAN CORPUSCULAR VOLUME (MCV), 84.3 fL; 90: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 3.23 K/uL; 90: WHITE BLOOD CELLS (WBC), 16.7 K/uL; 90: HEMOGLOBIN (HGB), 14.1 g/dL; 90: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 90: BASOPHIL % (AUTO DIFF), 0.2 %; 90: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.8 %; 90: RED BLOOD CELLS (RBC), 5.30 MIL/uL; 90: HR, 115.475; 90: RR, 23.610; 90: SpO2, 100.0; 90: Perf, 0.508; 90: 1min HRV, 6.293; 91: HR, 111.569; 91: RR, 21.431; 91: SpO2, 100.0; 91: Perf, 0.309; 91: 1min HRV, 21.705; 91: 5min HRV, 17.493; 92: HR, 111.254; 92: RR, 22.220; 92: SpO2, 100.0; 92: Perf, 0.163; 92: 1min HRV, 30.123; 93: HR, 116.879; 93: RR, 23.310; 93: SpO2, 100.0; 93: Perf, 0.206; 93: 1min HRV, 22.858; 94: HR, 108.288; 94: RR, 20.068; 94: SpO2, 100.0; 94: Perf, 0.269; 94: 1min HRV, 42.586; 95: HR, 117.898; 95: RR, 23.373; 95: SpO2, 100.0; 95: Perf, 0.270; 95: 1min HRV, 9.268; 96: HR, 110.034; 96: RR, 21.431; 96: SpO2, 100.0; 96: Perf, 0.355; 96: 1min HRV, 31.907; 96: 5min HRV, 32.721; 97: HR, 116.644; 97: RR, 24.763; 97: SpO2, 100.0; 97: Perf, 0.210; 97: 1min HRV, 12.208; 98: HR, 115.414; 98: RR, 21.086; 98: SpO2, 100.0; 98: Perf, 0.311; 98: 1min HRV, 13.967; 99: HR, 110.627; 99: RR, 21.593; 99: SpO2, 100.0; 99: Perf, 0.155; 99: 1min HRV, 30.190; 100: HR, 114.186; 100: RR, 23.339; 100: SpO2, 100.0; 100: Perf, 0.215; 100: 1min HRV, 10.330; 101: HR, 109.569; 101: RR, 22.655; 101: SpO2, 100.0; 101: Perf, 0.227; 101: 1min HRV, 24.137; 101: 5min HRV, 22.116; 102: HR, 117.085; 102: RR, 25.593; 102: SpO2, 100.0; 102: Perf, 0.183; 102: 1min HRV, 12.517; 103: HR, 115.603; 103: RR, 22.310; 103: SpO2, 100.0; 103: Perf, 0.356; 103: 1min HRV, 8.259; 104: HR, 114.559; 104: RR, 20.492; 104: SpO2, 100.0; 104: Perf, 0.360; 104: 1min HRV, 6.277; 105: HR, 114.542; 105: RR, 22.119; 105: SpO2, 100.0; 105: Perf, 0.311; 105: 1min HRV, 8.614; 106: HR, 114.483; 106: RR, 20.293; 106: SpO2, 100.0; 106: Perf, 0.302; 106: 1min HRV, 6.211; 106: 5min HRV, 9.837; 107: HR, 113.763; 107: RR, 20.237; 107: SpO2, 100.0; 107: Perf, 0.289; 107: 1min HRV, 7.220; 108: HR, 113.638; 108: RR, 21.931; 108: SpO2, 100.0; 108: Perf, 0.341; 108: 1min HRV, 6.759; 109: HR, 113.373; 109: RR, 21.864; 109: SpO2, 100.0; 109: Perf, 0.333; 109: 1min HRV, 5.955; 110: HR, 114.121; 110: RR, 20.603; 110: SpO2, 100.0; 110: Perf, 0.326; 110: 1min HRV, 8.640; 111: HR, 115.678; 111: RR, 24.254; 111: SpO2, 100.0; 111: Perf, 0.299; 111: 1min HRV, 4.160; 111: 5min HRV, 7.704; 112: HR, 113.322; 112: RR, 23.966; 112: SpO2, 100.0; 112: Perf, 0.428; 112: 1min HRV, 8.932; 113: HR, 114.017; 113: RR, 21.207; 113: SpO2, 100.0; 113: Perf, 0.405; 113: 1min HRV, 6.271; 114: HR, 112.797; 114: RR, 21.695; 114: SpO2, 100.0; 114: Perf, 0.374; 114: 1min HRV, 8.015; 115: HR, 113.288; 115: RR, 21.085; 115: SpO2, 100.0; 115: Perf, 0.393; 115: 1min HRV, 7.768; 116: HR, 113.586; 116: RR, 23.466; 116: SpO2, 100.0; 116: Perf, 0.332; 116: 1min HRV, 10.202; 116: 5min HRV, 8.462; 117: HR, 112.898; 117: RR, 20.695; 117: SpO2, 100.0; 117: Perf, 0.350; 117: 1min HRV, 5.507; 118: HR, 112.552; 118: RR, 20.552; 118: SpO2, 100.0; 118: Perf, 0.328; 118: 1min HRV, 9.157; 119: HR, 112.424; 119: RR, 20.814; 119: SpO2, 100.0; 119: Perf, 0.293; 119: 1min HRV, 7.331; 0: Age, 56; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.5; 0: Triage HR, 117.0; 0: Triage RR, 16.0; 0: Triage SBP, 103.0; 0: Triage DBP, 74.0; 0: Triage acuity, 2-Emergent; 0: CC, ABNORMAL LAB",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "The patient exhibits several indicators associated with a high risk of sepsis, including an elevated heart rate (persistent tachycardia), elevated respiratory rate, and abnormal lab values such as high lactate and low venous oxygen saturation, which suggest possible tissue hypoxia and metabolic acidosis. The high white blood cell count and acidosis reinforce the suspicion of sepsis. Additionally, the patient's condition has shown little improvement or stabilisation across the monitored period, warranting a high-risk classification for sepsis.",
            "claims": [
                "The patient exhibits several indicators associated with a high risk of sepsis.",
                "The patient has an elevated heart rate, indicating persistent tachycardia.",
                "The patient has an elevated respiratory rate.",
                "The patient has abnormal lab values, including high lactate.",
                "The patient has low venous oxygen saturation.",
                "High lactate and low venous oxygen saturation suggest possible tissue hypoxia and metabolic acidosis.",
                "The patient has a high white blood cell count.",
                "Acidosis reinforces the suspicion of sepsis.",
                "The patient's condition has shown little improvement or stabilization across the monitored period.",
                "The lack of improvement or stabilization warrants a high-risk classification for sepsis."
            ],
            "relevant_claims": [
                "The patient exhibits several indicators associated with a high risk of sepsis.",
                "The patient has an elevated heart rate, indicating persistent tachycardia.",
                "The patient has an elevated respiratory rate.",
                "The patient has abnormal lab values, including high lactate.",
                "The patient has low venous oxygen saturation.",
                "High lactate and low venous oxygen saturation suggest possible tissue hypoxia and metabolic acidosis.",
                "The patient has a high white blood cell count.",
                "Acidosis reinforces the suspicion of sepsis.",
                "The patient's condition has shown little improvement or stabilization across the monitored period.",
                "The lack of improvement or stabilization warrants a high-risk classification for sepsis."
            ],
            "alignment_scores": [
                0.5,
                0.5,
                0.5,
                1.0,
                0.7,
                0.9,
                1.0,
                0.7,
                0.3,
                0.5
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "SOFA Score Increase (\u22652 points)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated Serum Lactate (\u22652 mmol/L)",
                "Elevated NEWS Score (\u22655 points)",
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "The claim mentions \"several indicators associated with a high risk of sepsis,\" which aligns generally with the notion of an elevated NEWS score as it integrates various indicators (e.g., vital signs) to assess deterioration risk. However, without specific details about these indicators, the alignment is moderate rather than strong. The claim lacks specificity about which of the NEWS parameters are involved, which prevents a stronger alignment rating.",
                "Tachycardia (heart rate\u202f>\u202f90\u202fbpm) is one of the criteria listed under the SIRS criteria. However, the claim does not specify whether there are other SIRS criteria present, which would strengthen the alignment. Thus, while indicative of systemic inflammation consistent with early sepsis, the alignment is partial but noteworthy.",
                "An elevated respiratory rate is specifically one of the criteria listed for SIRS positivity (respiratory rate > 20/min). While the claim suggests the presence of one SIRS criterion, it does not specify whether there are enough criteria (\u22652) to confirm SIRS positivity. The alignment is partial because it pertains to the category but is not comprehensive in itself.",
                "The claim specifically mentions high lactate levels, which directly corresponds to the Elevated Serum Lactate category. This category indicates that serum lactate levels of \u22652 mmol/L are a marker of tissue hypoperfusion and increased risk of sepsis mortality. The alignment is perfect as the claim directly identifies this particular indicator.",
                "Low venous oxygen saturation is indicative of poor tissue oxygenation, which relates conceptually to impaired oxygen delivery, a condition that may affect measures like PaO\u2082/FiO\u2082 used in the SOFA score. While it is not a direct SOFA measure, it strongly indicates possible organ dysfunction, leading to a moderate-to-high alignment rating.",
                "The claim mentions \"high lactate,\" directly aligning with the Elevated Serum Lactate category, which signifies tissue hypoperfusion and increases sepsis mortality risk. Additionally, \"low venous oxygen saturation\" suggests hypoxia, reinforcing the elevated lactate implication. While it aligns closely with this category, the claim does not specify the numerical lactate level, which slightly reduces the certainty of perfect alignment.",
                "A high white blood cell count is explicitly one of the criteria for SIRS, which is used to identify systemic inflammation consistent with early sepsis. The claim directly pertains to SIRS, ensuring a perfect alignment.",
                "Acidosis can occur due to lactic acid buildup, which is related to elevated serum lactate, an important indicator of tissue hypoperfusion in sepsis. The claim suggests a suspicion of sepsis that is consistent with elevated lactate levels, but since acidosis is not exclusively indicative of serum lactate elevation, the alignment is not perfect but is still quite strong.",
                "The claim describes the patient's condition as showing little improvement or stabilization. This vaguely suggests ongoing clinical deterioration, which aligns somewhat with the purpose of the NEWS score \u2013 to predict clinical deterioration. However, without specific details about deranged vitals or a specific NEWS score, the alignment is weak. Hence, the rating is relatively low.",
                "The claim suggests a lack of improvement or stabilization, implying a deterioration of the patient's condition. The National Early Warning Score (NEWS) is designed to predict clinical deterioration, which could be interpreted as aligning with the claim's suggestion of increased risk. However, the claim does not provide specific information about a NEWS score or individual components that contribute to a high score, so while there is conceptual alignment, it is not direct or explicit enough to warrant a higher rating."
            ],
            "final_alignment_score": 0.6599999999999999
        },
        {
            "input": "5: SBP, 154.0; 5: DBP, 59.0; 5: MAP, 90.667; 6: HR, 109.0; 6: RR, 24.0; 6: SpO2, 86.4; 6: SBP, 154.0; 6: DBP, 59.0; 6: MAP, 90.667; 6: LPM O2, 2.0; 6: Pain, 10.0; 6: Temp, 102.7; 7: SpO2, 93.186; 7: Perf, 0.338; 8: SpO2, 95.897; 8: Perf, 0.303; 9: SpO2, 99.492; 9: Perf, 0.292; 10: SpO2, 99.833; 10: Perf, 0.281; 11: SpO2, 99.667; 11: Perf, 0.23; 12: SpO2, 100.0; 12: Perf, 0.244; 13: SpO2, 100.0; 13: Perf, 0.268; 14: SpO2, 99.853; 14: Perf, 0.239; 15: SpO2, 99.0; 15: Perf, 0.23; 17: SpO2, 98.833; 18: SpO2, 99.25; 18: Perf, 0.273; 19: SpO2, 96.306; 19: Perf, 0.232; 20: SpO2, 98.294; 20: Perf, 0.191; 24: SpO2, 99.0; 24: Perf, 0.15; 25: SpO2, 98.481; 25: Perf, 0.146; 26: SpO2, 99.667; 26: Perf, 0.157; 29: SpO2, 94.727; 29: Perf, 0.12; 30: SpO2, 97.0; 30: Perf, 0.13; 31: SpO2, 97.643; 31: Perf, 0.14; 32: SpO2, 98.333; 32: Perf, 0.143; 33: SpO2, 97.047; 33: Perf, 0.167; 34: SpO2, 94.625; 34: Perf, 0.175; 35: SpO2, 98.143; 35: Perf, 0.149; 36: SpO2, 98.321; 36: Perf, 0.145; 38: SpO2, 97.625; 38: Perf, 0.195; 39: SpO2, 97.818; 39: Perf, 0.2; 40: SpO2, 98.5; 40: Perf, 0.228; 41: SpO2, 96.922; 41: Perf, 0.204; 42: SpO2, 96.756; 42: Perf, 0.2; 43: SpO2, 98.595; 43: Perf, 0.2; 44: SpO2, 97.765; 44: Perf, 0.2; 45: SpO2, 99.407; 46: SpO2, 99.776; 46: Perf, 0.282; 47: SpO2, 99.362; 47: Perf, 0.349; 48: SpO2, 98.814; 48: Perf, 0.31; 49: SpO2, 99.424; 49: Perf, 0.279; 50: SpO2, 99.690; 50: Perf, 0.335; 50: ACETAMINOPHEN, 500 MG PO TABS; 51: POC PH (V), ISTAT: 7.37; 51: POC HCO3 (V) ISTAT, 28.5 mmol/L; 51: POC LACTATE ISTAT, 2.34 mmol/L; 51: POC TCO2 (V) ISTAT, 30 mmol/L; 51: POC BASE EXCESS ISTAT, 3 mmol/L; 51: POC PCO2 (V) ISTAT, 49.8 mmHg; 51: POC PO2 (V) ISTAT, 19 mmHg; 51: POC O2 SATURATION ISTAT VENOUS, 28 %; 51: SpO2, 97.780; 51: Perf, 0.297; 52: SpO2, 99.08; 52: Perf, 0.267; 53: SpO2, 99.224; 53: Perf, 0.257; 54: SpO2, 99.679; 54: Perf, 0.240; 55: SpO2, 99.26; 55: Perf, 0.221; 56: SpO2, 99.244; 56: Perf, 0.211; 57: SpO2, 97.9; 57: Perf, 0.213; 58: SpO2, 98.714; 58: Perf, 0.22; 59: SpO2, 99.0; 59: Perf, 0.22; 60: SpO2, 99.0; 60: Perf, 0.19; 61: SpO2, 99.12; 61: Perf, 0.205; 62: SpO2, 99.727; 62: Perf, 0.21; 63: SpO2, 98.524; 63: Perf, 0.206; 64: SpO2, 98.727; 64: Perf, 0.224; 65: SpO2, 98.981; 65: Perf, 0.262; 66: SpO2, 98.644; 66: Perf, 0.277; 67: SpO2, 99.667; 67: Perf, 0.278; 68: SpO2, 99.254; 68: Perf, 0.27; 69: POC, BHCG, ISTAT QUANTITATIVE: 17.6 IU/L; 69: SpO2, 99.537; 69: Perf, 0.286; 70: SpO2, 99.169; 70: Perf, 0.317; 71: SpO2, 98.068; 71: Perf, 0.315; 72: SpO2, 99.328; 72: Perf, 0.351; 73: SpO2, 99.797; 73: Perf, 0.553; 74: SpO2, 99.345; 74: Perf, 0.623; 75: SpO2, 98.288; 75: Perf, 0.858; 79: HR, 96.0; 79: RR, 22.0; 79: SpO2, 100.0; 79: SBP, 139.0; 79: DBP, 76.0; 79: MAP, 97.0; 82: NORMOSOL-R IV BOLUS -, 1000 ML; 106: WAM, DIFTYP: AUTO; 106: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 106: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.17 K/uL; 106: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 25.4 pg; 106: RED BLOOD CELLS (RBC), 4.06 MIL/uL; 106: MONOCYTE ABSOLUTE (AUTO DIFF), 0.74 K/uL; 106: NEUTROPHIL % (AUTO DIFF), 85.0 %; 106: MEAN CORPUSCULAR VOLUME (MCV), 84.2 fL; 106: WHITE BLOOD CELLS (WBC), 21.5 K/uL; 106: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 30.1 g/dL; 106: MONOCYTE % (AUTO DIFF), 3.4 %; 106: BASOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 106: HEMATOCRIT (HCT), 34.2 %; 106: PLATELET COUNT (PLT), 209 K/uL; 106: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.0 %; 106: HEMOGLOBIN (HGB), 10.3 g/dL; 106: LYMPHOCYTE % (AUTO DIFF), 10.1 %; 106: EOSINOPHIL % (AUTO DIFF), 0.2 %; 106: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 106: RED CELL DISTRIBUTION WIDTH (RDW), 17.2 %; 106: BASOPHIL % (AUTO DIFF), 0.3 %; 106: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.22 K/uL; 106: NEUTROPHIL ABSOLUTE (AUTO DIFF), 18.31 K/uL; 106: NRBC PERCENT (HEMATOLOGY), 0.0 %; 112: CEFEPIME, 2 GRAM/20 ML IV PUSH; 115: POTASSIUM:, 3.6 mmol/L; 115: BLOOD UREA NITROGEN (BUN), 10 mg/dL; 115: BILIRUBIN TOTAL, 1.2 mg/dL; 115: EGFR FOR AFRICAN AMERICAN, 64 mL/min/1.73 m2; 115: CORRECTED CALCIUM, 8.8 mg/dL; 115: ANION GAP, 10 mmol/L; 115: PROTEIN TOTAL, 7.0 g/dL; 115: ALT (SGPT), 17 U/L; 115: CHLORIDE, 95 mmol/L; 115: CO2, 24 mmol/L; 115: AST (SGOT), 30 U/L; 115: GLOBULIN, 3.4 g/dL; 115: CREATININE, 1.14 mg/dL; 115: ALKALINE PHOSPHATASE, 83 U/L; 115: ALBUMIN, 3.6 g/dL; 115: GLUCOSE, 97 mg/dL; 115: SODIUM, 129 mmol/L; 115: CALCIUM, 8.5 mg/dL; 115: EGFR REFIT WITHOUT RACE (2021), 55 mL/min/1.73 m2; 115: C-REACTIVE PROTEIN (CRP), 21.1 mg/dL; 116: NORMOSOL-R IV BOLUS -, 500 ML; 0: Age:, 51; 0: Gender, F; 0: Race, White; 0: Means of arrival, EMS; 0: Triage Temp, 39.3; 0: Triage HR, 109.0; 0: Triage RR, 24.0; 0: Triage SBP, 154.0; 0: Triage DBP, 59.0; 0: Triage acuity, 2-Emergent; 0: CC, LEG PAIN,FEVER,CHILLS",
            "answer": true,
            "llm_answer": "Yes",
            "llm_explanation": "This patient exhibits several indicators of sepsis risk: notably, they present with a fever (high temperature at 39.3\u00b0C), rapid heart rate (HR 109 beats per minute), elevated respiratory rate (RR 24 breaths per minute), and low blood pressure (DBP 59 mmHg), all of which are common signs of sepsis. The patient has leukocytosis, evidenced by a high white blood cell count (21.5 K/uL), and elevated C-reactive protein (CRP 21.1 mg/dL), signaling an inflammatory response. Furthermore, the administration of a broad-spectrum antibiotic (Cefepime) suggests that the healthcare team suspects a bacterial infection. Taken together, these factors place the patient at high risk for developing sepsis within 12 hours.",
            "claims": [
                "This patient exhibits several indicators of sepsis risk.",
                "The patient presents with a fever of 39.3\u00b0C.",
                "A temperature of 39.3\u00b0C is classified as a high fever.",
                "The patient has a rapid heart rate of 109 beats per minute.",
                "A heart rate of 109 beats per minute is considered rapid.",
                "The patient has an elevated respiratory rate of 24 breaths per minute.",
                "A respiratory rate of 24 breaths per minute is indicative of elevation.",
                "The patient has low blood pressure with a diastolic blood pressure of 59 mmHg.",
                "A diastolic blood pressure of 59 mmHg is classified as low.",
                "These signs are common indicators of sepsis.",
                "The patient has leukocytosis, evidenced by a high white blood cell count of 21.5 K/uL.",
                "A white blood cell count of 21.5 K/uL indicates leukocytosis.",
                "The patient has an elevated C-reactive protein level of 21.1 mg/dL.",
                "An elevated level of C-reactive protein signals an inflammatory response.",
                "The administration of a broad-spectrum antibiotic, Cefepime, has occurred.",
                "The use of Cefepime suggests that the healthcare team suspects a bacterial infection.",
                "Taken together, these factors place the patient at high risk for developing sepsis within 12 hours."
            ],
            "relevant_claims": [
                "This patient exhibits several indicators of sepsis risk.",
                "The patient presents with a fever of 39.3\u00b0C.",
                "A temperature of 39.3\u00b0C is classified as a high fever.",
                "The patient has a rapid heart rate of 109 beats per minute.",
                "A heart rate of 109 beats per minute is considered rapid.",
                "The patient has an elevated respiratory rate of 24 breaths per minute.",
                "A respiratory rate of 24 breaths per minute is indicative of elevation.",
                "The patient has low blood pressure with a diastolic blood pressure of 59 mmHg.",
                "A diastolic blood pressure of 59 mmHg is classified as low.",
                "These signs are common indicators of sepsis.",
                "The patient has leukocytosis, evidenced by a high white blood cell count of 21.5 K/uL.",
                "A white blood cell count of 21.5 K/uL indicates leukocytosis.",
                "The patient has an elevated C-reactive protein level of 21.1 mg/dL.",
                "An elevated level of C-reactive protein signals an inflammatory response.",
                "The administration of a broad-spectrum antibiotic, Cefepime, has occurred.",
                "The use of Cefepime suggests that the healthcare team suspects a bacterial infection.",
                "Taken together, these factors place the patient at high risk for developing sepsis within 12 hours."
            ],
            "alignment_scores": [
                0.3,
                0.8,
                0.8,
                0.8,
                0.7,
                0.7,
                0.9,
                0.7,
                0.6,
                0.2,
                1.0,
                1.0,
                0.7,
                0.3,
                1.0,
                1.0,
                0.3
            ],
            "alignment_category": [
                "Elevated NEWS Score (\u22655 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "Early Antibiotic/Culture Orders (within 2 hours)",
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "The claim mentions \"several indicators of sepsis risk,\" which is vague and could potentially relate to multiple expert categories. Of these, the Elevated NEWS Score (\u22655 points) is specifically designed to capture a combination of deranged vitals and signs indicating clinical deterioration that is compatible with sepsis. However, without specific indicators mentioned, the alignment is weak and generic, leading to a low alignment rating.",
                "The fever exceeds the SIRS threshold of >38\u00b0C, which is one of the explicit criteria used to identify systemic inflammation consistent with early sepsis. However, the alignment is not a full 1.0 since the fever alone does not satisfy the requirement of having \u22652 SIRS criteria.",
                "The claim references a temperature of 39.3\u00b0C, which is above the SIRS temperature threshold (>38\u00b0C). While meeting the temperature criterion is one component of SIRS positivity, it does not cover the complete criteria of having \u22652 SIRS indicators. Nevertheless, high fever strongly aligns with the SIRS positivity criteria, indicating systemic inflammation consistent with early sepsis.",
                "The claim mentions a heart rate of 109 beats per minute, which exceeds the SIRS criteria threshold of a heart rate >90 bpm. This suggests systemic inflammation consistent with early sepsis, aligning well with the SIRS Positivity category. However, since only one SIRS criterion is mentioned and SIRS requires \u22652 criteria, the alignment is strong but not perfect.",
                "The claim references a heart rate of 109 beats per minute, which directly exceeds the SIRS criterion of a heart rate >90 bpm. While it satisfies one part of the \u22652 criteria needed for full SIRS positivity, the heart rate itself is strongly aligned with systemic inflammation, justifying a relatively high alignment rating.",
                "The elevated respiratory rate (\u226520 breaths per minute) is specifically mentioned as one of the SIRS criteria for identifying systemic inflammation indicative of early sepsis. While only one criterion is mentioned and SIRS positivity requires two or more criteria, this finding strongly aligns with one part of the SIRS criteria, warranting a relatively high alignment rating.",
                "The claim highlights an elevated respiratory rate (24 breaths per minute), which is specifically mentioned as a criterion (respiratory rate >20/min) for SIRS positivity. This suggests systemic inflammation consistent with early sepsis, providing a strong alignment with the SIRS criterion. However, the alignment isn't perfect because SIRS positivity requires the presence of two or more criteria, and the claim mentions only one.",
                "The claim highlights low blood pressure, specifically mentioning diastolic hypotension. Although it does not provide systolic blood pressure (SBP) or mean arterial pressure (MAP) directly, low diastolic pressure suggests possible hypotension, indicating a risk of septic shock. Therefore, it is aligned with the category concerning hypotension linked with sepsis, despite not directly meeting all the specified criteria for SBP or MAP.",
                "The claim mentions low diastolic blood pressure, which alone does not fully specify sepsis-associated hypotension, but it suggests potential haemodynamic instability. Sepsis-associated hypotension considers systolic blood pressure or mean arterial pressure, so the alignment is partial. However, low diastolic blood pressure can be part of the broader context suggesting haemodynamic compromise, related to this category.",
                "The claim is very vague and lacks specific clinical details or actions, such as criteria for any particular sepsis indicator or an action like ordering antibiotics or cultures. It broadly suggests the possibility of sepsis without pinpointing any particular risk factor, score, or clinical measure typically used in predictive categories. Thus, it is most loosely connected with the general suspicion of sepsis, which might lead to clinical suspicion and actions, but the alignment is quite weak.",
                "Leukocytosis, or an elevated white blood cell (WBC) count, is explicitly included in the SIRS criteria (WBC\u202f>\u202f12,000/\u00b5L). The claim's white blood cell count of 21.5 K/uL significantly exceeds the threshold, directly indicating systemic inflammation consistent with early sepsis. Therefore, the category and claim have perfect alignment.",
                "The claim of a white blood cell count of 21.5 K/uL directly correlates to one of the SIRS criteria, which is an elevated WBC count (>12,000/\u00b5L). This criterion is used to identify systemic inflammation, consistent with early signs of sepsis. Therefore, the alignment is perfect with the SIRS Positivity category.",
                "An elevated C-reactive protein (CRP) level indicates inflammation in the body and can be associated with sepsis but is not explicitly a part of the SIRS criteria. However, CRP elevation is commonly used as a marker of systemic inflammation in clinical practice, suggesting a meaningful, albeit indirect, connection to the SIRS category. Therefore, the alignment is moderate, as CRP elevation supports systemic inflammation, which is linked to early sepsis identification according to SIRS.",
                "C-reactive protein (CRP) is a marker of inflammation, which relates conceptually to systemic inflammation consistent with early sepsis. However, CRP itself is not explicitly mentioned in the SIRS criteria, which rely on vital signs and white blood cell count. Therefore, the alignment is indirect and not strongly tied to any of the specified criteria, leading to a moderate rating.",
                "The claim directly mentions the administration of a broad-spectrum antibiotic, Cefepime, which aligns perfectly with the category of early antibiotic/culture orders. This category involves the administration of broad-spectrum antibiotics as an indication of clinician suspicion of a serious infection, thus reflecting high alignment.",
                "The claim specifically mentions the use of Cefepime, which is a broad-spectrum antibiotic. Administering antibiotics like Cefepime is a direct action taken when there is clinical suspicion of a serious bacterial infection, typical for anticipating or diagnosing sepsis. This aligns perfectly with the criterion of early antibiotic orders within 2 hours, indicating strong alignment.",
                "The claim is broad and implies a holistic assessment without detailing specific factors. The elevated NEWS Score (\u22655 points) involves evaluating numerous variables predicting clinical deterioration, aligning with the multifactorial nature of this claim. The alignment is weak due to the claim's lack of specificity regarding individual factors or scores typically used to predict sepsis risk."
            ],
            "final_alignment_score": 0.6941176470588236
        },
        {
            "input": "11: Pain, 8.0; 18: HR, 114.0; 18: RR, 22.0; 18: SpO2, 95.0; 18: SBP, 101.0; 18: DBP, 62.0; 18: MAP, 75.0; 18: LPM O2, 2.0; 18: Temp, 102.2; 21: ACETAMINOPHEN, 500 MG PO TABS; 29: POC PH (V), ISTAT: 7.44; 29: POC PCO2 (V) ISTAT, 45.7 mmHg; 29: POC HCO3 (V) ISTAT, 30.9 mmol/L; 29: POC O2 SATURATION ISTAT VENOUS, 57 %; 29: POC LACTATE ISTAT, 1.00 mmol/L; 29: POC PO2 (V) ISTAT, 29 mmHg; 29: POC TCO2 (V) ISTAT, 32 mmol/L; 29: POC BASE EXCESS ISTAT, 7 mmol/L; 40: SpO2, 89.769; 40: Perf, 1.475; 40: SBP, 110.0; 40: DBP, nan; 40: MAP, nan; 41: HR, 109.95; 41: SpO2, 88.828; 41: Perf, 1.977; 41: 1min HRV, 14.576; 42: HR, 110.525; 42: SpO2, 90.525; 42: Perf, 2.646; 42: 1min HRV, 16.205; 43: HR, 109.678; 43: SpO2, 91.881; 43: Perf, 3.402; 43: 1min HRV, 21.374; 43: 5min HRV, 18.328; 44: HR, 109.672; 44: SpO2, 95.172; 44: Perf, 3.964; 44: 1min HRV, 21.182; 45: HR, 108.390; 45: SpO2, 95.153; 45: Perf, 4.616; 45: 1min HRV, 21.246; 46: HR, 108.569; 46: SpO2, 94.914; 46: Perf, 4.833; 46: 1min HRV, 17.993; 47: HR, 107.085; 47: SpO2, 95.017; 47: Perf, 5.151; 47: 1min HRV, 18.946; 48: HR, 108.356; 48: SpO2, 95.373; 48: Perf, 5.283; 48: 1min HRV, 19.931; 48: 5min HRV, 20.167; 49: HR, 107.138; 49: SpO2, 95.155; 49: Perf, 5.190; 49: 1min HRV, 17.870; 50: HR, 106.424; 50: SpO2, 96.0; 50: Perf, 5.102; 50: 1min HRV, 19.279; 51: HR, 106.241; 51: SpO2, 96.0; 51: Perf, 4.463; 51: 1min HRV, 16.673; 52: HR, 107.186; 52: SpO2, 96.068; 52: Perf, 4.564; 52: 1min HRV, 20.341; 53: HR, 105.525; 53: RR, 17.0; 53: SpO2, 96.0; 53: Perf, 5.102; 53: 1min HRV, 18.524; 53: 5min HRV, 18.733; 54: HR, 106.276; 54: SpO2, 96.0; 54: Perf, 5.207; 54: 1min HRV, 18.691; 55: HR, 108.814; 55: SpO2, 94.339; 55: Perf, 5.860; 55: 1min HRV, 19.011; 56: HR, 108.017; 56: SpO2, 93.828; 56: Perf, 5.531; 56: 1min HRV, 17.191; 57: HR, 108.102; 57: SpO2, 93.831; 57: Perf, 5.456; 57: 1min HRV, 20.965; 58: HR, 107.322; 58: SpO2, 93.627; 58: Perf, 5.796; 58: 1min HRV, 18.570; 58: 5min HRV, 19.512; 59: HR, 107.897; 59: SpO2, 93.328; 59: Perf, 5.545; 59: 1min HRV, 18.361; 60: HR, 107.508; 60: SpO2, 95.729; 60: Perf, 4.673; 60: 1min HRV, 16.617; 61: HR, 106.672; 61: SpO2, 95.310; 61: Perf, 4.716; 61: 1min HRV, 18.259; 62: HR, 106.797; 62: SpO2, 95.678; 62: Perf, 4.453; 62: 1min HRV, 17.616; 63: HR, 107.831; 63: SpO2, 96.322; 63: Perf, 3.808; 63: 1min HRV, 23.819; 63: 5min HRV, 19.307; 64: HR, 105.172; 64: SpO2, 96.0; 64: Perf, 4.299; 64: 1min HRV, 23.239; 65: HR, 106.254; 65: RR, 22.056; 65: SpO2, 95.915; 65: Perf, 4.105; 65: 1min HRV, 17.162; 66: HR, 104.517; 66: SpO2, 95.828; 66: Perf, 4.427; 66: 1min HRV, 18.875; 67: HR, 104.085; 67: SpO2, 96.0; 67: Perf, 4.424; 67: 1min HRV, 17.668; 68: HR, 105.525; 68: SpO2, 95.017; 68: Perf, 5.536; 68: 1min HRV, 17.378; 68: 5min HRV, 19.579; 69: HR, 104.914; 69: SpO2, 94.0; 69: Perf, 5.951; 69: 1min HRV, 15.239; 70: HR, 104.695; 70: SpO2, 93.797; 70: Perf, 6.006; 70: 1min HRV, 14.047; 71: HR, 104.810; 71: SpO2, 93.224; 71: Perf, 5.726; 71: 1min HRV, 12.730; 72: HR, 103.288; 72: RR, 29.375; 72: SpO2, 93.661; 72: Perf, 5.810; 72: 1min HRV, 10.750; 73: HR, 103.431; 73: RR, 14.259; 73: SpO2, 94.0; 73: Perf, 5.949; 73: 1min HRV, 15.137; 73: 5min HRV, 14.475; 74: HR, 102.508; 74: RR, 18.593; 74: SpO2, 93.576; 74: Perf, 5.645; 74: 1min HRV, 18.665; 75: HR, 104.203; 75: RR, 18.559; 75: SpO2, 94.085; 75: Perf, 5.729; 75: 1min HRV, 19.603; 76: HR, 104.931; 76: RR, 19.655; 76: SpO2, 94.828; 76: Perf, 6.026; 76: 1min HRV, 17.125; 77: HR, 102.932; 77: RR, 20.729; 77: SpO2, 95.627; 77: Perf, 5.371; 77: 1min HRV, 16.380; 78: HR, 101.224; 78: RR, 20.241; 78: SpO2, 96.0; 78: Perf, 5.247; 78: 1min HRV, 17.340; 78: 5min HRV, 19.426; 79: HR, 100.607; 79: RR, 20.898; 79: SpO2, 95.424; 79: Perf, 4.697; 79: 1min HRV, 12.174; 80: HR, 100.847; 80: RR, 21.186; 80: SpO2, 95.136; 80: Perf, 4.427; 80: 1min HRV, 16.551; 83: INFLUENZA B, Not Detected; 83: SARS-COV-2 RNA, Not Detected; 83: RSV, Not Detected; 83: INFLUENZA A, Not Detected; 83: 5min HRV, 14.374; 98: PART. THROMBOPLASTIN TIME, 37.6 seconds; 103: INR, 1.3; 103: WAM DIFTYP, AUTO; 103: PROTHROMBIN TIME, 16.4 seconds; 103: MONOCYTE ABSOLUTE (AUTO DIFF), 1.80 K/uL; 103: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.45 K/uL; 103: RED BLOOD CELLS (RBC), 2.91 MIL/uL; 103: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.14 K/uL; 103: NEUTROPHIL % (AUTO DIFF), 64.1 %; 103: LYMPHOCYTE % (AUTO DIFF), 8.7 %; 103: HEMOGLOBIN (HGB), 8.8 g/dL; 103: EOSINOPHIL % (AUTO DIFF), 15.1 %; 103: BASOPHIL % (AUTO DIFF), 0.5 %; 103: MEAN CORPUSCULAR VOLUME (MCV), 92.8 fL; 103: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 103: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.63 K/uL; 103: EOSINOPHIL ABSOLUTE (AUTO DIFF), 2.50 K/uL; 103: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.8 %; 103: NRBC PERCENT (HEMATOLOGY), 0.0 %; 103: WHITE BLOOD CELLS (WBC), 16.6 K/uL; 103: PLATELET COUNT (PLT), 637 K/uL; 103: HEMATOCRIT (HCT), 27.0 %; 103: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.2 pg; 103: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.6 g/dL; 103: MONOCYTE % (AUTO DIFF), 10.8 %; 103: RED CELL DISTRIBUTION WIDTH (RDW), 13.5 %; 103: BASOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 0: Age, 39; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, nan; 0: Triage HR, 114.0; 0: Triage RR, 22.0; 0: Triage SBP, 101.0; 0: Triage DBP, 62.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER",
            "answer": false,
            "llm_answer": "Yes",
            "llm_explanation": "The patient presents with tachycardia (HR consistently over 100), mild hypotension at triage (SBP 101 mmHg, DBP 62 mmHg), and signs of respiratory distress (high RR and fluctuating low SpO2), pointing to hemodynamic instability. The fever of 102.2\u00b0F suggests a possible infection. Blood tests show leukocytosis (WBC 16.6 K/uL) and anemia (HGB 8.8 g/dL), which can be consistent with sepsis. Given these clinical signs alongside HRV data showing decreasing variability, the patient is at high risk for sepsis within 12 hours.",
            "claims": [
                "The patient presents with tachycardia.",
                "Tachycardia is defined as a heart rate consistently over 100 beats per minute.",
                "The patient's heart rate is consistently over 100 beats per minute.",
                "The patient has mild hypotension at triage.",
                "The patient's systolic blood pressure is 101 mmHg.",
                "The patient's diastolic blood pressure is 62 mmHg.",
                "The patient shows signs of respiratory distress.",
                "The patient has a high respiratory rate.",
                "The patient's pulse oximetry readings are fluctuating low.",
                "The patient\u2019s fever is 102.2\u00b0F.",
                "A fever of 102.2\u00b0F suggests a possible infection.",
                "Blood tests show leukocytosis.",
                "The patient's white blood cell count is 16.6 K/uL.",
                "Blood tests show anemia.",
                "The patient's hemoglobin level is 8.8 g/dL.",
                "Leukocytosis can be consistent with sepsis.",
                "Anemia can be consistent with sepsis.",
                "The patient has clinical signs indicating hemodynamic instability.",
                "The HRV data shows decreasing variability.",
                "The patient is at high risk for sepsis within the next 12 hours."
            ],
            "relevant_claims": [
                "The patient presents with tachycardia.",
                "Tachycardia is defined as a heart rate consistently over 100 beats per minute.",
                "The patient's heart rate is consistently over 100 beats per minute.",
                "The patient has mild hypotension at triage.",
                "The patient's systolic blood pressure is 101 mmHg.",
                "The patient shows signs of respiratory distress.",
                "The patient has a high respiratory rate.",
                "The patient's pulse oximetry readings are fluctuating low.",
                "The patient\u2019s fever is 102.2\u00b0F.",
                "A fever of 102.2\u00b0F suggests a possible infection.",
                "Blood tests show leukocytosis.",
                "The patient's white blood cell count is 16.6 K/uL.",
                "Blood tests show anemia.",
                "The patient's hemoglobin level is 8.8 g/dL.",
                "Leukocytosis can be consistent with sepsis.",
                "Anemia can be consistent with sepsis.",
                "The patient has clinical signs indicating hemodynamic instability.",
                "The HRV data shows decreasing variability.",
                "The patient is at high risk for sepsis within the next 12 hours."
            ],
            "alignment_scores": [
                0.6,
                0.7,
                0.8,
                0.7,
                0.7,
                0.7,
                0.7,
                0.6,
                0.8,
                0.7,
                0.9,
                1.0,
                0.3,
                0.2,
                1.0,
                0.3,
                0.7,
                0.3,
                0.3
            ],
            "alignment_category": [
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
                "High qSOFA Score (\u22652)",
                "High qSOFA Score (\u22652)",
                "SIRS Positivity (\u22652 Criteria)",
                "SOFA Score Increase (\u22652 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "SOFA Score Increase (\u22652 points)",
                "SOFA Score Increase (\u22652 points)",
                "SIRS Positivity (\u22652 Criteria)",
                "SOFA Score Increase (\u22652 points)",
                "Elevated Shock Index (\u22651.0)",
                "Elevated Shock Index (\u22651.0)",
                "Elevated NEWS Score (\u22655 points)"
            ],
            "alignment_reasonings": [
                "Tachycardia, defined as a heart rate >90 bpm, is explicitly one of the criteria under SIRS positivity. While the claim identifies tachycardia, it does not mention other SIRS criteria being met, thus the alignment is partial but significant.",
                "The claim references tachycardia, which is relevant to the SIRS criteria that include a heart rate >90 bpm as a marker of systemic inflammation. Although the claim uses a threshold of 100 bpm\u2014slightly higher than the SIRS threshold\u2014the concept aligns closely with the criteria used to identify early sepsis. Hence, a moderately strong alignment is appropriate.",
                "A heart rate of over 100 beats per minute exceeds the SIRS criteria threshold (>90 bpm), indicating systemic inflammation related to early sepsis. The alignment is quite strong because the claim directly involves one of the specific criteria used to identify SIRS positivity, but it does not cover a second criterion, which would be required for a perfect match.",
                "The claim about mild hypotension is relevant to the category that notes hypotension as a risk factor for sepsis progression, particularly septic shock. However, since it mentions \"mild\" hypotension and lacks detailed blood pressure values, it does not fully align with the definitive thresholds specified by the category but is still conceptually related.",
                "The patient's systolic blood pressure of 101 mmHg is close to the threshold of \u2264100 mmHg used in the qSOFA scoring system, which is designed to identify patients at high risk of sepsis-related organ dysfunction and mortality. While it doesn't meet the exact criterion, it is very near and suggests potential hemodynamic instability, which is relevant to the category. The alignment rating reflects the proximity to the criterion, indicating meaningful relevance.",
                "Respiratory distress is relevant to the qSOFA criteria, which include a respiratory rate \u226522/min. While the claim does not specify the respiratory rate, respiratory distress suggests an increased rate, aligning well with the qSOFA parameter. However, without specific quantification, this alignment is inferred rather than explicit, leading to a strong, but not perfect, alignment rating.",
                "The claim of a high respiratory rate relates directly to one of the SIRS criteria (respiratory rate >20/min). This criterion is used to identify systemic inflammation and is consistent with early sepsis, indicating a strong but somewhat indirect alignment as only one SIRS criterion is mentioned.",
                "Fluctuating low pulse oximetry readings suggest potential issues with oxygenation, which conceptually relates to impaired lung function, a consideration within the SOFA score (PaO\u2082/FiO\u2082\u202f<\u202f300). While pulse oximetry isn\u2019t directly assessed in the SOFA score, the implication of possible hypoxia aligns with the concept of new organ dysfunction as flagged by a SOFA score increase. Thus, the alignment is indirect but still relevant.",
                "The claim refers to the patient's fever of 102.2\u00b0F, which exceeds the SIRS criterion threshold of temperature >38\u00b0C (100.4\u00b0F) and indicates systemic inflammation consistent with early sepsis. While the claim only states one of the SIRS criteria, the presence of a significant fever aligns strongly with this category. Hence, the alignment rating is high but not perfect as it alone doesn't satisfy the SIRS requirement of having two or more criteria.",
                "The fever of 102.2\u00b0F (equivalent to 39\u00b0C) exceeds the SIRS criterion for temperature (>38\u00b0C), which is used to identify systemic inflammation consistent with early sepsis. Although fever alone does not fully satisfy the SIRS definition (which requires \u22652 criteria), it strongly indicates inflammation or infection and partially aligns with the SIRS framework. Therefore, the rating reflects a significant but not complete alignment with the criteria.",
                "Leukocytosis, an elevated white blood cell count, is explicitly listed under the SIRS criteria, which are used to identify systemic inflammation consistent with early sepsis. The presence of leukocytosis strongly aligns with the SIRS category, although a single element doesn't confirm SIRS positivity by itself, as it requires the presence of two or more criteria. Therefore, while the alignment is strong based on the provided information, it's slightly less than perfect since we only have one criterion met.",
                "The claim directly references an elevated white blood cell count (16.6 K/uL), which exceeds the SIRS threshold of WBC > 12,000/\u00b5L. This is explicit for SIRS Positivity, as the elevated WBC is a clear indicator of systemic inflammation associated with early sepsis. The alignment is perfect.",
                "Anemia, indicated by a low red blood cell count, relates indirectly to the SOFA category, particularly since one component of SOFA relates to platelets and blood indicators of organ dysfunction. However, anemia itself is not specific to SOFA criteria, and the alignment is weak as anemia alone doesn't directly suggest new organ dysfunction or increased sepsis risk in the same manner specific SOFA components would.",
                "While hemoglobin is not directly part of the SOFA score components, anemia can suggest underlying organ dysfunction or physiological stress, which can be associated with sepsis risk. However, the connection is indirect and weak compared to other parameters directly mentioned in the SOFA score. Thus, the alignment is minimal.",
                "Leukocytosis, or elevated white blood cell count, is explicitly part of the SIRS criteria used to identify systemic inflammation in the context of early sepsis. The claim directly aligns with this category, indicating a perfect alignment.",
                "Anemia can be indirectly related to SOFA score components, such as reduced hemoglobin affecting organ function, but it is not specifically listed as a criterion for SOFA score calculation. The alignment is weak, as anemia might suggest underlying issues compatible with sepsis-related organ dysfunction, such as impaired oxygen transportation, without directly aligning with the SOFA score criteria.",
                "The claim mentions \"hemodynamic instability,\" which strongly suggests issues with heart rate and blood pressure, as captured by the shock index. Elevated shock index indicates hemodynamic instability and alignment with the claim is good, though not direct, since specific measurements are not provided in the claim.",
                "Decreasing heart rate variability (HRV) is generally associated with autonomic dysfunction, which can occur in states of haemodynamic instability such as shock. Although HRV is not directly listed under the criteria for Elevated Shock Index, there is a conceptual link, as both are related to circulatory function and stability. However, since the claim mentions HRV without linking it to the specific criteria of shock index (heart\u202frate\u202f\u00f7\u202fsystolic\u202fBP), the alignment is indirect and therefore weak.",
                "The claim broadly states a high risk of sepsis without specific clinical criteria or actions. Of the listed categories, an elevated NEWS score reflects general clinical deterioration, which is compatible with an increased risk of sepsis within a short timeframe like 12 hours. However, no specific details are provided to strongly link this claim to any one category, resulting in a low alignment rating."
            ],
            "final_alignment_score": 0.631578947368421
        },
        {
            "input": "4: HR, 110.0; 4: RR, 18.0; 4: SpO2, 100.0; 4: SBP, 157.0; 4: DBP, 87.0; 4: MAP, 110.333; 4: Temp, 97.0; 12: Pain, 8.0; 52: SpO2, 98.0; 53: SpO2, 94.484; 53: Perf, 0.343; 54: SpO2, 93.154; 54: Perf, 0.300; 55: SpO2, 91.959; 55: Perf, 0.278; 56: SpO2, 93.019; 56: Perf, 0.450; 57: SpO2, 96.132; 57: Perf, 0.738; 58: SpO2, 97.0; 58: Perf, 0.945; 59: SpO2, 95.849; 59: Perf, 0.823; 60: SpO2, 94.981; 60: Perf, 0.576; 61: SpO2, 96.528; 61: Perf, 0.527; 62: SpO2, 95.509; 62: Perf, 0.607; 63: SpO2, 95.346; 63: Perf, 0.519; 64: SpO2, 95.604; 64: Perf, 0.626; 65: SpO2, 95.537; 65: Perf, 0.59; 66: SpO2, 94.458; 66: Perf, 0.586; 67: SpO2, 94.265; 67: Perf, 0.579; 68: SpO2, 95.0; 68: Perf, 0.574; 69: SpO2, 95.774; 69: Perf, 0.547; 70: SpO2, 95.774; 70: Perf, 0.425; 71: SpO2, 96.192; 71: Perf, 0.397; 72: HR, 111.0; 72: SpO2, 97.226; 72: Perf, 0.378; 72: SBP, 158.0; 72: DBP, 100.0; 72: MAP, 119.333; 73: SpO2, 97.0; 73: Perf, 0.373; 73: SBP, 158.0; 73: DBP, 100.0; 73: MAP, 119.333; 74: SpO2, 96.906; 74: Perf, 0.377; 75: SpO2, 96.5; 75: Perf, 0.406; 75: Pain, 0.0; 76: SpO2, 96.192; 76: Perf, 0.429; 77: SpO2, 96.415; 77: Perf, 0.455; 78: SpO2, 96.75; 78: Perf, 0.47; 79: SpO2, 97.377; 79: Perf, 0.436; 80: SpO2, 96.0; 80: Perf, 0.454; 81: SpO2, 95.308; 81: Perf, 0.439; 82: SpO2, 97.547; 82: Perf, 0.467; 83: SpO2, 97.942; 83: Perf, 0.528; 84: HR, 108.562; 84: RR, 23.333; 84: SpO2, 97.415; 84: Perf, 0.52; 84: 1min HRV, 6.283; 84: SBP, 146.0; 84: DBP, 95.0; 84: MAP, 112.0; 85: HR, 107.315; 85: RR, 18.796; 85: SpO2, 98.148; 85: Perf, 0.52; 85: 1min HRV, 9.190; 86: HR, 107.75; 86: RR, 22.269; 86: SpO2, 98.308; 86: Perf, 0.52; 86: 1min HRV, 7.709; 87: HR, 106.396; 87: RR, 16.415; 87: SpO2, 97.094; 87: Perf, 0.487; 87: 1min HRV, 8.475; 87: 5min HRV, 9.826; 88: HR, 106.115; 88: RR, 17.192; 88: SpO2, 96.75; 88: Perf, 0.403; 88: 1min HRV, 8.518; 89: HR, 108.278; 89: RR, 20.204; 89: SpO2, 95.852; 89: Perf, 0.376; 89: 1min HRV, 7.594; 90: HR, 109.377; 90: RR, 17.302; 90: SpO2, 95.321; 90: Perf, 0.383; 90: 1min HRV, 3.874; 91: HR, 109.135; 91: RR, 17.923; 91: SpO2, 96.673; 91: Perf, 0.398; 91: 1min HRV, 6.186; 92: HR, 105.509; 92: RR, 17.604; 92: SpO2, 97.0; 92: Perf, 0.399; 92: 1min HRV, 2.008; 92: 5min HRV, 10.216; 93: HR, 107.769; 93: RR, 18.365; 93: SpO2, 97.0; 93: Perf, 0.384; 93: 1min HRV, 5.526; 94: HR, 108.642; 94: RR, 19.679; 94: SpO2, 96.396; 94: Perf, 0.349; 94: 1min HRV, 5.896; 95: HR, 107.615; 95: RR, 19.865; 95: SpO2, 96.827; 95: Perf, 0.360; 95: 1min HRV, 6.318; 96: HR, 107.811; 96: RR, 19.604; 96: SpO2, 96.887; 96: Perf, 0.342; 96: 1min HRV, 9.593; 97: HR, 107.833; 97: RR, 17.630; 97: SpO2, 96.926; 97: Perf, 0.343; 97: 1min HRV, 8.945; 97: 5min HRV, 7.989; 98: HR, 109.115; 98: RR, 16.962; 98: SpO2, 96.365; 98: Perf, 0.352; 98: 1min HRV, 4.041; 99: HR, 108.132; 99: RR, 17.679; 99: SpO2, 96.057; 99: Perf, 0.367; 99: 1min HRV, 8.423; 100: HR, 111.019; 100: RR, 15.231; 100: SpO2, 96.442; 100: Perf, 0.388; 100: 1min HRV, 3.575; 101: HR, 110.585; 101: RR, 16.189; 101: SpO2, 96.943; 101: Perf, 0.372; 101: 1min HRV, 3.269; 102: HR, 110.226; 102: RR, 14.868; 102: SpO2, 96.472; 102: Perf, 0.343; 102: 1min HRV, 7.359; 102: 5min HRV, 7.762; 103: HR, 110.192; 103: RR, 17.404; 103: SpO2, 96.904; 103: Perf, 0.35; 103: 1min HRV, 6.722; 104: HR, 110.660; 104: RR, 18.623; 104: SpO2, 96.113; 104: Perf, 0.352; 104: 1min HRV, 5.132; 105: HR, 110.288; 105: RR, 17.885; 105: SpO2, 96.5; 105: Perf, 0.466; 105: 1min HRV, 7.060; 106: HR, 111.434; 106: RR, 16.811; 106: SpO2, 98.094; 106: Perf, 0.522; 106: 1min HRV, 29.379; 107: HR, 109.887; 107: RR, 16.623; 107: SpO2, 97.943; 107: Perf, 0.512; 107: 1min HRV, 6.777; 107: 5min HRV, 14.634; 108: HR, 111.75; 108: RR, 19.442; 108: SpO2, 97.981; 108: Perf, 0.464; 108: 1min HRV, 4.427; 108: SBP, 138.0; 108: DBP, 96.0; 108: MAP, 110.0; 109: HR, 110.113; 109: RR, 16.415; 109: SpO2, 96.811; 109: Perf, 0.469; 109: 1min HRV, 4.230; 110: HR, 108.358; 110: RR, 17.170; 110: SpO2, 97.642; 110: Perf, 0.568; 110: 1min HRV, 7.919; 111: HR, 109.226; 111: RR, 17.925; 111: SpO2, 97.472; 111: Perf, 0.575; 111: 1min HRV, 4.075; 112: HR, 109.340; 112: RR, 13.604; 112: SpO2, 96.887; 112: Perf, 0.533; 112: 1min HRV, 5.584; 112: 5min HRV, 7.998; 113: HR, 109.566; 113: RR, 12.717; 113: SpO2, 97.113; 113: Perf, 0.497; 113: 1min HRV, 6.331; 113: SBP, 139.0; 113: DBP, 88.0; 113: MAP, 105.0; 114: HR, 108.962; 114: RR, 18.830; 114: SpO2, 97.415; 114: Perf, 0.552; 114: 1min HRV, 10.085; 115: LACTATE.WHOLE BLD, 1.6 mmol/L; 115: HR, 109.115; 115: RR, 22.096; 115: SpO2, 94.069; 115: Perf, 0.574; 115: 1min HRV, 5.739; 116: HR, 109.038; 116: RR, 20.528; 116: SpO2, 95.778; 116: 1min HRV, 3.933; 117: HR, 109.774; 117: RR, 19.698; 117: 1min HRV, 5.480; 117: 5min HRV, 6.848; 118: HR, 109.154; 118: RR, 22.981; 118: 1min HRV, 4.851; 119: HR, 110.434; 119: RR, 22.302; 119: 1min HRV, 4.683; 0: Age, 59; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.1; 0: Triage HR, 110.0; 0: Triage RR, 18.0; 0: Triage SBP, 157.0; 0: Triage DBP, 87.0; 0: Triage acuity, 3-Urgent; 0: CC, MALE GENITAL PROBLEM,SHORTNESS OF BREATH",
            "answer": false,
            "llm_answer": "No",
            "llm_explanation": "Although the patient has elevated heart rate (HR) and respiratory rate (RR), which can be signs associated with sepsis, other key indicators such as blood pressure and oxygen saturation remain stable. The lactate level is 1.6 mmol/L, which is within the normal range, indicating no significant tissue hypoperfusion. The patient\u2019s condition does not present critical abnormalities like hypotension or marked signs of organ dysfunction within the 12-hour window, suggesting a low risk for sepsis.",
            "claims": [
                "The patient has an elevated heart rate (HR).",
                "An elevated heart rate (HR) can be a sign associated with sepsis.",
                "The patient has an elevated respiratory rate (RR).",
                "An elevated respiratory rate (RR) can be a sign associated with sepsis.",
                "Blood pressure remains stable for the patient.",
                "Oxygen saturation remains stable for the patient.",
                "The lactate level is 1.6 mmol/L.",
                "A lactate level of 1.6 mmol/L is within the normal range.",
                "A lactate level within the normal range indicates no significant tissue hypoperfusion.",
                "The patient\u2019s condition does not present critical abnormalities like hypotension.",
                "The patient does not present marked signs of organ dysfunction within the 12-hour window.",
                "The absence of critical abnormalities and marked signs of organ dysfunction suggests a low risk for sepsis."
            ],
            "relevant_claims": [
                "The patient has an elevated heart rate (HR).",
                "The patient has an elevated respiratory rate (RR).",
                "An elevated respiratory rate (RR) can be a sign associated with sepsis.",
                "The lactate level is 1.6 mmol/L."
            ],
            "alignment_scores": [
                0.3,
                0.8,
                0.8,
                0.2
            ],
            "alignment_category": [
                "Elevated Shock Index (\u22651.0)",
                "SIRS Positivity (\u22652 Criteria)",
                "SIRS Positivity (\u22652 Criteria)",
                "Elevated Serum Lactate (\u22652 mmol/L)"
            ],
            "alignment_reasonings": [
                "The claim highlights an elevated heart rate, which is a component of the Shock Index calculation (heart rate \u00f7 systolic BP). While the claim does not provide information about blood pressure to assess the full Shock Index, an elevated heart rate suggests concern for hemodynamic instability and potential sepsis. This makes the alignment indirect and partial.",
                "An elevated respiratory rate is one of the criteria listed under SIRS, indicating systemic inflammation consistent with early sepsis. Since the claim directly references an elevated respiratory rate, it aligns well with this category, although additional information (such as the exact RR value) is needed for perfect alignment.",
                "An elevated respiratory rate is explicitly one of the criteria for SIRS (respiratory rate\u202f>\u202f20/min), which identifies systemic inflammation consistent with early sepsis. However, without specific values or additional SIRS criteria mentioned, the alignment isn't perfect but strongly relevant.",
                "The claim addresses lactate levels, which directly relate to the Elevated Serum Lactate category. However, a lactate level of 1.6 mmol/L does not meet the threshold of \u22652 mmol/L that significantly indicates tissue hypoperfusion and elevated sepsis risk. Thus, the alignment is weak."
            ],
            "final_alignment_score": 0.525
        }
    ]
}